data_2e5o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e5o _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.57 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.4 m95 -82.48 161.62 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.748 0.309 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.6 t -138.12 130.18 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.9 tp -118.56 114.33 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.0 t -67.91 150.03 49.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 32.3 t -133.29 156.75 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.475 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 41.7 m-70 -90.73 115.38 27.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.491 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 65.9 mt-30 -61.66 160.82 24.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.962 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.83 -31.86 4.31 Favored 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.718 -1.784 . . . . 0.0 112.297 0.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.542 ' C ' ' O ' ' A' ' 15' ' ' PRO . 13.2 m-90 -25.47 -53.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -37.51 -61.3 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 7.2 m -64.88 -42.82 94.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.7 mt -51.77 -31.12 25.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 5.5 mp -66.27 -64.28 0.89 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.9 m -63.99 -16.39 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -76.87 -39.52 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.808 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 18.7 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.515 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.49 -42.1 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 17.3 tptt -99.05 104.54 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -97.87 17.34 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 27.4 m -149.38 147.1 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 3.5 tm-20 -118.62 141.81 48.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.516 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -102.89 126.82 8.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 12.6 mmt180 -148.42 146.37 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.472 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 10.4 m -84.25 20.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.563 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.3 p-90 -144.63 166.43 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -107.75 140.43 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.54 HG21 ' CE2' ' A' ' 112' ' ' PHE . 5.1 t -134.08 106.45 11.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.59 0.709 . . . . 0.0 111.128 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.3 Cg_endo -69.8 3.07 3.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.308 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -63.13 111.74 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 7.7 mmt85 -116.1 121.79 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.65 -126.69 2.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.522 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -98.62 138.36 35.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.833 0.349 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 tp -143.93 112.86 6.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.579 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 86.2 m95 -71.34 133.86 46.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -104.1 126.84 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.54 145.57 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.64 117.06 22.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.3 p -53.21 176.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.86 -11.38 59.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 5.7 ttpt -73.06 146.53 45.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -104.08 134.08 19.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 0.0 110.91 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.75 127.26 14.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.623 2.215 . . . . 0.0 112.364 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.9 m -73.23 155.59 89.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.648 0.737 . . . . 0.0 110.871 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -5.33 15.9 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.713 2.275 . . . . 0.0 112.309 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.48 -39.83 10.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.38 -39.13 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.9 t -66.3 -54.74 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.119 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 t -59.09 -43.78 91.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.16 -56.43 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.2 mt -54.94 -39.6 69.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.1 mt-30 -55.44 -45.76 76.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.0 -33.81 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -63.44 -51.17 66.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -68.55 -35.81 77.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' A' ' 67' ' ' LYS . 35.5 mtt-85 -50.96 -34.13 27.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.64 -13.2 34.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.453 HD12 ' NE2' ' A' ' 104' ' ' GLN . 73.5 mt -90.55 -29.24 17.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.7 mmm180 -121.47 -28.71 4.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.514 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 134.01 126.66 2.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.434 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 13.6 ptmt -45.98 -19.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.313 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -82.27 19.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 21.2 m -67.24 -178.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -114.96 162.81 16.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 47.9 m-85 -157.61 134.94 6.89 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 22' ' ' ARG . 54.3 Cg_endo -69.79 162.54 41.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 0.0 112.343 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -82.19 -29.27 31.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -147.35 175.19 10.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.604 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 51.7 m-85 -134.96 95.68 15.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.651 0.739 . . . . 0.0 110.966 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.411 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.76 177.02 6.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.357 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.5 p -147.22 138.38 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 43.78 47.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 64.8 m -156.36 149.74 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.19 118.21 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -84.5 -73.95 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.97 -144.29 4.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.579 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.9 p -153.32 155.41 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.408 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 26.2 m -140.97 136.41 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -77.85 110.43 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 tt -75.0 101.85 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.45 HD11 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -72.99 -47.12 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -164.53 167.09 19.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.401 ' SG ' ' CD1' ' A' ' 112' ' ' PHE . 1.2 t -127.74 97.46 4.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.485 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.8 mt -90.51 170.66 10.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.41 ' C ' ' N ' ' A' ' 93' ' ' LYS . 7.5 p -108.14 169.22 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 108' ' ' SER . 14.2 mm-40 -45.11 -21.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.41 ' N ' ' C ' ' A' ' 91' ' ' SER . 24.2 tttt -92.02 -63.54 1.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -61.38 -48.47 81.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.567 ' CD2' HG23 ' A' ' 111' ' ' VAL . 21.8 t80 -42.38 -57.81 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 9.7 ptpt -67.79 -43.59 79.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -48.36 -58.6 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.471 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.4 mt-30 -79.39 -47.16 16.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.3 m-85 -110.24 67.82 0.49 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.626 0.727 . . . . 0.0 110.846 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.6 Cg_endo -69.81 -12.4 32.73 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -77.84 -20.94 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.538 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 2.1 pt -126.46 23.51 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.459 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 40.7 p -64.16 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.56 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -94.35 -30.02 14.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.56 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 30.0 mt-10 -45.51 -36.24 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 t -122.97 153.89 39.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.439 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 16.4 t70 -119.48 -30.55 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.472 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -47.35 161.04 0.33 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 110.825 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.472 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.7 Cg_endo -69.7 -37.88 8.7 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.7 2.267 . . . . 0.0 112.374 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -118.74 102.81 9.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 95' ' ' PHE . 29.3 t -86.62 132.25 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.164 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 34' ' ' THR . 3.9 m-30 -99.63 105.21 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.81 122.56 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.45 ' CA ' HD11 ' A' ' 87' ' ' ILE . 2.1 m -125.71 154.44 42.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -141.9 175.2 9.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.44 53.2 8.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.646 0.736 . . . . 0.0 110.87 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.8 116.89 4.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.314 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -130.38 131.77 45.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.97 121.69 39.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.0 mtp -62.77 149.2 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.91 -35.75 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.33 134.16 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -102.43 149.49 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.454 ' CD2' HD12 ' A' ' 139' ' ' ILE . 0.8 OUTLIER -116.27 142.49 29.45 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.652 0.739 . . . . 0.0 110.857 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.413 ' C ' HD13 ' A' ' 126' ' ' ILE . 2.8 pp -125.69 164.36 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.598 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 40.6 mttp -105.23 139.18 40.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.03 172.81 37.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -154.17 153.57 28.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 1.75 4.15 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.354 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.563 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.2 mmmm -137.72 -174.95 3.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.57 HG22 ' CE3' ' A' ' 8' ' ' TRP . 75.5 mt -86.08 134.27 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.598 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.5 p-90 -140.64 130.71 24.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -57.94 128.04 35.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.554 HD11 ' CD1' ' A' ' 41' ' ' TRP . 29.3 mt -62.6 170.83 2.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.9 t0 -82.05 129.14 34.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -35.41 -49.5 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.84 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -65.3 -39.76 92.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 26.9 mm -64.75 -47.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.37 -61.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 142' ' ' GLY . 38.2 mt-30 -54.37 -69.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.55 -49.68 1.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.466 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . . . -55.99 -44.27 78.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.7 mtpp -65.07 -22.88 67.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -84.46 -40.72 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -53.35 -14.77 3.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.889 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.552 ' CZ2' ' HE3' ' A' ' 134' ' ' LYS . 92.5 m95 -84.56 163.58 19.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 133' ' ' TRP . 13.5 p -139.65 156.68 46.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -138.57 113.76 9.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 p -68.39 138.09 55.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 29.6 t -124.22 152.16 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 35.8 m-70 -87.4 114.89 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 57.9 mt-30 -60.58 161.44 14.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.77 -29.17 5.86 Favored 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.322 -0.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.512 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.6 m-90 -28.53 -49.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -37.77 -64.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 -42.1 99.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.2 mt -49.82 -35.33 22.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.476 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.2 mp -61.92 -64.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 22' ' ' ARG . 10.2 m -64.07 -22.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.484 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.4 mmt180 -69.32 -39.47 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.1 22.19 3.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.485 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.22 -44.62 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.466 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 13.8 tptt -95.01 101.25 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.428 ' C ' HG12 ' A' ' 27' ' ' VAL . 17.2 ptt180 -96.85 17.2 17.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 32.7 m -149.02 150.37 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.44 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.8 122.18 7.42 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.447 ' N ' ' CB ' ' A' ' 108' ' ' SER . 16.4 mmt180 -147.8 150.09 33.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.463 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 80.0 p -86.13 21.28 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.506 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 5.7 p-90 -142.19 157.53 44.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.447 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 4.9 t80 -100.73 141.43 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.561 HG23 ' CE2' ' A' ' 112' ' ' PHE . 9.4 t -134.84 101.04 11.79 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 4.53 2.16 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.664 2.243 . . . . 0.0 112.337 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -65.9 110.55 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -113.95 120.44 40.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.08 -120.48 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -106.06 140.68 38.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.891 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -144.19 114.7 7.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 95.6 m95 -72.37 132.25 43.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.1 mm -101.03 128.61 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.23 152.63 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.64 118.74 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -55.29 175.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.76 -18.32 60.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.061 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 7.9 ttpt -68.88 148.43 50.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.3 135.27 19.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 53.9 Cg_endo -69.75 127.98 15.38 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.342 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m -73.86 159.62 83.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.623 0.725 . . . . 0.0 110.883 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -6.75 19.34 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.37 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.63 -42.06 8.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.954 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.55 -42.72 86.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 ' NE2' ' A' ' 58' ' ' GLN . 27.7 t -66.34 -52.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -59.77 -45.23 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.41 -56.65 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.4 mt -53.96 -43.05 69.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 7.8 mt-30 -49.88 -46.56 51.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.57 -38.89 39.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -56.86 -52.06 66.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -68.98 -40.17 78.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.453 ' NH1' ' O ' ' A' ' 67' ' ' LYS . 44.7 mtt-85 -48.69 -35.17 13.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.2 mt -88.87 -14.75 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.3 mt -89.44 -28.12 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.405 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.8 mmm180 -121.91 -29.18 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 130.83 127.32 2.87 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.453 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -44.63 -21.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 66' ' ' GLY . 14.2 t0 -74.1 7.95 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.806 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 27.1 m -62.45 -178.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 2.4 mm-40 -117.0 172.42 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 56.7 m-85 -164.32 135.61 3.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.62 0.724 . . . . 0.0 110.939 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.82 161.77 44.66 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.296 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -83.73 -26.94 29.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -148.88 173.55 13.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.5 m-85 -134.69 95.38 15.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.687 0.756 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.2 Cg_endo -69.79 -178.21 2.25 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.6 m -149.93 139.05 21.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.52 44.6 63.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 19.6 m -156.68 149.06 23.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -74.81 118.37 17.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.47 ' N ' HD23 ' A' ' 80' ' ' LEU . 63.5 mt -83.07 -73.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.33 -141.02 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.498 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -151.92 166.87 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.42 HG13 ' C ' ' A' ' 83' ' ' CYS . 21.7 m -154.07 149.37 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -95.38 109.2 21.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -72.82 96.88 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.474 HD13 ' CG ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -66.7 -48.44 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.95 167.45 22.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.4 t -127.67 98.2 5.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.499 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 98.1 mt -94.45 166.71 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 93' ' ' LYS . 9.6 t -106.73 166.29 10.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 108' ' ' SER . 19.7 mm-40 -42.06 -23.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 91' ' ' SER . 24.9 ttmt -86.61 -63.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -66.09 -49.97 65.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.56 ' CD2' HG21 ' A' ' 111' ' ' VAL . 37.9 t80 -42.03 -56.78 2.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -67.16 -41.33 86.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.1 -59.18 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.461 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -77.2 -48.36 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 30.8 m-85 -111.1 66.26 0.55 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.73 -12.73 33.56 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.91 -24.12 55.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.436 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 2.3 pt -120.49 17.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.437 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 27.2 p -58.05 -24.96 60.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.814 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.604 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -91.26 -31.95 15.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.947 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.604 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 27.2 mt-10 -43.37 -37.1 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 t -125.96 146.92 49.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -33.77 6.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.5 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.8 m -45.12 161.62 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 0.0 110.867 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.463 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.2 Cg_endo -69.71 -48.8 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.353 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 18.4 m-85 -105.62 102.9 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 95' ' ' PHE . 20.1 t -86.2 137.3 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CE2' HG23 ' A' ' 34' ' ' THR . 11.1 m-30 -103.39 107.54 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.69 117.48 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.125 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -118.49 151.13 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.474 ' CG ' HD13 ' A' ' 87' ' ' ILE . 12.7 mmmt -143.1 175.62 9.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 52.09 52.34 11.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 0.0 110.915 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.0 Cg_endo -69.68 120.18 7.02 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.312 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -129.21 132.25 47.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -97.07 122.46 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.466 ' HE3' ' CE2' ' A' ' 124' ' ' PHE . 16.4 mtp -65.63 143.05 57.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.56 -24.73 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.01 138.73 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -106.79 149.08 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.466 ' CE2' ' HE3' ' A' ' 120' ' ' MET . 1.1 m-85 -116.84 142.32 29.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 86.76 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.276 . . . . 0.0 112.334 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.39 168.13 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.608 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 7.4 mtmp? -109.42 142.31 40.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.26 163.32 14.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -141.79 161.92 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 1.8 4.1 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.306 . . . . 0.0 112.317 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.1 mmmm -137.78 -175.08 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.487 HG23 ' CE3' ' A' ' 8' ' ' TRP . 97.1 mt -83.77 134.86 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.608 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 11.0 p-90 -140.75 127.34 20.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.97 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.552 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 9.7 ttmt -54.41 130.79 40.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.579 HD11 ' CD1' ' A' ' 41' ' ' TRP . 20.5 mt -66.4 176.37 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.9 t0 -86.18 126.03 33.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.23 -41.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -72.1 -43.23 65.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.497 ' N ' ' O ' ' A' ' 136' ' ' ASP . 30.0 mm -62.97 -43.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -40.25 -67.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 142' ' ' GLY . 70.1 mt-30 -49.03 -69.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.15 -46.57 0.98 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.44 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.67 -47.58 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -60.44 -25.18 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -85.58 -39.49 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.95 -8.85 6.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.482 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.954 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.518 ' CE3' HG21 ' A' ' 132' ' ' ILE . 92.0 m95 -72.52 163.29 28.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 t -136.4 129.91 31.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.454 ' CB ' HD21 ' A' ' 40' ' ' LEU . 60.3 tp -116.87 113.49 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.64 150.95 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 13' ' ' HIS . 94.1 t -138.18 146.46 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.082 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.477 ' N ' HG13 ' A' ' 12' ' ' VAL . 35.6 m-70 -82.01 119.75 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 56.5 mt-30 -64.63 162.28 36.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.589 0.709 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.78 -30.9 4.89 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.354 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.551 ' C ' ' O ' ' A' ' 15' ' ' PRO . 12.9 m-90 -25.08 -55.93 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -34.5 -61.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 4.7 m -64.61 -40.11 94.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.8 mt -54.23 -30.81 51.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -65.15 -65.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.44 HG21 ' CD ' ' A' ' 119' ' ' GLU . 5.4 m -63.31 -17.95 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -74.93 -39.28 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.77 20.07 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -107.09 -44.01 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -97.32 113.83 25.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.421 ' C ' HG12 ' A' ' 27' ' ' VAL . 11.3 ptm180 -109.84 19.84 18.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.8 m -152.54 145.2 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.65 142.17 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.406 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -106.48 126.07 8.36 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.453 ' N ' ' CB ' ' A' ' 108' ' ' SER . 33.1 mmt180 -150.0 150.47 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 110.836 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.468 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 8.8 m -84.66 25.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.513 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -147.47 162.98 37.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -104.64 141.53 36.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.486 HG22 ' CE2' ' A' ' 112' ' ' PHE . 10.3 t -134.37 99.11 13.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 0.0 111.191 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.438 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.6 Cg_endo -69.83 4.93 1.93 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -65.49 112.89 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 6.3 mmt85 -113.29 122.95 48.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.37 -129.49 2.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -99.15 140.03 33.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.454 HD21 ' CB ' ' A' ' 10' ' ' LEU . 24.5 tp -144.17 112.57 6.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.582 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 83.2 m95 -70.93 128.83 37.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.77 123.75 53.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.18 148.52 41.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.075 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.78 120.52 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.432 HG22 ' C ' ' A' ' 12' ' ' VAL . 73.2 p -55.73 169.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.79 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.3 ttpt -65.86 147.97 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -105.4 134.32 19.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.593 0.711 . . . . 0.0 110.894 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.73 126.63 13.56 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.33 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 m -72.22 158.91 86.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.725 . . . . 0.0 110.875 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.01 22.52 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.632 2.221 . . . . 0.0 112.351 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 52' ' ' GLN . 8.1 mm100 -94.4 -36.26 11.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.48 -41.2 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.45 HG11 ' NE2' ' A' ' 58' ' ' GLN . 34.7 t -68.15 -45.99 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.5 t -66.88 -42.87 84.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.19 -52.8 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.59 -41.11 85.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 9.3 mt-30 -53.06 -47.56 68.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -36.99 50.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 m -59.97 -51.68 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.169 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -69.26 -37.46 77.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 66' ' ' GLY . 53.9 mtt180 -48.81 -33.44 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.7 mt -90.83 -15.91 29.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.463 HD13 ' NE2' ' A' ' 104' ' ' GLN . 71.8 mt -87.25 -29.69 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -120.81 -29.13 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.62 126.35 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -44.8 -20.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -80.85 17.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 20.4 m -66.12 -178.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.8 162.97 15.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.572 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 44.4 m-85 -157.94 133.16 5.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.53 30.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -85.49 -29.21 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -146.78 173.21 12.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.645 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.71 96.2 15.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.698 0.761 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.423 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.71 172.7 12.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.264 . . . . 0.0 112.343 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.5 p -138.86 139.23 38.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.12 52.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 58.7 m -158.52 149.21 20.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.43 120.74 23.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.451 ' C ' ' OE1' ' A' ' 119' ' ' GLU . 35.9 mt -89.33 -71.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.422 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.33 -145.97 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.493 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.582 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.5 p -152.99 157.48 40.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.897 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.4 m -140.9 144.32 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -85.81 113.7 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.59 100.01 5.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.411 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.37 -48.07 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -163.09 167.26 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.77 101.19 6.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.49 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.8 mt -96.01 169.41 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' PHE . 13.2 p -108.36 169.12 8.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.839 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 108' ' ' SER . 21.8 mm-40 -47.25 -19.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 91' ' ' SER . 15.0 ttmm -90.35 -59.11 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -70.85 -50.13 38.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CD2' HG23 ' A' ' 111' ' ' VAL . 27.5 t80 -41.51 -54.85 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -67.52 -40.77 85.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.42 -58.72 6.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -75.67 -49.95 16.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.2 m-85 -109.85 68.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.656 0.741 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.75 -13.4 34.65 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -76.92 -24.68 52.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.496 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.1 pt -120.18 23.48 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 p -64.39 -27.15 68.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -90.33 -28.76 18.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.594 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 18.0 mt-10 -45.71 -39.38 7.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.937 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.4 t -124.64 147.95 48.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 7.3 t0 -110.99 -33.87 6.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.453 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 1.7 m -42.81 161.52 0.18 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 0.0 110.857 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.468 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.77 -45.49 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.692 2.262 . . . . 0.0 112.309 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -110.59 104.95 13.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.568 HG23 ' CD2' ' A' ' 95' ' ' PHE . 21.4 t -90.33 133.61 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 2.2 m-30 -100.86 109.73 21.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.36 121.94 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -124.56 154.04 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -141.4 175.8 9.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.97 52.41 5.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.651 0.739 . . . . 0.0 110.902 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.78 114.94 3.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.254 . . . . 0.0 112.318 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -130.08 145.31 51.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.451 ' OE1' ' C ' ' A' ' 81' ' ' LEU . 3.7 tp10 -107.14 123.56 48.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.426 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 12.8 mtp -63.13 149.26 45.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.39 -23.46 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.3 p -130.09 149.95 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 20.2 mmtm -117.35 151.81 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -120.43 141.68 32.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.656 0.741 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 86.5 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.73 165.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.617 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 48.8 mttp -101.59 143.17 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -87.44 -177.13 48.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 20.6 t-20 -170.52 142.45 1.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.632 0.729 . . . . 0.0 110.862 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.2 Cg_endo -69.74 9.76 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.685 2.257 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASN . 9.8 mmmm -141.44 -174.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.518 HG21 ' CE3' ' A' ' 8' ' ' TRP . 54.2 mt -88.6 132.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.617 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.0 p-90 -139.32 127.54 22.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.24 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.558 HD12 ' CD1' ' A' ' 41' ' ' TRP . 25.5 mt -61.0 172.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.45 152.65 30.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -58.9 -39.57 81.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -78.37 -38.09 42.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.3 mm -68.44 -36.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -49.07 -65.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 142' ' ' GLY . 47.5 mt-30 -48.51 -67.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.13 -52.65 1.25 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.575 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.0 -42.03 65.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.141 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 141' ' ' GLN . 9.8 mtpt -69.8 -17.86 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -90.17 -44.42 9.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.71 -19.69 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.6 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.553 ' CE3' HG21 ' A' ' 132' ' ' ILE . 91.5 m95 -77.42 161.76 27.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.762 0.315 . . . . 0.0 110.889 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.1 t -138.22 133.44 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.417 HD23 ' CD ' ' A' ' 28' ' ' GLU . 62.6 tp -121.16 114.24 21.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -67.92 154.67 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 37.2 t -137.08 155.95 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.461 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 35.3 m-70 -88.53 113.51 24.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 63.1 mt-30 -60.61 161.1 15.53 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.655 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.8 -30.13 5.32 Favored 'Cis proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 -1.819 . . . . 0.0 112.35 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.56 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 11.0 m-90 -27.63 -52.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.476 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -34.64 -62.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 m -64.98 -45.93 83.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -45.57 -30.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.0 mp -68.55 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 82' ' ' GLY . 15.9 m -61.11 -13.9 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.418 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -81.26 -39.46 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.04 -19.93 5.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -64.85 -60.32 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 111.174 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' CD ' ' OH ' ' A' ' 61' ' ' TYR . 7.5 tptp -83.34 120.97 26.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.423 ' C ' HG13 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -113.22 11.72 18.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 33.6 m -142.52 156.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.499 ' OE2' ' CG2' ' A' ' 12' ' ' VAL . 3.2 tt0 -120.9 138.11 54.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.457 ' O ' ' NH1' ' A' ' 30' ' ' ARG . . . -102.64 123.62 7.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 75.9 mmt-85 -149.16 151.15 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.845 0.355 . . . . 0.0 110.849 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.466 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.3 m -87.6 18.67 3.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.555 ' CZ2' ' HD2' ' A' ' 30' ' ' ARG . 6.4 p-90 -142.36 161.39 38.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.6 t80 -102.56 147.97 26.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.577 HG21 ' CE2' ' A' ' 112' ' ' PHE . 5.2 t -140.62 106.97 6.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 0.0 111.172 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.95 3.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.363 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -64.53 114.87 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -119.65 120.41 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.06 -122.58 1.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -105.09 139.49 39.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.877 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 tp -143.67 114.02 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.579 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 87.6 m95 -72.1 128.69 36.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -98.71 132.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.118 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.35 155.87 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.81 119.13 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -56.27 173.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.83 63.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 5.9 ttpt -65.37 146.4 54.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.19 135.49 19.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.577 0.703 . . . . 0.0 110.863 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.76 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.662 2.241 . . . . 0.0 112.354 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -71.55 159.63 84.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.696 0.76 . . . . 0.0 110.828 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -9.95 27.33 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 0.0 112.349 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -94.4 -37.97 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.72 -39.49 70.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.465 HG12 ' NE2' ' A' ' 58' ' ' GLN . 41.6 t -67.76 -46.32 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.15 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -67.4 -42.11 83.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.94 -48.96 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.56 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 83.5 mt -62.46 -40.85 97.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 9.3 mt-30 -54.81 -44.6 73.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.81 -34.82 30.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -62.04 -51.75 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.443 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 14.9 m-85 -67.5 -40.37 85.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.938 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.487 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 51.8 mtt180 -47.03 -35.93 7.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.08 -17.97 31.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' TYR . 60.2 mt -86.01 -26.8 25.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -123.69 -27.72 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 128.28 129.87 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -46.84 -18.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -72.73 3.61 4.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.526 HG22 ' CE2' ' A' ' 71' ' ' PHE . 34.3 m -62.02 179.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 12.1 pt-20 -122.93 173.77 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 72.9 m-85 -161.82 138.43 6.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.595 0.712 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 156.12 64.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.636 2.224 . . . . 0.0 112.337 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -72.91 -31.28 64.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -146.74 176.84 9.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.7 94.93 16.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 0.0 110.936 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.419 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 54.0 Cg_endo -69.74 173.99 10.14 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.2 p -142.59 135.49 28.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' ' SG ' ' A' ' 79' ' ' CYS . . . 72.86 50.09 14.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 78' ' ' GLY . 23.5 m -161.24 148.47 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 0.0 110.882 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -75.39 118.19 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' N ' HD22 ' A' ' 80' ' ' LEU . 40.3 mt -85.62 -70.94 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.402 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -147.36 -145.08 4.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.482 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.579 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 4.2 p -154.32 155.27 34.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 20.0 m -141.41 137.32 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.83 112.63 16.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tt -77.81 101.83 6.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.411 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.94 -47.33 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -163.44 169.0 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.4 t -127.4 100.83 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.483 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.7 mt -94.94 170.84 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 93' ' ' LYS . 32.8 t -110.9 169.04 9.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.445 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 18.6 mm-40 -45.83 -20.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.411 ' N ' ' C ' ' A' ' 91' ' ' SER . 32.7 ttpt -89.35 -60.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -68.9 -50.55 48.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.483 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 39.4 t80 -39.11 -55.66 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 7.0 ptmm? -68.59 -47.92 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.51 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.5 mt-10 -46.79 -58.57 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.438 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -76.56 -51.47 11.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 37.9 m-85 -110.03 67.81 0.47 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 110.916 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.74 -14.7 36.51 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.349 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.4 -23.31 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pt -121.38 15.27 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.3 p -55.96 -18.52 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.89 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.575 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -98.27 -31.6 11.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 10.8 mt-10 -46.14 -27.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -134.4 145.72 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -111.02 -35.3 5.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -42.34 161.72 0.16 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.702 0.763 . . . . 0.0 110.833 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.466 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.78 -48.92 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -106.56 103.63 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.475 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 26.2 t -88.95 136.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.577 ' CE2' HG21 ' A' ' 34' ' ' THR . 5.0 m-30 -102.33 108.47 19.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.57 120.46 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.445 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.2 m -124.87 154.09 41.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.21 175.99 9.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.449 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.22 54.17 9.64 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.855 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 116.99 4.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.656 2.237 . . . . 0.0 112.331 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -127.8 137.79 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -103.73 118.55 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.9 mtp -62.75 139.03 58.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.4 t -65.86 -30.83 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.47 143.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -111.68 151.89 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -118.36 141.04 28.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 82.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.11 166.69 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.592 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 34.3 mtpt -108.95 159.99 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.23 177.6 16.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -154.56 163.16 25.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 0.0 110.885 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 129' ' ' ASN . 53.5 Cg_endo -69.74 19.66 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.357 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.555 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.8 mmmm -152.82 -175.03 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.553 HG21 ' CE3' ' A' ' 8' ' ' TRP . 60.0 mt -84.33 131.75 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.592 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.1 p-90 -131.88 139.76 48.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -70.81 127.09 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 41' ' ' TRP . 22.3 mt -65.09 164.18 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.8 t0 -75.65 129.5 37.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -37.25 -47.76 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -66.77 -37.01 83.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 136' ' ' ASP . 11.9 mm -67.3 -48.1 79.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 139' ' ' ILE . 15.0 t-160 -37.09 -64.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.831 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 142' ' ' GLY . 36.1 mt-30 -51.37 -69.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.84 -49.48 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.421 ' HB1' ' CZ2' ' A' ' 41' ' ' TRP . . . -56.48 -45.02 81.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.8 mtpp -64.61 -23.34 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.52 -38.0 16.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -61.35 -6.64 8.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 -179.9 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.415 ' CH2' ' HE3' ' A' ' 134' ' ' LYS . 91.7 m95 -78.11 164.35 25.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t -137.12 144.84 43.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.7 tp -130.94 114.66 15.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.3 p -70.42 133.35 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 53.4 t -118.89 153.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.427 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 34.4 m-70 -88.49 113.0 23.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 78.5 mt-30 -59.76 160.01 16.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.614 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.76 -32.09 4.14 Favored 'Cis proline' 0 C--N 1.342 0.212 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.322 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.551 ' C ' ' O ' ' A' ' 15' ' ' PRO . 10.7 m-90 -25.12 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -37.76 -64.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.074 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.9 m -62.45 -42.43 99.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.0 mt -50.34 -37.64 37.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -58.96 -66.81 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.41 -27.12 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 11.0 mmt180 -66.86 -39.5 87.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.11 15.19 5.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.24 -41.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.8 tptp -99.64 100.87 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -93.41 16.11 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.409 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 27.8 m -149.04 145.85 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 2.8 tm-20 -114.23 142.11 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -103.13 128.42 9.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.1 mmt180 -151.59 146.63 25.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -85.08 17.96 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.561 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.8 p-90 -141.44 165.36 27.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.29 141.39 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.404 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.0 t -135.99 104.73 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 0.0 111.169 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.8 Cg_endo -69.77 4.3 2.28 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -64.85 111.82 2.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -115.55 119.99 37.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.84 -129.6 2.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.1 ttm-85 -96.5 139.41 32.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.88 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.4 tp -144.08 111.44 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 91.1 m95 -71.25 127.91 34.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -98.65 129.5 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.71 150.0 48.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.38 118.66 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.0 p -55.07 178.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.61 -14.07 60.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.1 ttpt -70.55 147.23 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.427 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -103.79 134.08 19.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.612 0.72 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 127.11 14.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.699 2.266 . . . . 0.0 112.358 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.4 m -72.61 155.05 91.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -7.21 20.45 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -94.55 -40.16 10.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -38.13 73.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.474 HG11 ' NE2' ' A' ' 58' ' ' GLN . 58.1 t -66.28 -50.2 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.129 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -64.27 -44.48 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.38 -49.73 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.527 HD13 ' CZ2' ' A' ' 16' ' ' TRP . 82.1 mt -62.72 -43.05 99.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 8.8 mt-30 -53.6 -43.4 68.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.4 29.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 m -62.38 -52.76 62.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.152 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -66.29 -38.49 87.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.445 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 66.5 mtt180 -49.81 -36.63 27.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.75 -12.76 44.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.505 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 69.0 mt -91.14 -28.04 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.505 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.7 mmp_? -123.64 -22.12 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.51 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 123.67 130.04 3.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -47.89 -18.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.73 0.3 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 1.4 6.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 34.9 m -59.29 179.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -120.07 166.96 12.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 55.6 m-85 -158.31 134.77 6.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.597 0.713 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.71 163.06 39.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.272 . . . . 0.0 112.357 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -83.01 -29.16 29.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.66 173.5 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.614 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 42.3 m-85 -134.79 98.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 110.901 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.7 Cg_endo -69.76 176.4 6.82 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -143.96 133.54 23.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.57 47.86 19.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.1 m -157.81 149.17 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -77.98 115.45 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.957 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.433 ' N ' HD22 ' A' ' 80' ' ' LEU . 69.8 mt -82.12 -72.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.1 -147.2 4.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.481 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.576 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 10.5 p -152.84 153.33 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 21.1 m -139.28 143.19 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.13 112.85 20.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tt -76.98 100.16 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.428 HD11 ' C ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -69.72 -46.83 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -165.44 167.54 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.45 99.25 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.502 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 99.1 mt -95.07 165.73 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 93' ' ' LYS . 17.7 t -103.92 169.03 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -41.12 -24.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' SER . 32.2 ttpt -87.32 -70.15 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.625 ' NE2' HE21 ' A' ' 98' ' ' GLN . 21.6 mm100 -57.12 -47.04 82.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.603 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 19.4 t80 -43.64 -57.21 3.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -69.36 -44.87 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.0 mt-10 -47.08 -59.56 3.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.869 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.625 HE21 ' NE2' ' A' ' 94' ' ' GLN . 6.3 mt-30 -79.1 -48.23 14.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.3 m-85 -110.06 67.64 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.642 0.735 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.418 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.71 -12.34 32.78 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.752 2.301 . . . . 0.0 112.313 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.24 -21.16 54.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.603 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.6 pt -125.43 23.95 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 p -65.35 -24.49 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.566 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -95.33 -25.59 16.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.566 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 24.1 mt-10 -48.17 -36.89 14.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -129.99 134.81 47.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -108.28 27.16 9.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.42 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 88.7 p -96.06 155.59 38.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.705 0.764 . . . . 0.0 110.841 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 53.9 Cg_endo -69.76 -24.36 29.74 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.413 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 17.1 m-85 -134.63 90.21 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.573 HG22 ' CD2' ' A' ' 95' ' ' PHE . 40.8 t -79.38 136.82 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.123 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 3.7 m-30 -103.98 104.13 14.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.88 122.72 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.129 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.428 ' C ' HD11 ' A' ' 87' ' ' ILE . 13.7 m -126.89 155.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -143.34 176.25 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.456 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.17 53.93 6.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.859 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.76 115.16 3.96 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.632 2.221 . . . . 0.0 112.357 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.54 134.64 49.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -100.61 120.82 40.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.457 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 13.6 mtp -62.5 152.92 33.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.0 t -78.67 -27.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.5 149.44 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.457 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 7.7 mmtm -114.21 144.77 42.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.457 ' CD2' HG21 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -114.84 140.79 25.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.51 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.359 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.37 168.58 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.596 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 47.5 mmtm -111.99 141.99 44.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.67 175.44 26.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.432 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -155.54 162.01 28.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.671 0.748 . . . . 0.0 110.875 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 1.78 4.11 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.561 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.9 mmmm -137.17 -175.01 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 79.4 mt -85.88 133.52 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.596 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.6 p-90 -137.13 127.31 26.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.415 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 11.0 ttmt -55.72 133.69 50.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.566 HD11 ' CD1' ' A' ' 41' ' ' TRP . 18.3 mt -68.17 174.17 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.49 158.71 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.85 -48.65 78.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -70.5 -37.16 74.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.457 HG21 ' CD2' ' A' ' 124' ' ' PHE . 44.9 mm -68.84 -41.29 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -45.58 -62.86 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 142' ' ' GLY . 46.4 mt-30 -53.59 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.57 -51.32 0.76 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.517 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.546 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -53.07 -47.6 68.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.5 mtpp -60.75 -24.24 65.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -50.81 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.87 -19.83 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.423 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.412 HD12 ' CH2' ' A' ' 41' ' ' TRP . 48.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.577 ' CE3' HG21 ' A' ' 132' ' ' ILE . 88.6 m95 -76.3 168.13 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.903 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.429 ' CB ' ' HG ' ' A' ' 135' ' ' LEU . 11.8 t -141.69 145.0 34.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.4 tp -134.47 112.03 10.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 13.1 p -67.99 137.77 55.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 25.3 t -121.73 157.52 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.493 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.3 m-70 -89.29 116.22 27.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.483 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 52.5 mt-30 -62.79 161.86 25.7 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 110.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.83 -28.98 5.98 Favored 'Cis proline' 0 C--N 1.341 0.15 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.328 0.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.507 ' C ' ' O ' ' A' ' 15' ' ' PRO . 12.5 m-90 -29.02 -53.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -33.38 -64.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -63.0 -45.04 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.5 mt -46.36 -35.54 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.479 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -62.25 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG22 ' CD ' ' A' ' 119' ' ' GLU . 5.3 m -65.93 -12.18 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.103 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.5 mmt180 -84.14 -39.6 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.53 20.38 3.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.474 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.38 -36.16 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 18.0 tptt -107.65 99.15 8.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.409 ' C ' HG13 ' A' ' 27' ' ' VAL . 22.4 ptt180 -96.53 29.1 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.2 m -156.55 145.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -121.31 118.98 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.456 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -84.99 123.19 6.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 14.7 mmt180 -142.72 152.3 42.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 110.859 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.471 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 17.8 p -86.93 18.18 3.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.548 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.0 p-90 -142.62 163.95 31.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -105.58 138.79 41.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.41 ' C ' ' H ' ' A' ' 36' ' ' HIS . 6.7 t -132.26 100.56 15.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.611 0.72 . . . . 0.0 111.099 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.1 Cg_endo -69.78 7.31 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.41 ' H ' ' C ' ' A' ' 34' ' ' THR . 28.7 t60 -63.83 107.76 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 44.2 mmt-85 -105.48 108.17 19.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.14 -145.19 10.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.408 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 0.2 OUTLIER -86.72 142.73 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.861 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.4 tp -144.13 115.34 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.605 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 90.4 m95 -73.37 137.75 44.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.0 mm -107.13 132.64 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.61 145.54 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.95 125.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.7 p -61.13 -178.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.08 7.13 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -99.92 129.94 46.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.06 135.71 28.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.498 0.666 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.76 133.99 26.9 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m -76.46 161.44 74.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.672 0.749 . . . . 0.0 110.851 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.18 27.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -43.23 8.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.35 -40.91 90.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG11 ' NE2' ' A' ' 58' ' ' GLN . 60.8 t -65.05 -56.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -57.4 -42.79 82.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -66.61 -57.73 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.431 HD12 ' CZ2' ' A' ' 16' ' ' TRP . 87.4 mt -54.22 -42.1 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.4 mt-30 -55.11 -42.54 73.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.5 -31.6 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.4 m -66.09 -52.02 52.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.84 -36.14 79.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -50.68 -34.23 25.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.5 mt -90.6 -12.57 36.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.479 HD13 ' NE2' ' A' ' 104' ' ' GLN . 61.3 mt -91.59 -28.14 17.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.984 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 4.3 mmm180 -121.97 -29.18 4.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.516 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.78 127.43 2.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -46.53 -19.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.47 16.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.516 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 21.4 m -65.29 179.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -115.98 160.06 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 51.2 m-85 -153.16 139.8 12.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.74 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.491 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.8 Cg_endo -69.79 170.61 16.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.6 -22.34 19.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.49 172.08 16.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.9 m-85 -134.97 87.96 28.29 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 0.0 110.933 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.45 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.1 Cg_endo -69.71 172.04 13.31 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -137.15 144.18 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.88 44.81 95.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.464 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.28 158.24 41.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.461 HD21 ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -85.04 117.23 23.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.461 ' N ' HD21 ' A' ' 80' ' ' LEU . 16.3 mt -85.87 -69.46 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.45 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -148.51 -142.49 3.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.605 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 35.7 t -154.41 162.33 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.439 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 22.4 m -149.85 140.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -81.75 114.86 20.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.17 97.78 5.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.466 HD12 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -67.89 -47.79 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -164.54 166.35 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -127.43 101.4 6.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.474 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.2 mt -99.48 167.04 10.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 95' ' ' PHE . 33.0 t -106.89 169.04 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.842 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -46.41 -20.48 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 12.6 tttm -85.08 -58.04 2.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -77.22 -51.31 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 111' ' ' VAL . 42.1 t80 -38.89 -50.14 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.08 -42.76 68.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -55.12 -61.39 2.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.8 mt-30 -71.38 -50.53 31.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 113' ' ' ILE . 25.0 m-85 -109.42 68.26 0.41 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.657 0.741 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.75 -14.66 36.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.279 . . . . 0.0 112.304 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.12 -23.77 57.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.453 ' CG2' ' CD ' ' A' ' 105' ' ' GLU . 1.2 pt -120.32 19.38 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 p -60.62 -27.32 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.6 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.2 pp0? -93.47 -25.09 17.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.6 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 16.8 mt-10 -49.92 -32.28 14.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.6 t -130.95 150.94 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.02 -23.89 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.796 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.402 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 1.8 m -51.19 160.19 0.94 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.647 0.737 . . . . 0.0 110.836 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.471 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.3 Cg_endo -69.73 -45.64 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.36 100.87 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 95' ' ' PHE . 39.4 t -84.74 142.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' N ' HG12 ' A' ' 111' ' ' VAL . 6.5 m-30 -109.13 106.92 17.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -74.56 122.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.466 ' CA ' HD12 ' A' ' 87' ' ' ILE . 3.5 m -125.43 155.21 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -143.18 176.62 8.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.492 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.58 51.2 6.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 0.0 110.941 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.7 Cg_endo -69.7 121.72 8.42 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.647 2.232 . . . . 0.0 112.367 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -136.4 136.1 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.454 ' CD ' HG22 ' A' ' 21' ' ' VAL . 4.3 tp10 -98.25 124.57 42.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.6 mtp -63.12 151.7 39.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.9 -31.04 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.19 145.01 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -107.18 148.86 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -113.18 142.28 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 82.54 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.233 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 pp -118.82 159.74 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 37.7 mttp -95.16 139.94 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.19 -179.6 46.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.48 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.9 t30 -165.53 145.24 5.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 53.8 Cg_endo -69.75 4.04 2.42 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.689 2.26 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.548 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 12.1 mmmm -136.36 -174.42 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.577 HG21 ' CE3' ' A' ' 8' ' ' TRP . 73.2 mt -88.53 130.01 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.7 p-90 -138.93 125.59 20.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -55.36 125.56 21.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.429 ' HG ' ' CB ' ' A' ' 9' ' ' CYS . 22.7 mt -59.76 169.64 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 139' ' ' ILE . 7.6 t0 -77.46 126.87 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.4 m -35.7 -41.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -72.85 -41.26 64.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.5 mm -64.85 -42.64 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -42.62 -64.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 142' ' ' GLY . 80.1 mt-30 -53.13 -66.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.0 -42.02 0.7 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.534 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . . . -65.18 -46.67 79.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -56.35 -26.37 52.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -80.05 -53.01 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -37.25 -27.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.495 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 145' ' ' LYS . 14.7 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.907 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.512 ' CH2' ' HE3' ' A' ' 134' ' ' LYS . 91.8 m95 -78.25 164.02 25.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.92 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 t -138.23 138.64 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.8 tp -125.56 111.94 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 22.2 p -68.3 140.0 55.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 37.7 t -126.3 152.14 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -85.87 116.3 24.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 54.7 mt-30 -62.54 162.1 22.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 -28.46 6.24 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.4 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.569 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 12.9 m-90 -29.11 -51.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.469 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -34.23 -62.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.106 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -65.69 -47.03 76.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.1 mt -44.04 -28.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.7 mp -70.59 -65.51 0.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -61.3 -12.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -82.47 -39.8 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.57 -17.2 5.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.6 mp -68.16 -59.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.108 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 4.5 tptp -82.71 117.69 22.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.442 ' C ' HG13 ' A' ' 27' ' ' VAL . 3.6 ptp180 -114.06 12.85 18.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 25.3 m -147.37 149.88 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -115.78 146.2 42.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.473 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -111.26 112.72 3.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.539 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 22.8 mmt180 -137.99 148.77 45.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.467 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 61.6 p -84.39 21.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.441 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 4.6 p-90 -141.84 161.84 36.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -105.12 141.47 36.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.0 t -135.19 105.01 10.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.609 0.719 . . . . 0.0 111.186 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 3.21 2.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.307 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -64.87 113.55 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -117.7 119.81 36.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.22 -124.93 1.63 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -100.98 140.75 34.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.852 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.5 tp -144.13 111.32 5.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 93.1 m95 -71.21 126.55 29.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 mm -96.84 125.49 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.8 148.87 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.89 117.46 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 p -54.08 -178.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.28 19.15 5.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.46 126.82 46.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -82.61 124.64 77.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.58 0.705 . . . . 0.0 110.871 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 126.61 13.48 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.351 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 m -70.04 156.08 92.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.616 0.722 . . . . 0.0 110.881 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -7.13 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.736 2.291 . . . . 0.0 112.341 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -35.18 12.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.96 -40.55 60.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.96 -47.22 82.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.7 t -65.47 -44.71 86.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.52 -52.57 30.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.569 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 77.1 mt -55.37 -40.2 71.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 12.5 mt-30 -54.95 -49.27 71.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.64 -33.07 62.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -64.28 -48.01 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -72.76 -30.03 63.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -56.48 -36.26 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.0 mt -89.59 -13.25 37.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 mt -90.36 -29.78 17.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.448 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 5.5 mmm180 -120.78 -29.44 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.512 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.46 125.1 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -42.83 -23.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.873 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -76.82 13.94 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.546 HG21 ' CE2' ' A' ' 71' ' ' PHE . 19.7 m -62.89 -179.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 31.7 mt-10 -117.99 165.12 14.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 54.1 m-85 -160.16 135.73 5.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.468 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.81 164.1 35.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.699 2.266 . . . . 0.0 112.286 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -80.18 -30.73 38.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -146.76 175.43 10.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 60.9 m-85 -133.87 94.06 19.41 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.69 0.757 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.412 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.9 Cg_endo -69.76 175.82 7.59 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.681 2.254 . . . . 0.0 112.36 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.1 p -142.1 139.19 32.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.27 49.58 44.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 66.0 m -158.22 148.2 19.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.32 114.24 15.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.3 mt -82.0 -74.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.62 -147.95 4.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.0 p -151.56 153.7 35.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.6 m -139.96 141.07 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.34 114.18 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 tt -78.48 96.96 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.435 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -66.56 -48.95 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.168 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER -162.5 167.84 22.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.49 99.63 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 91.5 mt -93.95 171.09 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 93' ' ' LYS . 38.2 t -109.81 169.22 8.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 108' ' ' SER . 18.8 mm-40 -44.54 -21.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.42 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.2 tttt -89.12 -63.1 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -65.58 -49.55 68.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.505 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 37.3 t80 -42.16 -56.12 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 8.7 ptmt -68.46 -42.9 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.421 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 6.6 mt-10 -51.7 -60.36 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.2 mt-30 -75.86 -49.74 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 34.7 m-85 -110.42 66.87 0.48 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.619 0.723 . . . . 0.0 110.844 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.418 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.78 -14.18 35.65 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 0.0 112.359 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.79 -22.39 58.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 pt -121.83 15.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.7 p -55.68 -21.82 20.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -95.05 -30.47 14.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 12.1 mt-10 -47.58 -26.41 1.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -136.26 141.92 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 5.4 t70 -106.96 -37.17 6.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.48 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.8 m -40.89 161.33 0.12 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 0.0 110.874 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.467 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.81 -43.59 2.53 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.297 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -110.06 101.95 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.487 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 25.7 t -87.07 134.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.8 m-30 -101.34 109.97 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.94 120.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.45 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.1 m -123.59 152.49 41.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.25 176.38 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.475 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 57.47 52.82 5.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 112.39 3.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.316 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -126.61 132.19 51.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -98.0 120.35 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.437 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 14.6 mtp -62.52 154.36 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 70.7 t -81.55 -25.72 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.07 148.56 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 10.9 mmtm -115.86 142.3 46.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -114.12 141.65 26.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.661 0.743 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 90.54 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.53 167.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.573 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 43.5 mtpt -110.13 142.61 41.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.99 174.98 24.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -155.87 162.27 27.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.718 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 2.3 3.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.272 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.8 mmmm -139.94 -175.01 4.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 133' ' ' TRP . 81.9 mt -83.15 141.92 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 14.5 p-90 -147.18 129.44 15.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.512 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 17.0 ttmt -58.71 128.83 39.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 41' ' ' TRP . 22.3 mt -63.22 -177.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.7 t70 -90.56 128.2 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.3 m -36.23 -41.16 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -72.97 -40.62 65.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 136' ' ' ASP . 14.4 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.78 -62.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' LYS . 16.1 mm100 -55.02 -69.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.56 -42.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.576 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -60.74 -46.18 91.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.5 mtpp -61.97 -24.05 66.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -86.56 -42.84 13.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -51.1 -15.18 1.44 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.512 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.575 ' CE3' HG21 ' A' ' 132' ' ' ILE . 92.3 m95 -83.32 162.37 21.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.406 ' CB ' ' HG ' ' A' ' 135' ' ' LEU . 7.2 t -135.16 129.81 34.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.473 ' CB ' HD23 ' A' ' 40' ' ' LEU . 57.5 tp -116.5 113.81 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.412 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 24.0 p -68.15 153.08 44.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.512 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 90.3 t -136.44 164.6 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.512 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 64.4 m-70 -102.1 110.2 22.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.9 mm-40 -56.37 157.89 8.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 16' ' ' TRP . 54.2 Cg_endo -69.69 -32.94 3.6 Favored 'Cis proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.382 -0.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.544 ' C ' ' O ' ' A' ' 15' ' ' PRO . 8.3 m-90 -25.16 -58.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.496 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -32.08 -53.7 0.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.094 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.0 m -69.71 -55.06 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.9 mt -40.17 -31.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' CD1' ' HG2' ' A' ' 25' ' ' LYS . 6.6 mp -64.26 -68.04 0.38 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 82' ' ' GLY . 16.5 m -61.6 -10.45 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.461 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -84.3 -40.12 18.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.26 -5.2 8.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.88 -43.28 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 8.4 tptp -100.24 105.54 17.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.552 HH21 ' NE ' ' A' ' 65' ' ' ARG . 6.3 ptp180 -102.48 23.63 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.1 m -152.51 146.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CD ' ' CD2' ' A' ' 10' ' ' LEU . 3.1 tt0 -117.57 122.1 42.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.03 124.69 7.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -146.45 150.19 35.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.401 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.7 p -86.98 21.26 2.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.55 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.4 p-90 -143.78 160.91 39.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.48 137.78 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.567 HG23 ' CE2' ' A' ' 112' ' ' PHE . 11.9 t -134.41 98.38 13.88 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.542 0.687 . . . . 0.0 111.16 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.431 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.0 Cg_endo -69.72 9.5 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.436 ' H ' ' C ' ' A' ' 34' ' ' THR . 14.4 t60 -67.93 110.15 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 72.2 mmt-85 -106.94 113.13 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.11 -151.9 22.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -78.58 142.67 37.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.473 HD23 ' CB ' ' A' ' 10' ' ' LEU . 21.8 tp -143.74 112.45 6.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 95.0 m95 -72.04 123.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.8 mm -94.77 130.07 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.97 154.72 46.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.07 132.22 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 12' ' ' VAL . 20.1 p -72.73 171.95 11.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.02 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 5.3 ttpt -64.3 130.16 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -91.36 129.27 43.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.91 18.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.669 2.246 . . . . 0.0 112.39 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -75.37 155.41 85.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.695 0.76 . . . . 0.0 110.84 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -3.91 12.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.693 2.262 . . . . 0.0 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -94.63 -44.37 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.508 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 14.2 mp0 -65.79 -41.86 91.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.47 HG13 ' NE2' ' A' ' 58' ' ' GLN . 43.6 t -63.76 -50.14 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.147 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -63.47 -45.36 91.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.22 -54.59 31.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 58' ' ' GLN . 79.8 mt -54.32 -58.36 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.4 mt-30 -34.85 -48.48 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.5 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -54.62 -52.68 61.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -67.69 -35.86 79.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 66' ' ' GLY . 31.1 mtt-85 -51.4 -33.84 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.6 mt -89.88 -14.28 34.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.46 HD12 ' NE2' ' A' ' 104' ' ' GLN . 60.4 mt -88.61 -31.02 18.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.552 ' NE ' HH21 ' A' ' 26' ' ' ARG . 4.6 mmm180 -119.39 -29.3 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.514 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 134.63 125.29 2.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.503 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -44.52 -20.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' GLY . 9.1 m-20 -82.67 21.49 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 27.4 m -70.69 -178.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.8 pt-20 -116.56 168.65 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 63.8 m-85 -159.93 141.38 9.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.67 0.748 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.75 168.04 22.69 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -92.89 -23.71 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -146.64 167.47 23.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 72' ' ' PRO . 83.3 m-85 -133.09 88.34 36.75 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.655 0.741 . . . . 0.0 110.907 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 169.18 19.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.0 p -136.92 136.65 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.29 46.22 50.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.6 m -155.28 152.3 29.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -77.56 116.08 17.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 80' ' ' LEU . 25.1 mt -83.74 -70.11 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -146.04 -141.82 3.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.573 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 6.5 t -153.47 161.37 42.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.417 HG13 ' C ' ' A' ' 83' ' ' CYS . 20.0 m -151.56 145.25 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -90.27 112.91 24.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 tt -75.12 98.12 3.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.941 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.455 HD12 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -67.22 -47.45 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -163.64 168.16 20.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.37 103.23 7.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.5 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.9 mt -100.49 165.74 11.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.954 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 93' ' ' LYS . 33.3 t -106.12 169.05 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 108' ' ' SER . 20.3 mm-40 -45.24 -20.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.415 ' N ' ' C ' ' A' ' 91' ' ' SER . 26.3 ttmt -87.94 -63.74 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -66.66 -49.19 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.5 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 32.2 t80 -42.76 -55.26 3.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -68.25 -40.34 81.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -54.8 -59.66 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -75.97 -48.55 20.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -110.88 66.74 0.53 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 0.0 110.88 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.71 -12.24 32.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.363 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.71 -22.99 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.465 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.4 pt -122.1 22.26 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 p -62.48 -22.24 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.602 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -94.37 -31.04 14.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.602 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 22.3 mt-10 -45.59 -37.06 5.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -128.52 134.32 48.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.448 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 10.4 t0 -97.91 -36.29 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.878 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.497 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -39.87 159.94 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 0.0 110.836 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.8 Cg_endo -69.76 -47.34 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -107.37 101.85 11.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.477 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 33.2 t -86.52 140.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.567 ' CE2' HG23 ' A' ' 34' ' ' THR . 8.7 m-30 -107.41 109.5 21.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.0 120.83 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.455 ' CA ' HD12 ' A' ' 87' ' ' ILE . 4.0 m -124.27 155.02 39.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' CG ' HD13 ' A' ' 87' ' ' ILE . 10.6 mmtp -141.17 177.36 8.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.91 52.35 7.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.74 116.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.317 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -130.88 133.62 46.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -97.77 122.22 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.427 ' HE2' ' CZ ' ' A' ' 124' ' ' PHE . 16.5 mtp -62.87 154.21 30.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.928 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -75.24 -30.03 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.56 142.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -107.55 140.02 41.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.427 ' CZ ' ' HE2' ' A' ' 120' ' ' MET . 0.7 OUTLIER -105.06 142.89 25.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.618 0.723 . . . . 0.0 110.876 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 83.07 0.72 Allowed 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.41 ' C ' HD13 ' A' ' 126' ' ' ILE . 2.7 pp -121.41 155.8 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.585 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 8.2 ptpt -97.08 141.53 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -104.45 162.4 15.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.459 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -137.86 160.66 63.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.62 0.724 . . . . 0.0 110.909 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 2.53 3.45 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.55 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.8 mmmm -136.88 -175.15 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.575 HG21 ' CE3' ' A' ' 8' ' ' TRP . 83.6 mt -85.24 133.58 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.585 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.0 p-90 -140.46 128.3 21.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -56.43 126.03 24.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.552 HD11 ' CD1' ' A' ' 41' ' ' TRP . 25.4 mt -59.98 173.25 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.7 t70 -82.46 127.46 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.54 -39.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -74.42 -41.69 60.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' ASP . 29.1 mm -64.46 -42.56 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -40.47 -63.22 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLY . 45.1 mt-30 -53.45 -69.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.75 -51.66 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.82 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -62.45 -23.36 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 147' ' ' LEU . 11.5 mmmm -80.38 -53.1 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -39.26 -24.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 145' ' ' LYS . 28.3 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.323 . . . . 0.0 110.877 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.542 ' CE3' HG23 ' A' ' 132' ' ' ILE . 92.9 m95 -81.4 164.22 22.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.925 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -138.69 133.34 32.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.1 tp -121.17 109.43 14.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.6 m -67.94 134.17 50.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.822 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 34.0 t -115.24 157.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.479 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 33.6 m-70 -90.54 113.71 25.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 71.3 mt-30 -59.06 160.51 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.561 0.696 . . . . 0.0 110.958 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.555 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -30.1 5.32 Favored 'Cis proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.36 -0.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.538 ' CD1' ' HE2' ' A' ' 25' ' ' LYS . 9.7 m-90 -26.98 -54.5 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -35.29 -65.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 3.4 m -59.67 -43.49 93.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.3 mt -50.78 -39.19 51.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 5.8 mp -58.53 -69.58 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.6 m -57.46 -23.55 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.8 mmt180 -71.02 -39.14 72.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.67 24.59 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.466 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.39 -37.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.538 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 13.8 tptt -105.17 103.48 13.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.411 ' CD ' HH12 ' A' ' 65' ' ' ARG . 18.7 ptt180 -102.06 28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.0 m -156.51 142.59 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.441 ' CD ' ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -115.16 137.92 51.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.98 115.03 5.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 75.0 mmt-85 -138.52 154.11 48.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.466 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 95.7 p -88.99 20.67 3.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 1.8 p-90 -141.74 165.57 27.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -106.54 139.08 41.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.552 HG21 ' CE2' ' A' ' 112' ' ' PHE . 9.8 t -133.89 99.16 14.01 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.3 Cg_endo -69.73 7.98 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.417 ' H ' ' C ' ' A' ' 34' ' ' THR . 23.7 t60 -64.46 107.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.439 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.4 mmt-85 -103.85 108.8 20.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.42 -148.79 16.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -85.55 144.54 27.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.0 tp -143.46 114.56 7.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.582 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 87.9 m95 -71.27 127.86 33.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -97.77 126.0 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.32 142.03 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.05 118.09 19.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.3 p -57.59 178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.5 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 11.8 ttpt -98.76 128.61 45.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -87.61 122.41 70.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.565 0.698 . . . . 0.0 110.869 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 133.0 24.48 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.668 2.246 . . . . 0.0 112.346 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -78.19 161.29 71.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.684 0.754 . . . . 0.0 110.821 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -10.79 29.41 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.646 2.231 . . . . 0.0 112.352 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -87.33 -49.11 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -41.16 99.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.72 -51.14 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 t -63.64 -43.52 96.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -66.7 -52.73 41.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.52 HD12 ' CE2' ' A' ' 16' ' ' TRP . 83.7 mt -58.47 -42.44 87.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.8 mt-30 -52.82 -45.29 67.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.43 -36.25 39.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 m -60.43 -52.21 66.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -68.43 -38.55 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' GLY . 64.8 mtt180 -49.1 -34.25 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.92 -13.93 35.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.465 HD11 ' NE2' ' A' ' 104' ' ' GLN . 61.0 mt -90.1 -27.86 19.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.411 HH12 ' CD ' ' A' ' 26' ' ' ARG . 3.9 mmm180 -122.66 -28.74 4.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.504 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.22 127.96 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.81 -19.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.55 14.71 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.537 HG22 ' CE2' ' A' ' 71' ' ' PHE . 19.8 m -64.45 -179.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -114.41 160.38 19.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 48.5 m-85 -155.44 134.87 7.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.471 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.4 Cg_endo -69.84 165.08 32.28 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.637 2.224 . . . . 0.0 112.331 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -85.34 -29.08 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -148.01 174.95 11.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.555 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 43.1 m-85 -134.78 100.65 12.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.68 0.752 . . . . 0.0 110.959 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.412 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.6 Cg_endo -69.76 179.68 3.53 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.701 2.267 . . . . 0.0 112.345 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.8 p -142.05 141.32 32.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.85 58.01 16.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 10.2 m -162.15 150.61 14.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.25 118.77 20.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.2 mt -88.52 -69.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.93 -143.52 3.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.582 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.5 p -157.5 148.63 21.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 110.883 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 18.9 m -135.96 136.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.12 111.58 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 tt -72.97 104.28 4.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.506 HD13 ' CG ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -73.15 -47.13 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.32 168.16 18.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.15 103.21 7.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.495 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 93.6 mt -100.17 165.92 11.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 93' ' ' LYS . 47.9 t -102.91 169.61 8.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 108' ' ' SER . 12.2 mm-40 -45.13 -20.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 91' ' ' SER . 25.9 ttpt -91.0 -67.94 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.93 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -58.45 -46.19 87.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.8 t80 -44.09 -57.86 3.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.481 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.9 ptpt -68.66 -43.05 77.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.7 mt-10 -49.14 -59.26 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.6 mt-30 -78.74 -46.62 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 33.2 m-85 -111.24 68.56 0.67 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.685 0.755 . . . . 0.0 110.86 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -12.5 32.94 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.644 2.229 . . . . 0.0 112.368 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.34 -22.22 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.582 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.9 pt -124.78 23.2 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.481 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 37.0 p -64.21 -28.27 69.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.597 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -90.07 -30.25 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.597 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 24.5 mt-10 -43.63 -36.09 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.2 t -125.09 151.24 45.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.14 -29.26 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.482 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.4 m -49.3 162.18 0.43 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.678 0.751 . . . . 0.0 110.887 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.466 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.3 Cg_endo -69.74 -46.13 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.714 2.276 . . . . 0.0 112.337 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -109.98 104.71 13.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.548 HG22 ' CD2' ' A' ' 95' ' ' PHE . 19.7 t -91.8 132.29 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.552 ' CE2' HG21 ' A' ' 34' ' ' THR . 2.9 m-30 -100.25 108.82 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.01 124.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.482 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -125.09 155.65 39.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.506 ' CG ' HD13 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -138.94 177.56 7.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.844 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 53.43 52.8 10.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.4 Cg_endo -69.76 115.14 3.96 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.266 . . . . 0.0 112.314 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.85 142.03 49.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.14 124.81 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 13.8 mtp -63.69 148.44 49.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.62 -33.64 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.092 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.63 142.35 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -106.46 152.93 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.12 140.06 28.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 88.22 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.294 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.18 158.91 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.595 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 30.3 mtpt -89.86 114.94 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.67 158.66 53.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.526 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -145.67 158.75 49.35 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 4.4 mmmm -91.73 -173.83 3.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.542 HG23 ' CE3' ' A' ' 8' ' ' TRP . 62.7 mt -82.89 137.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.1 p-90 -143.59 128.03 17.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -55.21 130.04 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.508 HD13 ' CD1' ' A' ' 41' ' ' TRP . 22.8 mt -63.6 178.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.0 167.45 15.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 p -72.2 -43.09 65.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -78.51 -18.86 54.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 15.7 mm -89.78 -36.23 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -51.29 -59.98 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 144' ' ' LYS . 82.2 mt-30 -56.7 -66.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.51 -42.18 0.91 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.458 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.569 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -61.86 -42.18 98.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.105 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.0 mtpp -65.82 -24.99 67.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 147' ' ' LEU . 23.7 mmmt -80.87 -52.13 7.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -41.9 -23.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.506 HD11 ' CH2' ' A' ' 41' ' ' TRP . 34.2 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.534 ' CZ2' ' HE3' ' A' ' 134' ' ' LYS . 92.0 m95 -72.65 165.04 25.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.726 0.298 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.459 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 14.1 p -137.76 137.69 38.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.7 tp -120.34 107.45 12.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 t -67.98 142.0 56.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 8.8 t -126.58 159.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.533 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.2 m-70 -90.52 112.89 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.487 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 57.9 mt-30 -58.57 160.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.577 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.72 -28.69 6.1 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.369 -0.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.539 ' CE2' HD13 ' A' ' 57' ' ' LEU . 9.5 m-90 -28.72 -57.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -33.26 -61.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 m -63.1 -46.51 87.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.1 mt -45.74 -31.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 8.8 mp -67.21 -68.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 82' ' ' GLY . 13.1 m -60.67 -10.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.7 mmt180 -84.34 -39.18 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' CG ' ' A' ' 117' ' ' PRO . . . 123.16 0.14 9.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -85.1 -49.63 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 0.0 111.153 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -88.91 118.54 28.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 10.1 ttt180 -103.8 -0.07 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 28.4 m -143.45 155.62 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 4.9 tm-20 -122.07 152.86 39.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.544 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -111.31 129.36 9.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.7 mmt180 -148.82 145.04 27.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.866 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.5 p -83.02 18.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.57 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.1 p-90 -143.98 165.82 26.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -105.5 140.67 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.501 HG22 ' CE2' ' A' ' 112' ' ' PHE . 6.3 t -135.03 104.82 10.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.709 . . . . 0.0 111.114 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.6 Cg_endo -69.8 2.63 3.38 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.641 2.227 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -62.17 111.77 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 5.8 mmt85 -114.24 122.09 45.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.52 -125.92 2.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -99.47 142.8 30.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -144.03 111.82 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.565 ' CZ3' ' HB2' ' A' ' 143' ' ' ALA . 94.5 m95 -72.44 121.73 20.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.62 130.14 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.67 142.08 51.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.17 122.31 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.9 p -58.96 175.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.35 -15.98 61.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 6.4 ttpt -73.41 144.39 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.52 137.37 19.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.614 0.721 . . . . 0.0 110.889 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.73 128.97 16.83 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.69 2.26 . . . . 0.0 112.324 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 m -73.06 156.2 89.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.665 0.745 . . . . 0.0 110.862 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -36.92 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.24 -42.36 68.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.31 -51.23 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -61.69 -44.58 96.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.29 -56.63 10.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.539 HD13 ' CE2' ' A' ' 16' ' ' TRP . 94.1 mt -54.73 -55.91 24.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.6 mt-30 -37.45 -48.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.48 -44.64 34.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 m -51.97 -53.36 42.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -66.79 -38.67 86.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.463 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 32.4 mtt180 -48.77 -37.63 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -86.47 -15.99 38.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.498 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 59.5 mt -85.78 -28.84 24.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.498 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.9 mmp_? -122.67 -27.44 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.516 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 128.64 129.08 3.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.441 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -45.06 -20.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.5 p30 -70.95 3.18 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.579 HG22 ' CE2' ' A' ' 71' ' ' PHE . 35.2 m -60.63 178.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 8.8 mp0 -122.94 172.3 8.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 76.7 m-85 -161.11 141.47 8.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.87 29.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 0.0 112.362 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.02 -27.03 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -144.87 166.1 26.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.577 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 76.0 m-85 -130.64 88.47 46.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.645 0.736 . . . . 0.0 110.884 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.3 Cg_endo -69.75 168.43 21.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.67 2.246 . . . . 0.0 112.368 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.3 p -133.36 150.25 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.06 40.42 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 28.2 m -147.27 151.72 37.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 143' ' ' ALA . 0.2 OUTLIER -78.85 113.12 16.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -81.18 -70.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -149.09 -142.95 3.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.544 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -153.79 153.68 32.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 m -140.99 139.86 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.88 112.72 19.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tt -77.45 100.38 5.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.415 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.98 -45.62 71.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 3.5 m-20 -165.46 165.9 18.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.407 ' SG ' ' CE1' ' A' ' 112' ' ' PHE . 1.3 t -127.77 97.09 4.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.497 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 95.4 mt -94.67 168.13 11.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 93' ' ' LYS . 46.3 t -104.84 169.41 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 108' ' ' SER . 11.6 mm-40 -45.04 -20.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.1 ttmt -91.65 -69.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -57.98 -45.74 86.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.558 ' CD2' HG22 ' A' ' 111' ' ' VAL . 16.5 t80 -44.43 -58.66 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 10.4 ptpt -66.91 -40.01 87.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.416 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.2 mt-10 -49.99 -56.01 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.484 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.7 mt-30 -81.87 -49.18 10.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 19.8 m-85 -109.77 69.13 0.48 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.664 0.745 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -11.79 31.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.665 2.244 . . . . 0.0 112.354 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.42 -22.14 51.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.526 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -122.44 22.75 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.6 p -64.07 -20.76 66.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.54 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.5 pp0? -96.54 -27.82 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.54 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 24.1 mt-10 -47.03 -40.06 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 t -120.09 150.64 40.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -116.2 -27.19 6.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.44 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -52.11 162.34 0.85 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.83 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -37.27 9.49 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.12 101.18 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 95' ' ' PHE . 50.7 t -84.39 136.43 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 7.5 m-30 -104.59 102.39 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.62 119.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.402 ' CA ' HD11 ' A' ' 87' ' ' ILE . 2.7 m -124.26 154.02 40.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -142.09 176.71 8.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 54.79 52.24 8.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.82 119.94 6.8 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.331 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -132.47 138.48 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -102.75 122.26 44.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 16.9 mtp -62.92 153.26 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.4 t -72.8 -37.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.474 HG21 ' N ' ' A' ' 123' ' ' LYS . 5.0 p -126.16 138.07 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.474 ' N ' HG21 ' A' ' 122' ' ' VAL . 17.3 mttp -102.49 149.58 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -113.11 142.34 27.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 86.66 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.06 160.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 15.0 ptmt -99.61 134.6 42.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.79 -178.01 39.45 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -161.12 159.22 24.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 0.3 5.87 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.629 2.219 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.57 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 9.1 mmmm -136.94 -175.0 3.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.466 HG21 ' CE3' ' A' ' 8' ' ' TRP . 71.9 mt -84.88 140.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.12 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.503 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 9.4 p-90 -146.51 128.96 15.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.534 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 15.2 ttmt -56.5 130.3 44.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.472 HD11 ' CD1' ' A' ' 41' ' ' TRP . 17.8 mt -65.71 168.85 7.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.3 t70 -77.4 127.19 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.13 -40.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.61 -42.54 58.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 24.9 mm -64.04 -38.72 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -46.54 -65.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.7 mm-40 -49.75 -68.49 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.05 -54.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.565 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.24 -40.91 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 111.097 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -67.83 -17.03 64.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.6 mmmm -89.84 -50.09 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -40.04 -23.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.539 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 145' ' ' LYS . 22.6 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.458 ' CZ2' ' NZ ' ' A' ' 134' ' ' LYS . 94.0 m95 -83.05 164.17 20.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 12.9 p -145.6 142.45 29.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.422 ' CD2' ' HG2' ' A' ' 28' ' ' GLU . 8.9 tp -130.95 114.16 14.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.7 m -69.59 147.45 50.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 19.7 t -129.76 154.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.437 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 37.3 m-70 -86.66 120.14 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 57.6 mt-30 -64.14 161.61 38.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 16' ' ' TRP . 53.5 Cg_endo -69.8 -30.53 5.1 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.325 -0.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.577 ' CZ2' HD13 ' A' ' 57' ' ' LEU . 13.3 m-90 -26.89 -54.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -33.26 -64.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -63.04 -45.76 90.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.4 mt -45.23 -30.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.48 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.6 mp -68.81 -69.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.425 HG23 ' CD ' ' A' ' 119' ' ' GLU . 5.0 m -57.26 -15.48 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.1 mmt180 -79.38 -39.57 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.63 7.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -76.38 -57.01 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 111.152 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 18.0 tptt -84.03 112.25 20.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -109.99 20.24 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 23.6 m -149.94 145.91 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.422 ' HG2' ' CD2' ' A' ' 10' ' ' LEU . 2.4 tp10 -109.15 146.53 33.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.56 119.86 5.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 24.7 mmt180 -148.89 145.44 27.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -83.31 17.71 2.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.482 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 4.9 p-90 -139.85 163.49 32.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.0 145.33 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.494 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.6 t -138.75 106.99 7.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.714 . . . . 0.0 111.128 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 3.86 2.51 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.677 2.251 . . . . 0.0 112.371 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -65.3 114.27 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -120.18 117.65 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.03 -121.32 1.05 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.464 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -106.35 140.08 39.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 15.6 tp -144.27 113.9 7.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.57 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 91.1 m95 -72.02 128.88 37.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.0 133.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.24 166.88 17.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.87 119.33 37.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.415 HG22 ' C ' ' A' ' 12' ' ' VAL . 51.5 p -55.22 -179.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.12 -5.45 57.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HD3' ' ND1' ' A' ' 13' ' ' HIS . 4.2 tttt -86.81 124.71 33.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -85.53 139.28 35.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.531 0.681 . . . . 0.0 110.939 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 54.2 Cg_endo -69.76 132.25 22.95 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -76.02 157.52 83.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.697 0.761 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -5.84 17.19 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.671 2.247 . . . . 0.0 112.342 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.03 -44.39 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.34 -49.42 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -65.27 -44.01 89.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.19 -53.77 27.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.953 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.577 HD13 ' CZ2' ' A' ' 16' ' ' TRP . 75.6 mt -56.49 -40.16 74.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.4 mt-30 -55.03 -42.7 72.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.61 -32.99 28.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -64.67 -52.86 55.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -64.34 -38.22 90.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -49.79 -34.25 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.0 mt -90.56 -12.19 37.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.89 -28.9 17.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -122.53 -29.25 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.513 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 134.24 126.11 2.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.432 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -44.44 -21.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -79.23 15.29 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 71' ' ' PHE . 19.5 m -64.02 -177.06 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 13.0 mt-10 -115.91 165.97 12.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 69' ' ' VAL . 55.4 m-85 -161.12 132.38 3.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.71 169.12 19.59 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.68 2.253 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -144.28 170.81 15.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.513 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 58.1 m-85 -134.21 93.36 19.66 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.628 0.728 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.482 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.77 169.79 18.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.2 m -136.37 139.44 42.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.851 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.58 49.41 60.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.1 m -157.08 147.62 21.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.878 0.37 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 120.81 21.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.461 ' C ' ' OE1' ' A' ' 119' ' ' GLU . 78.6 mt -88.8 -73.75 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -144.86 -144.63 4.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.57 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 14.2 t -151.14 157.84 43.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.425 HG11 ' C ' ' A' ' 83' ' ' CYS . 24.1 m -143.09 142.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.49 111.45 20.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 tt -75.24 98.39 3.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.426 HD11 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -68.25 -47.66 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -164.92 168.2 17.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -127.9 100.42 5.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.504 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.0 mt -94.01 170.06 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' LYS . 65.0 m -109.41 169.61 8.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -43.0 -22.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' SER . 29.0 ttmt -89.79 -66.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -60.35 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.504 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 28.6 t80 -46.02 -55.56 6.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 1.9 ptmt -69.69 -39.51 76.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.26 -59.41 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 9.6 mt-30 -77.51 -49.5 14.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 25.1 m-85 -109.95 67.62 0.46 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.633 0.73 . . . . 0.0 110.84 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.77 -12.19 32.37 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 -22.17 51.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.49 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.1 pt -121.35 15.99 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.3 p -58.4 -22.56 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.573 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -94.49 -30.69 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 8.7 mt-10 -47.04 -26.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 t -136.86 138.67 41.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.74 26.61 9.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.418 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 16.4 p -100.17 157.69 33.37 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.652 0.739 . . . . 0.0 110.86 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 53.9 Cg_endo -69.73 -23.2 31.19 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 0.0 112.348 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -134.97 95.0 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.457 HG23 ' CD2' ' A' ' 95' ' ' PHE . 43.4 t -85.63 137.55 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -104.44 108.01 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.13 122.92 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.426 ' CA ' HD11 ' A' ' 87' ' ' ILE . 3.4 m -125.67 155.97 40.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -144.02 176.49 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.49 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.83 51.73 4.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.634 0.73 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.4 Cg_endo -69.74 114.19 3.62 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.404 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.24 134.7 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.461 ' OE1' ' C ' ' A' ' 81' ' ' LEU . 3.9 tp10 -97.6 123.53 41.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.6 mtp -63.76 157.77 23.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.6 t -81.08 -32.5 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.4 144.42 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -111.05 148.22 33.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.54 142.53 30.61 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.71 0.767 . . . . 0.0 110.822 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 86.83 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.63 2.22 . . . . 0.0 112.391 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.01 162.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.5 mmtp -108.15 149.03 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.03 178.22 29.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.519 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -154.53 161.06 30.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.66 0.743 . . . . 0.0 110.876 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -1.61 8.79 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.482 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.2 mmmm -137.27 -174.99 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 133' ' ' TRP . 74.1 mt -83.11 139.79 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.2 p-90 -145.11 127.94 16.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.458 ' NZ ' ' CZ2' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -64.21 125.23 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.2 mt -52.76 -176.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.8 t0 -91.7 131.72 36.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -36.65 -36.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -40.33 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.2 mm -67.36 -45.77 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.8 t-160 -36.5 -63.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 41.4 mm-40 -52.48 -69.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.53 -48.23 0.65 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -58.45 -43.25 88.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.819 0.342 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 15.9 mtpp -64.46 -26.45 68.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.445 ' HE2' ' N ' ' A' ' 145' ' ' LYS . 8.5 mmpt? -80.37 -46.34 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -45.68 -22.38 0.71 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.466 HD11 ' CH2' ' A' ' 41' ' ' TRP . 34.3 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -72.35 169.79 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.0 t -140.33 139.15 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -130.05 115.57 17.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 m -67.77 156.38 37.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 53.7 t -139.03 157.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.457 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 43.1 m-70 -90.41 109.43 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.492 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 64.3 mt-30 -58.33 161.14 8.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.7 -30.57 5.05 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.73 -1.779 . . . . 0.0 112.325 -0.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.565 ' CZ2' HD12 ' A' ' 57' ' ' LEU . 9.6 m-90 -26.66 -49.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -35.28 -60.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -67.03 -51.09 59.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.3 mt -40.51 -30.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.501 ' CD2' ' OE1' ' A' ' 28' ' ' GLU . 5.8 mp -68.32 -65.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 82' ' ' GLY . 10.6 m -62.58 -18.38 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.469 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 14.4 mmt180 -74.81 -39.93 61.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.4 -2.18 7.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' A' ' 70' ' ' GLU . 5.1 mp -83.07 -55.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.391 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 4.5 tptp -86.59 120.26 27.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.408 ' C ' HG13 ' A' ' 27' ' ' VAL . 4.3 ptp180 -114.37 15.92 17.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.505 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 33.9 m -147.56 142.92 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.501 ' OE1' ' CD2' ' A' ' 20' ' ' LEU . 6.9 tp10 -107.97 147.01 31.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -113.18 119.54 4.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.0 mmt180 -146.22 151.96 38.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 0.0 110.887 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 84.2 p -87.42 22.31 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 3.4 p-90 -142.24 161.12 38.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 12.0 t80 -103.65 139.23 39.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 36' ' ' HIS . 7.6 t -134.41 101.66 12.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.566 0.698 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 8.33 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.646 2.231 . . . . 0.0 112.36 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' H ' ' C ' ' A' ' 34' ' ' THR . 20.4 t60 -68.67 109.73 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mmt-85 -109.62 107.25 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.98 -153.37 23.89 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -73.02 140.57 47.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 21.2 tp -143.95 113.88 7.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.565 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 95.4 m95 -73.54 120.95 19.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.62 128.94 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.48 153.27 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.75 122.55 32.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -62.45 173.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.27 -9.74 58.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 7.7 ttpt -70.47 127.27 32.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -85.46 125.68 68.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.567 0.698 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 130.82 20.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.247 . . . . 0.0 112.354 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m -76.89 158.97 79.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.666 0.746 . . . . 0.0 110.79 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 -16.98 38.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 0.0 112.372 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -84.44 -39.06 19.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -41.42 76.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.94 -48.87 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.162 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -63.62 -45.14 91.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.87 -52.44 43.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.565 HD12 ' CZ2' ' A' ' 16' ' ' TRP . 83.9 mt -59.31 -44.76 92.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.0 mt-30 -50.18 -46.12 54.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.89 -36.95 41.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.3 m -59.24 -51.18 71.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.403 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 26.5 m-85 -69.06 -37.26 78.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 66' ' ' GLY . 32.5 mtt-85 -49.88 -33.99 18.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.78 -15.94 31.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.457 HD12 ' NE2' ' A' ' 104' ' ' GLN . 57.8 mt -88.06 -28.66 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.453 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.6 mmm180 -121.47 -28.87 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.511 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 132.45 126.98 2.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.476 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.57 -20.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.1 m-20 -80.72 18.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.524 HG23 ' CE2' ' A' ' 71' ' ' PHE . 23.2 m -68.02 179.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.117 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.408 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 11.9 mt-10 -112.25 157.2 21.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -154.51 132.06 6.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.657 0.742 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.694 2.262 . . . . 0.0 112.322 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -81.4 -32.05 32.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -145.31 174.23 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.0 m-85 -133.45 95.47 18.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.665 0.745 . . . . 0.0 110.936 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.444 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.4 Cg_endo -69.75 171.59 14.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.332 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -141.33 133.25 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 46.13 9.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -159.27 149.39 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.455 ' CD1' ' HB1' ' A' ' 143' ' ' ALA . 0.2 OUTLIER -74.23 113.43 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.3 -74.4 0.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.9 -145.07 4.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.565 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 5.5 t -149.54 162.49 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG11 ' C ' ' A' ' 83' ' ' CYS . 24.9 m -151.71 140.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -85.63 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tt -73.48 99.82 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.426 HD11 ' C ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -68.89 -48.29 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.43 167.4 23.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.53 101.25 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.494 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.2 mt -96.37 168.38 10.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 15.0 p -106.29 169.19 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 108' ' ' SER . 19.6 mm-40 -46.65 -19.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 91' ' ' SER . 21.9 ttmt -90.88 -59.0 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -68.52 -50.21 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.525 ' CD2' HG23 ' A' ' 111' ' ' VAL . 31.3 t80 -41.91 -55.9 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -67.25 -41.32 85.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.49 -58.83 5.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.3 mt-30 -76.13 -50.11 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -109.88 67.91 0.46 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.1 Cg_endo -69.74 -13.57 34.92 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.71 2.273 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.68 -23.44 56.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.464 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.6 pt -121.91 23.45 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.2 p -65.0 -26.3 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.598 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.2 pp0? -91.53 -27.98 17.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.598 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 18.3 mt-10 -49.3 -38.39 27.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.515 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.3 p -124.08 144.42 49.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 27.2 t70 -107.94 -36.36 6.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.48 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 4.3 m -39.6 157.99 0.13 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.856 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.464 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.7 Cg_endo -69.79 -49.23 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.661 2.241 . . . . 0.0 112.319 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' A' ' 33' ' ' TYR . 26.2 m-85 -106.32 98.69 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.525 HG23 ' CD2' ' A' ' 95' ' ' PHE . 22.1 t -83.91 139.62 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -107.29 107.09 17.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.24 122.83 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.426 ' C ' HD11 ' A' ' 87' ' ' ILE . 3.1 m -126.8 155.41 42.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.08 176.25 9.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 56.59 51.97 6.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.73 115.52 4.13 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -127.92 134.79 49.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.426 ' OE2' ' NZ ' ' A' ' 123' ' ' LYS . 11.3 tm-20 -96.88 121.99 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.459 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 13.1 mtp -62.59 151.88 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.74 -37.52 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 1.8 p -118.22 158.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.486 ' N ' ' CG2' ' A' ' 122' ' ' VAL . 12.5 mmtm -120.65 140.29 51.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.64 136.86 19.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.628 0.728 . . . . 0.0 110.897 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 86.03 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.89 163.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 70.9 mttt -97.95 132.04 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.03 170.9 40.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -153.42 153.07 28.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 1.42 4.46 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.301 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.424 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.7 mmmm -134.07 -175.39 3.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.446 HG21 ' N ' ' A' ' 133' ' ' TRP . 72.7 mt -89.03 137.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.6 p-90 -146.05 131.48 18.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -59.62 124.59 20.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.1 mt -60.02 170.77 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.7 t70 -79.27 129.71 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.1 m -37.03 -37.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -76.05 -41.24 51.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 136' ' ' ASP . 37.5 mm -65.56 -39.65 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -45.92 -65.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.817 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 144' ' ' LYS . 28.1 mt-30 -47.89 -69.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.95 -52.85 1.54 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.455 ' HB1' ' CD1' ' A' ' 80' ' ' LEU . . . -52.52 -39.44 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 141' ' ' GLN . 10.7 mtpt -70.47 -14.73 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -86.08 -48.47 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.62 -19.15 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.41 ' CE3' HG23 ' A' ' 132' ' ' ILE . 94.7 m95 -94.96 161.97 13.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -137.24 140.25 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.403 ' CD2' ' HG2' ' A' ' 28' ' ' GLU . 26.7 tp -124.13 108.88 12.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.404 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 3.9 p -67.57 137.17 55.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 33.9 t -121.13 161.44 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.543 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.5 m-70 -95.99 111.76 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 10.8 mm-40 -56.34 157.83 8.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.78 -33.03 3.57 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.361 -0.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.546 ' C ' ' O ' ' A' ' 15' ' ' PRO . 10.7 m-90 -24.97 -54.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -36.69 -54.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.5 m -70.04 -47.81 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -45.39 -28.31 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.6 mp -68.07 -65.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 m -64.77 -14.2 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.479 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.3 mmt180 -78.64 -39.13 37.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.61 12.22 6.2 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.5 -47.63 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -88.79 116.66 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.49 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 11.4 ttt180 -101.94 -1.14 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 32.7 m -141.55 152.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.144 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HG2' ' CD2' ' A' ' 10' ' ' LEU . 2.2 tp10 -115.96 143.11 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.55 129.47 9.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.419 ' HD2' ' NE1' ' A' ' 32' ' ' TRP . 20.2 mmt180 -152.96 140.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.1 p -82.81 16.58 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.514 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.2 p-90 -139.29 166.44 24.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 34' ' ' THR . 8.8 t80 -106.45 148.39 28.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.576 HG22 ' CE2' ' A' ' 112' ' ' PHE . 5.8 t -143.95 107.09 4.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.709 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 2.83 3.14 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.37 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -65.42 117.91 8.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -123.53 120.43 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.57 -121.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -99.55 140.77 33.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 17.4 tp -144.73 108.99 4.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.599 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 94.8 m95 -71.65 126.15 28.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 mm -96.39 129.3 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.63 150.56 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.37 126.26 33.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.071 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 p -64.69 173.01 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.42 -21.15 62.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 9.0 ttpt -63.91 149.39 47.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -108.59 133.98 20.44 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.533 0.682 . . . . 0.0 110.921 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.478 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 128.32 15.86 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.708 2.272 . . . . 0.0 112.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -75.21 159.12 83.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 110.869 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -7.35 20.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.72 -41.78 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.63 -40.85 80.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.8 t -67.83 -49.6 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.4 t -64.2 -42.06 96.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -70.2 -55.15 10.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.521 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 86.5 mt -55.88 -44.03 77.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 8.5 mt-30 -51.05 -47.06 61.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.67 -36.71 51.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -60.17 -51.25 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -69.92 -38.59 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.468 ' O ' ' C ' ' A' ' 66' ' ' GLY . 44.8 mtt180 -47.98 -36.34 12.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 mt -87.23 -18.14 30.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.0 mt -83.41 -32.28 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -118.4 -27.38 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.519 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 129.4 124.9 2.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.428 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -42.34 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.927 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -70.15 4.77 1.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 35.3 m -61.5 176.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -116.71 167.82 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 49.5 m-85 -157.67 139.06 9.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.518 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.71 159.4 53.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.745 2.297 . . . . 0.0 112.334 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.88 -24.09 33.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -150.73 172.22 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.598 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 56.2 m-85 -134.41 98.59 13.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.66 0.743 . . . . 0.0 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -176.33 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.319 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.7 p -150.79 129.83 12.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.38 45.28 24.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.1 m -153.33 149.43 27.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.95 118.34 18.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.8 mt -85.68 -71.57 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.26 -143.11 3.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.599 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -152.46 158.18 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.845 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG11 ' C ' ' A' ' 83' ' ' CYS . 23.8 m -145.71 134.54 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.467 ' HB3' ' ND2' ' A' ' 116' ' ' ASN . 1.4 t70 -79.35 112.8 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -76.41 102.67 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.437 HD13 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -72.04 -47.07 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -166.17 170.02 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.11 99.42 5.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 96.9 mt -93.04 171.24 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 93' ' ' LYS . 4.7 p -109.79 169.16 8.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.472 ' O ' ' CE ' ' A' ' 96' ' ' LYS . 3.1 mm-40 -43.11 -23.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 91' ' ' SER . 18.4 ttmt -89.76 -65.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -59.38 -48.63 80.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.961 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.604 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.1 t80 -43.79 -56.9 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' CE ' ' O ' ' A' ' 92' ' ' GLN . 11.7 ptpt -69.0 -41.96 77.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -50.06 -59.13 4.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.481 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.4 mt-30 -78.05 -45.07 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.0 m-85 -113.66 69.98 1.6 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.666 0.746 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -14.54 36.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 0.0 112.349 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -19.67 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.604 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.5 pt -125.73 21.74 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.444 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 58.8 p -64.51 -27.63 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.581 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -89.39 -29.52 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.581 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 22.9 mt-10 -45.31 -40.03 7.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.8 t -120.39 140.76 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.18 25.43 10.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.459 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.7 p -101.16 160.34 26.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.869 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -25.16 28.73 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -134.82 95.55 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 39.7 t -84.51 135.73 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.576 ' CE2' HG22 ' A' ' 34' ' ' THR . 9.2 m-30 -101.9 103.54 14.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.12 122.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.437 ' CA ' HD13 ' A' ' 87' ' ' ILE . 3.9 m -125.56 156.08 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.433 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 1.9 mmmp? -143.53 176.36 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.488 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 58.15 51.95 4.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.5 Cg_endo -69.79 113.65 3.45 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.266 . . . . 0.0 112.303 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -127.35 141.7 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -103.67 120.96 41.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 17.3 mtp -64.05 143.01 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.4 t -69.96 -25.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.146 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.83 141.91 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -110.99 145.09 39.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.41 143.29 29.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 91.49 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.279 . . . . 0.0 112.316 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.63 158.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.11 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.591 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.0 mttm -103.5 137.23 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -96.24 166.87 24.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.468 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -140.53 161.7 53.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.714 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 0.56 5.45 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.514 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.5 mmmm -138.26 -174.99 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 133' ' ' TRP . 82.7 mt -83.09 138.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.591 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 6.7 p-90 -146.63 124.2 11.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.47 127.07 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.574 HD12 ' CD1' ' A' ' 41' ' ' TRP . 37.7 mt -60.17 -178.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -88.13 127.47 35.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.8 m -36.39 -40.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -73.44 -41.25 63.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 136' ' ' ASP . 23.5 mm -64.99 -44.99 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -38.55 -65.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 142' ' ' GLY . 14.4 mm100 -52.59 -68.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.21 -48.71 1.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.466 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.483 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.79 -45.79 81.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 111.089 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -63.57 -22.48 66.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -84.14 -46.63 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -45.44 -20.45 0.34 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.9 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.583 ' CE3' HG22 ' A' ' 132' ' ' ILE . 93.3 m95 -90.23 156.98 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB2' ' CG ' ' A' ' 135' ' ' LEU . 52.7 t -134.5 121.7 21.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.453 ' CB ' HD22 ' A' ' 40' ' ' LEU . 65.6 tp -107.44 109.19 20.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -68.09 154.53 41.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 24.5 t -133.65 159.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.094 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.511 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 57.4 m-70 -90.13 113.72 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 78.7 mt-30 -59.7 159.75 17.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.75 -31.52 4.5 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.355 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.53 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 10.0 m-90 -26.81 -48.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 15' ' ' PRO . . . -39.33 -63.44 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.1 mt -52.62 -28.52 21.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.1 mp -69.75 -60.46 2.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m -67.65 -20.5 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.474 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -73.12 -39.17 65.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 14.66 5.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.21 -45.14 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 111.154 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CD ' ' OH ' ' A' ' 61' ' ' TYR . 4.2 tptp -93.81 118.85 32.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -101.05 -4.39 27.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.469 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 8.0 m -141.33 152.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -120.35 130.51 54.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -86.57 132.06 10.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' N ' ' CB ' ' A' ' 108' ' ' SER . 18.9 mmt180 -152.63 144.64 23.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.511 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 9.8 t -85.63 24.26 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.576 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.0 p-90 -146.38 160.91 41.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.3 t80 -104.08 145.29 30.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.586 HG21 ' CE2' ' A' ' 112' ' ' PHE . 5.6 t -139.31 105.91 7.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.162 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 4.0 2.46 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.697 2.265 . . . . 0.0 112.308 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -65.86 114.68 5.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -119.69 122.92 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.41 -119.15 1.04 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -104.88 138.3 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.453 HD22 ' CB ' ' A' ' 10' ' ' LEU . 26.7 tp -143.57 112.69 6.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.36 132.56 45.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.5 mm -103.34 125.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.113 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.97 154.3 36.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.73 116.46 25.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -53.06 -177.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.13 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.65 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 6.2 ttpt -78.25 131.13 36.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -92.98 137.06 23.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.557 0.694 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 53.4 Cg_endo -69.72 130.36 19.24 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m -78.29 158.13 77.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 110.837 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -4.15 13.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.682 2.254 . . . . 0.0 112.317 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.491 ' NE2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -94.84 -38.67 10.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.933 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.17 -39.84 53.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.15 -52.73 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -58.12 -46.54 85.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 11.9 mt-10 -66.41 -57.54 7.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.53 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 76.7 mt -52.92 -41.21 64.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.8 mt-30 -52.47 -47.9 66.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -37.52 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.072 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -58.3 -50.59 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.438 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 24.8 m-85 -71.03 -31.88 68.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.431 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 32.2 mtt180 -56.05 -39.65 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 mt -86.33 -14.53 43.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.469 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 71.6 mt -89.02 -28.89 19.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.469 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 5.5 mmp_? -121.16 -28.74 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.521 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 131.27 128.21 2.94 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.19 -19.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.7 m-20 -78.4 13.4 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.545 HG23 ' CE2' ' A' ' 71' ' ' PHE . 28.6 m -66.33 -177.84 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 16.3 mm-40 -119.54 167.98 11.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 62.3 m-85 -161.86 135.06 4.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.625 0.726 . . . . 0.0 110.861 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.2 Cg_endo -69.77 159.96 51.47 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 0.0 112.322 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -81.11 -27.76 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -146.15 173.41 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.1 m-85 -134.85 94.61 16.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.683 0.754 . . . . 0.0 110.916 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.4 Cg_endo -69.76 174.36 9.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.5 p -141.26 139.81 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.86 45.36 84.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.7 m -153.45 145.18 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 110.884 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.93 117.85 17.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.1 mt -85.79 -71.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.61 -146.4 4.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.587 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.3 p -151.28 157.41 42.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.8 m -144.67 140.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.1 113.08 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 tt -77.42 93.41 4.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.446 HD12 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -60.73 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.184 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -163.01 168.46 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.9 t -127.73 101.74 6.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.502 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 88.8 mt -99.32 169.89 9.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' LYS . 34.7 t -105.12 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 108' ' ' SER . 10.1 mm-40 -42.07 -23.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' SER . 15.2 ttmm -91.34 -70.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -53.56 -47.37 70.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.577 ' CD2' HG23 ' A' ' 111' ' ' VAL . 16.9 t80 -43.3 -57.46 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HG2' ' N ' ' A' ' 97' ' ' GLU . 1.6 pttt -68.36 -38.79 81.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.491 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 12.1 mt-10 -49.56 -52.39 30.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.451 ' NE2' HD23 ' A' ' 90' ' ' LEU . 5.7 mt-30 -86.68 -45.97 10.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.7 m-85 -110.42 67.69 0.51 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 0.0 110.865 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.77 -10.35 28.33 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.695 2.264 . . . . 0.0 112.366 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.82 -19.16 55.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.449 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 pt -126.17 21.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.469 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 59.6 p -60.05 -20.78 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -97.94 -30.71 12.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 5.2 mt-10 -51.23 -28.36 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.471 ' CB ' HG12 ' A' ' 111' ' ' VAL . 25.5 p -114.24 156.84 23.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -130.15 -32.58 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.518 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -58.87 164.83 3.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 0.0 110.834 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.511 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.3 Cg_endo -69.78 -43.79 2.44 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.66 2.24 . . . . 0.0 112.322 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -110.34 97.51 6.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.577 HG23 ' CD2' ' A' ' 95' ' ' PHE . 12.9 t -79.3 139.21 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.586 ' CE2' HG21 ' A' ' 34' ' ' THR . 11.5 m-30 -106.58 105.84 16.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.405 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -74.41 117.57 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.093 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.455 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 6.9 m -125.07 151.55 45.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.874 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.403 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 11.3 mmmt -140.5 175.27 9.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 59.22 53.18 4.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 0.0 110.891 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.78 112.58 3.12 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -127.33 141.07 51.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.19 122.24 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.437 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 16.6 mtp -63.39 155.33 29.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.2 t -81.92 -27.69 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -127.27 135.22 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 14.0 mmtm -103.03 150.44 23.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -118.17 143.55 33.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.596 0.713 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 92.05 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.32 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.428 ' C ' HD13 ' A' ' 126' ' ' ILE . 2.9 pp -123.21 167.07 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -110.28 107.16 16.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.27 169.56 23.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.538 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.436 ' HB2' ' CD1' ' A' ' 133' ' ' TRP . 46.9 m-80 -155.29 157.9 31.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.928 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 0.86 5.03 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.576 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.4 mmmp? -136.84 -175.08 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.583 HG22 ' CE3' ' A' ' 8' ' ' TRP . 68.3 mt -86.89 131.99 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.154 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 129' ' ' ASN . 7.5 p-90 -133.8 136.24 44.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.531 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 8.8 ttmt -56.8 134.87 55.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.508 HD13 ' CD1' ' A' ' 41' ' ' TRP . 17.9 mt -76.96 133.29 39.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.498 ' HB2' ' CG1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -45.84 123.23 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 136' ' ' ASP . 4.4 m -34.02 -48.44 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.86 -43.62 87.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.498 ' CG1' ' HB2' ' A' ' 136' ' ' ASP . 38.7 mm -61.65 -46.09 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.139 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -38.56 -64.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 142' ' ' GLY . 79.9 mt-30 -51.68 -68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.7 -49.09 0.72 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.558 ' HB1' ' CH2' ' A' ' 41' ' ' TRP . . . -55.72 -46.06 77.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.2 mtpp -64.82 -24.12 67.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -82.8 -42.84 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -51.48 -16.51 2.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.891 -179.888 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.563 ' CE3' HG23 ' A' ' 132' ' ' ILE . 95.0 m95 -92.91 160.79 14.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.415 ' CB ' HD23 ' A' ' 135' ' ' LEU . 39.0 t -133.16 130.95 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.457 ' CB ' HD23 ' A' ' 40' ' ' LEU . 21.9 tp -111.6 110.7 21.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.435 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 2.9 m -69.92 131.09 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.522 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 69.6 t -116.19 163.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.522 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 59.0 m-70 -100.65 114.21 27.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 15' ' ' PRO . 15.0 mm-40 -58.36 157.8 16.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.587 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.76 -33.74 3.31 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.721 -1.783 . . . . 0.0 112.338 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.548 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.5 m-90 -25.07 -59.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.498 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -33.39 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.091 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.4 m -69.6 -53.91 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 mt -40.97 -29.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.7 mp -66.56 -68.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 82' ' ' GLY . 17.4 m -61.21 -11.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.45 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 12.2 mmt180 -82.98 -39.64 21.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.86 0.87 9.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.6 mp -85.6 -50.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 111.12 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.1 tptp -88.53 121.87 31.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.405 ' C ' HG11 ' A' ' 27' ' ' VAL . 5.7 mtt-85 -103.89 -4.06 23.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 15.6 m -140.34 162.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE1' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -129.03 130.88 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -86.43 128.24 8.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.52 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.435 ' NH2' ' O ' ' A' ' 11' ' ' SER . 13.0 mmt180 -146.11 143.97 29.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.823 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.9 p -83.66 19.47 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.554 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.5 p-90 -144.53 167.62 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.454 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 6.0 t80 -108.8 136.81 47.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.566 HG23 ' CE2' ' A' ' 112' ' ' PHE . 6.1 t -130.15 104.04 16.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.703 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -65.77 117.15 7.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -120.97 121.48 38.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.91 -116.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -104.2 138.95 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.457 HD23 ' CB ' ' A' ' 10' ' ' LEU . 19.3 tp -143.76 109.38 5.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.595 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 90.7 m95 -73.4 124.49 25.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 mm -94.84 127.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.18 141.18 51.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.102 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.58 121.29 22.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 p -59.94 -177.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.26 21.34 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.073 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 8.9 ttpt -100.77 132.94 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -87.67 126.7 60.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.555 0.693 . . . . 0.0 110.928 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 134.92 29.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.1 m -79.05 153.29 77.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.669 0.747 . . . . 0.0 110.841 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -6.55 18.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.297 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 -38.47 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.85 -43.52 71.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.476 HG13 ' NE2' ' A' ' 58' ' ' GLN . 42.6 t -63.88 -51.11 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -61.1 -47.44 86.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.17 -55.34 22.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.46 -54.29 42.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.5 mt-30 -38.44 -49.06 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.14 -43.09 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -52.85 -51.3 61.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.458 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 36.0 m-85 -69.08 -37.96 78.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 66' ' ' GLY . 58.6 mtt180 -48.44 -33.11 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.1 mt -91.4 -15.69 28.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.558 ' CD1' ' NE2' ' A' ' 104' ' ' GLN . 79.6 mt -86.76 -31.51 20.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -119.36 -28.66 5.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.528 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.46 124.68 2.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.46 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -44.55 -18.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.913 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 66' ' ' GLY . 2.9 m-20 -77.66 13.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' A' ' 71' ' ' PHE . 33.9 m -69.23 174.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 2.6 pm0 -119.66 173.5 6.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 83.1 m-85 -158.93 144.37 11.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.849 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.484 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.79 152.82 69.26 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.242 . . . . 0.0 112.321 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -73.23 -28.17 62.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -144.6 174.15 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.587 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 68.5 m-85 -134.97 89.64 23.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 172.1 13.34 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.5 p -143.55 142.27 31.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 37.27 60.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.9 m -149.83 147.62 28.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.03 114.48 13.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.2 mt -81.69 -72.37 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.44 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -147.16 -143.66 3.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.595 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 11.0 t -150.95 159.03 44.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.413 HG12 ' C ' ' A' ' 83' ' ' CYS . 21.8 m -147.66 133.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.16 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.417 ' HB3' ' ND2' ' A' ' 116' ' ' ASN . 1.9 t70 -77.79 112.62 14.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -77.01 100.4 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.421 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.39 -49.23 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.34 168.28 24.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.56 96.59 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.495 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.4 mt -93.48 166.35 12.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' LYS . 44.4 t -104.2 169.88 8.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 108' ' ' SER . 9.4 mm-40 -43.84 -21.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' SER . 17.1 ttmt -90.96 -69.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -56.49 -45.95 80.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 19.5 t80 -44.55 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.5 ptpt -68.73 -42.15 78.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 8.5 mt-10 -48.4 -58.23 4.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.6 mt-30 -80.11 -48.25 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 16.7 m-85 -109.78 68.65 0.47 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.1 Cg_endo -69.84 -11.1 30.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.672 2.248 . . . . 0.0 112.316 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -78.37 -21.82 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.817 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.578 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.9 pt -124.99 22.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.472 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 49.9 p -64.26 -19.94 65.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.581 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -97.17 -27.93 14.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.581 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 15.5 mt-10 -41.01 -42.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.2 t -123.14 159.37 28.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -119.01 -21.14 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.467 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -53.81 162.31 1.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.443 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.79 -43.21 2.77 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.378 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 15.7 m-85 -112.34 101.42 9.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 95' ' ' PHE . 25.6 t -80.91 136.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CE2' HG23 ' A' ' 34' ' ' THR . 9.8 m-30 -104.44 104.34 14.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.83 120.69 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.404 ' CA ' HD12 ' A' ' 87' ' ' ILE . 4.2 m -125.43 154.18 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.95 176.16 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 56.77 53.26 6.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.2 Cg_endo -69.76 116.41 4.55 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.724 2.283 . . . . 0.0 112.371 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.36 133.89 46.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.26 124.77 44.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.404 ' HE2' ' CE2' ' A' ' 124' ' ' PHE . 14.1 mtp -66.91 147.02 53.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.4 t -68.91 -31.77 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.09 153.0 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.05 146.22 45.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.404 ' CE2' ' HE2' ' A' ' 120' ' ' MET . 0.8 OUTLIER -112.72 141.96 26.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 0.0 110.879 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 87.21 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.91 163.35 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 76.1 mttt -102.18 136.36 42.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.99 161.81 27.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.459 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -142.65 156.71 62.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.644 0.735 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -3.08 11.33 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.554 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.6 mmmp? -134.2 -173.75 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.563 HG23 ' CE3' ' A' ' 8' ' ' TRP . 95.6 mt -85.91 142.07 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.3 p-90 -149.37 127.24 11.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -55.77 127.78 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.415 HD23 ' CB ' ' A' ' 9' ' ' CYS . 60.4 mt -65.35 167.94 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.6 t70 -73.81 126.46 30.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.0 m -34.94 -42.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -71.68 -44.96 63.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.1 mm -61.47 -41.13 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.106 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -44.27 -65.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 144' ' ' LYS . 26.5 mt-30 -50.07 -68.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.5 -54.69 1.02 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.521 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.495 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -56.18 -37.29 69.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.2 mtpt -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -92.86 -47.11 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -41.56 -23.43 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 145' ' ' LYS . 11.8 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.451 ' CE3' HG21 ' A' ' 132' ' ' ILE . 91.6 m95 -77.8 159.85 28.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.781 0.324 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.9 t -137.4 125.46 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.456 ' CB ' HD21 ' A' ' 40' ' ' LEU . 66.6 tp -112.27 116.84 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 m -68.74 153.85 43.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 13' ' ' HIS . 72.5 t -135.47 158.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.466 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.8 m-70 -94.54 113.75 25.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 79.0 mt-30 -60.53 159.28 25.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.624 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 -32.74 3.73 Favored 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.698 -1.792 . . . . 0.0 112.33 -0.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.548 ' C ' ' O ' ' A' ' 15' ' ' PRO . 13.4 m-90 -25.36 -52.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -35.4 -63.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -62.01 -46.15 90.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.3 mt -45.63 -39.32 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -57.93 -66.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 82' ' ' GLY . 18.2 m -61.29 -20.94 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.477 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 11.3 mmt180 -73.87 -39.67 63.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.41 20.07 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.532 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.69 -38.4 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 13.8 tptt -102.72 102.33 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -95.97 13.39 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.2 m -144.85 146.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -117.53 134.27 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.24 126.65 8.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.47 ' N ' ' HG ' ' A' ' 108' ' ' SER . 32.0 mmt180 -152.5 150.23 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 24.5 p -88.03 21.81 2.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.425 ' CH2' HG13 ' A' ' 132' ' ' ILE . 4.2 p-90 -142.73 166.46 24.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.5 t80 -110.23 144.47 38.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.474 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.1 t -136.99 105.51 8.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -64.11 111.89 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -115.52 120.11 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.01 -121.36 1.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.446 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -106.28 139.21 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.456 HD21 ' CB ' ' A' ' 10' ' ' LEU . 38.4 tp -143.95 116.0 8.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.942 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.4 m95 -72.05 132.43 44.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -102.14 130.41 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.77 154.73 42.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.08 118.64 28.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.8 p -56.12 179.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.36 4.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 14.6 ttpt -91.86 148.81 21.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.404 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 16.6 mtmt -105.55 121.54 45.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 127.91 15.25 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.5 m -73.63 158.24 86.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.619 0.723 . . . . 0.0 110.89 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -6.15 17.87 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.722 2.281 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.49 -41.68 9.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -41.8 78.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' NE2' ' A' ' 58' ' ' GLN . 38.7 t -67.03 -50.52 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 t -62.52 -44.64 95.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.33 -54.35 21.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.494 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.6 mt -56.61 -39.13 73.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.585 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.0 mt-30 -54.52 -47.17 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.05 -35.73 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -60.86 -49.68 76.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -69.83 -39.49 76.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.462 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 45.2 mtt180 -48.01 -36.2 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.24 -16.75 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.471 HD11 ' NE2' ' A' ' 104' ' ' GLN . 59.6 mt -87.05 -27.09 23.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.8 mmm180 -123.7 -28.92 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.52 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 131.2 127.83 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.92 -19.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 9.8 t70 -76.16 8.79 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 27.2 m -63.02 -179.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 3.4 mm-40 -118.2 171.87 7.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.585 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 53.5 m-85 -162.25 137.28 5.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 152.71 69.54 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.722 2.281 . . . . 0.0 112.324 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -72.49 -28.93 63.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.0 176.1 10.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.624 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.7 m-85 -134.42 93.94 18.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.955 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.0 Cg_endo -69.77 175.07 8.6 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.703 2.268 . . . . 0.0 112.384 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m -144.47 134.66 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.824 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.59 12.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.6 m -160.14 148.57 16.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -75.11 118.59 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' N ' HD23 ' A' ' 80' ' ' LEU . 80.7 mt -85.11 -74.06 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -145.94 -145.07 4.19 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.587 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.9 p -152.75 161.28 42.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.37 . . . . 0.0 110.841 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 83' ' ' CYS . 13.5 m -146.79 146.45 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.01 107.0 18.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.68 97.9 1.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.469 HD11 ' CG ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -67.88 -47.46 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -165.25 166.67 18.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 t -127.35 99.7 5.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.49 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.0 mt -94.25 169.19 10.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 p -106.91 169.25 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 108' ' ' SER . 19.8 mm-40 -47.99 -18.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -90.69 -58.13 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -71.28 -50.68 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.569 ' CD2' HG23 ' A' ' 111' ' ' VAL . 35.2 t80 -40.22 -55.99 2.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 4.2 ptmt -66.45 -42.41 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 9.1 mt-10 -53.23 -59.2 4.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.442 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -74.76 -50.27 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.8 m-85 -111.21 67.62 0.62 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.59 0.709 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -13.89 35.35 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.686 2.257 . . . . 0.0 112.363 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -74.33 -23.07 59.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.8 pt -122.14 20.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.9 p -63.22 -23.6 67.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.62 HE21 ' N ' ' A' ' 105' ' ' GLU . 1.8 pp0? -93.13 -25.69 17.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.62 ' N ' HE21 ' A' ' 104' ' ' GLN . 36.1 mt-10 -53.14 -33.36 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.436 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 2.2 p -127.47 146.51 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 1.6 t70 -111.75 -33.77 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.47 ' HG ' ' N ' ' A' ' 30' ' ' ARG . 1.8 m -43.6 161.39 0.2 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.686 0.755 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.464 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.93 102.79 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.569 HG23 ' CD2' ' A' ' 95' ' ' PHE . 39.7 t -85.91 136.93 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 5.0 m-30 -105.07 107.05 17.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.52 118.44 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.4 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -119.39 151.3 38.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.469 ' CG ' HD11 ' A' ' 87' ' ' ILE . 13.7 mmmt -143.03 174.07 11.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 53.95 54.74 11.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.652 0.739 . . . . 0.0 110.869 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.8 Cg_endo -69.8 121.81 8.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 0.0 112.292 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -132.0 131.69 42.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -97.67 123.55 41.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.4 mtp -64.34 149.92 47.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.9 t -78.08 -21.42 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 123' ' ' LYS . 2.3 p -132.85 135.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 122' ' ' VAL . 13.1 mmtp -102.15 154.71 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.19 142.72 37.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.415 HD11 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -123.06 158.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.603 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 28.8 mtmt -92.04 134.77 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.72 167.72 46.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.473 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 1.5 t-20 -156.74 144.34 13.96 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.638 0.733 . . . . 0.0 110.884 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.1 Cg_endo -69.75 3.12 2.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.679 2.253 . . . . 0.0 112.339 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.417 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 6.9 mmmm -135.34 -173.89 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.451 HG21 ' CE3' ' A' ' 8' ' ' TRP . 71.7 mt -91.57 134.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.603 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 1.3 p-90 -143.21 130.0 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.451 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 11.2 ttmt -53.67 129.81 34.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.468 HD11 ' CD1' ' A' ' 41' ' ' TRP . 22.9 mt -65.8 162.77 18.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.3 t0 -73.67 129.77 38.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.92 -50.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -65.09 -39.68 93.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.9 mm -64.66 -47.78 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ILE . 18.0 t-160 -37.09 -65.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 91.6 mt-30 -51.66 -69.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.42 -49.14 0.67 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.572 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -55.31 -43.55 74.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.1 mtpp -67.72 -23.24 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 147' ' ' LEU . 17.7 mmtp -77.89 -53.1 7.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.17 -27.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 145' ' ' LYS . 17.6 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.843 0.354 . . . . 0.0 110.919 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.546 ' CZ2' ' HE3' ' A' ' 134' ' ' LYS . 90.4 m95 -74.26 162.56 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.774 0.321 . . . . 0.0 110.895 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.2 t -138.83 138.8 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.4 tp -123.1 111.85 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.3 p -70.54 125.83 27.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.54 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 17.7 t -107.98 160.67 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.54 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 56.1 m-70 -91.14 111.14 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.493 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 70.0 mt-30 -58.85 159.93 12.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.664 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.75 -31.36 4.6 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.375 -0.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CZ2' HD13 ' A' ' 57' ' ' LEU . 9.1 m-90 -25.98 -54.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -36.52 -58.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 66.4 m -66.08 -40.74 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.87 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.0 mt -51.94 -26.34 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 9.2 mp -71.24 -69.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.885 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 m -58.84 -15.0 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.084 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.9 mmt180 -79.98 -39.49 29.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.44 6.21 8.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.458 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.81 -47.59 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 3.4 tptp -90.35 117.7 29.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 13.2 ttt180 -102.62 0.09 32.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 17.6 m -147.01 154.96 11.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 8.2 tm-20 -122.54 153.3 39.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -112.7 130.55 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.528 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.428 ' HG3' ' CZ2' ' A' ' 32' ' ' TRP . 9.2 mmt180 -149.05 149.7 31.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.433 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 57.7 p -85.27 20.36 2.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.521 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.9 p-90 -145.09 167.68 22.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.0 t80 -108.82 141.35 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.403 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 6.9 t -134.93 103.56 10.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.571 0.7 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.9 Cg_endo -69.71 2.39 3.55 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.273 . . . . 0.0 112.336 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -60.89 108.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.467 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 6.3 mmt85 -111.65 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.15 -123.2 1.65 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.1 ttm105 -104.98 140.97 37.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.0 tp -143.98 114.41 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 91.1 m95 -71.27 131.93 44.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.96 127.49 56.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.99 49.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.23 119.36 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.5 p -54.24 -174.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.78 -10.47 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 4.9 ttpt -73.6 148.7 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.479 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 1.2 pmtp? -108.53 132.56 21.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 0.0 110.872 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -73.97 159.81 83.24 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -8.3 23.26 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.739 2.293 . . . . 0.0 112.345 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -42.43 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -40.94 84.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.463 HG11 ' NE2' ' A' ' 58' ' ' GLN . 62.1 t -65.07 -51.15 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -64.07 -45.82 87.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.25 -53.27 46.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.574 HD13 ' CZ2' ' A' ' 16' ' ' TRP . 79.2 mt -56.03 -43.33 77.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.2 mt-30 -51.73 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.71 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -61.49 -48.76 79.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -70.89 -33.52 70.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 43.6 mtt180 -53.5 -36.07 61.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.4 -12.8 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.429 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 71.4 mt -90.65 -29.04 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.965 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.429 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.8 mmp_? -122.92 -29.06 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 134.12 129.01 2.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.9 -18.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.319 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.7 t70 -82.43 20.4 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 29.3 m -70.91 179.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 13.2 mt-10 -116.61 166.9 11.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 52.7 m-85 -159.87 138.56 7.78 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 0.0 110.842 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.3 Cg_endo -69.77 163.86 36.71 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.08 -22.91 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -150.61 166.69 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.1 m-85 -130.44 87.93 48.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.903 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 171.62 14.14 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.642 2.228 . . . . 0.0 112.325 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.6 p -138.91 144.38 39.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.6 89.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 67.0 m -149.79 146.74 27.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.26 118.66 19.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.69 -71.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.33 -150.44 5.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.501 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -149.59 153.69 37.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.89 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.3 m -140.2 142.23 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.29 114.45 21.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tt -77.1 95.67 4.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.482 HD11 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -64.61 -46.05 93.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.467 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 1.6 m-20 -166.7 165.9 16.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.411 ' SG ' ' CE1' ' A' ' 112' ' ' PHE . 1.2 t -127.37 99.04 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.484 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 83.0 mt -97.02 170.91 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 30.4 t -110.04 169.11 8.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -46.62 -20.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 91' ' ' SER . 24.7 ttmt -89.64 -60.62 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -70.53 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 21.1 t80 -39.24 -54.95 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.9 ptmm? -68.45 -47.52 66.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.7 mt-10 -46.01 -54.37 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -81.18 -51.81 8.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 18.6 m-85 -107.11 70.92 0.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.627 0.727 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.441 ' CD ' ' O ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.77 -17.48 37.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.385 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.3 -26.7 60.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.594 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.1 pt -120.23 24.35 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.457 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 22.1 p -68.25 -21.16 64.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.538 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -96.42 -23.52 16.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.538 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 11.3 mt-10 -48.04 -41.24 25.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 t -124.1 143.02 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -104.3 -28.63 11.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -45.85 161.49 0.26 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.652 0.739 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.433 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.2 Cg_endo -69.78 -43.66 2.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -112.92 102.49 10.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 95' ' ' PHE . 59.3 t -85.18 136.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.413 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 7.3 m-30 -105.0 104.22 13.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.818 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.17 121.84 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.106 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.482 ' CA ' HD11 ' A' ' 87' ' ' ILE . 3.7 m -122.78 154.09 38.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.48 ' CG ' HD12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -139.45 177.03 8.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 52.6 53.54 12.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.902 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.0 Cg_endo -69.66 117.46 5.09 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -131.33 143.59 50.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -107.95 120.6 42.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.446 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 14.2 mtp -62.67 153.47 32.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.62 -32.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.76 132.57 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.446 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 16.8 mmtm -102.18 154.28 19.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -120.48 142.35 33.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 88.23 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.92 165.24 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.6 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 50.0 mtpt -107.23 135.6 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.17 171.89 37.58 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.477 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -150.29 156.43 37.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.316 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.521 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.7 mmmm -139.37 -175.33 4.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.49 HG21 ' CE3' ' A' ' 8' ' ' TRP . 62.0 mt -84.8 132.18 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.6 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 4.4 p-90 -138.71 131.74 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.546 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 12.3 ttmt -58.25 128.78 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 41' ' ' TRP . 22.4 mt -64.68 170.61 3.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -78.63 127.01 31.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.41 -50.3 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -65.46 -40.29 93.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.9 mm -64.12 -45.93 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -40.45 -65.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.9 mt-30 -52.44 -70.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.67 -43.49 0.8 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.469 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.571 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . . . -61.55 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -61.06 -20.89 63.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' LEU . 18.3 mmmt -90.33 -48.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -40.94 -21.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 145' ' ' LYS . 42.0 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.864 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.597 ' CZ2' ' HD3' ' A' ' 134' ' ' LYS . 92.7 m95 -93.5 167.92 11.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -141.28 159.28 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.43 HD21 ' CD ' ' A' ' 28' ' ' GLU . 31.7 tp -145.42 116.65 7.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 2.7 t -67.99 146.34 53.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.51 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 74.3 t -134.26 153.97 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.422 ' N ' HG13 ' A' ' 12' ' ' VAL . 39.2 m-70 -88.68 113.68 24.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 46.3 mt-30 -59.94 161.88 11.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.621 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -28.43 6.25 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.338 -0.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.562 ' CZ2' HD13 ' A' ' 57' ' ' LEU . 10.5 m-90 -28.7 -53.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -35.57 -64.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.42 -43.22 99.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.6 mt -48.97 -36.61 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.8 mp -59.75 -64.83 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 82' ' ' GLY . 14.2 m -63.33 -17.92 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.481 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.0 mmt180 -76.49 -39.98 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.54 18.84 3.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.61 -37.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 111.162 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 4.9 tptp -102.91 95.54 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -92.24 14.53 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 30.6 m -146.76 143.94 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.51 ' OE2' ' CG2' ' A' ' 12' ' ' VAL . 2.5 tt0 -115.97 141.79 47.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.62 122.83 7.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -146.29 149.1 33.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 41.2 p -86.41 23.15 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.473 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -146.01 160.16 42.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -100.78 138.95 37.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.48 HG21 ' CE2' ' A' ' 112' ' ' PHE . 10.6 t -133.16 100.03 14.44 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.565 0.698 . . . . 0.0 111.109 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.76 8.9 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.354 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.421 ' H ' ' C ' ' A' ' 34' ' ' THR . 23.3 t60 -67.27 108.18 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.439 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 63.3 mmt-85 -106.86 115.83 30.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.45 -138.72 6.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -94.92 142.61 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -143.97 115.98 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.07 138.35 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.952 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -109.04 127.3 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.59 152.18 39.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.63 119.03 25.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.1 p -54.4 -179.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.142 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.83 22.41 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 4.8 ttpt -110.59 132.06 54.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -91.75 130.62 38.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.547 0.689 . . . . 0.0 110.937 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.6 Cg_endo -69.73 134.24 27.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 m -75.51 159.21 82.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.697 0.761 . . . . 0.0 110.857 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.689 2.259 . . . . 0.0 112.343 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -94.34 -42.34 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -40.28 86.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.5 t -65.62 -50.73 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.03 -42.3 99.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -67.92 -53.74 24.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.562 HD13 ' CZ2' ' A' ' 16' ' ' TRP . 93.9 mt -59.14 -38.74 80.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.569 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 10.5 mt-30 -55.26 -46.15 76.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -35.35 38.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -61.42 -51.63 67.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -67.48 -41.29 84.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.935 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.473 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 52.3 mtt180 -48.16 -36.07 12.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.907 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -86.74 -16.19 37.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD12 ' NE2' ' A' ' 104' ' ' GLN . 61.8 mt -88.17 -27.25 21.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -123.38 -26.93 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 127.74 129.03 3.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.455 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.29 -19.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -72.59 3.85 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 35.2 m -61.65 178.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -119.73 167.85 11.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 67.8 m-85 -155.47 141.14 12.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.9 Cg_endo -69.77 165.87 29.51 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.66 2.24 . . . . 0.0 112.323 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -88.88 -20.75 24.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.48 174.38 14.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.621 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 87.7 m-85 -134.99 89.73 23.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.66 0.743 . . . . 0.0 110.947 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.44 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.7 Cg_endo -69.75 168.9 20.21 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.719 2.279 . . . . 0.0 112.354 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.0 m -134.91 139.58 45.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.92 92.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 81.5 m -152.76 157.33 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.69 117.83 21.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.1 mt -85.87 -71.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.459 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -149.4 -140.35 3.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.484 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.2 p -156.33 166.36 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 16.4 m -154.16 138.71 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -81.6 113.91 19.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.66 94.38 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.473 HD12 ' CG ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -62.67 -46.85 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -165.53 170.19 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.17 102.08 6.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.7 mt -95.87 171.18 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.947 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 93' ' ' LYS . 5.3 p -106.92 169.2 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 108' ' ' SER . 10.0 mm-40 -43.87 -22.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' SER . 31.7 ttpt -92.65 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -56.3 -46.42 79.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.506 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 17.6 t80 -41.95 -58.95 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -68.86 -44.91 72.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 8.0 mt-10 -43.06 -55.72 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.449 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.9 mt-30 -83.62 -43.4 15.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.0 m-85 -115.81 68.41 3.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.681 0.753 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 96' ' ' LYS . 53.9 Cg_endo -69.76 -12.86 33.77 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 0.0 112.365 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.29 -16.45 60.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.466 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -128.77 21.15 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.473 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 21.9 p -60.25 -25.87 66.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.576 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -94.28 -28.8 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.576 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 20.8 mt-10 -47.44 -36.95 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 t -120.04 157.57 28.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.401 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 3.5 t0 -125.17 -29.27 3.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.505 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -50.19 161.54 0.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.893 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.6 Cg_endo -69.78 -41.53 4.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.673 2.248 . . . . 0.0 112.311 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -115.65 101.69 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 21.4 t -84.97 139.85 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' A' ' 34' ' ' THR . 7.3 m-30 -105.9 105.59 15.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.95 119.91 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.472 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.8 m -122.51 154.18 38.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.473 ' CG ' HD12 ' A' ' 87' ' ' ILE . 6.5 mmtp -141.36 177.07 8.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 53.51 51.6 8.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.74 120.6 7.37 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.99 138.94 47.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -101.73 123.13 45.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.5 mtp -65.43 136.58 56.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.07 -27.72 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 143.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mttp -114.23 142.73 45.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.03 146.37 33.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.91 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 89.92 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.28 157.82 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.624 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 10.5 pttm -92.33 157.17 16.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.41 -177.59 28.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.507 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.491 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.5 t30 -169.74 146.83 2.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.617 0.722 . . . . 0.0 110.885 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.0 Cg_endo -69.79 0.32 5.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.353 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.5 mmmm -133.93 -172.78 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.473 HG13 ' CH2' ' A' ' 32' ' ' TRP . 34.6 mt -82.93 130.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.624 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 6.1 p-90 -136.23 110.04 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.597 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 1.2 ttpp -54.76 127.09 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 41' ' ' TRP . 30.9 mt -57.4 169.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.58 163.1 28.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -42.25 99.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -77.08 -34.67 56.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.7 mm -72.22 -37.1 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.406 ' NE2' ' HD2' ' A' ' 144' ' ' LYS . 22.4 t-160 -48.89 -63.85 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 142' ' ' GLY . 34.4 mt-30 -50.67 -67.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -33.87 -54.33 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.482 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.485 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . . . -52.61 -43.53 65.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 141' ' ' GLN . 11.3 mtpt -66.17 -15.45 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -99.4 -34.09 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.02 9.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.916 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -73.81 160.89 30.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.728 0.299 . . . . 0.0 110.904 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.458 ' CB ' ' HG ' ' A' ' 135' ' ' LEU . 9.7 t -135.54 123.02 22.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.432 ' CB ' HD21 ' A' ' 40' ' ' LEU . 61.9 tp -112.11 118.31 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' CA ' ' A' ' 128' ' ' GLY . 3.2 m -71.83 155.13 40.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 53.4 t -138.44 162.3 30.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.543 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 67.2 m-70 -97.36 114.89 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.6 mm-40 -59.8 158.55 23.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 110.861 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HB3' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.77 -33.28 3.47 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 -1.807 . . . . 0.0 112.358 -0.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.566 ' CZ2' HD12 ' A' ' 57' ' ' LEU . 16.7 m-90 -25.01 -56.88 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -33.81 -53.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.7 m -72.9 -50.99 20.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.7 mt -40.55 -32.43 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.8 mp -64.75 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 m -60.78 -16.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.47 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.5 mmt180 -77.19 -39.31 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.21 12.17 5.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.29 -48.62 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 11.3 tptt -89.15 117.08 27.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.9 ttm180 -101.07 -6.85 23.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.5 m -133.33 158.34 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.52 124.97 41.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.18 128.45 8.85 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -147.51 147.74 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.404 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.1 p -85.15 17.52 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.452 ' CH2' HG13 ' A' ' 132' ' ' ILE . 2.5 p-90 -142.51 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 34' ' ' THR . 4.1 t80 -106.36 139.3 41.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.576 HG22 ' CE2' ' A' ' 112' ' ' PHE . 8.1 t -134.32 101.71 12.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.613 0.72 . . . . 0.0 111.163 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.447 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.8 6.79 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.357 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.403 ' H ' ' C ' ' A' ' 34' ' ' THR . 16.4 t60 -64.54 108.82 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.447 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.8 mmt-85 -105.23 112.67 25.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.31 -152.43 23.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -79.28 143.57 35.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.829 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.432 HD21 ' CB ' ' A' ' 10' ' ' LEU . 25.2 tp -143.87 115.08 7.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 95.5 m95 -71.12 124.8 25.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.72 122.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.131 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.92 149.84 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.21 123.63 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 p -59.43 -174.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.27 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -81.41 135.0 35.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.25 41.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.618 0.723 . . . . 0.0 110.867 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 129.54 17.76 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -76.35 159.27 80.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.68 0.752 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -3.62 12.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.96 -41.41 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.88 -43.31 72.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.3 t -65.78 -52.54 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -59.75 -45.7 91.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.34 -56.67 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.566 HD12 ' CZ2' ' A' ' 16' ' ' TRP . 92.1 mt -55.9 -38.51 70.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 9.7 mt-30 -57.46 -43.53 84.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.43 -32.61 32.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -66.24 -52.29 49.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 64' ' ' LEU . 31.9 m-85 -66.32 -38.26 87.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.464 ' O ' ' C ' ' A' ' 66' ' ' GLY . 65.0 mtt180 -47.71 -34.2 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.62 -16.01 31.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.468 HD11 ' NE2' ' A' ' 104' ' ' GLN . 48.6 mt -87.28 -29.96 21.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -120.27 -29.13 4.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.95 124.87 2.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -43.99 -21.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.776 0.322 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' GLY . 6.5 t0 -79.85 18.88 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 24.9 m -69.07 -178.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' O ' ' CD1' ' A' ' 71' ' ' PHE . 5.4 pt-20 -117.51 166.3 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -158.92 135.53 6.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.692 0.758 . . . . 0.0 110.87 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 145.76 58.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.364 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.19 -27.08 66.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.426 ' C ' ' CD1' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -149.4 -178.11 6.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.563 ' CE2' ' HB3' ' A' ' 15' ' ' PRO . 13.9 m-85 -141.19 105.0 6.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 178.35 4.65 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.652 2.235 . . . . 0.0 112.371 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.1 p -142.66 130.49 21.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.12 48.75 66.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 59.3 m -150.62 148.42 28.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.33 115.29 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.3 mt -83.25 -71.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.15 -139.68 3.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 7.1 p -155.81 157.68 36.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.418 HG13 ' C ' ' A' ' 83' ' ' CYS . 21.9 m -144.63 136.7 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.74 110.94 14.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.6 96.16 4.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.423 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -64.29 -50.37 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 87' ' ' ILE . 0.6 OUTLIER -161.23 167.88 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 t -128.2 101.3 6.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.492 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 80.8 mt -98.61 170.88 8.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 93' ' ' LYS . 29.3 t -109.44 169.18 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.455 ' NE2' ' O ' ' A' ' 108' ' ' SER . 20.4 mm-40 -46.29 -20.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 91' ' ' SER . 19.5 tttt -89.56 -60.61 1.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -70.02 -50.4 41.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.57 ' CD2' HG21 ' A' ' 111' ' ' VAL . 28.7 t80 -39.72 -55.32 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.8 ptmm? -67.96 -47.49 68.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.504 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 5.8 mt-10 -45.88 -55.93 6.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.479 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.0 mt-30 -78.67 -52.73 8.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.479 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 23.9 m-85 -108.15 70.1 0.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.77 -15.46 37.07 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.647 2.231 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -73.36 -26.3 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.479 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.4 pt -118.96 21.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.6 p -64.49 -22.14 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.606 HE21 ' N ' ' A' ' 105' ' ' GLU . 1.7 pp0? -96.04 -21.4 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.606 ' N ' HE21 ' A' ' 104' ' ' GLN . 7.5 mt-10 -56.23 -36.25 68.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.49 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.5 p -125.85 138.35 53.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.854 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 15.4 t70 -104.57 -30.57 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.455 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -44.28 161.04 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.673 0.749 . . . . 0.0 110.866 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.404 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.1 Cg_endo -69.75 -47.8 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.406 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 22.1 m-85 -110.0 99.52 8.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.57 HG21 ' CD2' ' A' ' 95' ' ' PHE . 46.5 t -80.86 144.61 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.576 ' CE2' HG22 ' A' ' 34' ' ' THR . 12.6 m-30 -110.99 106.18 15.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.07 120.0 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.421 ' C ' HD13 ' A' ' 87' ' ' ILE . 3.8 m -126.03 153.64 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.419 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 16.6 mmmt -143.09 174.07 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.62 52.97 5.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.3 Cg_endo -69.71 119.47 6.42 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.337 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -132.05 134.26 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -99.79 126.01 45.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 mtp -65.69 152.82 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.23 -36.58 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.07 142.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.152 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -104.74 152.4 22.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.02 139.53 24.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.01 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.66 160.35 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.599 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 5.7 mtmp? -92.12 128.29 37.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.419 ' CA ' ' OG ' ' A' ' 11' ' ' SER . . . -89.37 151.6 22.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.499 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -132.33 154.0 81.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 2.28 3.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.432 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 7.1 mmmm -135.83 -174.12 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.452 HG13 ' CH2' ' A' ' 32' ' ' TRP . 58.1 mt -89.05 132.57 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.599 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.3 p-90 -140.69 129.83 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.05 127.35 28.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.458 ' HG ' ' CB ' ' A' ' 9' ' ' CYS . 31.2 mt -62.45 166.86 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 4.4 t0 -76.38 129.04 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -35.55 -38.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -75.47 -42.62 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 mm -64.16 -40.16 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -44.22 -65.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 142' ' ' GLY . 28.3 mt-30 -51.86 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.05 -49.01 1.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.494 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.66 -51.02 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.104 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 144' ' ' LYS . 2.0 mtpm? -57.84 -32.45 67.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 147' ' ' LEU . 21.3 mmmt -71.59 -50.8 27.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.74 -25.51 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 145' ' ' LYS . 23.6 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.478 ' CH2' ' NZ ' ' A' ' 134' ' ' LYS . 91.7 m95 -72.39 167.51 20.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -135.85 140.54 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.1 tp -131.12 106.66 8.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -67.65 147.32 52.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 29.4 t -132.35 157.88 43.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.486 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.8 m-70 -88.03 115.26 25.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.479 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 45.1 mt-30 -61.22 162.21 14.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.78 -27.46 6.82 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.318 0.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.568 ' CZ2' HD12 ' A' ' 57' ' ' LEU . 11.5 m-90 -30.33 -52.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -35.88 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' LEU . 1.7 m -61.33 -52.75 63.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' SER . 57.1 mt -38.37 -41.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.481 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -55.99 -68.37 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -59.84 -12.94 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.7 mmt180 -83.13 -39.57 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.97 -6.5 8.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -78.8 -46.96 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.467 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 12.3 tptt -94.64 111.94 23.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -108.41 16.67 22.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 27.2 m -149.6 143.95 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -111.69 150.14 30.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.476 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -115.37 123.95 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.53 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 85.2 mmt-85 -149.8 151.71 34.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.49 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.2 t -87.93 24.0 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.53 ' CZ2' ' HD2' ' A' ' 30' ' ' ARG . 3.3 p-90 -144.6 157.78 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -99.26 137.77 37.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.538 HG21 ' CE2' ' A' ' 112' ' ' PHE . 9.3 t -133.59 100.94 13.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.577 0.704 . . . . 0.0 111.169 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.4 Cg_endo -69.77 6.22 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.712 2.275 . . . . 0.0 112.365 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -64.63 111.37 2.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' A' ' 34' ' ' THR . 15.8 mmt180 -112.67 110.54 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.14 -142.37 8.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.445 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.1 ttp-105 -82.11 142.31 32.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.854 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 tp -143.69 106.83 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.59 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 91.4 m95 -71.8 118.83 15.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 mm -91.59 129.85 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.75 148.57 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.42 112.42 19.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -48.5 175.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.57 -12.46 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -74.35 142.22 45.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -103.22 131.59 21.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.547 0.689 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 133.42 25.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.638 2.225 . . . . 0.0 112.392 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.8 m -82.16 159.17 65.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.683 0.754 . . . . 0.0 110.815 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -2.81 10.79 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.506 ' NE2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -94.31 -46.53 7.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -69.28 -41.19 77.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.433 HG12 ' NE2' ' A' ' 58' ' ' GLN . 56.9 t -63.15 -51.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -60.51 -44.22 96.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.506 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 18.6 mt-10 -66.69 -57.24 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.568 HD12 ' CZ2' ' A' ' 16' ' ' TRP . 90.0 mt -54.03 -40.25 66.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.7 mt-30 -55.0 -45.57 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -34.98 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.086 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -61.99 -50.76 70.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.408 ' O ' ' N ' ' A' ' 64' ' ' LEU . 30.9 m-85 -68.7 -39.18 80.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' GLY . 59.7 mtt180 -47.67 -34.03 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 25.7 mt -90.57 -15.53 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.43 HD11 ' NE2' ' A' ' 104' ' ' GLN . 59.1 mt -88.0 -29.42 20.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -121.21 -28.96 4.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.499 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.37 125.35 2.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.482 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.57 -19.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' GLY . 11.6 t70 -80.69 16.52 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 27.6 m -66.75 -177.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.502 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.4 pt-20 -116.09 170.07 8.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 52.1 m-85 -163.27 136.56 4.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.677 0.751 . . . . 0.0 110.855 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.446 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 54.4 Cg_endo -69.75 158.9 55.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.66 2.24 . . . . 0.0 112.385 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -76.92 -30.28 56.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -148.73 177.9 9.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.594 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 57.4 m-85 -134.87 95.84 15.13 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.65 0.738 . . . . 0.0 110.884 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.5 Cg_endo -69.8 -179.92 3.27 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.375 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -145.62 143.94 30.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.5 47.23 92.16 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 87.3 m -156.27 146.95 21.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.368 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.458 HD21 ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -74.53 121.51 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.458 ' N ' HD21 ' A' ' 80' ' ' LEU . 16.9 mt -88.9 -71.2 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.948 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.95 -147.47 4.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.455 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.59 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.1 p -153.57 154.68 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.425 HG11 ' C ' ' A' ' 83' ' ' CYS . 24.3 m -140.7 141.4 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.25 111.34 18.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -75.85 99.06 4.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.424 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.34 -48.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.181 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -162.27 168.57 22.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.87 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.43 103.11 7.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.493 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 87.0 mt -98.76 166.87 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 93' ' ' LYS . 48.5 t -104.72 168.5 9.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -45.81 -20.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.6 ttpt -91.3 -63.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.59 -49.48 75.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 103' ' ' SER . 61.3 t80 -43.2 -56.2 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.457 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -66.38 -38.36 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.16 -55.21 35.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.45 ' NE2' HD22 ' A' ' 90' ' ' LEU . 10.8 mt-30 -78.48 -52.09 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.4 m-85 -109.85 68.22 0.46 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.665 0.745 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.8 Cg_endo -69.81 -14.23 35.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.12 -22.31 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pt -121.34 8.22 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.501 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 89.5 p -49.06 -25.27 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -90.7 -28.69 18.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.881 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 4.1 mt-10 -56.36 -22.57 31.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 p -113.98 160.3 18.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -134.88 -33.15 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.476 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -62.34 165.51 8.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.719 0.771 . . . . 0.0 110.826 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.49 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.84 -45.11 1.66 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -110.55 98.0 7.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.476 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 13.5 t -83.37 140.26 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 34' ' ' THR . 3.0 m-30 -107.57 110.48 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.15 122.13 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.7 m -124.95 154.86 40.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -142.04 176.29 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 57.5 52.67 5.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.76 117.38 5.05 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.671 2.248 . . . . 0.0 112.354 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -133.08 139.08 46.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -101.47 125.55 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.2 mtp -67.01 150.91 48.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.2 t -75.18 -31.01 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.4 146.35 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -112.74 149.48 32.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.54 ' CD2' HG22 ' A' ' 139' ' ' ILE . 1.2 m-85 -115.18 141.07 26.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.864 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 84.58 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.341 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.2 158.81 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 39.5 mmtt -91.45 121.84 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.66 155.79 53.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -148.85 156.0 40.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -51.12 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.667 2.245 . . . . 0.0 112.32 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.446 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.0 mmmm -86.54 -174.53 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 133' ' ' TRP . 66.3 mt -83.03 141.63 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.571 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 1.6 p-90 -146.88 123.98 11.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.478 ' NZ ' ' CH2' ' A' ' 8' ' ' TRP . 1.1 ttmp? -56.1 128.31 34.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 mt -63.06 169.97 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.1 t70 -75.15 127.67 33.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.47 -40.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -40.99 63.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.54 HG22 ' CD2' ' A' ' 124' ' ' PHE . 22.2 mm -65.0 -44.37 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.9 t-160 -37.84 -62.51 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' GLY . 23.8 mt-30 -52.96 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.93 -46.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.52 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.95 -49.18 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -58.71 -27.82 65.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.4 mmpt? -76.37 -49.41 16.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.42 -22.72 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.449 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 145' ' ' LYS . 25.1 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.0 p -154.54 157.5 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -152.27 151.99 31.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.858 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.25 109.94 3.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m -81.87 41.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -91.14 153.49 20.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.91 93.67 0.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.57 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.4 m95 -82.48 161.62 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.748 0.309 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.6 t -138.12 130.18 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.9 tp -118.56 114.33 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.0 t -67.91 150.03 49.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 32.3 t -133.29 156.75 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.475 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 41.7 m-70 -90.73 115.38 27.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.491 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 65.9 mt-30 -61.66 160.82 24.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.962 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.83 -31.86 4.31 Favored 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.718 -1.784 . . . . 0.0 112.297 0.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.542 ' C ' ' O ' ' A' ' 15' ' ' PRO . 13.2 m-90 -25.47 -53.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -37.51 -61.3 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 7.2 m -64.88 -42.82 94.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.7 mt -51.77 -31.12 25.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 5.5 mp -66.27 -64.28 0.89 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.9 m -63.99 -16.39 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -76.87 -39.52 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.808 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 18.7 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.515 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.49 -42.1 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 17.3 tptt -99.05 104.54 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -97.87 17.34 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 27.4 m -149.38 147.1 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 3.5 tm-20 -118.62 141.81 48.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.516 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -102.89 126.82 8.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 12.6 mmt180 -148.42 146.37 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.472 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 10.4 m -84.25 20.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.563 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.3 p-90 -144.63 166.43 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -107.75 140.43 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.54 HG21 ' CE2' ' A' ' 112' ' ' PHE . 5.1 t -134.08 106.45 11.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.59 0.709 . . . . 0.0 111.128 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.3 Cg_endo -69.8 3.07 3.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.308 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -63.13 111.74 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 7.7 mmt85 -116.1 121.79 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.65 -126.69 2.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.522 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -98.62 138.36 35.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.833 0.349 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 tp -143.93 112.86 6.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.579 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 86.2 m95 -71.34 133.86 46.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -104.1 126.84 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.54 145.57 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.64 117.06 22.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.3 p -53.21 176.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.86 -11.38 59.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.45 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 5.7 ttpt -73.06 146.53 45.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -104.08 134.08 19.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 0.0 110.91 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.75 127.26 14.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.623 2.215 . . . . 0.0 112.364 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.9 m -73.23 155.59 89.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.648 0.737 . . . . 0.0 110.871 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -5.33 15.9 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.713 2.275 . . . . 0.0 112.309 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.48 -39.83 10.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.38 -39.13 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.9 t -66.3 -54.74 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.119 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 t -59.09 -43.78 91.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.16 -56.43 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.2 mt -54.94 -39.6 69.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.1 mt-30 -55.44 -45.76 76.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.0 -33.81 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -63.44 -51.17 66.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -68.55 -35.81 77.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' A' ' 67' ' ' LYS . 35.5 mtt-85 -50.96 -34.13 27.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.64 -13.2 34.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.453 HD12 ' NE2' ' A' ' 104' ' ' GLN . 73.5 mt -90.55 -29.24 17.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.7 mmm180 -121.47 -28.71 4.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.514 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 134.01 126.66 2.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.434 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 13.6 ptmt -45.98 -19.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.313 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -82.27 19.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 21.2 m -67.24 -178.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -114.96 162.81 16.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 47.9 m-85 -157.61 134.94 6.89 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 22' ' ' ARG . 54.3 Cg_endo -69.79 162.54 41.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 0.0 112.343 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -82.19 -29.27 31.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -147.35 175.19 10.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.604 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 51.7 m-85 -134.96 95.68 15.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.651 0.739 . . . . 0.0 110.966 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.411 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.76 177.02 6.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.357 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.5 p -147.22 138.38 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 43.78 47.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 64.8 m -156.36 149.74 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.19 118.21 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -84.5 -73.95 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.97 -144.29 4.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.579 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.9 p -153.32 155.41 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.408 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 26.2 m -140.97 136.41 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -77.85 110.43 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 tt -75.0 101.85 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.45 HD11 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -72.99 -47.12 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -164.53 167.09 19.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.401 ' SG ' ' CD1' ' A' ' 112' ' ' PHE . 1.2 t -127.74 97.46 4.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.485 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.8 mt -90.51 170.66 10.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.41 ' C ' ' N ' ' A' ' 93' ' ' LYS . 7.5 p -108.14 169.22 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 108' ' ' SER . 14.2 mm-40 -45.11 -21.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.41 ' N ' ' C ' ' A' ' 91' ' ' SER . 24.2 tttt -92.02 -63.54 1.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -61.38 -48.47 81.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.567 ' CD2' HG23 ' A' ' 111' ' ' VAL . 21.8 t80 -42.38 -57.81 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 9.7 ptpt -67.79 -43.59 79.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -48.36 -58.6 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.471 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.4 mt-30 -79.39 -47.16 16.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.3 m-85 -110.24 67.82 0.49 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.626 0.727 . . . . 0.0 110.846 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.6 Cg_endo -69.81 -12.4 32.73 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -77.84 -20.94 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.538 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 2.1 pt -126.46 23.51 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.459 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 40.7 p -64.16 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.56 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -94.35 -30.02 14.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.56 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 30.0 mt-10 -45.51 -36.24 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 t -122.97 153.89 39.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.439 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 16.4 t70 -119.48 -30.55 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.472 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -47.35 161.04 0.33 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 110.825 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.472 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.7 Cg_endo -69.7 -37.88 8.7 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.7 2.267 . . . . 0.0 112.374 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -118.74 102.81 9.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 95' ' ' PHE . 29.3 t -86.62 132.25 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.164 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 34' ' ' THR . 3.9 m-30 -99.63 105.21 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.81 122.56 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.45 ' CA ' HD11 ' A' ' 87' ' ' ILE . 2.1 m -125.71 154.44 42.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -141.9 175.2 9.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.44 53.2 8.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.646 0.736 . . . . 0.0 110.87 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.8 116.89 4.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.314 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -130.38 131.77 45.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.97 121.69 39.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.0 mtp -62.77 149.2 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 149' ' ' LYS . 47.5 t -74.91 -35.75 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.33 134.16 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -102.43 149.49 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.454 ' CD2' HD12 ' A' ' 139' ' ' ILE . 0.8 OUTLIER -116.27 142.49 29.45 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.652 0.739 . . . . 0.0 110.857 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.413 ' C ' HD13 ' A' ' 126' ' ' ILE . 2.8 pp -125.69 164.36 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.598 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 40.6 mttp -105.23 139.18 40.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.03 172.81 37.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -154.17 153.57 28.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 1.75 4.15 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.354 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.563 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.2 mmmm -137.72 -174.95 3.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.57 HG22 ' CE3' ' A' ' 8' ' ' TRP . 75.5 mt -86.08 134.27 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.598 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.5 p-90 -140.64 130.71 24.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -57.94 128.04 35.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.554 HD11 ' CD1' ' A' ' 41' ' ' TRP . 29.3 mt -62.6 170.83 2.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.9 t0 -82.05 129.14 34.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -35.41 -49.5 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.84 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -65.3 -39.76 92.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 26.9 mm -64.75 -47.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.37 -61.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 142' ' ' GLY . 38.2 mt-30 -54.37 -69.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.55 -49.68 1.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.466 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . . . -55.99 -44.27 78.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.7 mtpp -65.07 -22.88 67.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -84.46 -40.72 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -53.35 -14.77 3.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.5 mt -88.12 26.5 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.9 ptp -85.38 -25.04 27.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.479 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 19.2 mmmt -146.83 153.71 40.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -130.55 176.68 7.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -65.32 174.57 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -74.79 -27.0 60.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.61 -58.49 7.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 t -59.0 -46.78 87.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.866 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 p -163.03 154.55 17.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.35 91.49 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.506 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.2 t -108.88 106.38 16.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.889 0.376 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 m -125.85 165.82 18.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.64 91.25 1.07 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.552 ' CZ2' ' HE3' ' A' ' 134' ' ' LYS . 92.5 m95 -84.56 163.58 19.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 133' ' ' TRP . 13.5 p -139.65 156.68 46.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -138.57 113.76 9.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 p -68.39 138.09 55.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 29.6 t -124.22 152.16 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 35.8 m-70 -87.4 114.89 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 57.9 mt-30 -60.58 161.44 14.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.77 -29.17 5.86 Favored 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.322 -0.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.512 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.6 m-90 -28.53 -49.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -37.77 -64.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 -42.1 99.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.2 mt -49.82 -35.33 22.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.476 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.2 mp -61.92 -64.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 22' ' ' ARG . 10.2 m -64.07 -22.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.4 mmt180 -69.32 -39.47 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.1 22.19 3.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.485 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.22 -44.62 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.466 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 13.8 tptt -95.01 101.25 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.428 ' C ' HG12 ' A' ' 27' ' ' VAL . 17.2 ptt180 -96.85 17.2 17.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 32.7 m -149.02 150.37 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.44 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.8 122.18 7.42 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.447 ' N ' ' CB ' ' A' ' 108' ' ' SER . 16.4 mmt180 -147.8 150.09 33.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.463 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 80.0 p -86.13 21.28 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.506 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 5.7 p-90 -142.19 157.53 44.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.447 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 4.9 t80 -100.73 141.43 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.561 HG23 ' CE2' ' A' ' 112' ' ' PHE . 9.4 t -134.84 101.04 11.79 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 4.53 2.16 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.664 2.243 . . . . 0.0 112.337 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -65.9 110.55 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -113.95 120.44 40.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.08 -120.48 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -106.06 140.68 38.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.891 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -144.19 114.7 7.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 95.6 m95 -72.37 132.25 43.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.1 mm -101.03 128.61 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.23 152.63 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.64 118.74 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -55.29 175.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.76 -18.32 60.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.061 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 7.9 ttpt -68.88 148.43 50.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.3 135.27 19.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 53.9 Cg_endo -69.75 127.98 15.38 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.342 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m -73.86 159.62 83.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.623 0.725 . . . . 0.0 110.883 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -6.75 19.34 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.37 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.63 -42.06 8.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.954 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.55 -42.72 86.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 ' NE2' ' A' ' 58' ' ' GLN . 27.7 t -66.34 -52.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -59.77 -45.23 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.41 -56.65 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.4 mt -53.96 -43.05 69.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 7.8 mt-30 -49.88 -46.56 51.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.57 -38.89 39.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -56.86 -52.06 66.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -68.98 -40.17 78.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' NH1' ' O ' ' A' ' 67' ' ' LYS . 44.7 mtt-85 -48.69 -35.17 13.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.2 mt -88.87 -14.75 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.3 mt -89.44 -28.12 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.405 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.8 mmm180 -121.91 -29.18 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 130.83 127.32 2.87 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.453 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -44.63 -21.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 66' ' ' GLY . 14.2 t0 -74.1 7.95 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.806 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 27.1 m -62.45 -178.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 2.4 mm-40 -117.0 172.42 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 56.7 m-85 -164.32 135.61 3.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.62 0.724 . . . . 0.0 110.939 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.82 161.77 44.66 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.296 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -83.73 -26.94 29.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -148.88 173.55 13.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.5 m-85 -134.69 95.38 15.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.687 0.756 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.2 Cg_endo -69.79 -178.21 2.25 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.6 m -149.93 139.05 21.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.52 44.6 63.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 19.6 m -156.68 149.06 23.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -74.81 118.37 17.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.47 ' N ' HD23 ' A' ' 80' ' ' LEU . 63.5 mt -83.07 -73.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.33 -141.02 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.498 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -151.92 166.87 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.42 HG13 ' C ' ' A' ' 83' ' ' CYS . 21.7 m -154.07 149.37 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -95.38 109.2 21.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -72.82 96.88 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.474 HD13 ' CG ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -66.7 -48.44 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.95 167.45 22.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.4 t -127.67 98.2 5.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.499 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 98.1 mt -94.45 166.71 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 93' ' ' LYS . 9.6 t -106.73 166.29 10.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 108' ' ' SER . 19.7 mm-40 -42.06 -23.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 91' ' ' SER . 24.9 ttmt -86.61 -63.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -66.09 -49.97 65.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' CD2' HG21 ' A' ' 111' ' ' VAL . 37.9 t80 -42.03 -56.78 2.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -67.16 -41.33 86.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.1 -59.18 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.461 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -77.2 -48.36 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 30.8 m-85 -111.1 66.26 0.55 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.73 -12.73 33.56 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.91 -24.12 55.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.436 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 2.3 pt -120.49 17.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.437 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 27.2 p -58.05 -24.96 60.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.814 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.604 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -91.26 -31.95 15.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.947 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.604 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 27.2 mt-10 -43.37 -37.1 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 t -125.96 146.92 49.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -33.77 6.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.5 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.8 m -45.12 161.62 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 0.0 110.867 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.463 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.2 Cg_endo -69.71 -48.8 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.353 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 18.4 m-85 -105.62 102.9 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 95' ' ' PHE . 20.1 t -86.2 137.3 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CE2' HG23 ' A' ' 34' ' ' THR . 11.1 m-30 -103.39 107.54 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.69 117.48 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.125 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -118.49 151.13 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.474 ' CG ' HD13 ' A' ' 87' ' ' ILE . 12.7 mmmt -143.1 175.62 9.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 52.09 52.34 11.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 0.0 110.915 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.0 Cg_endo -69.68 120.18 7.02 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.312 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -129.21 132.25 47.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -97.07 122.46 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.466 ' HE3' ' CE2' ' A' ' 124' ' ' PHE . 16.4 mtp -65.63 143.05 57.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.56 -24.73 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.01 138.73 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -106.79 149.08 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.466 ' CE2' ' HE3' ' A' ' 120' ' ' MET . 1.1 m-85 -116.84 142.32 29.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 86.76 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.276 . . . . 0.0 112.334 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.39 168.13 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.608 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 7.4 mtmp? -109.42 142.31 40.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.26 163.32 14.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -141.79 161.92 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 1.8 4.1 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.306 . . . . 0.0 112.317 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.1 mmmm -137.78 -175.08 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.487 HG23 ' CE3' ' A' ' 8' ' ' TRP . 97.1 mt -83.77 134.86 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.608 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 11.0 p-90 -140.75 127.34 20.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.97 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.552 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 9.7 ttmt -54.41 130.79 40.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.579 HD11 ' CD1' ' A' ' 41' ' ' TRP . 20.5 mt -66.4 176.37 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.9 t0 -86.18 126.03 33.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.23 -41.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -72.1 -43.23 65.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.497 ' N ' ' O ' ' A' ' 136' ' ' ASP . 30.0 mm -62.97 -43.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -40.25 -67.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 142' ' ' GLY . 70.1 mt-30 -49.03 -69.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.15 -46.57 0.98 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.44 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.67 -47.58 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -60.44 -25.18 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -85.58 -39.49 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.95 -8.85 6.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.482 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.7 mt -83.88 29.3 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.954 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.452 ' O ' ' C ' ' A' ' 149' ' ' LYS . 6.9 ptp -109.77 175.82 5.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 148' ' ' MET . 58.5 tttt 34.37 38.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -49.05 173.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -70.82 171.05 11.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -93.63 35.94 1.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -130.64 -60.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.095 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 m -99.56 -53.61 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.91 0.386 . . . . 0.0 110.88 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -84.55 93.3 8.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.08 58.95 0.59 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.489 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 m -105.22 132.48 51.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -119.15 26.0 9.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.788 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.93 61.16 6.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.457 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.518 ' CE3' HG21 ' A' ' 132' ' ' ILE . 92.0 m95 -72.52 163.29 28.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 t -136.4 129.91 31.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.454 ' CB ' HD21 ' A' ' 40' ' ' LEU . 60.3 tp -116.87 113.49 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.64 150.95 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 13' ' ' HIS . 94.1 t -138.18 146.46 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.082 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.477 ' N ' HG13 ' A' ' 12' ' ' VAL . 35.6 m-70 -82.01 119.75 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 56.5 mt-30 -64.63 162.28 36.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.589 0.709 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.78 -30.9 4.89 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.354 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.551 ' C ' ' O ' ' A' ' 15' ' ' PRO . 12.9 m-90 -25.08 -55.93 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -34.5 -61.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 4.7 m -64.61 -40.11 94.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.8 mt -54.23 -30.81 51.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -65.15 -65.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.44 HG21 ' CD ' ' A' ' 119' ' ' GLU . 5.4 m -63.31 -17.95 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -74.93 -39.28 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.77 20.07 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -107.09 -44.01 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -97.32 113.83 25.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.421 ' C ' HG12 ' A' ' 27' ' ' VAL . 11.3 ptm180 -109.84 19.84 18.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.8 m -152.54 145.2 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.65 142.17 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -106.48 126.07 8.36 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.453 ' N ' ' CB ' ' A' ' 108' ' ' SER . 33.1 mmt180 -150.0 150.47 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 110.836 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.468 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 8.8 m -84.66 25.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.513 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -147.47 162.98 37.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -104.64 141.53 36.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.486 HG22 ' CE2' ' A' ' 112' ' ' PHE . 10.3 t -134.37 99.11 13.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 0.0 111.191 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.438 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.6 Cg_endo -69.83 4.93 1.93 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -65.49 112.89 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 6.3 mmt85 -113.29 122.95 48.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.37 -129.49 2.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -99.15 140.03 33.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.454 HD21 ' CB ' ' A' ' 10' ' ' LEU . 24.5 tp -144.17 112.57 6.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.582 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 83.2 m95 -70.93 128.83 37.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.77 123.75 53.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.18 148.52 41.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.075 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.78 120.52 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.432 HG22 ' C ' ' A' ' 12' ' ' VAL . 73.2 p -55.73 169.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.79 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.3 ttpt -65.86 147.97 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -105.4 134.32 19.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.593 0.711 . . . . 0.0 110.894 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.73 126.63 13.56 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.33 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 m -72.22 158.91 86.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.725 . . . . 0.0 110.875 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.01 22.52 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.632 2.221 . . . . 0.0 112.351 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 52' ' ' GLN . 8.1 mm100 -94.4 -36.26 11.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.48 -41.2 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.45 HG11 ' NE2' ' A' ' 58' ' ' GLN . 34.7 t -68.15 -45.99 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.5 t -66.88 -42.87 84.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.19 -52.8 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.59 -41.11 85.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 9.3 mt-30 -53.06 -47.56 68.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -36.99 50.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 m -59.97 -51.68 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.169 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -69.26 -37.46 77.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 66' ' ' GLY . 53.9 mtt180 -48.81 -33.44 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.7 mt -90.83 -15.91 29.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.463 HD13 ' NE2' ' A' ' 104' ' ' GLN . 71.8 mt -87.25 -29.69 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -120.81 -29.13 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.62 126.35 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -44.8 -20.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -80.85 17.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 20.4 m -66.12 -178.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.8 162.97 15.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.572 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 44.4 m-85 -157.94 133.16 5.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.53 30.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -85.49 -29.21 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -146.78 173.21 12.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.645 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.71 96.2 15.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.698 0.761 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.423 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.71 172.7 12.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.264 . . . . 0.0 112.343 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.5 p -138.86 139.23 38.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.12 52.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 58.7 m -158.52 149.21 20.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.43 120.74 23.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.451 ' C ' ' OE1' ' A' ' 119' ' ' GLU . 35.9 mt -89.33 -71.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.422 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.33 -145.97 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.493 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.582 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.5 p -152.99 157.48 40.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.897 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.4 m -140.9 144.32 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -85.81 113.7 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.59 100.01 5.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.411 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.37 -48.07 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -163.09 167.26 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.77 101.19 6.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.49 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.8 mt -96.01 169.41 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' PHE . 13.2 p -108.36 169.12 8.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.839 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 108' ' ' SER . 21.8 mm-40 -47.25 -19.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 91' ' ' SER . 15.0 ttmm -90.35 -59.11 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -70.85 -50.13 38.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CD2' HG23 ' A' ' 111' ' ' VAL . 27.5 t80 -41.51 -54.85 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -67.52 -40.77 85.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.42 -58.72 6.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -75.67 -49.95 16.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.2 m-85 -109.85 68.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.656 0.741 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.75 -13.4 34.65 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -76.92 -24.68 52.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.496 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.1 pt -120.18 23.48 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 p -64.39 -27.15 68.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -90.33 -28.76 18.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.594 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 18.0 mt-10 -45.71 -39.38 7.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.937 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.4 t -124.64 147.95 48.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 7.3 t0 -110.99 -33.87 6.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.453 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 1.7 m -42.81 161.52 0.18 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 0.0 110.857 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.468 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.77 -45.49 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.692 2.262 . . . . 0.0 112.309 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -110.59 104.95 13.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.568 HG23 ' CD2' ' A' ' 95' ' ' PHE . 21.4 t -90.33 133.61 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 2.2 m-30 -100.86 109.73 21.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.36 121.94 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -124.56 154.04 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -141.4 175.8 9.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.97 52.41 5.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.651 0.739 . . . . 0.0 110.902 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.78 114.94 3.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.254 . . . . 0.0 112.318 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -130.08 145.31 51.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.451 ' OE1' ' C ' ' A' ' 81' ' ' LEU . 3.7 tp10 -107.14 123.56 48.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.426 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 12.8 mtp -63.13 149.26 45.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.39 -23.46 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.3 p -130.09 149.95 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 20.2 mmtm -117.35 151.81 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -120.43 141.68 32.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.656 0.741 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 86.5 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.73 165.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.617 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 48.8 mttp -101.59 143.17 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -87.44 -177.13 48.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 20.6 t-20 -170.52 142.45 1.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.632 0.729 . . . . 0.0 110.862 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.2 Cg_endo -69.74 9.76 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.685 2.257 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASN . 9.8 mmmm -141.44 -174.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.518 HG21 ' CE3' ' A' ' 8' ' ' TRP . 54.2 mt -88.6 132.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.617 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.0 p-90 -139.32 127.54 22.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.24 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.558 HD12 ' CD1' ' A' ' 41' ' ' TRP . 25.5 mt -61.0 172.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.45 152.65 30.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -58.9 -39.57 81.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -78.37 -38.09 42.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.3 mm -68.44 -36.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -49.07 -65.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 142' ' ' GLY . 47.5 mt-30 -48.51 -67.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.13 -52.65 1.25 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.575 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.0 -42.03 65.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.141 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 141' ' ' GLN . 9.8 mtpt -69.8 -17.86 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -90.17 -44.42 9.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.71 -19.69 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.6 mt -83.07 34.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.9 ptp -93.67 -36.5 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 150' ' ' GLN . 14.5 ttmt -122.12 49.49 1.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.464 ' O ' ' C ' ' A' ' 151' ' ' ASN . 4.9 mm-40 -33.89 136.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 153' ' ' ALA . 12.3 m120 33.04 46.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 151' ' ' ASN . 59.9 pttt -34.16 -33.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 151' ' ' ASN . . . -56.64 -60.3 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.079 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 180.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m -137.82 110.61 7.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 110.909 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 t -53.08 113.45 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.74 44.7 0.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.497 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.5 t -81.25 105.97 12.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 0.0 110.881 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -71.95 143.21 49.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.33 91.35 0.64 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.457 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.553 ' CE3' HG21 ' A' ' 132' ' ' ILE . 91.5 m95 -77.42 161.76 27.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.762 0.315 . . . . 0.0 110.889 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.1 t -138.22 133.44 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.417 HD23 ' CD ' ' A' ' 28' ' ' GLU . 62.6 tp -121.16 114.24 21.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -67.92 154.67 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 37.2 t -137.08 155.95 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.461 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 35.3 m-70 -88.53 113.51 24.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 63.1 mt-30 -60.61 161.1 15.53 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.655 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.8 -30.13 5.32 Favored 'Cis proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 -1.819 . . . . 0.0 112.35 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.56 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 11.0 m-90 -27.63 -52.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.476 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -34.64 -62.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 m -64.98 -45.93 83.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -45.57 -30.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.0 mp -68.55 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 82' ' ' GLY . 15.9 m -61.11 -13.9 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.418 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -81.26 -39.46 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.04 -19.93 5.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -64.85 -60.32 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 111.174 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' CD ' ' OH ' ' A' ' 61' ' ' TYR . 7.5 tptp -83.34 120.97 26.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.423 ' C ' HG13 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -113.22 11.72 18.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 33.6 m -142.52 156.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.499 ' OE2' ' CG2' ' A' ' 12' ' ' VAL . 3.2 tt0 -120.9 138.11 54.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.457 ' O ' ' NH1' ' A' ' 30' ' ' ARG . . . -102.64 123.62 7.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 75.9 mmt-85 -149.16 151.15 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.845 0.355 . . . . 0.0 110.849 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.466 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.3 m -87.6 18.67 3.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.555 ' CZ2' ' HD2' ' A' ' 30' ' ' ARG . 6.4 p-90 -142.36 161.39 38.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.6 t80 -102.56 147.97 26.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.577 HG21 ' CE2' ' A' ' 112' ' ' PHE . 5.2 t -140.62 106.97 6.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 0.0 111.172 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.95 3.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.363 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -64.53 114.87 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -119.65 120.41 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.06 -122.58 1.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -105.09 139.49 39.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.877 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 tp -143.67 114.02 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.579 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 87.6 m95 -72.1 128.69 36.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -98.71 132.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.118 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.35 155.87 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.81 119.13 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -56.27 173.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.83 63.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 5.9 ttpt -65.37 146.4 54.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.19 135.49 19.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.577 0.703 . . . . 0.0 110.863 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.76 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.662 2.241 . . . . 0.0 112.354 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -71.55 159.63 84.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.696 0.76 . . . . 0.0 110.828 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -9.95 27.33 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 0.0 112.349 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -94.4 -37.97 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.72 -39.49 70.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.465 HG12 ' NE2' ' A' ' 58' ' ' GLN . 41.6 t -67.76 -46.32 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.15 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -67.4 -42.11 83.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.94 -48.96 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.56 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 83.5 mt -62.46 -40.85 97.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 9.3 mt-30 -54.81 -44.6 73.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.81 -34.82 30.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -62.04 -51.75 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.443 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 14.9 m-85 -67.5 -40.37 85.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.938 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.487 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 51.8 mtt180 -47.03 -35.93 7.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.08 -17.97 31.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' TYR . 60.2 mt -86.01 -26.8 25.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -123.69 -27.72 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 128.28 129.87 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -46.84 -18.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -72.73 3.61 4.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.526 HG22 ' CE2' ' A' ' 71' ' ' PHE . 34.3 m -62.02 179.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 12.1 pt-20 -122.93 173.77 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 72.9 m-85 -161.82 138.43 6.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.595 0.712 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 156.12 64.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.636 2.224 . . . . 0.0 112.337 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -72.91 -31.28 64.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -146.74 176.84 9.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.7 94.93 16.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 0.0 110.936 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.419 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 54.0 Cg_endo -69.74 173.99 10.14 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.2 p -142.59 135.49 28.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' O ' ' SG ' ' A' ' 79' ' ' CYS . . . 72.86 50.09 14.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 78' ' ' GLY . 23.5 m -161.24 148.47 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 0.0 110.882 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -75.39 118.19 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' N ' HD22 ' A' ' 80' ' ' LEU . 40.3 mt -85.62 -70.94 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.402 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -147.36 -145.08 4.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.482 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.579 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 4.2 p -154.32 155.27 34.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 20.0 m -141.41 137.32 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.83 112.63 16.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tt -77.81 101.83 6.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.411 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.94 -47.33 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -163.44 169.0 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.4 t -127.4 100.83 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.483 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.7 mt -94.94 170.84 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 93' ' ' LYS . 32.8 t -110.9 169.04 9.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.445 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 18.6 mm-40 -45.83 -20.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' N ' ' C ' ' A' ' 91' ' ' SER . 32.7 ttpt -89.35 -60.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -68.9 -50.55 48.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.483 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 39.4 t80 -39.11 -55.66 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 7.0 ptmm? -68.59 -47.92 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.51 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.5 mt-10 -46.79 -58.57 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.438 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -76.56 -51.47 11.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 37.9 m-85 -110.03 67.81 0.47 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 110.916 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.74 -14.7 36.51 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.349 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.4 -23.31 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pt -121.38 15.27 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.3 p -55.96 -18.52 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.89 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.575 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -98.27 -31.6 11.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 10.8 mt-10 -46.14 -27.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -134.4 145.72 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -111.02 -35.3 5.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -42.34 161.72 0.16 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.702 0.763 . . . . 0.0 110.833 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.466 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.78 -48.92 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -106.56 103.63 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.475 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 26.2 t -88.95 136.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.577 ' CE2' HG21 ' A' ' 34' ' ' THR . 5.0 m-30 -102.33 108.47 19.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.57 120.46 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.445 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.2 m -124.87 154.09 41.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.21 175.99 9.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.449 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.22 54.17 9.64 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.855 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 116.99 4.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.656 2.237 . . . . 0.0 112.331 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -127.8 137.79 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.49 ' O ' ' NE2' ' A' ' 150' ' ' GLN . 7.1 tm-20 -103.73 118.55 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.9 mtp -62.75 139.03 58.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.4 t -65.86 -30.83 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.47 143.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -111.68 151.89 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -118.36 141.04 28.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 0.0 110.862 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 82.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.11 166.69 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.592 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 34.3 mtpt -108.95 159.99 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.23 177.6 16.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -154.56 163.16 25.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 0.0 110.885 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 129' ' ' ASN . 53.5 Cg_endo -69.74 19.66 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.357 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.555 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.8 mmmm -152.82 -175.03 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.553 HG21 ' CE3' ' A' ' 8' ' ' TRP . 60.0 mt -84.33 131.75 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.592 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.1 p-90 -131.88 139.76 48.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -70.81 127.09 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 41' ' ' TRP . 22.3 mt -65.09 164.18 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.8 t0 -75.65 129.5 37.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -37.25 -47.76 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -66.77 -37.01 83.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 136' ' ' ASP . 11.9 mm -67.3 -48.1 79.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 139' ' ' ILE . 15.0 t-160 -37.09 -64.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.831 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 142' ' ' GLY . 36.1 mt-30 -51.37 -69.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.84 -49.48 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.421 ' HB1' ' CZ2' ' A' ' 41' ' ' TRP . . . -56.48 -45.02 81.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.8 mtpp -64.61 -23.34 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.52 -38.0 16.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -61.35 -6.64 8.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.409 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 85.5 mt -83.84 27.34 0.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 ptp -109.08 143.02 38.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.886 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm 39.21 54.02 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 119' ' ' GLU . 1.3 mt-30 -75.94 -71.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -133.19 147.57 52.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.17 -39.99 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.9 -58.78 6.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 1' ' ' GLY . 74.4 m -37.79 111.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.84 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 t -59.28 166.82 2.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.92 62.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 t -102.33 78.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 0.0 110.862 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 m -156.37 150.57 25.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.35 91.37 1.53 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.48 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.415 ' CH2' ' HE3' ' A' ' 134' ' ' LYS . 91.7 m95 -78.11 164.35 25.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t -137.12 144.84 43.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.7 tp -130.94 114.66 15.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.3 p -70.42 133.35 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 53.4 t -118.89 153.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.427 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 34.4 m-70 -88.49 113.0 23.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 78.5 mt-30 -59.76 160.01 16.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.614 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.76 -32.09 4.14 Favored 'Cis proline' 0 C--N 1.342 0.212 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.322 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.551 ' C ' ' O ' ' A' ' 15' ' ' PRO . 10.7 m-90 -25.12 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -37.76 -64.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.074 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.9 m -62.45 -42.43 99.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.0 mt -50.34 -37.64 37.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -58.96 -66.81 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.41 -27.12 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 11.0 mmt180 -66.86 -39.5 87.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.11 15.19 5.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.24 -41.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.8 tptp -99.64 100.87 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -93.41 16.11 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.409 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 27.8 m -149.04 145.85 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 2.8 tm-20 -114.23 142.11 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -103.13 128.42 9.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.1 mmt180 -151.59 146.63 25.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -85.08 17.96 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.561 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.8 p-90 -141.44 165.36 27.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.29 141.39 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.404 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.0 t -135.99 104.73 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 0.0 111.169 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.8 Cg_endo -69.77 4.3 2.28 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -64.85 111.82 2.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -115.55 119.99 37.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.84 -129.6 2.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.1 ttm-85 -96.5 139.41 32.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.88 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.4 tp -144.08 111.44 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 91.1 m95 -71.25 127.91 34.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -98.65 129.5 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.71 150.0 48.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.38 118.66 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.0 p -55.07 178.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.61 -14.07 60.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.1 ttpt -70.55 147.23 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.427 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -103.79 134.08 19.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.612 0.72 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 127.11 14.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.699 2.266 . . . . 0.0 112.358 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.4 m -72.61 155.05 91.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -7.21 20.45 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -94.55 -40.16 10.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -38.13 73.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.474 HG11 ' NE2' ' A' ' 58' ' ' GLN . 58.1 t -66.28 -50.2 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.129 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -64.27 -44.48 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.38 -49.73 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.527 HD13 ' CZ2' ' A' ' 16' ' ' TRP . 82.1 mt -62.72 -43.05 99.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 8.8 mt-30 -53.6 -43.4 68.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.4 29.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 m -62.38 -52.76 62.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.152 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -66.29 -38.49 87.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.445 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 66.5 mtt180 -49.81 -36.63 27.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.75 -12.76 44.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.505 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 69.0 mt -91.14 -28.04 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.505 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.7 mmp_? -123.64 -22.12 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 123.67 130.04 3.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -47.89 -18.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.73 0.3 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 1.4 6.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 34.9 m -59.29 179.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -120.07 166.96 12.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 55.6 m-85 -158.31 134.77 6.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.597 0.713 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.71 163.06 39.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.272 . . . . 0.0 112.357 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -83.01 -29.16 29.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.66 173.5 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.614 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 42.3 m-85 -134.79 98.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 110.901 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.7 Cg_endo -69.76 176.4 6.82 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -143.96 133.54 23.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.57 47.86 19.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.1 m -157.81 149.17 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -77.98 115.45 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.957 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.433 ' N ' HD22 ' A' ' 80' ' ' LEU . 69.8 mt -82.12 -72.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.1 -147.2 4.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.481 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.576 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 10.5 p -152.84 153.33 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 21.1 m -139.28 143.19 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.13 112.85 20.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tt -76.98 100.16 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.428 HD11 ' C ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -69.72 -46.83 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -165.44 167.54 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.45 99.25 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.502 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 99.1 mt -95.07 165.73 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 93' ' ' LYS . 17.7 t -103.92 169.03 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -41.12 -24.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' SER . 32.2 ttpt -87.32 -70.15 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.625 ' NE2' HE21 ' A' ' 98' ' ' GLN . 21.6 mm100 -57.12 -47.04 82.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.603 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 19.4 t80 -43.64 -57.21 3.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -69.36 -44.87 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.0 mt-10 -47.08 -59.56 3.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.869 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.625 HE21 ' NE2' ' A' ' 94' ' ' GLN . 6.3 mt-30 -79.1 -48.23 14.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.3 m-85 -110.06 67.64 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.642 0.735 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.418 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.71 -12.34 32.78 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.752 2.301 . . . . 0.0 112.313 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.24 -21.16 54.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.603 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.6 pt -125.43 23.95 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 p -65.35 -24.49 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.566 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -95.33 -25.59 16.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.566 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 24.1 mt-10 -48.17 -36.89 14.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -129.99 134.81 47.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -108.28 27.16 9.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.42 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 88.7 p -96.06 155.59 38.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.705 0.764 . . . . 0.0 110.841 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 53.9 Cg_endo -69.76 -24.36 29.74 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.413 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 17.1 m-85 -134.63 90.21 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.573 HG22 ' CD2' ' A' ' 95' ' ' PHE . 40.8 t -79.38 136.82 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.123 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 3.7 m-30 -103.98 104.13 14.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.88 122.72 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.129 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.428 ' C ' HD11 ' A' ' 87' ' ' ILE . 13.7 m -126.89 155.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -143.34 176.25 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.456 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.17 53.93 6.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.859 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.76 115.16 3.96 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.632 2.221 . . . . 0.0 112.357 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.54 134.64 49.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 150' ' ' GLN . 14.5 tm-20 -100.61 120.82 40.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.457 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 13.6 mtp -62.5 152.92 33.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.0 t -78.67 -27.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.5 149.44 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.457 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 7.7 mmtm -114.21 144.77 42.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.457 ' CD2' HG21 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -114.84 140.79 25.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.51 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.359 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.37 168.58 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.596 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 47.5 mmtm -111.99 141.99 44.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.67 175.44 26.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.432 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -155.54 162.01 28.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.671 0.748 . . . . 0.0 110.875 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 1.78 4.11 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.561 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.9 mmmm -137.17 -175.01 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 79.4 mt -85.88 133.52 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.596 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.6 p-90 -137.13 127.31 26.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.415 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 11.0 ttmt -55.72 133.69 50.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.566 HD11 ' CD1' ' A' ' 41' ' ' TRP . 18.3 mt -68.17 174.17 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.49 158.71 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.85 -48.65 78.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -70.5 -37.16 74.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.457 HG21 ' CD2' ' A' ' 124' ' ' PHE . 44.9 mm -68.84 -41.29 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -45.58 -62.86 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 142' ' ' GLY . 46.4 mt-30 -53.59 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.57 -51.32 0.76 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.517 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.546 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -53.07 -47.6 68.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.5 mtpp -60.75 -24.24 65.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -50.81 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.87 -19.83 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.423 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 48.5 mt -82.74 37.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 10.4 ptp -100.59 -39.94 7.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -134.91 67.39 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.471 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 2.7 mm-40 -53.99 -75.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -162.96 156.13 19.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.94 -39.17 2.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -47.54 -56.77 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.064 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 150' ' ' GLN . 14.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.139 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.0 p -94.0 174.95 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p -54.92 132.05 45.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.1 158.43 30.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.9 p -105.99 79.11 1.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.853 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 m -137.99 146.0 42.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.861 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.58 89.05 0.93 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.532 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.577 ' CE3' HG21 ' A' ' 132' ' ' ILE . 88.6 m95 -76.3 168.13 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.903 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.429 ' CB ' ' HG ' ' A' ' 135' ' ' LEU . 11.8 t -141.69 145.0 34.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.4 tp -134.47 112.03 10.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 13.1 p -67.99 137.77 55.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 25.3 t -121.73 157.52 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.493 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.3 m-70 -89.29 116.22 27.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.483 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 52.5 mt-30 -62.79 161.86 25.7 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 110.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.83 -28.98 5.98 Favored 'Cis proline' 0 C--N 1.341 0.15 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.328 0.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.507 ' C ' ' O ' ' A' ' 15' ' ' PRO . 12.5 m-90 -29.02 -53.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -33.38 -64.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -63.0 -45.04 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.5 mt -46.36 -35.54 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.479 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -62.25 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG22 ' CD ' ' A' ' 119' ' ' GLU . 5.3 m -65.93 -12.18 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.103 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.5 mmt180 -84.14 -39.6 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.53 20.38 3.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.474 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.38 -36.16 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 18.0 tptt -107.65 99.15 8.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' C ' HG13 ' A' ' 27' ' ' VAL . 22.4 ptt180 -96.53 29.1 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.2 m -156.55 145.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -121.31 118.98 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.456 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -84.99 123.19 6.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 14.7 mmt180 -142.72 152.3 42.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 110.859 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.471 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 17.8 p -86.93 18.18 3.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.548 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.0 p-90 -142.62 163.95 31.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -105.58 138.79 41.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.41 ' C ' ' H ' ' A' ' 36' ' ' HIS . 6.7 t -132.26 100.56 15.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.611 0.72 . . . . 0.0 111.099 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.1 Cg_endo -69.78 7.31 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.41 ' H ' ' C ' ' A' ' 34' ' ' THR . 28.7 t60 -63.83 107.76 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 44.2 mmt-85 -105.48 108.17 19.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.14 -145.19 10.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.408 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 0.2 OUTLIER -86.72 142.73 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.861 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.4 tp -144.13 115.34 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.605 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 90.4 m95 -73.37 137.75 44.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.0 mm -107.13 132.64 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.61 145.54 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.95 125.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.7 p -61.13 -178.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.08 7.13 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -99.92 129.94 46.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.06 135.71 28.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.498 0.666 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.76 133.99 26.9 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m -76.46 161.44 74.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.672 0.749 . . . . 0.0 110.851 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.18 27.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -43.23 8.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.35 -40.91 90.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG11 ' NE2' ' A' ' 58' ' ' GLN . 60.8 t -65.05 -56.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -57.4 -42.79 82.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -66.61 -57.73 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.431 HD12 ' CZ2' ' A' ' 16' ' ' TRP . 87.4 mt -54.22 -42.1 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.4 mt-30 -55.11 -42.54 73.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.5 -31.6 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.4 m -66.09 -52.02 52.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.84 -36.14 79.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -50.68 -34.23 25.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.5 mt -90.6 -12.57 36.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD13 ' NE2' ' A' ' 104' ' ' GLN . 61.3 mt -91.59 -28.14 17.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.984 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 4.3 mmm180 -121.97 -29.18 4.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.516 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.78 127.43 2.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -46.53 -19.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.47 16.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.516 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 21.4 m -65.29 179.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -115.98 160.06 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 51.2 m-85 -153.16 139.8 12.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.74 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.491 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.8 Cg_endo -69.79 170.61 16.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.6 -22.34 19.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.49 172.08 16.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.9 m-85 -134.97 87.96 28.29 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 0.0 110.933 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.45 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.1 Cg_endo -69.71 172.04 13.31 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -137.15 144.18 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.88 44.81 95.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.464 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.28 158.24 41.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.461 HD21 ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -85.04 117.23 23.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.461 ' N ' HD21 ' A' ' 80' ' ' LEU . 16.3 mt -85.87 -69.46 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.45 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -148.51 -142.49 3.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.605 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 35.7 t -154.41 162.33 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.439 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 22.4 m -149.85 140.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -81.75 114.86 20.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.17 97.78 5.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.466 HD12 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -67.89 -47.79 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -164.54 166.35 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -127.43 101.4 6.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.474 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.2 mt -99.48 167.04 10.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 95' ' ' PHE . 33.0 t -106.89 169.04 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.842 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -46.41 -20.48 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 12.6 tttm -85.08 -58.04 2.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -77.22 -51.31 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 111' ' ' VAL . 42.1 t80 -38.89 -50.14 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.08 -42.76 68.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -55.12 -61.39 2.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.8 mt-30 -71.38 -50.53 31.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 113' ' ' ILE . 25.0 m-85 -109.42 68.26 0.41 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.657 0.741 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.75 -14.66 36.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.279 . . . . 0.0 112.304 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.12 -23.77 57.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.453 ' CG2' ' CD ' ' A' ' 105' ' ' GLU . 1.2 pt -120.32 19.38 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 p -60.62 -27.32 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.6 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.2 pp0? -93.47 -25.09 17.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.6 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 16.8 mt-10 -49.92 -32.28 14.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.6 t -130.95 150.94 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.02 -23.89 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.796 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.402 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 1.8 m -51.19 160.19 0.94 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.647 0.737 . . . . 0.0 110.836 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.471 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.3 Cg_endo -69.73 -45.64 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.36 100.87 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 95' ' ' PHE . 39.4 t -84.74 142.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' N ' HG12 ' A' ' 111' ' ' VAL . 6.5 m-30 -109.13 106.92 17.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -74.56 122.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.466 ' CA ' HD12 ' A' ' 87' ' ' ILE . 3.5 m -125.43 155.21 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -143.18 176.62 8.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.492 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.58 51.2 6.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 0.0 110.941 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.7 Cg_endo -69.7 121.72 8.42 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.647 2.232 . . . . 0.0 112.367 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -136.4 136.1 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.454 ' CD ' HG22 ' A' ' 21' ' ' VAL . 4.3 tp10 -98.25 124.57 42.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.6 mtp -63.12 151.7 39.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.9 -31.04 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.19 145.01 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -107.18 148.86 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -113.18 142.28 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 82.54 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.233 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 pp -118.82 159.74 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 37.7 mttp -95.16 139.94 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.19 -179.6 46.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.48 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.9 t30 -165.53 145.24 5.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 53.8 Cg_endo -69.75 4.04 2.42 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.689 2.26 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.548 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 12.1 mmmm -136.36 -174.42 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.577 HG21 ' CE3' ' A' ' 8' ' ' TRP . 73.2 mt -88.53 130.01 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.7 p-90 -138.93 125.59 20.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -55.36 125.56 21.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.429 ' HG ' ' CB ' ' A' ' 9' ' ' CYS . 22.7 mt -59.76 169.64 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 139' ' ' ILE . 7.6 t0 -77.46 126.87 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.4 m -35.7 -41.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -72.85 -41.26 64.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.5 mm -64.85 -42.64 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -42.62 -64.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 142' ' ' GLY . 80.1 mt-30 -53.13 -66.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.0 -42.02 0.7 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.534 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . . . -65.18 -46.67 79.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -56.35 -26.37 52.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -80.05 -53.01 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -37.25 -27.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.495 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 145' ' ' LYS . 14.7 mt -84.51 38.55 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.6 ptp -99.5 -37.4 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.834 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -134.61 76.74 1.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -64.38 168.4 5.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.975 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -52.77 162.57 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -71.91 -40.36 68.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -59.53 -57.78 11.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.112 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t 60.35 44.09 12.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.388 . . . . 0.0 110.894 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 t 65.27 39.99 5.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.82 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.02 140.8 6.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.4 t -125.7 107.73 10.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.825 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.5 m -142.97 157.17 44.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.861 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.41 88.91 1.51 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.509 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.512 ' CH2' ' HE3' ' A' ' 134' ' ' LYS . 91.8 m95 -78.25 164.02 25.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.92 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 t -138.23 138.64 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.8 tp -125.56 111.94 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 22.2 p -68.3 140.0 55.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 37.7 t -126.3 152.14 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -85.87 116.3 24.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 54.7 mt-30 -62.54 162.1 22.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 -28.46 6.24 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.4 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.569 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 12.9 m-90 -29.11 -51.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.469 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -34.23 -62.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.106 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -65.69 -47.03 76.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.1 mt -44.04 -28.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.7 mp -70.59 -65.51 0.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -61.3 -12.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -82.47 -39.8 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.57 -17.2 5.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.6 mp -68.16 -59.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.108 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 4.5 tptp -82.71 117.69 22.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.442 ' C ' HG13 ' A' ' 27' ' ' VAL . 3.6 ptp180 -114.06 12.85 18.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 25.3 m -147.37 149.88 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -115.78 146.2 42.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.473 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -111.26 112.72 3.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.539 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 22.8 mmt180 -137.99 148.77 45.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.467 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 61.6 p -84.39 21.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.441 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 4.6 p-90 -141.84 161.84 36.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -105.12 141.47 36.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.0 t -135.19 105.01 10.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.609 0.719 . . . . 0.0 111.186 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 3.21 2.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.307 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -64.87 113.55 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -117.7 119.81 36.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.22 -124.93 1.63 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -100.98 140.75 34.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.852 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.5 tp -144.13 111.32 5.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 93.1 m95 -71.21 126.55 29.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 mm -96.84 125.49 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.8 148.87 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.89 117.46 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 p -54.08 -178.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.28 19.15 5.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.46 126.82 46.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -82.61 124.64 77.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.58 0.705 . . . . 0.0 110.871 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 126.61 13.48 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.351 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 m -70.04 156.08 92.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.616 0.722 . . . . 0.0 110.881 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -7.13 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.736 2.291 . . . . 0.0 112.341 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -35.18 12.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.96 -40.55 60.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.96 -47.22 82.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.7 t -65.47 -44.71 86.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.52 -52.57 30.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.569 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 77.1 mt -55.37 -40.2 71.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 12.5 mt-30 -54.95 -49.27 71.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.64 -33.07 62.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -64.28 -48.01 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -72.76 -30.03 63.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -56.48 -36.26 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.0 mt -89.59 -13.25 37.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 mt -90.36 -29.78 17.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.448 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 5.5 mmm180 -120.78 -29.44 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.512 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.46 125.1 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -42.83 -23.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.873 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -76.82 13.94 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.546 HG21 ' CE2' ' A' ' 71' ' ' PHE . 19.7 m -62.89 -179.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 31.7 mt-10 -117.99 165.12 14.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 54.1 m-85 -160.16 135.73 5.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.468 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.81 164.1 35.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.699 2.266 . . . . 0.0 112.286 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -80.18 -30.73 38.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -146.76 175.43 10.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 60.9 m-85 -133.87 94.06 19.41 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.69 0.757 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.412 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.9 Cg_endo -69.76 175.82 7.59 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.681 2.254 . . . . 0.0 112.36 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.1 p -142.1 139.19 32.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.27 49.58 44.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 66.0 m -158.22 148.2 19.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.32 114.24 15.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.3 mt -82.0 -74.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.62 -147.95 4.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.0 p -151.56 153.7 35.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.6 m -139.96 141.07 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.34 114.18 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 tt -78.48 96.96 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.435 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -66.56 -48.95 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.168 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER -162.5 167.84 22.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.49 99.63 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 91.5 mt -93.95 171.09 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 93' ' ' LYS . 38.2 t -109.81 169.22 8.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 108' ' ' SER . 18.8 mm-40 -44.54 -21.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.42 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.2 tttt -89.12 -63.1 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -65.58 -49.55 68.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.505 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 37.3 t80 -42.16 -56.12 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 8.7 ptmt -68.46 -42.9 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.421 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 6.6 mt-10 -51.7 -60.36 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.2 mt-30 -75.86 -49.74 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 34.7 m-85 -110.42 66.87 0.48 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.619 0.723 . . . . 0.0 110.844 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.418 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.78 -14.18 35.65 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 0.0 112.359 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.79 -22.39 58.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 pt -121.83 15.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.7 p -55.68 -21.82 20.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -95.05 -30.47 14.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 12.1 mt-10 -47.58 -26.41 1.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -136.26 141.92 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 5.4 t70 -106.96 -37.17 6.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.48 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.8 m -40.89 161.33 0.12 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 0.0 110.874 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.467 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.81 -43.59 2.53 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.297 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -110.06 101.95 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.487 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 25.7 t -87.07 134.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.8 m-30 -101.34 109.97 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.94 120.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.45 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.1 m -123.59 152.49 41.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.25 176.38 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.475 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 57.47 52.82 5.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 112.39 3.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.316 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -126.61 132.19 51.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -98.0 120.35 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.437 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 14.6 mtp -62.52 154.36 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 70.7 t -81.55 -25.72 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.07 148.56 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 10.9 mmtm -115.86 142.3 46.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -114.12 141.65 26.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.661 0.743 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 90.54 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.53 167.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.573 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 43.5 mtpt -110.13 142.61 41.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.99 174.98 24.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -155.87 162.27 27.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.718 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 2.3 3.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.272 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.8 mmmm -139.94 -175.01 4.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 133' ' ' TRP . 81.9 mt -83.15 141.92 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 14.5 p-90 -147.18 129.44 15.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.512 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 17.0 ttmt -58.71 128.83 39.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 41' ' ' TRP . 22.3 mt -63.22 -177.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.7 t70 -90.56 128.2 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.3 m -36.23 -41.16 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -72.97 -40.62 65.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 136' ' ' ASP . 14.4 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.78 -62.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' LYS . 16.1 mm100 -55.02 -69.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.56 -42.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.576 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -60.74 -46.18 91.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.5 mtpp -61.97 -24.05 66.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -86.56 -42.84 13.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -51.1 -15.18 1.44 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.512 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.439 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 79.4 mt -82.24 34.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.5 ptp -117.07 143.24 45.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt 55.33 42.77 29.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 31.2 mm-40 -50.37 175.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -40.4 134.72 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -50.28 -29.44 9.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.13 -67.34 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.5 p -98.36 169.28 9.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.874 0.369 . . . . 0.0 110.888 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -133.36 159.04 41.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.831 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.28 153.54 25.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.528 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.6 m -136.96 122.82 20.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 0.0 110.84 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 m -114.61 148.9 37.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.23 94.39 0.63 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.575 ' CE3' HG21 ' A' ' 132' ' ' ILE . 92.3 m95 -83.32 162.37 21.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.406 ' CB ' ' HG ' ' A' ' 135' ' ' LEU . 7.2 t -135.16 129.81 34.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.473 ' CB ' HD23 ' A' ' 40' ' ' LEU . 57.5 tp -116.5 113.81 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.412 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 24.0 p -68.15 153.08 44.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.512 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 90.3 t -136.44 164.6 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.512 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 64.4 m-70 -102.1 110.2 22.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.9 mm-40 -56.37 157.89 8.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 16' ' ' TRP . 54.2 Cg_endo -69.69 -32.94 3.6 Favored 'Cis proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.382 -0.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.544 ' C ' ' O ' ' A' ' 15' ' ' PRO . 8.3 m-90 -25.16 -58.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.496 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -32.08 -53.7 0.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.094 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.0 m -69.71 -55.06 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.9 mt -40.17 -31.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' CD1' ' HG2' ' A' ' 25' ' ' LYS . 6.6 mp -64.26 -68.04 0.38 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 82' ' ' GLY . 16.5 m -61.6 -10.45 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.461 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -84.3 -40.12 18.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.26 -5.2 8.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.88 -43.28 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 8.4 tptp -100.24 105.54 17.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.552 HH21 ' NE ' ' A' ' 65' ' ' ARG . 6.3 ptp180 -102.48 23.63 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.1 m -152.51 146.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CD ' ' CD2' ' A' ' 10' ' ' LEU . 3.1 tt0 -117.57 122.1 42.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.03 124.69 7.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -146.45 150.19 35.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.401 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.7 p -86.98 21.26 2.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.55 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.4 p-90 -143.78 160.91 39.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.48 137.78 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.567 HG23 ' CE2' ' A' ' 112' ' ' PHE . 11.9 t -134.41 98.38 13.88 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.542 0.687 . . . . 0.0 111.16 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.431 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.0 Cg_endo -69.72 9.5 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.436 ' H ' ' C ' ' A' ' 34' ' ' THR . 14.4 t60 -67.93 110.15 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 72.2 mmt-85 -106.94 113.13 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.11 -151.9 22.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -78.58 142.67 37.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.473 HD23 ' CB ' ' A' ' 10' ' ' LEU . 21.8 tp -143.74 112.45 6.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 95.0 m95 -72.04 123.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.8 mm -94.77 130.07 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.97 154.72 46.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.07 132.22 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 12' ' ' VAL . 20.1 p -72.73 171.95 11.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.02 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 5.3 ttpt -64.3 130.16 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -91.36 129.27 43.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.91 18.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.669 2.246 . . . . 0.0 112.39 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -75.37 155.41 85.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.695 0.76 . . . . 0.0 110.84 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -3.91 12.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.693 2.262 . . . . 0.0 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -94.63 -44.37 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.508 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 14.2 mp0 -65.79 -41.86 91.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.47 HG13 ' NE2' ' A' ' 58' ' ' GLN . 43.6 t -63.76 -50.14 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.147 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -63.47 -45.36 91.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.22 -54.59 31.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 58' ' ' GLN . 79.8 mt -54.32 -58.36 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.4 mt-30 -34.85 -48.48 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.5 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -54.62 -52.68 61.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -67.69 -35.86 79.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 66' ' ' GLY . 31.1 mtt-85 -51.4 -33.84 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.6 mt -89.88 -14.28 34.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.46 HD12 ' NE2' ' A' ' 104' ' ' GLN . 60.4 mt -88.61 -31.02 18.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.552 ' NE ' HH21 ' A' ' 26' ' ' ARG . 4.6 mmm180 -119.39 -29.3 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.514 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 134.63 125.29 2.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.503 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -44.52 -20.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' GLY . 9.1 m-20 -82.67 21.49 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 27.4 m -70.69 -178.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.8 pt-20 -116.56 168.65 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 63.8 m-85 -159.93 141.38 9.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.67 0.748 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.75 168.04 22.69 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -92.89 -23.71 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -146.64 167.47 23.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 72' ' ' PRO . 83.3 m-85 -133.09 88.34 36.75 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.655 0.741 . . . . 0.0 110.907 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 169.18 19.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.0 p -136.92 136.65 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.29 46.22 50.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.6 m -155.28 152.3 29.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -77.56 116.08 17.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 80' ' ' LEU . 25.1 mt -83.74 -70.11 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -146.04 -141.82 3.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.573 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 6.5 t -153.47 161.37 42.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.417 HG13 ' C ' ' A' ' 83' ' ' CYS . 20.0 m -151.56 145.25 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -90.27 112.91 24.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 tt -75.12 98.12 3.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.941 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.455 HD12 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -67.22 -47.45 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -163.64 168.16 20.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.37 103.23 7.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.5 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.9 mt -100.49 165.74 11.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.954 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 93' ' ' LYS . 33.3 t -106.12 169.05 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 108' ' ' SER . 20.3 mm-40 -45.24 -20.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' N ' ' C ' ' A' ' 91' ' ' SER . 26.3 ttmt -87.94 -63.74 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -66.66 -49.19 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.5 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 32.2 t80 -42.76 -55.26 3.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -68.25 -40.34 81.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -54.8 -59.66 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -75.97 -48.55 20.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -110.88 66.74 0.53 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 0.0 110.88 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.71 -12.24 32.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.363 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.71 -22.99 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.465 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.4 pt -122.1 22.26 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 p -62.48 -22.24 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.602 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -94.37 -31.04 14.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.602 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 22.3 mt-10 -45.59 -37.06 5.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -128.52 134.32 48.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 10.4 t0 -97.91 -36.29 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.878 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.497 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -39.87 159.94 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 0.0 110.836 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.8 Cg_endo -69.76 -47.34 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -107.37 101.85 11.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.477 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 33.2 t -86.52 140.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.567 ' CE2' HG23 ' A' ' 34' ' ' THR . 8.7 m-30 -107.41 109.5 21.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.0 120.83 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.455 ' CA ' HD12 ' A' ' 87' ' ' ILE . 4.0 m -124.27 155.02 39.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' CG ' HD13 ' A' ' 87' ' ' ILE . 10.6 mmtp -141.17 177.36 8.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.91 52.35 7.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.74 116.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.317 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -130.88 133.62 46.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -97.77 122.22 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.427 ' HE2' ' CZ ' ' A' ' 124' ' ' PHE . 16.5 mtp -62.87 154.21 30.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.928 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -75.24 -30.03 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.56 142.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -107.55 140.02 41.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.427 ' CZ ' ' HE2' ' A' ' 120' ' ' MET . 0.7 OUTLIER -105.06 142.89 25.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.618 0.723 . . . . 0.0 110.876 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 83.07 0.72 Allowed 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.41 ' C ' HD13 ' A' ' 126' ' ' ILE . 2.7 pp -121.41 155.8 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.585 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 8.2 ptpt -97.08 141.53 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -104.45 162.4 15.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.459 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -137.86 160.66 63.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.62 0.724 . . . . 0.0 110.909 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 2.53 3.45 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.55 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.8 mmmm -136.88 -175.15 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.575 HG21 ' CE3' ' A' ' 8' ' ' TRP . 83.6 mt -85.24 133.58 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.585 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.0 p-90 -140.46 128.3 21.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -56.43 126.03 24.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.552 HD11 ' CD1' ' A' ' 41' ' ' TRP . 25.4 mt -59.98 173.25 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.7 t70 -82.46 127.46 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.54 -39.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -74.42 -41.69 60.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' ASP . 29.1 mm -64.46 -42.56 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -40.47 -63.22 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLY . 45.1 mt-30 -53.45 -69.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.75 -51.66 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.82 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -62.45 -23.36 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 147' ' ' LEU . 11.5 mmmm -80.38 -53.1 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -39.26 -24.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 145' ' ' LYS . 28.3 mt -82.66 36.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.323 . . . . 0.0 110.877 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.2 ptp -97.66 -37.02 10.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -134.68 73.38 1.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -68.22 173.67 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -45.73 169.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -57.67 -43.86 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -55.51 -52.25 64.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.059 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.0 m -75.39 119.43 19.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.2 m -86.26 89.04 7.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.48 -178.61 53.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.513 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.8 p -102.49 156.82 17.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.93 0.395 . . . . 0.0 110.845 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 m -158.77 139.16 12.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.16 98.13 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.547 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.542 ' CE3' HG23 ' A' ' 132' ' ' ILE . 92.9 m95 -81.4 164.22 22.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.925 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -138.69 133.34 32.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.1 tp -121.17 109.43 14.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.6 m -67.94 134.17 50.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.822 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 34.0 t -115.24 157.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.479 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 33.6 m-70 -90.54 113.71 25.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 71.3 mt-30 -59.06 160.51 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.561 0.696 . . . . 0.0 110.958 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.555 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -30.1 5.32 Favored 'Cis proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.36 -0.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.538 ' CD1' ' HE2' ' A' ' 25' ' ' LYS . 9.7 m-90 -26.98 -54.5 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -35.29 -65.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 3.4 m -59.67 -43.49 93.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.3 mt -50.78 -39.19 51.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 5.8 mp -58.53 -69.58 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.6 m -57.46 -23.55 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.8 mmt180 -71.02 -39.14 72.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.67 24.59 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.466 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.39 -37.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.538 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 13.8 tptt -105.17 103.48 13.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.411 ' CD ' HH12 ' A' ' 65' ' ' ARG . 18.7 ptt180 -102.06 28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.0 m -156.51 142.59 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' CD ' ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -115.16 137.92 51.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.98 115.03 5.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 75.0 mmt-85 -138.52 154.11 48.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.466 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 95.7 p -88.99 20.67 3.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 1.8 p-90 -141.74 165.57 27.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -106.54 139.08 41.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.552 HG21 ' CE2' ' A' ' 112' ' ' PHE . 9.8 t -133.89 99.16 14.01 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.3 Cg_endo -69.73 7.98 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.417 ' H ' ' C ' ' A' ' 34' ' ' THR . 23.7 t60 -64.46 107.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.439 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.4 mmt-85 -103.85 108.8 20.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.42 -148.79 16.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -85.55 144.54 27.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.0 tp -143.46 114.56 7.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.582 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 87.9 m95 -71.27 127.86 33.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -97.77 126.0 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.32 142.03 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.05 118.09 19.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.3 p -57.59 178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.5 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 11.8 ttpt -98.76 128.61 45.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -87.61 122.41 70.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.565 0.698 . . . . 0.0 110.869 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 133.0 24.48 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.668 2.246 . . . . 0.0 112.346 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -78.19 161.29 71.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.684 0.754 . . . . 0.0 110.821 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -10.79 29.41 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.646 2.231 . . . . 0.0 112.352 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -87.33 -49.11 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -41.16 99.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.72 -51.14 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 t -63.64 -43.52 96.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -66.7 -52.73 41.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.52 HD12 ' CE2' ' A' ' 16' ' ' TRP . 83.7 mt -58.47 -42.44 87.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.8 mt-30 -52.82 -45.29 67.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.43 -36.25 39.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 m -60.43 -52.21 66.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -68.43 -38.55 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' GLY . 64.8 mtt180 -49.1 -34.25 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.92 -13.93 35.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.465 HD11 ' NE2' ' A' ' 104' ' ' GLN . 61.0 mt -90.1 -27.86 19.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.411 HH12 ' CD ' ' A' ' 26' ' ' ARG . 3.9 mmm180 -122.66 -28.74 4.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.504 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.22 127.96 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.81 -19.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.55 14.71 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.537 HG22 ' CE2' ' A' ' 71' ' ' PHE . 19.8 m -64.45 -179.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -114.41 160.38 19.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 48.5 m-85 -155.44 134.87 7.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.471 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.4 Cg_endo -69.84 165.08 32.28 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.637 2.224 . . . . 0.0 112.331 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -85.34 -29.08 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -148.01 174.95 11.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.555 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 43.1 m-85 -134.78 100.65 12.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.68 0.752 . . . . 0.0 110.959 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.412 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.6 Cg_endo -69.76 179.68 3.53 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.701 2.267 . . . . 0.0 112.345 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.8 p -142.05 141.32 32.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.85 58.01 16.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 10.2 m -162.15 150.61 14.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.25 118.77 20.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.2 mt -88.52 -69.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.93 -143.52 3.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.582 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.5 p -157.5 148.63 21.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 110.883 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 18.9 m -135.96 136.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.12 111.58 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 tt -72.97 104.28 4.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.506 HD13 ' CG ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -73.15 -47.13 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.32 168.16 18.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.15 103.21 7.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.495 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 93.6 mt -100.17 165.92 11.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 93' ' ' LYS . 47.9 t -102.91 169.61 8.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 108' ' ' SER . 12.2 mm-40 -45.13 -20.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 91' ' ' SER . 25.9 ttpt -91.0 -67.94 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.93 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -58.45 -46.19 87.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.8 t80 -44.09 -57.86 3.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.481 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.9 ptpt -68.66 -43.05 77.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.7 mt-10 -49.14 -59.26 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.6 mt-30 -78.74 -46.62 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 33.2 m-85 -111.24 68.56 0.67 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.685 0.755 . . . . 0.0 110.86 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -12.5 32.94 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.644 2.229 . . . . 0.0 112.368 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.34 -22.22 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.582 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.9 pt -124.78 23.2 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.481 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 37.0 p -64.21 -28.27 69.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.597 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -90.07 -30.25 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.597 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 24.5 mt-10 -43.63 -36.09 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.2 t -125.09 151.24 45.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.14 -29.26 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.482 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.4 m -49.3 162.18 0.43 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.678 0.751 . . . . 0.0 110.887 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.466 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.3 Cg_endo -69.74 -46.13 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.714 2.276 . . . . 0.0 112.337 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -109.98 104.71 13.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.548 HG22 ' CD2' ' A' ' 95' ' ' PHE . 19.7 t -91.8 132.29 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.552 ' CE2' HG21 ' A' ' 34' ' ' THR . 2.9 m-30 -100.25 108.82 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.01 124.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.482 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -125.09 155.65 39.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.506 ' CG ' HD13 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -138.94 177.56 7.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.844 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 53.43 52.8 10.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.4 Cg_endo -69.76 115.14 3.96 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.266 . . . . 0.0 112.314 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.85 142.03 49.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.14 124.81 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 13.8 mtp -63.69 148.44 49.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.62 -33.64 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.092 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.63 142.35 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -106.46 152.93 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.12 140.06 28.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 88.22 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.294 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.18 158.91 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.595 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 30.3 mtpt -89.86 114.94 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.67 158.66 53.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.526 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -145.67 158.75 49.35 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 4.4 mmmm -91.73 -173.83 3.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.542 HG23 ' CE3' ' A' ' 8' ' ' TRP . 62.7 mt -82.89 137.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.1 p-90 -143.59 128.03 17.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -55.21 130.04 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.508 HD13 ' CD1' ' A' ' 41' ' ' TRP . 22.8 mt -63.6 178.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.0 167.45 15.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 p -72.2 -43.09 65.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -78.51 -18.86 54.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 15.7 mm -89.78 -36.23 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -51.29 -59.98 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 144' ' ' LYS . 82.2 mt-30 -56.7 -66.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.51 -42.18 0.91 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.458 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.569 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -61.86 -42.18 98.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.105 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.0 mtpp -65.82 -24.99 67.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 147' ' ' LEU . 23.7 mmmt -80.87 -52.13 7.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 150' ' ' GLN . . . -41.9 -23.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.506 HD11 ' CH2' ' A' ' 41' ' ' TRP . 34.2 mt -82.6 42.16 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 9.5 ptp -107.78 -39.07 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -134.9 53.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.527 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 1.5 mm-40 -41.88 -75.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -168.33 165.46 12.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -42.17 -37.53 1.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.7 119.59 0.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.104 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.113 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t -94.97 -59.53 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.911 0.386 . . . . 0.0 110.88 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.0 p -83.93 104.4 13.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.97 -123.91 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.1 p -75.81 119.55 19.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -112.5 17.98 18.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.15 58.98 4.1 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.512 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.534 ' CZ2' ' HE3' ' A' ' 134' ' ' LYS . 92.0 m95 -72.65 165.04 25.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.726 0.298 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.459 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 14.1 p -137.76 137.69 38.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.7 tp -120.34 107.45 12.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 t -67.98 142.0 56.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 8.8 t -126.58 159.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.533 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.2 m-70 -90.52 112.89 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.487 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 57.9 mt-30 -58.57 160.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.577 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.72 -28.69 6.1 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.369 -0.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.539 ' CE2' HD13 ' A' ' 57' ' ' LEU . 9.5 m-90 -28.72 -57.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -33.26 -61.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 m -63.1 -46.51 87.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.1 mt -45.74 -31.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 8.8 mp -67.21 -68.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 82' ' ' GLY . 13.1 m -60.67 -10.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.7 mmt180 -84.34 -39.18 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' CG ' ' A' ' 117' ' ' PRO . . . 123.16 0.14 9.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -85.1 -49.63 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 0.0 111.153 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -88.91 118.54 28.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 10.1 ttt180 -103.8 -0.07 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 28.4 m -143.45 155.62 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 4.9 tm-20 -122.07 152.86 39.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.544 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -111.31 129.36 9.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.7 mmt180 -148.82 145.04 27.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.866 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.5 p -83.02 18.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.57 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.1 p-90 -143.98 165.82 26.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -105.5 140.67 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.501 HG22 ' CE2' ' A' ' 112' ' ' PHE . 6.3 t -135.03 104.82 10.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.709 . . . . 0.0 111.114 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.6 Cg_endo -69.8 2.63 3.38 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.641 2.227 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -62.17 111.77 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 5.8 mmt85 -114.24 122.09 45.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.52 -125.92 2.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -99.47 142.8 30.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -144.03 111.82 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.565 ' CZ3' ' HB2' ' A' ' 143' ' ' ALA . 94.5 m95 -72.44 121.73 20.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.62 130.14 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.67 142.08 51.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.17 122.31 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.9 p -58.96 175.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.35 -15.98 61.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 6.4 ttpt -73.41 144.39 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.52 137.37 19.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.614 0.721 . . . . 0.0 110.889 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.73 128.97 16.83 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.69 2.26 . . . . 0.0 112.324 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 m -73.06 156.2 89.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.665 0.745 . . . . 0.0 110.862 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -36.92 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.24 -42.36 68.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.31 -51.23 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -61.69 -44.58 96.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.29 -56.63 10.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.539 HD13 ' CE2' ' A' ' 16' ' ' TRP . 94.1 mt -54.73 -55.91 24.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.6 mt-30 -37.45 -48.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.48 -44.64 34.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 m -51.97 -53.36 42.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -66.79 -38.67 86.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.463 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 32.4 mtt180 -48.77 -37.63 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -86.47 -15.99 38.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.498 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 59.5 mt -85.78 -28.84 24.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.498 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.9 mmp_? -122.67 -27.44 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.516 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 128.64 129.08 3.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.441 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -45.06 -20.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.5 p30 -70.95 3.18 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.579 HG22 ' CE2' ' A' ' 71' ' ' PHE . 35.2 m -60.63 178.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 8.8 mp0 -122.94 172.3 8.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 76.7 m-85 -161.11 141.47 8.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.87 29.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 0.0 112.362 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.02 -27.03 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -144.87 166.1 26.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.577 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 76.0 m-85 -130.64 88.47 46.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.645 0.736 . . . . 0.0 110.884 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.3 Cg_endo -69.75 168.43 21.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.67 2.246 . . . . 0.0 112.368 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.3 p -133.36 150.25 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.06 40.42 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 28.2 m -147.27 151.72 37.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 143' ' ' ALA . 0.2 OUTLIER -78.85 113.12 16.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -81.18 -70.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -149.09 -142.95 3.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.544 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -153.79 153.68 32.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 m -140.99 139.86 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.88 112.72 19.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tt -77.45 100.38 5.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.415 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.98 -45.62 71.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 3.5 m-20 -165.46 165.9 18.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.407 ' SG ' ' CE1' ' A' ' 112' ' ' PHE . 1.3 t -127.77 97.09 4.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.497 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 95.4 mt -94.67 168.13 11.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 93' ' ' LYS . 46.3 t -104.84 169.41 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 108' ' ' SER . 11.6 mm-40 -45.04 -20.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.1 ttmt -91.65 -69.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -57.98 -45.74 86.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.558 ' CD2' HG22 ' A' ' 111' ' ' VAL . 16.5 t80 -44.43 -58.66 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 10.4 ptpt -66.91 -40.01 87.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.416 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.2 mt-10 -49.99 -56.01 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.484 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.7 mt-30 -81.87 -49.18 10.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 19.8 m-85 -109.77 69.13 0.48 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.664 0.745 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -11.79 31.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.665 2.244 . . . . 0.0 112.354 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.42 -22.14 51.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.526 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -122.44 22.75 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.6 p -64.07 -20.76 66.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.54 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.5 pp0? -96.54 -27.82 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.54 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 24.1 mt-10 -47.03 -40.06 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 t -120.09 150.64 40.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -116.2 -27.19 6.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.44 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -52.11 162.34 0.85 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.83 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -37.27 9.49 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.12 101.18 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 95' ' ' PHE . 50.7 t -84.39 136.43 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 7.5 m-30 -104.59 102.39 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.62 119.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.402 ' CA ' HD11 ' A' ' 87' ' ' ILE . 2.7 m -124.26 154.02 40.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -142.09 176.71 8.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 54.79 52.24 8.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.82 119.94 6.8 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.331 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -132.47 138.48 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -102.75 122.26 44.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 16.9 mtp -62.92 153.26 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 149' ' ' LYS . 90.4 t -72.8 -37.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.474 HG21 ' N ' ' A' ' 123' ' ' LYS . 5.0 p -126.16 138.07 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.474 ' N ' HG21 ' A' ' 122' ' ' VAL . 17.3 mttp -102.49 149.58 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -113.11 142.34 27.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 86.66 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.06 160.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 15.0 ptmt -99.61 134.6 42.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.79 -178.01 39.45 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -161.12 159.22 24.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 0.3 5.87 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.629 2.219 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.57 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 9.1 mmmm -136.94 -175.0 3.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.466 HG21 ' CE3' ' A' ' 8' ' ' TRP . 71.9 mt -84.88 140.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.12 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.503 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 9.4 p-90 -146.51 128.96 15.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.534 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 15.2 ttmt -56.5 130.3 44.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.472 HD11 ' CD1' ' A' ' 41' ' ' TRP . 17.8 mt -65.71 168.85 7.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.3 t70 -77.4 127.19 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.13 -40.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.61 -42.54 58.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 24.9 mm -64.04 -38.72 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -46.54 -65.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.7 mm-40 -49.75 -68.49 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.05 -54.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.565 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.24 -40.91 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 111.097 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -67.83 -17.03 64.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.6 mmmm -89.84 -50.09 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -40.04 -23.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.539 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 145' ' ' LYS . 22.6 mt -81.67 38.86 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.452 ' C ' ' HE3' ' A' ' 149' ' ' LYS . 6.9 ptp -105.02 -37.0 7.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.504 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -124.32 78.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.893 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.407 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 26.3 mm-40 -76.32 167.42 21.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -45.52 171.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.1 -40.01 62.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.74 -58.32 8.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.151 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -72.3 159.3 34.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -121.86 130.49 53.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.893 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.75 111.42 0.36 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.48 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.2 p -78.24 140.24 38.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.901 0.382 . . . . 0.0 110.803 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -98.68 18.86 15.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.9 66.47 1.92 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.486 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.458 ' CZ2' ' NZ ' ' A' ' 134' ' ' LYS . 94.0 m95 -83.05 164.17 20.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 12.9 p -145.6 142.45 29.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' CD2' ' HG2' ' A' ' 28' ' ' GLU . 8.9 tp -130.95 114.16 14.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.7 m -69.59 147.45 50.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 19.7 t -129.76 154.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.437 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 37.3 m-70 -86.66 120.14 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 57.6 mt-30 -64.14 161.61 38.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 16' ' ' TRP . 53.5 Cg_endo -69.8 -30.53 5.1 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.325 -0.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.577 ' CZ2' HD13 ' A' ' 57' ' ' LEU . 13.3 m-90 -26.89 -54.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -33.26 -64.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -63.04 -45.76 90.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.4 mt -45.23 -30.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.48 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.6 mp -68.81 -69.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.425 HG23 ' CD ' ' A' ' 119' ' ' GLU . 5.0 m -57.26 -15.48 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.1 mmt180 -79.38 -39.57 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.63 7.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -76.38 -57.01 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 111.152 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 18.0 tptt -84.03 112.25 20.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -109.99 20.24 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 23.6 m -149.94 145.91 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.422 ' HG2' ' CD2' ' A' ' 10' ' ' LEU . 2.4 tp10 -109.15 146.53 33.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.56 119.86 5.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 24.7 mmt180 -148.89 145.44 27.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -83.31 17.71 2.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.482 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 4.9 p-90 -139.85 163.49 32.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.0 145.33 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.494 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.6 t -138.75 106.99 7.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.714 . . . . 0.0 111.128 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 3.86 2.51 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.677 2.251 . . . . 0.0 112.371 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -65.3 114.27 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -120.18 117.65 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.03 -121.32 1.05 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.464 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -106.35 140.08 39.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 15.6 tp -144.27 113.9 7.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.57 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 91.1 m95 -72.02 128.88 37.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.0 133.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.24 166.88 17.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.87 119.33 37.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.415 HG22 ' C ' ' A' ' 12' ' ' VAL . 51.5 p -55.22 -179.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.12 -5.45 57.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HD3' ' ND1' ' A' ' 13' ' ' HIS . 4.2 tttt -86.81 124.71 33.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -85.53 139.28 35.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.531 0.681 . . . . 0.0 110.939 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 54.2 Cg_endo -69.76 132.25 22.95 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -76.02 157.52 83.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.697 0.761 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -5.84 17.19 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.671 2.247 . . . . 0.0 112.342 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.03 -44.39 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.34 -49.42 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -65.27 -44.01 89.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.19 -53.77 27.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.953 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.577 HD13 ' CZ2' ' A' ' 16' ' ' TRP . 75.6 mt -56.49 -40.16 74.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.4 mt-30 -55.03 -42.7 72.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.61 -32.99 28.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -64.67 -52.86 55.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -64.34 -38.22 90.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -49.79 -34.25 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.0 mt -90.56 -12.19 37.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.89 -28.9 17.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -122.53 -29.25 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 134.24 126.11 2.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.432 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -44.44 -21.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -79.23 15.29 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 71' ' ' PHE . 19.5 m -64.02 -177.06 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 13.0 mt-10 -115.91 165.97 12.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 69' ' ' VAL . 55.4 m-85 -161.12 132.38 3.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.71 169.12 19.59 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.68 2.253 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -144.28 170.81 15.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.513 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 58.1 m-85 -134.21 93.36 19.66 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.628 0.728 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.482 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.77 169.79 18.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.2 m -136.37 139.44 42.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.851 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.58 49.41 60.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.1 m -157.08 147.62 21.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.878 0.37 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 120.81 21.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.461 ' C ' ' OE1' ' A' ' 119' ' ' GLU . 78.6 mt -88.8 -73.75 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -144.86 -144.63 4.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.57 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 14.2 t -151.14 157.84 43.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.425 HG11 ' C ' ' A' ' 83' ' ' CYS . 24.1 m -143.09 142.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.49 111.45 20.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 tt -75.24 98.39 3.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.426 HD11 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -68.25 -47.66 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -164.92 168.2 17.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -127.9 100.42 5.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.504 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.0 mt -94.01 170.06 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' LYS . 65.0 m -109.41 169.61 8.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -43.0 -22.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' SER . 29.0 ttmt -89.79 -66.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -60.35 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.504 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 28.6 t80 -46.02 -55.56 6.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 1.9 ptmt -69.69 -39.51 76.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.26 -59.41 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 9.6 mt-30 -77.51 -49.5 14.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 25.1 m-85 -109.95 67.62 0.46 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.633 0.73 . . . . 0.0 110.84 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.77 -12.19 32.37 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 -22.17 51.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.49 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.1 pt -121.35 15.99 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.3 p -58.4 -22.56 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.573 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -94.49 -30.69 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 8.7 mt-10 -47.04 -26.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 t -136.86 138.67 41.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.74 26.61 9.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.418 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 16.4 p -100.17 157.69 33.37 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.652 0.739 . . . . 0.0 110.86 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 53.9 Cg_endo -69.73 -23.2 31.19 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 0.0 112.348 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -134.97 95.0 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.457 HG23 ' CD2' ' A' ' 95' ' ' PHE . 43.4 t -85.63 137.55 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -104.44 108.01 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.13 122.92 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.426 ' CA ' HD11 ' A' ' 87' ' ' ILE . 3.4 m -125.67 155.97 40.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -144.02 176.49 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.49 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.83 51.73 4.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.634 0.73 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.4 Cg_endo -69.74 114.19 3.62 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.404 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.24 134.7 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.461 ' OE1' ' C ' ' A' ' 81' ' ' LEU . 3.9 tp10 -97.6 123.53 41.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.6 mtp -63.76 157.77 23.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 149' ' ' LYS . 91.6 t -81.08 -32.5 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.4 144.42 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -111.05 148.22 33.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.54 142.53 30.61 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.71 0.767 . . . . 0.0 110.822 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 86.83 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.63 2.22 . . . . 0.0 112.391 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.01 162.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.5 mmtp -108.15 149.03 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.03 178.22 29.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.519 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -154.53 161.06 30.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.66 0.743 . . . . 0.0 110.876 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -1.61 8.79 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.482 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.2 mmmm -137.27 -174.99 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 133' ' ' TRP . 74.1 mt -83.11 139.79 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.2 p-90 -145.11 127.94 16.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.458 ' NZ ' ' CZ2' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -64.21 125.23 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.2 mt -52.76 -176.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.8 t0 -91.7 131.72 36.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -36.65 -36.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -40.33 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.2 mm -67.36 -45.77 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.8 t-160 -36.5 -63.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 41.4 mm-40 -52.48 -69.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.53 -48.23 0.65 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -58.45 -43.25 88.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.819 0.342 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 15.9 mtpp -64.46 -26.45 68.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.445 ' HE2' ' N ' ' A' ' 145' ' ' LYS . 8.5 mmpt? -80.37 -46.34 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -45.68 -22.38 0.71 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.466 HD11 ' CH2' ' A' ' 41' ' ' TRP . 34.3 mt -86.71 36.83 0.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.932 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.4 ptp -89.61 -36.89 15.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.499 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 1.4 mmmm -148.02 108.3 4.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -86.62 174.07 9.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -44.84 157.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -101.43 37.79 1.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -117.29 -54.85 2.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.8 m 57.89 41.29 24.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.6 m -125.16 39.77 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.854 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 158.65 31.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.494 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.2 m -112.64 105.84 14.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.833 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -86.47 29.76 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.56 63.29 5.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.505 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -72.35 169.79 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.0 t -140.33 139.15 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -130.05 115.57 17.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 m -67.77 156.38 37.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 53.7 t -139.03 157.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.457 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 43.1 m-70 -90.41 109.43 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.492 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 64.3 mt-30 -58.33 161.14 8.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.7 -30.57 5.05 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.73 -1.779 . . . . 0.0 112.325 -0.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.565 ' CZ2' HD12 ' A' ' 57' ' ' LEU . 9.6 m-90 -26.66 -49.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -35.28 -60.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -67.03 -51.09 59.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.3 mt -40.51 -30.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.501 ' CD2' ' OE1' ' A' ' 28' ' ' GLU . 5.8 mp -68.32 -65.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 82' ' ' GLY . 10.6 m -62.58 -18.38 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.469 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 14.4 mmt180 -74.81 -39.93 61.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.4 -2.18 7.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' A' ' 70' ' ' GLU . 5.1 mp -83.07 -55.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.391 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 4.5 tptp -86.59 120.26 27.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.408 ' C ' HG13 ' A' ' 27' ' ' VAL . 4.3 ptp180 -114.37 15.92 17.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.505 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 33.9 m -147.56 142.92 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.501 ' OE1' ' CD2' ' A' ' 20' ' ' LEU . 6.9 tp10 -107.97 147.01 31.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -113.18 119.54 4.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.0 mmt180 -146.22 151.96 38.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 0.0 110.887 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 84.2 p -87.42 22.31 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 3.4 p-90 -142.24 161.12 38.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 12.0 t80 -103.65 139.23 39.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 36' ' ' HIS . 7.6 t -134.41 101.66 12.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.566 0.698 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 8.33 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.646 2.231 . . . . 0.0 112.36 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' H ' ' C ' ' A' ' 34' ' ' THR . 20.4 t60 -68.67 109.73 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mmt-85 -109.62 107.25 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.98 -153.37 23.89 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -73.02 140.57 47.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 21.2 tp -143.95 113.88 7.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.565 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 95.4 m95 -73.54 120.95 19.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.62 128.94 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.48 153.27 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.75 122.55 32.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -62.45 173.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.27 -9.74 58.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 7.7 ttpt -70.47 127.27 32.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -85.46 125.68 68.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.567 0.698 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 130.82 20.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.247 . . . . 0.0 112.354 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m -76.89 158.97 79.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.666 0.746 . . . . 0.0 110.79 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 -16.98 38.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 0.0 112.372 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -84.44 -39.06 19.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -41.42 76.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.94 -48.87 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.162 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -63.62 -45.14 91.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.87 -52.44 43.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.565 HD12 ' CZ2' ' A' ' 16' ' ' TRP . 83.9 mt -59.31 -44.76 92.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.0 mt-30 -50.18 -46.12 54.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.89 -36.95 41.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.3 m -59.24 -51.18 71.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.403 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 26.5 m-85 -69.06 -37.26 78.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 66' ' ' GLY . 32.5 mtt-85 -49.88 -33.99 18.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.78 -15.94 31.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.457 HD12 ' NE2' ' A' ' 104' ' ' GLN . 57.8 mt -88.06 -28.66 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.453 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.6 mmm180 -121.47 -28.87 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.511 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 132.45 126.98 2.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.476 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.57 -20.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.1 m-20 -80.72 18.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.524 HG23 ' CE2' ' A' ' 71' ' ' PHE . 23.2 m -68.02 179.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.117 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.408 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 11.9 mt-10 -112.25 157.2 21.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -154.51 132.06 6.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.657 0.742 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.694 2.262 . . . . 0.0 112.322 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -81.4 -32.05 32.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -145.31 174.23 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.0 m-85 -133.45 95.47 18.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.665 0.745 . . . . 0.0 110.936 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.444 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.4 Cg_endo -69.75 171.59 14.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.332 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -141.33 133.25 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 46.13 9.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -159.27 149.39 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.455 ' CD1' ' HB1' ' A' ' 143' ' ' ALA . 0.2 OUTLIER -74.23 113.43 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.3 -74.4 0.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.9 -145.07 4.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.565 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 5.5 t -149.54 162.49 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG11 ' C ' ' A' ' 83' ' ' CYS . 24.9 m -151.71 140.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -85.63 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tt -73.48 99.82 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.426 HD11 ' C ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -68.89 -48.29 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.43 167.4 23.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.53 101.25 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.494 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.2 mt -96.37 168.38 10.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 15.0 p -106.29 169.19 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 108' ' ' SER . 19.6 mm-40 -46.65 -19.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 91' ' ' SER . 21.9 ttmt -90.88 -59.0 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -68.52 -50.21 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.525 ' CD2' HG23 ' A' ' 111' ' ' VAL . 31.3 t80 -41.91 -55.9 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -67.25 -41.32 85.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.49 -58.83 5.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.3 mt-30 -76.13 -50.11 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -109.88 67.91 0.46 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.1 Cg_endo -69.74 -13.57 34.92 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.71 2.273 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.68 -23.44 56.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.464 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.6 pt -121.91 23.45 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.2 p -65.0 -26.3 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.598 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.2 pp0? -91.53 -27.98 17.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.598 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 18.3 mt-10 -49.3 -38.39 27.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.515 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.3 p -124.08 144.42 49.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 27.2 t70 -107.94 -36.36 6.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.48 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 4.3 m -39.6 157.99 0.13 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.856 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.464 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.7 Cg_endo -69.79 -49.23 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.661 2.241 . . . . 0.0 112.319 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' A' ' 33' ' ' TYR . 26.2 m-85 -106.32 98.69 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.525 HG23 ' CD2' ' A' ' 95' ' ' PHE . 22.1 t -83.91 139.62 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -107.29 107.09 17.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.24 122.83 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.426 ' C ' HD11 ' A' ' 87' ' ' ILE . 3.1 m -126.8 155.41 42.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.08 176.25 9.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 56.59 51.97 6.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.73 115.52 4.13 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -127.92 134.79 49.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.426 ' OE2' ' NZ ' ' A' ' 123' ' ' LYS . 11.3 tm-20 -96.88 121.99 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.459 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 13.1 mtp -62.59 151.88 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.74 -37.52 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 1.8 p -118.22 158.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.486 ' N ' ' CG2' ' A' ' 122' ' ' VAL . 12.5 mmtm -120.65 140.29 51.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.64 136.86 19.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.628 0.728 . . . . 0.0 110.897 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 86.03 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.89 163.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 70.9 mttt -97.95 132.04 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.03 170.9 40.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -153.42 153.07 28.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 1.42 4.46 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.301 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.424 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.7 mmmm -134.07 -175.39 3.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.446 HG21 ' N ' ' A' ' 133' ' ' TRP . 72.7 mt -89.03 137.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.6 p-90 -146.05 131.48 18.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -59.62 124.59 20.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.1 mt -60.02 170.77 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.7 t70 -79.27 129.71 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.1 m -37.03 -37.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -76.05 -41.24 51.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 136' ' ' ASP . 37.5 mm -65.56 -39.65 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -45.92 -65.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.817 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 144' ' ' LYS . 28.1 mt-30 -47.89 -69.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.95 -52.85 1.54 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.455 ' HB1' ' CD1' ' A' ' 80' ' ' LEU . . . -52.52 -39.44 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 141' ' ' GLN . 10.7 mtpt -70.47 -14.73 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -86.08 -48.47 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.503 ' O ' ' NE2' ' A' ' 150' ' ' GLN . . . -46.62 -19.15 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.488 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 47.1 mt -82.33 37.51 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.9 ptp -103.83 -40.69 6.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -134.99 59.97 1.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 146' ' ' GLY . 2.3 mm-40 -45.95 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 140.75 9.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -65.95 -25.79 67.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -50.46 -50.8 51.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -101.09 163.91 12.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.881 0.372 . . . . 0.0 110.866 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 m -62.25 121.15 12.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.75 -84.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.47 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m 58.65 43.56 18.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.862 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -76.36 165.11 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.83 102.26 2.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.41 ' CE3' HG23 ' A' ' 132' ' ' ILE . 94.7 m95 -94.96 161.97 13.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -137.24 140.25 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.403 ' CD2' ' HG2' ' A' ' 28' ' ' GLU . 26.7 tp -124.13 108.88 12.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.404 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 3.9 p -67.57 137.17 55.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 33.9 t -121.13 161.44 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.543 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.5 m-70 -95.99 111.76 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 10.8 mm-40 -56.34 157.83 8.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.78 -33.03 3.57 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.361 -0.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.546 ' C ' ' O ' ' A' ' 15' ' ' PRO . 10.7 m-90 -24.97 -54.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -36.69 -54.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.5 m -70.04 -47.81 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -45.39 -28.31 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.6 mp -68.07 -65.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 m -64.77 -14.2 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.479 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.3 mmt180 -78.64 -39.13 37.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.61 12.22 6.2 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.5 -47.63 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -88.79 116.66 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.49 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 11.4 ttt180 -101.94 -1.14 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 32.7 m -141.55 152.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.144 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HG2' ' CD2' ' A' ' 10' ' ' LEU . 2.2 tp10 -115.96 143.11 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.55 129.47 9.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.419 ' HD2' ' NE1' ' A' ' 32' ' ' TRP . 20.2 mmt180 -152.96 140.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.1 p -82.81 16.58 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.514 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.2 p-90 -139.29 166.44 24.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 34' ' ' THR . 8.8 t80 -106.45 148.39 28.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.576 HG22 ' CE2' ' A' ' 112' ' ' PHE . 5.8 t -143.95 107.09 4.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.709 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 2.83 3.14 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.37 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -65.42 117.91 8.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -123.53 120.43 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.57 -121.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -99.55 140.77 33.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 17.4 tp -144.73 108.99 4.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.599 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 94.8 m95 -71.65 126.15 28.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 mm -96.39 129.3 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.63 150.56 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.37 126.26 33.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.071 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 p -64.69 173.01 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.42 -21.15 62.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 9.0 ttpt -63.91 149.39 47.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -108.59 133.98 20.44 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.533 0.682 . . . . 0.0 110.921 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.478 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 128.32 15.86 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.708 2.272 . . . . 0.0 112.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -75.21 159.12 83.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 110.869 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -7.35 20.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.72 -41.78 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.63 -40.85 80.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.8 t -67.83 -49.6 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.4 t -64.2 -42.06 96.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -70.2 -55.15 10.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.521 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 86.5 mt -55.88 -44.03 77.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 8.5 mt-30 -51.05 -47.06 61.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.67 -36.71 51.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -60.17 -51.25 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -69.92 -38.59 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.468 ' O ' ' C ' ' A' ' 66' ' ' GLY . 44.8 mtt180 -47.98 -36.34 12.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 mt -87.23 -18.14 30.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.0 mt -83.41 -32.28 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -118.4 -27.38 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.519 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 129.4 124.9 2.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.428 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -42.34 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.927 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -70.15 4.77 1.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 35.3 m -61.5 176.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -116.71 167.82 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 49.5 m-85 -157.67 139.06 9.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.518 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.71 159.4 53.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.745 2.297 . . . . 0.0 112.334 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.88 -24.09 33.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -150.73 172.22 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.598 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 56.2 m-85 -134.41 98.59 13.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.66 0.743 . . . . 0.0 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -176.33 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.319 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.7 p -150.79 129.83 12.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.38 45.28 24.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.1 m -153.33 149.43 27.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.95 118.34 18.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.8 mt -85.68 -71.57 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.26 -143.11 3.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.599 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -152.46 158.18 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.845 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG11 ' C ' ' A' ' 83' ' ' CYS . 23.8 m -145.71 134.54 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.467 ' HB3' ' ND2' ' A' ' 116' ' ' ASN . 1.4 t70 -79.35 112.8 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -76.41 102.67 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.437 HD13 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -72.04 -47.07 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -166.17 170.02 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.11 99.42 5.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 96.9 mt -93.04 171.24 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 93' ' ' LYS . 4.7 p -109.79 169.16 8.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' O ' ' CE ' ' A' ' 96' ' ' LYS . 3.1 mm-40 -43.11 -23.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 91' ' ' SER . 18.4 ttmt -89.76 -65.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -59.38 -48.63 80.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.961 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.604 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.1 t80 -43.79 -56.9 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' CE ' ' O ' ' A' ' 92' ' ' GLN . 11.7 ptpt -69.0 -41.96 77.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -50.06 -59.13 4.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.481 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.4 mt-30 -78.05 -45.07 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.0 m-85 -113.66 69.98 1.6 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.666 0.746 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -14.54 36.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 0.0 112.349 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -19.67 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.604 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.5 pt -125.73 21.74 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.444 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 58.8 p -64.51 -27.63 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.581 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -89.39 -29.52 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.581 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 22.9 mt-10 -45.31 -40.03 7.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.8 t -120.39 140.76 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.18 25.43 10.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.459 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.7 p -101.16 160.34 26.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.869 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -25.16 28.73 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -134.82 95.55 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 39.7 t -84.51 135.73 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.576 ' CE2' HG22 ' A' ' 34' ' ' THR . 9.2 m-30 -101.9 103.54 14.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.12 122.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.437 ' CA ' HD13 ' A' ' 87' ' ' ILE . 3.9 m -125.56 156.08 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.433 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 1.9 mmmp? -143.53 176.36 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.488 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 58.15 51.95 4.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.5 Cg_endo -69.79 113.65 3.45 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.266 . . . . 0.0 112.303 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -127.35 141.7 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -103.67 120.96 41.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 17.3 mtp -64.05 143.01 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 149' ' ' LYS . 29.4 t -69.96 -25.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.146 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.83 141.91 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -110.99 145.09 39.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.41 143.29 29.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 91.49 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.279 . . . . 0.0 112.316 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.63 158.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.11 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.591 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.0 mttm -103.5 137.23 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -96.24 166.87 24.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.468 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -140.53 161.7 53.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.714 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 0.56 5.45 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.514 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.5 mmmm -138.26 -174.99 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 133' ' ' TRP . 82.7 mt -83.09 138.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.591 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 6.7 p-90 -146.63 124.2 11.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.47 127.07 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.574 HD12 ' CD1' ' A' ' 41' ' ' TRP . 37.7 mt -60.17 -178.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -88.13 127.47 35.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.8 m -36.39 -40.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -73.44 -41.25 63.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 136' ' ' ASP . 23.5 mm -64.99 -44.99 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -38.55 -65.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 142' ' ' GLY . 14.4 mm100 -52.59 -68.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.21 -48.71 1.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.466 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.483 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.79 -45.79 81.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 111.089 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -63.57 -22.48 66.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -84.14 -46.63 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -45.44 -20.45 0.34 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.9 mt -83.33 32.84 0.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 7.2 ptp -94.74 -33.21 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.461 ' HB2' ' CG2' ' A' ' 121' ' ' VAL . 20.5 mtpt -120.95 50.71 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 149' ' ' LYS . 6.2 mm-40 -33.83 149.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 154' ' ' VAL . 0.9 OUTLIER -90.25 98.42 11.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -71.81 -34.97 69.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 154' ' ' VAL . . . -127.19 -61.01 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.486 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 97.2 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.105 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -137.96 143.78 40.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.6 p -93.1 151.38 19.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.879 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.23 119.41 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.3 m -111.49 172.6 6.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.872 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 57.8 m -141.24 138.3 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.82 102.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.456 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.583 ' CE3' HG22 ' A' ' 132' ' ' ILE . 93.3 m95 -90.23 156.98 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB2' ' CG ' ' A' ' 135' ' ' LEU . 52.7 t -134.5 121.7 21.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.453 ' CB ' HD22 ' A' ' 40' ' ' LEU . 65.6 tp -107.44 109.19 20.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -68.09 154.53 41.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 24.5 t -133.65 159.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.094 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.511 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 57.4 m-70 -90.13 113.72 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 78.7 mt-30 -59.7 159.75 17.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.75 -31.52 4.5 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.355 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.53 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 10.0 m-90 -26.81 -48.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 15' ' ' PRO . . . -39.33 -63.44 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.1 mt -52.62 -28.52 21.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.1 mp -69.75 -60.46 2.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m -67.65 -20.5 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -73.12 -39.17 65.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 14.66 5.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.21 -45.14 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 111.154 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CD ' ' OH ' ' A' ' 61' ' ' TYR . 4.2 tptp -93.81 118.85 32.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -101.05 -4.39 27.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.469 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 8.0 m -141.33 152.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -120.35 130.51 54.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -86.57 132.06 10.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' N ' ' CB ' ' A' ' 108' ' ' SER . 18.9 mmt180 -152.63 144.64 23.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.511 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 9.8 t -85.63 24.26 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.576 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.0 p-90 -146.38 160.91 41.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.3 t80 -104.08 145.29 30.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.586 HG21 ' CE2' ' A' ' 112' ' ' PHE . 5.6 t -139.31 105.91 7.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.162 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 4.0 2.46 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.697 2.265 . . . . 0.0 112.308 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -65.86 114.68 5.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -119.69 122.92 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.41 -119.15 1.04 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -104.88 138.3 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.453 HD22 ' CB ' ' A' ' 10' ' ' LEU . 26.7 tp -143.57 112.69 6.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.36 132.56 45.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.5 mm -103.34 125.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.113 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.97 154.3 36.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.73 116.46 25.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -53.06 -177.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.13 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.65 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 6.2 ttpt -78.25 131.13 36.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -92.98 137.06 23.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.557 0.694 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 53.4 Cg_endo -69.72 130.36 19.24 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m -78.29 158.13 77.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 110.837 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -4.15 13.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.682 2.254 . . . . 0.0 112.317 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.491 ' NE2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -94.84 -38.67 10.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.933 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.17 -39.84 53.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.15 -52.73 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -58.12 -46.54 85.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 11.9 mt-10 -66.41 -57.54 7.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.53 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 76.7 mt -52.92 -41.21 64.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.8 mt-30 -52.47 -47.9 66.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -37.52 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.072 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -58.3 -50.59 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.438 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 24.8 m-85 -71.03 -31.88 68.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.431 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 32.2 mtt180 -56.05 -39.65 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 mt -86.33 -14.53 43.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.469 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 71.6 mt -89.02 -28.89 19.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.469 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 5.5 mmp_? -121.16 -28.74 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.521 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 131.27 128.21 2.94 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.19 -19.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.7 m-20 -78.4 13.4 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.545 HG23 ' CE2' ' A' ' 71' ' ' PHE . 28.6 m -66.33 -177.84 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 16.3 mm-40 -119.54 167.98 11.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 62.3 m-85 -161.86 135.06 4.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.625 0.726 . . . . 0.0 110.861 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.2 Cg_endo -69.77 159.96 51.47 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 0.0 112.322 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -81.11 -27.76 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -146.15 173.41 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.1 m-85 -134.85 94.61 16.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.683 0.754 . . . . 0.0 110.916 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.4 Cg_endo -69.76 174.36 9.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.5 p -141.26 139.81 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.86 45.36 84.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.7 m -153.45 145.18 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 110.884 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.93 117.85 17.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.1 mt -85.79 -71.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.61 -146.4 4.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.587 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.3 p -151.28 157.41 42.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.8 m -144.67 140.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.1 113.08 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 tt -77.42 93.41 4.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.446 HD12 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -60.73 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.184 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -163.01 168.46 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.9 t -127.73 101.74 6.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.502 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 88.8 mt -99.32 169.89 9.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' LYS . 34.7 t -105.12 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 108' ' ' SER . 10.1 mm-40 -42.07 -23.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' SER . 15.2 ttmm -91.34 -70.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -53.56 -47.37 70.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.577 ' CD2' HG23 ' A' ' 111' ' ' VAL . 16.9 t80 -43.3 -57.46 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HG2' ' N ' ' A' ' 97' ' ' GLU . 1.6 pttt -68.36 -38.79 81.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.491 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 12.1 mt-10 -49.56 -52.39 30.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.451 ' NE2' HD23 ' A' ' 90' ' ' LEU . 5.7 mt-30 -86.68 -45.97 10.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.7 m-85 -110.42 67.69 0.51 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 0.0 110.865 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.77 -10.35 28.33 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.695 2.264 . . . . 0.0 112.366 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.82 -19.16 55.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.449 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 pt -126.17 21.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.469 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 59.6 p -60.05 -20.78 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -97.94 -30.71 12.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 5.2 mt-10 -51.23 -28.36 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.471 ' CB ' HG12 ' A' ' 111' ' ' VAL . 25.5 p -114.24 156.84 23.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -130.15 -32.58 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.518 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -58.87 164.83 3.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 0.0 110.834 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.511 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.3 Cg_endo -69.78 -43.79 2.44 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.66 2.24 . . . . 0.0 112.322 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -110.34 97.51 6.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.577 HG23 ' CD2' ' A' ' 95' ' ' PHE . 12.9 t -79.3 139.21 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.586 ' CE2' HG21 ' A' ' 34' ' ' THR . 11.5 m-30 -106.58 105.84 16.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.405 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -74.41 117.57 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.093 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.455 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 6.9 m -125.07 151.55 45.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.874 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.403 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 11.3 mmmt -140.5 175.27 9.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 59.22 53.18 4.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 0.0 110.891 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.78 112.58 3.12 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -127.33 141.07 51.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.19 122.24 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.437 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 16.6 mtp -63.39 155.33 29.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.2 t -81.92 -27.69 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -127.27 135.22 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 14.0 mmtm -103.03 150.44 23.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -118.17 143.55 33.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.596 0.713 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 92.05 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.32 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.428 ' C ' HD13 ' A' ' 126' ' ' ILE . 2.9 pp -123.21 167.07 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -110.28 107.16 16.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.27 169.56 23.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.538 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.436 ' HB2' ' CD1' ' A' ' 133' ' ' TRP . 46.9 m-80 -155.29 157.9 31.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.928 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 0.86 5.03 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.576 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.4 mmmp? -136.84 -175.08 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.583 HG22 ' CE3' ' A' ' 8' ' ' TRP . 68.3 mt -86.89 131.99 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.154 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 129' ' ' ASN . 7.5 p-90 -133.8 136.24 44.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.531 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 8.8 ttmt -56.8 134.87 55.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.508 HD13 ' CD1' ' A' ' 41' ' ' TRP . 17.9 mt -76.96 133.29 39.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.498 ' HB2' ' CG1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -45.84 123.23 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 136' ' ' ASP . 4.4 m -34.02 -48.44 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.86 -43.62 87.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.498 ' CG1' ' HB2' ' A' ' 136' ' ' ASP . 38.7 mm -61.65 -46.09 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.139 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -38.56 -64.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 142' ' ' GLY . 79.9 mt-30 -51.68 -68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.7 -49.09 0.72 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.558 ' HB1' ' CH2' ' A' ' 41' ' ' TRP . . . -55.72 -46.06 77.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.2 mtpp -64.82 -24.12 67.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -82.8 -42.84 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -51.48 -16.51 2.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.449 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 40.3 mt -85.72 31.91 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.891 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 ptp -92.39 -36.37 13.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 150' ' ' GLN . 32.5 mttt -120.71 54.04 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 149' ' ' LYS . 5.4 mm-40 -34.23 142.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 152' ' ' LYS . 0.8 OUTLIER -79.51 122.25 26.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 153' ' ' ALA . 6.0 mtmp? -48.25 177.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 152' ' ' LYS . . . -32.96 -61.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 153' ' ' ALA . 9.8 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.8 p -70.31 166.28 20.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.5 p -104.15 -47.71 4.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.851 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.96 106.73 0.21 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -100.39 77.0 1.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.407 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 57.7 m -149.29 144.68 26.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.82 105.24 1.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.563 ' CE3' HG23 ' A' ' 132' ' ' ILE . 95.0 m95 -92.91 160.79 14.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.415 ' CB ' HD23 ' A' ' 135' ' ' LEU . 39.0 t -133.16 130.95 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.457 ' CB ' HD23 ' A' ' 40' ' ' LEU . 21.9 tp -111.6 110.7 21.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.435 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 2.9 m -69.92 131.09 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.522 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 69.6 t -116.19 163.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.522 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 59.0 m-70 -100.65 114.21 27.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 15' ' ' PRO . 15.0 mm-40 -58.36 157.8 16.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.587 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.76 -33.74 3.31 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.721 -1.783 . . . . 0.0 112.338 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.548 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.5 m-90 -25.07 -59.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.498 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -33.39 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.091 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.4 m -69.6 -53.91 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 mt -40.97 -29.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.7 mp -66.56 -68.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 82' ' ' GLY . 17.4 m -61.21 -11.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.45 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 12.2 mmt180 -82.98 -39.64 21.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.86 0.87 9.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.6 mp -85.6 -50.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 111.12 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.1 tptp -88.53 121.87 31.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.405 ' C ' HG11 ' A' ' 27' ' ' VAL . 5.7 mtt-85 -103.89 -4.06 23.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 15.6 m -140.34 162.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE1' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -129.03 130.88 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -86.43 128.24 8.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.52 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.435 ' NH2' ' O ' ' A' ' 11' ' ' SER . 13.0 mmt180 -146.11 143.97 29.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.823 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.9 p -83.66 19.47 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.554 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.5 p-90 -144.53 167.62 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.454 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 6.0 t80 -108.8 136.81 47.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.566 HG23 ' CE2' ' A' ' 112' ' ' PHE . 6.1 t -130.15 104.04 16.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.703 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -65.77 117.15 7.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -120.97 121.48 38.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.91 -116.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -104.2 138.95 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.457 HD23 ' CB ' ' A' ' 10' ' ' LEU . 19.3 tp -143.76 109.38 5.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.595 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 90.7 m95 -73.4 124.49 25.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 mm -94.84 127.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.18 141.18 51.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.102 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.58 121.29 22.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 p -59.94 -177.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.26 21.34 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.073 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 8.9 ttpt -100.77 132.94 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -87.67 126.7 60.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.555 0.693 . . . . 0.0 110.928 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 134.92 29.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.1 m -79.05 153.29 77.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.669 0.747 . . . . 0.0 110.841 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -6.55 18.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.297 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 -38.47 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.85 -43.52 71.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.476 HG13 ' NE2' ' A' ' 58' ' ' GLN . 42.6 t -63.88 -51.11 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -61.1 -47.44 86.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.17 -55.34 22.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.46 -54.29 42.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.5 mt-30 -38.44 -49.06 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.14 -43.09 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -52.85 -51.3 61.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.458 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 36.0 m-85 -69.08 -37.96 78.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 66' ' ' GLY . 58.6 mtt180 -48.44 -33.11 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.1 mt -91.4 -15.69 28.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.558 ' CD1' ' NE2' ' A' ' 104' ' ' GLN . 79.6 mt -86.76 -31.51 20.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -119.36 -28.66 5.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.528 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.46 124.68 2.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.46 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -44.55 -18.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.913 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 66' ' ' GLY . 2.9 m-20 -77.66 13.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' A' ' 71' ' ' PHE . 33.9 m -69.23 174.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 2.6 pm0 -119.66 173.5 6.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 83.1 m-85 -158.93 144.37 11.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.849 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.484 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.79 152.82 69.26 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.242 . . . . 0.0 112.321 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -73.23 -28.17 62.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -144.6 174.15 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.587 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 68.5 m-85 -134.97 89.64 23.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 172.1 13.34 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.5 p -143.55 142.27 31.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 37.27 60.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.9 m -149.83 147.62 28.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.03 114.48 13.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.2 mt -81.69 -72.37 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.44 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -147.16 -143.66 3.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.595 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 11.0 t -150.95 159.03 44.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.413 HG12 ' C ' ' A' ' 83' ' ' CYS . 21.8 m -147.66 133.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.16 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.417 ' HB3' ' ND2' ' A' ' 116' ' ' ASN . 1.9 t70 -77.79 112.62 14.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -77.01 100.4 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.421 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.39 -49.23 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.34 168.28 24.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.56 96.59 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.495 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.4 mt -93.48 166.35 12.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' LYS . 44.4 t -104.2 169.88 8.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 108' ' ' SER . 9.4 mm-40 -43.84 -21.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' SER . 17.1 ttmt -90.96 -69.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -56.49 -45.95 80.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 19.5 t80 -44.55 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.5 ptpt -68.73 -42.15 78.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 8.5 mt-10 -48.4 -58.23 4.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.6 mt-30 -80.11 -48.25 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 16.7 m-85 -109.78 68.65 0.47 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.1 Cg_endo -69.84 -11.1 30.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.672 2.248 . . . . 0.0 112.316 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -78.37 -21.82 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.817 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.578 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.9 pt -124.99 22.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.472 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 49.9 p -64.26 -19.94 65.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.581 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -97.17 -27.93 14.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.581 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 15.5 mt-10 -41.01 -42.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.2 t -123.14 159.37 28.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -119.01 -21.14 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.467 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -53.81 162.31 1.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.443 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.79 -43.21 2.77 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.378 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 15.7 m-85 -112.34 101.42 9.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 95' ' ' PHE . 25.6 t -80.91 136.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CE2' HG23 ' A' ' 34' ' ' THR . 9.8 m-30 -104.44 104.34 14.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.83 120.69 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.404 ' CA ' HD12 ' A' ' 87' ' ' ILE . 4.2 m -125.43 154.18 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.95 176.16 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 56.77 53.26 6.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.2 Cg_endo -69.76 116.41 4.55 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.724 2.283 . . . . 0.0 112.371 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.36 133.89 46.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.26 124.77 44.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.404 ' HE2' ' CE2' ' A' ' 124' ' ' PHE . 14.1 mtp -66.91 147.02 53.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.4 t -68.91 -31.77 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.09 153.0 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.05 146.22 45.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.404 ' CE2' ' HE2' ' A' ' 120' ' ' MET . 0.8 OUTLIER -112.72 141.96 26.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 0.0 110.879 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 87.21 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.91 163.35 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 76.1 mttt -102.18 136.36 42.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.99 161.81 27.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.459 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -142.65 156.71 62.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.644 0.735 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -3.08 11.33 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.554 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.6 mmmp? -134.2 -173.75 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.563 HG23 ' CE3' ' A' ' 8' ' ' TRP . 95.6 mt -85.91 142.07 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.3 p-90 -149.37 127.24 11.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -55.77 127.78 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.415 HD23 ' CB ' ' A' ' 9' ' ' CYS . 60.4 mt -65.35 167.94 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.6 t70 -73.81 126.46 30.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.0 m -34.94 -42.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -71.68 -44.96 63.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.1 mm -61.47 -41.13 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.106 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -44.27 -65.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 144' ' ' LYS . 26.5 mt-30 -50.07 -68.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.5 -54.69 1.02 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.521 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.495 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -56.18 -37.29 69.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.2 mtpt -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -92.86 -47.11 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -41.56 -23.43 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 145' ' ' LYS . 11.8 mt -82.94 39.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 110.914 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.8 ptp -103.2 -33.65 9.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -131.98 74.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -73.7 177.12 5.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -61.85 159.72 13.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -34.85 79.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.26 -57.17 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -132.25 41.62 3.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.865 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 4' ' ' GLY . 60.0 p -97.34 123.41 41.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.838 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 3' ' ' SER . . . -35.02 132.45 0.55 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.515 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -95.69 37.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.831 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.8 m -108.65 160.77 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.44 84.17 1.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.451 ' CE3' HG21 ' A' ' 132' ' ' ILE . 91.6 m95 -77.8 159.85 28.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.781 0.324 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.9 t -137.4 125.46 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.456 ' CB ' HD21 ' A' ' 40' ' ' LEU . 66.6 tp -112.27 116.84 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 m -68.74 153.85 43.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 13' ' ' HIS . 72.5 t -135.47 158.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.466 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.8 m-70 -94.54 113.75 25.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 79.0 mt-30 -60.53 159.28 25.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.624 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 -32.74 3.73 Favored 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.698 -1.792 . . . . 0.0 112.33 -0.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.548 ' C ' ' O ' ' A' ' 15' ' ' PRO . 13.4 m-90 -25.36 -52.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -35.4 -63.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -62.01 -46.15 90.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.3 mt -45.63 -39.32 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -57.93 -66.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 82' ' ' GLY . 18.2 m -61.29 -20.94 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.477 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 11.3 mmt180 -73.87 -39.67 63.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.41 20.07 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.532 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.69 -38.4 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 13.8 tptt -102.72 102.33 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -95.97 13.39 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.2 m -144.85 146.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -117.53 134.27 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.24 126.65 8.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.47 ' N ' ' HG ' ' A' ' 108' ' ' SER . 32.0 mmt180 -152.5 150.23 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 24.5 p -88.03 21.81 2.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.425 ' CH2' HG13 ' A' ' 132' ' ' ILE . 4.2 p-90 -142.73 166.46 24.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.5 t80 -110.23 144.47 38.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.474 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.1 t -136.99 105.51 8.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -64.11 111.89 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -115.52 120.11 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.01 -121.36 1.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.446 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -106.28 139.21 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.456 HD21 ' CB ' ' A' ' 10' ' ' LEU . 38.4 tp -143.95 116.0 8.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.942 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.4 m95 -72.05 132.43 44.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -102.14 130.41 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.77 154.73 42.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.08 118.64 28.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.8 p -56.12 179.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.36 4.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 14.6 ttpt -91.86 148.81 21.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.404 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 16.6 mtmt -105.55 121.54 45.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 127.91 15.25 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.5 m -73.63 158.24 86.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.619 0.723 . . . . 0.0 110.89 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -6.15 17.87 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.722 2.281 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.49 -41.68 9.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -41.8 78.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' NE2' ' A' ' 58' ' ' GLN . 38.7 t -67.03 -50.52 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 t -62.52 -44.64 95.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.33 -54.35 21.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.494 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.6 mt -56.61 -39.13 73.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.585 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.0 mt-30 -54.52 -47.17 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.05 -35.73 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -60.86 -49.68 76.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -69.83 -39.49 76.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.462 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 45.2 mtt180 -48.01 -36.2 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.24 -16.75 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.471 HD11 ' NE2' ' A' ' 104' ' ' GLN . 59.6 mt -87.05 -27.09 23.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.8 mmm180 -123.7 -28.92 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.52 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 131.2 127.83 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.92 -19.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 9.8 t70 -76.16 8.79 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 27.2 m -63.02 -179.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 3.4 mm-40 -118.2 171.87 7.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.585 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 53.5 m-85 -162.25 137.28 5.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 152.71 69.54 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.722 2.281 . . . . 0.0 112.324 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -72.49 -28.93 63.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.0 176.1 10.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.624 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.7 m-85 -134.42 93.94 18.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.955 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.0 Cg_endo -69.77 175.07 8.6 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.703 2.268 . . . . 0.0 112.384 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m -144.47 134.66 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.824 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.59 12.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.6 m -160.14 148.57 16.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -75.11 118.59 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' N ' HD23 ' A' ' 80' ' ' LEU . 80.7 mt -85.11 -74.06 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -145.94 -145.07 4.19 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.587 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.9 p -152.75 161.28 42.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.37 . . . . 0.0 110.841 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 83' ' ' CYS . 13.5 m -146.79 146.45 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.01 107.0 18.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.68 97.9 1.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.469 HD11 ' CG ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -67.88 -47.46 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -165.25 166.67 18.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 t -127.35 99.7 5.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.49 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.0 mt -94.25 169.19 10.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 p -106.91 169.25 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 108' ' ' SER . 19.8 mm-40 -47.99 -18.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -90.69 -58.13 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -71.28 -50.68 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.569 ' CD2' HG23 ' A' ' 111' ' ' VAL . 35.2 t80 -40.22 -55.99 2.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 4.2 ptmt -66.45 -42.41 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 9.1 mt-10 -53.23 -59.2 4.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.442 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -74.76 -50.27 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.8 m-85 -111.21 67.62 0.62 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.59 0.709 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -13.89 35.35 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.686 2.257 . . . . 0.0 112.363 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -74.33 -23.07 59.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.8 pt -122.14 20.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.9 p -63.22 -23.6 67.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.62 HE21 ' N ' ' A' ' 105' ' ' GLU . 1.8 pp0? -93.13 -25.69 17.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.62 ' N ' HE21 ' A' ' 104' ' ' GLN . 36.1 mt-10 -53.14 -33.36 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.436 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 2.2 p -127.47 146.51 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 1.6 t70 -111.75 -33.77 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.47 ' HG ' ' N ' ' A' ' 30' ' ' ARG . 1.8 m -43.6 161.39 0.2 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.686 0.755 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.464 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.93 102.79 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.569 HG23 ' CD2' ' A' ' 95' ' ' PHE . 39.7 t -85.91 136.93 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 5.0 m-30 -105.07 107.05 17.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.52 118.44 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.4 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -119.39 151.3 38.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.469 ' CG ' HD11 ' A' ' 87' ' ' ILE . 13.7 mmmt -143.03 174.07 11.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 53.95 54.74 11.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.652 0.739 . . . . 0.0 110.869 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.8 Cg_endo -69.8 121.81 8.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 0.0 112.292 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -132.0 131.69 42.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -97.67 123.55 41.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.4 mtp -64.34 149.92 47.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.9 t -78.08 -21.42 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 123' ' ' LYS . 2.3 p -132.85 135.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 122' ' ' VAL . 13.1 mmtp -102.15 154.71 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.19 142.72 37.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.415 HD11 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -123.06 158.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.603 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 28.8 mtmt -92.04 134.77 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.72 167.72 46.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.473 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 1.5 t-20 -156.74 144.34 13.96 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.638 0.733 . . . . 0.0 110.884 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.1 Cg_endo -69.75 3.12 2.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.679 2.253 . . . . 0.0 112.339 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.417 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 6.9 mmmm -135.34 -173.89 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.451 HG21 ' CE3' ' A' ' 8' ' ' TRP . 71.7 mt -91.57 134.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.603 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 1.3 p-90 -143.21 130.0 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.451 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 11.2 ttmt -53.67 129.81 34.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.468 HD11 ' CD1' ' A' ' 41' ' ' TRP . 22.9 mt -65.8 162.77 18.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.3 t0 -73.67 129.77 38.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.92 -50.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -65.09 -39.68 93.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.9 mm -64.66 -47.78 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ILE . 18.0 t-160 -37.09 -65.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 91.6 mt-30 -51.66 -69.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.42 -49.14 0.67 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.572 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -55.31 -43.55 74.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.1 mtpp -67.72 -23.24 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 147' ' ' LEU . 17.7 mmtp -77.89 -53.1 7.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.17 -27.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 145' ' ' LYS . 17.6 mt -81.5 39.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.843 0.354 . . . . 0.0 110.919 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 5.5 ptp -108.27 -26.0 10.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 150' ' ' GLN . 20.8 mtpt -125.91 43.8 2.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 149' ' ' LYS . 9.8 mm-40 -34.52 150.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -38.71 155.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -45.69 -50.06 13.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -45.29 -57.45 3.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 p -118.99 -48.1 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 110.897 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.0 p -132.93 150.17 52.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.55 99.36 0.84 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.434 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.3 p -120.67 149.99 41.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 0.0 110.842 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 m -125.72 20.82 7.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.835 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.32 61.57 4.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.546 ' CZ2' ' HE3' ' A' ' 134' ' ' LYS . 90.4 m95 -74.26 162.56 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.774 0.321 . . . . 0.0 110.895 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.2 t -138.83 138.8 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.4 tp -123.1 111.85 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.3 p -70.54 125.83 27.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.54 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 17.7 t -107.98 160.67 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.54 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 56.1 m-70 -91.14 111.14 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.493 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 70.0 mt-30 -58.85 159.93 12.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.664 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.75 -31.36 4.6 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.375 -0.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CZ2' HD13 ' A' ' 57' ' ' LEU . 9.1 m-90 -25.98 -54.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -36.52 -58.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 66.4 m -66.08 -40.74 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.87 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.0 mt -51.94 -26.34 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 9.2 mp -71.24 -69.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.885 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 m -58.84 -15.0 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.084 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.9 mmt180 -79.98 -39.49 29.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.44 6.21 8.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.458 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.81 -47.59 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 3.4 tptp -90.35 117.7 29.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 13.2 ttt180 -102.62 0.09 32.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 17.6 m -147.01 154.96 11.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 8.2 tm-20 -122.54 153.3 39.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -112.7 130.55 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.528 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.428 ' HG3' ' CZ2' ' A' ' 32' ' ' TRP . 9.2 mmt180 -149.05 149.7 31.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.433 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 57.7 p -85.27 20.36 2.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.521 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.9 p-90 -145.09 167.68 22.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.0 t80 -108.82 141.35 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.403 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 6.9 t -134.93 103.56 10.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.571 0.7 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.9 Cg_endo -69.71 2.39 3.55 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.273 . . . . 0.0 112.336 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -60.89 108.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 6.3 mmt85 -111.65 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.15 -123.2 1.65 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.1 ttm105 -104.98 140.97 37.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.0 tp -143.98 114.41 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 91.1 m95 -71.27 131.93 44.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.96 127.49 56.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.99 49.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.23 119.36 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.5 p -54.24 -174.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.78 -10.47 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 4.9 ttpt -73.6 148.7 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.479 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 1.2 pmtp? -108.53 132.56 21.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 0.0 110.872 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -73.97 159.81 83.24 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -8.3 23.26 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.739 2.293 . . . . 0.0 112.345 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -42.43 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -40.94 84.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.463 HG11 ' NE2' ' A' ' 58' ' ' GLN . 62.1 t -65.07 -51.15 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -64.07 -45.82 87.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.25 -53.27 46.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.574 HD13 ' CZ2' ' A' ' 16' ' ' TRP . 79.2 mt -56.03 -43.33 77.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.2 mt-30 -51.73 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.71 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -61.49 -48.76 79.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -70.89 -33.52 70.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 43.6 mtt180 -53.5 -36.07 61.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.4 -12.8 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.429 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 71.4 mt -90.65 -29.04 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.965 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.8 mmp_? -122.92 -29.06 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 134.12 129.01 2.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.9 -18.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.319 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.7 t70 -82.43 20.4 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 29.3 m -70.91 179.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 13.2 mt-10 -116.61 166.9 11.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 52.7 m-85 -159.87 138.56 7.78 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 0.0 110.842 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.3 Cg_endo -69.77 163.86 36.71 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.08 -22.91 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -150.61 166.69 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.1 m-85 -130.44 87.93 48.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.903 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 171.62 14.14 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.642 2.228 . . . . 0.0 112.325 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.6 p -138.91 144.38 39.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.6 89.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 67.0 m -149.79 146.74 27.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.26 118.66 19.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.69 -71.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.33 -150.44 5.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.501 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -149.59 153.69 37.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.89 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.3 m -140.2 142.23 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.29 114.45 21.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tt -77.1 95.67 4.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.482 HD11 ' CA ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -64.61 -46.05 93.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.467 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 1.6 m-20 -166.7 165.9 16.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.411 ' SG ' ' CE1' ' A' ' 112' ' ' PHE . 1.2 t -127.37 99.04 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.484 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 83.0 mt -97.02 170.91 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 30.4 t -110.04 169.11 8.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -46.62 -20.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 91' ' ' SER . 24.7 ttmt -89.64 -60.62 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -70.53 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 21.1 t80 -39.24 -54.95 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.9 ptmm? -68.45 -47.52 66.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.7 mt-10 -46.01 -54.37 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -81.18 -51.81 8.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 18.6 m-85 -107.11 70.92 0.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.627 0.727 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.441 ' CD ' ' O ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.77 -17.48 37.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.385 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.3 -26.7 60.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.594 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.1 pt -120.23 24.35 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.457 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 22.1 p -68.25 -21.16 64.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.538 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -96.42 -23.52 16.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.538 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 11.3 mt-10 -48.04 -41.24 25.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 t -124.1 143.02 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -104.3 -28.63 11.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -45.85 161.49 0.26 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.652 0.739 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.433 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.2 Cg_endo -69.78 -43.66 2.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -112.92 102.49 10.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 95' ' ' PHE . 59.3 t -85.18 136.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.413 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 7.3 m-30 -105.0 104.22 13.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.818 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.17 121.84 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.106 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.482 ' CA ' HD11 ' A' ' 87' ' ' ILE . 3.7 m -122.78 154.09 38.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.48 ' CG ' HD12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -139.45 177.03 8.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 52.6 53.54 12.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.902 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.0 Cg_endo -69.66 117.46 5.09 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -131.33 143.59 50.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -107.95 120.6 42.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.446 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 14.2 mtp -62.67 153.47 32.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.62 -32.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.76 132.57 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.446 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 16.8 mmtm -102.18 154.28 19.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -120.48 142.35 33.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 88.23 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.92 165.24 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.6 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 50.0 mtpt -107.23 135.6 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.17 171.89 37.58 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.477 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -150.29 156.43 37.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.316 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.521 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.7 mmmm -139.37 -175.33 4.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.49 HG21 ' CE3' ' A' ' 8' ' ' TRP . 62.0 mt -84.8 132.18 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.6 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 4.4 p-90 -138.71 131.74 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.546 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 12.3 ttmt -58.25 128.78 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 41' ' ' TRP . 22.4 mt -64.68 170.61 3.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -78.63 127.01 31.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.41 -50.3 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -65.46 -40.29 93.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.9 mm -64.12 -45.93 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -40.45 -65.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.9 mt-30 -52.44 -70.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.67 -43.49 0.8 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.469 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.571 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . . . -61.55 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -61.06 -20.89 63.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' LEU . 18.3 mmmt -90.33 -48.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 148' ' ' MET . . . -40.94 -21.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 145' ' ' LYS . 42.0 mt -79.37 37.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.428 ' O ' ' HG3' ' A' ' 148' ' ' MET . 2.6 ptp -122.5 133.94 54.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt 60.28 54.96 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.472 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -101.64 176.89 5.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 150' ' ' GLN . 3.6 p30 -35.33 131.29 0.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -89.81 40.06 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.941 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.67 -49.02 1.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 179.931 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -64.81 126.54 28.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 110.822 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t -88.07 130.41 35.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.91 130.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.5 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 t -125.58 94.08 4.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.852 0.358 . . . . 0.0 110.852 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.73 115.6 30.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.42 109.16 2.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.475 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.597 ' CZ2' ' HD3' ' A' ' 134' ' ' LYS . 92.7 m95 -93.5 167.92 11.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -141.28 159.28 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.43 HD21 ' CD ' ' A' ' 28' ' ' GLU . 31.7 tp -145.42 116.65 7.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 2.7 t -67.99 146.34 53.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.51 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 74.3 t -134.26 153.97 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.422 ' N ' HG13 ' A' ' 12' ' ' VAL . 39.2 m-70 -88.68 113.68 24.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 46.3 mt-30 -59.94 161.88 11.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.621 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -28.43 6.25 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.338 -0.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.562 ' CZ2' HD13 ' A' ' 57' ' ' LEU . 10.5 m-90 -28.7 -53.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -35.57 -64.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.42 -43.22 99.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.6 mt -48.97 -36.61 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.8 mp -59.75 -64.83 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 82' ' ' GLY . 14.2 m -63.33 -17.92 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.481 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.0 mmt180 -76.49 -39.98 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.54 18.84 3.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.61 -37.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 111.162 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 4.9 tptp -102.91 95.54 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -92.24 14.53 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 30.6 m -146.76 143.94 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.51 ' OE2' ' CG2' ' A' ' 12' ' ' VAL . 2.5 tt0 -115.97 141.79 47.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.62 122.83 7.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -146.29 149.1 33.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 41.2 p -86.41 23.15 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.473 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -146.01 160.16 42.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -100.78 138.95 37.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.48 HG21 ' CE2' ' A' ' 112' ' ' PHE . 10.6 t -133.16 100.03 14.44 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.565 0.698 . . . . 0.0 111.109 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.76 8.9 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.354 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.421 ' H ' ' C ' ' A' ' 34' ' ' THR . 23.3 t60 -67.27 108.18 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.439 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 63.3 mmt-85 -106.86 115.83 30.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.45 -138.72 6.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -94.92 142.61 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -143.97 115.98 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.07 138.35 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.952 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -109.04 127.3 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.59 152.18 39.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.63 119.03 25.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.1 p -54.4 -179.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.142 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.83 22.41 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 4.8 ttpt -110.59 132.06 54.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -91.75 130.62 38.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.547 0.689 . . . . 0.0 110.937 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.6 Cg_endo -69.73 134.24 27.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 m -75.51 159.21 82.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.697 0.761 . . . . 0.0 110.857 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.689 2.259 . . . . 0.0 112.343 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -94.34 -42.34 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -40.28 86.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.5 t -65.62 -50.73 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.03 -42.3 99.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -67.92 -53.74 24.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.562 HD13 ' CZ2' ' A' ' 16' ' ' TRP . 93.9 mt -59.14 -38.74 80.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.569 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 10.5 mt-30 -55.26 -46.15 76.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -35.35 38.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -61.42 -51.63 67.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -67.48 -41.29 84.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.935 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.473 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 52.3 mtt180 -48.16 -36.07 12.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.907 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -86.74 -16.19 37.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD12 ' NE2' ' A' ' 104' ' ' GLN . 61.8 mt -88.17 -27.25 21.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -123.38 -26.93 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 127.74 129.03 3.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.455 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.29 -19.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -72.59 3.85 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 35.2 m -61.65 178.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -119.73 167.85 11.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 67.8 m-85 -155.47 141.14 12.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.9 Cg_endo -69.77 165.87 29.51 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.66 2.24 . . . . 0.0 112.323 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -88.88 -20.75 24.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.48 174.38 14.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.621 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 87.7 m-85 -134.99 89.73 23.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.66 0.743 . . . . 0.0 110.947 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.44 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.7 Cg_endo -69.75 168.9 20.21 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.719 2.279 . . . . 0.0 112.354 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.0 m -134.91 139.58 45.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.92 92.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 81.5 m -152.76 157.33 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.69 117.83 21.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.1 mt -85.87 -71.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.459 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -149.4 -140.35 3.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.484 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.2 p -156.33 166.36 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 16.4 m -154.16 138.71 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -81.6 113.91 19.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.66 94.38 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.473 HD12 ' CG ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -62.67 -46.85 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -165.53 170.19 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.17 102.08 6.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.7 mt -95.87 171.18 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.947 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 93' ' ' LYS . 5.3 p -106.92 169.2 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 108' ' ' SER . 10.0 mm-40 -43.87 -22.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' SER . 31.7 ttpt -92.65 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -56.3 -46.42 79.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.506 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 17.6 t80 -41.95 -58.95 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -68.86 -44.91 72.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 8.0 mt-10 -43.06 -55.72 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.449 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.9 mt-30 -83.62 -43.4 15.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.0 m-85 -115.81 68.41 3.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.681 0.753 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 96' ' ' LYS . 53.9 Cg_endo -69.76 -12.86 33.77 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 0.0 112.365 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.29 -16.45 60.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.466 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -128.77 21.15 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.473 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 21.9 p -60.25 -25.87 66.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.576 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -94.28 -28.8 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.576 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 20.8 mt-10 -47.44 -36.95 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 t -120.04 157.57 28.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.401 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 3.5 t0 -125.17 -29.27 3.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.505 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -50.19 161.54 0.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.893 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.6 Cg_endo -69.78 -41.53 4.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.673 2.248 . . . . 0.0 112.311 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -115.65 101.69 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 21.4 t -84.97 139.85 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' A' ' 34' ' ' THR . 7.3 m-30 -105.9 105.59 15.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.95 119.91 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.472 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.8 m -122.51 154.18 38.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' CG ' HD12 ' A' ' 87' ' ' ILE . 6.5 mmtp -141.36 177.07 8.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 53.51 51.6 8.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.74 120.6 7.37 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.99 138.94 47.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -101.73 123.13 45.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.5 mtp -65.43 136.58 56.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.07 -27.72 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 143.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mttp -114.23 142.73 45.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.03 146.37 33.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.91 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 89.92 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.28 157.82 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.624 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 10.5 pttm -92.33 157.17 16.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.41 -177.59 28.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.507 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.491 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.5 t30 -169.74 146.83 2.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.617 0.722 . . . . 0.0 110.885 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.0 Cg_endo -69.79 0.32 5.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.353 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.5 mmmm -133.93 -172.78 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.473 HG13 ' CH2' ' A' ' 32' ' ' TRP . 34.6 mt -82.93 130.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.624 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 6.1 p-90 -136.23 110.04 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.597 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 1.2 ttpp -54.76 127.09 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 41' ' ' TRP . 30.9 mt -57.4 169.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.58 163.1 28.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -42.25 99.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -77.08 -34.67 56.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.7 mm -72.22 -37.1 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.406 ' NE2' ' HD2' ' A' ' 144' ' ' LYS . 22.4 t-160 -48.89 -63.85 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 142' ' ' GLY . 34.4 mt-30 -50.67 -67.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -33.87 -54.33 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.482 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.485 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . . . -52.61 -43.53 65.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 141' ' ' GLN . 11.3 mtpt -66.17 -15.45 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -99.4 -34.09 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.02 9.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.454 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 72.5 mt -83.94 23.16 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.3 ptp -99.53 136.85 38.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? 48.02 42.44 16.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 3.1 mm-40 -37.83 -73.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -136.93 167.27 21.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -77.76 -40.13 41.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.84 -59.84 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -65.32 165.42 11.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.88 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 t -115.05 -44.32 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 5' ' ' SER . . . -149.59 46.52 0.65 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 4' ' ' GLY . 42.4 p -37.38 -47.78 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.834 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 23.8 m -50.46 135.59 22.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.85 92.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 6' ' ' SER . 90.6 m95 -73.81 160.89 30.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.728 0.299 . . . . 0.0 110.904 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.458 ' CB ' ' HG ' ' A' ' 135' ' ' LEU . 9.7 t -135.54 123.02 22.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.432 ' CB ' HD21 ' A' ' 40' ' ' LEU . 61.9 tp -112.11 118.31 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' CA ' ' A' ' 128' ' ' GLY . 3.2 m -71.83 155.13 40.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 53.4 t -138.44 162.3 30.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.543 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 67.2 m-70 -97.36 114.89 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.6 mm-40 -59.8 158.55 23.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 110.861 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HB3' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.77 -33.28 3.47 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 -1.807 . . . . 0.0 112.358 -0.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.566 ' CZ2' HD12 ' A' ' 57' ' ' LEU . 16.7 m-90 -25.01 -56.88 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -33.81 -53.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.7 m -72.9 -50.99 20.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.7 mt -40.55 -32.43 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.8 mp -64.75 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 m -60.78 -16.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.47 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.5 mmt180 -77.19 -39.31 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.21 12.17 5.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.29 -48.62 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 11.3 tptt -89.15 117.08 27.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.9 ttm180 -101.07 -6.85 23.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.5 m -133.33 158.34 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.52 124.97 41.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.18 128.45 8.85 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -147.51 147.74 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.404 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.1 p -85.15 17.52 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.452 ' CH2' HG13 ' A' ' 132' ' ' ILE . 2.5 p-90 -142.51 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 34' ' ' THR . 4.1 t80 -106.36 139.3 41.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.576 HG22 ' CE2' ' A' ' 112' ' ' PHE . 8.1 t -134.32 101.71 12.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.613 0.72 . . . . 0.0 111.163 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.447 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.8 6.79 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.357 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.403 ' H ' ' C ' ' A' ' 34' ' ' THR . 16.4 t60 -64.54 108.82 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.447 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.8 mmt-85 -105.23 112.67 25.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.31 -152.43 23.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -79.28 143.57 35.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.829 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD21 ' CB ' ' A' ' 10' ' ' LEU . 25.2 tp -143.87 115.08 7.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 95.5 m95 -71.12 124.8 25.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.72 122.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.131 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.92 149.84 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.21 123.63 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 p -59.43 -174.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.27 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -81.41 135.0 35.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.25 41.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.618 0.723 . . . . 0.0 110.867 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 129.54 17.76 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -76.35 159.27 80.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.68 0.752 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -3.62 12.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.96 -41.41 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.88 -43.31 72.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.3 t -65.78 -52.54 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -59.75 -45.7 91.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.34 -56.67 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.566 HD12 ' CZ2' ' A' ' 16' ' ' TRP . 92.1 mt -55.9 -38.51 70.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 9.7 mt-30 -57.46 -43.53 84.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.43 -32.61 32.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -66.24 -52.29 49.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 64' ' ' LEU . 31.9 m-85 -66.32 -38.26 87.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.464 ' O ' ' C ' ' A' ' 66' ' ' GLY . 65.0 mtt180 -47.71 -34.2 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.62 -16.01 31.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.468 HD11 ' NE2' ' A' ' 104' ' ' GLN . 48.6 mt -87.28 -29.96 21.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -120.27 -29.13 4.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.95 124.87 2.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -43.99 -21.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.776 0.322 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' GLY . 6.5 t0 -79.85 18.88 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 24.9 m -69.07 -178.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' O ' ' CD1' ' A' ' 71' ' ' PHE . 5.4 pt-20 -117.51 166.3 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -158.92 135.53 6.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.692 0.758 . . . . 0.0 110.87 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 145.76 58.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.364 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.19 -27.08 66.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.426 ' C ' ' CD1' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -149.4 -178.11 6.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.563 ' CE2' ' HB3' ' A' ' 15' ' ' PRO . 13.9 m-85 -141.19 105.0 6.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 178.35 4.65 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.652 2.235 . . . . 0.0 112.371 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.1 p -142.66 130.49 21.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.12 48.75 66.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 59.3 m -150.62 148.42 28.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.33 115.29 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.3 mt -83.25 -71.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.15 -139.68 3.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 7.1 p -155.81 157.68 36.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.418 HG13 ' C ' ' A' ' 83' ' ' CYS . 21.9 m -144.63 136.7 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.74 110.94 14.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.6 96.16 4.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.423 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -64.29 -50.37 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 87' ' ' ILE . 0.6 OUTLIER -161.23 167.88 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 t -128.2 101.3 6.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.492 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 80.8 mt -98.61 170.88 8.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 93' ' ' LYS . 29.3 t -109.44 169.18 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.455 ' NE2' ' O ' ' A' ' 108' ' ' SER . 20.4 mm-40 -46.29 -20.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 91' ' ' SER . 19.5 tttt -89.56 -60.61 1.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -70.02 -50.4 41.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.57 ' CD2' HG21 ' A' ' 111' ' ' VAL . 28.7 t80 -39.72 -55.32 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.8 ptmm? -67.96 -47.49 68.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.504 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 5.8 mt-10 -45.88 -55.93 6.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.479 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.0 mt-30 -78.67 -52.73 8.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.479 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 23.9 m-85 -108.15 70.1 0.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.77 -15.46 37.07 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.647 2.231 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -73.36 -26.3 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.479 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.4 pt -118.96 21.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.6 p -64.49 -22.14 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.606 HE21 ' N ' ' A' ' 105' ' ' GLU . 1.7 pp0? -96.04 -21.4 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.606 ' N ' HE21 ' A' ' 104' ' ' GLN . 7.5 mt-10 -56.23 -36.25 68.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.49 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.5 p -125.85 138.35 53.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.854 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 15.4 t70 -104.57 -30.57 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.455 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -44.28 161.04 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.673 0.749 . . . . 0.0 110.866 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.404 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.1 Cg_endo -69.75 -47.8 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.406 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 22.1 m-85 -110.0 99.52 8.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.57 HG21 ' CD2' ' A' ' 95' ' ' PHE . 46.5 t -80.86 144.61 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.576 ' CE2' HG22 ' A' ' 34' ' ' THR . 12.6 m-30 -110.99 106.18 15.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.07 120.0 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.421 ' C ' HD13 ' A' ' 87' ' ' ILE . 3.8 m -126.03 153.64 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 16.6 mmmt -143.09 174.07 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.62 52.97 5.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.3 Cg_endo -69.71 119.47 6.42 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.337 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -132.05 134.26 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -99.79 126.01 45.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.9 mtp -65.69 152.82 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.23 -36.58 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.07 142.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.152 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -104.74 152.4 22.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.02 139.53 24.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.01 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.66 160.35 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.599 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 5.7 mtmp? -92.12 128.29 37.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' CA ' ' OG ' ' A' ' 11' ' ' SER . . . -89.37 151.6 22.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.499 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -132.33 154.0 81.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 2.28 3.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.432 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 7.1 mmmm -135.83 -174.12 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.452 HG13 ' CH2' ' A' ' 32' ' ' TRP . 58.1 mt -89.05 132.57 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.599 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.3 p-90 -140.69 129.83 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.05 127.35 28.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.458 ' HG ' ' CB ' ' A' ' 9' ' ' CYS . 31.2 mt -62.45 166.86 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 4.4 t0 -76.38 129.04 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -35.55 -38.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -75.47 -42.62 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 mm -64.16 -40.16 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -44.22 -65.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 142' ' ' GLY . 28.3 mt-30 -51.86 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.05 -49.01 1.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.494 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.66 -51.02 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.104 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 144' ' ' LYS . 2.0 mtpm? -57.84 -32.45 67.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 147' ' ' LEU . 21.3 mmmt -71.59 -50.8 27.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.74 -25.51 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 145' ' ' LYS . 23.6 mt -85.18 42.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 ptp -104.59 -36.81 7.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -131.85 70.75 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 4.0 mm-40 -56.73 163.54 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.886 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -52.36 143.49 14.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 153' ' ' ALA . 41.2 mtpt -87.57 -43.96 11.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 152' ' ' LYS . . . -34.24 -61.49 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.087 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 179.948 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.3 p -42.17 117.83 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 110.823 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -147.45 122.04 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.882 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.03 54.9 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.491 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.0 t -104.2 45.7 0.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.845 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -85.75 29.06 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.07 63.79 4.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.478 ' CH2' ' NZ ' ' A' ' 134' ' ' LYS . 91.7 m95 -72.39 167.51 20.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -135.85 140.54 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.1 tp -131.12 106.66 8.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -67.65 147.32 52.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 29.4 t -132.35 157.88 43.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.486 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.8 m-70 -88.03 115.26 25.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.479 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 45.1 mt-30 -61.22 162.21 14.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.78 -27.46 6.82 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.318 0.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.568 ' CZ2' HD12 ' A' ' 57' ' ' LEU . 11.5 m-90 -30.33 -52.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 16' ' ' TRP . . . -35.88 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' LEU . 1.7 m -61.33 -52.75 63.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' SER . 57.1 mt -38.37 -41.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.481 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -55.99 -68.37 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -59.84 -12.94 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.7 mmt180 -83.13 -39.57 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.97 -6.5 8.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -78.8 -46.96 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.467 ' HG2' ' CD1' ' A' ' 20' ' ' LEU . 12.3 tptt -94.64 111.94 23.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -108.41 16.67 22.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 27.2 m -149.6 143.95 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -111.69 150.14 30.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.476 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -115.37 123.95 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.53 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 85.2 mmt-85 -149.8 151.71 34.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.49 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.2 t -87.93 24.0 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.53 ' CZ2' ' HD2' ' A' ' 30' ' ' ARG . 3.3 p-90 -144.6 157.78 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -99.26 137.77 37.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.538 HG21 ' CE2' ' A' ' 112' ' ' PHE . 9.3 t -133.59 100.94 13.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.577 0.704 . . . . 0.0 111.169 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.4 Cg_endo -69.77 6.22 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.712 2.275 . . . . 0.0 112.365 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -64.63 111.37 2.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' A' ' 34' ' ' THR . 15.8 mmt180 -112.67 110.54 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.14 -142.37 8.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.445 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.1 ttp-105 -82.11 142.31 32.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.854 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 tp -143.69 106.83 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.59 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 91.4 m95 -71.8 118.83 15.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 mm -91.59 129.85 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.75 148.57 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.42 112.42 19.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -48.5 175.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.57 -12.46 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -74.35 142.22 45.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -103.22 131.59 21.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.547 0.689 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 133.42 25.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.638 2.225 . . . . 0.0 112.392 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.8 m -82.16 159.17 65.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.683 0.754 . . . . 0.0 110.815 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -2.81 10.79 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.506 ' NE2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -94.31 -46.53 7.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -69.28 -41.19 77.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.433 HG12 ' NE2' ' A' ' 58' ' ' GLN . 56.9 t -63.15 -51.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -60.51 -44.22 96.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.506 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 18.6 mt-10 -66.69 -57.24 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.568 HD12 ' CZ2' ' A' ' 16' ' ' TRP . 90.0 mt -54.03 -40.25 66.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.7 mt-30 -55.0 -45.57 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -34.98 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.086 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -61.99 -50.76 70.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.408 ' O ' ' N ' ' A' ' 64' ' ' LEU . 30.9 m-85 -68.7 -39.18 80.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' GLY . 59.7 mtt180 -47.67 -34.03 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 25.7 mt -90.57 -15.53 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.43 HD11 ' NE2' ' A' ' 104' ' ' GLN . 59.1 mt -88.0 -29.42 20.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -121.21 -28.96 4.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.499 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 133.37 125.35 2.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.482 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.57 -19.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' GLY . 11.6 t70 -80.69 16.52 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 66' ' ' GLY . 27.6 m -66.75 -177.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.502 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.4 pt-20 -116.09 170.07 8.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 52.1 m-85 -163.27 136.56 4.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.677 0.751 . . . . 0.0 110.855 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.446 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 54.4 Cg_endo -69.75 158.9 55.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.66 2.24 . . . . 0.0 112.385 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -76.92 -30.28 56.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -148.73 177.9 9.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.594 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 57.4 m-85 -134.87 95.84 15.13 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.65 0.738 . . . . 0.0 110.884 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.5 Cg_endo -69.8 -179.92 3.27 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.375 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -145.62 143.94 30.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.5 47.23 92.16 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 87.3 m -156.27 146.95 21.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.368 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.458 HD21 ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -74.53 121.51 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.458 ' N ' HD21 ' A' ' 80' ' ' LEU . 16.9 mt -88.9 -71.2 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.948 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.95 -147.47 4.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.455 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.59 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.1 p -153.57 154.68 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.425 HG11 ' C ' ' A' ' 83' ' ' CYS . 24.3 m -140.7 141.4 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.25 111.34 18.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -75.85 99.06 4.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.424 ' CD1' ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.34 -48.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.181 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -162.27 168.57 22.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.87 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.43 103.11 7.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.493 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 87.0 mt -98.76 166.87 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 93' ' ' LYS . 48.5 t -104.72 168.5 9.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -45.81 -20.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.6 ttpt -91.3 -63.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.59 -49.48 75.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 103' ' ' SER . 61.3 t80 -43.2 -56.2 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.457 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -66.38 -38.36 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.16 -55.21 35.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.45 ' NE2' HD22 ' A' ' 90' ' ' LEU . 10.8 mt-30 -78.48 -52.09 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.4 m-85 -109.85 68.22 0.46 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.665 0.745 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.8 Cg_endo -69.81 -14.23 35.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.12 -22.31 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pt -121.34 8.22 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.501 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 89.5 p -49.06 -25.27 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -90.7 -28.69 18.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.881 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 4.1 mt-10 -56.36 -22.57 31.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 p -113.98 160.3 18.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -134.88 -33.15 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.476 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -62.34 165.51 8.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.719 0.771 . . . . 0.0 110.826 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.49 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.84 -45.11 1.66 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -110.55 98.0 7.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.476 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 13.5 t -83.37 140.26 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 34' ' ' THR . 3.0 m-30 -107.57 110.48 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.15 122.13 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.7 m -124.95 154.86 40.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -142.04 176.29 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 57.5 52.67 5.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.76 117.38 5.05 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.671 2.248 . . . . 0.0 112.354 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -133.08 139.08 46.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -101.47 125.55 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.2 mtp -67.01 150.91 48.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 149' ' ' LYS . 95.2 t -75.18 -31.01 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.4 146.35 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -112.74 149.48 32.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.54 ' CD2' HG22 ' A' ' 139' ' ' ILE . 1.2 m-85 -115.18 141.07 26.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.864 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 84.58 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.341 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.2 158.81 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 39.5 mmtt -91.45 121.84 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.66 155.79 53.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -148.85 156.0 40.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -51.12 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.667 2.245 . . . . 0.0 112.32 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.446 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.0 mmmm -86.54 -174.53 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 133' ' ' TRP . 66.3 mt -83.03 141.63 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.571 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 1.6 p-90 -146.88 123.98 11.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.478 ' NZ ' ' CH2' ' A' ' 8' ' ' TRP . 1.1 ttmp? -56.1 128.31 34.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 mt -63.06 169.97 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.1 t70 -75.15 127.67 33.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.47 -40.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -40.99 63.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.54 HG22 ' CD2' ' A' ' 124' ' ' PHE . 22.2 mm -65.0 -44.37 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.9 t-160 -37.84 -62.51 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' GLY . 23.8 mt-30 -52.96 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.93 -46.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.52 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.95 -49.18 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -58.71 -27.82 65.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.4 mmpt? -76.37 -49.41 16.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.42 -22.72 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.449 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.445 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 25.1 mt -85.75 35.42 0.62 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 7.5 ptp -97.1 -36.9 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.489 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 35.3 ttmt -134.31 77.67 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 23.8 mm-40 -71.19 172.82 8.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -70.4 161.56 30.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 153' ' ' ALA . 0.4 OUTLIER -43.86 -61.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 152' ' ' LYS . . . -34.08 -48.95 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.151 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.61 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.4 m95 -82.48 161.62 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.748 0.309 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB2' ' CG ' ' A' ' 135' ' ' LEU . 44.6 t -138.12 130.18 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.9 tp -118.56 114.33 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.0 t -67.91 150.03 49.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 32.3 t -133.29 156.75 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.475 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 41.7 m-70 -90.73 115.38 27.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.542 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 65.9 mt-30 -61.66 160.82 24.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.962 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.83 -31.86 4.31 Favored 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.718 -1.784 . . . . 0.0 112.297 0.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.587 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.2 m-90 -25.47 -53.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.542 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -37.51 -61.3 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 7.2 m -64.88 -42.82 94.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.7 mt -51.77 -31.12 25.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.5 mp -66.27 -64.28 0.89 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.9 m -63.99 -16.39 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -76.87 -39.52 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.808 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 18.7 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.515 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.49 -42.1 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.552 ' HG2' HD11 ' A' ' 20' ' ' LEU . 17.3 tptt -99.05 104.54 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.486 ' HD2' HD13 ' A' ' 102' ' ' ILE . 12.2 ptp180 -97.87 17.34 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.474 HG11 HD12 ' A' ' 102' ' ' ILE . 27.4 m -149.38 147.1 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 3.5 tm-20 -118.62 141.81 48.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.516 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -102.89 126.82 8.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 12.6 mmt180 -148.42 146.37 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 10.4 m -84.25 20.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.575 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.3 p-90 -144.63 166.43 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -107.75 140.43 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 34' ' ' THR . 5.1 t -134.08 106.45 11.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.59 0.709 . . . . 0.0 111.128 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.3 Cg_endo -69.8 3.07 3.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.308 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.562 ' O ' HD22 ' A' ' 86' ' ' LEU . 18.5 t60 -63.13 111.74 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 7.7 mmt85 -116.1 121.79 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.65 -126.69 2.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.522 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -98.62 138.36 35.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.833 0.349 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 tp -143.93 112.86 6.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 86.2 m95 -71.34 133.86 46.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -104.1 126.84 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.54 145.57 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.672 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.64 117.06 22.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.3 p -53.21 176.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.86 -11.38 59.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 5.7 ttpt -73.06 146.53 45.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -104.08 134.08 19.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 0.0 110.91 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.75 127.26 14.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.623 2.215 . . . . 0.0 112.364 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.9 m -73.23 155.59 89.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.648 0.737 . . . . 0.0 110.871 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -5.33 15.9 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.713 2.275 . . . . 0.0 112.309 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -94.48 -39.83 10.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.38 -39.13 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.592 HG12 ' OE1' ' A' ' 58' ' ' GLN . 44.9 t -66.3 -54.74 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 t -59.09 -43.78 91.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.16 -56.43 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.586 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 77.2 mt -54.94 -39.6 69.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.592 ' OE1' HG12 ' A' ' 54' ' ' VAL . 36.7 mt-30 -55.44 -45.76 76.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.0 -33.81 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -63.44 -51.17 66.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.418 ' HE2' HD22 ' A' ' 57' ' ' LEU . 22.8 m-85 -68.55 -35.81 77.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 69' ' ' VAL . 35.5 mtt-85 -50.96 -34.13 27.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.64 -13.2 34.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.55 -29.24 17.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 3.7 mmm180 -121.47 -28.71 4.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.053 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.01 126.66 2.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.434 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 13.6 ptmt -45.98 -19.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.313 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -82.27 19.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.053 HG13 ' O ' ' A' ' 66' ' ' GLY . 21.2 m -67.24 -178.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -114.96 162.81 16.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 47.9 m-85 -157.61 134.94 6.89 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.3 Cg_endo -69.79 162.54 41.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 0.0 112.343 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -82.19 -29.27 31.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -147.35 175.19 10.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.604 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 51.7 m-85 -134.96 95.68 15.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.651 0.739 . . . . 0.0 110.966 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.8 Cg_endo -69.76 177.02 6.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.357 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.5 p -147.22 138.38 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 43.78 47.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 64.8 m -156.36 149.74 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.53 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -76.19 118.21 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 44' ' ' ALA . 86.9 mt -84.5 -73.95 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.427 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.97 -144.29 4.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.9 p -153.32 155.41 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 26.2 m -140.97 136.41 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.428 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.7 t70 -77.85 110.43 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.562 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.8 tt -75.0 101.85 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -72.99 -47.12 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.412 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -164.53 167.09 19.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -127.74 97.46 4.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 94' ' ' GLN . 94.8 mt -90.51 170.66 10.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.41 ' C ' ' N ' ' A' ' 93' ' ' LYS . 7.5 p -108.14 169.22 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.451 ' NE2' ' O ' ' A' ' 107' ' ' ASP . 6.7 mm100 -45.11 -21.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 24.2 tttt -92.02 -63.54 1.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.509 ' HB3' HD22 ' A' ' 90' ' ' LEU . 8.5 mt-30 -61.38 -48.47 81.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.606 ' CD2' HG21 ' A' ' 111' ' ' VAL . 21.8 t80 -42.38 -57.81 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 9.7 ptpt -67.79 -43.59 79.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -48.36 -58.6 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.486 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.4 mt-30 -79.39 -47.16 16.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.3 m-85 -110.24 67.82 0.49 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.626 0.727 . . . . 0.0 110.846 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.6 Cg_endo -69.81 -12.4 32.73 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -77.84 -20.94 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.652 HG22 ' CD ' ' A' ' 105' ' ' GLU . 2.1 pt -126.46 23.51 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.486 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 40.7 p -64.16 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.405 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -94.35 -30.02 14.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.652 ' CD ' HG22 ' A' ' 102' ' ' ILE . 30.0 mt-10 -45.51 -36.24 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 t -122.97 153.89 39.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.451 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 16.4 t70 -119.48 -30.55 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -47.35 161.04 0.33 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 110.825 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.483 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.7 Cg_endo -69.7 -37.88 8.7 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.7 2.267 . . . . 0.0 112.374 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -118.74 102.81 9.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.606 HG21 ' CD2' ' A' ' 95' ' ' PHE . 29.3 t -86.62 132.25 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.164 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 3.9 m-30 -99.63 105.21 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.81 122.56 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.411 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 2.1 m -125.71 154.44 42.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -141.9 175.2 9.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 55.44 53.2 8.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.646 0.736 . . . . 0.0 110.87 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.8 116.89 4.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.314 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -130.38 131.77 45.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.97 121.69 39.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.53 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.0 mtp -62.77 149.2 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.91 -35.75 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.33 134.16 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -102.43 149.49 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.406 ' HE2' ' HB2' ' A' ' 143' ' ' ALA . 0.8 OUTLIER -116.27 142.49 29.45 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.652 0.739 . . . . 0.0 110.857 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.8 pp -125.69 164.36 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.598 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 40.6 mttp -105.23 139.18 40.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.03 172.81 37.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -154.17 153.57 28.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 53.6 Cg_endo -69.75 1.75 4.15 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.354 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.575 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.2 mmmm -137.72 -174.95 3.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.61 HG22 ' CE3' ' A' ' 8' ' ' TRP . 75.5 mt -86.08 134.27 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.598 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.5 p-90 -140.64 130.71 24.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -57.94 128.04 35.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.44 HD22 HG21 ' A' ' 139' ' ' ILE . 29.3 mt -62.6 170.83 2.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.9 t0 -82.05 129.14 34.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -35.41 -49.5 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.84 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -65.3 -39.76 92.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 26.9 mm -64.75 -47.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.37 -61.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 142' ' ' GLY . 38.2 mt-30 -54.37 -69.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.55 -49.68 1.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.509 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.99 -44.27 78.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.7 mtpp -65.07 -22.88 67.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -84.46 -40.72 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -53.35 -14.77 3.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.889 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.592 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.5 m95 -84.56 163.58 19.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 133' ' ' TRP . 13.5 p -139.65 156.68 46.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -138.57 113.76 9.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 p -68.39 138.09 55.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.464 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 29.6 t -124.22 152.16 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 35.8 m-70 -87.4 114.89 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.691 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 57.9 mt-30 -60.58 161.44 14.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.77 -29.17 5.86 Favored 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.322 -0.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.573 ' O ' HD12 ' A' ' 20' ' ' LEU . 11.6 m-90 -28.53 -49.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.691 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -37.77 -64.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 -42.1 99.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.2 mt -49.82 -35.33 22.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.2 mp -61.92 -64.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.2 m -64.07 -22.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.4 mmt180 -69.32 -39.47 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.1 22.19 3.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.485 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.22 -44.62 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -95.01 101.25 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.98 ' HE ' HD13 ' A' ' 102' ' ' ILE . 17.2 ptt180 -96.85 17.2 17.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.644 HG11 HD12 ' A' ' 102' ' ' ILE . 32.7 m -149.02 150.37 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.44 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.8 122.18 7.42 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.447 ' N ' ' CB ' ' A' ' 108' ' ' SER . 16.4 mmt180 -147.8 150.09 33.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.474 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 80.0 p -86.13 21.28 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.526 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 5.7 p-90 -142.19 157.53 44.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 4.9 t80 -100.73 141.43 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 34' ' ' THR . 9.4 t -134.84 101.04 11.79 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.7 Cg_endo -69.81 4.53 2.16 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.664 2.243 . . . . 0.0 112.337 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -65.9 110.55 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -113.95 120.44 40.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.08 -120.48 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -106.06 140.68 38.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.891 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -144.19 114.7 7.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.67 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 95.6 m95 -72.37 132.25 43.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.459 ' O ' HD23 ' A' ' 80' ' ' LEU . 34.1 mm -101.03 128.61 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.23 152.63 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.778 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -89.64 118.74 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -55.29 175.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.76 -18.32 60.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.061 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 7.9 ttpt -68.88 148.43 50.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.48 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.3 135.27 19.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.492 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.75 127.98 15.38 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.342 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.8 m -73.86 159.62 83.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.623 0.725 . . . . 0.0 110.883 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -6.75 19.34 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.37 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -94.63 -42.06 8.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.954 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.55 -42.72 86.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 50' ' ' SER . 27.7 t -66.34 -52.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -59.77 -45.23 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.41 -56.65 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.498 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.4 mt -53.96 -43.05 69.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.589 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 32.2 mt-30 -49.88 -46.56 51.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.57 -38.89 39.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -56.86 -52.06 66.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -68.98 -40.17 78.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.57 ' HG2' HG22 ' A' ' 69' ' ' VAL . 44.7 mtt-85 -48.69 -35.17 13.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.2 mt -88.87 -14.75 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.3 mt -89.44 -28.12 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 3.8 mmm180 -121.91 -29.18 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.058 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 130.83 127.32 2.87 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.453 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -44.63 -21.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 66' ' ' GLY . 14.2 t0 -74.1 7.95 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.806 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.058 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.1 m -62.45 -178.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 2.4 mm-40 -117.0 172.42 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 56.7 m-85 -164.32 135.61 3.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.62 0.724 . . . . 0.0 110.939 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.82 161.77 44.66 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.296 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -83.73 -26.94 29.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -148.88 173.55 13.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.5 m-85 -134.69 95.38 15.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.687 0.756 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.2 Cg_endo -69.79 -178.21 2.25 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.6 m -149.93 139.05 21.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.52 44.6 63.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 19.6 m -156.68 149.06 23.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.532 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -74.81 118.37 17.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 44' ' ' ALA . 63.5 mt -83.07 -73.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.449 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.33 -141.02 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.498 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.576 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -151.92 166.87 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 114' ' ' CYS . 21.7 m -154.07 149.37 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.452 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.9 t70 -95.38 109.2 21.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -72.82 96.88 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.539 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -66.7 -48.44 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -162.95 167.45 22.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.456 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.4 t -127.67 98.2 5.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 98.1 mt -94.45 166.71 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 93' ' ' LYS . 9.6 t -106.73 166.29 10.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.454 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 6.2 mm100 -42.06 -23.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 91' ' ' SER . 24.9 ttmt -86.61 -63.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.437 ' HB3' HD22 ' A' ' 90' ' ' LEU . 13.1 mt-30 -66.09 -49.97 65.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CD2' HG21 ' A' ' 111' ' ' VAL . 37.9 t80 -42.03 -56.78 2.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 5.0 ptmt -67.16 -41.33 86.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.1 -59.18 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -77.2 -48.36 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 30.8 m-85 -111.1 66.26 0.55 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.73 -12.73 33.56 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.91 -24.12 55.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.98 HD13 ' HE ' ' A' ' 26' ' ' ARG . 2.3 pt -120.49 17.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.444 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 27.2 p -58.05 -24.96 60.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.814 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.454 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -91.26 -31.95 15.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.947 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.678 ' CD ' HG22 ' A' ' 102' ' ' ILE . 27.2 mt-10 -43.37 -37.1 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 t -125.96 146.92 49.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -33.77 6.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.447 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 1.8 m -45.12 161.62 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 0.0 110.867 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.474 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.2 Cg_endo -69.71 -48.8 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.353 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 18.4 m-85 -105.62 102.9 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 95' ' ' PHE . 20.1 t -86.2 137.3 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.555 ' CE1' HG22 ' A' ' 34' ' ' THR . 11.1 m-30 -103.39 107.54 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.8 OUTLIER -74.69 117.48 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.125 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -118.49 151.13 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -143.1 175.62 9.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER 52.09 52.34 11.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 0.0 110.915 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.0 Cg_endo -69.68 120.18 7.02 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.312 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -129.21 132.25 47.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -97.07 122.46 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.648 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 16.4 mtp -65.63 143.05 57.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.56 -24.73 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.01 138.73 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -106.79 149.08 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.648 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 1.1 m-85 -116.84 142.32 29.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 86.76 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.276 . . . . 0.0 112.334 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.544 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -125.39 168.13 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.608 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 7.4 mtmp? -109.42 142.31 40.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.26 163.32 14.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -141.79 161.92 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 1.8 4.1 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.306 . . . . 0.0 112.317 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.526 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.1 mmmm -137.78 -175.08 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.592 HG22 ' CE3' ' A' ' 8' ' ' TRP . 97.1 mt -83.77 134.86 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.608 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 11.0 p-90 -140.75 127.34 20.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.97 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.572 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 9.7 ttmt -54.41 130.79 40.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 20.5 mt -66.4 176.37 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.9 t0 -86.18 126.03 33.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.23 -41.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -72.1 -43.23 65.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.514 HG23 ' CD2' ' A' ' 124' ' ' PHE . 30.0 mm -62.97 -43.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -40.25 -67.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 142' ' ' GLY . 70.1 mt-30 -49.03 -69.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.15 -46.57 0.98 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.44 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.67 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.67 -47.58 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -60.44 -25.18 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -85.58 -39.49 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.95 -8.85 6.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.482 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.954 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.691 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.0 m95 -72.52 163.29 28.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 t -136.4 129.91 31.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 40' ' ' LEU . 60.3 tp -116.87 113.49 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 0.5 OUTLIER -67.64 150.95 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.448 HG21 HD22 ' A' ' 20' ' ' LEU . 94.1 t -138.18 146.46 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.082 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 35.6 m-70 -82.01 119.75 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.562 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 56.5 mt-30 -64.63 162.28 36.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.589 0.709 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.78 -30.9 4.89 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.354 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.568 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 12.9 m-90 -25.08 -55.93 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.562 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.5 -61.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 4.7 m -64.61 -40.11 94.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 16' ' ' TRP . 67.8 mt -54.23 -30.81 51.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -65.15 -65.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.589 HG21 ' OE1' ' A' ' 119' ' ' GLU . 5.4 m -63.31 -17.95 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -74.93 -39.28 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.77 20.07 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -107.09 -44.01 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -97.32 113.83 25.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -109.84 19.84 18.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.83 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG11 HD12 ' A' ' 102' ' ' ILE . 34.8 m -152.54 145.2 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.422 ' HG2' HD21 ' A' ' 10' ' ' LEU . 9.4 tp10 -117.65 142.17 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -106.48 126.07 8.36 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.453 ' N ' ' CB ' ' A' ' 108' ' ' SER . 33.1 mmt180 -150.0 150.47 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 110.836 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.48 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 8.8 m -84.66 25.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.528 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -147.47 162.98 37.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -104.64 141.53 36.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.646 ' O ' HG23 ' A' ' 34' ' ' THR . 10.3 t -134.37 99.11 13.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 0.0 111.191 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.6 Cg_endo -69.83 4.93 1.93 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.459 ' O ' HD22 ' A' ' 86' ' ' LEU . 8.1 t60 -65.49 112.89 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.458 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 6.3 mmt85 -113.29 122.95 48.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.37 -129.49 2.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -99.15 140.03 33.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 10' ' ' LEU . 24.5 tp -144.17 112.57 6.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 83.2 m95 -70.93 128.83 37.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.77 123.75 53.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.18 148.52 41.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.075 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.753 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -83.78 120.52 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.2 p -55.73 169.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.79 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.459 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.3 ttpt -65.86 147.97 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -105.4 134.32 19.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.593 0.711 . . . . 0.0 110.894 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.73 126.63 13.56 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.33 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.6 m -72.22 158.91 86.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.725 . . . . 0.0 110.875 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.01 22.52 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.632 2.221 . . . . 0.0 112.351 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -94.4 -36.26 11.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.48 -41.2 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.511 HG12 ' OE1' ' A' ' 58' ' ' GLN . 34.7 t -68.15 -45.99 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.5 t -66.88 -42.87 84.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.19 -52.8 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.568 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 84.4 mt -58.59 -41.11 85.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.591 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 34.5 mt-30 -53.06 -47.56 68.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -36.99 50.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 m -59.97 -51.68 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.169 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -69.26 -37.46 77.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.474 ' HG2' HG22 ' A' ' 69' ' ' VAL . 53.9 mtt180 -48.81 -33.44 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.7 mt -90.83 -15.91 29.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.8 mt -87.25 -29.69 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -120.81 -29.13 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.039 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.62 126.35 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -44.8 -20.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -80.85 17.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 66' ' ' GLY . 20.4 m -66.12 -178.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.8 162.97 15.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.591 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 44.4 m-85 -157.94 133.16 5.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.552 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.53 30.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -85.49 -29.21 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -146.78 173.21 12.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.645 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.71 96.2 15.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.698 0.761 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.426 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.71 172.7 12.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.264 . . . . 0.0 112.343 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.5 p -138.86 139.23 38.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.12 52.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 58.7 m -158.52 149.21 20.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -78.43 120.74 23.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.753 HD11 ' HB2' ' A' ' 44' ' ' ALA . 35.9 mt -89.33 -71.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.471 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.33 -145.97 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.493 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.5 p -152.99 157.48 40.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.897 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.4 m -140.9 144.32 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -85.81 113.7 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.459 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.6 tt -77.59 100.01 5.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.537 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.37 -48.07 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -163.09 167.26 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.77 101.19 6.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.8 mt -96.01 169.41 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' PHE . 13.2 p -108.36 169.12 8.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.839 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.406 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 6.1 mm100 -47.25 -19.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 91' ' ' SER . 15.0 ttmm -90.35 -59.11 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -70.85 -50.13 38.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CD2' HG21 ' A' ' 111' ' ' VAL . 27.5 t80 -41.51 -54.85 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -67.52 -40.77 85.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.42 -58.72 6.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -75.67 -49.95 16.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.2 m-85 -109.85 68.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.656 0.741 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.75 -13.4 34.65 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -76.92 -24.68 52.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.709 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.1 pt -120.18 23.48 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 p -64.39 -27.15 68.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.447 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -90.33 -28.76 18.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.709 ' CD ' HG22 ' A' ' 102' ' ' ILE . 18.0 mt-10 -45.71 -39.38 7.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.937 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.4 t -124.64 147.95 48.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 7.3 t0 -110.99 -33.87 6.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.453 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 1.7 m -42.81 161.52 0.18 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 0.0 110.857 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.48 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.77 -45.49 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.692 2.262 . . . . 0.0 112.309 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -110.59 104.95 13.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.529 HG21 ' CD2' ' A' ' 95' ' ' PHE . 21.4 t -90.33 133.61 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 2.2 m-30 -100.86 109.73 21.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.36 121.94 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -124.56 154.04 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -141.4 175.8 9.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 57.97 52.41 5.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.651 0.739 . . . . 0.0 110.902 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.78 114.94 3.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.254 . . . . 0.0 112.318 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.41 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 4.1 pt20 -130.08 145.31 51.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.589 ' OE1' HG21 ' A' ' 21' ' ' VAL . 3.7 tp10 -107.14 123.56 48.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.51 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.8 mtp -63.13 149.26 45.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.39 -23.46 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.3 p -130.09 149.95 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 20.2 mmtm -117.35 151.81 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.488 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.5 m-85 -120.43 141.68 32.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.656 0.741 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 86.5 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.503 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -121.73 165.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.617 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 48.8 mttp -101.59 143.17 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -87.44 -177.13 48.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 20.6 t-20 -170.52 142.45 1.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.632 0.729 . . . . 0.0 110.862 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.2 Cg_endo -69.74 9.76 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.685 2.257 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASN . 9.8 mmmm -141.44 -174.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.691 HG22 ' CE3' ' A' ' 8' ' ' TRP . 54.2 mt -88.6 132.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.617 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.0 p-90 -139.32 127.54 22.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.24 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.5 mt -61.0 172.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.45 152.65 30.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -58.9 -39.57 81.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -78.37 -38.09 42.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.488 HG23 ' CD2' ' A' ' 124' ' ' PHE . 24.3 mm -68.44 -36.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -49.07 -65.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 144' ' ' LYS . 47.5 mt-30 -48.51 -67.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.13 -52.65 1.25 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.549 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.0 -42.03 65.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.141 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 141' ' ' GLN . 9.8 mtpt -69.8 -17.86 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -90.17 -44.42 9.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.71 -19.69 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.6 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.706 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.5 m95 -77.42 161.76 27.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.762 0.315 . . . . 0.0 110.889 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.1 t -138.22 133.44 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.713 HD23 ' OE1' ' A' ' 28' ' ' GLU . 62.6 tp -121.16 114.24 21.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -67.92 154.67 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 37.2 t -137.08 155.95 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.461 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 35.3 m-70 -88.53 113.51 24.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 14.3 mt-30 -60.61 161.1 15.53 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.655 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.8 -30.13 5.32 Favored 'Cis proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 -1.819 . . . . 0.0 112.35 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.517 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.0 m-90 -27.63 -52.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.559 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.64 -62.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 m -64.98 -45.93 83.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 16' ' ' TRP . 79.1 mt -45.57 -30.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 16' ' ' TRP . 7.0 mp -68.55 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.5 HG11 ' N ' ' A' ' 82' ' ' GLY . 15.9 m -61.11 -13.9 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.415 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -81.26 -39.46 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.04 -19.93 5.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.655 ' H ' HD12 ' A' ' 24' ' ' ILE . 5.4 mp -64.85 -60.32 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 111.174 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HG2' HD11 ' A' ' 20' ' ' LEU . 7.5 tptp -83.34 120.97 26.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.823 ' HD2' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -113.22 11.72 18.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.568 HG11 ' CE1' ' A' ' 95' ' ' PHE . 33.6 m -142.52 156.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.713 ' OE1' HD23 ' A' ' 10' ' ' LEU . 3.2 tt0 -120.9 138.11 54.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.457 ' O ' ' NH1' ' A' ' 30' ' ' ARG . . . -102.64 123.62 7.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.548 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 75.9 mmt-85 -149.16 151.15 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.845 0.355 . . . . 0.0 110.849 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.478 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.3 m -87.6 18.67 3.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.566 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 6.4 p-90 -142.36 161.39 38.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.6 t80 -102.56 147.97 26.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 34' ' ' THR . 5.2 t -140.62 106.97 6.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 0.0 111.172 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.9 Cg_endo -69.78 2.95 3.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.452 ' O ' HD22 ' A' ' 86' ' ' LEU . 13.6 t60 -64.53 114.87 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -119.65 120.41 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.06 -122.58 1.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -105.09 139.49 39.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.877 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 10' ' ' LEU . 23.0 tp -143.67 114.02 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.643 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 87.6 m95 -72.1 128.69 36.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -98.71 132.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.118 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.35 155.87 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.755 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -90.81 119.13 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -56.27 173.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.83 63.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 5.9 ttpt -65.37 146.4 54.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.453 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.19 135.49 19.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.577 0.703 . . . . 0.0 110.863 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.76 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.662 2.241 . . . . 0.0 112.354 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 54' ' ' VAL . 3.4 m -71.55 159.63 84.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.696 0.76 . . . . 0.0 110.828 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -9.95 27.33 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 0.0 112.349 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -94.4 -37.97 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.72 -39.49 70.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 50' ' ' SER . 41.6 t -67.76 -46.32 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.15 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -67.4 -42.11 83.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.94 -48.96 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.466 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 83.5 mt -62.46 -40.85 97.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 38.1 mt-30 -54.81 -44.6 73.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.81 -34.82 30.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -62.04 -51.75 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.443 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 14.9 m-85 -67.5 -40.37 85.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.938 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HG2' HG22 ' A' ' 69' ' ' VAL . 51.8 mtt180 -47.03 -35.93 7.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.08 -17.97 31.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' TYR . 60.2 mt -86.01 -26.8 25.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -123.69 -27.72 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.065 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 128.28 129.87 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -46.84 -18.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -72.73 3.61 4.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.065 HG13 ' O ' ' A' ' 66' ' ' GLY . 34.3 m -62.02 179.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 12.1 pt-20 -122.93 173.77 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 72.9 m-85 -161.82 138.43 6.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.595 0.712 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 156.12 64.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.636 2.224 . . . . 0.0 112.337 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -72.91 -31.28 64.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -146.74 176.84 9.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.7 94.93 16.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 0.0 110.936 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.569 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 54.0 Cg_endo -69.74 173.99 10.14 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.2 p -142.59 135.49 28.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.86 50.09 14.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.5 m -161.24 148.47 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 0.0 110.882 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.538 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.39 118.19 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.755 HD11 ' HB2' ' A' ' 44' ' ' ALA . 40.3 mt -85.62 -70.94 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.5 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.36 -145.08 4.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.482 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 4.2 p -154.32 155.27 34.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 20.0 m -141.41 137.32 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.83 112.63 16.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.1 tt -77.81 101.83 6.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.94 -47.33 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -163.44 169.0 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.4 t -127.4 100.83 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.7 mt -94.94 170.84 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 93' ' ' LYS . 32.8 t -110.9 169.04 9.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.445 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 6.3 mm100 -45.83 -20.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.411 ' N ' ' C ' ' A' ' 91' ' ' SER . 32.7 ttpt -89.35 -60.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -68.9 -50.55 48.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 27' ' ' VAL . 39.4 t80 -39.11 -55.66 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 7.0 ptmm? -68.59 -47.92 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.5 mt-10 -46.79 -58.57 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -76.56 -51.47 11.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 37.9 m-85 -110.03 67.81 0.47 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 110.916 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.74 -14.7 36.51 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.349 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.4 -23.31 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.823 HD13 ' HD2' ' A' ' 26' ' ' ARG . 2.2 pt -121.38 15.27 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.402 ' HB3' ' HA ' ' A' ' 100' ' ' PRO . 53.3 p -55.96 -18.52 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.89 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.575 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -98.27 -31.6 11.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 10.8 mt-10 -46.14 -27.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -134.4 145.72 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -111.02 -35.3 5.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 m -42.34 161.72 0.16 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.702 0.763 . . . . 0.0 110.833 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.478 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.78 -48.92 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -106.56 103.63 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.486 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 26.2 t -88.95 136.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 34' ' ' THR . 5.0 m-30 -102.33 108.47 19.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.57 120.46 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.444 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.2 m -124.87 154.09 41.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.21 175.99 9.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.449 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 55.22 54.17 9.64 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.855 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 116.99 4.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.656 2.237 . . . . 0.0 112.331 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -127.8 137.79 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -103.73 118.55 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.538 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.9 mtp -62.75 139.03 58.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.4 t -65.86 -30.83 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.47 143.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -111.68 151.89 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.47 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.8 OUTLIER -118.36 141.04 28.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 0.0 110.862 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 82.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.575 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.7 pp -121.11 166.69 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.592 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 34.3 mtpt -108.95 159.99 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.23 177.6 16.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -154.56 163.16 25.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 0.0 110.885 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 129' ' ' ASN . 53.5 Cg_endo -69.74 19.66 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.357 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.566 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.8 mmmm -152.82 -175.03 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.706 HG22 ' CE3' ' A' ' 8' ' ' TRP . 60.0 mt -84.33 131.75 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.592 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.1 p-90 -131.88 139.76 48.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -70.81 127.09 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.09 164.18 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.8 t0 -75.65 129.5 37.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -37.25 -47.76 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -66.77 -37.01 83.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 136' ' ' ASP . 11.9 mm -67.3 -48.1 79.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 139' ' ' ILE . 15.0 t-160 -37.09 -64.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.831 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 142' ' ' GLY . 36.1 mt-30 -51.37 -69.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.84 -49.48 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.643 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.48 -45.02 81.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.8 mtpp -64.61 -23.34 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.52 -38.0 16.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -61.35 -6.64 8.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 -179.9 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.528 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.7 m95 -78.11 164.35 25.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t -137.12 144.84 43.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.439 HD23 ' HG3' ' A' ' 28' ' ' GLU . 11.7 tp -130.94 114.66 15.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.3 p -70.42 133.35 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.518 HG21 HD22 ' A' ' 20' ' ' LEU . 53.4 t -118.89 153.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 34.4 m-70 -88.49 113.0 23.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 78.5 mt-30 -59.76 160.01 16.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.614 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.76 -32.09 4.14 Favored 'Cis proline' 0 C--N 1.342 0.212 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.322 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.581 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 10.7 m-90 -25.12 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -37.76 -64.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.074 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.9 m -62.45 -42.43 99.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 24' ' ' ILE . 45.0 mt -50.34 -37.64 37.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -58.96 -66.81 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.54 HG11 ' N ' ' A' ' 82' ' ' GLY . 16.8 m -60.41 -27.12 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 11.0 mmt180 -66.86 -39.5 87.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.11 15.19 5.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.402 HD13 HD23 ' A' ' 19' ' ' LEU . 5.3 mp -100.24 -41.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.494 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.8 tptp -99.64 100.87 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.696 ' HD2' HD13 ' A' ' 102' ' ' ILE . 6.4 ptp180 -93.41 16.11 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 102' ' ' ILE . 27.8 m -149.04 145.85 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 2.8 tm-20 -114.23 142.11 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -103.13 128.42 9.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.1 mmt180 -151.59 146.63 25.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -85.08 17.96 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.572 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.8 p-90 -141.44 165.36 27.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.29 141.39 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 34' ' ' THR . 5.0 t -135.99 104.73 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 0.0 111.169 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.8 Cg_endo -69.77 4.3 2.28 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.445 ' O ' HD22 ' A' ' 86' ' ' LEU . 17.3 t60 -64.85 111.82 2.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -115.55 119.99 37.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.84 -129.6 2.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.1 ttm-85 -96.5 139.41 32.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.88 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.4 tp -144.08 111.44 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.862 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.1 m95 -71.25 127.91 34.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.472 ' O ' HD23 ' A' ' 80' ' ' LEU . 50.5 mm -98.65 129.5 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -125.71 150.0 48.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -84.38 118.66 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.0 p -55.07 178.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.61 -14.07 60.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.1 ttpt -70.55 147.23 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.438 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -103.79 134.08 19.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.612 0.72 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 127.11 14.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.699 2.266 . . . . 0.0 112.358 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 54' ' ' VAL . 74.4 m -72.61 155.05 91.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 0.0 110.884 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -7.21 20.45 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -94.55 -40.16 10.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -38.13 73.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.567 HG12 ' OE1' ' A' ' 58' ' ' GLN . 58.1 t -66.28 -50.2 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.129 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -64.27 -44.48 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.38 -49.73 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.581 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.1 mt -62.72 -43.05 99.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 37.4 mt-30 -53.6 -43.4 68.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.4 29.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 m -62.38 -52.76 62.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.152 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.43 ' HE2' HD22 ' A' ' 57' ' ' LEU . 26.1 m-85 -66.29 -38.49 87.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 69' ' ' VAL . 66.5 mtt180 -49.81 -36.63 27.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.75 -12.76 44.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.505 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 69.0 mt -91.14 -28.04 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.505 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.7 mmp_? -123.64 -22.12 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.054 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 123.67 130.04 3.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 1.4 pptp? -47.89 -18.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.73 0.3 . . . . 0.0 110.88 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 1.4 6.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.054 HG13 ' O ' ' A' ' 66' ' ' GLY . 34.9 m -59.29 179.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -120.07 166.96 12.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 55.6 m-85 -158.31 134.77 6.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.597 0.713 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.71 163.06 39.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.272 . . . . 0.0 112.357 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -83.01 -29.16 29.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.66 173.5 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.614 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 42.3 m-85 -134.79 98.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 110.901 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.7 Cg_endo -69.76 176.4 6.82 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -143.96 133.54 23.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.57 47.86 19.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 17.1 m -157.81 149.17 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -77.98 115.45 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.957 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' ALA . 69.8 mt -82.12 -72.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.54 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.1 -147.2 4.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.481 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 10.5 p -152.84 153.33 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 21.1 m -139.28 143.19 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.13 112.85 20.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.6 tt -76.98 100.16 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -69.72 -46.83 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -165.44 167.54 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.45 99.25 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 94' ' ' GLN . 99.1 mt -95.07 165.73 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 93' ' ' LYS . 17.7 t -103.92 169.03 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 109' ' ' PRO . 10.9 mm100 -41.12 -24.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' SER . 32.2 ttpt -87.32 -70.15 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.76 ' HB3' HD22 ' A' ' 90' ' ' LEU . 79.2 mm-40 -57.12 -47.04 82.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.625 ' CD2' HG21 ' A' ' 111' ' ' VAL . 19.4 t80 -43.64 -57.21 3.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.47 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -69.36 -44.87 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.47 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.0 mt-10 -47.08 -59.56 3.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.869 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.448 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.3 mt-30 -79.1 -48.23 14.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.3 m-85 -110.06 67.64 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.642 0.735 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.71 -12.34 32.78 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.752 2.301 . . . . 0.0 112.313 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.24 -21.16 54.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.788 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.6 pt -125.43 23.95 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 44.4 p -65.35 -24.49 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -95.33 -25.59 16.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.788 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.1 mt-10 -48.17 -36.89 14.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -129.99 134.81 47.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -108.28 27.16 9.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 88.7 p -96.06 155.59 38.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.705 0.764 . . . . 0.0 110.841 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.454 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.76 -24.36 29.74 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.413 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 17.1 m-85 -134.63 90.21 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.625 HG21 ' CD2' ' A' ' 95' ' ' PHE . 40.8 t -79.38 136.82 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.123 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 3.7 m-30 -103.98 104.13 14.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.88 122.72 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.129 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 13.7 m -126.89 155.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -143.34 176.25 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.456 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 57.17 53.93 6.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.859 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.76 115.16 3.96 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.632 2.221 . . . . 0.0 112.357 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.54 134.64 49.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -100.61 120.82 40.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.547 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 13.6 mtp -62.5 152.92 33.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.0 t -78.67 -27.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.5 149.44 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 7.7 mmtm -114.21 144.77 42.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.638 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -114.84 140.79 25.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.51 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.359 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.619 HD13 ' HH2' ' A' ' 133' ' ' TRP . 2.8 pp -124.37 168.58 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.596 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 47.5 mmtm -111.99 141.99 44.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.67 175.44 26.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.432 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -155.54 162.01 28.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.671 0.748 . . . . 0.0 110.875 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 1.78 4.11 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.572 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.9 mmmm -137.17 -175.01 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.528 HG22 ' CE3' ' A' ' 8' ' ' TRP . 79.4 mt -85.88 133.52 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.619 ' HH2' HD13 ' A' ' 126' ' ' ILE . 7.6 p-90 -137.13 127.31 26.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.428 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 11.0 ttmt -55.72 133.69 50.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.17 174.17 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.49 158.71 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.85 -48.65 78.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -70.5 -37.16 74.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.638 HG23 ' CD2' ' A' ' 124' ' ' PHE . 44.9 mm -68.84 -41.29 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -45.58 -62.86 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 142' ' ' GLY . 46.4 mt-30 -53.59 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.57 -51.32 0.76 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.517 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.862 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.07 -47.6 68.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.5 mtpp -60.75 -24.24 65.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -50.81 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.87 -19.83 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.423 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.707 ' CE3' HG22 ' A' ' 132' ' ' ILE . 88.6 m95 -76.3 168.13 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.903 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' CB ' ' HG ' ' A' ' 135' ' ' LEU . 11.8 t -141.69 145.0 34.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.4 tp -134.47 112.03 10.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.403 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 13.1 p -67.99 137.77 55.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 45' ' ' THR . 25.3 t -121.73 157.52 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.493 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.3 m-70 -89.29 116.22 27.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.698 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 52.5 mt-30 -62.79 161.86 25.7 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 110.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.83 -28.98 5.98 Favored 'Cis proline' 0 C--N 1.341 0.15 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.328 0.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.671 ' O ' HD12 ' A' ' 20' ' ' LEU . 12.5 m-90 -29.02 -53.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.698 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.38 -64.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -63.0 -45.04 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 16' ' ' TRP . 70.5 mt -46.36 -35.54 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -62.25 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.486 HG11 ' N ' ' A' ' 82' ' ' GLY . 5.3 m -65.93 -12.18 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.103 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.487 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.5 mmt180 -84.14 -39.6 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.53 20.38 3.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.474 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.435 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.1 mp -108.38 -36.16 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.0 tptt -107.65 99.15 8.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.481 ' HE ' HD13 ' A' ' 102' ' ' ILE . 22.4 ptt180 -96.53 29.1 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 102' ' ' ILE . 34.2 m -156.55 145.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -121.31 118.98 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.456 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -84.99 123.19 6.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 14.7 mmt180 -142.72 152.3 42.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 110.859 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.482 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 17.8 p -86.93 18.18 3.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.559 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.0 p-90 -142.62 163.95 31.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -105.58 138.79 41.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 34' ' ' THR . 6.7 t -132.26 100.56 15.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.611 0.72 . . . . 0.0 111.099 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.495 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.1 Cg_endo -69.78 7.31 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.407 ' O ' HD22 ' A' ' 86' ' ' LEU . 28.7 t60 -63.83 107.76 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.497 ' NH1' HD22 ' A' ' 86' ' ' LEU . 44.2 mmt-85 -105.48 108.17 19.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.14 -145.19 10.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.405 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 0.2 OUTLIER -86.72 142.73 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.861 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.4 tp -144.13 115.34 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.672 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 90.4 m95 -73.37 137.75 44.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.527 ' O ' HD23 ' A' ' 80' ' ' LEU . 48.0 mm -107.13 132.64 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -130.61 145.54 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -75.95 125.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.7 p -61.13 -178.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.08 7.13 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -99.92 129.94 46.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.06 135.71 28.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.498 0.666 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.76 133.99 26.9 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.8 m -76.46 161.44 74.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.672 0.749 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.18 27.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -94.22 -43.23 8.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.35 -40.91 90.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.736 HG12 ' OE1' ' A' ' 58' ' ' GLN . 60.8 t -65.05 -56.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -57.4 -42.79 82.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -66.61 -57.73 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.465 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 87.4 mt -54.22 -42.1 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.736 ' OE1' HG12 ' A' ' 54' ' ' VAL . 37.6 mt-30 -55.11 -42.54 73.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.5 -31.6 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.4 m -66.09 -52.02 52.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.84 -36.14 79.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.502 ' HG2' HG22 ' A' ' 69' ' ' VAL . 56.5 mtt180 -50.68 -34.23 25.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.5 mt -90.6 -12.57 36.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.3 mt -91.59 -28.14 17.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.984 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 4.3 mmm180 -121.97 -29.18 4.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.032 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.78 127.43 2.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -46.53 -19.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.47 16.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.032 HG13 ' O ' ' A' ' 66' ' ' GLY . 21.4 m -65.29 179.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' O ' HD11 ' A' ' 24' ' ' ILE . 20.3 mp0 -115.98 160.06 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.588 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 51.2 m-85 -153.16 139.8 12.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.74 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.487 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.8 Cg_endo -69.79 170.61 16.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.6 -22.34 19.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.49 172.08 16.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.9 m-85 -134.97 87.96 28.29 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 0.0 110.933 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.1 Cg_endo -69.71 172.04 13.31 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -137.15 144.18 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.88 44.81 95.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.464 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.28 158.24 41.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.527 HD23 ' O ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -85.04 117.23 23.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 44' ' ' ALA . 16.3 mt -85.87 -69.46 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.486 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -148.51 -142.49 3.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.619 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 35.7 t -154.41 162.33 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.439 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 22.4 m -149.85 140.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -81.75 114.86 20.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.497 HD22 ' NH1' ' A' ' 37' ' ' ARG . 4.4 tt -78.17 97.78 5.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.569 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.89 -47.79 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 113' ' ' ILE . 5.0 m-20 -164.54 166.35 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -127.43 101.4 6.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.496 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.2 mt -99.48 167.04 10.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 95' ' ' PHE . 33.0 t -106.89 169.04 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.842 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -46.41 -20.48 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 12.6 tttm -85.08 -58.04 2.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.439 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.2 mm100 -77.22 -51.31 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.553 ' CD2' HG21 ' A' ' 111' ' ' VAL . 42.1 t80 -38.89 -50.14 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.08 -42.76 68.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -55.12 -61.39 2.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.492 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.8 mt-30 -71.38 -50.53 31.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 113' ' ' ILE . 25.0 m-85 -109.42 68.26 0.41 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.657 0.741 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.75 -14.66 36.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.279 . . . . 0.0 112.304 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.12 -23.77 57.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.832 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.2 pt -120.32 19.38 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 p -60.62 -27.32 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.447 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -93.47 -25.09 17.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.832 ' CD ' HG22 ' A' ' 102' ' ' ILE . 16.8 mt-10 -49.92 -32.28 14.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.6 t -130.95 150.94 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.02 -23.89 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.796 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.411 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 1.8 m -51.19 160.19 0.94 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.647 0.737 . . . . 0.0 110.836 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.482 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.3 Cg_endo -69.73 -45.64 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.36 100.87 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.553 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.4 t -84.74 142.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.447 ' CZ ' HG22 ' A' ' 34' ' ' THR . 6.5 m-30 -109.13 106.92 17.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -74.56 122.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.5 m -125.43 155.21 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -143.18 176.62 8.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.492 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 55.58 51.2 6.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 0.0 110.941 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.7 Cg_endo -69.7 121.72 8.42 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.647 2.232 . . . . 0.0 112.367 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -136.4 136.1 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.452 ' OE1' ' C ' ' A' ' 81' ' ' LEU . 4.3 tp10 -98.25 124.57 42.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.454 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.6 mtp -63.12 151.7 39.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 146' ' ' GLY . 95.0 t -70.9 -31.04 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.19 145.01 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -107.18 148.86 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.436 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.2 m-85 -113.18 142.28 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 82.54 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.233 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.633 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.7 pp -118.82 159.74 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 37.7 mttp -95.16 139.94 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.19 -179.6 46.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.489 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.9 t30 -165.53 145.24 5.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 53.8 Cg_endo -69.75 4.04 2.42 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.689 2.26 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.559 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 12.1 mmmm -136.36 -174.42 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.707 HG22 ' CE3' ' A' ' 8' ' ' TRP . 73.2 mt -88.53 130.01 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.7 p-90 -138.93 125.59 20.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -55.36 125.56 21.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.423 ' HG ' ' CB ' ' A' ' 9' ' ' CYS . 22.7 mt -59.76 169.64 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 139' ' ' ILE . 7.6 t0 -77.46 126.87 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.4 m -35.7 -41.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -72.85 -41.26 64.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.5 mm -64.85 -42.64 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -42.62 -64.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 142' ' ' GLY . 80.1 mt-30 -53.13 -66.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.0 -42.02 0.7 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.672 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -65.18 -46.67 79.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -56.35 -26.37 52.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -80.05 -53.01 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -37.25 -27.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.495 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 145' ' ' LYS . 14.7 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.907 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.53 ' CH2' ' HE3' ' A' ' 134' ' ' LYS . 91.8 m95 -78.25 164.02 25.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.92 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 t -138.23 138.64 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.8 tp -125.56 111.94 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 22.2 p -68.3 140.0 55.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 37.7 t -126.3 152.14 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.405 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 40.8 m-70 -85.87 116.3 24.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.659 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 54.7 mt-30 -62.54 162.1 22.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 -28.46 6.24 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.4 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.535 ' O ' HD12 ' A' ' 20' ' ' LEU . 12.9 m-90 -29.11 -51.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.659 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.23 -62.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.106 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -65.69 -47.03 76.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 16' ' ' TRP . 83.1 mt -44.04 -28.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.7 mp -70.59 -65.51 0.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.56 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.9 m -61.3 -12.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.465 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -82.47 -39.8 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.57 -17.2 5.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.697 ' H ' HD12 ' A' ' 24' ' ' ILE . 4.6 mp -68.16 -59.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.108 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.5 tptp -82.71 117.69 22.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.654 ' HD2' HD13 ' A' ' 102' ' ' ILE . 3.6 ptp180 -114.06 12.85 18.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.675 HG11 HD12 ' A' ' 102' ' ' ILE . 25.3 m -147.37 149.88 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.474 ' OE1' HD21 ' A' ' 20' ' ' LEU . 28.2 tp10 -115.78 146.2 42.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.48 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -111.26 112.72 3.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 22.8 mmt180 -137.99 148.77 45.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.479 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 61.6 p -84.39 21.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 4.6 p-90 -141.84 161.84 36.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . 9.8 t80 -105.12 141.47 36.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.544 ' O ' HG23 ' A' ' 34' ' ' THR . 6.0 t -135.19 105.01 10.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.609 0.719 . . . . 0.0 111.186 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.2 Cg_endo -69.81 3.21 2.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.451 ' O ' HD22 ' A' ' 86' ' ' LEU . 14.7 t60 -64.87 113.55 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -117.7 119.81 36.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.22 -124.93 1.63 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -100.98 140.75 34.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.852 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.5 tp -144.13 111.32 5.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.615 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 93.1 m95 -71.21 126.55 29.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 mm -96.84 125.49 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -121.8 148.87 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.611 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.89 117.46 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 p -54.08 -178.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.28 19.15 5.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.46 126.82 46.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -82.61 124.64 77.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.58 0.705 . . . . 0.0 110.871 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 126.61 13.48 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.351 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 m -70.04 156.08 92.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.616 0.722 . . . . 0.0 110.881 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -7.13 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.736 2.291 . . . . 0.0 112.341 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -94.23 -35.18 12.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.96 -40.55 60.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.96 -47.22 82.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.7 t -65.47 -44.71 86.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.52 -52.57 30.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.5 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 77.1 mt -55.37 -40.2 71.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 37.2 mt-30 -54.95 -49.27 71.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.64 -33.07 62.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -64.28 -48.01 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.412 ' HE2' HD22 ' A' ' 57' ' ' LEU . 30.3 m-85 -72.76 -30.03 63.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.545 ' HG2' HG22 ' A' ' 69' ' ' VAL . 42.0 mtt180 -56.48 -36.26 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.0 mt -89.59 -13.25 37.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 mt -90.36 -29.78 17.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.442 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 5.5 mmm180 -120.78 -29.44 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.045 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.46 125.1 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' C ' ' HD3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -42.83 -23.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.873 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -76.82 13.94 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.045 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.7 m -62.89 -179.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 31.7 mt-10 -117.99 165.12 14.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 54.1 m-85 -160.16 135.73 5.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.81 164.1 35.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.699 2.266 . . . . 0.0 112.286 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -80.18 -30.73 38.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -146.76 175.43 10.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 60.9 m-85 -133.87 94.06 19.41 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.69 0.757 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.506 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.9 Cg_endo -69.76 175.82 7.59 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.681 2.254 . . . . 0.0 112.36 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.1 p -142.1 139.19 32.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.27 49.58 44.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 66.0 m -158.22 148.2 19.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -77.32 114.24 15.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' ' 44' ' ' ALA . 81.3 mt -82.0 -74.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.56 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -142.62 -147.95 4.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.0 p -151.56 153.7 35.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.6 m -139.96 141.07 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.34 114.18 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.8 tt -78.48 96.96 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -66.56 -48.95 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.168 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER -162.5 167.84 22.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.49 99.63 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 94' ' ' GLN . 91.5 mt -93.95 171.09 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 93' ' ' LYS . 38.2 t -109.81 169.22 8.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.452 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 6.2 mm100 -44.54 -21.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.42 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.2 tttt -89.12 -63.1 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.589 ' HB3' HD22 ' A' ' 90' ' ' LEU . 11.0 mt-30 -65.58 -49.55 68.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.574 ' CD2' HG21 ' A' ' 111' ' ' VAL . 37.3 t80 -42.16 -56.12 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 8.7 ptmt -68.46 -42.9 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.421 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 6.6 mt-10 -51.7 -60.36 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.2 mt-30 -75.86 -49.74 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 34.7 m-85 -110.42 66.87 0.48 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.619 0.723 . . . . 0.0 110.844 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.78 -14.18 35.65 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 0.0 112.359 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.79 -22.39 58.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.675 HD12 HG11 ' A' ' 27' ' ' VAL . 1.9 pt -121.83 15.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.7 p -55.68 -21.82 20.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -95.05 -30.47 14.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 12.1 mt-10 -47.58 -26.41 1.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -136.26 141.92 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 5.4 t70 -106.96 -37.17 6.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.48 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 1.8 m -40.89 161.33 0.12 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 0.0 110.874 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.479 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.81 -43.59 2.53 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.297 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 33' ' ' TYR . 16.9 m-85 -110.06 101.95 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 95' ' ' PHE . 25.7 t -87.07 134.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.8 m-30 -101.34 109.97 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.94 120.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.455 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.1 m -123.59 152.49 41.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.25 176.38 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.475 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER 57.47 52.82 5.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 112.39 3.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.316 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -126.61 132.19 51.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -98.0 120.35 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.513 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.6 mtp -62.52 154.36 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 70.7 t -81.55 -25.72 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.07 148.56 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 10.9 mmtm -115.86 142.3 46.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.543 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.8 OUTLIER -114.12 141.65 26.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.661 0.743 . . . . 0.0 110.867 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 90.54 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.56 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.7 pp -125.53 167.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.573 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 43.5 mtpt -110.13 142.61 41.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.99 174.98 24.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -155.87 162.27 27.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.718 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 2.3 3.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.272 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.403 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 6.8 mmmm -139.94 -175.01 4.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 81.9 mt -83.15 141.92 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 14.5 p-90 -147.18 129.44 15.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.53 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 17.0 ttmt -58.71 128.83 39.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.3 mt -63.22 -177.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.7 t70 -90.56 128.2 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.3 m -36.23 -41.16 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -72.97 -40.62 65.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.543 HG23 ' CD2' ' A' ' 124' ' ' PHE . 14.4 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.78 -62.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' LYS . 16.1 mm100 -55.02 -69.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.56 -42.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.615 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -60.74 -46.18 91.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.5 mtpp -61.97 -24.05 66.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -86.56 -42.84 13.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -51.1 -15.18 1.44 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.512 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.594 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.3 m95 -83.32 162.37 21.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' HB2' ' CG ' ' A' ' 135' ' ' LEU . 7.2 t -135.16 129.81 34.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.598 HD23 ' CD ' ' A' ' 28' ' ' GLU . 57.5 tp -116.5 113.81 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.426 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 24.0 p -68.15 153.08 44.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.632 HG12 ' N ' ' A' ' 13' ' ' HIS . 90.3 t -136.44 164.6 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.632 ' N ' HG12 ' A' ' 12' ' ' VAL . 64.4 m-70 -102.1 110.2 22.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.526 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.9 mm-40 -56.37 157.89 8.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 16' ' ' TRP . 54.2 Cg_endo -69.69 -32.94 3.6 Favored 'Cis proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.382 -0.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.544 ' C ' ' O ' ' A' ' 15' ' ' PRO . 8.3 m-90 -25.16 -58.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -32.08 -53.7 0.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.094 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.0 m -69.71 -55.06 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.9 mt -40.17 -31.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.488 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.6 mp -64.26 -68.04 0.38 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.476 HG11 ' N ' ' A' ' 82' ' ' GLY . 16.5 m -61.6 -10.45 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.453 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -84.3 -40.12 18.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.26 -5.2 8.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.88 -43.28 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HG2' HD11 ' A' ' 20' ' ' LEU . 8.4 tptp -100.24 105.54 17.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.573 HH21 ' NE ' ' A' ' 65' ' ' ARG . 6.3 ptp180 -102.48 23.63 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.1 m -152.51 146.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.598 ' CD ' HD23 ' A' ' 10' ' ' LEU . 3.1 tt0 -117.57 122.1 42.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.03 124.69 7.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -146.45 150.19 35.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.412 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.7 p -86.98 21.26 2.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.562 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.4 p-90 -143.78 160.91 39.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.48 137.78 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 34' ' ' THR . 11.9 t -134.41 98.38 13.88 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.542 0.687 . . . . 0.0 111.16 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.438 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.0 Cg_endo -69.72 9.5 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.427 ' O ' HD22 ' A' ' 86' ' ' LEU . 14.4 t60 -67.93 110.15 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 72.2 mmt-85 -106.94 113.13 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.11 -151.9 22.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -78.58 142.67 37.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.8 tp -143.74 112.45 6.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.584 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 95.0 m95 -72.04 123.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.449 ' O ' HD23 ' A' ' 80' ' ' LEU . 51.8 mm -94.77 130.07 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -128.97 154.72 46.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.64 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -88.07 132.22 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 12' ' ' VAL . 20.1 p -72.73 171.95 11.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.02 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 5.3 ttpt -64.3 130.16 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -91.36 129.27 43.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.91 18.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.669 2.246 . . . . 0.0 112.39 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -75.37 155.41 85.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.695 0.76 . . . . 0.0 110.84 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -3.91 12.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.693 2.262 . . . . 0.0 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -94.63 -44.37 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.508 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 14.2 mp0 -65.79 -41.86 91.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.6 t -63.76 -50.14 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.147 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -63.47 -45.36 91.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.22 -54.59 31.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.467 HD22 ' HE2' ' A' ' 61' ' ' TYR . 79.8 mt -54.32 -58.36 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 37.6 mt-30 -34.85 -48.48 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.5 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -54.62 -52.68 61.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.467 ' HE2' HD22 ' A' ' 57' ' ' LEU . 24.0 m-85 -67.69 -35.86 79.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.456 ' HG2' HG22 ' A' ' 69' ' ' VAL . 31.1 mtt-85 -51.4 -33.84 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.6 mt -89.88 -14.28 34.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.541 HD11 ' NE2' ' A' ' 104' ' ' GLN . 60.4 mt -88.61 -31.02 18.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.573 ' NE ' HH21 ' A' ' 26' ' ' ARG . 4.6 mmm180 -119.39 -29.3 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.064 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.63 125.29 2.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.503 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -44.52 -20.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' GLY . 9.1 m-20 -82.67 21.49 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.064 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.4 m -70.69 -178.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.8 pt-20 -116.56 168.65 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 63.8 m-85 -159.93 141.38 9.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.67 0.748 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.75 168.04 22.69 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -92.89 -23.71 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -146.64 167.47 23.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 72' ' ' PRO . 83.3 m-85 -133.09 88.34 36.75 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.655 0.741 . . . . 0.0 110.907 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.46 ' HG2' HD21 ' A' ' 81' ' ' LEU . 54.2 Cg_endo -69.72 169.18 19.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.0 p -136.92 136.65 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.29 46.22 50.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.6 m -155.28 152.3 29.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.493 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -77.56 116.08 17.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 44' ' ' ALA . 25.1 mt -83.74 -70.11 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.476 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.04 -141.82 3.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.57 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 6.5 t -153.47 161.37 42.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.0 m -151.56 145.25 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.405 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.9 t70 -90.27 112.91 24.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.7 tt -75.12 98.12 3.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.22 -47.45 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.6 m-20 -163.64 168.16 20.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.37 103.23 7.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.9 mt -100.49 165.74 11.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.954 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 93' ' ' LYS . 33.3 t -106.12 169.05 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.468 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 6.0 mm100 -45.24 -20.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.415 ' N ' ' C ' ' A' ' 91' ' ' SER . 26.3 ttmt -87.94 -63.74 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -66.66 -49.19 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 111' ' ' VAL . 32.2 t80 -42.76 -55.26 3.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 97' ' ' GLU . 7.5 ptmt -68.25 -40.34 81.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.418 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 6.8 mt-10 -54.8 -59.66 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -75.97 -48.55 20.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -110.88 66.74 0.53 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 0.0 110.88 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.71 -12.24 32.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.363 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.71 -22.99 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.615 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.4 pt -122.1 22.26 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 p -62.48 -22.24 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.541 ' NE2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -94.37 -31.04 14.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.615 ' CD ' HG22 ' A' ' 102' ' ' ILE . 22.3 mt-10 -45.59 -37.06 5.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -128.52 134.32 48.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.448 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 10.4 t0 -97.91 -36.29 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.878 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 m -39.87 159.94 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 0.0 110.836 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.8 Cg_endo -69.76 -47.34 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -107.37 101.85 11.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.576 HG21 ' CD2' ' A' ' 95' ' ' PHE . 33.2 t -86.52 140.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.46 ' CE1' HG22 ' A' ' 34' ' ' THR . 8.7 m-30 -107.41 109.5 21.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -78.0 120.83 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.0 m -124.27 155.02 39.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -141.17 177.36 8.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 55.91 52.35 7.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.74 116.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.317 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -130.88 133.62 46.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -97.77 122.22 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.52 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 16.5 mtp -62.87 154.21 30.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.928 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -75.24 -30.03 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.56 142.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -107.55 140.02 41.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.52 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.7 OUTLIER -105.06 142.89 25.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.618 0.723 . . . . 0.0 110.876 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 83.07 0.72 Allowed 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.406 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.7 pp -121.41 155.8 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.585 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 8.2 ptpt -97.08 141.53 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -104.45 162.4 15.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.459 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -137.86 160.66 63.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.62 0.724 . . . . 0.0 110.909 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 2.53 3.45 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.8 mmmm -136.88 -175.15 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.594 HG22 ' CE3' ' A' ' 8' ' ' TRP . 83.6 mt -85.24 133.58 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.585 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.0 p-90 -140.46 128.3 21.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -56.43 126.03 24.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.419 ' CG ' ' HB2' ' A' ' 9' ' ' CYS . 25.4 mt -59.98 173.25 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.7 t70 -82.46 127.46 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.54 -39.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -74.42 -41.69 60.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' ASP . 29.1 mm -64.46 -42.56 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -40.47 -63.22 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLY . 45.1 mt-30 -53.45 -69.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.75 -51.66 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.584 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.09 -46.82 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -62.45 -23.36 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 147' ' ' LEU . 11.5 mmmm -80.38 -53.1 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -39.26 -24.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 145' ' ' LYS . 28.3 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.323 . . . . 0.0 110.877 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.688 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.9 m95 -81.4 164.22 22.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.925 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -138.69 133.34 32.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.597 ' HB2' HD21 ' A' ' 40' ' ' LEU . 31.1 tp -121.17 109.43 14.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.6 m -67.94 134.17 50.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.822 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.775 HG22 HH22 ' A' ' 30' ' ' ARG . 34.0 t -115.24 157.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.479 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 33.6 m-70 -90.54 113.71 25.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.566 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 16.3 mt-30 -59.06 160.51 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.561 0.696 . . . . 0.0 110.958 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.555 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -30.1 5.32 Favored 'Cis proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.36 -0.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.691 ' O ' HD12 ' A' ' 20' ' ' LEU . 9.7 m-90 -26.98 -54.5 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.29 -65.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 3.4 m -59.67 -43.49 93.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 16' ' ' TRP . 59.3 mt -50.78 -39.19 51.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.8 mp -58.53 -69.58 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.582 HG11 ' N ' ' A' ' 82' ' ' GLY . 26.6 m -57.46 -23.55 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.47 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.8 mmt180 -71.02 -39.14 72.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.67 24.59 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.466 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.39 -37.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.543 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -105.17 103.48 13.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.428 ' CD ' HH12 ' A' ' 65' ' ' ARG . 18.7 ptt180 -102.06 28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.494 HG11 HD12 ' A' ' 102' ' ' ILE . 34.0 m -156.51 142.59 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.441 ' CD ' ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -115.16 137.92 51.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.98 115.03 5.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.775 HH22 HG22 ' A' ' 12' ' ' VAL . 75.0 mmt-85 -138.52 154.11 48.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.477 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 95.7 p -88.99 20.67 3.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 1.8 p-90 -141.74 165.57 27.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -106.54 139.08 41.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 34' ' ' THR . 9.8 t -133.89 99.16 14.01 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.3 Cg_endo -69.73 7.98 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.428 ' O ' HD22 ' A' ' 86' ' ' LEU . 23.7 t60 -64.46 107.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.479 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.4 mmt-85 -103.85 108.8 20.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.42 -148.79 16.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -85.55 144.54 27.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 10' ' ' LEU . 22.0 tp -143.46 114.56 7.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 87.9 m95 -71.27 127.86 33.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -97.77 126.0 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.32 142.03 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.852 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -77.05 118.09 19.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.3 p -57.59 178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.5 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -98.76 128.61 45.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.909 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -87.61 122.41 70.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.565 0.698 . . . . 0.0 110.869 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 133.0 24.48 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.668 2.246 . . . . 0.0 112.346 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.9 m -78.19 161.29 71.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.684 0.754 . . . . 0.0 110.821 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -10.79 29.41 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.646 2.231 . . . . 0.0 112.352 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -87.33 -49.11 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -41.16 99.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 50' ' ' SER . 42.5 t -65.72 -51.14 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 t -63.64 -43.52 96.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -66.7 -52.73 41.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.489 HD22 ' HE2' ' A' ' 61' ' ' TYR . 83.7 mt -58.47 -42.44 87.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 36.3 mt-30 -52.82 -45.29 67.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.43 -36.25 39.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 m -60.43 -52.21 66.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.489 ' HE2' HD22 ' A' ' 57' ' ' LEU . 31.8 m-85 -68.43 -38.55 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.539 ' HG2' HG22 ' A' ' 69' ' ' VAL . 64.8 mtt180 -49.1 -34.25 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.92 -13.93 35.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.1 -27.86 19.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.428 HH12 ' CD ' ' A' ' 26' ' ' ARG . 3.9 mmm180 -122.66 -28.74 4.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.023 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.22 127.96 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.81 -19.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.55 14.71 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.023 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.8 m -64.45 -179.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -114.41 160.38 19.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 48.5 m-85 -155.44 134.87 7.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.477 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.84 165.08 32.28 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.637 2.224 . . . . 0.0 112.331 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -85.34 -29.08 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -148.01 174.95 11.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.555 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 43.1 m-85 -134.78 100.65 12.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.68 0.752 . . . . 0.0 110.959 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 53.6 Cg_endo -69.76 179.68 3.53 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.701 2.267 . . . . 0.0 112.345 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.8 p -142.05 141.32 32.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.85 58.01 16.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 10.2 m -162.15 150.61 14.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.598 HD22 ' SD ' ' A' ' 120' ' ' MET . 0.5 OUTLIER -77.25 118.77 20.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 44' ' ' ALA . 23.2 mt -88.52 -69.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.582 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.93 -143.52 3.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.5 p -157.5 148.63 21.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 110.883 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 18.9 m -135.96 136.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.12 111.58 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 112' ' ' PHE . 4.8 tt -72.97 104.28 4.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -73.15 -47.13 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.32 168.16 18.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.15 103.21 7.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 94' ' ' GLN . 93.6 mt -100.17 165.92 11.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 93' ' ' LYS . 47.9 t -102.91 169.61 8.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 107' ' ' ASP . 7.1 mm100 -45.13 -20.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 25.9 ttpt -91.0 -67.94 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.93 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.536 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.3 mt-30 -58.45 -46.19 87.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.8 t80 -44.09 -57.86 3.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.9 ptpt -68.66 -43.05 77.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.7 mt-10 -49.14 -59.26 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.6 mt-30 -78.74 -46.62 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 33.2 m-85 -111.24 68.56 0.67 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.685 0.755 . . . . 0.0 110.86 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.8 Cg_endo -69.8 -12.5 32.94 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.644 2.229 . . . . 0.0 112.368 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.34 -22.22 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.739 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.9 pt -124.78 23.2 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.506 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 37.0 p -64.21 -28.27 69.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.45 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -90.07 -30.25 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.739 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.5 mt-10 -43.63 -36.09 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.2 t -125.09 151.24 45.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.1 t70 -115.14 -29.26 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.42 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 1.4 m -49.3 162.18 0.43 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.678 0.751 . . . . 0.0 110.887 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.486 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.3 Cg_endo -69.74 -46.13 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.714 2.276 . . . . 0.0 112.337 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -109.98 104.71 13.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 95' ' ' PHE . 19.7 t -91.8 132.29 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 2.9 m-30 -100.25 108.82 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.41 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -76.01 124.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.482 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -125.09 155.65 39.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.444 ' CG ' HD12 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -138.94 177.56 7.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.844 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 53.43 52.8 10.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.4 Cg_endo -69.76 115.14 3.96 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.266 . . . . 0.0 112.314 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.85 142.03 49.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.14 124.81 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.598 ' SD ' HD22 ' A' ' 80' ' ' LEU . 13.8 mtp -63.69 148.44 49.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.62 -33.64 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.092 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.63 142.35 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -106.46 152.93 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.568 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.1 m-85 -119.12 140.06 28.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 88.22 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.294 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.461 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -118.18 158.91 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.595 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 30.3 mtpt -89.86 114.94 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.67 158.66 53.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.526 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -145.67 158.75 49.35 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 4.4 mmmm -91.73 -173.83 3.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.688 HG22 ' CE3' ' A' ' 8' ' ' TRP . 62.7 mt -82.89 137.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.1 p-90 -143.59 128.03 17.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -55.21 130.04 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.8 mt -63.6 178.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.0 167.45 15.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 p -72.2 -43.09 65.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -78.51 -18.86 54.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.568 HG23 ' CD2' ' A' ' 124' ' ' PHE . 15.7 mm -89.78 -36.23 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -51.29 -59.98 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 144' ' ' LYS . 82.2 mt-30 -56.7 -66.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.51 -42.18 0.91 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.458 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -61.86 -42.18 98.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.105 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.0 mtpp -65.82 -24.99 67.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 147' ' ' LEU . 23.7 mmmt -80.87 -52.13 7.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -41.9 -23.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.504 HD11 ' SG ' ' A' ' 83' ' ' CYS . 34.2 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.654 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.0 m95 -72.65 165.04 25.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.726 0.298 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.477 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 14.1 p -137.76 137.69 38.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 40' ' ' LEU . 10.7 tp -120.34 107.45 12.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 t -67.98 142.0 56.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 8.8 t -126.58 159.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.533 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.2 m-70 -90.52 112.89 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.554 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 13.0 mt-30 -58.57 160.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.577 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.72 -28.69 6.1 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.369 -0.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.506 ' C ' ' O ' ' A' ' 15' ' ' PRO . 9.5 m-90 -28.72 -57.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.26 -61.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 22' ' ' ARG . 2.2 m -63.1 -46.51 87.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.415 HD23 HD13 ' A' ' 24' ' ' ILE . 53.1 mt -45.74 -31.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 8.8 mp -67.21 -68.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.581 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.1 m -60.67 -10.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.7 mmt180 -84.34 -39.18 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 117' ' ' PRO . . . 123.16 0.14 9.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.431 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.2 mp -85.1 -49.63 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -88.91 118.54 28.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 26' ' ' ARG . 10.1 ttt180 -103.8 -0.07 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 28.4 m -143.45 155.62 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 4.9 tm-20 -122.07 152.86 39.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.544 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -111.31 129.36 9.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.7 mmt180 -148.82 145.04 27.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.866 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.402 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 61.5 p -83.02 18.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.582 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.1 p-90 -143.98 165.82 26.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -105.5 140.67 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 34' ' ' THR . 6.3 t -135.03 104.82 10.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.709 . . . . 0.0 111.114 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.6 Cg_endo -69.8 2.63 3.38 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.641 2.227 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.439 ' O ' HD22 ' A' ' 86' ' ' LEU . 16.4 t60 -62.17 111.77 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 5.8 mmt85 -114.24 122.09 45.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.52 -125.92 2.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -99.47 142.8 30.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 10' ' ' LEU . 15.0 tp -144.03 111.82 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.557 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 94.5 m95 -72.44 121.73 20.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.62 130.14 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -127.67 142.08 51.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.749 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -76.17 122.31 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.9 p -58.96 175.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.35 -15.98 61.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 6.4 ttpt -73.41 144.39 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.52 137.37 19.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.614 0.721 . . . . 0.0 110.889 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.73 128.97 16.83 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.69 2.26 . . . . 0.0 112.324 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 m -73.06 156.2 89.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.665 0.745 . . . . 0.0 110.862 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -94.52 -36.92 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.24 -42.36 68.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.647 HG12 ' OE1' ' A' ' 58' ' ' GLN . 47.8 t -64.31 -51.23 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -61.69 -44.58 96.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.29 -56.63 10.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 58' ' ' GLN . 94.1 mt -54.73 -55.91 24.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.647 ' OE1' HG12 ' A' ' 54' ' ' VAL . 37.6 mt-30 -37.45 -48.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.48 -44.64 34.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 m -51.97 -53.36 42.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -66.79 -38.67 86.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.4 mtt180 -48.77 -37.63 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -86.47 -15.99 38.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.498 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 59.5 mt -85.78 -28.84 24.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.498 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.9 mmp_? -122.67 -27.44 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.059 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 128.64 129.08 3.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.448 ' C ' ' HD3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -45.06 -20.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.5 p30 -70.95 3.18 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.059 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.2 m -60.63 178.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 8.8 mp0 -122.94 172.3 8.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 76.7 m-85 -161.11 141.47 8.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.557 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.87 29.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 0.0 112.362 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.02 -27.03 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -144.87 166.1 26.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.577 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 76.0 m-85 -130.64 88.47 46.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.645 0.736 . . . . 0.0 110.884 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 54.3 Cg_endo -69.75 168.43 21.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.67 2.246 . . . . 0.0 112.368 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.3 p -133.36 150.25 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.06 40.42 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 28.2 m -147.27 151.72 37.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.665 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -78.85 113.12 16.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 44' ' ' ALA . 26.3 mt -81.18 -70.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.581 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -149.09 -142.95 3.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.541 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -153.79 153.68 32.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 m -140.99 139.86 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.403 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.6 t70 -81.88 112.72 19.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.439 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.5 tt -77.45 100.38 5.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.532 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.98 -45.62 71.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 3.5 m-20 -165.46 165.9 18.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.421 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.3 t -127.77 97.09 4.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.519 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 95.4 mt -94.67 168.13 11.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 93' ' ' LYS . 46.3 t -104.84 169.41 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 108' ' ' SER . 11.6 mm-40 -45.04 -20.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.1 ttmt -91.65 -69.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -57.98 -45.74 86.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.605 ' CD2' HG21 ' A' ' 111' ' ' VAL . 16.5 t80 -44.43 -58.66 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 10.4 ptpt -66.91 -40.01 87.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.2 mt-10 -49.99 -56.01 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.498 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.7 mt-30 -81.87 -49.18 10.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.498 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 19.8 m-85 -109.77 69.13 0.48 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.664 0.745 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.2 Cg_endo -69.78 -11.79 31.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.665 2.244 . . . . 0.0 112.354 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.42 -22.14 51.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.717 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.0 OUTLIER -122.44 22.75 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.6 p -64.07 -20.76 66.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.428 ' NE2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -96.54 -27.82 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.717 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.1 mt-10 -47.03 -40.06 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 t -120.09 150.64 40.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -116.2 -27.19 6.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.44 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -52.11 162.34 0.85 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.83 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 54.3 Cg_endo -69.72 -37.27 9.49 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.12 101.18 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.605 HG21 ' CD2' ' A' ' 95' ' ' PHE . 50.7 t -84.39 136.43 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 7.5 m-30 -104.59 102.39 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -70.62 119.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 2.7 m -124.26 154.02 40.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -142.09 176.71 8.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 54.79 52.24 8.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.82 119.94 6.8 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.331 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -132.47 138.48 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -102.75 122.26 44.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.665 ' HE1' HD13 ' A' ' 80' ' ' LEU . 16.9 mtp -62.92 153.26 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.4 t -72.8 -37.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.16 138.07 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -102.49 149.58 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -113.11 142.34 27.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 86.66 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.535 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -121.06 160.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 15.0 ptmt -99.61 134.6 42.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.79 -178.01 39.45 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -161.12 159.22 24.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 0.3 5.87 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.629 2.219 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.582 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 9.1 mmmm -136.94 -175.0 3.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.654 HG22 ' CE3' ' A' ' 8' ' ' TRP . 71.9 mt -84.88 140.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.12 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.503 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 9.4 p-90 -146.51 128.96 15.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.557 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 15.2 ttmt -56.5 130.3 44.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 139' ' ' ILE . 17.8 mt -65.71 168.85 7.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.3 t70 -77.4 127.19 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.13 -40.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.61 -42.54 58.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 24.9 mm -64.04 -38.72 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -46.54 -65.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.7 mm-40 -49.75 -68.49 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.05 -54.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.557 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.24 -40.91 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 111.097 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -67.83 -17.03 64.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.6 mmmm -89.84 -50.09 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -40.04 -23.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.539 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 145' ' ' LYS . 22.6 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.481 ' CE3' HG22 ' A' ' 132' ' ' ILE . 94.0 m95 -83.05 164.17 20.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 12.9 p -145.6 142.45 29.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.436 ' CD2' ' HG2' ' A' ' 28' ' ' GLU . 8.9 tp -130.95 114.16 14.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 18.7 m -69.59 147.45 50.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 19.7 t -129.76 154.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.437 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 37.3 m-70 -86.66 120.14 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.631 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 57.6 mt-30 -64.14 161.61 38.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 16' ' ' TRP . 53.5 Cg_endo -69.8 -30.53 5.1 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.325 -0.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.606 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.3 m-90 -26.89 -54.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.631 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.26 -64.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -63.04 -45.76 90.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 16' ' ' TRP . 57.4 mt -45.23 -30.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.678 HD21 ' OE1' ' A' ' 28' ' ' GLU . 6.6 mp -68.81 -69.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG21 ' OE1' ' A' ' 119' ' ' GLU . 5.0 m -57.26 -15.48 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.461 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.1 mmt180 -79.38 -39.57 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.63 7.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.3 mp -76.38 -57.01 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 111.152 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.0 tptt -84.03 112.25 20.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HG3' HG13 ' A' ' 27' ' ' VAL . 8.1 ptm180 -109.99 20.24 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.479 HG11 ' CE1' ' A' ' 95' ' ' PHE . 23.6 m -149.94 145.91 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.678 ' OE1' HD21 ' A' ' 20' ' ' LEU . 2.4 tp10 -109.15 146.53 33.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.56 119.86 5.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 24.7 mmt180 -148.89 145.44 27.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -83.31 17.71 2.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 4.9 p-90 -139.85 163.49 32.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.0 145.33 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.494 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.6 t -138.75 106.99 7.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.714 . . . . 0.0 111.128 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 54.1 Cg_endo -69.72 3.86 2.51 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.677 2.251 . . . . 0.0 112.371 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.571 ' O ' HD22 ' A' ' 86' ' ' LEU . 24.1 t60 -65.3 114.27 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -120.18 117.65 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.03 -121.32 1.05 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.464 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -106.35 140.08 39.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 15.6 tp -144.27 113.9 7.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.608 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.1 m95 -72.02 128.88 37.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.0 133.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.24 166.88 17.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -98.87 119.33 37.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.5 p -55.22 -179.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.12 -5.45 57.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HD3' ' ND1' ' A' ' 13' ' ' HIS . 4.2 tttt -86.81 124.71 33.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -85.53 139.28 35.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.531 0.681 . . . . 0.0 110.939 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 54.2 Cg_endo -69.76 132.25 22.95 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 54' ' ' VAL . 15.4 m -76.02 157.52 83.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.697 0.761 . . . . 0.0 110.845 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -5.84 17.19 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.671 2.247 . . . . 0.0 112.342 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -95.03 -44.39 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 50' ' ' SER . 59.7 t -65.34 -49.42 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -65.27 -44.01 89.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.19 -53.77 27.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.953 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.458 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 75.6 mt -56.49 -40.16 74.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 36.4 mt-30 -55.03 -42.7 72.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.61 -32.99 28.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -64.67 -52.86 55.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -64.34 -38.22 90.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.534 ' HG2' HG22 ' A' ' 69' ' ' VAL . 54.2 mtt180 -49.79 -34.25 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.0 mt -90.56 -12.19 37.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.89 -28.9 17.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -122.53 -29.25 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.039 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.24 126.11 2.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.435 ' C ' ' HD3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -44.44 -21.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -79.23 15.29 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.5 m -64.02 -177.06 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 24' ' ' ILE . 13.0 mt-10 -115.91 165.97 12.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 55.4 m-85 -161.12 132.38 3.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.526 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.71 169.12 19.59 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.68 2.253 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -144.28 170.81 15.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' CZ ' ' HG2' ' A' ' 72' ' ' PRO . 58.1 m-85 -134.21 93.36 19.66 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.628 0.728 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.52 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.77 169.79 18.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.2 m -136.37 139.44 42.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.851 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.58 49.41 60.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.1 m -157.08 147.62 21.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.878 0.37 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.656 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.27 120.81 21.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 44' ' ' ALA . 78.6 mt -88.8 -73.75 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.86 -144.63 4.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.572 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 14.2 t -151.14 157.84 43.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 m -143.09 142.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.422 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.5 t70 -86.49 111.45 20.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.571 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.9 tt -75.24 98.39 3.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.552 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.25 -47.66 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.7 m-20 -164.92 168.2 17.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -127.9 100.42 5.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 94' ' ' GLN . 94.0 mt -94.01 170.06 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' LYS . 65.0 m -109.41 169.61 8.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 109' ' ' PRO . 10.6 mm100 -43.0 -22.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' SER . 29.0 ttmt -89.79 -66.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.623 ' HB3' HD22 ' A' ' 90' ' ' LEU . 10.3 mt-30 -60.35 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.526 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 28.6 t80 -46.02 -55.56 6.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 1.9 ptmt -69.69 -39.51 76.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.26 -59.41 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.481 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 9.6 mt-30 -77.51 -49.5 14.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 25.1 m-85 -109.95 67.62 0.46 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.633 0.73 . . . . 0.0 110.84 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.77 -12.19 32.37 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 -22.17 51.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.513 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.1 pt -121.35 15.99 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.3 p -58.4 -22.56 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.573 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -94.49 -30.69 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 8.7 mt-10 -47.04 -26.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 t -136.86 138.67 41.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.74 26.61 9.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 16.4 p -100.17 157.69 33.37 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.652 0.739 . . . . 0.0 110.86 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.73 -23.2 31.19 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 0.0 112.348 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -134.97 95.0 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 95' ' ' PHE . 43.4 t -85.63 137.55 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -104.44 108.01 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER -75.13 122.92 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.4 m -125.67 155.97 40.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -144.02 176.49 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.49 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 57.83 51.73 4.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.634 0.73 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.4 Cg_endo -69.74 114.19 3.62 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.404 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.24 134.7 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.541 ' OE1' HG21 ' A' ' 21' ' ' VAL . 3.9 tp10 -97.6 123.53 41.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.656 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.6 mtp -63.76 157.77 23.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.6 t -81.08 -32.5 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.4 144.42 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -111.05 148.22 33.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.467 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.0 OUTLIER -117.54 142.53 30.61 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.71 0.767 . . . . 0.0 110.822 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 86.83 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.63 2.22 . . . . 0.0 112.391 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.468 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -125.01 162.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.5 mmtp -108.15 149.03 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -100.03 178.22 29.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.519 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -154.53 161.06 30.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.66 0.743 . . . . 0.0 110.876 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -1.61 8.79 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.2 mmmm -137.27 -174.99 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.481 HG22 ' CE3' ' A' ' 8' ' ' TRP . 74.1 mt -83.11 139.79 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.2 p-90 -145.11 127.94 16.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.453 ' NZ ' ' CZ2' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -64.21 125.23 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 139' ' ' ILE . 30.2 mt -52.76 -176.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.8 t0 -91.7 131.72 36.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -36.65 -36.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -40.33 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.623 HG21 HD22 ' A' ' 135' ' ' LEU . 32.2 mm -67.36 -45.77 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.8 t-160 -36.5 -63.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 41.4 mm-40 -52.48 -69.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.53 -48.23 0.65 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.608 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -58.45 -43.25 88.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.819 0.342 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 15.9 mtpp -64.46 -26.45 68.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.455 ' HE2' ' N ' ' A' ' 145' ' ' LYS . 8.5 mmpt? -80.37 -46.34 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -45.68 -22.38 0.71 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 34.3 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.932 -179.97 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.453 ' CE3' HG22 ' A' ' 132' ' ' ILE . 87.3 m95 -72.35 169.79 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HB2' HD11 ' A' ' 135' ' ' LEU . 43.0 t -140.33 139.15 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -130.05 115.57 17.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 m -67.77 156.38 37.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.657 HG22 ' OE2' ' A' ' 28' ' ' GLU . 53.7 t -139.03 157.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.482 ' N ' HG12 ' A' ' 12' ' ' VAL . 43.1 m-70 -90.41 109.43 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.578 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 16.5 mt-30 -58.33 161.14 8.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.7 -30.57 5.05 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.73 -1.779 . . . . 0.0 112.325 -0.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 9.6 m-90 -26.66 -49.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.578 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -35.28 -60.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -67.03 -51.09 59.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 16' ' ' TRP . 91.3 mt -40.51 -30.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.8 mp -68.32 -65.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.6 m -62.58 -18.38 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.47 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 14.4 mmt180 -74.81 -39.93 61.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.4 -2.18 7.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.778 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.1 mp -83.07 -55.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.391 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.506 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.5 tptp -86.59 120.26 27.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.618 ' HD2' HD13 ' A' ' 102' ' ' ILE . 4.3 ptp180 -114.37 15.92 17.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.518 HG11 HD12 ' A' ' 102' ' ' ILE . 33.9 m -147.56 142.92 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.657 ' OE2' HG22 ' A' ' 12' ' ' VAL . 6.9 tp10 -107.97 147.01 31.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -113.18 119.54 4.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.0 mmt180 -146.22 151.96 38.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 0.0 110.887 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.476 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 84.2 p -87.42 22.31 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.458 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 3.4 p-90 -142.24 161.12 38.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 12.0 t80 -103.65 139.23 39.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 34' ' ' THR . 7.6 t -134.41 101.66 12.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.566 0.698 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.5 Cg_endo -69.8 8.33 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.646 2.231 . . . . 0.0 112.36 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.599 ' O ' HD22 ' A' ' 86' ' ' LEU . 20.4 t60 -68.67 109.73 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mmt-85 -109.62 107.25 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.98 -153.37 23.89 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -73.02 140.57 47.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 21.2 tp -143.95 113.88 7.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.562 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 95.4 m95 -73.54 120.95 19.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.62 128.94 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.48 153.27 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -88.75 122.55 32.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.8 p -62.45 173.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.27 -9.74 58.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 7.7 ttpt -70.47 127.27 32.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -85.46 125.68 68.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.567 0.698 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD3' HE21 ' A' ' 14' ' ' GLN . 54.2 Cg_endo -69.72 130.82 20.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.247 . . . . 0.0 112.354 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.6 m -76.89 158.97 79.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.666 0.746 . . . . 0.0 110.79 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 -16.98 38.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 0.0 112.372 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -84.44 -39.06 19.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -41.42 76.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.7 HG12 ' OE1' ' A' ' 58' ' ' GLN . 52.5 t -67.94 -48.87 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.162 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -63.62 -45.14 91.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.87 -52.44 43.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.651 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 83.9 mt -59.31 -44.76 92.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.7 ' OE1' HG12 ' A' ' 54' ' ' VAL . 33.7 mt-30 -50.18 -46.12 54.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.89 -36.95 41.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.3 m -59.24 -51.18 71.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.403 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 26.5 m-85 -69.06 -37.26 78.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.5 mtt-85 -49.88 -33.99 18.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.78 -15.94 31.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.8 mt -88.06 -28.66 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.448 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 3.6 mmm180 -121.47 -28.87 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.034 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 132.45 126.98 2.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.476 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.57 -20.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.1 m-20 -80.72 18.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.034 HG13 ' O ' ' A' ' 66' ' ' GLY . 23.2 m -68.02 179.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.117 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.778 ' O ' HD11 ' A' ' 24' ' ' ILE . 11.9 mt-10 -112.25 157.2 21.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -154.51 132.06 6.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.657 0.742 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.694 2.262 . . . . 0.0 112.322 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -81.4 -32.05 32.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -145.31 174.23 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.0 m-85 -133.45 95.47 18.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.665 0.745 . . . . 0.0 110.936 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 53.4 Cg_endo -69.75 171.59 14.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.332 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -141.33 133.25 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 46.13 9.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -159.27 149.39 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.409 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -74.23 113.43 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.743 HD11 ' HB2' ' A' ' 44' ' ' ALA . 77.8 mt -79.3 -74.4 0.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.501 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -143.9 -145.07 4.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.562 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 5.5 t -149.54 162.49 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.9 m -151.71 140.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.41 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.4 t70 -85.63 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.599 HD22 ' O ' ' A' ' 36' ' ' HIS . 5.6 tt -73.48 99.82 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.526 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.89 -48.29 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.43 167.4 23.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.53 101.25 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.517 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.2 mt -96.37 168.38 10.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 15.0 p -106.29 169.19 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.495 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 6.0 mm100 -46.65 -19.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 91' ' ' SER . 21.9 ttmt -90.88 -59.0 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.504 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.5 mt-30 -68.52 -50.21 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.517 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 31.3 t80 -41.91 -55.9 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -67.25 -41.32 85.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.49 -58.83 5.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.3 mt-30 -76.13 -50.11 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -109.88 67.91 0.46 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.1 Cg_endo -69.74 -13.57 34.92 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.71 2.273 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.68 -23.44 56.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.659 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.6 pt -121.91 23.45 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.2 p -65.0 -26.3 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.445 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -91.53 -27.98 17.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.659 ' CD ' HG22 ' A' ' 102' ' ' ILE . 18.3 mt-10 -49.3 -38.39 27.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.515 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.3 p -124.08 144.42 49.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 27.2 t70 -107.94 -36.36 6.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 m -39.6 157.99 0.13 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.856 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.7 Cg_endo -69.79 -49.23 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.661 2.241 . . . . 0.0 112.319 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' A' ' 33' ' ' TYR . 26.2 m-85 -106.32 98.69 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.516 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 22.1 t -83.91 139.62 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -107.29 107.09 17.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.24 122.83 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.1 m -126.8 155.41 42.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.08 176.25 9.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 56.59 51.97 6.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.73 115.52 4.13 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -127.92 134.79 49.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -96.88 121.99 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.459 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 13.1 mtp -62.59 151.88 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 146' ' ' GLY . 59.3 t -72.74 -37.52 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 1.8 p -118.22 158.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.486 ' N ' ' CG2' ' A' ' 122' ' ' VAL . 12.5 mmtm -120.65 140.29 51.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -107.64 136.86 19.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.628 0.728 . . . . 0.0 110.897 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 86.03 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.438 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.9 pp -121.89 163.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 70.9 mttt -97.95 132.04 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.03 170.9 40.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -153.42 153.07 28.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 1.42 4.46 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.301 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.435 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.7 mmmm -134.07 -175.39 3.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.453 HG22 ' CE3' ' A' ' 8' ' ' TRP . 72.7 mt -89.03 137.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.6 p-90 -146.05 131.48 18.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -59.62 124.59 20.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.476 HD22 HG21 ' A' ' 139' ' ' ILE . 27.1 mt -60.02 170.77 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.7 t70 -79.27 129.71 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.1 m -37.03 -37.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -76.05 -41.24 51.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 124' ' ' PHE . 37.5 mm -65.56 -39.65 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -45.92 -65.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.817 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 144' ' ' LYS . 28.1 mt-30 -47.89 -69.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.95 -52.85 1.54 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.445 ' HB2' ' HE2' ' A' ' 124' ' ' PHE . . . -52.52 -39.44 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 141' ' ' GLN . 10.7 mtpt -70.47 -14.73 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -86.08 -48.47 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -46.62 -19.15 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.574 ' CE3' HG22 ' A' ' 132' ' ' ILE . 94.7 m95 -94.96 161.97 13.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -137.24 140.25 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 28' ' ' GLU . 26.7 tp -124.13 108.88 12.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 3.9 p -67.57 137.17 55.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.718 HG22 ' OE2' ' A' ' 28' ' ' GLU . 33.9 t -121.13 161.44 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.543 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.5 m-70 -95.99 111.76 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.524 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 10.8 mm-40 -56.34 157.83 8.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.78 -33.03 3.57 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.361 -0.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 10.7 m-90 -24.97 -54.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.516 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -36.69 -54.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.5 m -70.04 -47.81 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -45.39 -28.31 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.6 mp -68.07 -65.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.651 HG11 ' N ' ' A' ' 82' ' ' GLY . 14.6 m -64.77 -14.2 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.3 mmt180 -78.64 -39.13 37.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.61 12.22 6.2 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.5 -47.63 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -88.79 116.66 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.49 ' CG ' ' O ' ' A' ' 26' ' ' ARG . 11.4 ttt180 -101.94 -1.14 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.59 HG11 ' CE1' ' A' ' 95' ' ' PHE . 32.7 m -141.55 152.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.144 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.718 ' OE2' HG22 ' A' ' 12' ' ' VAL . 2.2 tp10 -115.96 143.11 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.55 129.47 9.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.416 ' HD2' ' NE1' ' A' ' 32' ' ' TRP . 20.2 mmt180 -152.96 140.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.1 p -82.81 16.58 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.535 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.2 p-90 -139.29 166.44 24.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 34' ' ' THR . 8.8 t80 -106.45 148.39 28.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.618 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 5.8 t -143.95 107.09 4.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.709 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 54.2 Cg_endo -69.69 2.83 3.14 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.37 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.5 ' O ' HD22 ' A' ' 86' ' ' LEU . 13.3 t60 -65.42 117.91 8.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -123.53 120.43 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 85' ' ' ASP . . . 153.57 -121.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -99.55 140.77 33.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 17.4 tp -144.73 108.99 4.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.61 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 94.8 m95 -71.65 126.15 28.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 mm -96.39 129.3 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -126.63 150.56 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -85.37 126.26 33.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.071 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 12' ' ' VAL . 23.8 p -64.69 173.01 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.42 -21.15 62.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 9.0 ttpt -63.91 149.39 47.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.471 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -108.59 133.98 20.44 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.533 0.682 . . . . 0.0 110.921 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 128.32 15.86 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.708 2.272 . . . . 0.0 112.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.9 m -75.21 159.12 83.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 110.869 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -7.35 20.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -94.72 -41.78 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.63 -40.85 80.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 50' ' ' SER . 33.8 t -67.83 -49.6 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.4 t -64.2 -42.06 96.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -70.2 -55.15 10.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HE2' ' A' ' 61' ' ' TYR . 86.5 mt -55.88 -44.03 77.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 37.3 mt-30 -51.05 -47.06 61.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.67 -36.71 51.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -60.17 -51.25 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.676 ' HE2' HD22 ' A' ' 57' ' ' LEU . 46.0 m-85 -69.92 -38.59 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 69' ' ' VAL . 44.8 mtt180 -47.98 -36.34 12.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 mt -87.23 -18.14 30.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.0 mt -83.41 -32.28 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -118.4 -27.38 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.056 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 129.4 124.9 2.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.428 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -70.15 4.77 1.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.056 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.3 m -61.5 176.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -116.71 167.82 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 49.5 m-85 -157.67 139.06 9.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.71 159.4 53.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.745 2.297 . . . . 0.0 112.334 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.88 -24.09 33.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -150.73 172.22 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.598 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 56.2 m-85 -134.41 98.59 13.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.66 0.743 . . . . 0.0 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.76 -176.33 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.319 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.7 p -150.79 129.83 12.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.38 45.28 24.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.1 m -153.33 149.43 27.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.598 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -75.95 118.34 18.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 44' ' ' ALA . 43.8 mt -85.68 -71.57 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.651 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.26 -143.11 3.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.598 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -152.46 158.18 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.845 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.8 m -145.71 134.54 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 1.4 t70 -79.35 112.8 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.2 tt -76.41 102.67 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -72.04 -47.07 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . 7.0 m-20 -166.17 170.02 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.475 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -128.11 99.42 5.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.534 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 96.9 mt -93.04 171.24 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 93' ' ' LYS . 4.7 p -109.79 169.16 8.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.472 ' O ' ' CE ' ' A' ' 96' ' ' LYS . 10.5 mm100 -43.11 -23.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 18.4 ttmt -89.76 -65.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.501 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.1 mt-30 -59.38 -48.63 80.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.604 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.1 t80 -43.79 -56.9 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 11.7 ptpt -69.0 -41.96 77.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -50.06 -59.13 4.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.496 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.4 mt-30 -78.05 -45.07 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.0 m-85 -113.66 69.98 1.6 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.666 0.746 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -14.54 36.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 0.0 112.349 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -19.67 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.654 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.5 pt -125.73 21.74 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.469 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 58.8 p -64.51 -27.63 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.427 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -89.39 -29.52 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.654 ' CD ' HG22 ' A' ' 102' ' ' ILE . 22.9 mt-10 -45.31 -40.03 7.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.8 t -120.39 140.76 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.18 25.43 10.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.455 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 1.7 p -101.16 160.34 26.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.869 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.3 Cg_endo -69.79 -25.16 28.73 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 32' ' ' TRP . 20.2 m-85 -134.82 95.55 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.498 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.7 t -84.51 135.73 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.618 ' CZ ' HG22 ' A' ' 34' ' ' THR . 9.2 m-30 -101.9 103.54 14.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -71.12 122.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.9 m -125.56 156.08 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -143.53 176.36 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.488 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 58.15 51.95 4.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.5 Cg_endo -69.79 113.65 3.45 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.266 . . . . 0.0 112.303 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -127.35 141.7 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -103.67 120.96 41.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.598 ' HE1' HD13 ' A' ' 80' ' ' LEU . 17.3 mtp -64.05 143.01 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 146' ' ' GLY . 29.4 t -69.96 -25.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.146 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.83 141.91 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -110.99 145.09 39.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.445 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.0 OUTLIER -113.41 143.29 29.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 91.49 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.279 . . . . 0.0 112.316 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.45 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.8 pp -130.63 158.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.11 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.591 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.0 mttm -103.5 137.23 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -96.24 166.87 24.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.468 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -140.53 161.7 53.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.714 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 0.56 5.45 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.535 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.5 mmmm -138.26 -174.99 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.574 HG22 ' CE3' ' A' ' 8' ' ' TRP . 82.7 mt -83.09 138.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.591 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 6.7 p-90 -146.63 124.2 11.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.47 127.07 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.17 -178.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -88.13 127.47 35.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.8 m -36.39 -40.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -73.44 -41.25 63.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 136' ' ' ASP . 23.5 mm -64.99 -44.99 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -38.55 -65.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 142' ' ' GLY . 14.4 mm100 -52.59 -68.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.21 -48.71 1.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.466 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.61 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.79 -45.79 81.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 111.089 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -63.57 -22.48 66.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -84.14 -46.63 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -45.44 -20.45 0.34 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.9 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.72 ' CE3' HG22 ' A' ' 132' ' ' ILE . 93.3 m95 -90.23 156.98 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.587 ' HB2' HD11 ' A' ' 135' ' ' LEU . 52.7 t -134.5 121.7 21.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.463 HD13 ' HH2' ' A' ' 32' ' ' TRP . 65.6 tp -107.44 109.19 20.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -68.09 154.53 41.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 20' ' ' LEU . 24.5 t -133.65 159.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.094 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.511 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 57.4 m-70 -90.13 113.72 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.557 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 78.7 mt-30 -59.7 159.75 17.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.75 -31.52 4.5 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.355 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.529 ' C ' ' O ' ' A' ' 15' ' ' PRO . 10.0 m-90 -26.81 -48.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.557 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -39.33 -63.44 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.1 mt -52.62 -28.52 21.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 12' ' ' VAL . 7.1 mp -69.75 -60.46 2.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 82' ' ' GLY . 18.6 m -67.65 -20.5 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -73.12 -39.17 65.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 14.66 5.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.21 -45.14 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 111.154 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CD ' ' OH ' ' A' ' 61' ' ' TYR . 4.2 tptp -93.81 118.85 32.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -101.05 -4.39 27.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 8.0 m -141.33 152.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -120.35 130.51 54.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.453 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -86.57 132.06 10.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' N ' ' CB ' ' A' ' 108' ' ' SER . 18.9 mmt180 -152.63 144.64 23.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.522 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 9.8 t -85.63 24.26 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.596 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.0 p-90 -146.38 160.91 41.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.3 t80 -104.08 145.29 30.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 5.6 t -139.31 105.91 7.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.162 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.1 Cg_endo -69.78 4.0 2.46 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.697 2.265 . . . . 0.0 112.308 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.404 ' O ' HD22 ' A' ' 86' ' ' LEU . 15.5 t60 -65.86 114.68 5.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -119.69 122.92 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.41 -119.15 1.04 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -104.88 138.3 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.405 HD21 ' CB ' ' A' ' 10' ' ' LEU . 26.7 tp -143.57 112.69 6.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.36 132.56 45.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.5 mm -103.34 125.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.113 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.97 154.3 36.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -87.73 116.46 25.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -53.06 -177.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.13 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.65 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 6.2 ttpt -78.25 131.13 36.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -92.98 137.06 23.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.557 0.694 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 53.4 Cg_endo -69.72 130.36 19.24 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.4 m -78.29 158.13 77.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 110.837 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -4.15 13.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.682 2.254 . . . . 0.0 112.317 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -94.84 -38.67 10.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.933 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.17 -39.84 53.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.607 HG12 ' OE1' ' A' ' 58' ' ' GLN . 61.6 t -64.15 -52.73 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -58.12 -46.54 85.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -66.41 -57.54 7.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.489 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 76.7 mt -52.92 -41.21 64.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.607 ' OE1' HG12 ' A' ' 54' ' ' VAL . 34.2 mt-30 -52.47 -47.9 66.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -37.52 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.072 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -58.3 -50.59 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.438 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 24.8 m-85 -71.03 -31.88 68.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.2 mtt180 -56.05 -39.65 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 mt -86.33 -14.53 43.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.469 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 71.6 mt -89.02 -28.89 19.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.469 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 5.5 mmp_? -121.16 -28.74 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.065 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 131.27 128.21 2.94 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.19 -19.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.7 m-20 -78.4 13.4 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.065 HG13 ' O ' ' A' ' 66' ' ' GLY . 28.6 m -66.33 -177.84 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 16.3 mm-40 -119.54 167.98 11.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 62.3 m-85 -161.86 135.06 4.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.625 0.726 . . . . 0.0 110.861 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.2 Cg_endo -69.77 159.96 51.47 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 0.0 112.322 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -81.11 -27.76 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -146.15 173.41 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.1 m-85 -134.85 94.61 16.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.683 0.754 . . . . 0.0 110.916 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.4 Cg_endo -69.76 174.36 9.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.5 p -141.26 139.81 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.86 45.36 84.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.7 m -153.45 145.18 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 110.884 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.677 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.1 OUTLIER -74.93 117.85 17.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' ALA . 50.1 mt -85.79 -71.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.49 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.61 -146.4 4.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.587 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.3 p -151.28 157.41 42.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.461 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.8 m -144.67 140.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.1 113.08 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 36' ' ' HIS . 4.2 tt -77.42 93.41 4.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.622 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -60.73 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.184 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.407 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.5 m-20 -163.01 168.46 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.9 t -127.73 101.74 6.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.525 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 88.8 mt -99.32 169.89 9.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' LYS . 34.7 t -105.12 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.487 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 10.1 mm-40 -42.07 -23.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' SER . 15.2 ttmm -91.34 -70.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -53.56 -47.37 70.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.572 ' CD2' HG21 ' A' ' 111' ' ' VAL . 16.9 t80 -43.3 -57.46 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.506 ' HG2' ' N ' ' A' ' 97' ' ' GLU . 1.6 pttt -68.36 -38.79 81.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.506 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 12.1 mt-10 -49.56 -52.39 30.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.7 mt-30 -86.68 -45.97 10.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.7 m-85 -110.42 67.69 0.51 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 0.0 110.865 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.77 -10.35 28.33 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.695 2.264 . . . . 0.0 112.366 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.82 -19.16 55.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.449 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 pt -126.17 21.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 59.6 p -60.05 -20.78 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -97.94 -30.71 12.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 5.2 mt-10 -51.23 -28.36 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.5 p -114.24 156.84 23.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -130.15 -32.58 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.518 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -58.87 164.83 3.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 0.0 110.834 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.522 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.3 Cg_endo -69.78 -43.79 2.44 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.66 2.24 . . . . 0.0 112.322 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -110.34 97.51 6.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 95' ' ' PHE . 12.9 t -79.3 139.21 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CZ ' HG22 ' A' ' 34' ' ' THR . 11.5 m-30 -106.58 105.84 16.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -74.41 117.57 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.093 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.461 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 6.9 m -125.07 151.55 45.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.874 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -140.5 175.27 9.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER 59.22 53.18 4.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 0.0 110.891 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.78 112.58 3.12 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.402 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 4.2 pt20 -127.33 141.07 51.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.19 122.24 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.677 ' HE1' HD13 ' A' ' 80' ' ' LEU . 16.6 mtp -63.39 155.33 29.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 146' ' ' GLY . 32.2 t -81.92 -27.69 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -127.27 135.22 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 14.0 mmtm -103.03 150.44 23.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.577 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.3 m-85 -118.17 143.55 33.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.596 0.713 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 92.05 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.32 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.509 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.9 pp -123.21 167.07 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -110.28 107.16 16.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.27 169.56 23.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.538 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 133' ' ' TRP . 46.9 m-80 -155.29 157.9 31.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.928 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 0.86 5.03 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.596 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.4 mmmp? -136.84 -175.08 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.72 HG22 ' CE3' ' A' ' 8' ' ' TRP . 68.3 mt -86.89 131.99 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.154 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 129' ' ' ASN . 7.5 p-90 -133.8 136.24 44.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.549 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 8.8 ttmt -56.8 134.87 55.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 9' ' ' CYS . 17.9 mt -76.96 133.29 39.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.521 ' HB2' ' CG1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -45.84 123.23 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 136' ' ' ASP . 4.4 m -34.02 -48.44 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.86 -43.62 87.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.577 HG23 ' CD2' ' A' ' 124' ' ' PHE . 38.7 mm -61.65 -46.09 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.139 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -38.56 -64.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 142' ' ' GLY . 79.9 mt-30 -51.68 -68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.7 -49.09 0.72 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.506 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.72 -46.06 77.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.2 mtpp -64.82 -24.12 67.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -82.8 -42.84 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -51.48 -16.51 2.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.891 -179.888 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.675 ' CE3' HG22 ' A' ' 132' ' ' ILE . 95.0 m95 -92.91 160.79 14.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB2' HD11 ' A' ' 135' ' ' LEU . 39.0 t -133.16 130.95 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.555 HD11 ' HE ' ' A' ' 30' ' ' ARG . 21.9 tp -111.6 110.7 21.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.435 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 2.9 m -69.92 131.09 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 13' ' ' HIS . 69.6 t -116.19 163.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.6 ' N ' HG12 ' A' ' 12' ' ' VAL . 59.0 m-70 -100.65 114.21 27.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 15' ' ' PRO . 15.0 mm-40 -58.36 157.8 16.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.587 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.76 -33.74 3.31 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.721 -1.783 . . . . 0.0 112.338 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.548 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.5 m-90 -25.07 -59.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -33.39 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.091 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.4 m -69.6 -53.91 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 mt -40.97 -29.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.7 mp -66.56 -68.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 82' ' ' GLY . 17.4 m -61.21 -11.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.453 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 12.2 mmt180 -82.98 -39.64 21.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.86 0.87 9.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.545 HD11 ' O ' ' A' ' 70' ' ' GLU . 4.6 mp -85.6 -50.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 111.12 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.1 tptp -88.53 121.87 31.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -103.89 -4.06 23.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.615 HG11 ' CE1' ' A' ' 95' ' ' PHE . 15.6 m -140.34 162.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE1' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -129.03 130.88 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -86.43 128.24 8.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.52 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HE ' HD11 ' A' ' 10' ' ' LEU . 13.0 mmt180 -146.11 143.97 29.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.823 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 77.9 p -83.66 19.47 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.578 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.5 p-90 -144.53 167.62 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.462 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 6.0 t80 -108.8 136.81 47.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.566 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 6.1 t -130.15 104.04 16.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.703 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.421 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.8 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.408 ' O ' HD22 ' A' ' 86' ' ' LEU . 15.6 t60 -65.77 117.15 7.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.421 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 8.4 mmt85 -120.97 121.48 38.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.91 -116.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -104.2 138.95 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 10' ' ' LEU . 19.3 tp -143.76 109.38 5.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.597 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 90.7 m95 -73.4 124.49 25.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 mm -94.84 127.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -127.18 141.18 51.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.102 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.654 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -75.58 121.29 22.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 p -59.94 -177.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.26 21.34 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.073 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' HB3' ' A' ' 13' ' ' HIS . 8.9 ttpt -100.77 132.94 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -87.67 126.7 60.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.555 0.693 . . . . 0.0 110.928 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 134.92 29.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.1 m -79.05 153.29 77.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.669 0.747 . . . . 0.0 110.841 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -6.55 18.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.297 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -94.57 -38.47 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.85 -43.52 71.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.88 -51.11 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -61.1 -47.44 86.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.17 -55.34 22.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.417 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 84.8 mt -54.46 -54.29 42.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 39.5 mt-30 -38.44 -49.06 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.14 -43.09 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -52.85 -51.3 61.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.458 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 36.0 m-85 -69.08 -37.96 78.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.507 ' HG2' HG22 ' A' ' 69' ' ' VAL . 58.6 mtt180 -48.44 -33.11 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.1 mt -91.4 -15.69 28.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.438 HD11 ' NE2' ' A' ' 104' ' ' GLN . 79.6 mt -86.76 -31.51 20.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -119.36 -28.66 5.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.04 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.46 124.68 2.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.46 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -44.55 -18.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.913 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 66' ' ' GLY . 2.9 m-20 -77.66 13.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.04 HG13 ' O ' ' A' ' 66' ' ' GLY . 33.9 m -69.23 174.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.545 ' O ' HD11 ' A' ' 24' ' ' ILE . 2.6 pm0 -119.66 173.5 6.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 83.1 m-85 -158.93 144.37 11.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.849 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.79 152.82 69.26 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.242 . . . . 0.0 112.321 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -73.23 -28.17 62.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -144.6 174.15 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.587 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 68.5 m-85 -134.97 89.64 23.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 75' ' ' TYR . 53.0 Cg_endo -69.83 172.1 13.34 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.5 p -143.55 142.27 31.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 37.27 60.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 86.9 m -149.83 147.62 28.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.618 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -75.03 114.48 13.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' A' ' 44' ' ' ALA . 48.2 mt -81.69 -72.37 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.16 -143.66 3.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.597 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 11.0 t -150.95 159.03 44.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 m -147.66 133.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.79 112.62 14.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.415 HD12 HD22 ' A' ' 40' ' ' LEU . 3.3 tt -77.01 100.4 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.549 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.39 -49.23 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.34 168.28 24.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.466 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -127.56 96.59 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.518 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.4 mt -93.48 166.35 12.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' LYS . 44.4 t -104.2 169.88 8.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.489 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 9.4 mm-40 -43.84 -21.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.1 ttmt -90.96 -69.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.448 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.9 mt-30 -56.49 -45.95 80.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.886 ' CD2' HG21 ' A' ' 111' ' ' VAL . 19.5 t80 -44.55 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.496 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.5 ptpt -68.73 -42.15 78.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 8.5 mt-10 -48.4 -58.23 4.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.6 mt-30 -80.11 -48.25 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 16.7 m-85 -109.78 68.65 0.47 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.1 Cg_endo -69.84 -11.1 30.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.672 2.248 . . . . 0.0 112.316 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -78.37 -21.82 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.817 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.578 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.9 pt -124.99 22.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 49.9 p -64.26 -19.94 65.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.438 ' NE2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -97.17 -27.93 14.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.53 ' CD ' HG22 ' A' ' 102' ' ' ILE . 15.5 mt-10 -41.01 -42.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.2 t -123.14 159.37 28.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -119.01 -21.14 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.467 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -53.81 162.31 1.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.79 -43.21 2.77 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.378 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 15.7 m-85 -112.34 101.42 9.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.886 HG21 ' CD2' ' A' ' 95' ' ' PHE . 25.6 t -80.91 136.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CZ ' HG22 ' A' ' 34' ' ' THR . 9.8 m-30 -104.44 104.34 14.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.83 120.69 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.2 m -125.43 154.18 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.95 176.16 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 56.77 53.26 6.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.2 Cg_endo -69.76 116.41 4.55 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.724 2.283 . . . . 0.0 112.371 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.36 133.89 46.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.26 124.77 44.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.618 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.1 mtp -66.91 147.02 53.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.4 t -68.91 -31.77 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.09 153.0 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.05 146.22 45.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.538 ' HE2' ' HB2' ' A' ' 143' ' ' ALA . 0.8 OUTLIER -112.72 141.96 26.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 0.0 110.879 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 87.21 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.46 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.9 pp -121.91 163.35 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 76.1 mttt -102.18 136.36 42.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.99 161.81 27.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.459 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -142.65 156.71 62.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.644 0.735 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -3.08 11.33 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.578 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.6 mmmp? -134.2 -173.75 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.675 HG22 ' CE3' ' A' ' 8' ' ' TRP . 95.6 mt -85.91 142.07 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.3 p-90 -149.37 127.24 11.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -55.77 127.78 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 9' ' ' CYS . 60.4 mt -65.35 167.94 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.6 t70 -73.81 126.46 30.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.0 m -34.94 -42.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -71.68 -44.96 63.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.1 mm -61.47 -41.13 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.106 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -44.27 -65.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 144' ' ' LYS . 26.5 mt-30 -50.07 -68.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.5 -54.69 1.02 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.521 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.565 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.18 -37.29 69.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.2 mtpt -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -92.86 -47.11 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -41.56 -23.43 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 145' ' ' LYS . 11.8 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.615 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.6 m95 -77.8 159.85 28.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.781 0.324 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB2' HD11 ' A' ' 135' ' ' LEU . 40.9 t -137.4 125.46 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.469 ' HB2' HD21 ' A' ' 40' ' ' LEU . 66.6 tp -112.27 116.84 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.416 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 14.6 m -68.74 153.85 43.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 13' ' ' HIS . 72.5 t -135.47 158.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.52 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.8 m-70 -94.54 113.75 25.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 22.2 mt-30 -60.53 159.28 25.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.624 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 -32.74 3.73 Favored 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.698 -1.792 . . . . 0.0 112.33 -0.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.628 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.4 m-90 -25.36 -52.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -35.4 -63.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -62.01 -46.15 90.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.3 mt -45.63 -39.32 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -57.93 -66.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 82' ' ' GLY . 18.2 m -61.29 -20.94 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 11.3 mmt180 -73.87 -39.67 63.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.41 20.07 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.532 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.69 -38.4 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -102.72 102.33 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -95.97 13.39 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.2 m -144.85 146.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.455 ' OE2' HG22 ' A' ' 12' ' ' VAL . 6.7 tt0 -117.53 134.27 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.24 126.65 8.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 32.0 mmt180 -152.5 150.23 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.475 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 24.5 p -88.03 21.81 2.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.439 ' HH2' HD13 ' A' ' 10' ' ' LEU . 4.2 p-90 -142.73 166.46 24.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.5 t80 -110.23 144.47 38.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.522 ' O ' HG23 ' A' ' 34' ' ' THR . 5.1 t -136.99 105.51 8.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.5 Cg_endo -69.78 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -64.11 111.89 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -115.52 120.11 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.01 -121.36 1.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.446 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -106.28 139.21 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 10' ' ' LEU . 38.4 tp -143.95 116.0 8.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.942 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.4 m95 -72.05 132.43 44.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -102.14 130.41 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.77 154.73 42.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.664 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -89.08 118.64 28.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 12' ' ' VAL . 39.8 p -56.12 179.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.36 4.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 14.6 ttpt -91.86 148.81 21.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 16.6 mtmt -105.55 121.54 45.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 127.91 15.25 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 54' ' ' VAL . 4.5 m -73.63 158.24 86.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.619 0.723 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -6.15 17.87 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.722 2.281 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -93.49 -41.68 9.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -41.8 78.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.43 HG12 ' OE1' ' A' ' 58' ' ' GLN . 38.7 t -67.03 -50.52 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 t -62.52 -44.64 95.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.33 -54.35 21.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.628 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.6 mt -56.61 -39.13 73.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 35.0 mt-30 -54.52 -47.17 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.05 -35.73 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -60.86 -49.68 76.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -69.83 -39.49 76.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' A' ' 69' ' ' VAL . 45.2 mtt180 -48.01 -36.2 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.24 -16.75 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.05 -27.09 23.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.414 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 3.8 mmm180 -123.7 -28.92 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.051 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 131.2 127.83 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.92 -19.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 9.8 t70 -76.16 8.79 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.051 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.2 m -63.02 -179.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 3.4 mm-40 -118.2 171.87 7.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 53.5 m-85 -162.25 137.28 5.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 152.71 69.54 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.722 2.281 . . . . 0.0 112.324 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -72.49 -28.93 63.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.0 176.1 10.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.624 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.7 m-85 -134.42 93.94 18.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.955 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 54.0 Cg_endo -69.77 175.07 8.6 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.703 2.268 . . . . 0.0 112.384 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m -144.47 134.66 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.824 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.59 12.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.6 m -160.14 148.57 16.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.512 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.11 118.59 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.664 HD11 ' HB2' ' A' ' 44' ' ' ALA . 80.7 mt -85.11 -74.06 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.467 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.94 -145.07 4.19 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.9 p -152.75 161.28 42.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.37 . . . . 0.0 110.841 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 114' ' ' CYS . 13.5 m -146.79 146.45 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.456 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.8 t70 -87.01 107.0 18.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.68 97.9 1.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.552 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.88 -47.46 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 3.1 m-20 -165.25 166.67 18.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 t -127.35 99.7 5.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.0 mt -94.25 169.19 10.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 p -106.91 169.25 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.45 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 6.2 mm100 -47.99 -18.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -90.69 -58.13 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -71.28 -50.68 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.563 ' CD2' HG21 ' A' ' 111' ' ' VAL . 35.2 t80 -40.22 -55.99 2.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 4.2 ptmt -66.45 -42.41 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 9.1 mt-10 -53.23 -59.2 4.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.458 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -74.76 -50.27 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.8 m-85 -111.21 67.62 0.62 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.59 0.709 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.75 -13.89 35.35 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.686 2.257 . . . . 0.0 112.363 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -74.33 -23.07 59.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.699 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.8 pt -122.14 20.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.9 p -63.22 -23.6 67.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.435 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -93.13 -25.69 17.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.699 ' CD ' HG22 ' A' ' 102' ' ' ILE . 36.1 mt-10 -53.14 -33.36 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.436 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 2.2 p -127.47 146.51 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 1.6 t70 -111.75 -33.77 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 m -43.6 161.39 0.2 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.686 0.755 . . . . 0.0 110.841 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.475 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.93 102.79 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.7 t -85.91 136.93 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 5.0 m-30 -105.07 107.05 17.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -74.52 118.44 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -119.39 151.3 38.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -143.03 174.07 11.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 53.95 54.74 11.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.652 0.739 . . . . 0.0 110.869 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.8 Cg_endo -69.8 121.81 8.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 0.0 112.292 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -132.0 131.69 42.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -97.67 123.55 41.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.512 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.4 mtp -64.34 149.92 47.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.9 t -78.08 -21.42 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.85 135.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -102.15 154.71 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.5 OUTLIER -122.19 142.72 37.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.919 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.06 158.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.603 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 28.8 mtmt -92.04 134.77 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.72 167.72 46.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.483 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 1.5 t-20 -156.74 144.34 13.96 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.638 0.733 . . . . 0.0 110.884 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.1 Cg_endo -69.75 3.12 2.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.679 2.253 . . . . 0.0 112.339 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 6.9 mmmm -135.34 -173.89 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.615 HG22 ' CE3' ' A' ' 8' ' ' TRP . 71.7 mt -91.57 134.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.603 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 1.3 p-90 -143.21 130.0 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.471 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 11.2 ttmt -53.67 129.81 34.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.589 HD22 HG21 ' A' ' 139' ' ' ILE . 22.9 mt -65.8 162.77 18.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.3 t0 -73.67 129.77 38.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.92 -50.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -65.09 -39.68 93.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.589 HG21 HD22 ' A' ' 135' ' ' LEU . 19.9 mm -64.66 -47.78 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ILE . 18.0 t-160 -37.09 -65.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 91.6 mt-30 -51.66 -69.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.42 -49.14 0.67 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.503 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.31 -43.55 74.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.1 mtpp -67.72 -23.24 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 147' ' ' LEU . 17.7 mmtp -77.89 -53.1 7.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.17 -27.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 145' ' ' LYS . 17.6 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.843 0.354 . . . . 0.0 110.919 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.7 ' CE3' HG22 ' A' ' 132' ' ' ILE . 90.4 m95 -74.26 162.56 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.774 0.321 . . . . 0.0 110.895 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.2 t -138.83 138.8 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.449 HD13 ' HH2' ' A' ' 32' ' ' TRP . 25.4 tp -123.1 111.85 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.409 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 60.3 p -70.54 125.83 27.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.54 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 17.7 t -107.98 160.67 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.54 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 56.1 m-70 -91.14 111.14 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 18.6 mt-30 -58.85 159.93 12.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.664 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.75 -31.36 4.6 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.375 -0.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.541 ' C ' ' O ' ' A' ' 15' ' ' PRO . 9.1 m-90 -25.98 -54.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -36.52 -58.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 66.4 m -66.08 -40.74 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.87 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 16' ' ' TRP . 63.0 mt -51.94 -26.34 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 9.2 mp -71.24 -69.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.885 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.4 m -58.84 -15.0 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.9 mmt180 -79.98 -39.49 29.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.44 6.21 8.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.458 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.81 -47.59 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 3.4 tptp -90.35 117.7 29.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 26' ' ' ARG . 13.2 ttt180 -102.62 0.09 32.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.484 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 17.6 m -147.01 154.96 11.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 8.2 tm-20 -122.54 153.3 39.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -112.7 130.55 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.528 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HG3' ' CZ2' ' A' ' 32' ' ' TRP . 9.2 mmt180 -149.05 149.7 31.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.444 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 57.7 p -85.27 20.36 2.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.539 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.9 p-90 -145.09 167.68 22.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.0 t80 -108.82 141.35 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.57 ' O ' HG23 ' A' ' 34' ' ' THR . 6.9 t -134.93 103.56 10.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.571 0.7 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.9 Cg_endo -69.71 2.39 3.55 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.273 . . . . 0.0 112.336 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -60.89 108.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 6.3 mmt85 -111.65 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.15 -123.2 1.65 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.1 ttm105 -104.98 140.97 37.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.0 tp -143.98 114.41 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 91.1 m95 -71.27 131.93 44.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.96 127.49 56.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.99 49.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -83.23 119.36 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.5 p -54.24 -174.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.78 -10.47 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 4.9 ttpt -73.6 148.7 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 1.2 pmtp? -108.53 132.56 21.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 0.0 110.872 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 54' ' ' VAL . 3.3 m -73.97 159.81 83.24 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -8.3 23.26 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.739 2.293 . . . . 0.0 112.345 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -94.81 -42.43 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -40.94 84.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 50' ' ' SER . 62.1 t -65.07 -51.15 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -64.07 -45.82 87.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.25 -53.27 46.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.51 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 79.2 mt -56.03 -43.33 77.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 35.7 mt-30 -51.73 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.71 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -61.49 -48.76 79.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -70.89 -33.52 70.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HG2' HG22 ' A' ' 69' ' ' VAL . 43.6 mtt180 -53.5 -36.07 61.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.4 -12.8 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.438 HD11 HE22 ' A' ' 104' ' ' GLN . 71.4 mt -90.65 -29.04 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.965 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.429 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.8 mmp_? -122.92 -29.06 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.067 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.12 129.01 2.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.9 -18.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.319 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.7 t70 -82.43 20.4 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.067 HG13 ' O ' ' A' ' 66' ' ' GLY . 29.3 m -70.91 179.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 13.2 mt-10 -116.61 166.9 11.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 52.7 m-85 -159.87 138.56 7.78 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 0.0 110.842 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.3 Cg_endo -69.77 163.86 36.71 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.08 -22.91 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -150.61 166.69 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.1 m-85 -130.44 87.93 48.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.903 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.54 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.2 Cg_endo -69.77 171.62 14.14 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.642 2.228 . . . . 0.0 112.325 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.6 p -138.91 144.38 39.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.6 89.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 67.0 m -149.79 146.74 27.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -76.26 118.66 19.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 44' ' ' ALA . 56.1 mt -87.69 -71.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.572 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.33 -150.44 5.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.501 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -149.59 153.69 37.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.89 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.3 m -140.2 142.23 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.29 114.45 21.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tt -77.1 95.67 4.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.597 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -64.61 -46.05 93.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.478 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 1.6 m-20 -166.7 165.9 16.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.44 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.2 t -127.37 99.04 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 83.0 mt -97.02 170.91 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 30.4 t -110.04 169.11 8.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -46.62 -20.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 24.7 ttmt -89.64 -60.62 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -70.53 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.615 ' CD2' HG21 ' A' ' 111' ' ' VAL . 21.1 t80 -39.24 -54.95 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.9 ptmm? -68.45 -47.52 66.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.7 mt-10 -46.01 -54.37 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -81.18 -51.81 8.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 18.6 m-85 -107.11 70.92 0.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.627 0.727 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.77 -17.48 37.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.385 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.3 -26.7 60.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.594 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.1 pt -120.23 24.35 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.481 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 22.1 p -68.25 -21.16 64.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.438 HE22 HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -96.42 -23.52 16.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.565 ' OE2' HG22 ' A' ' 102' ' ' ILE . 11.3 mt-10 -48.04 -41.24 25.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 111' ' ' VAL . 1.5 t -124.1 143.02 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -104.3 -28.63 11.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -45.85 161.49 0.26 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.652 0.739 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.444 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.2 Cg_endo -69.78 -43.66 2.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -112.92 102.49 10.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.615 HG21 ' CD2' ' A' ' 95' ' ' PHE . 59.3 t -85.18 136.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.44 ' HE1' ' HG ' ' A' ' 89' ' ' CYS . 7.3 m-30 -105.0 104.22 13.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.818 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -74.17 121.84 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.106 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.447 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.7 m -122.78 154.09 38.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.42 ' CG ' HD12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -139.45 177.03 8.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 52.6 53.54 12.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.902 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.0 Cg_endo -69.66 117.46 5.09 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -131.33 143.59 50.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -107.95 120.6 42.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.584 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.2 mtp -62.67 153.47 32.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.62 -32.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.76 132.57 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.446 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 16.8 mmtm -102.18 154.28 19.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 79' ' ' CYS . 1.1 m-85 -120.48 142.35 33.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 88.23 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.92 165.24 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.6 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 50.0 mtpt -107.23 135.6 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.409 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -90.17 171.89 37.58 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.477 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -150.29 156.43 37.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.316 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.7 mmmm -139.37 -175.33 4.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.7 HG22 ' CE3' ' A' ' 8' ' ' TRP . 62.0 mt -84.8 132.18 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.6 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 4.4 p-90 -138.71 131.74 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.567 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 12.3 ttmt -58.25 128.78 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.4 mt -64.68 170.61 3.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -78.63 127.01 31.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.41 -50.3 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -65.46 -40.29 93.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.9 mm -64.12 -45.93 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -40.45 -65.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.9 mt-30 -52.44 -70.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.67 -43.49 0.8 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.469 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.434 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -61.55 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -61.06 -20.89 63.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' LEU . 18.3 mmmt -90.33 -48.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -40.94 -21.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 145' ' ' LYS . 42.0 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.864 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.607 ' CZ2' ' HD3' ' A' ' 134' ' ' LYS . 92.7 m95 -93.5 167.92 11.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -141.28 159.28 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.702 HD23 ' CD ' ' A' ' 28' ' ' GLU . 31.7 tp -145.42 116.65 7.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 2.7 t -67.99 146.34 53.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.51 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 74.3 t -134.26 153.97 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.415 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.2 m-70 -88.68 113.68 24.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.77 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 46.3 mt-30 -59.94 161.88 11.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.621 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -28.43 6.25 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.338 -0.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.563 ' O ' HD12 ' A' ' 20' ' ' LEU . 10.5 m-90 -28.7 -53.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.77 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.57 -64.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.42 -43.22 99.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.6 mt -48.97 -36.61 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.8 mp -59.75 -64.83 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.637 HG11 ' N ' ' A' ' 82' ' ' GLY . 14.2 m -63.33 -17.92 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.469 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.0 mmt180 -76.49 -39.98 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.54 18.84 3.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.3 mp -105.61 -37.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 111.162 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.9 tptp -102.91 95.54 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.607 ' NE ' HD13 ' A' ' 102' ' ' ILE . 22.4 ptt180 -92.24 14.53 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.623 ' CG1' HD12 ' A' ' 102' ' ' ILE . 30.6 m -146.76 143.94 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.702 ' CD ' HD23 ' A' ' 10' ' ' LEU . 2.5 tt0 -115.97 141.79 47.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.62 122.83 7.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -146.29 149.1 33.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 41.2 p -86.41 23.15 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.49 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -146.01 160.16 42.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -100.78 138.95 37.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.685 ' O ' HG23 ' A' ' 34' ' ' THR . 10.6 t -133.16 100.03 14.44 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.565 0.698 . . . . 0.0 111.109 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.76 8.9 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.354 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -67.27 108.18 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.471 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 63.3 mmt-85 -106.86 115.83 30.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.45 -138.72 6.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -94.92 142.61 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -143.97 115.98 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.07 138.35 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.952 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -109.04 127.3 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.59 152.18 39.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.832 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -85.63 119.03 25.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 12' ' ' VAL . 41.1 p -54.4 -179.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.142 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.83 22.41 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -110.59 132.06 54.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -91.75 130.62 38.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.547 0.689 . . . . 0.0 110.937 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.6 Cg_endo -69.73 134.24 27.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.0 m -75.51 159.21 82.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.697 0.761 . . . . 0.0 110.857 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.689 2.259 . . . . 0.0 112.343 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -94.34 -42.34 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -40.28 86.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 50' ' ' SER . 43.5 t -65.62 -50.73 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.03 -42.3 99.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -67.92 -53.74 24.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.405 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 93.9 mt -59.14 -38.74 80.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.587 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 37.2 mt-30 -55.26 -46.15 76.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -35.35 38.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -61.42 -51.63 67.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -67.48 -41.29 84.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.935 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 69' ' ' VAL . 52.3 mtt180 -48.16 -36.07 12.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.907 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -86.74 -16.19 37.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.8 mt -88.17 -27.25 21.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -123.38 -26.93 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.066 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 127.74 129.03 3.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.455 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.29 -19.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -72.59 3.85 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.066 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.2 m -61.65 178.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.528 ' O ' HD11 ' A' ' 24' ' ' ILE . 10.7 mp0 -119.73 167.85 11.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.587 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 67.8 m-85 -155.47 141.14 12.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.9 Cg_endo -69.77 165.87 29.51 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.66 2.24 . . . . 0.0 112.323 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -88.88 -20.75 24.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.48 174.38 14.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.621 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 87.7 m-85 -134.99 89.73 23.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.66 0.743 . . . . 0.0 110.947 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.468 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.7 Cg_endo -69.75 168.9 20.21 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.719 2.279 . . . . 0.0 112.354 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.0 m -134.91 139.58 45.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.92 92.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.44 ' C ' HD11 ' A' ' 126' ' ' ILE . 81.5 m -152.76 157.33 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.866 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.77 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -80.69 117.83 21.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.832 HD11 ' HB2' ' A' ' 44' ' ' ALA . 17.1 mt -85.87 -71.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.637 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -149.4 -140.35 3.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.484 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.2 p -156.33 166.36 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 16.4 m -154.16 138.71 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -81.6 113.91 19.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.66 94.38 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.607 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -62.67 -46.85 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 5.5 m-20 -165.53 170.19 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.17 102.08 6.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 94' ' ' GLN . 97.7 mt -95.87 171.18 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.947 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 93' ' ' LYS . 5.3 p -106.92 169.2 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 107' ' ' ASP . 7.4 mm100 -43.87 -22.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 31.7 ttpt -92.65 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.632 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.9 mm100 -56.3 -46.42 79.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.59 ' CE1' HG11 ' A' ' 27' ' ' VAL . 17.6 t80 -41.95 -58.95 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -68.86 -44.91 72.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 8.0 mt-10 -43.06 -55.72 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.462 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.9 mt-30 -83.62 -43.4 15.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.0 m-85 -115.81 68.41 3.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.681 0.753 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 96' ' ' LYS . 53.9 Cg_endo -69.76 -12.86 33.77 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 0.0 112.365 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.29 -16.45 60.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.723 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.0 OUTLIER -128.77 21.15 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 21.9 p -60.25 -25.87 66.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.432 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -94.28 -28.8 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.723 ' CD ' HG22 ' A' ' 102' ' ' ILE . 20.8 mt-10 -47.44 -36.95 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 t -120.04 157.57 28.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 3.5 t0 -125.17 -29.27 3.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -50.19 161.54 0.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.893 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.6 Cg_endo -69.78 -41.53 4.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.673 2.248 . . . . 0.0 112.311 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -115.65 101.69 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.558 HG21 ' CD2' ' A' ' 95' ' ' PHE . 21.4 t -84.97 139.85 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CZ ' HG22 ' A' ' 34' ' ' THR . 7.3 m-30 -105.9 105.59 15.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -73.95 119.91 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.134 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.8 m -122.51 154.18 38.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -141.36 177.07 8.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 53.51 51.6 8.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.74 120.6 7.37 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.99 138.94 47.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -101.73 123.13 45.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.77 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.5 mtp -65.43 136.58 56.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.07 -27.72 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 143.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mttp -114.23 142.73 45.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.8 OUTLIER -108.03 146.37 33.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.91 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 89.92 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.4 pp -126.28 157.82 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.624 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 10.5 pttm -92.33 157.17 16.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.41 -177.59 28.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.507 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.502 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.5 t30 -169.74 146.83 2.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.617 0.722 . . . . 0.0 110.885 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.0 Cg_endo -69.79 0.32 5.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.353 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.5 mmmm -133.93 -172.78 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.517 HG22 ' CE3' ' A' ' 8' ' ' TRP . 34.6 mt -82.93 130.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.624 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 6.1 p-90 -136.23 110.04 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.607 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 1.2 ttpp -54.76 127.09 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.9 mt -57.4 169.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.58 163.1 28.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -42.25 99.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -77.08 -34.67 56.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 124' ' ' PHE . 48.7 mm -72.22 -37.1 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.426 ' NE2' ' HD2' ' A' ' 144' ' ' LYS . 22.4 t-160 -48.89 -63.85 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 142' ' ' GLY . 34.4 mt-30 -50.67 -67.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -33.87 -54.33 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.482 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -52.61 -43.53 65.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 141' ' ' GLN . 11.3 mtpt -66.17 -15.45 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -99.4 -34.09 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.02 9.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.916 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.578 ' CE3' HG22 ' A' ' 132' ' ' ILE . 90.6 m95 -73.81 160.89 30.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.728 0.299 . . . . 0.0 110.904 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' HD11 ' A' ' 135' ' ' LEU . 9.7 t -135.54 123.02 22.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.479 HD13 ' HH2' ' A' ' 32' ' ' TRP . 61.9 tp -112.11 118.31 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' CA ' ' A' ' 128' ' ' GLY . 3.2 m -71.83 155.13 40.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 13' ' ' HIS . 53.4 t -138.44 162.3 30.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.573 ' N ' HG12 ' A' ' 12' ' ' VAL . 67.2 m-70 -97.36 114.89 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.518 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.6 mm-40 -59.8 158.55 23.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 110.861 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.77 -33.28 3.47 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 -1.807 . . . . 0.0 112.358 -0.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.61 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 16.7 m-90 -25.01 -56.88 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -33.81 -53.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.7 m -72.9 -50.99 20.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.43 HD23 HD13 ' A' ' 24' ' ' ILE . 51.7 mt -40.55 -32.43 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.484 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.8 mp -64.75 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.7 m -60.78 -16.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.5 mmt180 -77.19 -39.31 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.21 12.17 5.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.43 HD13 HD23 ' A' ' 19' ' ' LEU . 5.3 mp -98.29 -48.62 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.3 tptt -89.15 117.08 27.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.9 ttm180 -101.07 -6.85 23.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.521 HG11 ' CE1' ' A' ' 95' ' ' PHE . 21.5 m -133.33 158.34 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.52 124.97 41.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.18 128.45 8.85 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -147.51 147.74 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.1 p -85.15 17.52 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.479 ' HH2' HD13 ' A' ' 10' ' ' LEU . 2.5 p-90 -142.51 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.414 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 4.1 t80 -106.36 139.3 41.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 34' ' ' THR . 8.1 t -134.32 101.71 12.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.613 0.72 . . . . 0.0 111.163 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.8 6.79 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.357 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -64.54 108.82 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.49 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.8 mmt-85 -105.23 112.67 25.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.31 -152.43 23.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -79.28 143.57 35.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.829 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.415 HD21 ' HB2' ' A' ' 10' ' ' LEU . 25.2 tp -143.87 115.08 7.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.572 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 95.5 m95 -71.12 124.8 25.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.72 122.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.131 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.92 149.84 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.646 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.21 123.63 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 12' ' ' VAL . 28.5 p -59.43 -174.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.27 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -81.41 135.0 35.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.25 41.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.618 0.723 . . . . 0.0 110.867 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 129.54 17.76 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -76.35 159.27 80.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.68 0.752 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -3.62 12.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -93.96 -41.41 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.88 -43.31 72.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.562 HG12 ' OE1' ' A' ' 58' ' ' GLN . 33.3 t -65.78 -52.54 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -59.75 -45.7 91.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.34 -56.67 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.61 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 92.1 mt -55.9 -38.51 70.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 38.7 mt-30 -57.46 -43.53 84.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.43 -32.61 32.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -66.24 -52.29 49.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.536 ' HE2' HD22 ' A' ' 57' ' ' LEU . 31.9 m-85 -66.32 -38.26 87.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.573 ' HG2' HG22 ' A' ' 69' ' ' VAL . 65.0 mtt180 -47.71 -34.2 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.62 -16.01 31.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 61' ' ' TYR . 48.6 mt -87.28 -29.96 21.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -120.27 -29.13 4.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.056 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.95 124.87 2.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -43.99 -21.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.776 0.322 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' GLY . 6.5 t0 -79.85 18.88 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.056 HG13 ' O ' ' A' ' 66' ' ' GLY . 24.9 m -69.07 -178.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' O ' ' CD1' ' A' ' 71' ' ' PHE . 5.4 pt-20 -117.51 166.3 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -158.92 135.53 6.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.692 0.758 . . . . 0.0 110.87 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 145.76 58.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.364 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.19 -27.08 66.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.426 ' C ' ' CD1' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -149.4 -178.11 6.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.571 ' CE2' ' HB3' ' A' ' 15' ' ' PRO . 13.9 m-85 -141.19 105.0 6.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.613 ' HG2' HD21 ' A' ' 81' ' ' LEU . 54.1 Cg_endo -69.75 178.35 4.65 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.652 2.235 . . . . 0.0 112.371 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.1 p -142.66 130.49 21.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.12 48.75 66.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 59.3 m -150.62 148.42 28.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -77.33 115.29 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 44' ' ' ALA . 32.3 mt -83.25 -71.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.15 -139.68 3.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.572 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 7.1 p -155.81 157.68 36.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 m -144.63 136.7 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.74 110.94 14.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.6 96.16 4.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -64.29 -50.37 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.405 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -161.23 167.88 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.479 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.3 t -128.2 101.3 6.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 80.8 mt -98.61 170.88 8.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 93' ' ' LYS . 29.3 t -109.44 169.18 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.45 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 6.3 mm100 -46.29 -20.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 91' ' ' SER . 19.5 tttt -89.56 -60.61 1.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.02 -50.4 41.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.557 ' CD2' HG21 ' A' ' 111' ' ' VAL . 28.7 t80 -39.72 -55.32 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.8 ptmm? -67.96 -47.49 68.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.519 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 5.8 mt-10 -45.88 -55.93 6.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.0 mt-30 -78.67 -52.73 8.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 23.9 m-85 -108.15 70.1 0.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.77 -15.46 37.07 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.647 2.231 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -73.36 -26.3 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.479 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.4 pt -118.96 21.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 17.6 p -64.49 -22.14 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.421 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -96.04 -21.4 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.431 ' CD ' HG22 ' A' ' 102' ' ' ILE . 7.5 mt-10 -56.23 -36.25 68.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.49 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.5 p -125.85 138.35 53.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.854 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 15.4 t70 -104.57 -30.57 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -44.28 161.04 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.673 0.749 . . . . 0.0 110.866 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.414 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.1 Cg_endo -69.75 -47.8 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 22.1 m-85 -110.0 99.52 8.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 95' ' ' PHE . 46.5 t -80.86 144.61 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CZ ' HG22 ' A' ' 34' ' ' THR . 12.6 m-30 -110.99 106.18 15.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER -75.07 120.0 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.8 m -126.03 153.64 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -143.09 174.07 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 57.62 52.97 5.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.3 Cg_endo -69.71 119.47 6.42 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.337 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -132.05 134.26 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -99.79 126.01 45.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.51 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.9 mtp -65.69 152.82 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.23 -36.58 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.07 142.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.152 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -104.74 152.4 22.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.02 139.53 24.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.01 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.66 160.35 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.599 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 5.7 mtmp? -92.12 128.29 37.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.419 ' CA ' ' OG ' ' A' ' 11' ' ' SER . . . -89.37 151.6 22.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.499 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -132.33 154.0 81.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 2.28 3.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.455 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 7.1 mmmm -135.83 -174.12 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.578 HG22 ' CE3' ' A' ' 8' ' ' TRP . 58.1 mt -89.05 132.57 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.599 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.3 p-90 -140.69 129.83 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.05 127.35 28.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 9' ' ' CYS . 31.2 mt -62.45 166.86 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 4.4 t0 -76.38 129.04 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -35.55 -38.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -75.47 -42.62 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 mm -64.16 -40.16 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -44.22 -65.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 142' ' ' GLY . 28.3 mt-30 -51.86 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.05 -49.01 1.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.494 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.444 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.66 -51.02 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.104 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HZ2' ' HB2' ' A' ' 144' ' ' LYS . 2.0 mtpm? -57.84 -32.45 67.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 147' ' ' LEU . 21.3 mmmt -71.59 -50.8 27.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.74 -25.51 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 145' ' ' LYS . 23.6 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -72.39 167.51 20.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -135.85 140.54 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.1 tp -131.12 106.66 8.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -67.65 147.32 52.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 29.4 t -132.35 157.88 43.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.486 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.8 m-70 -88.03 115.26 25.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.78 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 45.1 mt-30 -61.22 162.21 14.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.78 -27.46 6.82 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.318 0.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.514 ' O ' HD12 ' A' ' 20' ' ' LEU . 11.5 m-90 -30.33 -52.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.78 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.88 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' LEU . 1.7 m -61.33 -52.75 63.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.529 HD23 HD13 ' A' ' 24' ' ' ILE . 57.1 mt -38.37 -41.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -55.99 -68.37 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' N ' ' A' ' 82' ' ' GLY . 33.0 m -59.84 -12.94 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.441 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.7 mmt180 -83.13 -39.57 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.97 -6.5 8.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.529 HD13 HD23 ' A' ' 19' ' ' LEU . 5.4 mp -78.8 -46.96 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HG2' HD11 ' A' ' 20' ' ' LEU . 12.3 tptt -94.64 111.94 23.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.415 ' HG3' HG13 ' A' ' 27' ' ' VAL . 15.5 ptm180 -108.41 16.67 22.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.568 HG11 ' CE1' ' A' ' 95' ' ' PHE . 27.2 m -149.6 143.95 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' OE1' HD21 ' A' ' 20' ' ' LEU . 6.6 tp10 -111.69 150.14 30.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -115.37 123.95 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 85.2 mmt-85 -149.8 151.71 34.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.5 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.2 t -87.93 24.0 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.518 ' CZ2' ' HD2' ' A' ' 30' ' ' ARG . 3.3 p-90 -144.6 157.78 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -99.26 137.77 37.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 34' ' ' THR . 9.3 t -133.59 100.94 13.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.577 0.704 . . . . 0.0 111.169 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.4 Cg_endo -69.77 6.22 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.712 2.275 . . . . 0.0 112.365 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.43 ' O ' HD22 ' A' ' 86' ' ' LEU . 17.8 t60 -64.63 111.37 2.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' A' ' 34' ' ' THR . 15.8 mmt180 -112.67 110.54 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.14 -142.37 8.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.445 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.1 ttp-105 -82.11 142.31 32.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.854 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 tp -143.69 106.83 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.622 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.4 m95 -71.8 118.83 15.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 43.6 mm -91.59 129.85 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -122.75 148.57 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.819 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.42 112.42 19.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.3 p -48.5 175.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.57 -12.46 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -74.35 142.22 45.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -103.22 131.59 21.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.547 0.689 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 133.42 25.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.638 2.225 . . . . 0.0 112.392 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.8 m -82.16 159.17 65.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.683 0.754 . . . . 0.0 110.815 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -2.81 10.79 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -94.31 -46.53 7.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -69.28 -41.19 77.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.566 HG12 ' OE1' ' A' ' 58' ' ' GLN . 56.9 t -63.15 -51.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -60.51 -44.22 96.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -66.69 -57.24 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.407 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 90.0 mt -54.03 -40.25 66.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 36.6 mt-30 -55.0 -45.57 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -34.98 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.086 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -61.99 -50.76 70.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.413 ' HA ' HD12 ' A' ' 64' ' ' LEU . 30.9 m-85 -68.7 -39.18 80.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HG2' HG22 ' A' ' 69' ' ' VAL . 59.7 mtt180 -47.67 -34.03 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 25.7 mt -90.57 -15.53 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 61' ' ' TYR . 59.1 mt -88.0 -29.42 20.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -121.21 -28.96 4.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 1.032 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.37 125.35 2.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.482 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.57 -19.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' GLY . 11.6 t70 -80.69 16.52 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.032 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.6 m -66.75 -177.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.502 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.4 pt-20 -116.09 170.07 8.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 52.1 m-85 -163.27 136.56 4.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.677 0.751 . . . . 0.0 110.855 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 54.4 Cg_endo -69.75 158.9 55.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.66 2.24 . . . . 0.0 112.385 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -76.92 -30.28 56.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -148.73 177.9 9.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.594 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 57.4 m-85 -134.87 95.84 15.13 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.65 0.738 . . . . 0.0 110.884 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.5 Cg_endo -69.8 -179.92 3.27 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.375 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -145.62 143.94 30.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.5 47.23 92.16 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 87.3 m -156.27 146.95 21.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.368 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -74.53 121.51 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 44' ' ' ALA . 16.9 mt -88.9 -71.2 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.948 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.639 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.95 -147.47 4.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.455 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.585 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.1 p -153.57 154.68 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 24.3 m -140.7 141.4 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.25 111.34 18.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 112' ' ' PHE . 2.8 tt -75.85 99.06 4.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.34 -48.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.181 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -162.27 168.57 22.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.87 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.43 103.11 7.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 87.0 mt -98.76 166.87 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 93' ' ' LYS . 48.5 t -104.72 168.5 9.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -45.81 -20.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.6 ttpt -91.3 -63.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.59 -49.48 75.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 27' ' ' VAL . 61.3 t80 -43.2 -56.2 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -66.38 -38.36 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.406 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 7.0 mt-10 -56.16 -55.21 35.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 10.8 mt-30 -78.48 -52.09 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.4 m-85 -109.85 68.22 0.46 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.665 0.745 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.8 Cg_endo -69.81 -14.23 35.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.12 -22.31 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 27' ' ' VAL . 2.4 pt -121.34 8.22 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.509 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 89.5 p -49.06 -25.27 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -90.7 -28.69 18.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.881 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 4.1 mt-10 -56.36 -22.57 31.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.498 ' OG ' HG21 ' A' ' 111' ' ' VAL . 1.9 p -113.98 160.3 18.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -134.88 -33.15 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.486 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -62.34 165.51 8.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.719 0.771 . . . . 0.0 110.826 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.5 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.84 -45.11 1.66 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -110.55 98.0 7.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.498 HG21 ' OG ' ' A' ' 106' ' ' SER . 13.5 t -83.37 140.26 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.488 ' HB3' HD11 ' A' ' 86' ' ' LEU . 3.0 m-30 -107.57 110.48 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.15 122.13 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.7 m -124.95 154.86 40.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -142.04 176.29 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER 57.5 52.67 5.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.76 117.38 5.05 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.671 2.248 . . . . 0.0 112.354 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -133.08 139.08 46.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -101.47 125.55 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.599 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.2 mtp -67.01 150.91 48.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.2 t -75.18 -31.01 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.4 146.35 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 20.1 mmtm -112.74 149.48 32.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.555 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.2 m-85 -115.18 141.07 26.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.864 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 84.58 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.341 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.593 HD13 ' HH2' ' A' ' 133' ' ' TRP . 2.7 pp -115.2 158.81 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 39.5 mmtt -91.45 121.84 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.66 155.79 53.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -148.85 156.0 40.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -51.12 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.667 2.245 . . . . 0.0 112.32 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.466 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.0 mmmm -86.54 -174.53 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.426 HG13 ' CH2' ' A' ' 32' ' ' TRP . 66.3 mt -83.03 141.63 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.593 ' HH2' HD13 ' A' ' 126' ' ' ILE . 1.6 p-90 -146.88 123.98 11.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -56.1 128.31 34.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 mt -63.06 169.97 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.1 t70 -75.15 127.67 33.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.47 -40.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -40.99 63.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.555 HG23 ' CD2' ' A' ' 124' ' ' PHE . 22.2 mm -65.0 -44.37 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.9 t-160 -37.84 -62.51 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' GLY . 23.8 mt-30 -52.96 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.93 -46.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.622 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.95 -49.18 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -58.71 -27.82 65.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.4 mmpt? -76.37 -49.41 16.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.42 -22.72 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.449 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 145' ' ' LYS . 25.1 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.0 p -154.54 157.5 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -152.27 151.99 31.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.858 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.25 109.94 3.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m -81.87 41.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -91.14 153.49 20.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.91 93.67 0.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.61 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.4 m95 -82.48 161.62 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.748 0.309 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB2' ' CG ' ' A' ' 135' ' ' LEU . 44.6 t -138.12 130.18 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.9 tp -118.56 114.33 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.0 t -67.91 150.03 49.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 32.3 t -133.29 156.75 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.475 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 41.7 m-70 -90.73 115.38 27.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.542 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 65.9 mt-30 -61.66 160.82 24.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.962 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.83 -31.86 4.31 Favored 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.718 -1.784 . . . . 0.0 112.297 0.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.587 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.2 m-90 -25.47 -53.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.542 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -37.51 -61.3 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 7.2 m -64.88 -42.82 94.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.7 mt -51.77 -31.12 25.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.5 mp -66.27 -64.28 0.89 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.9 m -63.99 -16.39 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -76.87 -39.52 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.808 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 18.7 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.515 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.49 -42.1 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.552 ' HG2' HD11 ' A' ' 20' ' ' LEU . 17.3 tptt -99.05 104.54 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.486 ' HD2' HD13 ' A' ' 102' ' ' ILE . 12.2 ptp180 -97.87 17.34 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.474 HG11 HD12 ' A' ' 102' ' ' ILE . 27.4 m -149.38 147.1 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 3.5 tm-20 -118.62 141.81 48.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.516 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -102.89 126.82 8.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 12.6 mmt180 -148.42 146.37 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 10.4 m -84.25 20.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.575 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.3 p-90 -144.63 166.43 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -107.75 140.43 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 34' ' ' THR . 5.1 t -134.08 106.45 11.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.59 0.709 . . . . 0.0 111.128 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.3 Cg_endo -69.8 3.07 3.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.308 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.562 ' O ' HD22 ' A' ' 86' ' ' LEU . 18.5 t60 -63.13 111.74 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 7.7 mmt85 -116.1 121.79 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.65 -126.69 2.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.522 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -98.62 138.36 35.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.833 0.349 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 tp -143.93 112.86 6.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 86.2 m95 -71.34 133.86 46.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -104.1 126.84 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.54 145.57 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.672 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.64 117.06 22.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.3 p -53.21 176.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.86 -11.38 59.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 5.7 ttpt -73.06 146.53 45.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -104.08 134.08 19.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 0.0 110.91 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.75 127.26 14.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.623 2.215 . . . . 0.0 112.364 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.9 m -73.23 155.59 89.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.648 0.737 . . . . 0.0 110.871 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -5.33 15.9 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.713 2.275 . . . . 0.0 112.309 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -94.48 -39.83 10.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.38 -39.13 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.592 HG12 ' OE1' ' A' ' 58' ' ' GLN . 44.9 t -66.3 -54.74 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 t -59.09 -43.78 91.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.16 -56.43 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.586 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 77.2 mt -54.94 -39.6 69.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.592 ' OE1' HG12 ' A' ' 54' ' ' VAL . 36.7 mt-30 -55.44 -45.76 76.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.0 -33.81 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -63.44 -51.17 66.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.418 ' HE2' HD22 ' A' ' 57' ' ' LEU . 22.8 m-85 -68.55 -35.81 77.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 69' ' ' VAL . 35.5 mtt-85 -50.96 -34.13 27.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.64 -13.2 34.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.55 -29.24 17.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 3.7 mmm180 -121.47 -28.71 4.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.053 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.01 126.66 2.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.434 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 13.6 ptmt -45.98 -19.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.313 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -82.27 19.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.053 HG13 ' O ' ' A' ' 66' ' ' GLY . 21.2 m -67.24 -178.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -114.96 162.81 16.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 47.9 m-85 -157.61 134.94 6.89 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.3 Cg_endo -69.79 162.54 41.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 0.0 112.343 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -82.19 -29.27 31.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -147.35 175.19 10.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.604 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 51.7 m-85 -134.96 95.68 15.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.651 0.739 . . . . 0.0 110.966 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.8 Cg_endo -69.76 177.02 6.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.357 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.5 p -147.22 138.38 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 43.78 47.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 64.8 m -156.36 149.74 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.53 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -76.19 118.21 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 44' ' ' ALA . 86.9 mt -84.5 -73.95 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.427 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.97 -144.29 4.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.9 p -153.32 155.41 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 26.2 m -140.97 136.41 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.428 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.7 t70 -77.85 110.43 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.562 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.8 tt -75.0 101.85 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -72.99 -47.12 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.412 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -164.53 167.09 19.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -127.74 97.46 4.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 94' ' ' GLN . 94.8 mt -90.51 170.66 10.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.41 ' C ' ' N ' ' A' ' 93' ' ' LYS . 7.5 p -108.14 169.22 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.451 ' NE2' ' O ' ' A' ' 107' ' ' ASP . 6.7 mm100 -45.11 -21.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 24.2 tttt -92.02 -63.54 1.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.509 ' HB3' HD22 ' A' ' 90' ' ' LEU . 8.5 mt-30 -61.38 -48.47 81.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.606 ' CD2' HG21 ' A' ' 111' ' ' VAL . 21.8 t80 -42.38 -57.81 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 9.7 ptpt -67.79 -43.59 79.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -48.36 -58.6 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.486 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.4 mt-30 -79.39 -47.16 16.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.3 m-85 -110.24 67.82 0.49 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.626 0.727 . . . . 0.0 110.846 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.6 Cg_endo -69.81 -12.4 32.73 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -77.84 -20.94 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.652 HG22 ' CD ' ' A' ' 105' ' ' GLU . 2.1 pt -126.46 23.51 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.486 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 40.7 p -64.16 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.405 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -94.35 -30.02 14.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.652 ' CD ' HG22 ' A' ' 102' ' ' ILE . 30.0 mt-10 -45.51 -36.24 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 t -122.97 153.89 39.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 16.4 t70 -119.48 -30.55 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -47.35 161.04 0.33 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 110.825 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.483 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.7 Cg_endo -69.7 -37.88 8.7 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.7 2.267 . . . . 0.0 112.374 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -118.74 102.81 9.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.606 HG21 ' CD2' ' A' ' 95' ' ' PHE . 29.3 t -86.62 132.25 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.164 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 3.9 m-30 -99.63 105.21 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.81 122.56 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.411 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 2.1 m -125.71 154.44 42.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -141.9 175.2 9.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 55.44 53.2 8.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.646 0.736 . . . . 0.0 110.87 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.8 116.89 4.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.314 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -130.38 131.77 45.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.97 121.69 39.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.53 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.0 mtp -62.77 149.2 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 149' ' ' LYS . 47.5 t -74.91 -35.75 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.33 134.16 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -102.43 149.49 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.406 ' HE2' ' HB2' ' A' ' 143' ' ' ALA . 0.8 OUTLIER -116.27 142.49 29.45 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.652 0.739 . . . . 0.0 110.857 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.8 pp -125.69 164.36 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.598 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 40.6 mttp -105.23 139.18 40.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.03 172.81 37.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -154.17 153.57 28.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 53.6 Cg_endo -69.75 1.75 4.15 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.354 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.575 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.2 mmmm -137.72 -174.95 3.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.61 HG22 ' CE3' ' A' ' 8' ' ' TRP . 75.5 mt -86.08 134.27 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.598 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.5 p-90 -140.64 130.71 24.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -57.94 128.04 35.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.44 HD22 HG21 ' A' ' 139' ' ' ILE . 29.3 mt -62.6 170.83 2.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.9 t0 -82.05 129.14 34.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -35.41 -49.5 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.84 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -65.3 -39.76 92.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 26.9 mm -64.75 -47.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.37 -61.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 142' ' ' GLY . 38.2 mt-30 -54.37 -69.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.55 -49.68 1.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.509 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.99 -44.27 78.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.7 mtpp -65.07 -22.88 67.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -84.46 -40.72 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -53.35 -14.77 3.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.5 mt -88.12 26.5 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.9 ptp -85.38 -25.04 27.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.479 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 19.2 mmmt -146.83 153.71 40.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -130.55 176.68 7.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -65.32 174.57 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -74.79 -27.0 60.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.61 -58.49 7.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 154' ' ' VAL . 12.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 t -59.0 -46.78 87.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.866 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 p -163.03 154.55 17.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.35 91.49 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.506 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.2 t -108.88 106.38 16.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.889 0.376 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 m -125.85 165.82 18.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.64 91.25 1.07 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.592 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.5 m95 -84.56 163.58 19.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 133' ' ' TRP . 13.5 p -139.65 156.68 46.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -138.57 113.76 9.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 p -68.39 138.09 55.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.464 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 29.6 t -124.22 152.16 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 35.8 m-70 -87.4 114.89 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.691 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 57.9 mt-30 -60.58 161.44 14.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.77 -29.17 5.86 Favored 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.322 -0.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.573 ' O ' HD12 ' A' ' 20' ' ' LEU . 11.6 m-90 -28.53 -49.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.691 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -37.77 -64.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 -42.1 99.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.2 mt -49.82 -35.33 22.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.2 mp -61.92 -64.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.2 m -64.07 -22.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.4 mmt180 -69.32 -39.47 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.1 22.19 3.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.485 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.22 -44.62 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -95.01 101.25 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.98 ' HE ' HD13 ' A' ' 102' ' ' ILE . 17.2 ptt180 -96.85 17.2 17.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.644 HG11 HD12 ' A' ' 102' ' ' ILE . 32.7 m -149.02 150.37 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.44 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.8 122.18 7.42 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.447 ' N ' ' CB ' ' A' ' 108' ' ' SER . 16.4 mmt180 -147.8 150.09 33.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.474 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 80.0 p -86.13 21.28 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.526 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 5.7 p-90 -142.19 157.53 44.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 4.9 t80 -100.73 141.43 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 34' ' ' THR . 9.4 t -134.84 101.04 11.79 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.7 Cg_endo -69.81 4.53 2.16 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.664 2.243 . . . . 0.0 112.337 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -65.9 110.55 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -113.95 120.44 40.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.08 -120.48 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -106.06 140.68 38.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.891 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -144.19 114.7 7.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.67 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 95.6 m95 -72.37 132.25 43.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.459 ' O ' HD23 ' A' ' 80' ' ' LEU . 34.1 mm -101.03 128.61 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.23 152.63 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.778 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -89.64 118.74 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -55.29 175.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.76 -18.32 60.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.061 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 7.9 ttpt -68.88 148.43 50.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.48 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.3 135.27 19.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.492 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.75 127.98 15.38 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.342 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.8 m -73.86 159.62 83.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.623 0.725 . . . . 0.0 110.883 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -6.75 19.34 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.37 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -94.63 -42.06 8.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.954 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.55 -42.72 86.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 50' ' ' SER . 27.7 t -66.34 -52.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -59.77 -45.23 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.41 -56.65 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.498 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.4 mt -53.96 -43.05 69.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.589 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 32.2 mt-30 -49.88 -46.56 51.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.57 -38.89 39.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -56.86 -52.06 66.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -68.98 -40.17 78.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.57 ' HG2' HG22 ' A' ' 69' ' ' VAL . 44.7 mtt-85 -48.69 -35.17 13.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.2 mt -88.87 -14.75 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.3 mt -89.44 -28.12 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 3.8 mmm180 -121.91 -29.18 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.058 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 130.83 127.32 2.87 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.453 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -44.63 -21.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 66' ' ' GLY . 14.2 t0 -74.1 7.95 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.806 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.058 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.1 m -62.45 -178.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 2.4 mm-40 -117.0 172.42 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 56.7 m-85 -164.32 135.61 3.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.62 0.724 . . . . 0.0 110.939 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.82 161.77 44.66 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.296 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -83.73 -26.94 29.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -148.88 173.55 13.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.5 m-85 -134.69 95.38 15.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.687 0.756 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.2 Cg_endo -69.79 -178.21 2.25 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.6 m -149.93 139.05 21.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.52 44.6 63.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 19.6 m -156.68 149.06 23.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.532 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -74.81 118.37 17.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 44' ' ' ALA . 63.5 mt -83.07 -73.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.449 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.33 -141.02 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.498 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.576 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -151.92 166.87 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 114' ' ' CYS . 21.7 m -154.07 149.37 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.452 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.9 t70 -95.38 109.2 21.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -72.82 96.88 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.539 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -66.7 -48.44 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -162.95 167.45 22.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.456 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.4 t -127.67 98.2 5.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 98.1 mt -94.45 166.71 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 93' ' ' LYS . 9.6 t -106.73 166.29 10.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.454 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 6.2 mm100 -42.06 -23.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 91' ' ' SER . 24.9 ttmt -86.61 -63.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.437 ' HB3' HD22 ' A' ' 90' ' ' LEU . 13.1 mt-30 -66.09 -49.97 65.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CD2' HG21 ' A' ' 111' ' ' VAL . 37.9 t80 -42.03 -56.78 2.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 5.0 ptmt -67.16 -41.33 86.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.1 -59.18 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -77.2 -48.36 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 30.8 m-85 -111.1 66.26 0.55 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.73 -12.73 33.56 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.91 -24.12 55.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.98 HD13 ' HE ' ' A' ' 26' ' ' ARG . 2.3 pt -120.49 17.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.444 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 27.2 p -58.05 -24.96 60.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.814 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.454 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -91.26 -31.95 15.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.947 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.678 ' CD ' HG22 ' A' ' 102' ' ' ILE . 27.2 mt-10 -43.37 -37.1 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 t -125.96 146.92 49.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -33.77 6.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.447 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 1.8 m -45.12 161.62 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 0.0 110.867 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.474 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.2 Cg_endo -69.71 -48.8 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.353 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 18.4 m-85 -105.62 102.9 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 95' ' ' PHE . 20.1 t -86.2 137.3 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.555 ' CE1' HG22 ' A' ' 34' ' ' THR . 11.1 m-30 -103.39 107.54 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.8 OUTLIER -74.69 117.48 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.125 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -118.49 151.13 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -143.1 175.62 9.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER 52.09 52.34 11.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 0.0 110.915 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.763 ' O ' HG11 ' A' ' 154' ' ' VAL . 54.0 Cg_endo -69.68 120.18 7.02 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.312 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -129.21 132.25 47.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -97.07 122.46 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.648 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 16.4 mtp -65.63 143.05 57.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.56 -24.73 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.01 138.73 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -106.79 149.08 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.648 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 1.1 m-85 -116.84 142.32 29.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 86.76 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.276 . . . . 0.0 112.334 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.544 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -125.39 168.13 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.608 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 7.4 mtmp? -109.42 142.31 40.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.26 163.32 14.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -141.79 161.92 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 1.8 4.1 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.306 . . . . 0.0 112.317 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.526 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.1 mmmm -137.78 -175.08 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.592 HG22 ' CE3' ' A' ' 8' ' ' TRP . 97.1 mt -83.77 134.86 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.608 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 11.0 p-90 -140.75 127.34 20.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.97 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.572 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 9.7 ttmt -54.41 130.79 40.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 20.5 mt -66.4 176.37 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.9 t0 -86.18 126.03 33.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.23 -41.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -72.1 -43.23 65.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.514 HG23 ' CD2' ' A' ' 124' ' ' PHE . 30.0 mm -62.97 -43.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -40.25 -67.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 142' ' ' GLY . 70.1 mt-30 -49.03 -69.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.15 -46.57 0.98 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.44 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.67 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.67 -47.58 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -60.44 -25.18 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -85.58 -39.49 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.95 -8.85 6.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.482 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.7 mt -83.88 29.3 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.954 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.452 ' O ' ' C ' ' A' ' 149' ' ' LYS . 6.9 ptp -109.77 175.82 5.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 148' ' ' MET . 58.5 tttt 34.37 38.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -49.05 173.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -70.82 171.05 11.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -93.63 35.94 1.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -130.64 -60.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.095 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.763 HG11 ' O ' ' A' ' 117' ' ' PRO . 89.8 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 m -99.56 -53.61 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.91 0.386 . . . . 0.0 110.88 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -84.55 93.3 8.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.08 58.95 0.59 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.489 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 m -105.22 132.48 51.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -119.15 26.0 9.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.788 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.93 61.16 6.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.457 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.691 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.0 m95 -72.52 163.29 28.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 t -136.4 129.91 31.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 40' ' ' LEU . 60.3 tp -116.87 113.49 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 0.5 OUTLIER -67.64 150.95 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.448 HG21 HD22 ' A' ' 20' ' ' LEU . 94.1 t -138.18 146.46 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.082 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 35.6 m-70 -82.01 119.75 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.562 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 56.5 mt-30 -64.63 162.28 36.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.589 0.709 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.78 -30.9 4.89 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.354 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.568 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 12.9 m-90 -25.08 -55.93 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.562 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.5 -61.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 4.7 m -64.61 -40.11 94.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 16' ' ' TRP . 67.8 mt -54.23 -30.81 51.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -65.15 -65.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.589 HG21 ' OE1' ' A' ' 119' ' ' GLU . 5.4 m -63.31 -17.95 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -74.93 -39.28 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.77 20.07 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -107.09 -44.01 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -97.32 113.83 25.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -109.84 19.84 18.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.83 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG11 HD12 ' A' ' 102' ' ' ILE . 34.8 m -152.54 145.2 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.422 ' HG2' HD21 ' A' ' 10' ' ' LEU . 9.4 tp10 -117.65 142.17 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -106.48 126.07 8.36 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.453 ' N ' ' CB ' ' A' ' 108' ' ' SER . 33.1 mmt180 -150.0 150.47 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 110.836 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.48 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 8.8 m -84.66 25.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.528 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -147.47 162.98 37.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -104.64 141.53 36.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.646 ' O ' HG23 ' A' ' 34' ' ' THR . 10.3 t -134.37 99.11 13.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 0.0 111.191 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.6 Cg_endo -69.83 4.93 1.93 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.459 ' O ' HD22 ' A' ' 86' ' ' LEU . 8.1 t60 -65.49 112.89 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.458 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 6.3 mmt85 -113.29 122.95 48.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.37 -129.49 2.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -99.15 140.03 33.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 10' ' ' LEU . 24.5 tp -144.17 112.57 6.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 83.2 m95 -70.93 128.83 37.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.77 123.75 53.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.18 148.52 41.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.075 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.753 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -83.78 120.52 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.2 p -55.73 169.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.79 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.459 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.3 ttpt -65.86 147.97 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -105.4 134.32 19.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.593 0.711 . . . . 0.0 110.894 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.73 126.63 13.56 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.33 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.6 m -72.22 158.91 86.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.725 . . . . 0.0 110.875 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.01 22.52 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.632 2.221 . . . . 0.0 112.351 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -94.4 -36.26 11.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.48 -41.2 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.511 HG12 ' OE1' ' A' ' 58' ' ' GLN . 34.7 t -68.15 -45.99 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.5 t -66.88 -42.87 84.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.19 -52.8 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.568 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 84.4 mt -58.59 -41.11 85.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.591 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 34.5 mt-30 -53.06 -47.56 68.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -36.99 50.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 m -59.97 -51.68 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.169 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -69.26 -37.46 77.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.474 ' HG2' HG22 ' A' ' 69' ' ' VAL . 53.9 mtt180 -48.81 -33.44 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.7 mt -90.83 -15.91 29.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.8 mt -87.25 -29.69 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -120.81 -29.13 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.039 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.62 126.35 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -44.8 -20.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -80.85 17.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 66' ' ' GLY . 20.4 m -66.12 -178.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.8 162.97 15.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.591 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 44.4 m-85 -157.94 133.16 5.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.552 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.53 30.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -85.49 -29.21 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -146.78 173.21 12.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.645 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.71 96.2 15.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.698 0.761 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.71 172.7 12.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.264 . . . . 0.0 112.343 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.5 p -138.86 139.23 38.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.12 52.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 58.7 m -158.52 149.21 20.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -78.43 120.74 23.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.753 HD11 ' HB2' ' A' ' 44' ' ' ALA . 35.9 mt -89.33 -71.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.471 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.33 -145.97 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.493 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.5 p -152.99 157.48 40.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.897 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.4 m -140.9 144.32 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -85.81 113.7 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.459 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.6 tt -77.59 100.01 5.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.537 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.37 -48.07 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -163.09 167.26 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.77 101.19 6.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.8 mt -96.01 169.41 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' PHE . 13.2 p -108.36 169.12 8.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.839 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.406 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 6.1 mm100 -47.25 -19.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 91' ' ' SER . 15.0 ttmm -90.35 -59.11 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -70.85 -50.13 38.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CD2' HG21 ' A' ' 111' ' ' VAL . 27.5 t80 -41.51 -54.85 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -67.52 -40.77 85.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.42 -58.72 6.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -75.67 -49.95 16.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.2 m-85 -109.85 68.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.656 0.741 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.75 -13.4 34.65 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -76.92 -24.68 52.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.709 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.1 pt -120.18 23.48 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 p -64.39 -27.15 68.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.447 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -90.33 -28.76 18.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.709 ' CD ' HG22 ' A' ' 102' ' ' ILE . 18.0 mt-10 -45.71 -39.38 7.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.937 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.4 t -124.64 147.95 48.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 7.3 t0 -110.99 -33.87 6.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.453 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 1.7 m -42.81 161.52 0.18 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 0.0 110.857 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.48 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.77 -45.49 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.692 2.262 . . . . 0.0 112.309 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -110.59 104.95 13.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.529 HG21 ' CD2' ' A' ' 95' ' ' PHE . 21.4 t -90.33 133.61 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 2.2 m-30 -100.86 109.73 21.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.36 121.94 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -124.56 154.04 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -141.4 175.8 9.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 57.97 52.41 5.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.651 0.739 . . . . 0.0 110.902 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.78 114.94 3.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.254 . . . . 0.0 112.318 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.41 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 5.6 pt20 -130.08 145.31 51.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.589 ' OE1' HG21 ' A' ' 21' ' ' VAL . 3.7 tp10 -107.14 123.56 48.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.51 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.8 mtp -63.13 149.26 45.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 149' ' ' LYS . 63.1 t -73.39 -23.46 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.3 p -130.09 149.95 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 20.2 mmtm -117.35 151.81 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.488 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.5 m-85 -120.43 141.68 32.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.656 0.741 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 86.5 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.503 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -121.73 165.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.617 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 48.8 mttp -101.59 143.17 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -87.44 -177.13 48.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 20.6 t-20 -170.52 142.45 1.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.632 0.729 . . . . 0.0 110.862 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.2 Cg_endo -69.74 9.76 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.685 2.257 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASN . 9.8 mmmm -141.44 -174.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.691 HG22 ' CE3' ' A' ' 8' ' ' TRP . 54.2 mt -88.6 132.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.617 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.0 p-90 -139.32 127.54 22.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.24 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.5 mt -61.0 172.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.45 152.65 30.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -58.9 -39.57 81.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -78.37 -38.09 42.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.488 HG23 ' CD2' ' A' ' 124' ' ' PHE . 24.3 mm -68.44 -36.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -49.07 -65.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 144' ' ' LYS . 47.5 mt-30 -48.51 -67.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.13 -52.65 1.25 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.549 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.0 -42.03 65.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.141 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 141' ' ' GLN . 9.8 mtpt -69.8 -17.86 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -90.17 -44.42 9.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.71 -19.69 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.404 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 32.6 mt -83.07 34.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.9 ptp -93.67 -36.5 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.476 ' HB3' HG21 ' A' ' 121' ' ' VAL . 14.5 ttmt -122.12 49.49 1.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.464 ' O ' ' C ' ' A' ' 151' ' ' ASN . 4.9 mm-40 -33.89 136.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 153' ' ' ALA . 12.3 m120 33.04 46.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 151' ' ' ASN . 59.9 pttt -34.16 -33.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 151' ' ' ASN . . . -56.64 -60.3 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.079 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 180.0 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m -137.82 110.61 7.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 110.909 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 t -53.08 113.45 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.74 44.7 0.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.497 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.5 t -81.25 105.97 12.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 0.0 110.881 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -71.95 143.21 49.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.33 91.35 0.64 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.457 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.706 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.5 m95 -77.42 161.76 27.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.762 0.315 . . . . 0.0 110.889 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.1 t -138.22 133.44 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.713 HD23 ' OE1' ' A' ' 28' ' ' GLU . 62.6 tp -121.16 114.24 21.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -67.92 154.67 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 37.2 t -137.08 155.95 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.461 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 35.3 m-70 -88.53 113.51 24.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 14.3 mt-30 -60.61 161.1 15.53 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.655 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.8 -30.13 5.32 Favored 'Cis proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 -1.819 . . . . 0.0 112.35 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.517 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.0 m-90 -27.63 -52.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.559 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.64 -62.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 m -64.98 -45.93 83.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 16' ' ' TRP . 79.1 mt -45.57 -30.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 16' ' ' TRP . 7.0 mp -68.55 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.5 HG11 ' N ' ' A' ' 82' ' ' GLY . 15.9 m -61.11 -13.9 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.415 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -81.26 -39.46 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.04 -19.93 5.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.655 ' H ' HD12 ' A' ' 24' ' ' ILE . 5.4 mp -64.85 -60.32 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 111.174 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HG2' HD11 ' A' ' 20' ' ' LEU . 7.5 tptp -83.34 120.97 26.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.823 ' HD2' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -113.22 11.72 18.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.568 HG11 ' CE1' ' A' ' 95' ' ' PHE . 33.6 m -142.52 156.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.713 ' OE1' HD23 ' A' ' 10' ' ' LEU . 3.2 tt0 -120.9 138.11 54.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.457 ' O ' ' NH1' ' A' ' 30' ' ' ARG . . . -102.64 123.62 7.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.548 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 75.9 mmt-85 -149.16 151.15 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.845 0.355 . . . . 0.0 110.849 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.478 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.3 m -87.6 18.67 3.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.566 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 6.4 p-90 -142.36 161.39 38.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.6 t80 -102.56 147.97 26.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 34' ' ' THR . 5.2 t -140.62 106.97 6.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 0.0 111.172 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.9 Cg_endo -69.78 2.95 3.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.452 ' O ' HD22 ' A' ' 86' ' ' LEU . 13.6 t60 -64.53 114.87 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -119.65 120.41 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.06 -122.58 1.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -105.09 139.49 39.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.877 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 10' ' ' LEU . 23.0 tp -143.67 114.02 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.643 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 87.6 m95 -72.1 128.69 36.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -98.71 132.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.118 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.35 155.87 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.755 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -90.81 119.13 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -56.27 173.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.83 63.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 5.9 ttpt -65.37 146.4 54.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.453 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.19 135.49 19.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.577 0.703 . . . . 0.0 110.863 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.76 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.662 2.241 . . . . 0.0 112.354 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 54' ' ' VAL . 3.4 m -71.55 159.63 84.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.696 0.76 . . . . 0.0 110.828 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -9.95 27.33 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 0.0 112.349 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -94.4 -37.97 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.72 -39.49 70.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 50' ' ' SER . 41.6 t -67.76 -46.32 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.15 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -67.4 -42.11 83.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.94 -48.96 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.466 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 83.5 mt -62.46 -40.85 97.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 38.1 mt-30 -54.81 -44.6 73.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.81 -34.82 30.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -62.04 -51.75 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.443 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 14.9 m-85 -67.5 -40.37 85.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.938 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HG2' HG22 ' A' ' 69' ' ' VAL . 51.8 mtt180 -47.03 -35.93 7.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.08 -17.97 31.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' TYR . 60.2 mt -86.01 -26.8 25.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -123.69 -27.72 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.065 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 128.28 129.87 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -46.84 -18.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -72.73 3.61 4.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.065 HG13 ' O ' ' A' ' 66' ' ' GLY . 34.3 m -62.02 179.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 12.1 pt-20 -122.93 173.77 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 72.9 m-85 -161.82 138.43 6.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.595 0.712 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 156.12 64.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.636 2.224 . . . . 0.0 112.337 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -72.91 -31.28 64.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -146.74 176.84 9.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.7 94.93 16.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 0.0 110.936 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.569 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 54.0 Cg_endo -69.74 173.99 10.14 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.2 p -142.59 135.49 28.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.86 50.09 14.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.5 m -161.24 148.47 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 0.0 110.882 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.538 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.39 118.19 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.755 HD11 ' HB2' ' A' ' 44' ' ' ALA . 40.3 mt -85.62 -70.94 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.5 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.36 -145.08 4.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.482 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 4.2 p -154.32 155.27 34.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 20.0 m -141.41 137.32 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.83 112.63 16.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.1 tt -77.81 101.83 6.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.94 -47.33 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -163.44 169.0 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.4 t -127.4 100.83 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.7 mt -94.94 170.84 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 93' ' ' LYS . 32.8 t -110.9 169.04 9.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.445 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 6.3 mm100 -45.83 -20.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' N ' ' C ' ' A' ' 91' ' ' SER . 32.7 ttpt -89.35 -60.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -68.9 -50.55 48.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 27' ' ' VAL . 39.4 t80 -39.11 -55.66 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 7.0 ptmm? -68.59 -47.92 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.5 mt-10 -46.79 -58.57 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -76.56 -51.47 11.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 37.9 m-85 -110.03 67.81 0.47 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 110.916 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.74 -14.7 36.51 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.349 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.4 -23.31 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.823 HD13 ' HD2' ' A' ' 26' ' ' ARG . 2.2 pt -121.38 15.27 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.402 ' HB3' ' HA ' ' A' ' 100' ' ' PRO . 53.3 p -55.96 -18.52 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.89 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.575 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -98.27 -31.6 11.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 10.8 mt-10 -46.14 -27.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -134.4 145.72 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -111.02 -35.3 5.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 m -42.34 161.72 0.16 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.702 0.763 . . . . 0.0 110.833 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.478 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.78 -48.92 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -106.56 103.63 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.486 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 26.2 t -88.95 136.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 34' ' ' THR . 5.0 m-30 -102.33 108.47 19.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.57 120.46 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.444 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.2 m -124.87 154.09 41.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.21 175.99 9.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.449 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 55.22 54.17 9.64 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.855 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 116.99 4.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.656 2.237 . . . . 0.0 112.331 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.593 ' HB2' HE22 ' A' ' 150' ' ' GLN . 3.9 pt20 -127.8 137.79 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -103.73 118.55 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.538 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.9 mtp -62.75 139.03 58.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.4 t -65.86 -30.83 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.47 143.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -111.68 151.89 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.47 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.8 OUTLIER -118.36 141.04 28.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 0.0 110.862 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 82.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.575 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.7 pp -121.11 166.69 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.592 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 34.3 mtpt -108.95 159.99 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.23 177.6 16.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -154.56 163.16 25.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 0.0 110.885 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 129' ' ' ASN . 53.5 Cg_endo -69.74 19.66 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.357 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.566 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.8 mmmm -152.82 -175.03 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.706 HG22 ' CE3' ' A' ' 8' ' ' TRP . 60.0 mt -84.33 131.75 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.592 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.1 p-90 -131.88 139.76 48.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -70.81 127.09 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.09 164.18 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.8 t0 -75.65 129.5 37.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -37.25 -47.76 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -66.77 -37.01 83.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 136' ' ' ASP . 11.9 mm -67.3 -48.1 79.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 139' ' ' ILE . 15.0 t-160 -37.09 -64.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.831 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 142' ' ' GLY . 36.1 mt-30 -51.37 -69.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.84 -49.48 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.643 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.48 -45.02 81.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.8 mtpp -64.61 -23.34 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.52 -38.0 16.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -61.35 -6.64 8.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.5 mt -83.84 27.34 0.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 ptp -109.08 143.02 38.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.886 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm 39.21 54.02 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.593 HE22 ' HB2' ' A' ' 118' ' ' GLN . 2.3 mt-30 -75.94 -71.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -133.19 147.57 52.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.17 -39.99 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.9 -58.78 6.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 1' ' ' GLY . 74.4 m -37.79 111.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.84 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 t -59.28 166.82 2.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.92 62.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 t -102.33 78.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 0.0 110.862 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 m -156.37 150.57 25.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.35 91.37 1.53 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.48 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.528 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.7 m95 -78.11 164.35 25.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t -137.12 144.84 43.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.439 HD23 ' HG3' ' A' ' 28' ' ' GLU . 11.7 tp -130.94 114.66 15.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.3 p -70.42 133.35 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.518 HG21 HD22 ' A' ' 20' ' ' LEU . 53.4 t -118.89 153.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 34.4 m-70 -88.49 113.0 23.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 78.5 mt-30 -59.76 160.01 16.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.614 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.76 -32.09 4.14 Favored 'Cis proline' 0 C--N 1.342 0.212 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.322 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.581 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 10.7 m-90 -25.12 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -37.76 -64.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.074 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.9 m -62.45 -42.43 99.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 24' ' ' ILE . 45.0 mt -50.34 -37.64 37.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -58.96 -66.81 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.54 HG11 ' N ' ' A' ' 82' ' ' GLY . 16.8 m -60.41 -27.12 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 11.0 mmt180 -66.86 -39.5 87.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.11 15.19 5.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.402 HD13 HD23 ' A' ' 19' ' ' LEU . 5.3 mp -100.24 -41.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.494 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.8 tptp -99.64 100.87 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.696 ' HD2' HD13 ' A' ' 102' ' ' ILE . 6.4 ptp180 -93.41 16.11 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 102' ' ' ILE . 27.8 m -149.04 145.85 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 2.8 tm-20 -114.23 142.11 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -103.13 128.42 9.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.1 mmt180 -151.59 146.63 25.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -85.08 17.96 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.572 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.8 p-90 -141.44 165.36 27.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.29 141.39 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 34' ' ' THR . 5.0 t -135.99 104.73 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 0.0 111.169 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.8 Cg_endo -69.77 4.3 2.28 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.445 ' O ' HD22 ' A' ' 86' ' ' LEU . 17.3 t60 -64.85 111.82 2.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -115.55 119.99 37.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.84 -129.6 2.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.1 ttm-85 -96.5 139.41 32.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.88 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.4 tp -144.08 111.44 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.862 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.1 m95 -71.25 127.91 34.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.472 ' O ' HD23 ' A' ' 80' ' ' LEU . 50.5 mm -98.65 129.5 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -125.71 150.0 48.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -84.38 118.66 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.0 p -55.07 178.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.61 -14.07 60.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.1 ttpt -70.55 147.23 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.438 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -103.79 134.08 19.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.612 0.72 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 127.11 14.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.699 2.266 . . . . 0.0 112.358 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 54' ' ' VAL . 74.4 m -72.61 155.05 91.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 0.0 110.884 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -7.21 20.45 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -94.55 -40.16 10.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -38.13 73.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.567 HG12 ' OE1' ' A' ' 58' ' ' GLN . 58.1 t -66.28 -50.2 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.129 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -64.27 -44.48 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.38 -49.73 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.581 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.1 mt -62.72 -43.05 99.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 37.4 mt-30 -53.6 -43.4 68.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.4 29.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 m -62.38 -52.76 62.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.152 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.43 ' HE2' HD22 ' A' ' 57' ' ' LEU . 26.1 m-85 -66.29 -38.49 87.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 69' ' ' VAL . 66.5 mtt180 -49.81 -36.63 27.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.75 -12.76 44.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.505 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 69.0 mt -91.14 -28.04 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.505 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.7 mmp_? -123.64 -22.12 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.054 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 123.67 130.04 3.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 1.4 pptp? -47.89 -18.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.73 0.3 . . . . 0.0 110.88 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 1.4 6.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.054 HG13 ' O ' ' A' ' 66' ' ' GLY . 34.9 m -59.29 179.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -120.07 166.96 12.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 55.6 m-85 -158.31 134.77 6.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.597 0.713 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.71 163.06 39.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.272 . . . . 0.0 112.357 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -83.01 -29.16 29.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.66 173.5 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.614 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 42.3 m-85 -134.79 98.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 110.901 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.7 Cg_endo -69.76 176.4 6.82 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -143.96 133.54 23.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.57 47.86 19.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 17.1 m -157.81 149.17 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -77.98 115.45 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.957 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' ALA . 69.8 mt -82.12 -72.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.54 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.1 -147.2 4.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.481 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 10.5 p -152.84 153.33 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 21.1 m -139.28 143.19 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.13 112.85 20.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.6 tt -76.98 100.16 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -69.72 -46.83 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -165.44 167.54 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.45 99.25 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 94' ' ' GLN . 99.1 mt -95.07 165.73 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 93' ' ' LYS . 17.7 t -103.92 169.03 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 109' ' ' PRO . 10.9 mm100 -41.12 -24.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' SER . 32.2 ttpt -87.32 -70.15 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.76 ' HB3' HD22 ' A' ' 90' ' ' LEU . 79.2 mm-40 -57.12 -47.04 82.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.625 ' CD2' HG21 ' A' ' 111' ' ' VAL . 19.4 t80 -43.64 -57.21 3.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.47 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -69.36 -44.87 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.47 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.0 mt-10 -47.08 -59.56 3.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.869 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.448 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.3 mt-30 -79.1 -48.23 14.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.3 m-85 -110.06 67.64 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.642 0.735 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.71 -12.34 32.78 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.752 2.301 . . . . 0.0 112.313 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.24 -21.16 54.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.788 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.6 pt -125.43 23.95 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 44.4 p -65.35 -24.49 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -95.33 -25.59 16.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.788 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.1 mt-10 -48.17 -36.89 14.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -129.99 134.81 47.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -108.28 27.16 9.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 88.7 p -96.06 155.59 38.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.705 0.764 . . . . 0.0 110.841 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.454 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.76 -24.36 29.74 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.413 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 17.1 m-85 -134.63 90.21 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.625 HG21 ' CD2' ' A' ' 95' ' ' PHE . 40.8 t -79.38 136.82 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.123 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 3.7 m-30 -103.98 104.13 14.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.88 122.72 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.129 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 13.7 m -126.89 155.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -143.34 176.25 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.456 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 57.17 53.93 6.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.859 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.76 115.16 3.96 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.632 2.221 . . . . 0.0 112.357 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.54 134.64 49.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 150' ' ' GLN . 14.5 tm-20 -100.61 120.82 40.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.547 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 13.6 mtp -62.5 152.92 33.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 149' ' ' LYS . 72.0 t -78.67 -27.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.5 149.44 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 7.7 mmtm -114.21 144.77 42.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.638 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -114.84 140.79 25.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.51 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.359 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.619 HD13 ' HH2' ' A' ' 133' ' ' TRP . 2.8 pp -124.37 168.58 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.596 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 47.5 mmtm -111.99 141.99 44.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.67 175.44 26.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.432 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -155.54 162.01 28.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.671 0.748 . . . . 0.0 110.875 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 1.78 4.11 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.572 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.9 mmmm -137.17 -175.01 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.528 HG22 ' CE3' ' A' ' 8' ' ' TRP . 79.4 mt -85.88 133.52 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.619 ' HH2' HD13 ' A' ' 126' ' ' ILE . 7.6 p-90 -137.13 127.31 26.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.428 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 11.0 ttmt -55.72 133.69 50.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.17 174.17 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.49 158.71 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.85 -48.65 78.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -70.5 -37.16 74.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.638 HG23 ' CD2' ' A' ' 124' ' ' PHE . 44.9 mm -68.84 -41.29 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -45.58 -62.86 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 142' ' ' GLY . 46.4 mt-30 -53.59 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.57 -51.32 0.76 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.517 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.862 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.07 -47.6 68.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.5 mtpp -60.75 -24.24 65.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -50.81 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.87 -19.83 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.423 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.474 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 48.5 mt -82.74 37.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 10.4 ptp -100.59 -39.94 7.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 121' ' ' VAL . 26.0 tttp -134.91 67.39 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 2.7 mm-40 -53.99 -75.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.527 ' OD1' HG12 ' A' ' 154' ' ' VAL . 3.1 p30 -162.96 156.13 19.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.94 -39.17 2.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -47.54 -56.77 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.064 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.527 HG12 ' OD1' ' A' ' 151' ' ' ASN . 14.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.139 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.0 p -94.0 174.95 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p -54.92 132.05 45.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.1 158.43 30.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.9 p -105.99 79.11 1.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.853 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 m -137.99 146.0 42.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.861 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.58 89.05 0.93 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.532 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.707 ' CE3' HG22 ' A' ' 132' ' ' ILE . 88.6 m95 -76.3 168.13 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.903 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' CB ' ' HG ' ' A' ' 135' ' ' LEU . 11.8 t -141.69 145.0 34.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.4 tp -134.47 112.03 10.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.403 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 13.1 p -67.99 137.77 55.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 45' ' ' THR . 25.3 t -121.73 157.52 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.493 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.3 m-70 -89.29 116.22 27.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.698 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 52.5 mt-30 -62.79 161.86 25.7 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 110.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.83 -28.98 5.98 Favored 'Cis proline' 0 C--N 1.341 0.15 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.328 0.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.671 ' O ' HD12 ' A' ' 20' ' ' LEU . 12.5 m-90 -29.02 -53.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.698 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.38 -64.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -63.0 -45.04 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 16' ' ' TRP . 70.5 mt -46.36 -35.54 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -62.25 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.486 HG11 ' N ' ' A' ' 82' ' ' GLY . 5.3 m -65.93 -12.18 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.103 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.5 mmt180 -84.14 -39.6 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.53 20.38 3.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.474 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.435 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.1 mp -108.38 -36.16 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.0 tptt -107.65 99.15 8.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.481 ' HE ' HD13 ' A' ' 102' ' ' ILE . 22.4 ptt180 -96.53 29.1 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 102' ' ' ILE . 34.2 m -156.55 145.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -121.31 118.98 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.456 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -84.99 123.19 6.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 14.7 mmt180 -142.72 152.3 42.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 110.859 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.482 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 17.8 p -86.93 18.18 3.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.559 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.0 p-90 -142.62 163.95 31.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -105.58 138.79 41.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 34' ' ' THR . 6.7 t -132.26 100.56 15.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.611 0.72 . . . . 0.0 111.099 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.495 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.1 Cg_endo -69.78 7.31 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.407 ' O ' HD22 ' A' ' 86' ' ' LEU . 28.7 t60 -63.83 107.76 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.497 ' NH1' HD22 ' A' ' 86' ' ' LEU . 44.2 mmt-85 -105.48 108.17 19.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.14 -145.19 10.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.405 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 0.2 OUTLIER -86.72 142.73 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.861 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.4 tp -144.13 115.34 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.672 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 90.4 m95 -73.37 137.75 44.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.527 ' O ' HD23 ' A' ' 80' ' ' LEU . 48.0 mm -107.13 132.64 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -130.61 145.54 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -75.95 125.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.7 p -61.13 -178.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.08 7.13 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -99.92 129.94 46.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.06 135.71 28.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.498 0.666 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.76 133.99 26.9 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.8 m -76.46 161.44 74.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.672 0.749 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.18 27.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -94.22 -43.23 8.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.35 -40.91 90.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.736 HG12 ' OE1' ' A' ' 58' ' ' GLN . 60.8 t -65.05 -56.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -57.4 -42.79 82.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -66.61 -57.73 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.465 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 87.4 mt -54.22 -42.1 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.736 ' OE1' HG12 ' A' ' 54' ' ' VAL . 37.6 mt-30 -55.11 -42.54 73.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.5 -31.6 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.4 m -66.09 -52.02 52.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.84 -36.14 79.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.502 ' HG2' HG22 ' A' ' 69' ' ' VAL . 56.5 mtt180 -50.68 -34.23 25.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.5 mt -90.6 -12.57 36.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.3 mt -91.59 -28.14 17.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.984 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 4.3 mmm180 -121.97 -29.18 4.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.032 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.78 127.43 2.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -46.53 -19.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.47 16.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.032 HG13 ' O ' ' A' ' 66' ' ' GLY . 21.4 m -65.29 179.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' O ' HD11 ' A' ' 24' ' ' ILE . 20.3 mp0 -115.98 160.06 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.588 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 51.2 m-85 -153.16 139.8 12.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.74 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.487 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.8 Cg_endo -69.79 170.61 16.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.6 -22.34 19.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.49 172.08 16.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.9 m-85 -134.97 87.96 28.29 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 0.0 110.933 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.1 Cg_endo -69.71 172.04 13.31 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -137.15 144.18 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.88 44.81 95.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.464 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.28 158.24 41.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.527 HD23 ' O ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -85.04 117.23 23.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 44' ' ' ALA . 16.3 mt -85.87 -69.46 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.486 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -148.51 -142.49 3.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.619 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 35.7 t -154.41 162.33 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.439 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 22.4 m -149.85 140.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -81.75 114.86 20.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.497 HD22 ' NH1' ' A' ' 37' ' ' ARG . 4.4 tt -78.17 97.78 5.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.569 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.89 -47.79 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 113' ' ' ILE . 5.0 m-20 -164.54 166.35 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -127.43 101.4 6.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.496 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.2 mt -99.48 167.04 10.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 95' ' ' PHE . 33.0 t -106.89 169.04 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.842 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -46.41 -20.48 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 12.6 tttm -85.08 -58.04 2.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.439 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.2 mm100 -77.22 -51.31 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.553 ' CD2' HG21 ' A' ' 111' ' ' VAL . 42.1 t80 -38.89 -50.14 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.08 -42.76 68.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -55.12 -61.39 2.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.492 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.8 mt-30 -71.38 -50.53 31.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 113' ' ' ILE . 25.0 m-85 -109.42 68.26 0.41 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.657 0.741 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.75 -14.66 36.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.279 . . . . 0.0 112.304 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.12 -23.77 57.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.832 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.2 pt -120.32 19.38 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 p -60.62 -27.32 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.447 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -93.47 -25.09 17.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.832 ' CD ' HG22 ' A' ' 102' ' ' ILE . 16.8 mt-10 -49.92 -32.28 14.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.6 t -130.95 150.94 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.02 -23.89 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.796 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.411 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 1.8 m -51.19 160.19 0.94 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.647 0.737 . . . . 0.0 110.836 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.482 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.3 Cg_endo -69.73 -45.64 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.36 100.87 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.553 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.4 t -84.74 142.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.447 ' CZ ' HG22 ' A' ' 34' ' ' THR . 6.5 m-30 -109.13 106.92 17.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -74.56 122.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.5 m -125.43 155.21 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -143.18 176.62 8.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.492 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 55.58 51.2 6.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 0.0 110.941 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.7 Cg_endo -69.7 121.72 8.42 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.647 2.232 . . . . 0.0 112.367 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -136.4 136.1 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.452 ' OE1' ' C ' ' A' ' 81' ' ' LEU . 4.3 tp10 -98.25 124.57 42.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.454 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.6 mtp -63.12 151.7 39.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 146' ' ' GLY . 95.0 t -70.9 -31.04 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.19 145.01 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -107.18 148.86 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.436 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.2 m-85 -113.18 142.28 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 82.54 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.233 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.633 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.7 pp -118.82 159.74 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 37.7 mttp -95.16 139.94 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.19 -179.6 46.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.489 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.9 t30 -165.53 145.24 5.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 53.8 Cg_endo -69.75 4.04 2.42 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.689 2.26 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.559 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 12.1 mmmm -136.36 -174.42 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.707 HG22 ' CE3' ' A' ' 8' ' ' TRP . 73.2 mt -88.53 130.01 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.7 p-90 -138.93 125.59 20.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -55.36 125.56 21.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.423 ' HG ' ' CB ' ' A' ' 9' ' ' CYS . 22.7 mt -59.76 169.64 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 139' ' ' ILE . 7.6 t0 -77.46 126.87 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.4 m -35.7 -41.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -72.85 -41.26 64.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.5 mm -64.85 -42.64 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -42.62 -64.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 142' ' ' GLY . 80.1 mt-30 -53.13 -66.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.0 -42.02 0.7 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.672 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -65.18 -46.67 79.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -56.35 -26.37 52.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -80.05 -53.01 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -37.25 -27.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.495 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 145' ' ' LYS . 14.7 mt -84.51 38.55 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.6 ptp -99.5 -37.4 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.834 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -134.61 76.74 1.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.415 ' HB3' HG11 ' A' ' 154' ' ' VAL . 16.5 mm-40 -64.38 168.4 5.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.975 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -52.77 162.57 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -71.91 -40.36 68.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -59.53 -57.78 11.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 150' ' ' GLN . 12.1 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t 60.35 44.09 12.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.388 . . . . 0.0 110.894 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 t 65.27 39.99 5.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.82 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.02 140.8 6.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.4 t -125.7 107.73 10.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.825 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.5 m -142.97 157.17 44.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.861 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.41 88.91 1.51 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.509 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.53 ' CH2' ' HE3' ' A' ' 134' ' ' LYS . 91.8 m95 -78.25 164.02 25.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.92 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 t -138.23 138.64 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.8 tp -125.56 111.94 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 22.2 p -68.3 140.0 55.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 37.7 t -126.3 152.14 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.405 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 40.8 m-70 -85.87 116.3 24.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.659 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 54.7 mt-30 -62.54 162.1 22.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 -28.46 6.24 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.4 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.535 ' O ' HD12 ' A' ' 20' ' ' LEU . 12.9 m-90 -29.11 -51.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.659 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.23 -62.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.106 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -65.69 -47.03 76.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 16' ' ' TRP . 83.1 mt -44.04 -28.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.7 mp -70.59 -65.51 0.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.56 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.9 m -61.3 -12.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -82.47 -39.8 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.57 -17.2 5.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.697 ' H ' HD12 ' A' ' 24' ' ' ILE . 4.6 mp -68.16 -59.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.108 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.5 tptp -82.71 117.69 22.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.654 ' HD2' HD13 ' A' ' 102' ' ' ILE . 3.6 ptp180 -114.06 12.85 18.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.675 HG11 HD12 ' A' ' 102' ' ' ILE . 25.3 m -147.37 149.88 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.474 ' OE1' HD21 ' A' ' 20' ' ' LEU . 28.2 tp10 -115.78 146.2 42.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -111.26 112.72 3.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 22.8 mmt180 -137.99 148.77 45.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.479 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 61.6 p -84.39 21.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 4.6 p-90 -141.84 161.84 36.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . 9.8 t80 -105.12 141.47 36.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.544 ' O ' HG23 ' A' ' 34' ' ' THR . 6.0 t -135.19 105.01 10.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.609 0.719 . . . . 0.0 111.186 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.2 Cg_endo -69.81 3.21 2.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.451 ' O ' HD22 ' A' ' 86' ' ' LEU . 14.7 t60 -64.87 113.55 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -117.7 119.81 36.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.22 -124.93 1.63 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -100.98 140.75 34.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.852 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.5 tp -144.13 111.32 5.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.615 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 93.1 m95 -71.21 126.55 29.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 mm -96.84 125.49 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -121.8 148.87 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.611 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.89 117.46 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 p -54.08 -178.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.28 19.15 5.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.46 126.82 46.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -82.61 124.64 77.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.58 0.705 . . . . 0.0 110.871 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 126.61 13.48 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.351 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 m -70.04 156.08 92.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.616 0.722 . . . . 0.0 110.881 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -7.13 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.736 2.291 . . . . 0.0 112.341 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -94.23 -35.18 12.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.96 -40.55 60.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.96 -47.22 82.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.7 t -65.47 -44.71 86.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.52 -52.57 30.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.5 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 77.1 mt -55.37 -40.2 71.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 37.2 mt-30 -54.95 -49.27 71.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.64 -33.07 62.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -64.28 -48.01 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.412 ' HE2' HD22 ' A' ' 57' ' ' LEU . 30.3 m-85 -72.76 -30.03 63.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.545 ' HG2' HG22 ' A' ' 69' ' ' VAL . 42.0 mtt180 -56.48 -36.26 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.0 mt -89.59 -13.25 37.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 mt -90.36 -29.78 17.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.442 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 5.5 mmm180 -120.78 -29.44 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.045 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.46 125.1 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' C ' ' HD3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -42.83 -23.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.873 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -76.82 13.94 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.045 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.7 m -62.89 -179.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 31.7 mt-10 -117.99 165.12 14.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 54.1 m-85 -160.16 135.73 5.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.81 164.1 35.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.699 2.266 . . . . 0.0 112.286 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -80.18 -30.73 38.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -146.76 175.43 10.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 60.9 m-85 -133.87 94.06 19.41 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.69 0.757 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.506 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.9 Cg_endo -69.76 175.82 7.59 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.681 2.254 . . . . 0.0 112.36 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.1 p -142.1 139.19 32.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.27 49.58 44.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 66.0 m -158.22 148.2 19.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -77.32 114.24 15.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' ' 44' ' ' ALA . 81.3 mt -82.0 -74.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.56 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -142.62 -147.95 4.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.0 p -151.56 153.7 35.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.6 m -139.96 141.07 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.34 114.18 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.8 tt -78.48 96.96 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -66.56 -48.95 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.168 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER -162.5 167.84 22.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.49 99.63 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 94' ' ' GLN . 91.5 mt -93.95 171.09 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 93' ' ' LYS . 38.2 t -109.81 169.22 8.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.452 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 6.2 mm100 -44.54 -21.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.42 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.2 tttt -89.12 -63.1 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.589 ' HB3' HD22 ' A' ' 90' ' ' LEU . 11.0 mt-30 -65.58 -49.55 68.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.574 ' CD2' HG21 ' A' ' 111' ' ' VAL . 37.3 t80 -42.16 -56.12 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 8.7 ptmt -68.46 -42.9 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.421 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 6.6 mt-10 -51.7 -60.36 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.2 mt-30 -75.86 -49.74 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 34.7 m-85 -110.42 66.87 0.48 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.619 0.723 . . . . 0.0 110.844 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.78 -14.18 35.65 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 0.0 112.359 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.79 -22.39 58.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.675 HD12 HG11 ' A' ' 27' ' ' VAL . 1.9 pt -121.83 15.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.7 p -55.68 -21.82 20.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -95.05 -30.47 14.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 12.1 mt-10 -47.58 -26.41 1.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -136.26 141.92 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 5.4 t70 -106.96 -37.17 6.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.48 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 1.8 m -40.89 161.33 0.12 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 0.0 110.874 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.479 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.81 -43.59 2.53 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.297 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 33' ' ' TYR . 16.9 m-85 -110.06 101.95 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 95' ' ' PHE . 25.7 t -87.07 134.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.8 m-30 -101.34 109.97 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.94 120.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.455 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.1 m -123.59 152.49 41.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.25 176.38 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.475 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER 57.47 52.82 5.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 112.39 3.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.316 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -126.61 132.19 51.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -98.0 120.35 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.513 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.6 mtp -62.52 154.36 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 148' ' ' MET . 70.7 t -81.55 -25.72 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.07 148.56 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 10.9 mmtm -115.86 142.3 46.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.543 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.8 OUTLIER -114.12 141.65 26.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.661 0.743 . . . . 0.0 110.867 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 90.54 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.56 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.7 pp -125.53 167.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.573 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 43.5 mtpt -110.13 142.61 41.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.99 174.98 24.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -155.87 162.27 27.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.718 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 2.3 3.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.272 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.403 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 6.8 mmmm -139.94 -175.01 4.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 81.9 mt -83.15 141.92 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 14.5 p-90 -147.18 129.44 15.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.53 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 17.0 ttmt -58.71 128.83 39.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.3 mt -63.22 -177.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.7 t70 -90.56 128.2 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.3 m -36.23 -41.16 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -72.97 -40.62 65.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.543 HG23 ' CD2' ' A' ' 124' ' ' PHE . 14.4 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.78 -62.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' LYS . 16.1 mm100 -55.02 -69.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.56 -42.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.615 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -60.74 -46.18 91.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.5 mtpp -61.97 -24.05 66.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -86.56 -42.84 13.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -51.1 -15.18 1.44 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.512 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.45 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 79.4 mt -82.24 34.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.565 ' O ' HG21 ' A' ' 121' ' ' VAL . 4.5 ptp -117.07 143.24 45.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt 55.33 42.77 29.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 31.2 mm-40 -50.37 175.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -40.4 134.72 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -50.28 -29.44 9.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.13 -67.34 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.5 p -98.36 169.28 9.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.874 0.369 . . . . 0.0 110.888 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -133.36 159.04 41.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.831 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.28 153.54 25.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.528 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.6 m -136.96 122.82 20.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 0.0 110.84 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 m -114.61 148.9 37.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.23 94.39 0.63 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.594 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.3 m95 -83.32 162.37 21.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' HB2' ' CG ' ' A' ' 135' ' ' LEU . 7.2 t -135.16 129.81 34.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.598 HD23 ' CD ' ' A' ' 28' ' ' GLU . 57.5 tp -116.5 113.81 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.426 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 24.0 p -68.15 153.08 44.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.632 HG12 ' N ' ' A' ' 13' ' ' HIS . 90.3 t -136.44 164.6 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.632 ' N ' HG12 ' A' ' 12' ' ' VAL . 64.4 m-70 -102.1 110.2 22.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.526 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.9 mm-40 -56.37 157.89 8.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 16' ' ' TRP . 54.2 Cg_endo -69.69 -32.94 3.6 Favored 'Cis proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.382 -0.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.544 ' C ' ' O ' ' A' ' 15' ' ' PRO . 8.3 m-90 -25.16 -58.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -32.08 -53.7 0.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.094 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.0 m -69.71 -55.06 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.9 mt -40.17 -31.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.488 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.6 mp -64.26 -68.04 0.38 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.476 HG11 ' N ' ' A' ' 82' ' ' GLY . 16.5 m -61.6 -10.45 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.453 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -84.3 -40.12 18.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.26 -5.2 8.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.88 -43.28 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HG2' HD11 ' A' ' 20' ' ' LEU . 8.4 tptp -100.24 105.54 17.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.573 HH21 ' NE ' ' A' ' 65' ' ' ARG . 6.3 ptp180 -102.48 23.63 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.1 m -152.51 146.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.598 ' CD ' HD23 ' A' ' 10' ' ' LEU . 3.1 tt0 -117.57 122.1 42.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.03 124.69 7.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -146.45 150.19 35.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.412 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.7 p -86.98 21.26 2.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.562 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.4 p-90 -143.78 160.91 39.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.48 137.78 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 34' ' ' THR . 11.9 t -134.41 98.38 13.88 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.542 0.687 . . . . 0.0 111.16 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.438 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.0 Cg_endo -69.72 9.5 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.427 ' O ' HD22 ' A' ' 86' ' ' LEU . 14.4 t60 -67.93 110.15 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 72.2 mmt-85 -106.94 113.13 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.11 -151.9 22.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -78.58 142.67 37.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.8 tp -143.74 112.45 6.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.584 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 95.0 m95 -72.04 123.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.449 ' O ' HD23 ' A' ' 80' ' ' LEU . 51.8 mm -94.77 130.07 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -128.97 154.72 46.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.64 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -88.07 132.22 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 12' ' ' VAL . 20.1 p -72.73 171.95 11.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.02 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 5.3 ttpt -64.3 130.16 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -91.36 129.27 43.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.91 18.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.669 2.246 . . . . 0.0 112.39 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -75.37 155.41 85.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.695 0.76 . . . . 0.0 110.84 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -3.91 12.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.693 2.262 . . . . 0.0 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -94.63 -44.37 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.508 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 14.2 mp0 -65.79 -41.86 91.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.6 t -63.76 -50.14 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.147 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -63.47 -45.36 91.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.22 -54.59 31.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.467 HD22 ' HE2' ' A' ' 61' ' ' TYR . 79.8 mt -54.32 -58.36 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 37.6 mt-30 -34.85 -48.48 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.5 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -54.62 -52.68 61.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.467 ' HE2' HD22 ' A' ' 57' ' ' LEU . 24.0 m-85 -67.69 -35.86 79.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.456 ' HG2' HG22 ' A' ' 69' ' ' VAL . 31.1 mtt-85 -51.4 -33.84 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.6 mt -89.88 -14.28 34.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.541 HD11 ' NE2' ' A' ' 104' ' ' GLN . 60.4 mt -88.61 -31.02 18.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.573 ' NE ' HH21 ' A' ' 26' ' ' ARG . 4.6 mmm180 -119.39 -29.3 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.064 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.63 125.29 2.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.503 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -44.52 -20.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' GLY . 9.1 m-20 -82.67 21.49 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.064 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.4 m -70.69 -178.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.8 pt-20 -116.56 168.65 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 63.8 m-85 -159.93 141.38 9.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.67 0.748 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.75 168.04 22.69 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -92.89 -23.71 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -146.64 167.47 23.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 72' ' ' PRO . 83.3 m-85 -133.09 88.34 36.75 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.655 0.741 . . . . 0.0 110.907 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.46 ' HG2' HD21 ' A' ' 81' ' ' LEU . 54.2 Cg_endo -69.72 169.18 19.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.0 p -136.92 136.65 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.29 46.22 50.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.6 m -155.28 152.3 29.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.493 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -77.56 116.08 17.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 44' ' ' ALA . 25.1 mt -83.74 -70.11 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.476 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.04 -141.82 3.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.57 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 6.5 t -153.47 161.37 42.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.0 m -151.56 145.25 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.405 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.9 t70 -90.27 112.91 24.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.7 tt -75.12 98.12 3.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.22 -47.45 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.6 m-20 -163.64 168.16 20.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.37 103.23 7.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.9 mt -100.49 165.74 11.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.954 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 93' ' ' LYS . 33.3 t -106.12 169.05 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 6.0 mm100 -45.24 -20.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' N ' ' C ' ' A' ' 91' ' ' SER . 26.3 ttmt -87.94 -63.74 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -66.66 -49.19 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 111' ' ' VAL . 32.2 t80 -42.76 -55.26 3.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 97' ' ' GLU . 7.5 ptmt -68.25 -40.34 81.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 6.8 mt-10 -54.8 -59.66 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -75.97 -48.55 20.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -110.88 66.74 0.53 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 0.0 110.88 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.71 -12.24 32.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.363 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.71 -22.99 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.615 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.4 pt -122.1 22.26 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 p -62.48 -22.24 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.541 ' NE2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -94.37 -31.04 14.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.615 ' CD ' HG22 ' A' ' 102' ' ' ILE . 22.3 mt-10 -45.59 -37.06 5.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -128.52 134.32 48.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 10.4 t0 -97.91 -36.29 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.878 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 m -39.87 159.94 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 0.0 110.836 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.8 Cg_endo -69.76 -47.34 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -107.37 101.85 11.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.576 HG21 ' CD2' ' A' ' 95' ' ' PHE . 33.2 t -86.52 140.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.46 ' CE1' HG22 ' A' ' 34' ' ' THR . 8.7 m-30 -107.41 109.5 21.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -78.0 120.83 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.0 m -124.27 155.02 39.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -141.17 177.36 8.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 55.91 52.35 7.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.74 116.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.317 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -130.88 133.62 46.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -97.77 122.22 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.52 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 16.5 mtp -62.87 154.21 30.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.928 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -75.24 -30.03 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.56 142.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -107.55 140.02 41.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.52 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.7 OUTLIER -105.06 142.89 25.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.618 0.723 . . . . 0.0 110.876 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 83.07 0.72 Allowed 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.406 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.7 pp -121.41 155.8 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.585 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 8.2 ptpt -97.08 141.53 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -104.45 162.4 15.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.459 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -137.86 160.66 63.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.62 0.724 . . . . 0.0 110.909 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 2.53 3.45 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.8 mmmm -136.88 -175.15 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.594 HG22 ' CE3' ' A' ' 8' ' ' TRP . 83.6 mt -85.24 133.58 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.585 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.0 p-90 -140.46 128.3 21.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -56.43 126.03 24.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' CG ' ' HB2' ' A' ' 9' ' ' CYS . 25.4 mt -59.98 173.25 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.7 t70 -82.46 127.46 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.54 -39.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -74.42 -41.69 60.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' ASP . 29.1 mm -64.46 -42.56 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -40.47 -63.22 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLY . 45.1 mt-30 -53.45 -69.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.75 -51.66 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.584 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.09 -46.82 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -62.45 -23.36 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 147' ' ' LEU . 11.5 mmmm -80.38 -53.1 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -39.26 -24.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 145' ' ' LYS . 28.3 mt -82.66 36.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.323 . . . . 0.0 110.877 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.2 ptp -97.66 -37.02 10.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -134.68 73.38 1.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -68.22 173.67 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -45.73 169.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -57.67 -43.86 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -55.51 -52.25 64.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.059 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.0 m -75.39 119.43 19.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.2 m -86.26 89.04 7.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.48 -178.61 53.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.513 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.8 p -102.49 156.82 17.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.93 0.395 . . . . 0.0 110.845 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 m -158.77 139.16 12.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.16 98.13 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.547 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.688 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.9 m95 -81.4 164.22 22.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.925 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -138.69 133.34 32.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.597 ' HB2' HD21 ' A' ' 40' ' ' LEU . 31.1 tp -121.17 109.43 14.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.6 m -67.94 134.17 50.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.822 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.775 HG22 HH22 ' A' ' 30' ' ' ARG . 34.0 t -115.24 157.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.479 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 33.6 m-70 -90.54 113.71 25.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.566 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 16.3 mt-30 -59.06 160.51 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.561 0.696 . . . . 0.0 110.958 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.555 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -30.1 5.32 Favored 'Cis proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.36 -0.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.691 ' O ' HD12 ' A' ' 20' ' ' LEU . 9.7 m-90 -26.98 -54.5 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.29 -65.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 3.4 m -59.67 -43.49 93.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 16' ' ' TRP . 59.3 mt -50.78 -39.19 51.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.8 mp -58.53 -69.58 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.582 HG11 ' N ' ' A' ' 82' ' ' GLY . 26.6 m -57.46 -23.55 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.47 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.8 mmt180 -71.02 -39.14 72.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.67 24.59 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.466 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.39 -37.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.543 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -105.17 103.48 13.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.428 ' CD ' HH12 ' A' ' 65' ' ' ARG . 18.7 ptt180 -102.06 28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.494 HG11 HD12 ' A' ' 102' ' ' ILE . 34.0 m -156.51 142.59 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' CD ' ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -115.16 137.92 51.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.98 115.03 5.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.775 HH22 HG22 ' A' ' 12' ' ' VAL . 75.0 mmt-85 -138.52 154.11 48.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.477 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 95.7 p -88.99 20.67 3.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 1.8 p-90 -141.74 165.57 27.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -106.54 139.08 41.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 34' ' ' THR . 9.8 t -133.89 99.16 14.01 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.3 Cg_endo -69.73 7.98 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.428 ' O ' HD22 ' A' ' 86' ' ' LEU . 23.7 t60 -64.46 107.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.479 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.4 mmt-85 -103.85 108.8 20.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.42 -148.79 16.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -85.55 144.54 27.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 10' ' ' LEU . 22.0 tp -143.46 114.56 7.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 87.9 m95 -71.27 127.86 33.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -97.77 126.0 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.32 142.03 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.852 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -77.05 118.09 19.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.3 p -57.59 178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.5 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -98.76 128.61 45.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.909 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -87.61 122.41 70.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.565 0.698 . . . . 0.0 110.869 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 133.0 24.48 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.668 2.246 . . . . 0.0 112.346 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.9 m -78.19 161.29 71.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.684 0.754 . . . . 0.0 110.821 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -10.79 29.41 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.646 2.231 . . . . 0.0 112.352 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -87.33 -49.11 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -41.16 99.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 50' ' ' SER . 42.5 t -65.72 -51.14 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 t -63.64 -43.52 96.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -66.7 -52.73 41.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.489 HD22 ' HE2' ' A' ' 61' ' ' TYR . 83.7 mt -58.47 -42.44 87.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 36.3 mt-30 -52.82 -45.29 67.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.43 -36.25 39.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 m -60.43 -52.21 66.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.489 ' HE2' HD22 ' A' ' 57' ' ' LEU . 31.8 m-85 -68.43 -38.55 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.539 ' HG2' HG22 ' A' ' 69' ' ' VAL . 64.8 mtt180 -49.1 -34.25 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.92 -13.93 35.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.1 -27.86 19.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.428 HH12 ' CD ' ' A' ' 26' ' ' ARG . 3.9 mmm180 -122.66 -28.74 4.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.023 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.22 127.96 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.81 -19.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.55 14.71 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.023 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.8 m -64.45 -179.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -114.41 160.38 19.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 48.5 m-85 -155.44 134.87 7.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.477 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.84 165.08 32.28 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.637 2.224 . . . . 0.0 112.331 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -85.34 -29.08 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -148.01 174.95 11.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.555 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 43.1 m-85 -134.78 100.65 12.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.68 0.752 . . . . 0.0 110.959 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 53.6 Cg_endo -69.76 179.68 3.53 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.701 2.267 . . . . 0.0 112.345 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.8 p -142.05 141.32 32.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.85 58.01 16.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 10.2 m -162.15 150.61 14.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.598 HD22 ' SD ' ' A' ' 120' ' ' MET . 0.5 OUTLIER -77.25 118.77 20.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 44' ' ' ALA . 23.2 mt -88.52 -69.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.582 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.93 -143.52 3.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.5 p -157.5 148.63 21.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 110.883 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 18.9 m -135.96 136.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.12 111.58 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 112' ' ' PHE . 4.8 tt -72.97 104.28 4.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -73.15 -47.13 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.32 168.16 18.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.15 103.21 7.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 94' ' ' GLN . 93.6 mt -100.17 165.92 11.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 93' ' ' LYS . 47.9 t -102.91 169.61 8.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 107' ' ' ASP . 7.1 mm100 -45.13 -20.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 25.9 ttpt -91.0 -67.94 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.93 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.536 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.3 mt-30 -58.45 -46.19 87.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.8 t80 -44.09 -57.86 3.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.9 ptpt -68.66 -43.05 77.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.7 mt-10 -49.14 -59.26 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.6 mt-30 -78.74 -46.62 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 33.2 m-85 -111.24 68.56 0.67 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.685 0.755 . . . . 0.0 110.86 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.8 Cg_endo -69.8 -12.5 32.94 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.644 2.229 . . . . 0.0 112.368 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.34 -22.22 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.739 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.9 pt -124.78 23.2 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.506 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 37.0 p -64.21 -28.27 69.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.45 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -90.07 -30.25 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.739 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.5 mt-10 -43.63 -36.09 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.2 t -125.09 151.24 45.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.1 t70 -115.14 -29.26 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.42 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 1.4 m -49.3 162.18 0.43 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.678 0.751 . . . . 0.0 110.887 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.486 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.3 Cg_endo -69.74 -46.13 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.714 2.276 . . . . 0.0 112.337 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -109.98 104.71 13.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 95' ' ' PHE . 19.7 t -91.8 132.29 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 2.9 m-30 -100.25 108.82 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.41 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -76.01 124.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.482 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -125.09 155.65 39.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' CG ' HD12 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -138.94 177.56 7.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.844 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 53.43 52.8 10.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.506 ' O ' HG11 ' A' ' 154' ' ' VAL . 53.4 Cg_endo -69.76 115.14 3.96 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.266 . . . . 0.0 112.314 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.85 142.03 49.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.14 124.81 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.598 ' SD ' HD22 ' A' ' 80' ' ' LEU . 13.8 mtp -63.69 148.44 49.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.62 -33.64 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.092 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.63 142.35 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -106.46 152.93 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.568 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.1 m-85 -119.12 140.06 28.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 88.22 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.294 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.461 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -118.18 158.91 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.595 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 30.3 mtpt -89.86 114.94 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.67 158.66 53.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.526 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -145.67 158.75 49.35 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 4.4 mmmm -91.73 -173.83 3.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.688 HG22 ' CE3' ' A' ' 8' ' ' TRP . 62.7 mt -82.89 137.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.1 p-90 -143.59 128.03 17.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -55.21 130.04 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.8 mt -63.6 178.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.0 167.45 15.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 p -72.2 -43.09 65.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -78.51 -18.86 54.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.568 HG23 ' CD2' ' A' ' 124' ' ' PHE . 15.7 mm -89.78 -36.23 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -51.29 -59.98 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 144' ' ' LYS . 82.2 mt-30 -56.7 -66.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.51 -42.18 0.91 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.458 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -61.86 -42.18 98.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.105 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.0 mtpp -65.82 -24.99 67.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 147' ' ' LEU . 23.7 mmmt -80.87 -52.13 7.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 150' ' ' GLN . . . -41.9 -23.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.504 HD11 ' SG ' ' A' ' 83' ' ' CYS . 34.2 mt -82.6 42.16 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 9.5 ptp -107.78 -39.07 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -134.9 53.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.527 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 1.5 mm-40 -41.88 -75.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -168.33 165.46 12.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -42.17 -37.53 1.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.7 119.59 0.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.104 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 117' ' ' PRO . 93.8 t . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.113 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t -94.97 -59.53 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.911 0.386 . . . . 0.0 110.88 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.0 p -83.93 104.4 13.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.97 -123.91 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.1 p -75.81 119.55 19.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -112.5 17.98 18.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.15 58.98 4.1 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.512 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.654 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.0 m95 -72.65 165.04 25.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.726 0.298 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.477 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 14.1 p -137.76 137.69 38.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 40' ' ' LEU . 10.7 tp -120.34 107.45 12.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 t -67.98 142.0 56.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 8.8 t -126.58 159.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.533 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.2 m-70 -90.52 112.89 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.554 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 13.0 mt-30 -58.57 160.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.577 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.72 -28.69 6.1 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.369 -0.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.506 ' C ' ' O ' ' A' ' 15' ' ' PRO . 9.5 m-90 -28.72 -57.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.26 -61.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 22' ' ' ARG . 2.2 m -63.1 -46.51 87.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.415 HD23 HD13 ' A' ' 24' ' ' ILE . 53.1 mt -45.74 -31.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 8.8 mp -67.21 -68.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.581 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.1 m -60.67 -10.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.7 mmt180 -84.34 -39.18 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 117' ' ' PRO . . . 123.16 0.14 9.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.431 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.2 mp -85.1 -49.63 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -88.91 118.54 28.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 26' ' ' ARG . 10.1 ttt180 -103.8 -0.07 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 28.4 m -143.45 155.62 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 4.9 tm-20 -122.07 152.86 39.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.544 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -111.31 129.36 9.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.7 mmt180 -148.82 145.04 27.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.866 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.402 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 61.5 p -83.02 18.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.582 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.1 p-90 -143.98 165.82 26.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -105.5 140.67 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 34' ' ' THR . 6.3 t -135.03 104.82 10.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.709 . . . . 0.0 111.114 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.6 Cg_endo -69.8 2.63 3.38 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.641 2.227 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.439 ' O ' HD22 ' A' ' 86' ' ' LEU . 16.4 t60 -62.17 111.77 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 5.8 mmt85 -114.24 122.09 45.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.52 -125.92 2.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -99.47 142.8 30.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 10' ' ' LEU . 15.0 tp -144.03 111.82 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.557 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 94.5 m95 -72.44 121.73 20.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.62 130.14 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -127.67 142.08 51.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.749 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -76.17 122.31 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.9 p -58.96 175.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.35 -15.98 61.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 6.4 ttpt -73.41 144.39 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.52 137.37 19.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.614 0.721 . . . . 0.0 110.889 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.73 128.97 16.83 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.69 2.26 . . . . 0.0 112.324 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 m -73.06 156.2 89.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.665 0.745 . . . . 0.0 110.862 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -94.52 -36.92 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.24 -42.36 68.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.647 HG12 ' OE1' ' A' ' 58' ' ' GLN . 47.8 t -64.31 -51.23 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -61.69 -44.58 96.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.29 -56.63 10.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 58' ' ' GLN . 94.1 mt -54.73 -55.91 24.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.647 ' OE1' HG12 ' A' ' 54' ' ' VAL . 37.6 mt-30 -37.45 -48.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.48 -44.64 34.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 m -51.97 -53.36 42.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -66.79 -38.67 86.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.4 mtt180 -48.77 -37.63 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -86.47 -15.99 38.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.498 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 59.5 mt -85.78 -28.84 24.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.498 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.9 mmp_? -122.67 -27.44 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.059 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 128.64 129.08 3.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.448 ' C ' ' HD3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -45.06 -20.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.5 p30 -70.95 3.18 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.059 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.2 m -60.63 178.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 8.8 mp0 -122.94 172.3 8.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 76.7 m-85 -161.11 141.47 8.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.557 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.87 29.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 0.0 112.362 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.02 -27.03 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -144.87 166.1 26.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.577 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 76.0 m-85 -130.64 88.47 46.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.645 0.736 . . . . 0.0 110.884 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 54.3 Cg_endo -69.75 168.43 21.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.67 2.246 . . . . 0.0 112.368 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.3 p -133.36 150.25 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.06 40.42 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 28.2 m -147.27 151.72 37.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.665 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -78.85 113.12 16.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 44' ' ' ALA . 26.3 mt -81.18 -70.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.581 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -149.09 -142.95 3.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.541 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -153.79 153.68 32.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 m -140.99 139.86 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.403 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.6 t70 -81.88 112.72 19.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.439 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.5 tt -77.45 100.38 5.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.532 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.98 -45.62 71.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 3.5 m-20 -165.46 165.9 18.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.421 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.3 t -127.77 97.09 4.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.519 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 95.4 mt -94.67 168.13 11.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 93' ' ' LYS . 46.3 t -104.84 169.41 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 108' ' ' SER . 11.6 mm-40 -45.04 -20.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.1 ttmt -91.65 -69.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -57.98 -45.74 86.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.605 ' CD2' HG21 ' A' ' 111' ' ' VAL . 16.5 t80 -44.43 -58.66 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 10.4 ptpt -66.91 -40.01 87.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.2 mt-10 -49.99 -56.01 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.498 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.7 mt-30 -81.87 -49.18 10.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.498 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 19.8 m-85 -109.77 69.13 0.48 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.664 0.745 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.2 Cg_endo -69.78 -11.79 31.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.665 2.244 . . . . 0.0 112.354 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.42 -22.14 51.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.717 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.0 OUTLIER -122.44 22.75 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.6 p -64.07 -20.76 66.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.428 ' NE2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -96.54 -27.82 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.717 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.1 mt-10 -47.03 -40.06 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 t -120.09 150.64 40.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -116.2 -27.19 6.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.44 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -52.11 162.34 0.85 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.83 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 54.3 Cg_endo -69.72 -37.27 9.49 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.12 101.18 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.605 HG21 ' CD2' ' A' ' 95' ' ' PHE . 50.7 t -84.39 136.43 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 7.5 m-30 -104.59 102.39 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -70.62 119.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 2.7 m -124.26 154.02 40.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -142.09 176.71 8.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 54.79 52.24 8.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.82 119.94 6.8 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.331 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -132.47 138.48 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -102.75 122.26 44.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.665 ' HE1' HD13 ' A' ' 80' ' ' LEU . 16.9 mtp -62.92 153.26 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 149' ' ' LYS . 90.4 t -72.8 -37.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.16 138.07 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -102.49 149.58 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -113.11 142.34 27.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 86.66 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.535 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -121.06 160.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 15.0 ptmt -99.61 134.6 42.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.79 -178.01 39.45 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -161.12 159.22 24.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 0.3 5.87 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.629 2.219 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.582 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 9.1 mmmm -136.94 -175.0 3.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.654 HG22 ' CE3' ' A' ' 8' ' ' TRP . 71.9 mt -84.88 140.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.12 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.503 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 9.4 p-90 -146.51 128.96 15.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.557 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 15.2 ttmt -56.5 130.3 44.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 139' ' ' ILE . 17.8 mt -65.71 168.85 7.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.3 t70 -77.4 127.19 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.13 -40.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.61 -42.54 58.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 24.9 mm -64.04 -38.72 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -46.54 -65.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.7 mm-40 -49.75 -68.49 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.05 -54.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.557 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.24 -40.91 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 111.097 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -67.83 -17.03 64.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.6 mmmm -89.84 -50.09 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -40.04 -23.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.539 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 145' ' ' LYS . 22.6 mt -81.67 38.86 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.472 ' C ' ' HE3' ' A' ' 149' ' ' LYS . 6.9 ptp -105.02 -37.0 7.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.649 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -124.32 78.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.893 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 26.3 mm-40 -76.32 167.42 21.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -45.52 171.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.1 -40.01 62.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.74 -58.32 8.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.151 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -72.3 159.3 34.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -121.86 130.49 53.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.893 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.75 111.42 0.36 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.48 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.2 p -78.24 140.24 38.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.901 0.382 . . . . 0.0 110.803 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -98.68 18.86 15.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.9 66.47 1.92 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.486 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.481 ' CE3' HG22 ' A' ' 132' ' ' ILE . 94.0 m95 -83.05 164.17 20.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 12.9 p -145.6 142.45 29.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.436 ' CD2' ' HG2' ' A' ' 28' ' ' GLU . 8.9 tp -130.95 114.16 14.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 18.7 m -69.59 147.45 50.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 19.7 t -129.76 154.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.437 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 37.3 m-70 -86.66 120.14 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.631 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 57.6 mt-30 -64.14 161.61 38.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 16' ' ' TRP . 53.5 Cg_endo -69.8 -30.53 5.1 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.325 -0.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.606 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.3 m-90 -26.89 -54.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.631 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.26 -64.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -63.04 -45.76 90.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 16' ' ' TRP . 57.4 mt -45.23 -30.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.678 HD21 ' OE1' ' A' ' 28' ' ' GLU . 6.6 mp -68.81 -69.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG21 ' OE1' ' A' ' 119' ' ' GLU . 5.0 m -57.26 -15.48 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.461 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.1 mmt180 -79.38 -39.57 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.63 7.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.3 mp -76.38 -57.01 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 111.152 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.0 tptt -84.03 112.25 20.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HG3' HG13 ' A' ' 27' ' ' VAL . 8.1 ptm180 -109.99 20.24 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.479 HG11 ' CE1' ' A' ' 95' ' ' PHE . 23.6 m -149.94 145.91 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.678 ' OE1' HD21 ' A' ' 20' ' ' LEU . 2.4 tp10 -109.15 146.53 33.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.56 119.86 5.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 24.7 mmt180 -148.89 145.44 27.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -83.31 17.71 2.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 4.9 p-90 -139.85 163.49 32.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.0 145.33 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.494 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.6 t -138.75 106.99 7.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.714 . . . . 0.0 111.128 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 54.1 Cg_endo -69.72 3.86 2.51 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.677 2.251 . . . . 0.0 112.371 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.571 ' O ' HD22 ' A' ' 86' ' ' LEU . 24.1 t60 -65.3 114.27 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -120.18 117.65 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.03 -121.32 1.05 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.464 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -106.35 140.08 39.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 15.6 tp -144.27 113.9 7.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.608 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.1 m95 -72.02 128.88 37.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.0 133.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.24 166.88 17.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -98.87 119.33 37.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.5 p -55.22 -179.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.12 -5.45 57.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HD3' ' ND1' ' A' ' 13' ' ' HIS . 4.2 tttt -86.81 124.71 33.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -85.53 139.28 35.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.531 0.681 . . . . 0.0 110.939 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 54.2 Cg_endo -69.76 132.25 22.95 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 54' ' ' VAL . 15.4 m -76.02 157.52 83.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.697 0.761 . . . . 0.0 110.845 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -5.84 17.19 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.671 2.247 . . . . 0.0 112.342 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -95.03 -44.39 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 50' ' ' SER . 59.7 t -65.34 -49.42 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -65.27 -44.01 89.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.19 -53.77 27.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.953 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.458 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 75.6 mt -56.49 -40.16 74.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 36.4 mt-30 -55.03 -42.7 72.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.61 -32.99 28.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -64.67 -52.86 55.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -64.34 -38.22 90.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.534 ' HG2' HG22 ' A' ' 69' ' ' VAL . 54.2 mtt180 -49.79 -34.25 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.0 mt -90.56 -12.19 37.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.89 -28.9 17.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -122.53 -29.25 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.039 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.24 126.11 2.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.435 ' C ' ' HD3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -44.44 -21.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -79.23 15.29 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.5 m -64.02 -177.06 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 24' ' ' ILE . 13.0 mt-10 -115.91 165.97 12.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 55.4 m-85 -161.12 132.38 3.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.526 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.71 169.12 19.59 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.68 2.253 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -144.28 170.81 15.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' CZ ' ' HG2' ' A' ' 72' ' ' PRO . 58.1 m-85 -134.21 93.36 19.66 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.628 0.728 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.52 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.77 169.79 18.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.2 m -136.37 139.44 42.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.851 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.58 49.41 60.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.1 m -157.08 147.62 21.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.878 0.37 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.656 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.27 120.81 21.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 44' ' ' ALA . 78.6 mt -88.8 -73.75 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.86 -144.63 4.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.572 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 14.2 t -151.14 157.84 43.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 m -143.09 142.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.422 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.5 t70 -86.49 111.45 20.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.571 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.9 tt -75.24 98.39 3.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.552 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.25 -47.66 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.7 m-20 -164.92 168.2 17.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -127.9 100.42 5.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 94' ' ' GLN . 94.0 mt -94.01 170.06 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' LYS . 65.0 m -109.41 169.61 8.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 109' ' ' PRO . 10.6 mm100 -43.0 -22.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' SER . 29.0 ttmt -89.79 -66.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.623 ' HB3' HD22 ' A' ' 90' ' ' LEU . 10.3 mt-30 -60.35 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.526 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 28.6 t80 -46.02 -55.56 6.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 1.9 ptmt -69.69 -39.51 76.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.26 -59.41 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.481 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 9.6 mt-30 -77.51 -49.5 14.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 25.1 m-85 -109.95 67.62 0.46 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.633 0.73 . . . . 0.0 110.84 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.77 -12.19 32.37 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 -22.17 51.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.513 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.1 pt -121.35 15.99 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.3 p -58.4 -22.56 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.573 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -94.49 -30.69 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 8.7 mt-10 -47.04 -26.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 t -136.86 138.67 41.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.74 26.61 9.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 16.4 p -100.17 157.69 33.37 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.652 0.739 . . . . 0.0 110.86 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.73 -23.2 31.19 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 0.0 112.348 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -134.97 95.0 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 95' ' ' PHE . 43.4 t -85.63 137.55 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -104.44 108.01 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER -75.13 122.92 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.4 m -125.67 155.97 40.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -144.02 176.49 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.49 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 57.83 51.73 4.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.634 0.73 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.4 Cg_endo -69.74 114.19 3.62 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.404 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.24 134.7 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.541 ' OE1' HG21 ' A' ' 21' ' ' VAL . 3.9 tp10 -97.6 123.53 41.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.656 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.6 mtp -63.76 157.77 23.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 149' ' ' LYS . 91.6 t -81.08 -32.5 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.4 144.42 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -111.05 148.22 33.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.467 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.0 OUTLIER -117.54 142.53 30.61 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.71 0.767 . . . . 0.0 110.822 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 86.83 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.63 2.22 . . . . 0.0 112.391 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.468 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.8 pp -125.01 162.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.5 mmtp -108.15 149.03 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -100.03 178.22 29.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.519 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -154.53 161.06 30.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.66 0.743 . . . . 0.0 110.876 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -1.61 8.79 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.2 mmmm -137.27 -174.99 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.481 HG22 ' CE3' ' A' ' 8' ' ' TRP . 74.1 mt -83.11 139.79 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.2 p-90 -145.11 127.94 16.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.453 ' NZ ' ' CZ2' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -64.21 125.23 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 139' ' ' ILE . 30.2 mt -52.76 -176.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.8 t0 -91.7 131.72 36.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -36.65 -36.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -40.33 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.623 HG21 HD22 ' A' ' 135' ' ' LEU . 32.2 mm -67.36 -45.77 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.8 t-160 -36.5 -63.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 41.4 mm-40 -52.48 -69.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.53 -48.23 0.65 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.608 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -58.45 -43.25 88.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.819 0.342 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 15.9 mtpp -64.46 -26.45 68.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.455 ' HE2' ' N ' ' A' ' 145' ' ' LYS . 8.5 mmpt? -80.37 -46.34 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -45.68 -22.38 0.71 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 34.3 mt -86.71 36.83 0.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.4 ptp -89.61 -36.89 15.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.499 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 1.4 mmmm -148.02 108.3 4.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -86.62 174.07 9.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.436 ' OD1' HG12 ' A' ' 154' ' ' VAL . 6.9 p30 -44.84 157.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -101.43 37.79 1.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -117.29 -54.85 2.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.436 HG12 ' OD1' ' A' ' 151' ' ' ASN . 11.0 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.8 m 57.89 41.29 24.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.6 m -125.16 39.77 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.854 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 158.65 31.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.494 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.2 m -112.64 105.84 14.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.833 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -86.47 29.76 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.56 63.29 5.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.505 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.453 ' CE3' HG22 ' A' ' 132' ' ' ILE . 87.3 m95 -72.35 169.79 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HB2' HD11 ' A' ' 135' ' ' LEU . 43.0 t -140.33 139.15 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -130.05 115.57 17.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 m -67.77 156.38 37.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.657 HG22 ' OE2' ' A' ' 28' ' ' GLU . 53.7 t -139.03 157.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.482 ' N ' HG12 ' A' ' 12' ' ' VAL . 43.1 m-70 -90.41 109.43 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.578 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 16.5 mt-30 -58.33 161.14 8.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.7 -30.57 5.05 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.73 -1.779 . . . . 0.0 112.325 -0.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 9.6 m-90 -26.66 -49.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.578 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -35.28 -60.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -67.03 -51.09 59.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 16' ' ' TRP . 91.3 mt -40.51 -30.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.8 mp -68.32 -65.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.6 m -62.58 -18.38 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.47 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 14.4 mmt180 -74.81 -39.93 61.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.4 -2.18 7.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.778 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.1 mp -83.07 -55.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.391 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.506 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.5 tptp -86.59 120.26 27.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.618 ' HD2' HD13 ' A' ' 102' ' ' ILE . 4.3 ptp180 -114.37 15.92 17.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.518 HG11 HD12 ' A' ' 102' ' ' ILE . 33.9 m -147.56 142.92 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.657 ' OE2' HG22 ' A' ' 12' ' ' VAL . 6.9 tp10 -107.97 147.01 31.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -113.18 119.54 4.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.0 mmt180 -146.22 151.96 38.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 0.0 110.887 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.476 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 84.2 p -87.42 22.31 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.458 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 3.4 p-90 -142.24 161.12 38.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 12.0 t80 -103.65 139.23 39.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 34' ' ' THR . 7.6 t -134.41 101.66 12.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.566 0.698 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.5 Cg_endo -69.8 8.33 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.646 2.231 . . . . 0.0 112.36 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.599 ' O ' HD22 ' A' ' 86' ' ' LEU . 20.4 t60 -68.67 109.73 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mmt-85 -109.62 107.25 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.98 -153.37 23.89 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -73.02 140.57 47.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 21.2 tp -143.95 113.88 7.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.562 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 95.4 m95 -73.54 120.95 19.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.62 128.94 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.48 153.27 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -88.75 122.55 32.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.8 p -62.45 173.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.27 -9.74 58.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 7.7 ttpt -70.47 127.27 32.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -85.46 125.68 68.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.567 0.698 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD3' HE21 ' A' ' 14' ' ' GLN . 54.2 Cg_endo -69.72 130.82 20.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.247 . . . . 0.0 112.354 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.6 m -76.89 158.97 79.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.666 0.746 . . . . 0.0 110.79 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 -16.98 38.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 0.0 112.372 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -84.44 -39.06 19.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -41.42 76.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.7 HG12 ' OE1' ' A' ' 58' ' ' GLN . 52.5 t -67.94 -48.87 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.162 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -63.62 -45.14 91.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.87 -52.44 43.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.651 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 83.9 mt -59.31 -44.76 92.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.7 ' OE1' HG12 ' A' ' 54' ' ' VAL . 33.7 mt-30 -50.18 -46.12 54.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.89 -36.95 41.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.3 m -59.24 -51.18 71.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.403 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 26.5 m-85 -69.06 -37.26 78.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.5 mtt-85 -49.88 -33.99 18.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.78 -15.94 31.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.8 mt -88.06 -28.66 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.448 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 3.6 mmm180 -121.47 -28.87 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.034 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 132.45 126.98 2.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.476 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.57 -20.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.1 m-20 -80.72 18.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.034 HG13 ' O ' ' A' ' 66' ' ' GLY . 23.2 m -68.02 179.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.117 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.778 ' O ' HD11 ' A' ' 24' ' ' ILE . 11.9 mt-10 -112.25 157.2 21.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -154.51 132.06 6.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.657 0.742 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.694 2.262 . . . . 0.0 112.322 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -81.4 -32.05 32.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -145.31 174.23 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.0 m-85 -133.45 95.47 18.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.665 0.745 . . . . 0.0 110.936 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 53.4 Cg_endo -69.75 171.59 14.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.332 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -141.33 133.25 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 46.13 9.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -159.27 149.39 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.409 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -74.23 113.43 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.743 HD11 ' HB2' ' A' ' 44' ' ' ALA . 77.8 mt -79.3 -74.4 0.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.501 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -143.9 -145.07 4.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.562 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 5.5 t -149.54 162.49 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.9 m -151.71 140.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.41 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.4 t70 -85.63 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.599 HD22 ' O ' ' A' ' 36' ' ' HIS . 5.6 tt -73.48 99.82 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.526 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.89 -48.29 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.43 167.4 23.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.53 101.25 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.517 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.2 mt -96.37 168.38 10.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 15.0 p -106.29 169.19 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.495 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 6.0 mm100 -46.65 -19.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 91' ' ' SER . 21.9 ttmt -90.88 -59.0 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.504 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.5 mt-30 -68.52 -50.21 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.517 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 31.3 t80 -41.91 -55.9 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -67.25 -41.32 85.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.49 -58.83 5.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.3 mt-30 -76.13 -50.11 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -109.88 67.91 0.46 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.1 Cg_endo -69.74 -13.57 34.92 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.71 2.273 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.68 -23.44 56.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.659 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.6 pt -121.91 23.45 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.2 p -65.0 -26.3 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.445 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -91.53 -27.98 17.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.659 ' CD ' HG22 ' A' ' 102' ' ' ILE . 18.3 mt-10 -49.3 -38.39 27.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.515 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.3 p -124.08 144.42 49.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 27.2 t70 -107.94 -36.36 6.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 m -39.6 157.99 0.13 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.856 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.7 Cg_endo -69.79 -49.23 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.661 2.241 . . . . 0.0 112.319 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' A' ' 33' ' ' TYR . 26.2 m-85 -106.32 98.69 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.516 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 22.1 t -83.91 139.62 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -107.29 107.09 17.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.24 122.83 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.1 m -126.8 155.41 42.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.08 176.25 9.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 56.59 51.97 6.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.73 115.52 4.13 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -127.92 134.79 49.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.4 ' O ' ' CD ' ' A' ' 150' ' ' GLN . 11.3 tm-20 -96.88 121.99 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.459 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 13.1 mtp -62.59 151.88 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 146' ' ' GLY . 59.3 t -72.74 -37.52 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 1.8 p -118.22 158.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.486 ' N ' ' CG2' ' A' ' 122' ' ' VAL . 12.5 mmtm -120.65 140.29 51.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -107.64 136.86 19.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.628 0.728 . . . . 0.0 110.897 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 86.03 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.438 HD12 ' C ' ' A' ' 126' ' ' ILE . 2.9 pp -121.89 163.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 70.9 mttt -97.95 132.04 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.03 170.9 40.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -153.42 153.07 28.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 1.42 4.46 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.301 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.435 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.7 mmmm -134.07 -175.39 3.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.453 HG22 ' CE3' ' A' ' 8' ' ' TRP . 72.7 mt -89.03 137.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.6 p-90 -146.05 131.48 18.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -59.62 124.59 20.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.476 HD22 HG21 ' A' ' 139' ' ' ILE . 27.1 mt -60.02 170.77 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.7 t70 -79.27 129.71 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.1 m -37.03 -37.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -76.05 -41.24 51.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 124' ' ' PHE . 37.5 mm -65.56 -39.65 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -45.92 -65.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.817 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 144' ' ' LYS . 28.1 mt-30 -47.89 -69.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.95 -52.85 1.54 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.445 ' HB2' ' HE2' ' A' ' 124' ' ' PHE . . . -52.52 -39.44 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 141' ' ' GLN . 10.7 mtpt -70.47 -14.73 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -86.08 -48.47 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -46.62 -19.15 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.497 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 47.1 mt -82.33 37.51 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.9 ptp -103.83 -40.69 6.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -134.99 59.97 1.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 146' ' ' GLY . 2.3 mm-40 -45.95 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.424 ' OD1' HG12 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -161.76 140.75 9.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -65.95 -25.79 67.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -50.46 -50.8 51.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.424 HG12 ' OD1' ' A' ' 151' ' ' ASN . 14.1 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -101.09 163.91 12.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.881 0.372 . . . . 0.0 110.866 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 m -62.25 121.15 12.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.75 -84.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.47 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m 58.65 43.56 18.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.862 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -76.36 165.11 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.83 102.26 2.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.574 ' CE3' HG22 ' A' ' 132' ' ' ILE . 94.7 m95 -94.96 161.97 13.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -137.24 140.25 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 28' ' ' GLU . 26.7 tp -124.13 108.88 12.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 3.9 p -67.57 137.17 55.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.718 HG22 ' OE2' ' A' ' 28' ' ' GLU . 33.9 t -121.13 161.44 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.543 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.5 m-70 -95.99 111.76 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.524 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 10.8 mm-40 -56.34 157.83 8.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.78 -33.03 3.57 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.361 -0.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 10.7 m-90 -24.97 -54.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.516 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -36.69 -54.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.5 m -70.04 -47.81 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -45.39 -28.31 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.6 mp -68.07 -65.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.651 HG11 ' N ' ' A' ' 82' ' ' GLY . 14.6 m -64.77 -14.2 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.3 mmt180 -78.64 -39.13 37.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.61 12.22 6.2 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.5 -47.63 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -88.79 116.66 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.49 ' CG ' ' O ' ' A' ' 26' ' ' ARG . 11.4 ttt180 -101.94 -1.14 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.59 HG11 ' CE1' ' A' ' 95' ' ' PHE . 32.7 m -141.55 152.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.144 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.718 ' OE2' HG22 ' A' ' 12' ' ' VAL . 2.2 tp10 -115.96 143.11 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.55 129.47 9.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.416 ' HD2' ' NE1' ' A' ' 32' ' ' TRP . 20.2 mmt180 -152.96 140.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.1 p -82.81 16.58 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.535 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.2 p-90 -139.29 166.44 24.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 34' ' ' THR . 8.8 t80 -106.45 148.39 28.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.618 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 5.8 t -143.95 107.09 4.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.709 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 54.2 Cg_endo -69.69 2.83 3.14 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.37 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.5 ' O ' HD22 ' A' ' 86' ' ' LEU . 13.3 t60 -65.42 117.91 8.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -123.53 120.43 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 85' ' ' ASP . . . 153.57 -121.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -99.55 140.77 33.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 17.4 tp -144.73 108.99 4.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.61 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 94.8 m95 -71.65 126.15 28.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 mm -96.39 129.3 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -126.63 150.56 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -85.37 126.26 33.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.071 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 12' ' ' VAL . 23.8 p -64.69 173.01 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.42 -21.15 62.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 9.0 ttpt -63.91 149.39 47.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.471 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -108.59 133.98 20.44 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.533 0.682 . . . . 0.0 110.921 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 128.32 15.86 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.708 2.272 . . . . 0.0 112.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.9 m -75.21 159.12 83.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 110.869 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -7.35 20.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -94.72 -41.78 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.63 -40.85 80.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 50' ' ' SER . 33.8 t -67.83 -49.6 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.4 t -64.2 -42.06 96.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -70.2 -55.15 10.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HE2' ' A' ' 61' ' ' TYR . 86.5 mt -55.88 -44.03 77.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 37.3 mt-30 -51.05 -47.06 61.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.67 -36.71 51.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -60.17 -51.25 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.676 ' HE2' HD22 ' A' ' 57' ' ' LEU . 46.0 m-85 -69.92 -38.59 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 69' ' ' VAL . 44.8 mtt180 -47.98 -36.34 12.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 mt -87.23 -18.14 30.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.0 mt -83.41 -32.28 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -118.4 -27.38 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.056 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 129.4 124.9 2.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.428 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -70.15 4.77 1.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.056 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.3 m -61.5 176.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -116.71 167.82 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 49.5 m-85 -157.67 139.06 9.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.71 159.4 53.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.745 2.297 . . . . 0.0 112.334 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.88 -24.09 33.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -150.73 172.22 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.598 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 56.2 m-85 -134.41 98.59 13.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.66 0.743 . . . . 0.0 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.76 -176.33 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.319 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.7 p -150.79 129.83 12.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.38 45.28 24.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.1 m -153.33 149.43 27.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.598 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -75.95 118.34 18.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 44' ' ' ALA . 43.8 mt -85.68 -71.57 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.651 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.26 -143.11 3.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.598 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -152.46 158.18 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.845 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.8 m -145.71 134.54 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 1.4 t70 -79.35 112.8 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.2 tt -76.41 102.67 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -72.04 -47.07 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . 7.0 m-20 -166.17 170.02 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.475 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -128.11 99.42 5.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.534 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 96.9 mt -93.04 171.24 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 93' ' ' LYS . 4.7 p -109.79 169.16 8.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' O ' ' CE ' ' A' ' 96' ' ' LYS . 10.5 mm100 -43.11 -23.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 18.4 ttmt -89.76 -65.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.501 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.1 mt-30 -59.38 -48.63 80.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.604 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.1 t80 -43.79 -56.9 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 11.7 ptpt -69.0 -41.96 77.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -50.06 -59.13 4.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.496 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.4 mt-30 -78.05 -45.07 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.0 m-85 -113.66 69.98 1.6 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.666 0.746 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -14.54 36.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 0.0 112.349 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -19.67 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.654 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.5 pt -125.73 21.74 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.469 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 58.8 p -64.51 -27.63 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.427 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -89.39 -29.52 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.654 ' CD ' HG22 ' A' ' 102' ' ' ILE . 22.9 mt-10 -45.31 -40.03 7.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.8 t -120.39 140.76 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.18 25.43 10.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.455 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 1.7 p -101.16 160.34 26.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.869 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.3 Cg_endo -69.79 -25.16 28.73 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 32' ' ' TRP . 20.2 m-85 -134.82 95.55 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.498 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.7 t -84.51 135.73 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.618 ' CZ ' HG22 ' A' ' 34' ' ' THR . 9.2 m-30 -101.9 103.54 14.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -71.12 122.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.9 m -125.56 156.08 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -143.53 176.36 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.488 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 58.15 51.95 4.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.5 Cg_endo -69.79 113.65 3.45 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.266 . . . . 0.0 112.303 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -127.35 141.7 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -103.67 120.96 41.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.598 ' HE1' HD13 ' A' ' 80' ' ' LEU . 17.3 mtp -64.05 143.01 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.94 HG21 ' HB2' ' A' ' 149' ' ' LYS . 29.4 t -69.96 -25.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.146 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.83 141.91 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -110.99 145.09 39.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.445 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.0 OUTLIER -113.41 143.29 29.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 91.49 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.279 . . . . 0.0 112.316 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.45 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.8 pp -130.63 158.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.11 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.591 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.0 mttm -103.5 137.23 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -96.24 166.87 24.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.468 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -140.53 161.7 53.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.714 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 0.56 5.45 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.535 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.5 mmmm -138.26 -174.99 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.574 HG22 ' CE3' ' A' ' 8' ' ' TRP . 82.7 mt -83.09 138.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.591 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 6.7 p-90 -146.63 124.2 11.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.47 127.07 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.17 -178.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -88.13 127.47 35.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.8 m -36.39 -40.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -73.44 -41.25 63.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 136' ' ' ASP . 23.5 mm -64.99 -44.99 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -38.55 -65.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 142' ' ' GLY . 14.4 mm100 -52.59 -68.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.21 -48.71 1.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.466 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.61 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.79 -45.79 81.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 111.089 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -63.57 -22.48 66.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -84.14 -46.63 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -45.44 -20.45 0.34 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.9 mt -83.33 32.84 0.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 7.2 ptp -94.74 -33.21 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.94 ' HB2' HG21 ' A' ' 121' ' ' VAL . 20.5 mtpt -120.95 50.71 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 149' ' ' LYS . 6.2 mm-40 -33.83 149.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 154' ' ' VAL . 0.9 OUTLIER -90.25 98.42 11.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -71.81 -34.97 69.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 154' ' ' VAL . . . -127.19 -61.01 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.486 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 97.2 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.105 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -137.96 143.78 40.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.6 p -93.1 151.38 19.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.879 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.23 119.41 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.3 m -111.49 172.6 6.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.872 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 57.8 m -141.24 138.3 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.82 102.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.456 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.72 ' CE3' HG22 ' A' ' 132' ' ' ILE . 93.3 m95 -90.23 156.98 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.587 ' HB2' HD11 ' A' ' 135' ' ' LEU . 52.7 t -134.5 121.7 21.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.463 HD13 ' HH2' ' A' ' 32' ' ' TRP . 65.6 tp -107.44 109.19 20.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -68.09 154.53 41.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 20' ' ' LEU . 24.5 t -133.65 159.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.094 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.511 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 57.4 m-70 -90.13 113.72 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.557 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 78.7 mt-30 -59.7 159.75 17.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.75 -31.52 4.5 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.355 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.529 ' C ' ' O ' ' A' ' 15' ' ' PRO . 10.0 m-90 -26.81 -48.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.557 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -39.33 -63.44 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.1 mt -52.62 -28.52 21.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 12' ' ' VAL . 7.1 mp -69.75 -60.46 2.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 82' ' ' GLY . 18.6 m -67.65 -20.5 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -73.12 -39.17 65.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 14.66 5.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.21 -45.14 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 111.154 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CD ' ' OH ' ' A' ' 61' ' ' TYR . 4.2 tptp -93.81 118.85 32.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -101.05 -4.39 27.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 8.0 m -141.33 152.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -120.35 130.51 54.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.453 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -86.57 132.06 10.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' N ' ' CB ' ' A' ' 108' ' ' SER . 18.9 mmt180 -152.63 144.64 23.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.522 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 9.8 t -85.63 24.26 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.596 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.0 p-90 -146.38 160.91 41.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.3 t80 -104.08 145.29 30.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 5.6 t -139.31 105.91 7.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.162 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.1 Cg_endo -69.78 4.0 2.46 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.697 2.265 . . . . 0.0 112.308 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.404 ' O ' HD22 ' A' ' 86' ' ' LEU . 15.5 t60 -65.86 114.68 5.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -119.69 122.92 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.41 -119.15 1.04 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -104.88 138.3 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.405 HD21 ' CB ' ' A' ' 10' ' ' LEU . 26.7 tp -143.57 112.69 6.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.36 132.56 45.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.5 mm -103.34 125.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.113 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.97 154.3 36.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -87.73 116.46 25.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -53.06 -177.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.13 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.65 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 6.2 ttpt -78.25 131.13 36.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -92.98 137.06 23.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.557 0.694 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 53.4 Cg_endo -69.72 130.36 19.24 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.4 m -78.29 158.13 77.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 110.837 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -4.15 13.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.682 2.254 . . . . 0.0 112.317 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -94.84 -38.67 10.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.933 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.17 -39.84 53.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.607 HG12 ' OE1' ' A' ' 58' ' ' GLN . 61.6 t -64.15 -52.73 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -58.12 -46.54 85.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -66.41 -57.54 7.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.489 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 76.7 mt -52.92 -41.21 64.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.607 ' OE1' HG12 ' A' ' 54' ' ' VAL . 34.2 mt-30 -52.47 -47.9 66.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -37.52 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.072 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -58.3 -50.59 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.438 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 24.8 m-85 -71.03 -31.88 68.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.2 mtt180 -56.05 -39.65 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 mt -86.33 -14.53 43.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.469 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 71.6 mt -89.02 -28.89 19.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.469 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 5.5 mmp_? -121.16 -28.74 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.065 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 131.27 128.21 2.94 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.19 -19.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.7 m-20 -78.4 13.4 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.065 HG13 ' O ' ' A' ' 66' ' ' GLY . 28.6 m -66.33 -177.84 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 16.3 mm-40 -119.54 167.98 11.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 62.3 m-85 -161.86 135.06 4.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.625 0.726 . . . . 0.0 110.861 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.2 Cg_endo -69.77 159.96 51.47 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 0.0 112.322 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -81.11 -27.76 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -146.15 173.41 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.1 m-85 -134.85 94.61 16.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.683 0.754 . . . . 0.0 110.916 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.4 Cg_endo -69.76 174.36 9.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.5 p -141.26 139.81 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.86 45.36 84.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.7 m -153.45 145.18 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 110.884 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.677 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.1 OUTLIER -74.93 117.85 17.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' ALA . 50.1 mt -85.79 -71.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.49 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.61 -146.4 4.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.587 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.3 p -151.28 157.41 42.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.8 m -144.67 140.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.1 113.08 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 36' ' ' HIS . 4.2 tt -77.42 93.41 4.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.622 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -60.73 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.184 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.407 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.5 m-20 -163.01 168.46 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.9 t -127.73 101.74 6.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.525 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 88.8 mt -99.32 169.89 9.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' LYS . 34.7 t -105.12 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.487 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 10.1 mm-40 -42.07 -23.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' SER . 15.2 ttmm -91.34 -70.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -53.56 -47.37 70.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.572 ' CD2' HG21 ' A' ' 111' ' ' VAL . 16.9 t80 -43.3 -57.46 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.506 ' HG2' ' N ' ' A' ' 97' ' ' GLU . 1.6 pttt -68.36 -38.79 81.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.506 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 12.1 mt-10 -49.56 -52.39 30.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.7 mt-30 -86.68 -45.97 10.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.7 m-85 -110.42 67.69 0.51 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 0.0 110.865 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.77 -10.35 28.33 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.695 2.264 . . . . 0.0 112.366 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.82 -19.16 55.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.449 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 pt -126.17 21.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 59.6 p -60.05 -20.78 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -97.94 -30.71 12.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 5.2 mt-10 -51.23 -28.36 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.5 p -114.24 156.84 23.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -130.15 -32.58 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.518 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -58.87 164.83 3.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 0.0 110.834 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.522 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.3 Cg_endo -69.78 -43.79 2.44 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.66 2.24 . . . . 0.0 112.322 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -110.34 97.51 6.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 95' ' ' PHE . 12.9 t -79.3 139.21 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CZ ' HG22 ' A' ' 34' ' ' THR . 11.5 m-30 -106.58 105.84 16.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -74.41 117.57 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.093 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.461 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 6.9 m -125.07 151.55 45.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.874 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -140.5 175.27 9.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER 59.22 53.18 4.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 0.0 110.891 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.78 112.58 3.12 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.402 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 5.7 pt20 -127.33 141.07 51.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.19 122.24 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.677 ' HE1' HD13 ' A' ' 80' ' ' LEU . 16.6 mtp -63.39 155.33 29.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.693 HG21 ' HB2' ' A' ' 149' ' ' LYS . 32.2 t -81.92 -27.69 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -127.27 135.22 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 14.0 mmtm -103.03 150.44 23.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.577 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.3 m-85 -118.17 143.55 33.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.596 0.713 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 92.05 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.32 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.509 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.9 pp -123.21 167.07 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -110.28 107.16 16.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.27 169.56 23.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.538 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 133' ' ' TRP . 46.9 m-80 -155.29 157.9 31.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.928 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 0.86 5.03 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.596 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.4 mmmp? -136.84 -175.08 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.72 HG22 ' CE3' ' A' ' 8' ' ' TRP . 68.3 mt -86.89 131.99 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.154 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 129' ' ' ASN . 7.5 p-90 -133.8 136.24 44.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.549 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 8.8 ttmt -56.8 134.87 55.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 9' ' ' CYS . 17.9 mt -76.96 133.29 39.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.521 ' HB2' ' CG1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -45.84 123.23 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 136' ' ' ASP . 4.4 m -34.02 -48.44 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.86 -43.62 87.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.577 HG23 ' CD2' ' A' ' 124' ' ' PHE . 38.7 mm -61.65 -46.09 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.139 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -38.56 -64.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 142' ' ' GLY . 79.9 mt-30 -51.68 -68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.7 -49.09 0.72 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.506 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.72 -46.06 77.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.2 mtpp -64.82 -24.12 67.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -82.8 -42.84 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -51.48 -16.51 2.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.46 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 40.3 mt -85.72 31.91 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.891 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 ptp -92.39 -36.37 13.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.693 ' HB2' HG21 ' A' ' 121' ' ' VAL . 32.5 mttt -120.71 54.04 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 5.4 mm-40 -34.23 142.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 152' ' ' LYS . 0.8 OUTLIER -79.51 122.25 26.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 153' ' ' ALA . 6.0 mtmp? -48.25 177.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 152' ' ' LYS . . . -32.96 -61.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 153' ' ' ALA . 9.8 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.8 p -70.31 166.28 20.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.5 p -104.15 -47.71 4.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.851 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.96 106.73 0.21 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -100.39 77.0 1.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.407 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 57.7 m -149.29 144.68 26.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.82 105.24 1.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.675 ' CE3' HG22 ' A' ' 132' ' ' ILE . 95.0 m95 -92.91 160.79 14.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB2' HD11 ' A' ' 135' ' ' LEU . 39.0 t -133.16 130.95 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.555 HD11 ' HE ' ' A' ' 30' ' ' ARG . 21.9 tp -111.6 110.7 21.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.435 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 2.9 m -69.92 131.09 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 13' ' ' HIS . 69.6 t -116.19 163.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.6 ' N ' HG12 ' A' ' 12' ' ' VAL . 59.0 m-70 -100.65 114.21 27.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 15' ' ' PRO . 15.0 mm-40 -58.36 157.8 16.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.587 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.76 -33.74 3.31 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.721 -1.783 . . . . 0.0 112.338 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.548 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.5 m-90 -25.07 -59.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -33.39 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.091 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.4 m -69.6 -53.91 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 mt -40.97 -29.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.7 mp -66.56 -68.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 82' ' ' GLY . 17.4 m -61.21 -11.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.453 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 12.2 mmt180 -82.98 -39.64 21.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.86 0.87 9.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.545 HD11 ' O ' ' A' ' 70' ' ' GLU . 4.6 mp -85.6 -50.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 111.12 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.1 tptp -88.53 121.87 31.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -103.89 -4.06 23.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.615 HG11 ' CE1' ' A' ' 95' ' ' PHE . 15.6 m -140.34 162.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE1' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -129.03 130.88 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -86.43 128.24 8.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.52 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HE ' HD11 ' A' ' 10' ' ' LEU . 13.0 mmt180 -146.11 143.97 29.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.823 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 77.9 p -83.66 19.47 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.578 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.5 p-90 -144.53 167.62 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.462 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 6.0 t80 -108.8 136.81 47.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.566 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 6.1 t -130.15 104.04 16.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.703 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.421 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.8 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.408 ' O ' HD22 ' A' ' 86' ' ' LEU . 15.6 t60 -65.77 117.15 7.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.421 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 8.4 mmt85 -120.97 121.48 38.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.91 -116.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -104.2 138.95 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 10' ' ' LEU . 19.3 tp -143.76 109.38 5.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.597 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 90.7 m95 -73.4 124.49 25.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 mm -94.84 127.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -127.18 141.18 51.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.102 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.654 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -75.58 121.29 22.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 p -59.94 -177.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.26 21.34 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.073 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' HB3' ' A' ' 13' ' ' HIS . 8.9 ttpt -100.77 132.94 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -87.67 126.7 60.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.555 0.693 . . . . 0.0 110.928 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 134.92 29.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.1 m -79.05 153.29 77.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.669 0.747 . . . . 0.0 110.841 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -6.55 18.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.297 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -94.57 -38.47 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.85 -43.52 71.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.88 -51.11 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -61.1 -47.44 86.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.17 -55.34 22.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.417 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 84.8 mt -54.46 -54.29 42.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 39.5 mt-30 -38.44 -49.06 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.14 -43.09 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -52.85 -51.3 61.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.458 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 36.0 m-85 -69.08 -37.96 78.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.507 ' HG2' HG22 ' A' ' 69' ' ' VAL . 58.6 mtt180 -48.44 -33.11 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.1 mt -91.4 -15.69 28.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD11 ' NE2' ' A' ' 104' ' ' GLN . 79.6 mt -86.76 -31.51 20.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -119.36 -28.66 5.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.04 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.46 124.68 2.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.46 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -44.55 -18.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.913 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 66' ' ' GLY . 2.9 m-20 -77.66 13.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.04 HG13 ' O ' ' A' ' 66' ' ' GLY . 33.9 m -69.23 174.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.545 ' O ' HD11 ' A' ' 24' ' ' ILE . 2.6 pm0 -119.66 173.5 6.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 83.1 m-85 -158.93 144.37 11.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.849 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.79 152.82 69.26 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.242 . . . . 0.0 112.321 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -73.23 -28.17 62.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -144.6 174.15 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.587 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 68.5 m-85 -134.97 89.64 23.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 75' ' ' TYR . 53.0 Cg_endo -69.83 172.1 13.34 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.5 p -143.55 142.27 31.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 37.27 60.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 86.9 m -149.83 147.62 28.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.618 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -75.03 114.48 13.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' A' ' 44' ' ' ALA . 48.2 mt -81.69 -72.37 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.16 -143.66 3.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.597 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 11.0 t -150.95 159.03 44.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 m -147.66 133.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.79 112.62 14.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.415 HD12 HD22 ' A' ' 40' ' ' LEU . 3.3 tt -77.01 100.4 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.549 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.39 -49.23 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.34 168.28 24.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.466 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -127.56 96.59 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.518 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.4 mt -93.48 166.35 12.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' LYS . 44.4 t -104.2 169.88 8.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.489 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 9.4 mm-40 -43.84 -21.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.1 ttmt -90.96 -69.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.448 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.9 mt-30 -56.49 -45.95 80.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.886 ' CD2' HG21 ' A' ' 111' ' ' VAL . 19.5 t80 -44.55 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.496 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.5 ptpt -68.73 -42.15 78.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 8.5 mt-10 -48.4 -58.23 4.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.6 mt-30 -80.11 -48.25 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 16.7 m-85 -109.78 68.65 0.47 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.1 Cg_endo -69.84 -11.1 30.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.672 2.248 . . . . 0.0 112.316 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -78.37 -21.82 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.817 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.578 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.9 pt -124.99 22.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 49.9 p -64.26 -19.94 65.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.438 ' NE2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -97.17 -27.93 14.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.53 ' CD ' HG22 ' A' ' 102' ' ' ILE . 15.5 mt-10 -41.01 -42.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.2 t -123.14 159.37 28.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -119.01 -21.14 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.467 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -53.81 162.31 1.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.79 -43.21 2.77 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.378 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 15.7 m-85 -112.34 101.42 9.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.886 HG21 ' CD2' ' A' ' 95' ' ' PHE . 25.6 t -80.91 136.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CZ ' HG22 ' A' ' 34' ' ' THR . 9.8 m-30 -104.44 104.34 14.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.83 120.69 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.2 m -125.43 154.18 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.95 176.16 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 56.77 53.26 6.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.2 Cg_endo -69.76 116.41 4.55 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.724 2.283 . . . . 0.0 112.371 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.36 133.89 46.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.26 124.77 44.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.618 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.1 mtp -66.91 147.02 53.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.4 t -68.91 -31.77 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.09 153.0 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.05 146.22 45.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.538 ' HE2' ' HB2' ' A' ' 143' ' ' ALA . 0.8 OUTLIER -112.72 141.96 26.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 0.0 110.879 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 87.21 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.46 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.9 pp -121.91 163.35 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 76.1 mttt -102.18 136.36 42.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.99 161.81 27.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.459 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -142.65 156.71 62.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.644 0.735 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -3.08 11.33 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.578 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.6 mmmp? -134.2 -173.75 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.675 HG22 ' CE3' ' A' ' 8' ' ' TRP . 95.6 mt -85.91 142.07 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.3 p-90 -149.37 127.24 11.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -55.77 127.78 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 9' ' ' CYS . 60.4 mt -65.35 167.94 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.6 t70 -73.81 126.46 30.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.0 m -34.94 -42.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -71.68 -44.96 63.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.1 mm -61.47 -41.13 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.106 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -44.27 -65.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 144' ' ' LYS . 26.5 mt-30 -50.07 -68.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.5 -54.69 1.02 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.521 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.565 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.18 -37.29 69.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.2 mtpt -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -92.86 -47.11 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -41.56 -23.43 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 145' ' ' LYS . 11.8 mt -82.94 39.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 110.914 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.8 ptp -103.2 -33.65 9.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -131.98 74.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -73.7 177.12 5.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -61.85 159.72 13.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -34.85 79.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.26 -57.17 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -132.25 41.62 3.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.865 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 4' ' ' GLY . 60.0 p -97.34 123.41 41.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.838 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 3' ' ' SER . . . -35.02 132.45 0.55 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.515 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -95.69 37.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.831 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.8 m -108.65 160.77 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.44 84.17 1.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.615 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.6 m95 -77.8 159.85 28.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.781 0.324 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB2' HD11 ' A' ' 135' ' ' LEU . 40.9 t -137.4 125.46 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' HB2' HD21 ' A' ' 40' ' ' LEU . 66.6 tp -112.27 116.84 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.416 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 14.6 m -68.74 153.85 43.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 13' ' ' HIS . 72.5 t -135.47 158.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.52 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.8 m-70 -94.54 113.75 25.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 22.2 mt-30 -60.53 159.28 25.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.624 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 -32.74 3.73 Favored 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.698 -1.792 . . . . 0.0 112.33 -0.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.628 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.4 m-90 -25.36 -52.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -35.4 -63.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -62.01 -46.15 90.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.3 mt -45.63 -39.32 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -57.93 -66.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 82' ' ' GLY . 18.2 m -61.29 -20.94 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 11.3 mmt180 -73.87 -39.67 63.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.41 20.07 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.532 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.69 -38.4 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -102.72 102.33 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -95.97 13.39 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.2 m -144.85 146.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.455 ' OE2' HG22 ' A' ' 12' ' ' VAL . 6.7 tt0 -117.53 134.27 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.24 126.65 8.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 32.0 mmt180 -152.5 150.23 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.475 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 24.5 p -88.03 21.81 2.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.439 ' HH2' HD13 ' A' ' 10' ' ' LEU . 4.2 p-90 -142.73 166.46 24.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.5 t80 -110.23 144.47 38.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.522 ' O ' HG23 ' A' ' 34' ' ' THR . 5.1 t -136.99 105.51 8.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.5 Cg_endo -69.78 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -64.11 111.89 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -115.52 120.11 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.01 -121.36 1.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.446 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -106.28 139.21 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 10' ' ' LEU . 38.4 tp -143.95 116.0 8.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.942 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.4 m95 -72.05 132.43 44.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -102.14 130.41 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.77 154.73 42.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.664 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -89.08 118.64 28.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 12' ' ' VAL . 39.8 p -56.12 179.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.36 4.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 14.6 ttpt -91.86 148.81 21.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 16.6 mtmt -105.55 121.54 45.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 127.91 15.25 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 54' ' ' VAL . 4.5 m -73.63 158.24 86.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.619 0.723 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -6.15 17.87 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.722 2.281 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -93.49 -41.68 9.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -41.8 78.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.43 HG12 ' OE1' ' A' ' 58' ' ' GLN . 38.7 t -67.03 -50.52 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 t -62.52 -44.64 95.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.33 -54.35 21.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.628 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.6 mt -56.61 -39.13 73.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 35.0 mt-30 -54.52 -47.17 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.05 -35.73 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -60.86 -49.68 76.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -69.83 -39.49 76.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' A' ' 69' ' ' VAL . 45.2 mtt180 -48.01 -36.2 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.24 -16.75 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.05 -27.09 23.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.414 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 3.8 mmm180 -123.7 -28.92 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.051 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 131.2 127.83 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.92 -19.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 9.8 t70 -76.16 8.79 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.051 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.2 m -63.02 -179.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 3.4 mm-40 -118.2 171.87 7.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 53.5 m-85 -162.25 137.28 5.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 152.71 69.54 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.722 2.281 . . . . 0.0 112.324 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -72.49 -28.93 63.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.0 176.1 10.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.624 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.7 m-85 -134.42 93.94 18.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.955 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 54.0 Cg_endo -69.77 175.07 8.6 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.703 2.268 . . . . 0.0 112.384 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m -144.47 134.66 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.824 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.59 12.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.6 m -160.14 148.57 16.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.512 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.11 118.59 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.664 HD11 ' HB2' ' A' ' 44' ' ' ALA . 80.7 mt -85.11 -74.06 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.467 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.94 -145.07 4.19 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.9 p -152.75 161.28 42.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.37 . . . . 0.0 110.841 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 114' ' ' CYS . 13.5 m -146.79 146.45 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.456 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.8 t70 -87.01 107.0 18.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.68 97.9 1.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.552 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.88 -47.46 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 3.1 m-20 -165.25 166.67 18.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 t -127.35 99.7 5.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.0 mt -94.25 169.19 10.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 p -106.91 169.25 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 6.2 mm100 -47.99 -18.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -90.69 -58.13 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -71.28 -50.68 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.563 ' CD2' HG21 ' A' ' 111' ' ' VAL . 35.2 t80 -40.22 -55.99 2.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 4.2 ptmt -66.45 -42.41 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 9.1 mt-10 -53.23 -59.2 4.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.458 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -74.76 -50.27 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.8 m-85 -111.21 67.62 0.62 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.59 0.709 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.75 -13.89 35.35 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.686 2.257 . . . . 0.0 112.363 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -74.33 -23.07 59.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.699 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.8 pt -122.14 20.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.9 p -63.22 -23.6 67.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.435 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -93.13 -25.69 17.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.699 ' CD ' HG22 ' A' ' 102' ' ' ILE . 36.1 mt-10 -53.14 -33.36 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.436 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 2.2 p -127.47 146.51 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 1.6 t70 -111.75 -33.77 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 m -43.6 161.39 0.2 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.686 0.755 . . . . 0.0 110.841 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.475 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.93 102.79 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.7 t -85.91 136.93 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 5.0 m-30 -105.07 107.05 17.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -74.52 118.44 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -119.39 151.3 38.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -143.03 174.07 11.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.6 OUTLIER 53.95 54.74 11.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.652 0.739 . . . . 0.0 110.869 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.8 Cg_endo -69.8 121.81 8.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 0.0 112.292 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -132.0 131.69 42.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -97.67 123.55 41.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.512 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.4 mtp -64.34 149.92 47.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.736 HG21 ' HB2' ' A' ' 149' ' ' LYS . 98.9 t -78.08 -21.42 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.85 135.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -102.15 154.71 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.5 OUTLIER -122.19 142.72 37.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.919 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.06 158.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.603 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 28.8 mtmt -92.04 134.77 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.72 167.72 46.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.483 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 1.5 t-20 -156.74 144.34 13.96 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.638 0.733 . . . . 0.0 110.884 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.1 Cg_endo -69.75 3.12 2.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.679 2.253 . . . . 0.0 112.339 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 6.9 mmmm -135.34 -173.89 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.615 HG22 ' CE3' ' A' ' 8' ' ' TRP . 71.7 mt -91.57 134.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.603 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 1.3 p-90 -143.21 130.0 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.471 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 11.2 ttmt -53.67 129.81 34.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.589 HD22 HG21 ' A' ' 139' ' ' ILE . 22.9 mt -65.8 162.77 18.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.3 t0 -73.67 129.77 38.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.92 -50.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -65.09 -39.68 93.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.589 HG21 HD22 ' A' ' 135' ' ' LEU . 19.9 mm -64.66 -47.78 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ILE . 18.0 t-160 -37.09 -65.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 91.6 mt-30 -51.66 -69.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.42 -49.14 0.67 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.503 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.31 -43.55 74.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.1 mtpp -67.72 -23.24 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 147' ' ' LEU . 17.7 mmtp -77.89 -53.1 7.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.17 -27.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 145' ' ' LYS . 17.6 mt -81.5 39.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.843 0.354 . . . . 0.0 110.919 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 5.5 ptp -108.27 -26.0 10.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.736 ' HB2' HG21 ' A' ' 121' ' ' VAL . 20.8 mtpt -125.91 43.8 2.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 149' ' ' LYS . 9.8 mm-40 -34.52 150.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -38.71 155.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -45.69 -50.06 13.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -45.29 -57.45 3.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 p -118.99 -48.1 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 110.897 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.0 p -132.93 150.17 52.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.55 99.36 0.84 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.434 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.3 p -120.67 149.99 41.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 0.0 110.842 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 m -125.72 20.82 7.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.835 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.32 61.57 4.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.7 ' CE3' HG22 ' A' ' 132' ' ' ILE . 90.4 m95 -74.26 162.56 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.774 0.321 . . . . 0.0 110.895 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.2 t -138.83 138.8 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.449 HD13 ' HH2' ' A' ' 32' ' ' TRP . 25.4 tp -123.1 111.85 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.409 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 60.3 p -70.54 125.83 27.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.54 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 17.7 t -107.98 160.67 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.54 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 56.1 m-70 -91.14 111.14 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 18.6 mt-30 -58.85 159.93 12.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.664 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.75 -31.36 4.6 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.375 -0.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.541 ' C ' ' O ' ' A' ' 15' ' ' PRO . 9.1 m-90 -25.98 -54.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -36.52 -58.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 66.4 m -66.08 -40.74 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.87 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 16' ' ' TRP . 63.0 mt -51.94 -26.34 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 9.2 mp -71.24 -69.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.885 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.4 m -58.84 -15.0 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.9 mmt180 -79.98 -39.49 29.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.44 6.21 8.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.458 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.81 -47.59 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 3.4 tptp -90.35 117.7 29.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 26' ' ' ARG . 13.2 ttt180 -102.62 0.09 32.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.484 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 17.6 m -147.01 154.96 11.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 8.2 tm-20 -122.54 153.3 39.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -112.7 130.55 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.528 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HG3' ' CZ2' ' A' ' 32' ' ' TRP . 9.2 mmt180 -149.05 149.7 31.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.444 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 57.7 p -85.27 20.36 2.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.539 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.9 p-90 -145.09 167.68 22.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.0 t80 -108.82 141.35 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.57 ' O ' HG23 ' A' ' 34' ' ' THR . 6.9 t -134.93 103.56 10.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.571 0.7 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.9 Cg_endo -69.71 2.39 3.55 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.273 . . . . 0.0 112.336 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -60.89 108.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 6.3 mmt85 -111.65 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.15 -123.2 1.65 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.1 ttm105 -104.98 140.97 37.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.0 tp -143.98 114.41 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 91.1 m95 -71.27 131.93 44.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.96 127.49 56.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.99 49.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -83.23 119.36 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.5 p -54.24 -174.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.78 -10.47 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 4.9 ttpt -73.6 148.7 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 1.2 pmtp? -108.53 132.56 21.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 0.0 110.872 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 54' ' ' VAL . 3.3 m -73.97 159.81 83.24 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -8.3 23.26 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.739 2.293 . . . . 0.0 112.345 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -94.81 -42.43 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -40.94 84.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 50' ' ' SER . 62.1 t -65.07 -51.15 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -64.07 -45.82 87.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.25 -53.27 46.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.51 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 79.2 mt -56.03 -43.33 77.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 35.7 mt-30 -51.73 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.71 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -61.49 -48.76 79.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -70.89 -33.52 70.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HG2' HG22 ' A' ' 69' ' ' VAL . 43.6 mtt180 -53.5 -36.07 61.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.4 -12.8 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD11 HE22 ' A' ' 104' ' ' GLN . 71.4 mt -90.65 -29.04 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.965 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.8 mmp_? -122.92 -29.06 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.067 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.12 129.01 2.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.9 -18.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.319 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.7 t70 -82.43 20.4 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.067 HG13 ' O ' ' A' ' 66' ' ' GLY . 29.3 m -70.91 179.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 13.2 mt-10 -116.61 166.9 11.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 52.7 m-85 -159.87 138.56 7.78 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 0.0 110.842 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.3 Cg_endo -69.77 163.86 36.71 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.08 -22.91 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -150.61 166.69 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.1 m-85 -130.44 87.93 48.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.903 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.54 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.2 Cg_endo -69.77 171.62 14.14 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.642 2.228 . . . . 0.0 112.325 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.6 p -138.91 144.38 39.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.6 89.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 67.0 m -149.79 146.74 27.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -76.26 118.66 19.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 44' ' ' ALA . 56.1 mt -87.69 -71.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.572 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.33 -150.44 5.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.501 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -149.59 153.69 37.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.89 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.3 m -140.2 142.23 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.29 114.45 21.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tt -77.1 95.67 4.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.597 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -64.61 -46.05 93.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.478 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 1.6 m-20 -166.7 165.9 16.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.44 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.2 t -127.37 99.04 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 83.0 mt -97.02 170.91 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 30.4 t -110.04 169.11 8.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -46.62 -20.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 24.7 ttmt -89.64 -60.62 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -70.53 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.615 ' CD2' HG21 ' A' ' 111' ' ' VAL . 21.1 t80 -39.24 -54.95 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.9 ptmm? -68.45 -47.52 66.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.7 mt-10 -46.01 -54.37 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -81.18 -51.81 8.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 18.6 m-85 -107.11 70.92 0.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.627 0.727 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.77 -17.48 37.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.385 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.3 -26.7 60.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.594 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.1 pt -120.23 24.35 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.481 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 22.1 p -68.25 -21.16 64.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.438 HE22 HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -96.42 -23.52 16.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.565 ' OE2' HG22 ' A' ' 102' ' ' ILE . 11.3 mt-10 -48.04 -41.24 25.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 111' ' ' VAL . 1.5 t -124.1 143.02 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -104.3 -28.63 11.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -45.85 161.49 0.26 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.652 0.739 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.444 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.2 Cg_endo -69.78 -43.66 2.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -112.92 102.49 10.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.615 HG21 ' CD2' ' A' ' 95' ' ' PHE . 59.3 t -85.18 136.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.44 ' HE1' ' HG ' ' A' ' 89' ' ' CYS . 7.3 m-30 -105.0 104.22 13.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.818 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -74.17 121.84 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.106 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.447 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.7 m -122.78 154.09 38.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' CG ' HD12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -139.45 177.03 8.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 52.6 53.54 12.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.902 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.0 Cg_endo -69.66 117.46 5.09 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -131.33 143.59 50.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -107.95 120.6 42.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.584 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.2 mtp -62.67 153.47 32.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.62 -32.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.76 132.57 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.446 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 16.8 mmtm -102.18 154.28 19.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 79' ' ' CYS . 1.1 m-85 -120.48 142.35 33.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 88.23 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.92 165.24 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.6 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 50.0 mtpt -107.23 135.6 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.409 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -90.17 171.89 37.58 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.477 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -150.29 156.43 37.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.316 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.7 mmmm -139.37 -175.33 4.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.7 HG22 ' CE3' ' A' ' 8' ' ' TRP . 62.0 mt -84.8 132.18 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.6 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 4.4 p-90 -138.71 131.74 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.567 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 12.3 ttmt -58.25 128.78 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.4 mt -64.68 170.61 3.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -78.63 127.01 31.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.41 -50.3 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -65.46 -40.29 93.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.9 mm -64.12 -45.93 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -40.45 -65.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.9 mt-30 -52.44 -70.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.67 -43.49 0.8 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.469 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.434 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -61.55 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -61.06 -20.89 63.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' LEU . 18.3 mmmt -90.33 -48.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -40.94 -21.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 145' ' ' LYS . 42.0 mt -79.37 37.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' A' ' 148' ' ' MET . 2.6 ptp -122.5 133.94 54.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt 60.28 54.96 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 151' ' ' ASN . 0.6 OUTLIER -101.64 176.89 5.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 150' ' ' GLN . 3.6 p30 -35.33 131.29 0.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -89.81 40.06 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.941 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.67 -49.02 1.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 179.931 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -64.81 126.54 28.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 110.822 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t -88.07 130.41 35.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.91 130.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.5 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 t -125.58 94.08 4.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.852 0.358 . . . . 0.0 110.852 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.73 115.6 30.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.42 109.16 2.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.475 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.607 ' CZ2' ' HD3' ' A' ' 134' ' ' LYS . 92.7 m95 -93.5 167.92 11.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -141.28 159.28 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.702 HD23 ' CD ' ' A' ' 28' ' ' GLU . 31.7 tp -145.42 116.65 7.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 2.7 t -67.99 146.34 53.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.51 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 74.3 t -134.26 153.97 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.415 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.2 m-70 -88.68 113.68 24.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.77 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 46.3 mt-30 -59.94 161.88 11.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.621 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -28.43 6.25 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.338 -0.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.563 ' O ' HD12 ' A' ' 20' ' ' LEU . 10.5 m-90 -28.7 -53.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.77 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.57 -64.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.42 -43.22 99.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.6 mt -48.97 -36.61 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.8 mp -59.75 -64.83 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG11 ' N ' ' A' ' 82' ' ' GLY . 14.2 m -63.33 -17.92 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.469 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.0 mmt180 -76.49 -39.98 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.54 18.84 3.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.3 mp -105.61 -37.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 111.162 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.9 tptp -102.91 95.54 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.607 ' NE ' HD13 ' A' ' 102' ' ' ILE . 22.4 ptt180 -92.24 14.53 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.623 ' CG1' HD12 ' A' ' 102' ' ' ILE . 30.6 m -146.76 143.94 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.702 ' CD ' HD23 ' A' ' 10' ' ' LEU . 2.5 tt0 -115.97 141.79 47.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.62 122.83 7.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -146.29 149.1 33.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 41.2 p -86.41 23.15 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.49 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -146.01 160.16 42.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -100.78 138.95 37.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.685 ' O ' HG23 ' A' ' 34' ' ' THR . 10.6 t -133.16 100.03 14.44 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.565 0.698 . . . . 0.0 111.109 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.76 8.9 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.354 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -67.27 108.18 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.471 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 63.3 mmt-85 -106.86 115.83 30.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.45 -138.72 6.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -94.92 142.61 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -143.97 115.98 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.07 138.35 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.952 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -109.04 127.3 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.59 152.18 39.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.832 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -85.63 119.03 25.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 12' ' ' VAL . 41.1 p -54.4 -179.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.142 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.83 22.41 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -110.59 132.06 54.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -91.75 130.62 38.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.547 0.689 . . . . 0.0 110.937 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.6 Cg_endo -69.73 134.24 27.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.0 m -75.51 159.21 82.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.697 0.761 . . . . 0.0 110.857 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.689 2.259 . . . . 0.0 112.343 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -94.34 -42.34 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -40.28 86.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 50' ' ' SER . 43.5 t -65.62 -50.73 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.03 -42.3 99.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -67.92 -53.74 24.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.405 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 93.9 mt -59.14 -38.74 80.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.587 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 37.2 mt-30 -55.26 -46.15 76.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -35.35 38.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -61.42 -51.63 67.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -67.48 -41.29 84.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.935 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 69' ' ' VAL . 52.3 mtt180 -48.16 -36.07 12.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.907 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -86.74 -16.19 37.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.8 mt -88.17 -27.25 21.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -123.38 -26.93 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.066 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 127.74 129.03 3.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.455 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.29 -19.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -72.59 3.85 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.066 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.2 m -61.65 178.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.528 ' O ' HD11 ' A' ' 24' ' ' ILE . 10.7 mp0 -119.73 167.85 11.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.587 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 67.8 m-85 -155.47 141.14 12.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.9 Cg_endo -69.77 165.87 29.51 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.66 2.24 . . . . 0.0 112.323 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -88.88 -20.75 24.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.48 174.38 14.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.621 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 87.7 m-85 -134.99 89.73 23.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.66 0.743 . . . . 0.0 110.947 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.468 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.7 Cg_endo -69.75 168.9 20.21 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.719 2.279 . . . . 0.0 112.354 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.0 m -134.91 139.58 45.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.92 92.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.44 ' C ' HD11 ' A' ' 126' ' ' ILE . 81.5 m -152.76 157.33 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.866 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.77 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -80.69 117.83 21.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.832 HD11 ' HB2' ' A' ' 44' ' ' ALA . 17.1 mt -85.87 -71.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.637 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -149.4 -140.35 3.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.484 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.2 p -156.33 166.36 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 16.4 m -154.16 138.71 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -81.6 113.91 19.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.66 94.38 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.607 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -62.67 -46.85 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 5.5 m-20 -165.53 170.19 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.17 102.08 6.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 94' ' ' GLN . 97.7 mt -95.87 171.18 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.947 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 93' ' ' LYS . 5.3 p -106.92 169.2 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 107' ' ' ASP . 7.4 mm100 -43.87 -22.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 31.7 ttpt -92.65 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.632 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.9 mm100 -56.3 -46.42 79.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.59 ' CE1' HG11 ' A' ' 27' ' ' VAL . 17.6 t80 -41.95 -58.95 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -68.86 -44.91 72.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 8.0 mt-10 -43.06 -55.72 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.462 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.9 mt-30 -83.62 -43.4 15.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.0 m-85 -115.81 68.41 3.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.681 0.753 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 96' ' ' LYS . 53.9 Cg_endo -69.76 -12.86 33.77 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 0.0 112.365 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.29 -16.45 60.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.723 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.0 OUTLIER -128.77 21.15 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 21.9 p -60.25 -25.87 66.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.432 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -94.28 -28.8 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.723 ' CD ' HG22 ' A' ' 102' ' ' ILE . 20.8 mt-10 -47.44 -36.95 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 t -120.04 157.57 28.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 3.5 t0 -125.17 -29.27 3.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -50.19 161.54 0.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.893 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.6 Cg_endo -69.78 -41.53 4.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.673 2.248 . . . . 0.0 112.311 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -115.65 101.69 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.558 HG21 ' CD2' ' A' ' 95' ' ' PHE . 21.4 t -84.97 139.85 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CZ ' HG22 ' A' ' 34' ' ' THR . 7.3 m-30 -105.9 105.59 15.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -73.95 119.91 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.134 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.8 m -122.51 154.18 38.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -141.36 177.07 8.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 53.51 51.6 8.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.74 120.6 7.37 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.99 138.94 47.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -101.73 123.13 45.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.77 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.5 mtp -65.43 136.58 56.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 148' ' ' MET . 51.2 t -62.07 -27.72 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 143.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mttp -114.23 142.73 45.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.8 OUTLIER -108.03 146.37 33.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.91 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 89.92 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.4 pp -126.28 157.82 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.624 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 10.5 pttm -92.33 157.17 16.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.41 -177.59 28.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.507 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.502 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.5 t30 -169.74 146.83 2.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.617 0.722 . . . . 0.0 110.885 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.0 Cg_endo -69.79 0.32 5.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.353 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.5 mmmm -133.93 -172.78 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.517 HG22 ' CE3' ' A' ' 8' ' ' TRP . 34.6 mt -82.93 130.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.624 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 6.1 p-90 -136.23 110.04 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.607 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 1.2 ttpp -54.76 127.09 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.9 mt -57.4 169.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.58 163.1 28.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -42.25 99.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -77.08 -34.67 56.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 124' ' ' PHE . 48.7 mm -72.22 -37.1 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.426 ' NE2' ' HD2' ' A' ' 144' ' ' LYS . 22.4 t-160 -48.89 -63.85 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 142' ' ' GLY . 34.4 mt-30 -50.67 -67.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -33.87 -54.33 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.482 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -52.61 -43.53 65.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 141' ' ' GLN . 11.3 mtpt -66.17 -15.45 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -99.4 -34.09 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.02 9.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.464 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 72.5 mt -83.94 23.16 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.406 ' O ' HG21 ' A' ' 121' ' ' VAL . 4.3 ptp -99.53 136.85 38.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? 48.02 42.44 16.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 3.1 mm-40 -37.83 -73.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.477 ' O ' HG12 ' A' ' 154' ' ' VAL . 62.9 m-20 -136.93 167.27 21.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -77.76 -40.13 41.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.84 -59.84 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 151' ' ' ASN . 12.6 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -65.32 165.42 11.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.88 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 t -115.05 -44.32 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 5' ' ' SER . . . -149.59 46.52 0.65 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 4' ' ' GLY . 42.4 p -37.38 -47.78 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.834 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 23.8 m -50.46 135.59 22.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.85 92.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.578 ' CE3' HG22 ' A' ' 132' ' ' ILE . 90.6 m95 -73.81 160.89 30.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.728 0.299 . . . . 0.0 110.904 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' HD11 ' A' ' 135' ' ' LEU . 9.7 t -135.54 123.02 22.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD13 ' HH2' ' A' ' 32' ' ' TRP . 61.9 tp -112.11 118.31 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' CA ' ' A' ' 128' ' ' GLY . 3.2 m -71.83 155.13 40.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 13' ' ' HIS . 53.4 t -138.44 162.3 30.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.573 ' N ' HG12 ' A' ' 12' ' ' VAL . 67.2 m-70 -97.36 114.89 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.518 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.6 mm-40 -59.8 158.55 23.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 110.861 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.77 -33.28 3.47 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 -1.807 . . . . 0.0 112.358 -0.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.61 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 16.7 m-90 -25.01 -56.88 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -33.81 -53.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.7 m -72.9 -50.99 20.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD23 HD13 ' A' ' 24' ' ' ILE . 51.7 mt -40.55 -32.43 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.484 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.8 mp -64.75 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.7 m -60.78 -16.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.5 mmt180 -77.19 -39.31 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.21 12.17 5.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.43 HD13 HD23 ' A' ' 19' ' ' LEU . 5.3 mp -98.29 -48.62 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.3 tptt -89.15 117.08 27.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.9 ttm180 -101.07 -6.85 23.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.521 HG11 ' CE1' ' A' ' 95' ' ' PHE . 21.5 m -133.33 158.34 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.52 124.97 41.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.18 128.45 8.85 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -147.51 147.74 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.1 p -85.15 17.52 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.479 ' HH2' HD13 ' A' ' 10' ' ' LEU . 2.5 p-90 -142.51 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.414 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 4.1 t80 -106.36 139.3 41.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 34' ' ' THR . 8.1 t -134.32 101.71 12.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.613 0.72 . . . . 0.0 111.163 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.8 6.79 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.357 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -64.54 108.82 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.8 mmt-85 -105.23 112.67 25.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.31 -152.43 23.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -79.28 143.57 35.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.829 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.415 HD21 ' HB2' ' A' ' 10' ' ' LEU . 25.2 tp -143.87 115.08 7.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.572 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 95.5 m95 -71.12 124.8 25.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.72 122.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.131 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.92 149.84 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.646 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.21 123.63 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 12' ' ' VAL . 28.5 p -59.43 -174.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.27 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -81.41 135.0 35.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.25 41.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.618 0.723 . . . . 0.0 110.867 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 129.54 17.76 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -76.35 159.27 80.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.68 0.752 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -3.62 12.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -93.96 -41.41 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.88 -43.31 72.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.562 HG12 ' OE1' ' A' ' 58' ' ' GLN . 33.3 t -65.78 -52.54 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -59.75 -45.7 91.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.34 -56.67 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.61 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 92.1 mt -55.9 -38.51 70.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 38.7 mt-30 -57.46 -43.53 84.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.43 -32.61 32.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -66.24 -52.29 49.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.536 ' HE2' HD22 ' A' ' 57' ' ' LEU . 31.9 m-85 -66.32 -38.26 87.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.573 ' HG2' HG22 ' A' ' 69' ' ' VAL . 65.0 mtt180 -47.71 -34.2 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.62 -16.01 31.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 61' ' ' TYR . 48.6 mt -87.28 -29.96 21.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -120.27 -29.13 4.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.056 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.95 124.87 2.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -43.99 -21.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.776 0.322 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' GLY . 6.5 t0 -79.85 18.88 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.056 HG13 ' O ' ' A' ' 66' ' ' GLY . 24.9 m -69.07 -178.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' O ' ' CD1' ' A' ' 71' ' ' PHE . 5.4 pt-20 -117.51 166.3 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -158.92 135.53 6.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.692 0.758 . . . . 0.0 110.87 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 145.76 58.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.364 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.19 -27.08 66.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.426 ' C ' ' CD1' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -149.4 -178.11 6.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.571 ' CE2' ' HB3' ' A' ' 15' ' ' PRO . 13.9 m-85 -141.19 105.0 6.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.613 ' HG2' HD21 ' A' ' 81' ' ' LEU . 54.1 Cg_endo -69.75 178.35 4.65 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.652 2.235 . . . . 0.0 112.371 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.1 p -142.66 130.49 21.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.12 48.75 66.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 59.3 m -150.62 148.42 28.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -77.33 115.29 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 44' ' ' ALA . 32.3 mt -83.25 -71.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.15 -139.68 3.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.572 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 7.1 p -155.81 157.68 36.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 m -144.63 136.7 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.74 110.94 14.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.6 96.16 4.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -64.29 -50.37 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.405 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -161.23 167.88 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.479 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.3 t -128.2 101.3 6.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 80.8 mt -98.61 170.88 8.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 93' ' ' LYS . 29.3 t -109.44 169.18 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 6.3 mm100 -46.29 -20.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 91' ' ' SER . 19.5 tttt -89.56 -60.61 1.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.02 -50.4 41.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.557 ' CD2' HG21 ' A' ' 111' ' ' VAL . 28.7 t80 -39.72 -55.32 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.8 ptmm? -67.96 -47.49 68.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.519 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 5.8 mt-10 -45.88 -55.93 6.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.0 mt-30 -78.67 -52.73 8.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 23.9 m-85 -108.15 70.1 0.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.77 -15.46 37.07 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.647 2.231 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -73.36 -26.3 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.479 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.4 pt -118.96 21.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 17.6 p -64.49 -22.14 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.421 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -96.04 -21.4 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.431 ' CD ' HG22 ' A' ' 102' ' ' ILE . 7.5 mt-10 -56.23 -36.25 68.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.49 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.5 p -125.85 138.35 53.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.854 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 15.4 t70 -104.57 -30.57 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -44.28 161.04 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.673 0.749 . . . . 0.0 110.866 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.414 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.1 Cg_endo -69.75 -47.8 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 22.1 m-85 -110.0 99.52 8.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 95' ' ' PHE . 46.5 t -80.86 144.61 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CZ ' HG22 ' A' ' 34' ' ' THR . 12.6 m-30 -110.99 106.18 15.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER -75.07 120.0 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.8 m -126.03 153.64 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -143.09 174.07 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 57.62 52.97 5.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.3 Cg_endo -69.71 119.47 6.42 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.337 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.516 ' HB2' ' NE2' ' A' ' 150' ' ' GLN . 3.3 pt20 -132.05 134.26 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -99.79 126.01 45.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.51 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.9 mtp -65.69 152.82 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 149' ' ' LYS . 99.3 t -70.23 -36.58 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.07 142.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.152 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -104.74 152.4 22.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.02 139.53 24.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.01 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.66 160.35 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.599 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 5.7 mtmp? -92.12 128.29 37.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' CA ' ' OG ' ' A' ' 11' ' ' SER . . . -89.37 151.6 22.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.499 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -132.33 154.0 81.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 2.28 3.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.455 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 7.1 mmmm -135.83 -174.12 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.578 HG22 ' CE3' ' A' ' 8' ' ' TRP . 58.1 mt -89.05 132.57 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.599 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.3 p-90 -140.69 129.83 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.05 127.35 28.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 9' ' ' CYS . 31.2 mt -62.45 166.86 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 4.4 t0 -76.38 129.04 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -35.55 -38.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -75.47 -42.62 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 mm -64.16 -40.16 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -44.22 -65.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 142' ' ' GLY . 28.3 mt-30 -51.86 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.05 -49.01 1.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.494 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.444 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.66 -51.02 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.104 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HZ2' ' HB2' ' A' ' 144' ' ' LYS . 2.0 mtpm? -57.84 -32.45 67.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 147' ' ' LEU . 21.3 mmmt -71.59 -50.8 27.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.74 -25.51 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 145' ' ' LYS . 23.6 mt -85.18 42.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 ptp -104.59 -36.81 7.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.437 ' O ' HG22 ' A' ' 121' ' ' VAL . 15.9 tptp -131.85 70.75 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.516 ' NE2' ' HB2' ' A' ' 118' ' ' GLN . 9.7 mm100 -56.73 163.54 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.886 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -52.36 143.49 14.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 153' ' ' ALA . 41.2 mtpt -87.57 -43.96 11.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 152' ' ' LYS . . . -34.24 -61.49 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.087 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 179.948 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.3 p -42.17 117.83 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 110.823 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -147.45 122.04 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.882 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.03 54.9 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.491 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.0 t -104.2 45.7 0.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.845 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -85.75 29.06 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.07 63.79 4.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -72.39 167.51 20.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -135.85 140.54 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.1 tp -131.12 106.66 8.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -67.65 147.32 52.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 29.4 t -132.35 157.88 43.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.486 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.8 m-70 -88.03 115.26 25.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.78 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 45.1 mt-30 -61.22 162.21 14.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.78 -27.46 6.82 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.318 0.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.514 ' O ' HD12 ' A' ' 20' ' ' LEU . 11.5 m-90 -30.33 -52.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.78 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.88 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' LEU . 1.7 m -61.33 -52.75 63.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.529 HD23 HD13 ' A' ' 24' ' ' ILE . 57.1 mt -38.37 -41.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -55.99 -68.37 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' N ' ' A' ' 82' ' ' GLY . 33.0 m -59.84 -12.94 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.7 mmt180 -83.13 -39.57 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.97 -6.5 8.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.529 HD13 HD23 ' A' ' 19' ' ' LEU . 5.4 mp -78.8 -46.96 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HG2' HD11 ' A' ' 20' ' ' LEU . 12.3 tptt -94.64 111.94 23.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.415 ' HG3' HG13 ' A' ' 27' ' ' VAL . 15.5 ptm180 -108.41 16.67 22.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.568 HG11 ' CE1' ' A' ' 95' ' ' PHE . 27.2 m -149.6 143.95 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' OE1' HD21 ' A' ' 20' ' ' LEU . 6.6 tp10 -111.69 150.14 30.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -115.37 123.95 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 85.2 mmt-85 -149.8 151.71 34.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.5 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.2 t -87.93 24.0 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.518 ' CZ2' ' HD2' ' A' ' 30' ' ' ARG . 3.3 p-90 -144.6 157.78 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -99.26 137.77 37.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 34' ' ' THR . 9.3 t -133.59 100.94 13.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.577 0.704 . . . . 0.0 111.169 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.4 Cg_endo -69.77 6.22 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.712 2.275 . . . . 0.0 112.365 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.43 ' O ' HD22 ' A' ' 86' ' ' LEU . 17.8 t60 -64.63 111.37 2.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' A' ' 34' ' ' THR . 15.8 mmt180 -112.67 110.54 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.14 -142.37 8.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.445 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.1 ttp-105 -82.11 142.31 32.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.854 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 tp -143.69 106.83 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.622 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.4 m95 -71.8 118.83 15.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 43.6 mm -91.59 129.85 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -122.75 148.57 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.819 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.42 112.42 19.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.3 p -48.5 175.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.57 -12.46 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -74.35 142.22 45.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -103.22 131.59 21.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.547 0.689 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 133.42 25.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.638 2.225 . . . . 0.0 112.392 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.8 m -82.16 159.17 65.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.683 0.754 . . . . 0.0 110.815 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -2.81 10.79 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -94.31 -46.53 7.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -69.28 -41.19 77.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.566 HG12 ' OE1' ' A' ' 58' ' ' GLN . 56.9 t -63.15 -51.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -60.51 -44.22 96.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -66.69 -57.24 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.407 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 90.0 mt -54.03 -40.25 66.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 36.6 mt-30 -55.0 -45.57 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -34.98 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.086 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -61.99 -50.76 70.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.413 ' HA ' HD12 ' A' ' 64' ' ' LEU . 30.9 m-85 -68.7 -39.18 80.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HG2' HG22 ' A' ' 69' ' ' VAL . 59.7 mtt180 -47.67 -34.03 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 25.7 mt -90.57 -15.53 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 61' ' ' TYR . 59.1 mt -88.0 -29.42 20.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -121.21 -28.96 4.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.032 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.37 125.35 2.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.482 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.57 -19.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' GLY . 11.6 t70 -80.69 16.52 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.032 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.6 m -66.75 -177.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.502 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.4 pt-20 -116.09 170.07 8.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 52.1 m-85 -163.27 136.56 4.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.677 0.751 . . . . 0.0 110.855 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 54.4 Cg_endo -69.75 158.9 55.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.66 2.24 . . . . 0.0 112.385 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -76.92 -30.28 56.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -148.73 177.9 9.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.594 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 57.4 m-85 -134.87 95.84 15.13 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.65 0.738 . . . . 0.0 110.884 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.5 Cg_endo -69.8 -179.92 3.27 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.375 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -145.62 143.94 30.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.5 47.23 92.16 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 87.3 m -156.27 146.95 21.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.368 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -74.53 121.51 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 44' ' ' ALA . 16.9 mt -88.9 -71.2 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.948 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.639 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.95 -147.47 4.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.455 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.585 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.1 p -153.57 154.68 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 24.3 m -140.7 141.4 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.25 111.34 18.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 112' ' ' PHE . 2.8 tt -75.85 99.06 4.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.34 -48.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.181 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -162.27 168.57 22.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.87 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.43 103.11 7.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 87.0 mt -98.76 166.87 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 93' ' ' LYS . 48.5 t -104.72 168.5 9.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -45.81 -20.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.6 ttpt -91.3 -63.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.59 -49.48 75.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 27' ' ' VAL . 61.3 t80 -43.2 -56.2 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -66.38 -38.36 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.406 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 7.0 mt-10 -56.16 -55.21 35.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 10.8 mt-30 -78.48 -52.09 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.4 m-85 -109.85 68.22 0.46 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.665 0.745 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.8 Cg_endo -69.81 -14.23 35.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.12 -22.31 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 27' ' ' VAL . 2.4 pt -121.34 8.22 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.509 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 89.5 p -49.06 -25.27 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -90.7 -28.69 18.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.881 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 4.1 mt-10 -56.36 -22.57 31.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.498 ' OG ' HG21 ' A' ' 111' ' ' VAL . 1.9 p -113.98 160.3 18.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -134.88 -33.15 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.486 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -62.34 165.51 8.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.719 0.771 . . . . 0.0 110.826 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.5 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.84 -45.11 1.66 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -110.55 98.0 7.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.498 HG21 ' OG ' ' A' ' 106' ' ' SER . 13.5 t -83.37 140.26 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.488 ' HB3' HD11 ' A' ' 86' ' ' LEU . 3.0 m-30 -107.57 110.48 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.15 122.13 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.7 m -124.95 154.86 40.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -142.04 176.29 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER 57.5 52.67 5.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.76 117.38 5.05 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.671 2.248 . . . . 0.0 112.354 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -133.08 139.08 46.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -101.47 125.55 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.599 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.2 mtp -67.01 150.91 48.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 149' ' ' LYS . 95.2 t -75.18 -31.01 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.4 146.35 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 20.1 mmtm -112.74 149.48 32.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.555 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.2 m-85 -115.18 141.07 26.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.864 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 84.58 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.341 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.593 HD13 ' HH2' ' A' ' 133' ' ' TRP . 2.7 pp -115.2 158.81 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 39.5 mmtt -91.45 121.84 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.66 155.79 53.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -148.85 156.0 40.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -51.12 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.667 2.245 . . . . 0.0 112.32 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.466 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.0 mmmm -86.54 -174.53 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.426 HG13 ' CH2' ' A' ' 32' ' ' TRP . 66.3 mt -83.03 141.63 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.593 ' HH2' HD13 ' A' ' 126' ' ' ILE . 1.6 p-90 -146.88 123.98 11.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -56.1 128.31 34.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 mt -63.06 169.97 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.1 t70 -75.15 127.67 33.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.47 -40.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -40.99 63.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.555 HG23 ' CD2' ' A' ' 124' ' ' PHE . 22.2 mm -65.0 -44.37 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.9 t-160 -37.84 -62.51 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' GLY . 23.8 mt-30 -52.96 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.93 -46.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.622 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.95 -49.18 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -58.71 -27.82 65.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.4 mmpt? -76.37 -49.41 16.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.42 -22.72 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.449 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.456 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 25.1 mt -85.75 35.42 0.62 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 7.5 ptp -97.1 -36.9 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.489 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 35.3 ttmt -134.31 77.67 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.456 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 23.8 mm-40 -71.19 172.82 8.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -70.4 161.56 30.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 153' ' ' ALA . 0.4 OUTLIER -43.86 -61.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 152' ' ' LYS . . . -34.08 -48.95 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.151 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.61 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.4 m95 -82.48 161.62 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.748 0.309 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB2' ' CG ' ' A' ' 135' ' ' LEU . 44.6 t -138.12 130.18 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.9 tp -118.56 114.33 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.0 t -67.91 150.03 49.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 32.3 t -133.29 156.75 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.475 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 41.7 m-70 -90.73 115.38 27.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.542 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 65.9 mt-30 -61.66 160.82 24.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.962 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.83 -31.86 4.31 Favored 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.718 -1.784 . . . . 0.0 112.297 0.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.587 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.2 m-90 -25.47 -53.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.542 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -37.51 -61.3 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 7.2 m -64.88 -42.82 94.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.7 mt -51.77 -31.12 25.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.5 mp -66.27 -64.28 0.89 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.9 m -63.99 -16.39 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -76.87 -39.52 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.808 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 18.7 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.515 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.49 -42.1 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.552 ' HG2' HD11 ' A' ' 20' ' ' LEU . 17.3 tptt -99.05 104.54 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.486 ' HD2' HD13 ' A' ' 102' ' ' ILE . 12.2 ptp180 -97.87 17.34 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.474 HG11 HD12 ' A' ' 102' ' ' ILE . 27.4 m -149.38 147.1 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 3.5 tm-20 -118.62 141.81 48.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.516 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -102.89 126.82 8.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 12.6 mmt180 -148.42 146.37 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 10.4 m -84.25 20.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.575 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.3 p-90 -144.63 166.43 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -107.75 140.43 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 34' ' ' THR . 5.1 t -134.08 106.45 11.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.59 0.709 . . . . 0.0 111.128 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.3 Cg_endo -69.8 3.07 3.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.308 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.562 ' O ' HD22 ' A' ' 86' ' ' LEU . 18.5 t60 -63.13 111.74 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 7.7 mmt85 -116.1 121.79 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.65 -126.69 2.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.522 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -98.62 138.36 35.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.833 0.349 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 tp -143.93 112.86 6.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 86.2 m95 -71.34 133.86 46.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -104.1 126.84 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.54 145.57 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.672 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.64 117.06 22.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.3 p -53.21 176.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.86 -11.38 59.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 5.7 ttpt -73.06 146.53 45.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -104.08 134.08 19.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 0.0 110.91 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.75 127.26 14.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.623 2.215 . . . . 0.0 112.364 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.9 m -73.23 155.59 89.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.648 0.737 . . . . 0.0 110.871 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -5.33 15.9 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.713 2.275 . . . . 0.0 112.309 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.48 -39.83 10.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.38 -39.13 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.735 HG12 ' NE2' ' A' ' 58' ' ' GLN . 44.9 t -66.3 -54.74 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 t -59.09 -43.78 91.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.16 -56.43 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.586 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 77.2 mt -54.94 -39.6 69.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.735 ' NE2' HG12 ' A' ' 54' ' ' VAL . 11.1 mt-30 -55.44 -45.76 76.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.0 -33.81 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -63.44 -51.17 66.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.418 ' HE2' HD22 ' A' ' 57' ' ' LEU . 22.8 m-85 -68.55 -35.81 77.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 69' ' ' VAL . 35.5 mtt-85 -50.96 -34.13 27.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.64 -13.2 34.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.55 -29.24 17.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.444 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.7 mmm180 -121.47 -28.71 4.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.053 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.01 126.66 2.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.434 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 13.6 ptmt -45.98 -19.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.313 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -82.27 19.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.053 HG13 ' O ' ' A' ' 66' ' ' GLY . 21.2 m -67.24 -178.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -114.96 162.81 16.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 47.9 m-85 -157.61 134.94 6.89 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.3 Cg_endo -69.79 162.54 41.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 0.0 112.343 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -82.19 -29.27 31.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -147.35 175.19 10.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.604 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 51.7 m-85 -134.96 95.68 15.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.651 0.739 . . . . 0.0 110.966 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.8 Cg_endo -69.76 177.02 6.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.357 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.5 p -147.22 138.38 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 43.78 47.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 64.8 m -156.36 149.74 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.53 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -76.19 118.21 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 44' ' ' ALA . 86.9 mt -84.5 -73.95 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.427 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.97 -144.29 4.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.9 p -153.32 155.41 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 26.2 m -140.97 136.41 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.428 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.7 t70 -77.85 110.43 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.562 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.8 tt -75.0 101.85 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.524 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -72.99 -47.12 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.412 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -164.53 167.09 19.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -127.74 97.46 4.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 94' ' ' GLN . 94.8 mt -90.51 170.66 10.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.41 ' C ' ' N ' ' A' ' 93' ' ' LYS . 7.5 p -108.14 169.22 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 108' ' ' SER . 14.2 mm-40 -45.11 -21.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 24.2 tttt -92.02 -63.54 1.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.509 ' HB3' HD22 ' A' ' 90' ' ' LEU . 8.5 mt-30 -61.38 -48.47 81.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.606 ' CD2' HG21 ' A' ' 111' ' ' VAL . 21.8 t80 -42.38 -57.81 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 9.7 ptpt -67.79 -43.59 79.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -48.36 -58.6 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.486 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.4 mt-30 -79.39 -47.16 16.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.3 m-85 -110.24 67.82 0.49 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.626 0.727 . . . . 0.0 110.846 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.6 Cg_endo -69.81 -12.4 32.73 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -77.84 -20.94 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.652 HG22 ' CD ' ' A' ' 105' ' ' GLU . 2.1 pt -126.46 23.51 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.486 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 40.7 p -64.16 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.56 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -94.35 -30.02 14.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.652 ' CD ' HG22 ' A' ' 102' ' ' ILE . 30.0 mt-10 -45.51 -36.24 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 t -122.97 153.89 39.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.439 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 16.4 t70 -119.48 -30.55 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.472 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -47.35 161.04 0.33 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 110.825 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.483 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.7 Cg_endo -69.7 -37.88 8.7 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.7 2.267 . . . . 0.0 112.374 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -118.74 102.81 9.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.606 HG21 ' CD2' ' A' ' 95' ' ' PHE . 29.3 t -86.62 132.25 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.164 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 3.9 m-30 -99.63 105.21 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.81 122.56 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.411 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 2.1 m -125.71 154.44 42.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -141.9 175.2 9.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.44 53.2 8.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.646 0.736 . . . . 0.0 110.87 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.8 116.89 4.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.314 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -130.38 131.77 45.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.97 121.69 39.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.53 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.0 mtp -62.77 149.2 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.91 -35.75 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.33 134.16 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -102.43 149.49 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.406 ' HE2' ' HB2' ' A' ' 143' ' ' ALA . 0.8 OUTLIER -116.27 142.49 29.45 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.652 0.739 . . . . 0.0 110.857 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.8 pp -125.69 164.36 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.598 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 40.6 mttp -105.23 139.18 40.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.03 172.81 37.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -154.17 153.57 28.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 53.6 Cg_endo -69.75 1.75 4.15 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.354 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.575 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.2 mmmm -137.72 -174.95 3.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.61 HG22 ' CE3' ' A' ' 8' ' ' TRP . 75.5 mt -86.08 134.27 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.598 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.5 p-90 -140.64 130.71 24.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -57.94 128.04 35.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.44 HD22 HG21 ' A' ' 139' ' ' ILE . 29.3 mt -62.6 170.83 2.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.9 t0 -82.05 129.14 34.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -35.41 -49.5 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.84 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -65.3 -39.76 92.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 26.9 mm -64.75 -47.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.37 -61.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 142' ' ' GLY . 38.2 mt-30 -54.37 -69.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.55 -49.68 1.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.509 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.99 -44.27 78.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.7 mtpp -65.07 -22.88 67.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -84.46 -40.72 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -53.35 -14.77 3.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.889 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.592 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.5 m95 -84.56 163.58 19.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 133' ' ' TRP . 13.5 p -139.65 156.68 46.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -138.57 113.76 9.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 p -68.39 138.09 55.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.464 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 29.6 t -124.22 152.16 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 35.8 m-70 -87.4 114.89 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.691 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 57.9 mt-30 -60.58 161.44 14.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.77 -29.17 5.86 Favored 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.322 -0.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.573 ' O ' HD12 ' A' ' 20' ' ' LEU . 11.6 m-90 -28.53 -49.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.691 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -37.77 -64.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 -42.1 99.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.2 mt -49.82 -35.33 22.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.2 mp -61.92 -64.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.2 m -64.07 -22.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.4 mmt180 -69.32 -39.47 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.1 22.19 3.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.485 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.22 -44.62 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -95.01 101.25 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.98 ' HE ' HD13 ' A' ' 102' ' ' ILE . 17.2 ptt180 -96.85 17.2 17.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.644 HG11 HD12 ' A' ' 102' ' ' ILE . 32.7 m -149.02 150.37 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.44 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.8 122.18 7.42 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.447 ' N ' ' CB ' ' A' ' 108' ' ' SER . 16.4 mmt180 -147.8 150.09 33.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.474 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 80.0 p -86.13 21.28 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.526 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 5.7 p-90 -142.19 157.53 44.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 4.9 t80 -100.73 141.43 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 34' ' ' THR . 9.4 t -134.84 101.04 11.79 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.7 Cg_endo -69.81 4.53 2.16 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.664 2.243 . . . . 0.0 112.337 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -65.9 110.55 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -113.95 120.44 40.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.08 -120.48 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -106.06 140.68 38.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.891 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -144.19 114.7 7.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.67 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 95.6 m95 -72.37 132.25 43.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.459 ' O ' HD23 ' A' ' 80' ' ' LEU . 34.1 mm -101.03 128.61 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.23 152.63 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.778 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -89.64 118.74 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -55.29 175.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.76 -18.32 60.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.061 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 7.9 ttpt -68.88 148.43 50.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.48 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.3 135.27 19.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.492 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.75 127.98 15.38 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.342 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.8 m -73.86 159.62 83.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.623 0.725 . . . . 0.0 110.883 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -6.75 19.34 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.37 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.63 -42.06 8.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.954 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.55 -42.72 86.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG12 ' NE2' ' A' ' 58' ' ' GLN . 27.7 t -66.34 -52.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -59.77 -45.23 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.41 -56.65 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.498 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.4 mt -53.96 -43.05 69.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.589 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 7.8 mt-30 -49.88 -46.56 51.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.57 -38.89 39.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -56.86 -52.06 66.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -68.98 -40.17 78.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.57 ' HG2' HG22 ' A' ' 69' ' ' VAL . 44.7 mtt-85 -48.69 -35.17 13.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.2 mt -88.87 -14.75 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.406 HD13 ' NE2' ' A' ' 104' ' ' GLN . 62.3 mt -89.44 -28.12 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.402 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.8 mmm180 -121.91 -29.18 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.058 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 130.83 127.32 2.87 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.453 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -44.63 -21.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 66' ' ' GLY . 14.2 t0 -74.1 7.95 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.806 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.058 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.1 m -62.45 -178.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 2.4 mm-40 -117.0 172.42 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 56.7 m-85 -164.32 135.61 3.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.62 0.724 . . . . 0.0 110.939 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.82 161.77 44.66 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.296 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -83.73 -26.94 29.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -148.88 173.55 13.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.5 m-85 -134.69 95.38 15.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.687 0.756 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.2 Cg_endo -69.79 -178.21 2.25 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.6 m -149.93 139.05 21.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.52 44.6 63.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 19.6 m -156.68 149.06 23.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.532 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -74.81 118.37 17.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 44' ' ' ALA . 63.5 mt -83.07 -73.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.449 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.33 -141.02 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.498 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.576 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -151.92 166.87 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 114' ' ' CYS . 21.7 m -154.07 149.37 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.452 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.9 t70 -95.38 109.2 21.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -72.82 96.88 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.539 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -66.7 -48.44 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -162.95 167.45 22.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.456 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.4 t -127.67 98.2 5.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 98.1 mt -94.45 166.71 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 93' ' ' LYS . 9.6 t -106.73 166.29 10.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 108' ' ' SER . 19.7 mm-40 -42.06 -23.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 91' ' ' SER . 24.9 ttmt -86.61 -63.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.437 ' HB3' HD22 ' A' ' 90' ' ' LEU . 13.1 mt-30 -66.09 -49.97 65.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CD2' HG21 ' A' ' 111' ' ' VAL . 37.9 t80 -42.03 -56.78 2.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 5.0 ptmt -67.16 -41.33 86.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.1 -59.18 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -77.2 -48.36 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 30.8 m-85 -111.1 66.26 0.55 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.73 -12.73 33.56 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.91 -24.12 55.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.98 HD13 ' HE ' ' A' ' 26' ' ' ARG . 2.3 pt -120.49 17.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.444 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 27.2 p -58.05 -24.96 60.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.814 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.604 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -91.26 -31.95 15.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.947 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.678 ' CD ' HG22 ' A' ' 102' ' ' ILE . 27.2 mt-10 -43.37 -37.1 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 t -125.96 146.92 49.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -33.77 6.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.5 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.8 m -45.12 161.62 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 0.0 110.867 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.474 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.2 Cg_endo -69.71 -48.8 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.353 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 18.4 m-85 -105.62 102.9 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 95' ' ' PHE . 20.1 t -86.2 137.3 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.555 ' CE1' HG22 ' A' ' 34' ' ' THR . 11.1 m-30 -103.39 107.54 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.8 OUTLIER -74.69 117.48 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.125 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -118.49 151.13 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -143.1 175.62 9.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 52.09 52.34 11.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 0.0 110.915 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.0 Cg_endo -69.68 120.18 7.02 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.312 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -129.21 132.25 47.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -97.07 122.46 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.648 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 16.4 mtp -65.63 143.05 57.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.56 -24.73 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.01 138.73 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -106.79 149.08 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.648 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 1.1 m-85 -116.84 142.32 29.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 86.76 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.276 . . . . 0.0 112.334 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.544 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.8 pp -125.39 168.13 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.608 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 7.4 mtmp? -109.42 142.31 40.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.26 163.32 14.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -141.79 161.92 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 1.8 4.1 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.306 . . . . 0.0 112.317 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.526 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.1 mmmm -137.78 -175.08 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.592 HG22 ' CE3' ' A' ' 8' ' ' TRP . 97.1 mt -83.77 134.86 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.608 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 11.0 p-90 -140.75 127.34 20.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.97 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.572 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 9.7 ttmt -54.41 130.79 40.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 20.5 mt -66.4 176.37 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.9 t0 -86.18 126.03 33.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.23 -41.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -72.1 -43.23 65.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.514 HG23 ' CD2' ' A' ' 124' ' ' PHE . 30.0 mm -62.97 -43.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -40.25 -67.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 142' ' ' GLY . 70.1 mt-30 -49.03 -69.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.15 -46.57 0.98 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.44 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.67 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.67 -47.58 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -60.44 -25.18 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -85.58 -39.49 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.95 -8.85 6.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.482 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.954 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.691 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.0 m95 -72.52 163.29 28.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 t -136.4 129.91 31.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 40' ' ' LEU . 60.3 tp -116.87 113.49 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 0.5 OUTLIER -67.64 150.95 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.448 HG21 HD22 ' A' ' 20' ' ' LEU . 94.1 t -138.18 146.46 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.082 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 35.6 m-70 -82.01 119.75 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.562 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 56.5 mt-30 -64.63 162.28 36.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.589 0.709 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.78 -30.9 4.89 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.354 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.568 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 12.9 m-90 -25.08 -55.93 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.562 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.5 -61.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 4.7 m -64.61 -40.11 94.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 16' ' ' TRP . 67.8 mt -54.23 -30.81 51.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -65.15 -65.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.589 HG21 ' OE1' ' A' ' 119' ' ' GLU . 5.4 m -63.31 -17.95 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -74.93 -39.28 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.77 20.07 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -107.09 -44.01 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -97.32 113.83 25.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -109.84 19.84 18.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.83 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG11 HD12 ' A' ' 102' ' ' ILE . 34.8 m -152.54 145.2 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.422 ' HG2' HD21 ' A' ' 10' ' ' LEU . 9.4 tp10 -117.65 142.17 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -106.48 126.07 8.36 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.453 ' N ' ' CB ' ' A' ' 108' ' ' SER . 33.1 mmt180 -150.0 150.47 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 110.836 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.48 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 8.8 m -84.66 25.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.528 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -147.47 162.98 37.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -104.64 141.53 36.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 34' ' ' THR . 10.3 t -134.37 99.11 13.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 0.0 111.191 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.6 Cg_endo -69.83 4.93 1.93 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.459 ' O ' HD22 ' A' ' 86' ' ' LEU . 8.1 t60 -65.49 112.89 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.458 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 6.3 mmt85 -113.29 122.95 48.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.37 -129.49 2.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -99.15 140.03 33.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 10' ' ' LEU . 24.5 tp -144.17 112.57 6.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 83.2 m95 -70.93 128.83 37.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.77 123.75 53.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.18 148.52 41.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.075 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.753 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -83.78 120.52 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.2 p -55.73 169.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.79 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.459 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.3 ttpt -65.86 147.97 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -105.4 134.32 19.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.593 0.711 . . . . 0.0 110.894 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.73 126.63 13.56 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.33 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.6 m -72.22 158.91 86.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.725 . . . . 0.0 110.875 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.01 22.52 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.632 2.221 . . . . 0.0 112.351 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.42 ' NE2' ' HA ' ' A' ' 52' ' ' GLN . 8.1 mm100 -94.4 -36.26 11.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.48 -41.2 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.661 HG12 ' NE2' ' A' ' 58' ' ' GLN . 34.7 t -68.15 -45.99 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.5 t -66.88 -42.87 84.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.19 -52.8 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.568 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 84.4 mt -58.59 -41.11 85.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.661 ' NE2' HG12 ' A' ' 54' ' ' VAL . 9.3 mt-30 -53.06 -47.56 68.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -36.99 50.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 m -59.97 -51.68 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.169 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -69.26 -37.46 77.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.474 ' HG2' HG22 ' A' ' 69' ' ' VAL . 53.9 mtt180 -48.81 -33.44 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.7 mt -90.83 -15.91 29.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.8 mt -87.25 -29.69 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -120.81 -29.13 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.039 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.62 126.35 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -44.8 -20.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -80.85 17.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 66' ' ' GLY . 20.4 m -66.12 -178.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.8 162.97 15.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.591 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 44.4 m-85 -157.94 133.16 5.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.552 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.53 30.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -85.49 -29.21 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -146.78 173.21 12.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.645 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.71 96.2 15.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.698 0.761 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.426 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.71 172.7 12.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.264 . . . . 0.0 112.343 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.5 p -138.86 139.23 38.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.12 52.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 58.7 m -158.52 149.21 20.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -78.43 120.74 23.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.753 HD11 ' HB2' ' A' ' 44' ' ' ALA . 35.9 mt -89.33 -71.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.471 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.33 -145.97 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.493 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.5 p -152.99 157.48 40.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.897 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.4 m -140.9 144.32 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -85.81 113.7 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.459 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.6 tt -77.59 100.01 5.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.37 -48.07 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -163.09 167.26 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.77 101.19 6.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.8 mt -96.01 169.41 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' PHE . 13.2 p -108.36 169.12 8.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.839 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 108' ' ' SER . 21.8 mm-40 -47.25 -19.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 91' ' ' SER . 15.0 ttmm -90.35 -59.11 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -70.85 -50.13 38.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CD2' HG21 ' A' ' 111' ' ' VAL . 27.5 t80 -41.51 -54.85 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -67.52 -40.77 85.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.42 -58.72 6.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -75.67 -49.95 16.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.2 m-85 -109.85 68.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.656 0.741 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.75 -13.4 34.65 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -76.92 -24.68 52.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.709 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.1 pt -120.18 23.48 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 p -64.39 -27.15 68.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -90.33 -28.76 18.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.709 ' CD ' HG22 ' A' ' 102' ' ' ILE . 18.0 mt-10 -45.71 -39.38 7.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.937 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.4 t -124.64 147.95 48.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 7.3 t0 -110.99 -33.87 6.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.453 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 1.7 m -42.81 161.52 0.18 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 0.0 110.857 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.48 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.77 -45.49 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.692 2.262 . . . . 0.0 112.309 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -110.59 104.95 13.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.529 HG21 ' CD2' ' A' ' 95' ' ' PHE . 21.4 t -90.33 133.61 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 2.2 m-30 -100.86 109.73 21.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.36 121.94 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -124.56 154.04 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -141.4 175.8 9.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.97 52.41 5.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.651 0.739 . . . . 0.0 110.902 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.78 114.94 3.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.254 . . . . 0.0 112.318 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.41 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 4.1 pt20 -130.08 145.31 51.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.589 ' OE1' HG21 ' A' ' 21' ' ' VAL . 3.7 tp10 -107.14 123.56 48.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.51 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.8 mtp -63.13 149.26 45.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.39 -23.46 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.3 p -130.09 149.95 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 20.2 mmtm -117.35 151.81 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.488 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.5 m-85 -120.43 141.68 32.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.656 0.741 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 86.5 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.503 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.8 pp -121.73 165.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.617 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 48.8 mttp -101.59 143.17 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -87.44 -177.13 48.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 20.6 t-20 -170.52 142.45 1.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.632 0.729 . . . . 0.0 110.862 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.2 Cg_endo -69.74 9.76 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.685 2.257 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASN . 9.8 mmmm -141.44 -174.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.691 HG22 ' CE3' ' A' ' 8' ' ' TRP . 54.2 mt -88.6 132.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.617 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.0 p-90 -139.32 127.54 22.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.24 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.5 mt -61.0 172.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.45 152.65 30.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -58.9 -39.57 81.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -78.37 -38.09 42.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.488 HG23 ' CD2' ' A' ' 124' ' ' PHE . 24.3 mm -68.44 -36.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -49.07 -65.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 142' ' ' GLY . 47.5 mt-30 -48.51 -67.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.13 -52.65 1.25 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.549 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.0 -42.03 65.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.141 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 141' ' ' GLN . 9.8 mtpt -69.8 -17.86 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -90.17 -44.42 9.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.71 -19.69 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.6 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.706 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.5 m95 -77.42 161.76 27.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.762 0.315 . . . . 0.0 110.889 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.1 t -138.22 133.44 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.713 HD23 ' OE1' ' A' ' 28' ' ' GLU . 62.6 tp -121.16 114.24 21.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -67.92 154.67 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 37.2 t -137.08 155.95 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.461 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 35.3 m-70 -88.53 113.51 24.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.559 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 63.1 mt-30 -60.61 161.1 15.53 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.655 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.8 -30.13 5.32 Favored 'Cis proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 -1.819 . . . . 0.0 112.35 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.517 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.0 m-90 -27.63 -52.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.559 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.64 -62.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 m -64.98 -45.93 83.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 16' ' ' TRP . 79.1 mt -45.57 -30.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 16' ' ' TRP . 7.0 mp -68.55 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.5 HG11 ' N ' ' A' ' 82' ' ' GLY . 15.9 m -61.11 -13.9 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.415 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -81.26 -39.46 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.04 -19.93 5.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.655 ' H ' HD12 ' A' ' 24' ' ' ILE . 5.4 mp -64.85 -60.32 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 111.174 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HG2' HD11 ' A' ' 20' ' ' LEU . 7.5 tptp -83.34 120.97 26.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.823 ' HD2' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -113.22 11.72 18.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.568 HG11 ' CE1' ' A' ' 95' ' ' PHE . 33.6 m -142.52 156.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.713 ' OE1' HD23 ' A' ' 10' ' ' LEU . 3.2 tt0 -120.9 138.11 54.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.457 ' O ' ' NH1' ' A' ' 30' ' ' ARG . . . -102.64 123.62 7.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.548 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 75.9 mmt-85 -149.16 151.15 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.845 0.355 . . . . 0.0 110.849 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.478 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.3 m -87.6 18.67 3.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.566 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 6.4 p-90 -142.36 161.39 38.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.6 t80 -102.56 147.97 26.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 34' ' ' THR . 5.2 t -140.62 106.97 6.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 0.0 111.172 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.9 Cg_endo -69.78 2.95 3.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.452 ' O ' HD22 ' A' ' 86' ' ' LEU . 13.6 t60 -64.53 114.87 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -119.65 120.41 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.06 -122.58 1.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -105.09 139.49 39.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.877 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 10' ' ' LEU . 23.0 tp -143.67 114.02 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.643 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 87.6 m95 -72.1 128.69 36.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -98.71 132.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.118 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.35 155.87 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.755 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -90.81 119.13 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -56.27 173.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.83 63.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 5.9 ttpt -65.37 146.4 54.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.453 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.19 135.49 19.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.577 0.703 . . . . 0.0 110.863 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.76 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.662 2.241 . . . . 0.0 112.354 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 54' ' ' VAL . 3.4 m -71.55 159.63 84.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.696 0.76 . . . . 0.0 110.828 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -9.95 27.33 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 0.0 112.349 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -94.4 -37.97 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.72 -39.49 70.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 50' ' ' SER . 41.6 t -67.76 -46.32 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.15 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -67.4 -42.11 83.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.94 -48.96 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.466 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 83.5 mt -62.46 -40.85 97.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 9.3 mt-30 -54.81 -44.6 73.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.81 -34.82 30.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -62.04 -51.75 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.443 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 14.9 m-85 -67.5 -40.37 85.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.938 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HG2' HG22 ' A' ' 69' ' ' VAL . 51.8 mtt180 -47.03 -35.93 7.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.08 -17.97 31.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' TYR . 60.2 mt -86.01 -26.8 25.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -123.69 -27.72 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.065 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 128.28 129.87 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -46.84 -18.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -72.73 3.61 4.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.065 HG13 ' O ' ' A' ' 66' ' ' GLY . 34.3 m -62.02 179.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 12.1 pt-20 -122.93 173.77 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 72.9 m-85 -161.82 138.43 6.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.595 0.712 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 156.12 64.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.636 2.224 . . . . 0.0 112.337 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -72.91 -31.28 64.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -146.74 176.84 9.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.7 94.93 16.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 0.0 110.936 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.434 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.0 Cg_endo -69.74 173.99 10.14 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.2 p -142.59 135.49 28.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.86 50.09 14.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.5 m -161.24 148.47 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 0.0 110.882 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.538 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.39 118.19 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.755 HD11 ' HB2' ' A' ' 44' ' ' ALA . 40.3 mt -85.62 -70.94 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.5 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.36 -145.08 4.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.482 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 4.2 p -154.32 155.27 34.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 20.0 m -141.41 137.32 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.83 112.63 16.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.1 tt -77.81 101.83 6.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.522 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.94 -47.33 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -163.44 169.0 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.4 t -127.4 100.83 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.7 mt -94.94 170.84 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 93' ' ' LYS . 32.8 t -110.9 169.04 9.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.445 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 18.6 mm-40 -45.83 -20.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.411 ' N ' ' C ' ' A' ' 91' ' ' SER . 32.7 ttpt -89.35 -60.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -68.9 -50.55 48.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 27' ' ' VAL . 39.4 t80 -39.11 -55.66 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 7.0 ptmm? -68.59 -47.92 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.5 mt-10 -46.79 -58.57 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -76.56 -51.47 11.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 37.9 m-85 -110.03 67.81 0.47 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 110.916 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.74 -14.7 36.51 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.349 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.4 -23.31 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.823 HD13 ' HD2' ' A' ' 26' ' ' ARG . 2.2 pt -121.38 15.27 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.402 ' HB3' ' HA ' ' A' ' 100' ' ' PRO . 53.3 p -55.96 -18.52 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.89 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.575 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -98.27 -31.6 11.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 10.8 mt-10 -46.14 -27.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -134.4 145.72 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -111.02 -35.3 5.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -42.34 161.72 0.16 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.702 0.763 . . . . 0.0 110.833 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.478 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.78 -48.92 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -106.56 103.63 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.486 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 26.2 t -88.95 136.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 34' ' ' THR . 5.0 m-30 -102.33 108.47 19.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.57 120.46 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.444 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.2 m -124.87 154.09 41.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.21 175.99 9.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.449 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.22 54.17 9.64 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.855 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 116.99 4.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.656 2.237 . . . . 0.0 112.331 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -127.8 137.79 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -103.73 118.55 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.538 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.9 mtp -62.75 139.03 58.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.4 t -65.86 -30.83 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.47 143.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -111.68 151.89 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.47 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.8 OUTLIER -118.36 141.04 28.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 0.0 110.862 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 82.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.575 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.7 pp -121.11 166.69 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.592 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 34.3 mtpt -108.95 159.99 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.23 177.6 16.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -154.56 163.16 25.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 0.0 110.885 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 129' ' ' ASN . 53.5 Cg_endo -69.74 19.66 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.357 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.566 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.8 mmmm -152.82 -175.03 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.706 HG22 ' CE3' ' A' ' 8' ' ' TRP . 60.0 mt -84.33 131.75 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.592 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.1 p-90 -131.88 139.76 48.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -70.81 127.09 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.09 164.18 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.8 t0 -75.65 129.5 37.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -37.25 -47.76 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -66.77 -37.01 83.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 136' ' ' ASP . 11.9 mm -67.3 -48.1 79.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 139' ' ' ILE . 15.0 t-160 -37.09 -64.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.831 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 142' ' ' GLY . 36.1 mt-30 -51.37 -69.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.84 -49.48 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.643 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.48 -45.02 81.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.8 mtpp -64.61 -23.34 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.52 -38.0 16.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -61.35 -6.64 8.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 -179.9 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.528 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.7 m95 -78.11 164.35 25.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t -137.12 144.84 43.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.439 HD23 ' HG3' ' A' ' 28' ' ' GLU . 11.7 tp -130.94 114.66 15.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.3 p -70.42 133.35 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.518 HG21 HD22 ' A' ' 20' ' ' LEU . 53.4 t -118.89 153.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 34.4 m-70 -88.49 113.0 23.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 78.5 mt-30 -59.76 160.01 16.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.614 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.76 -32.09 4.14 Favored 'Cis proline' 0 C--N 1.342 0.212 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.322 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.581 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 10.7 m-90 -25.12 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -37.76 -64.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.074 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.9 m -62.45 -42.43 99.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 24' ' ' ILE . 45.0 mt -50.34 -37.64 37.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -58.96 -66.81 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.54 HG11 ' N ' ' A' ' 82' ' ' GLY . 16.8 m -60.41 -27.12 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 11.0 mmt180 -66.86 -39.5 87.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.11 15.19 5.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.402 HD13 HD23 ' A' ' 19' ' ' LEU . 5.3 mp -100.24 -41.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.494 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.8 tptp -99.64 100.87 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.696 ' HD2' HD13 ' A' ' 102' ' ' ILE . 6.4 ptp180 -93.41 16.11 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 102' ' ' ILE . 27.8 m -149.04 145.85 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 2.8 tm-20 -114.23 142.11 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -103.13 128.42 9.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.1 mmt180 -151.59 146.63 25.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -85.08 17.96 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.572 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.8 p-90 -141.44 165.36 27.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.29 141.39 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 34' ' ' THR . 5.0 t -135.99 104.73 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 0.0 111.169 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.8 Cg_endo -69.77 4.3 2.28 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.445 ' O ' HD22 ' A' ' 86' ' ' LEU . 17.3 t60 -64.85 111.82 2.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -115.55 119.99 37.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.84 -129.6 2.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.1 ttm-85 -96.5 139.41 32.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.88 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.4 tp -144.08 111.44 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.862 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.1 m95 -71.25 127.91 34.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.472 ' O ' HD23 ' A' ' 80' ' ' LEU . 50.5 mm -98.65 129.5 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -125.71 150.0 48.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -84.38 118.66 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.0 p -55.07 178.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.61 -14.07 60.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.1 ttpt -70.55 147.23 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.438 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -103.79 134.08 19.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.612 0.72 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 127.11 14.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.699 2.266 . . . . 0.0 112.358 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 54' ' ' VAL . 74.4 m -72.61 155.05 91.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 0.0 110.884 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -7.21 20.45 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -94.55 -40.16 10.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -38.13 73.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.717 HG12 ' NE2' ' A' ' 58' ' ' GLN . 58.1 t -66.28 -50.2 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.129 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -64.27 -44.48 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.38 -49.73 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.581 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.1 mt -62.72 -43.05 99.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.717 ' NE2' HG12 ' A' ' 54' ' ' VAL . 8.8 mt-30 -53.6 -43.4 68.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.4 29.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 m -62.38 -52.76 62.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.152 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.43 ' HE2' HD22 ' A' ' 57' ' ' LEU . 26.1 m-85 -66.29 -38.49 87.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 69' ' ' VAL . 66.5 mtt180 -49.81 -36.63 27.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.75 -12.76 44.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.505 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 69.0 mt -91.14 -28.04 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.505 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.7 mmp_? -123.64 -22.12 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.054 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 123.67 130.04 3.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 1.4 pptp? -47.89 -18.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.73 0.3 . . . . 0.0 110.88 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 1.4 6.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.054 HG13 ' O ' ' A' ' 66' ' ' GLY . 34.9 m -59.29 179.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -120.07 166.96 12.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.577 ' CD1' ' HG2' ' A' ' 58' ' ' GLN . 55.6 m-85 -158.31 134.77 6.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.597 0.713 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.71 163.06 39.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.272 . . . . 0.0 112.357 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -83.01 -29.16 29.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.66 173.5 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.614 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 42.3 m-85 -134.79 98.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 110.901 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.7 Cg_endo -69.76 176.4 6.82 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -143.96 133.54 23.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.57 47.86 19.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 17.1 m -157.81 149.17 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -77.98 115.45 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.957 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' ALA . 69.8 mt -82.12 -72.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.54 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.1 -147.2 4.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.481 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 10.5 p -152.84 153.33 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 21.1 m -139.28 143.19 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.13 112.85 20.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.6 tt -76.98 100.16 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.528 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -69.72 -46.83 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -165.44 167.54 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.45 99.25 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 94' ' ' GLN . 99.1 mt -95.07 165.73 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 93' ' ' LYS . 17.7 t -103.92 169.03 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 109' ' ' PRO . 4.1 mm-40 -41.12 -24.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' SER . 32.2 ttpt -87.32 -70.15 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.76 ' HB3' HD22 ' A' ' 90' ' ' LEU . 21.6 mm100 -57.12 -47.04 82.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.625 ' CD2' HG21 ' A' ' 111' ' ' VAL . 19.4 t80 -43.64 -57.21 3.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.47 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -69.36 -44.87 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.47 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.0 mt-10 -47.08 -59.56 3.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.869 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.674 HE21 ' NE2' ' A' ' 94' ' ' GLN . 6.3 mt-30 -79.1 -48.23 14.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.3 m-85 -110.06 67.64 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.642 0.735 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.71 -12.34 32.78 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.752 2.301 . . . . 0.0 112.313 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.24 -21.16 54.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.788 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.6 pt -125.43 23.95 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 44.4 p -65.35 -24.49 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.566 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -95.33 -25.59 16.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.788 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.1 mt-10 -48.17 -36.89 14.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -129.99 134.81 47.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -108.28 27.16 9.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 88.7 p -96.06 155.59 38.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.705 0.764 . . . . 0.0 110.841 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.454 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.76 -24.36 29.74 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.413 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 17.1 m-85 -134.63 90.21 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.625 HG21 ' CD2' ' A' ' 95' ' ' PHE . 40.8 t -79.38 136.82 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.123 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 3.7 m-30 -103.98 104.13 14.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.88 122.72 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.129 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 13.7 m -126.89 155.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -143.34 176.25 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.456 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.17 53.93 6.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.859 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.76 115.16 3.96 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.632 2.221 . . . . 0.0 112.357 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.54 134.64 49.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -100.61 120.82 40.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.547 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 13.6 mtp -62.5 152.92 33.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.0 t -78.67 -27.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.5 149.44 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 7.7 mmtm -114.21 144.77 42.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.638 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -114.84 140.79 25.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.51 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.359 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.619 HD13 ' HH2' ' A' ' 133' ' ' TRP . 2.8 pp -124.37 168.58 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.596 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 47.5 mmtm -111.99 141.99 44.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.67 175.44 26.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.432 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -155.54 162.01 28.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.671 0.748 . . . . 0.0 110.875 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 1.78 4.11 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.572 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.9 mmmm -137.17 -175.01 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.528 HG22 ' CE3' ' A' ' 8' ' ' TRP . 79.4 mt -85.88 133.52 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.619 ' HH2' HD13 ' A' ' 126' ' ' ILE . 7.6 p-90 -137.13 127.31 26.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.428 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 11.0 ttmt -55.72 133.69 50.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.17 174.17 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.49 158.71 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.85 -48.65 78.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -70.5 -37.16 74.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.638 HG23 ' CD2' ' A' ' 124' ' ' PHE . 44.9 mm -68.84 -41.29 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -45.58 -62.86 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 142' ' ' GLY . 46.4 mt-30 -53.59 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.57 -51.32 0.76 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.517 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.862 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.07 -47.6 68.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.5 mtpp -60.75 -24.24 65.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -50.81 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.87 -19.83 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.423 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.707 ' CE3' HG22 ' A' ' 132' ' ' ILE . 88.6 m95 -76.3 168.13 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.903 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' CB ' ' HG ' ' A' ' 135' ' ' LEU . 11.8 t -141.69 145.0 34.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.4 tp -134.47 112.03 10.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.403 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 13.1 p -67.99 137.77 55.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 45' ' ' THR . 25.3 t -121.73 157.52 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.493 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.3 m-70 -89.29 116.22 27.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.698 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 52.5 mt-30 -62.79 161.86 25.7 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 110.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.83 -28.98 5.98 Favored 'Cis proline' 0 C--N 1.341 0.15 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.328 0.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.671 ' O ' HD12 ' A' ' 20' ' ' LEU . 12.5 m-90 -29.02 -53.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.698 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.38 -64.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -63.0 -45.04 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 16' ' ' TRP . 70.5 mt -46.36 -35.54 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -62.25 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.486 HG11 ' N ' ' A' ' 82' ' ' GLY . 5.3 m -65.93 -12.18 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.103 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.487 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.5 mmt180 -84.14 -39.6 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.53 20.38 3.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.474 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.435 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.1 mp -108.38 -36.16 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.0 tptt -107.65 99.15 8.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.481 ' HE ' HD13 ' A' ' 102' ' ' ILE . 22.4 ptt180 -96.53 29.1 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 102' ' ' ILE . 34.2 m -156.55 145.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -121.31 118.98 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.456 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -84.99 123.19 6.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 14.7 mmt180 -142.72 152.3 42.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 110.859 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.482 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 17.8 p -86.93 18.18 3.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.559 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.0 p-90 -142.62 163.95 31.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -105.58 138.79 41.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 34' ' ' THR . 6.7 t -132.26 100.56 15.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.611 0.72 . . . . 0.0 111.099 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.495 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.1 Cg_endo -69.78 7.31 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.407 ' O ' HD22 ' A' ' 86' ' ' LEU . 28.7 t60 -63.83 107.76 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.497 ' NH1' HD22 ' A' ' 86' ' ' LEU . 44.2 mmt-85 -105.48 108.17 19.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.14 -145.19 10.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.405 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 0.2 OUTLIER -86.72 142.73 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.861 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.4 tp -144.13 115.34 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.672 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 90.4 m95 -73.37 137.75 44.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.527 ' O ' HD23 ' A' ' 80' ' ' LEU . 48.0 mm -107.13 132.64 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -130.61 145.54 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -75.95 125.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.7 p -61.13 -178.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.08 7.13 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -99.92 129.94 46.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.06 135.71 28.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.498 0.666 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.76 133.99 26.9 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.8 m -76.46 161.44 74.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.672 0.749 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.18 27.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -43.23 8.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.35 -40.91 90.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.886 HG12 ' NE2' ' A' ' 58' ' ' GLN . 60.8 t -65.05 -56.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -57.4 -42.79 82.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -66.61 -57.73 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.465 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 87.4 mt -54.22 -42.1 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.886 ' NE2' HG12 ' A' ' 54' ' ' VAL . 11.4 mt-30 -55.11 -42.54 73.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.5 -31.6 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.4 m -66.09 -52.02 52.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.84 -36.14 79.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.502 ' HG2' HG22 ' A' ' 69' ' ' VAL . 56.5 mtt180 -50.68 -34.23 25.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.5 mt -90.6 -12.57 36.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.3 mt -91.59 -28.14 17.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.984 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 4.3 mmm180 -121.97 -29.18 4.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.032 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.78 127.43 2.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -46.53 -19.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.47 16.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.032 HG13 ' O ' ' A' ' 66' ' ' GLY . 21.4 m -65.29 179.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' O ' HD11 ' A' ' 24' ' ' ILE . 20.3 mp0 -115.98 160.06 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.588 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 51.2 m-85 -153.16 139.8 12.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.74 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.487 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.8 Cg_endo -69.79 170.61 16.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.6 -22.34 19.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.49 172.08 16.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.9 m-85 -134.97 87.96 28.29 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 0.0 110.933 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.1 Cg_endo -69.71 172.04 13.31 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -137.15 144.18 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.88 44.81 95.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.464 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.28 158.24 41.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.527 HD23 ' O ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -85.04 117.23 23.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 44' ' ' ALA . 16.3 mt -85.87 -69.46 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.486 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -148.51 -142.49 3.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.619 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 35.7 t -154.41 162.33 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.439 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 22.4 m -149.85 140.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.409 ' CB ' HD22 ' A' ' 116' ' ' ASN . 1.8 t70 -81.75 114.86 20.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.497 HD22 ' NH1' ' A' ' 37' ' ' ARG . 4.4 tt -78.17 97.78 5.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.569 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.89 -47.79 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 113' ' ' ILE . 5.0 m-20 -164.54 166.35 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -127.43 101.4 6.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.496 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.2 mt -99.48 167.04 10.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 95' ' ' PHE . 33.0 t -106.89 169.04 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.842 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -46.41 -20.48 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 12.6 tttm -85.08 -58.04 2.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.439 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.2 mm100 -77.22 -51.31 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.553 ' CD2' HG21 ' A' ' 111' ' ' VAL . 42.1 t80 -38.89 -50.14 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.08 -42.76 68.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -55.12 -61.39 2.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.492 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.8 mt-30 -71.38 -50.53 31.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 113' ' ' ILE . 25.0 m-85 -109.42 68.26 0.41 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.657 0.741 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.75 -14.66 36.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.279 . . . . 0.0 112.304 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.12 -23.77 57.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.832 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.2 pt -120.32 19.38 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 p -60.62 -27.32 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.6 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.2 pp0? -93.47 -25.09 17.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.832 ' CD ' HG22 ' A' ' 102' ' ' ILE . 16.8 mt-10 -49.92 -32.28 14.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.6 t -130.95 150.94 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.02 -23.89 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.796 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.411 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 1.8 m -51.19 160.19 0.94 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.647 0.737 . . . . 0.0 110.836 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.482 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.3 Cg_endo -69.73 -45.64 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.36 100.87 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.553 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.4 t -84.74 142.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.447 ' CZ ' HG22 ' A' ' 34' ' ' THR . 6.5 m-30 -109.13 106.92 17.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -74.56 122.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.5 m -125.43 155.21 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -143.18 176.62 8.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.492 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.58 51.2 6.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 0.0 110.941 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.7 Cg_endo -69.7 121.72 8.42 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.647 2.232 . . . . 0.0 112.367 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -136.4 136.1 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.452 ' OE1' ' C ' ' A' ' 81' ' ' LEU . 4.3 tp10 -98.25 124.57 42.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.454 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.6 mtp -63.12 151.7 39.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 146' ' ' GLY . 95.0 t -70.9 -31.04 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.19 145.01 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -107.18 148.86 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.436 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.2 m-85 -113.18 142.28 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 82.54 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.233 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.633 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.7 pp -118.82 159.74 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 37.7 mttp -95.16 139.94 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.19 -179.6 46.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.489 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.9 t30 -165.53 145.24 5.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 53.8 Cg_endo -69.75 4.04 2.42 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.689 2.26 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.559 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 12.1 mmmm -136.36 -174.42 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.707 HG22 ' CE3' ' A' ' 8' ' ' TRP . 73.2 mt -88.53 130.01 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.7 p-90 -138.93 125.59 20.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -55.36 125.56 21.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.423 ' HG ' ' CB ' ' A' ' 9' ' ' CYS . 22.7 mt -59.76 169.64 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 139' ' ' ILE . 7.6 t0 -77.46 126.87 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.4 m -35.7 -41.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -72.85 -41.26 64.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.5 mm -64.85 -42.64 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -42.62 -64.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 142' ' ' GLY . 80.1 mt-30 -53.13 -66.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.0 -42.02 0.7 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.672 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -65.18 -46.67 79.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -56.35 -26.37 52.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -80.05 -53.01 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -37.25 -27.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.495 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 145' ' ' LYS . 14.7 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.907 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.53 ' CH2' ' HE3' ' A' ' 134' ' ' LYS . 91.8 m95 -78.25 164.02 25.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.92 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 t -138.23 138.64 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.8 tp -125.56 111.94 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 22.2 p -68.3 140.0 55.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 37.7 t -126.3 152.14 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.405 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 40.8 m-70 -85.87 116.3 24.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.659 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 54.7 mt-30 -62.54 162.1 22.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 -28.46 6.24 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.4 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.535 ' O ' HD12 ' A' ' 20' ' ' LEU . 12.9 m-90 -29.11 -51.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.659 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.23 -62.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.106 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -65.69 -47.03 76.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 16' ' ' TRP . 83.1 mt -44.04 -28.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.7 mp -70.59 -65.51 0.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.56 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.9 m -61.3 -12.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.465 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -82.47 -39.8 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.57 -17.2 5.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.697 ' H ' HD12 ' A' ' 24' ' ' ILE . 4.6 mp -68.16 -59.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.108 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.5 tptp -82.71 117.69 22.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.654 ' HD2' HD13 ' A' ' 102' ' ' ILE . 3.6 ptp180 -114.06 12.85 18.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.675 HG11 HD12 ' A' ' 102' ' ' ILE . 25.3 m -147.37 149.88 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.474 ' OE1' HD21 ' A' ' 20' ' ' LEU . 28.2 tp10 -115.78 146.2 42.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.48 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -111.26 112.72 3.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 22.8 mmt180 -137.99 148.77 45.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.479 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 61.6 p -84.39 21.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 4.6 p-90 -141.84 161.84 36.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . 9.8 t80 -105.12 141.47 36.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 34' ' ' THR . 6.0 t -135.19 105.01 10.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.609 0.719 . . . . 0.0 111.186 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.2 Cg_endo -69.81 3.21 2.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.451 ' O ' HD22 ' A' ' 86' ' ' LEU . 14.7 t60 -64.87 113.55 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -117.7 119.81 36.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.22 -124.93 1.63 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -100.98 140.75 34.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.852 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.5 tp -144.13 111.32 5.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.615 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 93.1 m95 -71.21 126.55 29.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 mm -96.84 125.49 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -121.8 148.87 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.611 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.89 117.46 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 p -54.08 -178.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.28 19.15 5.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.46 126.82 46.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -82.61 124.64 77.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.58 0.705 . . . . 0.0 110.871 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 126.61 13.48 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.351 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 m -70.04 156.08 92.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.616 0.722 . . . . 0.0 110.881 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -7.13 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.736 2.291 . . . . 0.0 112.341 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -35.18 12.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.96 -40.55 60.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.502 HG12 ' NE2' ' A' ' 58' ' ' GLN . 46.8 t -66.96 -47.22 82.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.7 t -65.47 -44.71 86.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.52 -52.57 30.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.5 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 77.1 mt -55.37 -40.2 71.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 12.5 mt-30 -54.95 -49.27 71.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.64 -33.07 62.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -64.28 -48.01 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.412 ' HE2' HD22 ' A' ' 57' ' ' LEU . 30.3 m-85 -72.76 -30.03 63.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.545 ' HG2' HG22 ' A' ' 69' ' ' VAL . 42.0 mtt180 -56.48 -36.26 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.0 mt -89.59 -13.25 37.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 mt -90.36 -29.78 17.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.442 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 5.5 mmm180 -120.78 -29.44 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.045 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.46 125.1 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -42.83 -23.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.873 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -76.82 13.94 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.045 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.7 m -62.89 -179.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 31.7 mt-10 -117.99 165.12 14.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 54.1 m-85 -160.16 135.73 5.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.81 164.1 35.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.699 2.266 . . . . 0.0 112.286 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -80.18 -30.73 38.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -146.76 175.43 10.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 60.9 m-85 -133.87 94.06 19.41 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.69 0.757 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.506 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.9 Cg_endo -69.76 175.82 7.59 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.681 2.254 . . . . 0.0 112.36 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.1 p -142.1 139.19 32.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.27 49.58 44.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 66.0 m -158.22 148.2 19.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -77.32 114.24 15.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' ' 44' ' ' ALA . 81.3 mt -82.0 -74.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.56 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -142.62 -147.95 4.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.0 p -151.56 153.7 35.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.6 m -139.96 141.07 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.411 ' CB ' HD22 ' A' ' 116' ' ' ASN . 1.7 t70 -83.34 114.18 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.8 tt -78.48 96.96 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.58 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -66.56 -48.95 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.168 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER -162.5 167.84 22.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.49 99.63 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 94' ' ' GLN . 91.5 mt -93.95 171.09 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 93' ' ' LYS . 38.2 t -109.81 169.22 8.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 108' ' ' SER . 18.8 mm-40 -44.54 -21.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.42 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.2 tttt -89.12 -63.1 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.589 ' HB3' HD22 ' A' ' 90' ' ' LEU . 11.0 mt-30 -65.58 -49.55 68.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.574 ' CD2' HG21 ' A' ' 111' ' ' VAL . 37.3 t80 -42.16 -56.12 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 8.7 ptmt -68.46 -42.9 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.421 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 6.6 mt-10 -51.7 -60.36 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.2 mt-30 -75.86 -49.74 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 34.7 m-85 -110.42 66.87 0.48 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.619 0.723 . . . . 0.0 110.844 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.78 -14.18 35.65 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 0.0 112.359 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.79 -22.39 58.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.675 HD12 HG11 ' A' ' 27' ' ' VAL . 1.9 pt -121.83 15.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.7 p -55.68 -21.82 20.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -95.05 -30.47 14.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 12.1 mt-10 -47.58 -26.41 1.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -136.26 141.92 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 5.4 t70 -106.96 -37.17 6.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.48 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.8 m -40.89 161.33 0.12 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 0.0 110.874 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.479 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.81 -43.59 2.53 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.297 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 33' ' ' TYR . 16.9 m-85 -110.06 101.95 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 95' ' ' PHE . 25.7 t -87.07 134.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.8 m-30 -101.34 109.97 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.94 120.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.455 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.1 m -123.59 152.49 41.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.25 176.38 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.475 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 57.47 52.82 5.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 112.39 3.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.316 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -126.61 132.19 51.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -98.0 120.35 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.513 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.6 mtp -62.52 154.36 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 70.7 t -81.55 -25.72 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.07 148.56 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 10.9 mmtm -115.86 142.3 46.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.543 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.8 OUTLIER -114.12 141.65 26.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.661 0.743 . . . . 0.0 110.867 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 90.54 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.56 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.7 pp -125.53 167.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.573 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 43.5 mtpt -110.13 142.61 41.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.99 174.98 24.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -155.87 162.27 27.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.718 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 2.3 3.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.272 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.403 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 6.8 mmmm -139.94 -175.01 4.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 81.9 mt -83.15 141.92 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 14.5 p-90 -147.18 129.44 15.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.53 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 17.0 ttmt -58.71 128.83 39.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.3 mt -63.22 -177.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.7 t70 -90.56 128.2 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.3 m -36.23 -41.16 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -72.97 -40.62 65.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.543 HG23 ' CD2' ' A' ' 124' ' ' PHE . 14.4 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.78 -62.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' LYS . 16.1 mm100 -55.02 -69.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.56 -42.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.615 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -60.74 -46.18 91.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.5 mtpp -61.97 -24.05 66.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -86.56 -42.84 13.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -51.1 -15.18 1.44 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.512 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.594 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.3 m95 -83.32 162.37 21.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' HB2' ' CG ' ' A' ' 135' ' ' LEU . 7.2 t -135.16 129.81 34.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.598 HD23 ' CD ' ' A' ' 28' ' ' GLU . 57.5 tp -116.5 113.81 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.426 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 24.0 p -68.15 153.08 44.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.632 HG12 ' N ' ' A' ' 13' ' ' HIS . 90.3 t -136.44 164.6 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.632 ' N ' HG12 ' A' ' 12' ' ' VAL . 64.4 m-70 -102.1 110.2 22.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.526 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.9 mm-40 -56.37 157.89 8.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 16' ' ' TRP . 54.2 Cg_endo -69.69 -32.94 3.6 Favored 'Cis proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.382 -0.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.544 ' C ' ' O ' ' A' ' 15' ' ' PRO . 8.3 m-90 -25.16 -58.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -32.08 -53.7 0.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.094 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.0 m -69.71 -55.06 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.9 mt -40.17 -31.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.488 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.6 mp -64.26 -68.04 0.38 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.476 HG11 ' N ' ' A' ' 82' ' ' GLY . 16.5 m -61.6 -10.45 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.453 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -84.3 -40.12 18.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.26 -5.2 8.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.88 -43.28 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HG2' HD11 ' A' ' 20' ' ' LEU . 8.4 tptp -100.24 105.54 17.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.573 HH21 ' NE ' ' A' ' 65' ' ' ARG . 6.3 ptp180 -102.48 23.63 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.1 m -152.51 146.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.598 ' CD ' HD23 ' A' ' 10' ' ' LEU . 3.1 tt0 -117.57 122.1 42.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.03 124.69 7.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -146.45 150.19 35.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.412 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.7 p -86.98 21.26 2.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.562 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.4 p-90 -143.78 160.91 39.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.48 137.78 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 34' ' ' THR . 11.9 t -134.41 98.38 13.88 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.542 0.687 . . . . 0.0 111.16 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.438 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.0 Cg_endo -69.72 9.5 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.427 ' O ' HD22 ' A' ' 86' ' ' LEU . 14.4 t60 -67.93 110.15 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 72.2 mmt-85 -106.94 113.13 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.11 -151.9 22.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -78.58 142.67 37.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.8 tp -143.74 112.45 6.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.584 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 95.0 m95 -72.04 123.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.449 ' O ' HD23 ' A' ' 80' ' ' LEU . 51.8 mm -94.77 130.07 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -128.97 154.72 46.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.64 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -88.07 132.22 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 12' ' ' VAL . 20.1 p -72.73 171.95 11.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.02 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 5.3 ttpt -64.3 130.16 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -91.36 129.27 43.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.91 18.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.669 2.246 . . . . 0.0 112.39 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -75.37 155.41 85.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.695 0.76 . . . . 0.0 110.84 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -3.91 12.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.693 2.262 . . . . 0.0 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -94.63 -44.37 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.508 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 14.2 mp0 -65.79 -41.86 91.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG12 ' NE2' ' A' ' 58' ' ' GLN . 43.6 t -63.76 -50.14 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.147 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -63.47 -45.36 91.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.22 -54.59 31.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.467 HD22 ' HE2' ' A' ' 61' ' ' TYR . 79.8 mt -54.32 -58.36 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.4 mt-30 -34.85 -48.48 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.5 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -54.62 -52.68 61.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.467 ' HE2' HD22 ' A' ' 57' ' ' LEU . 24.0 m-85 -67.69 -35.86 79.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.456 ' HG2' HG22 ' A' ' 69' ' ' VAL . 31.1 mtt-85 -51.4 -33.84 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.6 mt -89.88 -14.28 34.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.434 HD13 ' NE2' ' A' ' 104' ' ' GLN . 60.4 mt -88.61 -31.02 18.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.573 ' NE ' HH21 ' A' ' 26' ' ' ARG . 4.6 mmm180 -119.39 -29.3 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.064 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.63 125.29 2.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.503 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -44.52 -20.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' GLY . 9.1 m-20 -82.67 21.49 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.064 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.4 m -70.69 -178.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.8 pt-20 -116.56 168.65 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 63.8 m-85 -159.93 141.38 9.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.67 0.748 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.75 168.04 22.69 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -92.89 -23.71 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -146.64 167.47 23.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 72' ' ' PRO . 83.3 m-85 -133.09 88.34 36.75 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.655 0.741 . . . . 0.0 110.907 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.46 ' HG2' HD21 ' A' ' 81' ' ' LEU . 54.2 Cg_endo -69.72 169.18 19.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.0 p -136.92 136.65 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.29 46.22 50.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.6 m -155.28 152.3 29.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.493 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -77.56 116.08 17.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 44' ' ' ALA . 25.1 mt -83.74 -70.11 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.476 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.04 -141.82 3.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.57 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 6.5 t -153.47 161.37 42.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.0 m -151.56 145.25 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.405 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.9 t70 -90.27 112.91 24.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.7 tt -75.12 98.12 3.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.22 -47.45 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.6 m-20 -163.64 168.16 20.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.37 103.23 7.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.9 mt -100.49 165.74 11.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.954 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 93' ' ' LYS . 33.3 t -106.12 169.05 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 108' ' ' SER . 20.3 mm-40 -45.24 -20.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.415 ' N ' ' C ' ' A' ' 91' ' ' SER . 26.3 ttmt -87.94 -63.74 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -66.66 -49.19 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 111' ' ' VAL . 32.2 t80 -42.76 -55.26 3.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 97' ' ' GLU . 7.5 ptmt -68.25 -40.34 81.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.418 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 6.8 mt-10 -54.8 -59.66 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -75.97 -48.55 20.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -110.88 66.74 0.53 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 0.0 110.88 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.71 -12.24 32.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.363 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.71 -22.99 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.615 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.4 pt -122.1 22.26 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 p -62.48 -22.24 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.602 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -94.37 -31.04 14.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.615 ' CD ' HG22 ' A' ' 102' ' ' ILE . 22.3 mt-10 -45.59 -37.06 5.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -128.52 134.32 48.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.448 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 10.4 t0 -97.91 -36.29 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.878 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.497 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -39.87 159.94 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 0.0 110.836 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.8 Cg_endo -69.76 -47.34 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -107.37 101.85 11.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.576 HG21 ' CD2' ' A' ' 95' ' ' PHE . 33.2 t -86.52 140.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.46 ' CE1' HG22 ' A' ' 34' ' ' THR . 8.7 m-30 -107.41 109.5 21.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -78.0 120.83 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.0 m -124.27 155.02 39.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -141.17 177.36 8.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.91 52.35 7.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.74 116.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.317 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -130.88 133.62 46.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -97.77 122.22 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.52 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 16.5 mtp -62.87 154.21 30.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.928 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -75.24 -30.03 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.56 142.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -107.55 140.02 41.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.52 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.7 OUTLIER -105.06 142.89 25.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.618 0.723 . . . . 0.0 110.876 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 83.07 0.72 Allowed 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.406 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.7 pp -121.41 155.8 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.585 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 8.2 ptpt -97.08 141.53 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -104.45 162.4 15.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.459 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -137.86 160.66 63.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.62 0.724 . . . . 0.0 110.909 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 2.53 3.45 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.8 mmmm -136.88 -175.15 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.594 HG22 ' CE3' ' A' ' 8' ' ' TRP . 83.6 mt -85.24 133.58 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.585 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.0 p-90 -140.46 128.3 21.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -56.43 126.03 24.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.419 ' CG ' ' HB2' ' A' ' 9' ' ' CYS . 25.4 mt -59.98 173.25 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.7 t70 -82.46 127.46 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.54 -39.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -74.42 -41.69 60.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' ASP . 29.1 mm -64.46 -42.56 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -40.47 -63.22 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLY . 45.1 mt-30 -53.45 -69.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.75 -51.66 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.584 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.09 -46.82 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -62.45 -23.36 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 147' ' ' LEU . 11.5 mmmm -80.38 -53.1 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -39.26 -24.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 145' ' ' LYS . 28.3 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.323 . . . . 0.0 110.877 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.688 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.9 m95 -81.4 164.22 22.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.925 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -138.69 133.34 32.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.597 ' HB2' HD21 ' A' ' 40' ' ' LEU . 31.1 tp -121.17 109.43 14.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.6 m -67.94 134.17 50.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.822 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.775 HG22 HH22 ' A' ' 30' ' ' ARG . 34.0 t -115.24 157.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.479 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 33.6 m-70 -90.54 113.71 25.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.519 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 71.3 mt-30 -59.06 160.51 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.561 0.696 . . . . 0.0 110.958 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.555 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -30.1 5.32 Favored 'Cis proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.36 -0.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.691 ' O ' HD12 ' A' ' 20' ' ' LEU . 9.7 m-90 -26.98 -54.5 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.29 -65.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 3.4 m -59.67 -43.49 93.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 16' ' ' TRP . 59.3 mt -50.78 -39.19 51.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.8 mp -58.53 -69.58 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.582 HG11 ' N ' ' A' ' 82' ' ' GLY . 26.6 m -57.46 -23.55 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.47 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.8 mmt180 -71.02 -39.14 72.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.67 24.59 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.466 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.39 -37.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.543 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -105.17 103.48 13.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.428 ' CD ' HH12 ' A' ' 65' ' ' ARG . 18.7 ptt180 -102.06 28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.494 HG11 HD12 ' A' ' 102' ' ' ILE . 34.0 m -156.51 142.59 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.441 ' CD ' ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -115.16 137.92 51.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.98 115.03 5.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.775 HH22 HG22 ' A' ' 12' ' ' VAL . 75.0 mmt-85 -138.52 154.11 48.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.477 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 95.7 p -88.99 20.67 3.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 1.8 p-90 -141.74 165.57 27.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -106.54 139.08 41.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 34' ' ' THR . 9.8 t -133.89 99.16 14.01 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.3 Cg_endo -69.73 7.98 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.428 ' O ' HD22 ' A' ' 86' ' ' LEU . 23.7 t60 -64.46 107.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.479 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.4 mmt-85 -103.85 108.8 20.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.42 -148.79 16.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -85.55 144.54 27.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 10' ' ' LEU . 22.0 tp -143.46 114.56 7.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 87.9 m95 -71.27 127.86 33.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -97.77 126.0 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.32 142.03 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.852 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -77.05 118.09 19.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.3 p -57.59 178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.5 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -98.76 128.61 45.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.909 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -87.61 122.41 70.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.565 0.698 . . . . 0.0 110.869 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 133.0 24.48 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.668 2.246 . . . . 0.0 112.346 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.9 m -78.19 161.29 71.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.684 0.754 . . . . 0.0 110.821 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -10.79 29.41 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.646 2.231 . . . . 0.0 112.352 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -87.33 -49.11 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -41.16 99.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.69 HG12 ' NE2' ' A' ' 58' ' ' GLN . 42.5 t -65.72 -51.14 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 t -63.64 -43.52 96.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -66.7 -52.73 41.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.489 HD22 ' HE2' ' A' ' 61' ' ' TYR . 83.7 mt -58.47 -42.44 87.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.69 ' NE2' HG12 ' A' ' 54' ' ' VAL . 11.8 mt-30 -52.82 -45.29 67.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.43 -36.25 39.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 m -60.43 -52.21 66.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.489 ' HE2' HD22 ' A' ' 57' ' ' LEU . 31.8 m-85 -68.43 -38.55 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.539 ' HG2' HG22 ' A' ' 69' ' ' VAL . 64.8 mtt180 -49.1 -34.25 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.92 -13.93 35.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.1 -27.86 19.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.428 HH12 ' CD ' ' A' ' 26' ' ' ARG . 3.9 mmm180 -122.66 -28.74 4.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.023 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.22 127.96 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.81 -19.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.55 14.71 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.023 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.8 m -64.45 -179.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -114.41 160.38 19.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 48.5 m-85 -155.44 134.87 7.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.477 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.84 165.08 32.28 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.637 2.224 . . . . 0.0 112.331 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -85.34 -29.08 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -148.01 174.95 11.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.555 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 43.1 m-85 -134.78 100.65 12.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.68 0.752 . . . . 0.0 110.959 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.6 Cg_endo -69.76 179.68 3.53 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.701 2.267 . . . . 0.0 112.345 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.8 p -142.05 141.32 32.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.85 58.01 16.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 10.2 m -162.15 150.61 14.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.598 HD22 ' SD ' ' A' ' 120' ' ' MET . 0.5 OUTLIER -77.25 118.77 20.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 44' ' ' ALA . 23.2 mt -88.52 -69.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.582 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.93 -143.52 3.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.5 p -157.5 148.63 21.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 110.883 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 18.9 m -135.96 136.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.12 111.58 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 112' ' ' PHE . 4.8 tt -72.97 104.28 4.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -73.15 -47.13 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.32 168.16 18.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.15 103.21 7.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 94' ' ' GLN . 93.6 mt -100.17 165.92 11.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 93' ' ' LYS . 47.9 t -102.91 169.61 8.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.486 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 12.2 mm-40 -45.13 -20.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 25.9 ttpt -91.0 -67.94 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.93 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.536 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.3 mt-30 -58.45 -46.19 87.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.8 t80 -44.09 -57.86 3.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.9 ptpt -68.66 -43.05 77.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.7 mt-10 -49.14 -59.26 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.6 mt-30 -78.74 -46.62 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 33.2 m-85 -111.24 68.56 0.67 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.685 0.755 . . . . 0.0 110.86 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.8 Cg_endo -69.8 -12.5 32.94 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.644 2.229 . . . . 0.0 112.368 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.34 -22.22 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.739 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.9 pt -124.78 23.2 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.506 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 37.0 p -64.21 -28.27 69.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.597 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -90.07 -30.25 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.739 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.5 mt-10 -43.63 -36.09 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.2 t -125.09 151.24 45.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.14 -29.26 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.482 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.4 m -49.3 162.18 0.43 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.678 0.751 . . . . 0.0 110.887 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.486 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.3 Cg_endo -69.74 -46.13 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.714 2.276 . . . . 0.0 112.337 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -109.98 104.71 13.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 95' ' ' PHE . 19.7 t -91.8 132.29 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 2.9 m-30 -100.25 108.82 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.41 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -76.01 124.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.482 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -125.09 155.65 39.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.444 ' CG ' HD12 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -138.94 177.56 7.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.844 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 53.43 52.8 10.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.4 Cg_endo -69.76 115.14 3.96 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.266 . . . . 0.0 112.314 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.85 142.03 49.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.14 124.81 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.598 ' SD ' HD22 ' A' ' 80' ' ' LEU . 13.8 mtp -63.69 148.44 49.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.62 -33.64 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.092 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.63 142.35 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -106.46 152.93 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.568 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.1 m-85 -119.12 140.06 28.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 88.22 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.294 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.461 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.8 pp -118.18 158.91 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.595 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 30.3 mtpt -89.86 114.94 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.67 158.66 53.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.526 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -145.67 158.75 49.35 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 4.4 mmmm -91.73 -173.83 3.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.688 HG22 ' CE3' ' A' ' 8' ' ' TRP . 62.7 mt -82.89 137.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.1 p-90 -143.59 128.03 17.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -55.21 130.04 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.8 mt -63.6 178.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.0 167.45 15.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 p -72.2 -43.09 65.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -78.51 -18.86 54.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.568 HG23 ' CD2' ' A' ' 124' ' ' PHE . 15.7 mm -89.78 -36.23 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -51.29 -59.98 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 144' ' ' LYS . 82.2 mt-30 -56.7 -66.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.51 -42.18 0.91 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.458 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -61.86 -42.18 98.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.105 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.0 mtpp -65.82 -24.99 67.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 147' ' ' LEU . 23.7 mmmt -80.87 -52.13 7.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -41.9 -23.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.504 HD11 ' SG ' ' A' ' 83' ' ' CYS . 34.2 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.654 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.0 m95 -72.65 165.04 25.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.726 0.298 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.477 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 14.1 p -137.76 137.69 38.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 40' ' ' LEU . 10.7 tp -120.34 107.45 12.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 t -67.98 142.0 56.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 8.8 t -126.58 159.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.533 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.2 m-70 -90.52 112.89 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.554 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 57.9 mt-30 -58.57 160.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.577 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.72 -28.69 6.1 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.369 -0.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.506 ' C ' ' O ' ' A' ' 15' ' ' PRO . 9.5 m-90 -28.72 -57.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.26 -61.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 22' ' ' ARG . 2.2 m -63.1 -46.51 87.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.415 HD23 HD13 ' A' ' 24' ' ' ILE . 53.1 mt -45.74 -31.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 8.8 mp -67.21 -68.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.581 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.1 m -60.67 -10.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.7 mmt180 -84.34 -39.18 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 117' ' ' PRO . . . 123.16 0.14 9.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.431 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.2 mp -85.1 -49.63 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -88.91 118.54 28.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 10.1 ttt180 -103.8 -0.07 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 28.4 m -143.45 155.62 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 4.9 tm-20 -122.07 152.86 39.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.544 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -111.31 129.36 9.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.7 mmt180 -148.82 145.04 27.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.866 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.402 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 61.5 p -83.02 18.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.582 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.1 p-90 -143.98 165.82 26.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -105.5 140.67 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 34' ' ' THR . 6.3 t -135.03 104.82 10.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.709 . . . . 0.0 111.114 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.6 Cg_endo -69.8 2.63 3.38 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.641 2.227 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.439 ' O ' HD22 ' A' ' 86' ' ' LEU . 16.4 t60 -62.17 111.77 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 5.8 mmt85 -114.24 122.09 45.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.52 -125.92 2.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -99.47 142.8 30.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 10' ' ' LEU . 15.0 tp -144.03 111.82 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.557 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 94.5 m95 -72.44 121.73 20.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.62 130.14 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -127.67 142.08 51.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.749 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -76.17 122.31 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.9 p -58.96 175.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.35 -15.98 61.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 6.4 ttpt -73.41 144.39 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.52 137.37 19.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.614 0.721 . . . . 0.0 110.889 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.73 128.97 16.83 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.69 2.26 . . . . 0.0 112.324 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 m -73.06 156.2 89.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.665 0.745 . . . . 0.0 110.862 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -36.92 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.24 -42.36 68.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.797 HG12 ' NE2' ' A' ' 58' ' ' GLN . 47.8 t -64.31 -51.23 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -61.69 -44.58 96.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.29 -56.63 10.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 58' ' ' GLN . 94.1 mt -54.73 -55.91 24.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.797 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.6 mt-30 -37.45 -48.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.48 -44.64 34.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 m -51.97 -53.36 42.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -66.79 -38.67 86.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.4 mtt180 -48.77 -37.63 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -86.47 -15.99 38.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.498 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 59.5 mt -85.78 -28.84 24.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.498 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.9 mmp_? -122.67 -27.44 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.059 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 128.64 129.08 3.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.448 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -45.06 -20.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.5 p30 -70.95 3.18 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.059 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.2 m -60.63 178.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 8.8 mp0 -122.94 172.3 8.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 76.7 m-85 -161.11 141.47 8.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.557 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.87 29.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 0.0 112.362 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.02 -27.03 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -144.87 166.1 26.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.577 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 76.0 m-85 -130.64 88.47 46.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.645 0.736 . . . . 0.0 110.884 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.3 Cg_endo -69.75 168.43 21.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.67 2.246 . . . . 0.0 112.368 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.3 p -133.36 150.25 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.06 40.42 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 28.2 m -147.27 151.72 37.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.665 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -78.85 113.12 16.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 44' ' ' ALA . 26.3 mt -81.18 -70.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.581 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -149.09 -142.95 3.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.541 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -153.79 153.68 32.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 m -140.99 139.86 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.403 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.6 t70 -81.88 112.72 19.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.439 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.5 tt -77.45 100.38 5.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.532 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.98 -45.62 71.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 3.5 m-20 -165.46 165.9 18.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.421 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.3 t -127.77 97.09 4.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.519 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 95.4 mt -94.67 168.13 11.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 93' ' ' LYS . 46.3 t -104.84 169.41 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 108' ' ' SER . 11.6 mm-40 -45.04 -20.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.1 ttmt -91.65 -69.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -57.98 -45.74 86.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.605 ' CD2' HG21 ' A' ' 111' ' ' VAL . 16.5 t80 -44.43 -58.66 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 10.4 ptpt -66.91 -40.01 87.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.2 mt-10 -49.99 -56.01 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.498 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.7 mt-30 -81.87 -49.18 10.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.498 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 19.8 m-85 -109.77 69.13 0.48 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.664 0.745 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.2 Cg_endo -69.78 -11.79 31.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.665 2.244 . . . . 0.0 112.354 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.42 -22.14 51.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.717 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.0 OUTLIER -122.44 22.75 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.6 p -64.07 -20.76 66.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.54 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.5 pp0? -96.54 -27.82 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.717 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.1 mt-10 -47.03 -40.06 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 t -120.09 150.64 40.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -116.2 -27.19 6.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.44 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -52.11 162.34 0.85 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.83 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 54.3 Cg_endo -69.72 -37.27 9.49 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.12 101.18 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.605 HG21 ' CD2' ' A' ' 95' ' ' PHE . 50.7 t -84.39 136.43 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 7.5 m-30 -104.59 102.39 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -70.62 119.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 2.7 m -124.26 154.02 40.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -142.09 176.71 8.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 54.79 52.24 8.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.82 119.94 6.8 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.331 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -132.47 138.48 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -102.75 122.26 44.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.665 ' HE1' HD13 ' A' ' 80' ' ' LEU . 16.9 mtp -62.92 153.26 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.4 t -72.8 -37.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.16 138.07 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -102.49 149.58 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -113.11 142.34 27.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 86.66 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.535 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.8 pp -121.06 160.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 15.0 ptmt -99.61 134.6 42.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.79 -178.01 39.45 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -161.12 159.22 24.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 0.3 5.87 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.629 2.219 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.582 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 9.1 mmmm -136.94 -175.0 3.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.654 HG22 ' CE3' ' A' ' 8' ' ' TRP . 71.9 mt -84.88 140.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.12 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.503 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 9.4 p-90 -146.51 128.96 15.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.557 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 15.2 ttmt -56.5 130.3 44.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 139' ' ' ILE . 17.8 mt -65.71 168.85 7.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.3 t70 -77.4 127.19 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.13 -40.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.61 -42.54 58.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 24.9 mm -64.04 -38.72 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -46.54 -65.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.7 mm-40 -49.75 -68.49 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.05 -54.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.557 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.24 -40.91 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 111.097 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -67.83 -17.03 64.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.6 mmmm -89.84 -50.09 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -40.04 -23.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.539 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 145' ' ' LYS . 22.6 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.481 ' CE3' HG22 ' A' ' 132' ' ' ILE . 94.0 m95 -83.05 164.17 20.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 12.9 p -145.6 142.45 29.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.436 ' CD2' ' HG2' ' A' ' 28' ' ' GLU . 8.9 tp -130.95 114.16 14.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 18.7 m -69.59 147.45 50.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 19.7 t -129.76 154.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.437 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 37.3 m-70 -86.66 120.14 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.631 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 57.6 mt-30 -64.14 161.61 38.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 16' ' ' TRP . 53.5 Cg_endo -69.8 -30.53 5.1 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.325 -0.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.606 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.3 m-90 -26.89 -54.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.631 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.26 -64.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -63.04 -45.76 90.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 16' ' ' TRP . 57.4 mt -45.23 -30.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.678 HD21 ' OE1' ' A' ' 28' ' ' GLU . 6.6 mp -68.81 -69.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG21 ' OE1' ' A' ' 119' ' ' GLU . 5.0 m -57.26 -15.48 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.461 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.1 mmt180 -79.38 -39.57 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.63 7.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.3 mp -76.38 -57.01 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 111.152 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.0 tptt -84.03 112.25 20.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HG3' HG13 ' A' ' 27' ' ' VAL . 8.1 ptm180 -109.99 20.24 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.479 HG11 ' CE1' ' A' ' 95' ' ' PHE . 23.6 m -149.94 145.91 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.678 ' OE1' HD21 ' A' ' 20' ' ' LEU . 2.4 tp10 -109.15 146.53 33.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.56 119.86 5.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 24.7 mmt180 -148.89 145.44 27.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -83.31 17.71 2.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 4.9 p-90 -139.85 163.49 32.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.0 145.33 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.494 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.6 t -138.75 106.99 7.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.714 . . . . 0.0 111.128 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 54.1 Cg_endo -69.72 3.86 2.51 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.677 2.251 . . . . 0.0 112.371 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.571 ' O ' HD22 ' A' ' 86' ' ' LEU . 24.1 t60 -65.3 114.27 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -120.18 117.65 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.03 -121.32 1.05 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.464 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -106.35 140.08 39.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 15.6 tp -144.27 113.9 7.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.608 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.1 m95 -72.02 128.88 37.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.0 133.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.24 166.88 17.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -98.87 119.33 37.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.5 p -55.22 -179.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.12 -5.45 57.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HD3' ' ND1' ' A' ' 13' ' ' HIS . 4.2 tttt -86.81 124.71 33.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -85.53 139.28 35.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.531 0.681 . . . . 0.0 110.939 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 54.2 Cg_endo -69.76 132.25 22.95 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 54' ' ' VAL . 15.4 m -76.02 157.52 83.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.697 0.761 . . . . 0.0 110.845 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -5.84 17.19 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.671 2.247 . . . . 0.0 112.342 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.03 -44.39 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.584 HG12 ' NE2' ' A' ' 58' ' ' GLN . 59.7 t -65.34 -49.42 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -65.27 -44.01 89.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.19 -53.77 27.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.953 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.458 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 75.6 mt -56.49 -40.16 74.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.584 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.4 mt-30 -55.03 -42.7 72.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.61 -32.99 28.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -64.67 -52.86 55.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -64.34 -38.22 90.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.534 ' HG2' HG22 ' A' ' 69' ' ' VAL . 54.2 mtt180 -49.79 -34.25 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.0 mt -90.56 -12.19 37.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.89 -28.9 17.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -122.53 -29.25 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.039 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.24 126.11 2.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.435 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -44.44 -21.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -79.23 15.29 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.5 m -64.02 -177.06 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 24' ' ' ILE . 13.0 mt-10 -115.91 165.97 12.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 55.4 m-85 -161.12 132.38 3.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.526 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.71 169.12 19.59 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.68 2.253 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -144.28 170.81 15.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' CZ ' ' HG2' ' A' ' 72' ' ' PRO . 58.1 m-85 -134.21 93.36 19.66 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.628 0.728 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.52 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.77 169.79 18.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.2 m -136.37 139.44 42.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.851 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.58 49.41 60.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.1 m -157.08 147.62 21.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.878 0.37 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.656 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.27 120.81 21.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 44' ' ' ALA . 78.6 mt -88.8 -73.75 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.86 -144.63 4.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.572 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 14.2 t -151.14 157.84 43.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 m -143.09 142.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.422 ' CB ' HD22 ' A' ' 116' ' ' ASN . 1.5 t70 -86.49 111.45 20.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.571 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.9 tt -75.24 98.39 3.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.552 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.25 -47.66 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.7 m-20 -164.92 168.2 17.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -127.9 100.42 5.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 94' ' ' GLN . 94.0 mt -94.01 170.06 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' LYS . 65.0 m -109.41 169.61 8.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 109' ' ' PRO . 3.7 mm-40 -43.0 -22.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' SER . 29.0 ttmt -89.79 -66.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.623 ' HB3' HD22 ' A' ' 90' ' ' LEU . 10.3 mt-30 -60.35 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.526 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 28.6 t80 -46.02 -55.56 6.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 1.9 ptmt -69.69 -39.51 76.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.26 -59.41 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.481 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 9.6 mt-30 -77.51 -49.5 14.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 25.1 m-85 -109.95 67.62 0.46 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.633 0.73 . . . . 0.0 110.84 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.77 -12.19 32.37 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 -22.17 51.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.513 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.1 pt -121.35 15.99 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.3 p -58.4 -22.56 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.573 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -94.49 -30.69 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 8.7 mt-10 -47.04 -26.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 t -136.86 138.67 41.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.74 26.61 9.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 16.4 p -100.17 157.69 33.37 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.652 0.739 . . . . 0.0 110.86 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.73 -23.2 31.19 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 0.0 112.348 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -134.97 95.0 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 95' ' ' PHE . 43.4 t -85.63 137.55 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -104.44 108.01 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER -75.13 122.92 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.4 m -125.67 155.97 40.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -144.02 176.49 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.49 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.83 51.73 4.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.634 0.73 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.4 Cg_endo -69.74 114.19 3.62 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.404 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.24 134.7 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.541 ' OE1' HG21 ' A' ' 21' ' ' VAL . 3.9 tp10 -97.6 123.53 41.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.656 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.6 mtp -63.76 157.77 23.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.6 t -81.08 -32.5 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.4 144.42 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -111.05 148.22 33.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.467 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.0 OUTLIER -117.54 142.53 30.61 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.71 0.767 . . . . 0.0 110.822 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 86.83 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.63 2.22 . . . . 0.0 112.391 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.468 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.8 pp -125.01 162.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.5 mmtp -108.15 149.03 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -100.03 178.22 29.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.519 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -154.53 161.06 30.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.66 0.743 . . . . 0.0 110.876 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -1.61 8.79 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.2 mmmm -137.27 -174.99 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.481 HG22 ' CE3' ' A' ' 8' ' ' TRP . 74.1 mt -83.11 139.79 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.2 p-90 -145.11 127.94 16.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.453 ' NZ ' ' CZ2' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -64.21 125.23 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 139' ' ' ILE . 30.2 mt -52.76 -176.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.8 t0 -91.7 131.72 36.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -36.65 -36.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -40.33 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.623 HG21 HD22 ' A' ' 135' ' ' LEU . 32.2 mm -67.36 -45.77 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.8 t-160 -36.5 -63.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 41.4 mm-40 -52.48 -69.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.53 -48.23 0.65 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.608 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -58.45 -43.25 88.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.819 0.342 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 15.9 mtpp -64.46 -26.45 68.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.455 ' HE2' ' N ' ' A' ' 145' ' ' LYS . 8.5 mmpt? -80.37 -46.34 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -45.68 -22.38 0.71 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 34.3 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.932 -179.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.453 ' CE3' HG22 ' A' ' 132' ' ' ILE . 87.3 m95 -72.35 169.79 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HB2' HD11 ' A' ' 135' ' ' LEU . 43.0 t -140.33 139.15 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -130.05 115.57 17.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 m -67.77 156.38 37.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.657 HG22 ' OE2' ' A' ' 28' ' ' GLU . 53.7 t -139.03 157.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.482 ' N ' HG12 ' A' ' 12' ' ' VAL . 43.1 m-70 -90.41 109.43 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.578 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 64.3 mt-30 -58.33 161.14 8.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.7 -30.57 5.05 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.73 -1.779 . . . . 0.0 112.325 -0.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 9.6 m-90 -26.66 -49.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.578 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -35.28 -60.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -67.03 -51.09 59.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 16' ' ' TRP . 91.3 mt -40.51 -30.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.8 mp -68.32 -65.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.6 m -62.58 -18.38 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.47 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 14.4 mmt180 -74.81 -39.93 61.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.4 -2.18 7.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.778 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.1 mp -83.07 -55.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.391 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.506 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.5 tptp -86.59 120.26 27.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.618 ' HD2' HD13 ' A' ' 102' ' ' ILE . 4.3 ptp180 -114.37 15.92 17.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.518 HG11 HD12 ' A' ' 102' ' ' ILE . 33.9 m -147.56 142.92 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.657 ' OE2' HG22 ' A' ' 12' ' ' VAL . 6.9 tp10 -107.97 147.01 31.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -113.18 119.54 4.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.0 mmt180 -146.22 151.96 38.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 0.0 110.887 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.476 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 84.2 p -87.42 22.31 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.458 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 3.4 p-90 -142.24 161.12 38.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 12.0 t80 -103.65 139.23 39.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 34' ' ' THR . 7.6 t -134.41 101.66 12.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.566 0.698 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.5 Cg_endo -69.8 8.33 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.646 2.231 . . . . 0.0 112.36 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.599 ' O ' HD22 ' A' ' 86' ' ' LEU . 20.4 t60 -68.67 109.73 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mmt-85 -109.62 107.25 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.98 -153.37 23.89 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -73.02 140.57 47.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 21.2 tp -143.95 113.88 7.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.562 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 95.4 m95 -73.54 120.95 19.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.62 128.94 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.48 153.27 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -88.75 122.55 32.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.8 p -62.45 173.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.27 -9.74 58.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 7.7 ttpt -70.47 127.27 32.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -85.46 125.68 68.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.567 0.698 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 130.82 20.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.247 . . . . 0.0 112.354 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.6 m -76.89 158.97 79.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.666 0.746 . . . . 0.0 110.79 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 -16.98 38.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 0.0 112.372 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -84.44 -39.06 19.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -41.42 76.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.85 HG12 ' NE2' ' A' ' 58' ' ' GLN . 52.5 t -67.94 -48.87 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.162 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -63.62 -45.14 91.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.87 -52.44 43.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.651 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 83.9 mt -59.31 -44.76 92.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.85 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.0 mt-30 -50.18 -46.12 54.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.89 -36.95 41.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.3 m -59.24 -51.18 71.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.403 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 26.5 m-85 -69.06 -37.26 78.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.5 mtt-85 -49.88 -33.99 18.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.78 -15.94 31.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.8 mt -88.06 -28.66 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.448 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.6 mmm180 -121.47 -28.87 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.034 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 132.45 126.98 2.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.476 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.57 -20.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.1 m-20 -80.72 18.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.034 HG13 ' O ' ' A' ' 66' ' ' GLY . 23.2 m -68.02 179.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.117 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.778 ' O ' HD11 ' A' ' 24' ' ' ILE . 11.9 mt-10 -112.25 157.2 21.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -154.51 132.06 6.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.657 0.742 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.694 2.262 . . . . 0.0 112.322 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -81.4 -32.05 32.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -145.31 174.23 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.0 m-85 -133.45 95.47 18.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.665 0.745 . . . . 0.0 110.936 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.507 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.4 Cg_endo -69.75 171.59 14.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.332 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -141.33 133.25 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 46.13 9.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -159.27 149.39 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.409 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -74.23 113.43 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.743 HD11 ' HB2' ' A' ' 44' ' ' ALA . 77.8 mt -79.3 -74.4 0.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.501 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -143.9 -145.07 4.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.562 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 5.5 t -149.54 162.49 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.9 m -151.71 140.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.41 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.4 t70 -85.63 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.599 HD22 ' O ' ' A' ' 36' ' ' HIS . 5.6 tt -73.48 99.82 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.526 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.89 -48.29 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.43 167.4 23.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.53 101.25 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.517 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.2 mt -96.37 168.38 10.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 15.0 p -106.29 169.19 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.495 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 19.6 mm-40 -46.65 -19.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 91' ' ' SER . 21.9 ttmt -90.88 -59.0 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.504 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.5 mt-30 -68.52 -50.21 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.517 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 31.3 t80 -41.91 -55.9 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -67.25 -41.32 85.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.49 -58.83 5.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.3 mt-30 -76.13 -50.11 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -109.88 67.91 0.46 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.1 Cg_endo -69.74 -13.57 34.92 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.71 2.273 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.68 -23.44 56.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.659 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.6 pt -121.91 23.45 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.2 p -65.0 -26.3 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.598 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.2 pp0? -91.53 -27.98 17.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.659 ' CD ' HG22 ' A' ' 102' ' ' ILE . 18.3 mt-10 -49.3 -38.39 27.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.515 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.3 p -124.08 144.42 49.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 27.2 t70 -107.94 -36.36 6.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.48 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 4.3 m -39.6 157.99 0.13 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.856 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.7 Cg_endo -69.79 -49.23 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.661 2.241 . . . . 0.0 112.319 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' A' ' 33' ' ' TYR . 26.2 m-85 -106.32 98.69 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.516 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 22.1 t -83.91 139.62 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -107.29 107.09 17.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.24 122.83 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.1 m -126.8 155.41 42.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.08 176.25 9.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 56.59 51.97 6.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.73 115.52 4.13 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -127.92 134.79 49.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -96.88 121.99 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.459 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 13.1 mtp -62.59 151.88 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 146' ' ' GLY . 59.3 t -72.74 -37.52 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 1.8 p -118.22 158.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.486 ' N ' ' CG2' ' A' ' 122' ' ' VAL . 12.5 mmtm -120.65 140.29 51.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -107.64 136.86 19.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.628 0.728 . . . . 0.0 110.897 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 86.03 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.438 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.9 pp -121.89 163.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 70.9 mttt -97.95 132.04 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.03 170.9 40.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -153.42 153.07 28.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 1.42 4.46 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.301 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.435 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.7 mmmm -134.07 -175.39 3.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.453 HG22 ' CE3' ' A' ' 8' ' ' TRP . 72.7 mt -89.03 137.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.6 p-90 -146.05 131.48 18.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -59.62 124.59 20.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.476 HD22 HG21 ' A' ' 139' ' ' ILE . 27.1 mt -60.02 170.77 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.7 t70 -79.27 129.71 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.1 m -37.03 -37.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -76.05 -41.24 51.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 124' ' ' PHE . 37.5 mm -65.56 -39.65 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -45.92 -65.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.817 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 144' ' ' LYS . 28.1 mt-30 -47.89 -69.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.95 -52.85 1.54 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.445 ' HB2' ' HE2' ' A' ' 124' ' ' PHE . . . -52.52 -39.44 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 141' ' ' GLN . 10.7 mtpt -70.47 -14.73 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -86.08 -48.47 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -46.62 -19.15 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.574 ' CE3' HG22 ' A' ' 132' ' ' ILE . 94.7 m95 -94.96 161.97 13.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -137.24 140.25 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 28' ' ' GLU . 26.7 tp -124.13 108.88 12.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 3.9 p -67.57 137.17 55.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.718 HG22 ' OE2' ' A' ' 28' ' ' GLU . 33.9 t -121.13 161.44 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.543 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.5 m-70 -95.99 111.76 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.524 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 10.8 mm-40 -56.34 157.83 8.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.78 -33.03 3.57 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.361 -0.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 10.7 m-90 -24.97 -54.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.516 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -36.69 -54.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.5 m -70.04 -47.81 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -45.39 -28.31 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.6 mp -68.07 -65.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.651 HG11 ' N ' ' A' ' 82' ' ' GLY . 14.6 m -64.77 -14.2 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.3 mmt180 -78.64 -39.13 37.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.61 12.22 6.2 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.5 -47.63 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -88.79 116.66 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.49 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 11.4 ttt180 -101.94 -1.14 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.59 HG11 ' CE1' ' A' ' 95' ' ' PHE . 32.7 m -141.55 152.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.144 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.718 ' OE2' HG22 ' A' ' 12' ' ' VAL . 2.2 tp10 -115.96 143.11 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.55 129.47 9.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.416 ' HD2' ' NE1' ' A' ' 32' ' ' TRP . 20.2 mmt180 -152.96 140.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.1 p -82.81 16.58 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.535 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.2 p-90 -139.29 166.44 24.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 34' ' ' THR . 8.8 t80 -106.45 148.39 28.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.618 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 5.8 t -143.95 107.09 4.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.709 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 54.2 Cg_endo -69.69 2.83 3.14 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.37 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.5 ' O ' HD22 ' A' ' 86' ' ' LEU . 13.3 t60 -65.42 117.91 8.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -123.53 120.43 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 85' ' ' ASP . . . 153.57 -121.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -99.55 140.77 33.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 17.4 tp -144.73 108.99 4.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.61 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 94.8 m95 -71.65 126.15 28.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 mm -96.39 129.3 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -126.63 150.56 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -85.37 126.26 33.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.071 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 12' ' ' VAL . 23.8 p -64.69 173.01 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.42 -21.15 62.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 9.0 ttpt -63.91 149.39 47.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.471 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -108.59 133.98 20.44 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.533 0.682 . . . . 0.0 110.921 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 128.32 15.86 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.708 2.272 . . . . 0.0 112.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.9 m -75.21 159.12 83.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 110.869 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -7.35 20.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.72 -41.78 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.63 -40.85 80.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 50' ' ' SER . 33.8 t -67.83 -49.6 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.4 t -64.2 -42.06 96.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -70.2 -55.15 10.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HE2' ' A' ' 61' ' ' TYR . 86.5 mt -55.88 -44.03 77.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 8.5 mt-30 -51.05 -47.06 61.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.67 -36.71 51.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -60.17 -51.25 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.676 ' HE2' HD22 ' A' ' 57' ' ' LEU . 46.0 m-85 -69.92 -38.59 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 69' ' ' VAL . 44.8 mtt180 -47.98 -36.34 12.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 mt -87.23 -18.14 30.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.0 mt -83.41 -32.28 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -118.4 -27.38 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.056 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 129.4 124.9 2.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.428 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -70.15 4.77 1.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.056 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.3 m -61.5 176.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -116.71 167.82 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 49.5 m-85 -157.67 139.06 9.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.71 159.4 53.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.745 2.297 . . . . 0.0 112.334 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.88 -24.09 33.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -150.73 172.22 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.598 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 56.2 m-85 -134.41 98.59 13.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.66 0.743 . . . . 0.0 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.76 -176.33 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.319 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.7 p -150.79 129.83 12.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.38 45.28 24.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.1 m -153.33 149.43 27.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.598 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -75.95 118.34 18.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 44' ' ' ALA . 43.8 mt -85.68 -71.57 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.651 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.26 -143.11 3.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.598 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -152.46 158.18 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.845 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.8 m -145.71 134.54 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.49 ' HB3' ' ND2' ' A' ' 116' ' ' ASN . 1.4 t70 -79.35 112.8 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.2 tt -76.41 102.67 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.53 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -72.04 -47.07 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . 7.0 m-20 -166.17 170.02 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.475 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -128.11 99.42 5.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.534 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 96.9 mt -93.04 171.24 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 93' ' ' LYS . 4.7 p -109.79 169.16 8.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.472 ' O ' ' CE ' ' A' ' 96' ' ' LYS . 3.1 mm-40 -43.11 -23.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 18.4 ttmt -89.76 -65.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.501 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.1 mt-30 -59.38 -48.63 80.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.604 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.1 t80 -43.79 -56.9 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 11.7 ptpt -69.0 -41.96 77.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -50.06 -59.13 4.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.496 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.4 mt-30 -78.05 -45.07 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.0 m-85 -113.66 69.98 1.6 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.666 0.746 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -14.54 36.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 0.0 112.349 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -19.67 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.654 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.5 pt -125.73 21.74 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.469 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 58.8 p -64.51 -27.63 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.581 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -89.39 -29.52 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.654 ' CD ' HG22 ' A' ' 102' ' ' ILE . 22.9 mt-10 -45.31 -40.03 7.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.8 t -120.39 140.76 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.18 25.43 10.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.459 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.7 p -101.16 160.34 26.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.869 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.3 Cg_endo -69.79 -25.16 28.73 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 32' ' ' TRP . 20.2 m-85 -134.82 95.55 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.498 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.7 t -84.51 135.73 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.618 ' CZ ' HG22 ' A' ' 34' ' ' THR . 9.2 m-30 -101.9 103.54 14.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -71.12 122.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.9 m -125.56 156.08 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.433 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 1.9 mmmp? -143.53 176.36 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 85' ' ' ASP . 0.3 OUTLIER 58.15 51.95 4.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.5 Cg_endo -69.79 113.65 3.45 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.266 . . . . 0.0 112.303 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -127.35 141.7 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -103.67 120.96 41.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.598 ' HE1' HD13 ' A' ' 80' ' ' LEU . 17.3 mtp -64.05 143.01 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 146' ' ' GLY . 29.4 t -69.96 -25.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.146 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.83 141.91 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -110.99 145.09 39.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.445 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.0 OUTLIER -113.41 143.29 29.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 91.49 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.279 . . . . 0.0 112.316 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.45 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.8 pp -130.63 158.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.11 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.591 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.0 mttm -103.5 137.23 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -96.24 166.87 24.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.468 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -140.53 161.7 53.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.714 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 0.56 5.45 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.535 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.5 mmmm -138.26 -174.99 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.574 HG22 ' CE3' ' A' ' 8' ' ' TRP . 82.7 mt -83.09 138.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.591 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 6.7 p-90 -146.63 124.2 11.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.47 127.07 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.17 -178.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -88.13 127.47 35.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.8 m -36.39 -40.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -73.44 -41.25 63.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 136' ' ' ASP . 23.5 mm -64.99 -44.99 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -38.55 -65.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 142' ' ' GLY . 14.4 mm100 -52.59 -68.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.21 -48.71 1.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.466 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.61 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.79 -45.79 81.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 111.089 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -63.57 -22.48 66.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -84.14 -46.63 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -45.44 -20.45 0.34 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.9 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.72 ' CE3' HG22 ' A' ' 132' ' ' ILE . 93.3 m95 -90.23 156.98 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.587 ' HB2' HD11 ' A' ' 135' ' ' LEU . 52.7 t -134.5 121.7 21.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.463 HD13 ' HH2' ' A' ' 32' ' ' TRP . 65.6 tp -107.44 109.19 20.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -68.09 154.53 41.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 20' ' ' LEU . 24.5 t -133.65 159.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.094 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.511 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 57.4 m-70 -90.13 113.72 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.557 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 78.7 mt-30 -59.7 159.75 17.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.75 -31.52 4.5 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.355 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.529 ' C ' ' O ' ' A' ' 15' ' ' PRO . 10.0 m-90 -26.81 -48.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.557 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -39.33 -63.44 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.1 mt -52.62 -28.52 21.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 12' ' ' VAL . 7.1 mp -69.75 -60.46 2.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 82' ' ' GLY . 18.6 m -67.65 -20.5 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -73.12 -39.17 65.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 14.66 5.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.21 -45.14 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 111.154 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CD ' ' OH ' ' A' ' 61' ' ' TYR . 4.2 tptp -93.81 118.85 32.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -101.05 -4.39 27.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 8.0 m -141.33 152.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -120.35 130.51 54.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.453 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -86.57 132.06 10.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' N ' ' CB ' ' A' ' 108' ' ' SER . 18.9 mmt180 -152.63 144.64 23.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.522 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 9.8 t -85.63 24.26 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.596 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.0 p-90 -146.38 160.91 41.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.3 t80 -104.08 145.29 30.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 5.6 t -139.31 105.91 7.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.162 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.1 Cg_endo -69.78 4.0 2.46 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.697 2.265 . . . . 0.0 112.308 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.404 ' O ' HD22 ' A' ' 86' ' ' LEU . 15.5 t60 -65.86 114.68 5.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -119.69 122.92 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.41 -119.15 1.04 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -104.88 138.3 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.405 HD21 ' CB ' ' A' ' 10' ' ' LEU . 26.7 tp -143.57 112.69 6.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.36 132.56 45.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.5 mm -103.34 125.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.113 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.97 154.3 36.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -87.73 116.46 25.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -53.06 -177.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.13 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.65 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 6.2 ttpt -78.25 131.13 36.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -92.98 137.06 23.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.557 0.694 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 53.4 Cg_endo -69.72 130.36 19.24 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.4 m -78.29 158.13 77.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 110.837 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -4.15 13.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.682 2.254 . . . . 0.0 112.317 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.497 ' NE2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -94.84 -38.67 10.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.933 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.17 -39.84 53.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.757 HG12 ' NE2' ' A' ' 58' ' ' GLN . 61.6 t -64.15 -52.73 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -58.12 -46.54 85.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.497 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 11.9 mt-10 -66.41 -57.54 7.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.489 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 76.7 mt -52.92 -41.21 64.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.757 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.8 mt-30 -52.47 -47.9 66.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -37.52 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.072 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -58.3 -50.59 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.438 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 24.8 m-85 -71.03 -31.88 68.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.2 mtt180 -56.05 -39.65 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 mt -86.33 -14.53 43.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.469 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 71.6 mt -89.02 -28.89 19.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.469 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 5.5 mmp_? -121.16 -28.74 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.065 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 131.27 128.21 2.94 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.19 -19.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.7 m-20 -78.4 13.4 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.065 HG13 ' O ' ' A' ' 66' ' ' GLY . 28.6 m -66.33 -177.84 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 16.3 mm-40 -119.54 167.98 11.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 62.3 m-85 -161.86 135.06 4.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.625 0.726 . . . . 0.0 110.861 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.2 Cg_endo -69.77 159.96 51.47 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 0.0 112.322 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -81.11 -27.76 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -146.15 173.41 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.1 m-85 -134.85 94.61 16.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.683 0.754 . . . . 0.0 110.916 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.4 Cg_endo -69.76 174.36 9.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.5 p -141.26 139.81 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.86 45.36 84.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.7 m -153.45 145.18 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 110.884 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.677 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.1 OUTLIER -74.93 117.85 17.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' ALA . 50.1 mt -85.79 -71.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.49 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.61 -146.4 4.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.587 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.3 p -151.28 157.41 42.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.461 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.8 m -144.67 140.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.1 113.08 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 36' ' ' HIS . 4.2 tt -77.42 93.41 4.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.622 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -60.73 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.184 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.407 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.5 m-20 -163.01 168.46 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.9 t -127.73 101.74 6.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.525 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 88.8 mt -99.32 169.89 9.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' LYS . 34.7 t -105.12 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.487 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 10.1 mm-40 -42.07 -23.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' SER . 15.2 ttmm -91.34 -70.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -53.56 -47.37 70.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.572 ' CD2' HG21 ' A' ' 111' ' ' VAL . 16.9 t80 -43.3 -57.46 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.506 ' HG2' ' N ' ' A' ' 97' ' ' GLU . 1.6 pttt -68.36 -38.79 81.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.506 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 12.1 mt-10 -49.56 -52.39 30.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.7 mt-30 -86.68 -45.97 10.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.7 m-85 -110.42 67.69 0.51 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 0.0 110.865 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.77 -10.35 28.33 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.695 2.264 . . . . 0.0 112.366 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.82 -19.16 55.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.449 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 pt -126.17 21.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 59.6 p -60.05 -20.78 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -97.94 -30.71 12.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 5.2 mt-10 -51.23 -28.36 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.5 p -114.24 156.84 23.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -130.15 -32.58 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.518 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -58.87 164.83 3.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 0.0 110.834 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.522 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.3 Cg_endo -69.78 -43.79 2.44 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.66 2.24 . . . . 0.0 112.322 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -110.34 97.51 6.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 95' ' ' PHE . 12.9 t -79.3 139.21 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CZ ' HG22 ' A' ' 34' ' ' THR . 11.5 m-30 -106.58 105.84 16.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -74.41 117.57 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.093 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.461 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 6.9 m -125.07 151.55 45.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.874 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.403 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 11.3 mmmt -140.5 175.27 9.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 59.22 53.18 4.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 0.0 110.891 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.78 112.58 3.12 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.402 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 4.2 pt20 -127.33 141.07 51.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.19 122.24 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.677 ' HE1' HD13 ' A' ' 80' ' ' LEU . 16.6 mtp -63.39 155.33 29.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 146' ' ' GLY . 32.2 t -81.92 -27.69 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -127.27 135.22 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 14.0 mmtm -103.03 150.44 23.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.577 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.3 m-85 -118.17 143.55 33.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.596 0.713 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 92.05 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.32 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.509 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.9 pp -123.21 167.07 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -110.28 107.16 16.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.27 169.56 23.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.538 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 133' ' ' TRP . 46.9 m-80 -155.29 157.9 31.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.928 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 0.86 5.03 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.596 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.4 mmmp? -136.84 -175.08 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.72 HG22 ' CE3' ' A' ' 8' ' ' TRP . 68.3 mt -86.89 131.99 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.154 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 129' ' ' ASN . 7.5 p-90 -133.8 136.24 44.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.549 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 8.8 ttmt -56.8 134.87 55.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 9' ' ' CYS . 17.9 mt -76.96 133.29 39.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.521 ' HB2' ' CG1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -45.84 123.23 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 136' ' ' ASP . 4.4 m -34.02 -48.44 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.86 -43.62 87.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.577 HG23 ' CD2' ' A' ' 124' ' ' PHE . 38.7 mm -61.65 -46.09 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.139 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -38.56 -64.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 142' ' ' GLY . 79.9 mt-30 -51.68 -68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.7 -49.09 0.72 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.506 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.72 -46.06 77.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.2 mtpp -64.82 -24.12 67.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -82.8 -42.84 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -51.48 -16.51 2.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.891 -179.888 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.675 ' CE3' HG22 ' A' ' 132' ' ' ILE . 95.0 m95 -92.91 160.79 14.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB2' HD11 ' A' ' 135' ' ' LEU . 39.0 t -133.16 130.95 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.555 HD11 ' HE ' ' A' ' 30' ' ' ARG . 21.9 tp -111.6 110.7 21.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.435 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 2.9 m -69.92 131.09 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 13' ' ' HIS . 69.6 t -116.19 163.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.6 ' N ' HG12 ' A' ' 12' ' ' VAL . 59.0 m-70 -100.65 114.21 27.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 15' ' ' PRO . 15.0 mm-40 -58.36 157.8 16.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.587 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.76 -33.74 3.31 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.721 -1.783 . . . . 0.0 112.338 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.548 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.5 m-90 -25.07 -59.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -33.39 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.091 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.4 m -69.6 -53.91 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 mt -40.97 -29.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.7 mp -66.56 -68.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 82' ' ' GLY . 17.4 m -61.21 -11.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.453 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 12.2 mmt180 -82.98 -39.64 21.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.86 0.87 9.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.545 HD11 ' O ' ' A' ' 70' ' ' GLU . 4.6 mp -85.6 -50.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 111.12 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.1 tptp -88.53 121.87 31.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -103.89 -4.06 23.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.615 HG11 ' CE1' ' A' ' 95' ' ' PHE . 15.6 m -140.34 162.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE1' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -129.03 130.88 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -86.43 128.24 8.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.52 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HE ' HD11 ' A' ' 10' ' ' LEU . 13.0 mmt180 -146.11 143.97 29.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.823 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 77.9 p -83.66 19.47 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.578 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.5 p-90 -144.53 167.62 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.462 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 6.0 t80 -108.8 136.81 47.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.566 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 6.1 t -130.15 104.04 16.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.703 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.421 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.8 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.408 ' O ' HD22 ' A' ' 86' ' ' LEU . 15.6 t60 -65.77 117.15 7.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.421 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 8.4 mmt85 -120.97 121.48 38.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.91 -116.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -104.2 138.95 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 10' ' ' LEU . 19.3 tp -143.76 109.38 5.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.597 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 90.7 m95 -73.4 124.49 25.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 mm -94.84 127.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -127.18 141.18 51.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.102 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.654 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -75.58 121.29 22.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 p -59.94 -177.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.26 21.34 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.073 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' HB3' ' A' ' 13' ' ' HIS . 8.9 ttpt -100.77 132.94 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -87.67 126.7 60.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.555 0.693 . . . . 0.0 110.928 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 134.92 29.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.1 m -79.05 153.29 77.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.669 0.747 . . . . 0.0 110.841 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -6.55 18.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.297 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 -38.47 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.85 -43.52 71.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.542 HG12 ' NE2' ' A' ' 58' ' ' GLN . 42.6 t -63.88 -51.11 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -61.1 -47.44 86.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.17 -55.34 22.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.417 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 84.8 mt -54.46 -54.29 42.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.5 mt-30 -38.44 -49.06 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.14 -43.09 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -52.85 -51.3 61.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.458 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 36.0 m-85 -69.08 -37.96 78.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.507 ' HG2' HG22 ' A' ' 69' ' ' VAL . 58.6 mtt180 -48.44 -33.11 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.1 mt -91.4 -15.69 28.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.558 ' CD1' ' NE2' ' A' ' 104' ' ' GLN . 79.6 mt -86.76 -31.51 20.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -119.36 -28.66 5.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.04 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.46 124.68 2.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.46 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -44.55 -18.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.913 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 66' ' ' GLY . 2.9 m-20 -77.66 13.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.04 HG13 ' O ' ' A' ' 66' ' ' GLY . 33.9 m -69.23 174.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.545 ' O ' HD11 ' A' ' 24' ' ' ILE . 2.6 pm0 -119.66 173.5 6.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 83.1 m-85 -158.93 144.37 11.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.849 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.79 152.82 69.26 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.242 . . . . 0.0 112.321 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -73.23 -28.17 62.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -144.6 174.15 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.587 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 68.5 m-85 -134.97 89.64 23.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 75' ' ' TYR . 53.0 Cg_endo -69.83 172.1 13.34 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.5 p -143.55 142.27 31.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 37.27 60.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 86.9 m -149.83 147.62 28.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.618 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -75.03 114.48 13.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' A' ' 44' ' ' ALA . 48.2 mt -81.69 -72.37 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.16 -143.66 3.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.597 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 11.0 t -150.95 159.03 44.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 m -147.66 133.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.439 ' HB3' ' ND2' ' A' ' 116' ' ' ASN . 1.9 t70 -77.79 112.62 14.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.415 HD12 HD22 ' A' ' 40' ' ' LEU . 3.3 tt -77.01 100.4 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.549 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.39 -49.23 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.34 168.28 24.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.466 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -127.56 96.59 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.518 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.4 mt -93.48 166.35 12.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' LYS . 44.4 t -104.2 169.88 8.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.489 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 9.4 mm-40 -43.84 -21.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.1 ttmt -90.96 -69.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.448 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.9 mt-30 -56.49 -45.95 80.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.886 ' CD2' HG21 ' A' ' 111' ' ' VAL . 19.5 t80 -44.55 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.496 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.5 ptpt -68.73 -42.15 78.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 8.5 mt-10 -48.4 -58.23 4.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.6 mt-30 -80.11 -48.25 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 16.7 m-85 -109.78 68.65 0.47 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.1 Cg_endo -69.84 -11.1 30.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.672 2.248 . . . . 0.0 112.316 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -78.37 -21.82 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.817 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.578 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.9 pt -124.99 22.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 49.9 p -64.26 -19.94 65.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.581 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -97.17 -27.93 14.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.581 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 15.5 mt-10 -41.01 -42.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.2 t -123.14 159.37 28.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -119.01 -21.14 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.467 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -53.81 162.31 1.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.79 -43.21 2.77 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.378 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 15.7 m-85 -112.34 101.42 9.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.886 HG21 ' CD2' ' A' ' 95' ' ' PHE . 25.6 t -80.91 136.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CZ ' HG22 ' A' ' 34' ' ' THR . 9.8 m-30 -104.44 104.34 14.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.83 120.69 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.2 m -125.43 154.18 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.95 176.16 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 56.77 53.26 6.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.2 Cg_endo -69.76 116.41 4.55 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.724 2.283 . . . . 0.0 112.371 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.36 133.89 46.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.26 124.77 44.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.618 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.1 mtp -66.91 147.02 53.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.4 t -68.91 -31.77 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.09 153.0 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.05 146.22 45.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.538 ' HE2' ' HB2' ' A' ' 143' ' ' ALA . 0.8 OUTLIER -112.72 141.96 26.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 0.0 110.879 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 87.21 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.46 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.9 pp -121.91 163.35 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 76.1 mttt -102.18 136.36 42.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.99 161.81 27.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.459 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -142.65 156.71 62.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.644 0.735 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -3.08 11.33 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.578 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.6 mmmp? -134.2 -173.75 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.675 HG22 ' CE3' ' A' ' 8' ' ' TRP . 95.6 mt -85.91 142.07 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.3 p-90 -149.37 127.24 11.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -55.77 127.78 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 9' ' ' CYS . 60.4 mt -65.35 167.94 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.6 t70 -73.81 126.46 30.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.0 m -34.94 -42.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -71.68 -44.96 63.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.1 mm -61.47 -41.13 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.106 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -44.27 -65.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 144' ' ' LYS . 26.5 mt-30 -50.07 -68.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.5 -54.69 1.02 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.521 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.565 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.18 -37.29 69.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.2 mtpt -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -92.86 -47.11 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -41.56 -23.43 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 145' ' ' LYS . 11.8 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.615 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.6 m95 -77.8 159.85 28.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.781 0.324 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB2' HD11 ' A' ' 135' ' ' LEU . 40.9 t -137.4 125.46 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.469 ' HB2' HD21 ' A' ' 40' ' ' LEU . 66.6 tp -112.27 116.84 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.416 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 14.6 m -68.74 153.85 43.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 13' ' ' HIS . 72.5 t -135.47 158.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.52 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.8 m-70 -94.54 113.75 25.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.52 ' HG2' ' HB3' ' A' ' 17' ' ' ALA . 79.0 mt-30 -60.53 159.28 25.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.624 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 -32.74 3.73 Favored 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.698 -1.792 . . . . 0.0 112.33 -0.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.628 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.4 m-90 -25.36 -52.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -35.4 -63.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -62.01 -46.15 90.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.3 mt -45.63 -39.32 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -57.93 -66.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 82' ' ' GLY . 18.2 m -61.29 -20.94 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 11.3 mmt180 -73.87 -39.67 63.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.41 20.07 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.532 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.69 -38.4 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -102.72 102.33 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -95.97 13.39 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.2 m -144.85 146.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.455 ' OE2' HG22 ' A' ' 12' ' ' VAL . 6.7 tt0 -117.53 134.27 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.24 126.65 8.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 32.0 mmt180 -152.5 150.23 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.475 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 24.5 p -88.03 21.81 2.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.439 ' HH2' HD13 ' A' ' 10' ' ' LEU . 4.2 p-90 -142.73 166.46 24.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.5 t80 -110.23 144.47 38.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 34' ' ' THR . 5.1 t -136.99 105.51 8.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.5 Cg_endo -69.78 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -64.11 111.89 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -115.52 120.11 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.01 -121.36 1.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.446 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -106.28 139.21 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 10' ' ' LEU . 38.4 tp -143.95 116.0 8.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.942 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.4 m95 -72.05 132.43 44.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -102.14 130.41 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.77 154.73 42.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.664 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -89.08 118.64 28.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 12' ' ' VAL . 39.8 p -56.12 179.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.36 4.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 14.6 ttpt -91.86 148.81 21.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 16.6 mtmt -105.55 121.54 45.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 127.91 15.25 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 54' ' ' VAL . 4.5 m -73.63 158.24 86.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.619 0.723 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -6.15 17.87 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.722 2.281 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.49 -41.68 9.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -41.8 78.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.58 HG12 ' NE2' ' A' ' 58' ' ' GLN . 38.7 t -67.03 -50.52 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 t -62.52 -44.64 95.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.33 -54.35 21.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.628 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.6 mt -56.61 -39.13 73.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.0 mt-30 -54.52 -47.17 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.05 -35.73 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -60.86 -49.68 76.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -69.83 -39.49 76.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' A' ' 69' ' ' VAL . 45.2 mtt180 -48.01 -36.2 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.24 -16.75 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.05 -27.09 23.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.8 mmm180 -123.7 -28.92 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.051 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 131.2 127.83 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.92 -19.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 9.8 t70 -76.16 8.79 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.051 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.2 m -63.02 -179.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 3.4 mm-40 -118.2 171.87 7.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 53.5 m-85 -162.25 137.28 5.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 152.71 69.54 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.722 2.281 . . . . 0.0 112.324 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -72.49 -28.93 63.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.0 176.1 10.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.624 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.7 m-85 -134.42 93.94 18.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.955 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.475 ' HG2' HD21 ' A' ' 81' ' ' LEU . 54.0 Cg_endo -69.77 175.07 8.6 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.703 2.268 . . . . 0.0 112.384 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m -144.47 134.66 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.824 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.59 12.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.6 m -160.14 148.57 16.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.512 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.11 118.59 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.664 HD11 ' HB2' ' A' ' 44' ' ' ALA . 80.7 mt -85.11 -74.06 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.467 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.94 -145.07 4.19 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.9 p -152.75 161.28 42.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.37 . . . . 0.0 110.841 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 114' ' ' CYS . 13.5 m -146.79 146.45 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.456 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.8 t70 -87.01 107.0 18.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.68 97.9 1.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.552 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.88 -47.46 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 3.1 m-20 -165.25 166.67 18.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 t -127.35 99.7 5.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.0 mt -94.25 169.19 10.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 p -106.91 169.25 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 108' ' ' SER . 19.8 mm-40 -47.99 -18.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -90.69 -58.13 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -71.28 -50.68 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.563 ' CD2' HG21 ' A' ' 111' ' ' VAL . 35.2 t80 -40.22 -55.99 2.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 4.2 ptmt -66.45 -42.41 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 9.1 mt-10 -53.23 -59.2 4.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.458 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -74.76 -50.27 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.8 m-85 -111.21 67.62 0.62 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.59 0.709 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.75 -13.89 35.35 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.686 2.257 . . . . 0.0 112.363 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -74.33 -23.07 59.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.699 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.8 pt -122.14 20.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.9 p -63.22 -23.6 67.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.634 HE21 ' N ' ' A' ' 105' ' ' GLU . 1.8 pp0? -93.13 -25.69 17.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.699 ' CD ' HG22 ' A' ' 102' ' ' ILE . 36.1 mt-10 -53.14 -33.36 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.436 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 2.2 p -127.47 146.51 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 1.6 t70 -111.75 -33.77 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.461 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.8 m -43.6 161.39 0.2 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.686 0.755 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.475 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.93 102.79 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.7 t -85.91 136.93 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 5.0 m-30 -105.07 107.05 17.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -74.52 118.44 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -119.39 151.3 38.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -143.03 174.07 11.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 53.95 54.74 11.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.652 0.739 . . . . 0.0 110.869 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.8 Cg_endo -69.8 121.81 8.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 0.0 112.292 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -132.0 131.69 42.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -97.67 123.55 41.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.512 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.4 mtp -64.34 149.92 47.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.9 t -78.08 -21.42 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.85 135.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -102.15 154.71 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.5 OUTLIER -122.19 142.72 37.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.919 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.06 158.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.603 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 28.8 mtmt -92.04 134.77 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.72 167.72 46.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.483 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 1.5 t-20 -156.74 144.34 13.96 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.638 0.733 . . . . 0.0 110.884 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.1 Cg_endo -69.75 3.12 2.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.679 2.253 . . . . 0.0 112.339 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 6.9 mmmm -135.34 -173.89 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.615 HG22 ' CE3' ' A' ' 8' ' ' TRP . 71.7 mt -91.57 134.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.603 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 1.3 p-90 -143.21 130.0 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.471 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 11.2 ttmt -53.67 129.81 34.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.589 HD22 HG21 ' A' ' 139' ' ' ILE . 22.9 mt -65.8 162.77 18.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.3 t0 -73.67 129.77 38.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.92 -50.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -65.09 -39.68 93.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.589 HG21 HD22 ' A' ' 135' ' ' LEU . 19.9 mm -64.66 -47.78 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ILE . 18.0 t-160 -37.09 -65.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 91.6 mt-30 -51.66 -69.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.42 -49.14 0.67 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.503 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.31 -43.55 74.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.1 mtpp -67.72 -23.24 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 147' ' ' LEU . 17.7 mmtp -77.89 -53.1 7.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.17 -27.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 145' ' ' LYS . 17.6 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.843 0.354 . . . . 0.0 110.919 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.7 ' CE3' HG22 ' A' ' 132' ' ' ILE . 90.4 m95 -74.26 162.56 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.774 0.321 . . . . 0.0 110.895 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.2 t -138.83 138.8 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.449 HD13 ' HH2' ' A' ' 32' ' ' TRP . 25.4 tp -123.1 111.85 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.409 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 60.3 p -70.54 125.83 27.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.54 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 17.7 t -107.98 160.67 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.54 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 56.1 m-70 -91.14 111.14 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.503 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 70.0 mt-30 -58.85 159.93 12.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.664 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.75 -31.36 4.6 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.375 -0.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.541 ' C ' ' O ' ' A' ' 15' ' ' PRO . 9.1 m-90 -25.98 -54.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -36.52 -58.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 66.4 m -66.08 -40.74 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.87 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 16' ' ' TRP . 63.0 mt -51.94 -26.34 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 9.2 mp -71.24 -69.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.885 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.4 m -58.84 -15.0 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.9 mmt180 -79.98 -39.49 29.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.44 6.21 8.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.458 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.81 -47.59 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 3.4 tptp -90.35 117.7 29.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 13.2 ttt180 -102.62 0.09 32.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.484 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 17.6 m -147.01 154.96 11.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 8.2 tm-20 -122.54 153.3 39.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -112.7 130.55 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.528 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HG3' ' CZ2' ' A' ' 32' ' ' TRP . 9.2 mmt180 -149.05 149.7 31.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.444 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 57.7 p -85.27 20.36 2.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.539 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.9 p-90 -145.09 167.68 22.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.0 t80 -108.82 141.35 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 34' ' ' THR . 6.9 t -134.93 103.56 10.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.571 0.7 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.9 Cg_endo -69.71 2.39 3.55 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.273 . . . . 0.0 112.336 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -60.89 108.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 6.3 mmt85 -111.65 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.15 -123.2 1.65 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.1 ttm105 -104.98 140.97 37.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.0 tp -143.98 114.41 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 91.1 m95 -71.27 131.93 44.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.96 127.49 56.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.99 49.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -83.23 119.36 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.5 p -54.24 -174.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.78 -10.47 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 4.9 ttpt -73.6 148.7 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 1.2 pmtp? -108.53 132.56 21.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 0.0 110.872 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 54' ' ' VAL . 3.3 m -73.97 159.81 83.24 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -8.3 23.26 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.739 2.293 . . . . 0.0 112.345 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -42.43 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -40.94 84.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 50' ' ' SER . 62.1 t -65.07 -51.15 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -64.07 -45.82 87.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.25 -53.27 46.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.51 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 79.2 mt -56.03 -43.33 77.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.2 mt-30 -51.73 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.71 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -61.49 -48.76 79.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -70.89 -33.52 70.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HG2' HG22 ' A' ' 69' ' ' VAL . 43.6 mtt180 -53.5 -36.07 61.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.4 -12.8 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.429 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 71.4 mt -90.65 -29.04 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.965 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.429 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.8 mmp_? -122.92 -29.06 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.067 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.12 129.01 2.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.9 -18.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.319 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.7 t70 -82.43 20.4 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.067 HG13 ' O ' ' A' ' 66' ' ' GLY . 29.3 m -70.91 179.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 13.2 mt-10 -116.61 166.9 11.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 52.7 m-85 -159.87 138.56 7.78 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 0.0 110.842 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.3 Cg_endo -69.77 163.86 36.71 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.08 -22.91 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -150.61 166.69 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.1 m-85 -130.44 87.93 48.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.903 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.54 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.2 Cg_endo -69.77 171.62 14.14 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.642 2.228 . . . . 0.0 112.325 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.6 p -138.91 144.38 39.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.6 89.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 67.0 m -149.79 146.74 27.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -76.26 118.66 19.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 44' ' ' ALA . 56.1 mt -87.69 -71.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.572 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.33 -150.44 5.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.501 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -149.59 153.69 37.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.89 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.3 m -140.2 142.23 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.29 114.45 21.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tt -77.1 95.67 4.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.597 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -64.61 -46.05 93.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.478 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 1.6 m-20 -166.7 165.9 16.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.44 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.2 t -127.37 99.04 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 83.0 mt -97.02 170.91 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 30.4 t -110.04 169.11 8.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -46.62 -20.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 24.7 ttmt -89.64 -60.62 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -70.53 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.615 ' CD2' HG21 ' A' ' 111' ' ' VAL . 21.1 t80 -39.24 -54.95 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.9 ptmm? -68.45 -47.52 66.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.7 mt-10 -46.01 -54.37 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -81.18 -51.81 8.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 18.6 m-85 -107.11 70.92 0.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.627 0.727 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.77 -17.48 37.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.385 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.3 -26.7 60.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.594 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.1 pt -120.23 24.35 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.481 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 22.1 p -68.25 -21.16 64.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.538 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -96.42 -23.52 16.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.565 ' OE2' HG22 ' A' ' 102' ' ' ILE . 11.3 mt-10 -48.04 -41.24 25.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 111' ' ' VAL . 1.5 t -124.1 143.02 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -104.3 -28.63 11.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -45.85 161.49 0.26 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.652 0.739 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.444 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.2 Cg_endo -69.78 -43.66 2.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -112.92 102.49 10.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.615 HG21 ' CD2' ' A' ' 95' ' ' PHE . 59.3 t -85.18 136.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.44 ' HE1' ' HG ' ' A' ' 89' ' ' CYS . 7.3 m-30 -105.0 104.22 13.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.818 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -74.17 121.84 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.106 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.447 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.7 m -122.78 154.09 38.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.42 ' CG ' HD12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -139.45 177.03 8.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 52.6 53.54 12.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.902 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.0 Cg_endo -69.66 117.46 5.09 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -131.33 143.59 50.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -107.95 120.6 42.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.584 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.2 mtp -62.67 153.47 32.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.62 -32.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.76 132.57 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.446 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 16.8 mmtm -102.18 154.28 19.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 79' ' ' CYS . 1.1 m-85 -120.48 142.35 33.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 88.23 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.92 165.24 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.6 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 50.0 mtpt -107.23 135.6 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.409 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -90.17 171.89 37.58 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.477 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -150.29 156.43 37.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.316 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.7 mmmm -139.37 -175.33 4.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.7 HG22 ' CE3' ' A' ' 8' ' ' TRP . 62.0 mt -84.8 132.18 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.6 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 4.4 p-90 -138.71 131.74 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.567 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 12.3 ttmt -58.25 128.78 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.4 mt -64.68 170.61 3.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -78.63 127.01 31.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.41 -50.3 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -65.46 -40.29 93.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.9 mm -64.12 -45.93 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -40.45 -65.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.9 mt-30 -52.44 -70.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.67 -43.49 0.8 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.469 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.434 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -61.55 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -61.06 -20.89 63.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' LEU . 18.3 mmmt -90.33 -48.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -40.94 -21.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 145' ' ' LYS . 42.0 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.864 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.607 ' CZ2' ' HD3' ' A' ' 134' ' ' LYS . 92.7 m95 -93.5 167.92 11.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -141.28 159.28 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.702 HD23 ' CD ' ' A' ' 28' ' ' GLU . 31.7 tp -145.42 116.65 7.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 2.7 t -67.99 146.34 53.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.51 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 74.3 t -134.26 153.97 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.415 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.2 m-70 -88.68 113.68 24.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.77 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 46.3 mt-30 -59.94 161.88 11.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.621 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -28.43 6.25 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.338 -0.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.563 ' O ' HD12 ' A' ' 20' ' ' LEU . 10.5 m-90 -28.7 -53.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.77 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.57 -64.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.42 -43.22 99.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.6 mt -48.97 -36.61 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.8 mp -59.75 -64.83 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.637 HG11 ' N ' ' A' ' 82' ' ' GLY . 14.2 m -63.33 -17.92 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.469 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.0 mmt180 -76.49 -39.98 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.54 18.84 3.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.3 mp -105.61 -37.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 111.162 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.9 tptp -102.91 95.54 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.607 ' NE ' HD13 ' A' ' 102' ' ' ILE . 22.4 ptt180 -92.24 14.53 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.623 ' CG1' HD12 ' A' ' 102' ' ' ILE . 30.6 m -146.76 143.94 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.702 ' CD ' HD23 ' A' ' 10' ' ' LEU . 2.5 tt0 -115.97 141.79 47.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.62 122.83 7.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -146.29 149.1 33.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 41.2 p -86.41 23.15 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.49 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -146.01 160.16 42.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -100.78 138.95 37.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 34' ' ' THR . 10.6 t -133.16 100.03 14.44 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.565 0.698 . . . . 0.0 111.109 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.76 8.9 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.354 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -67.27 108.18 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.471 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 63.3 mmt-85 -106.86 115.83 30.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.45 -138.72 6.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -94.92 142.61 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -143.97 115.98 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.07 138.35 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.952 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -109.04 127.3 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.59 152.18 39.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.832 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -85.63 119.03 25.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 12' ' ' VAL . 41.1 p -54.4 -179.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.142 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.83 22.41 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -110.59 132.06 54.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -91.75 130.62 38.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.547 0.689 . . . . 0.0 110.937 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.6 Cg_endo -69.73 134.24 27.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.0 m -75.51 159.21 82.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.697 0.761 . . . . 0.0 110.857 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.689 2.259 . . . . 0.0 112.343 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -94.34 -42.34 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -40.28 86.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.672 HG12 ' NE2' ' A' ' 58' ' ' GLN . 43.5 t -65.62 -50.73 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.03 -42.3 99.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -67.92 -53.74 24.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.405 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 93.9 mt -59.14 -38.74 80.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.672 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.5 mt-30 -55.26 -46.15 76.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -35.35 38.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -61.42 -51.63 67.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -67.48 -41.29 84.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.935 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 69' ' ' VAL . 52.3 mtt180 -48.16 -36.07 12.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.907 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -86.74 -16.19 37.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.8 mt -88.17 -27.25 21.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -123.38 -26.93 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.066 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 127.74 129.03 3.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.455 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.29 -19.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -72.59 3.85 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.066 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.2 m -61.65 178.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.528 ' O ' HD11 ' A' ' 24' ' ' ILE . 10.7 mp0 -119.73 167.85 11.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.587 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 67.8 m-85 -155.47 141.14 12.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.9 Cg_endo -69.77 165.87 29.51 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.66 2.24 . . . . 0.0 112.323 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -88.88 -20.75 24.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.48 174.38 14.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.621 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 87.7 m-85 -134.99 89.73 23.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.66 0.743 . . . . 0.0 110.947 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.468 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.7 Cg_endo -69.75 168.9 20.21 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.719 2.279 . . . . 0.0 112.354 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.0 m -134.91 139.58 45.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.92 92.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.44 ' C ' HD11 ' A' ' 126' ' ' ILE . 81.5 m -152.76 157.33 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.866 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.77 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -80.69 117.83 21.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.832 HD11 ' HB2' ' A' ' 44' ' ' ALA . 17.1 mt -85.87 -71.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.637 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -149.4 -140.35 3.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.484 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.2 p -156.33 166.36 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 16.4 m -154.16 138.71 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.417 ' CB ' HD22 ' A' ' 116' ' ' ASN . 1.5 t70 -81.6 113.91 19.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.66 94.38 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.607 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -62.67 -46.85 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 5.5 m-20 -165.53 170.19 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.17 102.08 6.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 94' ' ' GLN . 97.7 mt -95.87 171.18 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.947 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 93' ' ' LYS . 5.3 p -106.92 169.2 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 108' ' ' SER . 10.0 mm-40 -43.87 -22.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 31.7 ttpt -92.65 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.632 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.9 mm100 -56.3 -46.42 79.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.59 ' CE1' HG11 ' A' ' 27' ' ' VAL . 17.6 t80 -41.95 -58.95 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -68.86 -44.91 72.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 8.0 mt-10 -43.06 -55.72 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.462 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.9 mt-30 -83.62 -43.4 15.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.0 m-85 -115.81 68.41 3.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.681 0.753 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 96' ' ' LYS . 53.9 Cg_endo -69.76 -12.86 33.77 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 0.0 112.365 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.29 -16.45 60.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.723 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.0 OUTLIER -128.77 21.15 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 21.9 p -60.25 -25.87 66.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.576 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -94.28 -28.8 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.723 ' CD ' HG22 ' A' ' 102' ' ' ILE . 20.8 mt-10 -47.44 -36.95 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 t -120.04 157.57 28.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.401 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 3.5 t0 -125.17 -29.27 3.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.505 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -50.19 161.54 0.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.893 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.6 Cg_endo -69.78 -41.53 4.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.673 2.248 . . . . 0.0 112.311 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -115.65 101.69 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.558 HG21 ' CD2' ' A' ' 95' ' ' PHE . 21.4 t -84.97 139.85 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CZ ' HG22 ' A' ' 34' ' ' THR . 7.3 m-30 -105.9 105.59 15.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -73.95 119.91 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.134 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.8 m -122.51 154.18 38.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -141.36 177.07 8.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 53.51 51.6 8.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.74 120.6 7.37 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.99 138.94 47.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -101.73 123.13 45.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.77 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.5 mtp -65.43 136.58 56.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.07 -27.72 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 143.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mttp -114.23 142.73 45.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.8 OUTLIER -108.03 146.37 33.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.91 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 89.92 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.4 pp -126.28 157.82 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.624 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 10.5 pttm -92.33 157.17 16.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.41 -177.59 28.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.507 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.502 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.5 t30 -169.74 146.83 2.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.617 0.722 . . . . 0.0 110.885 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.0 Cg_endo -69.79 0.32 5.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.353 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.5 mmmm -133.93 -172.78 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.517 HG22 ' CE3' ' A' ' 8' ' ' TRP . 34.6 mt -82.93 130.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.624 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 6.1 p-90 -136.23 110.04 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.607 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 1.2 ttpp -54.76 127.09 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.9 mt -57.4 169.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.58 163.1 28.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -42.25 99.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -77.08 -34.67 56.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 124' ' ' PHE . 48.7 mm -72.22 -37.1 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.426 ' NE2' ' HD2' ' A' ' 144' ' ' LYS . 22.4 t-160 -48.89 -63.85 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 142' ' ' GLY . 34.4 mt-30 -50.67 -67.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -33.87 -54.33 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.482 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -52.61 -43.53 65.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 141' ' ' GLN . 11.3 mtpt -66.17 -15.45 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -99.4 -34.09 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.02 9.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.916 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.578 ' CE3' HG22 ' A' ' 132' ' ' ILE . 90.6 m95 -73.81 160.89 30.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.728 0.299 . . . . 0.0 110.904 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' HD11 ' A' ' 135' ' ' LEU . 9.7 t -135.54 123.02 22.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.479 HD13 ' HH2' ' A' ' 32' ' ' TRP . 61.9 tp -112.11 118.31 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' CA ' ' A' ' 128' ' ' GLY . 3.2 m -71.83 155.13 40.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 13' ' ' HIS . 53.4 t -138.44 162.3 30.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.573 ' N ' HG12 ' A' ' 12' ' ' VAL . 67.2 m-70 -97.36 114.89 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.518 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.6 mm-40 -59.8 158.55 23.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 110.861 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.77 -33.28 3.47 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 -1.807 . . . . 0.0 112.358 -0.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.61 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 16.7 m-90 -25.01 -56.88 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -33.81 -53.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.7 m -72.9 -50.99 20.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.43 HD23 HD13 ' A' ' 24' ' ' ILE . 51.7 mt -40.55 -32.43 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.484 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.8 mp -64.75 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.7 m -60.78 -16.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.5 mmt180 -77.19 -39.31 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.21 12.17 5.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.43 HD13 HD23 ' A' ' 19' ' ' LEU . 5.3 mp -98.29 -48.62 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.3 tptt -89.15 117.08 27.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.9 ttm180 -101.07 -6.85 23.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.521 HG11 ' CE1' ' A' ' 95' ' ' PHE . 21.5 m -133.33 158.34 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.52 124.97 41.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.18 128.45 8.85 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -147.51 147.74 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.1 p -85.15 17.52 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.479 ' HH2' HD13 ' A' ' 10' ' ' LEU . 2.5 p-90 -142.51 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.414 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 4.1 t80 -106.36 139.3 41.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 34' ' ' THR . 8.1 t -134.32 101.71 12.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.613 0.72 . . . . 0.0 111.163 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.8 6.79 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.357 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -64.54 108.82 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.49 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.8 mmt-85 -105.23 112.67 25.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.31 -152.43 23.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -79.28 143.57 35.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.829 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.415 HD21 ' HB2' ' A' ' 10' ' ' LEU . 25.2 tp -143.87 115.08 7.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.572 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 95.5 m95 -71.12 124.8 25.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.72 122.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.131 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.92 149.84 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.646 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.21 123.63 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 12' ' ' VAL . 28.5 p -59.43 -174.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.27 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -81.41 135.0 35.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.25 41.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.618 0.723 . . . . 0.0 110.867 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 129.54 17.76 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -76.35 159.27 80.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.68 0.752 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -3.62 12.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.96 -41.41 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.88 -43.31 72.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.712 HG12 ' NE2' ' A' ' 58' ' ' GLN . 33.3 t -65.78 -52.54 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -59.75 -45.7 91.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.34 -56.67 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.61 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 92.1 mt -55.9 -38.51 70.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.712 ' NE2' HG12 ' A' ' 54' ' ' VAL . 9.7 mt-30 -57.46 -43.53 84.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.43 -32.61 32.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -66.24 -52.29 49.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.536 ' HE2' HD22 ' A' ' 57' ' ' LEU . 31.9 m-85 -66.32 -38.26 87.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.573 ' HG2' HG22 ' A' ' 69' ' ' VAL . 65.0 mtt180 -47.71 -34.2 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.62 -16.01 31.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 61' ' ' TYR . 48.6 mt -87.28 -29.96 21.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -120.27 -29.13 4.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.056 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.95 124.87 2.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -43.99 -21.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.776 0.322 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' GLY . 6.5 t0 -79.85 18.88 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.056 HG13 ' O ' ' A' ' 66' ' ' GLY . 24.9 m -69.07 -178.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' O ' ' CD1' ' A' ' 71' ' ' PHE . 5.4 pt-20 -117.51 166.3 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -158.92 135.53 6.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.692 0.758 . . . . 0.0 110.87 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 145.76 58.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.364 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.19 -27.08 66.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.426 ' C ' ' CD1' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -149.4 -178.11 6.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.571 ' CE2' ' HB3' ' A' ' 15' ' ' PRO . 13.9 m-85 -141.19 105.0 6.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.613 ' HG2' HD21 ' A' ' 81' ' ' LEU . 54.1 Cg_endo -69.75 178.35 4.65 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.652 2.235 . . . . 0.0 112.371 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.1 p -142.66 130.49 21.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.12 48.75 66.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 59.3 m -150.62 148.42 28.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -77.33 115.29 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 44' ' ' ALA . 32.3 mt -83.25 -71.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.15 -139.68 3.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.572 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 7.1 p -155.81 157.68 36.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 m -144.63 136.7 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.74 110.94 14.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.6 96.16 4.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.58 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -64.29 -50.37 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.405 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -161.23 167.88 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.479 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.3 t -128.2 101.3 6.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 80.8 mt -98.61 170.88 8.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 93' ' ' LYS . 29.3 t -109.44 169.18 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.455 ' NE2' ' O ' ' A' ' 108' ' ' SER . 20.4 mm-40 -46.29 -20.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 91' ' ' SER . 19.5 tttt -89.56 -60.61 1.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -70.02 -50.4 41.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.557 ' CD2' HG21 ' A' ' 111' ' ' VAL . 28.7 t80 -39.72 -55.32 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.8 ptmm? -67.96 -47.49 68.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.519 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 5.8 mt-10 -45.88 -55.93 6.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.0 mt-30 -78.67 -52.73 8.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 23.9 m-85 -108.15 70.1 0.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.77 -15.46 37.07 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.647 2.231 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -73.36 -26.3 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.479 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.4 pt -118.96 21.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 17.6 p -64.49 -22.14 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.624 HE21 ' N ' ' A' ' 105' ' ' GLU . 1.7 pp0? -96.04 -21.4 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.624 ' N ' HE21 ' A' ' 104' ' ' GLN . 7.5 mt-10 -56.23 -36.25 68.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.49 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.5 p -125.85 138.35 53.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.854 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 15.4 t70 -104.57 -30.57 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.455 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -44.28 161.04 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.673 0.749 . . . . 0.0 110.866 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.414 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.1 Cg_endo -69.75 -47.8 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 22.1 m-85 -110.0 99.52 8.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 95' ' ' PHE . 46.5 t -80.86 144.61 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CZ ' HG22 ' A' ' 34' ' ' THR . 12.6 m-30 -110.99 106.18 15.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER -75.07 120.0 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.8 m -126.03 153.64 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.419 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 16.6 mmmt -143.09 174.07 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.62 52.97 5.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.3 Cg_endo -69.71 119.47 6.42 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.337 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -132.05 134.26 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -99.79 126.01 45.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.51 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.9 mtp -65.69 152.82 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.23 -36.58 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.07 142.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.152 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -104.74 152.4 22.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.02 139.53 24.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.01 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.66 160.35 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.599 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 5.7 mtmp? -92.12 128.29 37.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.419 ' CA ' ' OG ' ' A' ' 11' ' ' SER . . . -89.37 151.6 22.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.499 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -132.33 154.0 81.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 2.28 3.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.455 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 7.1 mmmm -135.83 -174.12 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.578 HG22 ' CE3' ' A' ' 8' ' ' TRP . 58.1 mt -89.05 132.57 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.599 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.3 p-90 -140.69 129.83 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.05 127.35 28.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 9' ' ' CYS . 31.2 mt -62.45 166.86 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 4.4 t0 -76.38 129.04 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -35.55 -38.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -75.47 -42.62 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 mm -64.16 -40.16 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -44.22 -65.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 142' ' ' GLY . 28.3 mt-30 -51.86 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.05 -49.01 1.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.494 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.444 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.66 -51.02 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.104 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HB2' ' HZ2' ' A' ' 144' ' ' LYS . 2.0 mtpm? -57.84 -32.45 67.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 147' ' ' LEU . 21.3 mmmt -71.59 -50.8 27.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.74 -25.51 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 145' ' ' LYS . 23.6 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -72.39 167.51 20.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -135.85 140.54 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.1 tp -131.12 106.66 8.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -67.65 147.32 52.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 29.4 t -132.35 157.88 43.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.486 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.8 m-70 -88.03 115.26 25.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.78 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 45.1 mt-30 -61.22 162.21 14.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.78 -27.46 6.82 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.318 0.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.514 ' O ' HD12 ' A' ' 20' ' ' LEU . 11.5 m-90 -30.33 -52.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.78 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.88 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' LEU . 1.7 m -61.33 -52.75 63.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.529 HD23 HD13 ' A' ' 24' ' ' ILE . 57.1 mt -38.37 -41.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -55.99 -68.37 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' N ' ' A' ' 82' ' ' GLY . 33.0 m -59.84 -12.94 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.441 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.7 mmt180 -83.13 -39.57 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.97 -6.5 8.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.529 HD13 HD23 ' A' ' 19' ' ' LEU . 5.4 mp -78.8 -46.96 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HG2' HD11 ' A' ' 20' ' ' LEU . 12.3 tptt -94.64 111.94 23.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.415 ' HG3' HG13 ' A' ' 27' ' ' VAL . 15.5 ptm180 -108.41 16.67 22.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.568 HG11 ' CE1' ' A' ' 95' ' ' PHE . 27.2 m -149.6 143.95 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' OE1' HD21 ' A' ' 20' ' ' LEU . 6.6 tp10 -111.69 150.14 30.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -115.37 123.95 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 85.2 mmt-85 -149.8 151.71 34.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.5 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.2 t -87.93 24.0 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.518 ' CZ2' ' HD2' ' A' ' 30' ' ' ARG . 3.3 p-90 -144.6 157.78 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -99.26 137.77 37.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 34' ' ' THR . 9.3 t -133.59 100.94 13.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.577 0.704 . . . . 0.0 111.169 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.4 Cg_endo -69.77 6.22 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.712 2.275 . . . . 0.0 112.365 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.43 ' O ' HD22 ' A' ' 86' ' ' LEU . 17.8 t60 -64.63 111.37 2.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' A' ' 34' ' ' THR . 15.8 mmt180 -112.67 110.54 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.14 -142.37 8.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.445 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.1 ttp-105 -82.11 142.31 32.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.854 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 tp -143.69 106.83 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.622 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.4 m95 -71.8 118.83 15.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 43.6 mm -91.59 129.85 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -122.75 148.57 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.819 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.42 112.42 19.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.3 p -48.5 175.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.57 -12.46 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -74.35 142.22 45.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -103.22 131.59 21.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.547 0.689 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 133.42 25.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.638 2.225 . . . . 0.0 112.392 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.8 m -82.16 159.17 65.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.683 0.754 . . . . 0.0 110.815 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -2.81 10.79 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.513 ' NE2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -94.31 -46.53 7.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -69.28 -41.19 77.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.711 HG12 ' NE2' ' A' ' 58' ' ' GLN . 56.9 t -63.15 -51.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -60.51 -44.22 96.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 18.6 mt-10 -66.69 -57.24 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.407 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 90.0 mt -54.03 -40.25 66.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.711 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.7 mt-30 -55.0 -45.57 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -34.98 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.086 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -61.99 -50.76 70.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.413 ' HA ' HD12 ' A' ' 64' ' ' LEU . 30.9 m-85 -68.7 -39.18 80.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HG2' HG22 ' A' ' 69' ' ' VAL . 59.7 mtt180 -47.67 -34.03 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 25.7 mt -90.57 -15.53 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 61' ' ' TYR . 59.1 mt -88.0 -29.42 20.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -121.21 -28.96 4.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 1.032 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.37 125.35 2.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.482 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.57 -19.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' GLY . 11.6 t70 -80.69 16.52 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.032 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.6 m -66.75 -177.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.502 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.4 pt-20 -116.09 170.07 8.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.597 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 52.1 m-85 -163.27 136.56 4.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.677 0.751 . . . . 0.0 110.855 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 54.4 Cg_endo -69.75 158.9 55.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.66 2.24 . . . . 0.0 112.385 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -76.92 -30.28 56.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -148.73 177.9 9.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.594 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 57.4 m-85 -134.87 95.84 15.13 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.65 0.738 . . . . 0.0 110.884 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.5 Cg_endo -69.8 -179.92 3.27 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.375 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -145.62 143.94 30.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.5 47.23 92.16 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 87.3 m -156.27 146.95 21.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.368 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -74.53 121.51 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 44' ' ' ALA . 16.9 mt -88.9 -71.2 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.948 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.639 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.95 -147.47 4.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.455 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.585 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.1 p -153.57 154.68 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 24.3 m -140.7 141.4 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.401 ' CB ' HD22 ' A' ' 116' ' ' ASN . 2.9 t70 -83.25 111.34 18.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 112' ' ' PHE . 2.8 tt -75.85 99.06 4.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.554 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.34 -48.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.181 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -162.27 168.57 22.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.87 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.43 103.11 7.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 87.0 mt -98.76 166.87 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 93' ' ' LYS . 48.5 t -104.72 168.5 9.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -45.81 -20.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.6 ttpt -91.3 -63.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.59 -49.48 75.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 27' ' ' VAL . 61.3 t80 -43.2 -56.2 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -66.38 -38.36 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.406 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 7.0 mt-10 -56.16 -55.21 35.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 10.8 mt-30 -78.48 -52.09 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.4 m-85 -109.85 68.22 0.46 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.665 0.745 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.8 Cg_endo -69.81 -14.23 35.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.12 -22.31 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 27' ' ' VAL . 2.4 pt -121.34 8.22 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.509 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 89.5 p -49.06 -25.27 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -90.7 -28.69 18.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.881 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 4.1 mt-10 -56.36 -22.57 31.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.498 ' OG ' HG21 ' A' ' 111' ' ' VAL . 1.9 p -113.98 160.3 18.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -134.88 -33.15 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.486 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -62.34 165.51 8.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.719 0.771 . . . . 0.0 110.826 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.5 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.84 -45.11 1.66 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -110.55 98.0 7.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.498 HG21 ' OG ' ' A' ' 106' ' ' SER . 13.5 t -83.37 140.26 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.488 ' HB3' HD11 ' A' ' 86' ' ' LEU . 3.0 m-30 -107.57 110.48 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.15 122.13 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.7 m -124.95 154.86 40.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -142.04 176.29 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 57.5 52.67 5.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.76 117.38 5.05 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.671 2.248 . . . . 0.0 112.354 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -133.08 139.08 46.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -101.47 125.55 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.599 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.2 mtp -67.01 150.91 48.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.2 t -75.18 -31.01 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.4 146.35 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 20.1 mmtm -112.74 149.48 32.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.555 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.2 m-85 -115.18 141.07 26.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.864 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 84.58 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.341 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.593 HD13 ' HH2' ' A' ' 133' ' ' TRP . 2.7 pp -115.2 158.81 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 39.5 mmtt -91.45 121.84 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.66 155.79 53.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -148.85 156.0 40.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -51.12 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.667 2.245 . . . . 0.0 112.32 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.466 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.0 mmmm -86.54 -174.53 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.426 HG13 ' CH2' ' A' ' 32' ' ' TRP . 66.3 mt -83.03 141.63 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.593 ' HH2' HD13 ' A' ' 126' ' ' ILE . 1.6 p-90 -146.88 123.98 11.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -56.1 128.31 34.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 mt -63.06 169.97 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.1 t70 -75.15 127.67 33.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.47 -40.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -40.99 63.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.555 HG23 ' CD2' ' A' ' 124' ' ' PHE . 22.2 mm -65.0 -44.37 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.9 t-160 -37.84 -62.51 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' GLY . 23.8 mt-30 -52.96 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.93 -46.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.622 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.95 -49.18 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -58.71 -27.82 65.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.4 mmpt? -76.37 -49.41 16.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.42 -22.72 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.449 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 145' ' ' LYS . 25.1 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.0 p -154.54 157.5 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -152.27 151.99 31.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.858 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.25 109.94 3.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m -81.87 41.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 110.835 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -91.14 153.49 20.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.91 93.67 0.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.61 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.4 m95 -82.48 161.62 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.748 0.309 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB2' ' CG ' ' A' ' 135' ' ' LEU . 44.6 t -138.12 130.18 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.9 tp -118.56 114.33 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.0 t -67.91 150.03 49.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 32.3 t -133.29 156.75 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.475 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 41.7 m-70 -90.73 115.38 27.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.542 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 65.9 mt-30 -61.66 160.82 24.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.558 0.694 . . . . 0.0 110.962 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.83 -31.86 4.31 Favored 'Cis proline' 0 C--O 1.231 0.147 0 C-N-CA 122.718 -1.784 . . . . 0.0 112.297 0.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.587 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.2 m-90 -25.47 -53.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.542 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -37.51 -61.3 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 7.2 m -64.88 -42.82 94.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.7 mt -51.77 -31.12 25.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.5 mp -66.27 -64.28 0.89 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.9 m -63.99 -16.39 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -76.87 -39.52 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.808 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 18.7 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.515 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.49 -42.1 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.552 ' HG2' HD11 ' A' ' 20' ' ' LEU . 17.3 tptt -99.05 104.54 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.486 ' HD2' HD13 ' A' ' 102' ' ' ILE . 12.2 ptp180 -97.87 17.34 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.474 HG11 HD12 ' A' ' 102' ' ' ILE . 27.4 m -149.38 147.1 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 3.5 tm-20 -118.62 141.81 48.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.516 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -102.89 126.82 8.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 12.6 mmt180 -148.42 146.37 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 10.4 m -84.25 20.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.575 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.3 p-90 -144.63 166.43 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -107.75 140.43 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 34' ' ' THR . 5.1 t -134.08 106.45 11.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.59 0.709 . . . . 0.0 111.128 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.3 Cg_endo -69.8 3.07 3.0 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.308 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.562 ' O ' HD22 ' A' ' 86' ' ' LEU . 18.5 t60 -63.13 111.74 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 7.7 mmt85 -116.1 121.79 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.65 -126.69 2.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.522 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -98.62 138.36 35.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.833 0.349 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 tp -143.93 112.86 6.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 86.2 m95 -71.34 133.86 46.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -104.1 126.84 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.1 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.54 145.57 47.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.672 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.64 117.06 22.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.3 p -53.21 176.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.86 -11.38 59.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 5.7 ttpt -73.06 146.53 45.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -104.08 134.08 19.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 0.0 110.91 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.75 127.26 14.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.623 2.215 . . . . 0.0 112.364 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.9 m -73.23 155.59 89.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.648 0.737 . . . . 0.0 110.871 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -5.33 15.9 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.713 2.275 . . . . 0.0 112.309 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.48 -39.83 10.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -72.38 -39.13 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.735 HG12 ' NE2' ' A' ' 58' ' ' GLN . 44.9 t -66.3 -54.74 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 t -59.09 -43.78 91.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.16 -56.43 8.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.586 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 77.2 mt -54.94 -39.6 69.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.735 ' NE2' HG12 ' A' ' 54' ' ' VAL . 11.1 mt-30 -55.44 -45.76 76.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.0 -33.81 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -63.44 -51.17 66.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.418 ' HE2' HD22 ' A' ' 57' ' ' LEU . 22.8 m-85 -68.55 -35.81 77.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 69' ' ' VAL . 35.5 mtt-85 -50.96 -34.13 27.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.64 -13.2 34.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.55 -29.24 17.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.444 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.7 mmm180 -121.47 -28.71 4.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.053 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.01 126.66 2.68 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.434 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 13.6 ptmt -45.98 -19.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.313 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -82.27 19.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.053 HG13 ' O ' ' A' ' 66' ' ' GLY . 21.2 m -67.24 -178.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -114.96 162.81 16.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 47.9 m-85 -157.61 134.94 6.89 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.3 Cg_endo -69.79 162.54 41.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 0.0 112.343 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -82.19 -29.27 31.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -147.35 175.19 10.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.604 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 51.7 m-85 -134.96 95.68 15.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.651 0.739 . . . . 0.0 110.966 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.8 Cg_endo -69.76 177.02 6.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.357 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.5 p -147.22 138.38 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 43.78 47.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 64.8 m -156.36 149.74 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.53 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -76.19 118.21 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 44' ' ' ALA . 86.9 mt -84.5 -73.95 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.427 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.97 -144.29 4.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.9 p -153.32 155.41 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 26.2 m -140.97 136.41 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.428 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.7 t70 -77.85 110.43 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.562 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.8 tt -75.0 101.85 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.524 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -72.99 -47.12 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.412 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -164.53 167.09 19.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -127.74 97.46 4.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 94' ' ' GLN . 94.8 mt -90.51 170.66 10.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.41 ' C ' ' N ' ' A' ' 93' ' ' LYS . 7.5 p -108.14 169.22 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 108' ' ' SER . 14.2 mm-40 -45.11 -21.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 24.2 tttt -92.02 -63.54 1.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.509 ' HB3' HD22 ' A' ' 90' ' ' LEU . 8.5 mt-30 -61.38 -48.47 81.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.606 ' CD2' HG21 ' A' ' 111' ' ' VAL . 21.8 t80 -42.38 -57.81 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 9.7 ptpt -67.79 -43.59 79.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -48.36 -58.6 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.486 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.4 mt-30 -79.39 -47.16 16.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.3 m-85 -110.24 67.82 0.49 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.626 0.727 . . . . 0.0 110.846 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.6 Cg_endo -69.81 -12.4 32.73 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.657 2.238 . . . . 0.0 112.369 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -77.84 -20.94 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.652 HG22 ' CD ' ' A' ' 105' ' ' GLU . 2.1 pt -126.46 23.51 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.486 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 40.7 p -64.16 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.862 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.56 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -94.35 -30.02 14.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.652 ' CD ' HG22 ' A' ' 102' ' ' ILE . 30.0 mt-10 -45.51 -36.24 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 t -122.97 153.89 39.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.439 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 16.4 t70 -119.48 -30.55 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.472 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -47.35 161.04 0.33 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 110.825 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.483 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.7 Cg_endo -69.7 -37.88 8.7 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.7 2.267 . . . . 0.0 112.374 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -118.74 102.81 9.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.606 HG21 ' CD2' ' A' ' 95' ' ' PHE . 29.3 t -86.62 132.25 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.164 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 3.9 m-30 -99.63 105.21 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.81 122.56 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.411 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 2.1 m -125.71 154.44 42.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -141.9 175.2 9.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.44 53.2 8.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.646 0.736 . . . . 0.0 110.87 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.8 116.89 4.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.314 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -130.38 131.77 45.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.97 121.69 39.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.53 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.0 mtp -62.77 149.2 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 149' ' ' LYS . 47.5 t -74.91 -35.75 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.33 134.16 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -102.43 149.49 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.406 ' HE2' ' HB2' ' A' ' 143' ' ' ALA . 0.8 OUTLIER -116.27 142.49 29.45 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.652 0.739 . . . . 0.0 110.857 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 88.32 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.308 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.8 pp -125.69 164.36 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.598 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 40.6 mttp -105.23 139.18 40.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.03 172.81 37.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -154.17 153.57 28.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 53.6 Cg_endo -69.75 1.75 4.15 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.354 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.575 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.2 mmmm -137.72 -174.95 3.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.61 HG22 ' CE3' ' A' ' 8' ' ' TRP . 75.5 mt -86.08 134.27 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.598 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.5 p-90 -140.64 130.71 24.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -57.94 128.04 35.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.44 HD22 HG21 ' A' ' 139' ' ' ILE . 29.3 mt -62.6 170.83 2.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.9 t0 -82.05 129.14 34.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -35.41 -49.5 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.84 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -65.3 -39.76 92.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 26.9 mm -64.75 -47.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.37 -61.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 142' ' ' GLY . 38.2 mt-30 -54.37 -69.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.55 -49.68 1.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.509 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.99 -44.27 78.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.7 mtpp -65.07 -22.88 67.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -84.46 -40.72 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -53.35 -14.77 3.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.495 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.5 mt -88.12 26.5 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.9 ptp -85.38 -25.04 27.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.479 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 19.2 mmmt -146.83 153.71 40.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -130.55 176.68 7.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -65.32 174.57 2.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -74.79 -27.0 60.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.61 -58.49 7.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 154' ' ' VAL . 12.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 t -59.0 -46.78 87.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.866 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 p -163.03 154.55 17.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.35 91.49 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.506 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.2 t -108.88 106.38 16.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.889 0.376 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 m -125.85 165.82 18.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.64 91.25 1.07 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.592 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.5 m95 -84.56 163.58 19.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 133' ' ' TRP . 13.5 p -139.65 156.68 46.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -138.57 113.76 9.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 p -68.39 138.09 55.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.464 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 29.6 t -124.22 152.16 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 35.8 m-70 -87.4 114.89 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.691 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 57.9 mt-30 -60.58 161.44 14.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.77 -29.17 5.86 Favored 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.322 -0.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.573 ' O ' HD12 ' A' ' 20' ' ' LEU . 11.6 m-90 -28.53 -49.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.691 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -37.77 -64.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 -42.1 99.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.2 mt -49.82 -35.33 22.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.2 mp -61.92 -64.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.2 m -64.07 -22.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.4 mmt180 -69.32 -39.47 78.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.1 22.19 3.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.485 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.22 -44.62 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -95.01 101.25 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.98 ' HE ' HD13 ' A' ' 102' ' ' ILE . 17.2 ptt180 -96.85 17.2 17.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.644 HG11 HD12 ' A' ' 102' ' ' ILE . 32.7 m -149.02 150.37 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.44 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.8 122.18 7.42 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.447 ' N ' ' CB ' ' A' ' 108' ' ' SER . 16.4 mmt180 -147.8 150.09 33.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.474 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 80.0 p -86.13 21.28 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.526 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 5.7 p-90 -142.19 157.53 44.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 4.9 t80 -100.73 141.43 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 34' ' ' THR . 9.4 t -134.84 101.04 11.79 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.7 Cg_endo -69.81 4.53 2.16 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.664 2.243 . . . . 0.0 112.337 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -65.9 110.55 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -113.95 120.44 40.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.08 -120.48 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -106.06 140.68 38.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.891 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -144.19 114.7 7.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.67 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 95.6 m95 -72.37 132.25 43.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.459 ' O ' HD23 ' A' ' 80' ' ' LEU . 34.1 mm -101.03 128.61 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.23 152.63 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.778 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -89.64 118.74 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -55.29 175.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.76 -18.32 60.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.061 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 7.9 ttpt -68.88 148.43 50.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.48 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.3 135.27 19.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.553 0.692 . . . . 0.0 110.908 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.492 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.75 127.98 15.38 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.342 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.8 m -73.86 159.62 83.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.623 0.725 . . . . 0.0 110.883 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -6.75 19.34 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.37 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.63 -42.06 8.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.954 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.55 -42.72 86.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG12 ' NE2' ' A' ' 58' ' ' GLN . 27.7 t -66.34 -52.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -59.77 -45.23 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.41 -56.65 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.498 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.4 mt -53.96 -43.05 69.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.589 ' HG2' ' CE1' ' A' ' 71' ' ' PHE . 7.8 mt-30 -49.88 -46.56 51.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.57 -38.89 39.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -56.86 -52.06 66.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -68.98 -40.17 78.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.57 ' HG2' HG22 ' A' ' 69' ' ' VAL . 44.7 mtt-85 -48.69 -35.17 13.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.2 mt -88.87 -14.75 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.406 HD13 ' NE2' ' A' ' 104' ' ' GLN . 62.3 mt -89.44 -28.12 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.402 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.8 mmm180 -121.91 -29.18 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.058 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 130.83 127.32 2.87 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.453 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -44.63 -21.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 66' ' ' GLY . 14.2 t0 -74.1 7.95 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.806 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.058 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.1 m -62.45 -178.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 2.4 mm-40 -117.0 172.42 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 56.7 m-85 -164.32 135.61 3.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.62 0.724 . . . . 0.0 110.939 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.82 161.77 44.66 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.296 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -83.73 -26.94 29.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -148.88 173.55 13.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.5 m-85 -134.69 95.38 15.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.687 0.756 . . . . 0.0 110.939 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.2 Cg_endo -69.79 -178.21 2.25 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.6 m -149.93 139.05 21.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.52 44.6 63.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 19.6 m -156.68 149.06 23.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.532 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -74.81 118.37 17.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 44' ' ' ALA . 63.5 mt -83.07 -73.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.449 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.33 -141.02 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.498 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.576 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -151.92 166.87 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 114' ' ' CYS . 21.7 m -154.07 149.37 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.452 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.9 t70 -95.38 109.2 21.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -72.82 96.88 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.539 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -66.7 -48.44 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -162.95 167.45 22.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.456 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.4 t -127.67 98.2 5.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 98.1 mt -94.45 166.71 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 93' ' ' LYS . 9.6 t -106.73 166.29 10.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 108' ' ' SER . 19.7 mm-40 -42.06 -23.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 91' ' ' SER . 24.9 ttmt -86.61 -63.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.437 ' HB3' HD22 ' A' ' 90' ' ' LEU . 13.1 mt-30 -66.09 -49.97 65.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CD2' HG21 ' A' ' 111' ' ' VAL . 37.9 t80 -42.03 -56.78 2.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 5.0 ptmt -67.16 -41.33 86.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.1 -59.18 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -77.2 -48.36 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 30.8 m-85 -111.1 66.26 0.55 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.73 -12.73 33.56 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.91 -24.12 55.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.98 HD13 ' HE ' ' A' ' 26' ' ' ARG . 2.3 pt -120.49 17.47 6.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.444 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 27.2 p -58.05 -24.96 60.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.814 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.604 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -91.26 -31.95 15.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.947 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.678 ' CD ' HG22 ' A' ' 102' ' ' ILE . 27.2 mt-10 -43.37 -37.1 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 t -125.96 146.92 49.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -33.77 6.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.5 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.8 m -45.12 161.62 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.685 0.755 . . . . 0.0 110.867 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.474 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.2 Cg_endo -69.71 -48.8 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.353 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 18.4 m-85 -105.62 102.9 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 95' ' ' PHE . 20.1 t -86.2 137.3 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.555 ' CE1' HG22 ' A' ' 34' ' ' THR . 11.1 m-30 -103.39 107.54 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.8 OUTLIER -74.69 117.48 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.125 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -118.49 151.13 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -143.1 175.62 9.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 52.09 52.34 11.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 0.0 110.915 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.763 ' O ' HG11 ' A' ' 154' ' ' VAL . 54.0 Cg_endo -69.68 120.18 7.02 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.312 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -129.21 132.25 47.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -97.07 122.46 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.648 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 16.4 mtp -65.63 143.05 57.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.56 -24.73 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.01 138.73 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -106.79 149.08 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.648 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 1.1 m-85 -116.84 142.32 29.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 86.76 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.713 2.276 . . . . 0.0 112.334 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.544 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.8 pp -125.39 168.13 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.608 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 7.4 mtmp? -109.42 142.31 40.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.26 163.32 14.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -141.79 161.92 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 1.8 4.1 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.306 . . . . 0.0 112.317 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.526 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.1 mmmm -137.78 -175.08 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.592 HG22 ' CE3' ' A' ' 8' ' ' TRP . 97.1 mt -83.77 134.86 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.608 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 11.0 p-90 -140.75 127.34 20.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.97 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.572 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 9.7 ttmt -54.41 130.79 40.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 20.5 mt -66.4 176.37 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.9 t0 -86.18 126.03 33.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.23 -41.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -72.1 -43.23 65.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.514 HG23 ' CD2' ' A' ' 124' ' ' PHE . 30.0 mm -62.97 -43.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -40.25 -67.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 142' ' ' GLY . 70.1 mt-30 -49.03 -69.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.15 -46.57 0.98 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.44 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.67 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.67 -47.58 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -60.44 -25.18 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -85.58 -39.49 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.95 -8.85 6.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.482 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.7 mt -83.88 29.3 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.954 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.452 ' O ' ' C ' ' A' ' 149' ' ' LYS . 6.9 ptp -109.77 175.82 5.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 148' ' ' MET . 58.5 tttt 34.37 38.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -49.05 173.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -70.82 171.05 11.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -93.63 35.94 1.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -130.64 -60.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.095 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.763 HG11 ' O ' ' A' ' 117' ' ' PRO . 89.8 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 m -99.56 -53.61 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.91 0.386 . . . . 0.0 110.88 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -84.55 93.3 8.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.08 58.95 0.59 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.489 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 m -105.22 132.48 51.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -119.15 26.0 9.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.788 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.93 61.16 6.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.457 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.691 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.0 m95 -72.52 163.29 28.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 110.955 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 t -136.4 129.91 31.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 40' ' ' LEU . 60.3 tp -116.87 113.49 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 0.5 OUTLIER -67.64 150.95 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.448 HG21 HD22 ' A' ' 20' ' ' LEU . 94.1 t -138.18 146.46 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.082 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 35.6 m-70 -82.01 119.75 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.562 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 56.5 mt-30 -64.63 162.28 36.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.589 0.709 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.78 -30.9 4.89 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.354 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.568 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 12.9 m-90 -25.08 -55.93 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.562 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.5 -61.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 4.7 m -64.61 -40.11 94.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 16' ' ' TRP . 67.8 mt -54.23 -30.81 51.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -65.15 -65.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.589 HG21 ' OE1' ' A' ' 119' ' ' GLU . 5.4 m -63.31 -17.95 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -74.93 -39.28 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.77 20.07 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -107.09 -44.01 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -97.32 113.83 25.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -109.84 19.84 18.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.83 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG11 HD12 ' A' ' 102' ' ' ILE . 34.8 m -152.54 145.2 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.422 ' HG2' HD21 ' A' ' 10' ' ' LEU . 9.4 tp10 -117.65 142.17 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -106.48 126.07 8.36 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.453 ' N ' ' CB ' ' A' ' 108' ' ' SER . 33.1 mmt180 -150.0 150.47 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 110.836 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.48 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 8.8 m -84.66 25.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.528 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -147.47 162.98 37.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -104.64 141.53 36.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 34' ' ' THR . 10.3 t -134.37 99.11 13.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 0.0 111.191 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.6 Cg_endo -69.83 4.93 1.93 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.459 ' O ' HD22 ' A' ' 86' ' ' LEU . 8.1 t60 -65.49 112.89 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.458 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 6.3 mmt85 -113.29 122.95 48.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.37 -129.49 2.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -99.15 140.03 33.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.847 0.356 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 10' ' ' LEU . 24.5 tp -144.17 112.57 6.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 83.2 m95 -70.93 128.83 37.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.77 123.75 53.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.18 148.52 41.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.075 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.753 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -83.78 120.52 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.2 p -55.73 169.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.68 -19.79 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.459 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.3 ttpt -65.86 147.97 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -105.4 134.32 19.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.593 0.711 . . . . 0.0 110.894 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.73 126.63 13.56 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 0.0 112.33 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.6 m -72.22 158.91 86.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.725 . . . . 0.0 110.875 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.01 22.52 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.632 2.221 . . . . 0.0 112.351 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.42 ' NE2' ' HA ' ' A' ' 52' ' ' GLN . 8.1 mm100 -94.4 -36.26 11.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.48 -41.2 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.661 HG12 ' NE2' ' A' ' 58' ' ' GLN . 34.7 t -68.15 -45.99 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.5 t -66.88 -42.87 84.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.19 -52.8 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.568 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 84.4 mt -58.59 -41.11 85.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.661 ' NE2' HG12 ' A' ' 54' ' ' VAL . 9.3 mt-30 -53.06 -47.56 68.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -36.99 50.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 m -59.97 -51.68 68.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.169 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -69.26 -37.46 77.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.474 ' HG2' HG22 ' A' ' 69' ' ' VAL . 53.9 mtt180 -48.81 -33.44 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.7 mt -90.83 -15.91 29.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.8 mt -87.25 -29.69 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -120.81 -29.13 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.039 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.62 126.35 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -44.8 -20.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -80.85 17.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 66' ' ' GLY . 20.4 m -66.12 -178.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.8 162.97 15.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.591 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 44.4 m-85 -157.94 133.16 5.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.552 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.53 30.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -85.49 -29.21 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -146.78 173.21 12.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.645 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.71 96.2 15.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.698 0.761 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.71 172.7 12.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.264 . . . . 0.0 112.343 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.5 p -138.86 139.23 38.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.12 52.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 58.7 m -158.52 149.21 20.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -78.43 120.74 23.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.753 HD11 ' HB2' ' A' ' 44' ' ' ALA . 35.9 mt -89.33 -71.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.471 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.33 -145.97 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.493 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.5 p -152.99 157.48 40.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.897 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.4 m -140.9 144.32 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.133 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -85.81 113.7 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.459 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.6 tt -77.59 100.01 5.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.37 -48.07 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -163.09 167.26 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.77 101.19 6.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.8 mt -96.01 169.41 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' PHE . 13.2 p -108.36 169.12 8.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.839 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 108' ' ' SER . 21.8 mm-40 -47.25 -19.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 91' ' ' SER . 15.0 ttmm -90.35 -59.11 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -70.85 -50.13 38.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CD2' HG21 ' A' ' 111' ' ' VAL . 27.5 t80 -41.51 -54.85 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -67.52 -40.77 85.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.42 -58.72 6.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.2 mt-30 -75.67 -49.95 16.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.2 m-85 -109.85 68.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.656 0.741 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.75 -13.4 34.65 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -76.92 -24.68 52.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.709 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.1 pt -120.18 23.48 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 p -64.39 -27.15 68.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -90.33 -28.76 18.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.709 ' CD ' HG22 ' A' ' 102' ' ' ILE . 18.0 mt-10 -45.71 -39.38 7.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.937 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.4 t -124.64 147.95 48.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 7.3 t0 -110.99 -33.87 6.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.453 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 1.7 m -42.81 161.52 0.18 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 0.0 110.857 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.48 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.77 -45.49 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.692 2.262 . . . . 0.0 112.309 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -110.59 104.95 13.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.529 HG21 ' CD2' ' A' ' 95' ' ' PHE . 21.4 t -90.33 133.61 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 2.2 m-30 -100.86 109.73 21.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.36 121.94 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -124.56 154.04 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -141.4 175.8 9.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.97 52.41 5.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.651 0.739 . . . . 0.0 110.902 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.78 114.94 3.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.254 . . . . 0.0 112.318 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.41 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 4.1 pt20 -130.08 145.31 51.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.589 ' OE1' HG21 ' A' ' 21' ' ' VAL . 3.7 tp10 -107.14 123.56 48.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.51 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.8 mtp -63.13 149.26 45.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 149' ' ' LYS . 63.1 t -73.39 -23.46 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.3 p -130.09 149.95 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 20.2 mmtm -117.35 151.81 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.488 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.5 m-85 -120.43 141.68 32.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.656 0.741 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 86.5 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.503 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.8 pp -121.73 165.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.617 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 48.8 mttp -101.59 143.17 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -87.44 -177.13 48.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 20.6 t-20 -170.52 142.45 1.71 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.632 0.729 . . . . 0.0 110.862 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.2 Cg_endo -69.74 9.76 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.685 2.257 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASN . 9.8 mmmm -141.44 -174.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.691 HG22 ' CE3' ' A' ' 8' ' ' TRP . 54.2 mt -88.6 132.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.617 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.0 p-90 -139.32 127.54 22.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.24 126.52 27.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.5 mt -61.0 172.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.45 152.65 30.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -58.9 -39.57 81.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -78.37 -38.09 42.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.488 HG23 ' CD2' ' A' ' 124' ' ' PHE . 24.3 mm -68.44 -36.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -49.07 -65.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 142' ' ' GLY . 47.5 mt-30 -48.51 -67.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.13 -52.65 1.25 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.549 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.0 -42.03 65.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.141 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 141' ' ' GLN . 9.8 mtpt -69.8 -17.86 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -90.17 -44.42 9.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.71 -19.69 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.404 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 32.6 mt -83.07 34.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.9 ptp -93.67 -36.5 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.476 ' HB3' HG21 ' A' ' 121' ' ' VAL . 14.5 ttmt -122.12 49.49 1.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.464 ' O ' ' C ' ' A' ' 151' ' ' ASN . 4.9 mm-40 -33.89 136.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 153' ' ' ALA . 12.3 m120 33.04 46.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 151' ' ' ASN . 59.9 pttt -34.16 -33.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 151' ' ' ASN . . . -56.64 -60.3 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.079 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 180.0 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m -137.82 110.61 7.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 110.909 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 t -53.08 113.45 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.74 44.7 0.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.497 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.5 t -81.25 105.97 12.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 0.0 110.881 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -71.95 143.21 49.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.33 91.35 0.64 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.457 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.706 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.5 m95 -77.42 161.76 27.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.762 0.315 . . . . 0.0 110.889 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.1 t -138.22 133.44 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.713 HD23 ' OE1' ' A' ' 28' ' ' GLU . 62.6 tp -121.16 114.24 21.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -67.92 154.67 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 37.2 t -137.08 155.95 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.461 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 35.3 m-70 -88.53 113.51 24.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.559 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 63.1 mt-30 -60.61 161.1 15.53 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.655 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.8 -30.13 5.32 Favored 'Cis proline' 0 C--O 1.231 0.153 0 C-N-CA 122.636 -1.819 . . . . 0.0 112.35 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.517 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.0 m-90 -27.63 -52.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.559 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.64 -62.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 m -64.98 -45.93 83.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 16' ' ' TRP . 79.1 mt -45.57 -30.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 16' ' ' TRP . 7.0 mp -68.55 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.5 HG11 ' N ' ' A' ' 82' ' ' GLY . 15.9 m -61.11 -13.9 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.415 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -81.26 -39.46 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.04 -19.93 5.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.655 ' H ' HD12 ' A' ' 24' ' ' ILE . 5.4 mp -64.85 -60.32 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 111.174 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HG2' HD11 ' A' ' 20' ' ' LEU . 7.5 tptp -83.34 120.97 26.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.823 ' HD2' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -113.22 11.72 18.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.568 HG11 ' CE1' ' A' ' 95' ' ' PHE . 33.6 m -142.52 156.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.713 ' OE1' HD23 ' A' ' 10' ' ' LEU . 3.2 tt0 -120.9 138.11 54.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.457 ' O ' ' NH1' ' A' ' 30' ' ' ARG . . . -102.64 123.62 7.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.548 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 75.9 mmt-85 -149.16 151.15 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.845 0.355 . . . . 0.0 110.849 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.478 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.3 m -87.6 18.67 3.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.566 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 6.4 p-90 -142.36 161.39 38.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.6 t80 -102.56 147.97 26.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 34' ' ' THR . 5.2 t -140.62 106.97 6.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 0.0 111.172 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.9 Cg_endo -69.78 2.95 3.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.452 ' O ' HD22 ' A' ' 86' ' ' LEU . 13.6 t60 -64.53 114.87 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -119.65 120.41 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.06 -122.58 1.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -105.09 139.49 39.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.877 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 10' ' ' LEU . 23.0 tp -143.67 114.02 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.643 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 87.6 m95 -72.1 128.69 36.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -98.71 132.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.118 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.35 155.87 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.755 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -90.81 119.13 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -56.27 173.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.83 63.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 5.9 ttpt -65.37 146.4 54.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.453 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.19 135.49 19.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.577 0.703 . . . . 0.0 110.863 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.76 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.662 2.241 . . . . 0.0 112.354 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 54' ' ' VAL . 3.4 m -71.55 159.63 84.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.696 0.76 . . . . 0.0 110.828 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -9.95 27.33 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 0.0 112.349 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -94.4 -37.97 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.72 -39.49 70.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 50' ' ' SER . 41.6 t -67.76 -46.32 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.15 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -67.4 -42.11 83.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.94 -48.96 61.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.466 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 83.5 mt -62.46 -40.85 97.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 9.3 mt-30 -54.81 -44.6 73.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.81 -34.82 30.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -62.04 -51.75 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.443 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 14.9 m-85 -67.5 -40.37 85.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.938 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HG2' HG22 ' A' ' 69' ' ' VAL . 51.8 mtt180 -47.03 -35.93 7.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.08 -17.97 31.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' TYR . 60.2 mt -86.01 -26.8 25.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -123.69 -27.72 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.065 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 128.28 129.87 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -46.84 -18.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -72.73 3.61 4.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.065 HG13 ' O ' ' A' ' 66' ' ' GLY . 34.3 m -62.02 179.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 12.1 pt-20 -122.93 173.77 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 72.9 m-85 -161.82 138.43 6.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.595 0.712 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 156.12 64.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.636 2.224 . . . . 0.0 112.337 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -72.91 -31.28 64.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -146.74 176.84 9.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.655 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 59.7 m-85 -134.7 94.93 16.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 0.0 110.936 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.434 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.0 Cg_endo -69.74 173.99 10.14 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.2 p -142.59 135.49 28.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.86 50.09 14.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.5 m -161.24 148.47 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 0.0 110.882 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.538 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.39 118.19 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.755 HD11 ' HB2' ' A' ' 44' ' ' ALA . 40.3 mt -85.62 -70.94 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.5 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.36 -145.08 4.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.482 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 4.2 p -154.32 155.27 34.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 20.0 m -141.41 137.32 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.83 112.63 16.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.1 tt -77.81 101.83 6.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.522 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.94 -47.33 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -163.44 169.0 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.4 t -127.4 100.83 6.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.7 mt -94.94 170.84 9.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 93' ' ' LYS . 32.8 t -110.9 169.04 9.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.445 ' CD ' ' O ' ' A' ' 107' ' ' ASP . 18.6 mm-40 -45.83 -20.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' N ' ' C ' ' A' ' 91' ' ' SER . 32.7 ttpt -89.35 -60.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -68.9 -50.55 48.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 27' ' ' VAL . 39.4 t80 -39.11 -55.66 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 7.0 ptmm? -68.59 -47.92 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.5 mt-10 -46.79 -58.57 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -76.56 -51.47 11.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 37.9 m-85 -110.03 67.81 0.47 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 110.916 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.74 -14.7 36.51 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.349 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.4 -23.31 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.823 HD13 ' HD2' ' A' ' 26' ' ' ARG . 2.2 pt -121.38 15.27 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.402 ' HB3' ' HA ' ' A' ' 100' ' ' PRO . 53.3 p -55.96 -18.52 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.89 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.575 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -98.27 -31.6 11.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 10.8 mt-10 -46.14 -27.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -134.4 145.72 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -111.02 -35.3 5.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -42.34 161.72 0.16 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.702 0.763 . . . . 0.0 110.833 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.478 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.78 -48.92 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -106.56 103.63 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.486 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 26.2 t -88.95 136.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 34' ' ' THR . 5.0 m-30 -102.33 108.47 19.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.57 120.46 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.444 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.2 m -124.87 154.09 41.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.21 175.99 9.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.449 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.22 54.17 9.64 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.855 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 116.99 4.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.656 2.237 . . . . 0.0 112.331 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -127.8 137.79 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.49 ' O ' ' NE2' ' A' ' 150' ' ' GLN . 7.1 tm-20 -103.73 118.55 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.538 ' HE1' HD13 ' A' ' 80' ' ' LEU . 12.9 mtp -62.75 139.03 58.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.4 t -65.86 -30.83 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -120.47 143.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -111.68 151.89 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.47 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.8 OUTLIER -118.36 141.04 28.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 0.0 110.862 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 82.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.575 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.7 pp -121.11 166.69 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.592 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 34.3 mtpt -108.95 159.99 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.23 177.6 16.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.417 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -154.56 163.16 25.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 0.0 110.885 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 129' ' ' ASN . 53.5 Cg_endo -69.74 19.66 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.357 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.566 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.8 mmmm -152.82 -175.03 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.706 HG22 ' CE3' ' A' ' 8' ' ' TRP . 60.0 mt -84.33 131.75 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.592 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.1 p-90 -131.88 139.76 48.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -70.81 127.09 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.09 164.18 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.8 t0 -75.65 129.5 37.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -37.25 -47.76 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -66.77 -37.01 83.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 136' ' ' ASP . 11.9 mm -67.3 -48.1 79.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 139' ' ' ILE . 15.0 t-160 -37.09 -64.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.831 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 142' ' ' GLY . 36.1 mt-30 -51.37 -69.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.84 -49.48 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.643 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.48 -45.02 81.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.8 mtpp -64.61 -23.34 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.52 -38.0 16.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -61.35 -6.64 8.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.421 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 85.5 mt -83.84 27.34 0.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 ptp -109.08 143.02 38.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.886 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm 39.21 54.02 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 119' ' ' GLU . 1.3 mt-30 -75.94 -71.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -133.19 147.57 52.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.17 -39.99 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.9 -58.78 6.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 1' ' ' GLY . 74.4 m -37.79 111.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.84 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 t -59.28 166.82 2.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.92 62.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.452 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 t -102.33 78.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 0.0 110.862 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 m -156.37 150.57 25.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.35 91.37 1.53 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.48 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.528 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.7 m95 -78.11 164.35 25.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t -137.12 144.84 43.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.439 HD23 ' HG3' ' A' ' 28' ' ' GLU . 11.7 tp -130.94 114.66 15.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.3 p -70.42 133.35 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.518 HG21 HD22 ' A' ' 20' ' ' LEU . 53.4 t -118.89 153.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 34.4 m-70 -88.49 113.0 23.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 78.5 mt-30 -59.76 160.01 16.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.614 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.76 -32.09 4.14 Favored 'Cis proline' 0 C--N 1.342 0.212 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.322 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.581 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 10.7 m-90 -25.12 -50.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.911 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -37.76 -64.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.074 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.9 m -62.45 -42.43 99.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 24' ' ' ILE . 45.0 mt -50.34 -37.64 37.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -58.96 -66.81 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.54 HG11 ' N ' ' A' ' 82' ' ' GLY . 16.8 m -60.41 -27.12 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 11.0 mmt180 -66.86 -39.5 87.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.11 15.19 5.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.402 HD13 HD23 ' A' ' 19' ' ' LEU . 5.3 mp -100.24 -41.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.494 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.8 tptp -99.64 100.87 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.696 ' HD2' HD13 ' A' ' 102' ' ' ILE . 6.4 ptp180 -93.41 16.11 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 102' ' ' ILE . 27.8 m -149.04 145.85 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 2.8 tm-20 -114.23 142.11 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -103.13 128.42 9.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.1 mmt180 -151.59 146.63 25.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -85.08 17.96 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.572 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.8 p-90 -141.44 165.36 27.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.29 141.39 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 34' ' ' THR . 5.0 t -135.99 104.73 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 0.0 111.169 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.8 Cg_endo -69.77 4.3 2.28 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.445 ' O ' HD22 ' A' ' 86' ' ' LEU . 17.3 t60 -64.85 111.82 2.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -115.55 119.99 37.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.84 -129.6 2.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.1 ttm-85 -96.5 139.41 32.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 110.88 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.4 tp -144.08 111.44 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.862 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.1 m95 -71.25 127.91 34.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.472 ' O ' HD23 ' A' ' 80' ' ' LEU . 50.5 mm -98.65 129.5 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -125.71 150.0 48.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -84.38 118.66 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.0 p -55.07 178.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.61 -14.07 60.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 8.1 ttpt -70.55 147.23 49.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.438 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -103.79 134.08 19.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.612 0.72 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 127.11 14.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.699 2.266 . . . . 0.0 112.358 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 54' ' ' VAL . 74.4 m -72.61 155.05 91.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 0.0 110.884 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -7.21 20.45 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -94.55 -40.16 10.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.76 -38.13 73.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.717 HG12 ' NE2' ' A' ' 58' ' ' GLN . 58.1 t -66.28 -50.2 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.129 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -64.27 -44.48 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.38 -49.73 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.581 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.1 mt -62.72 -43.05 99.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.717 ' NE2' HG12 ' A' ' 54' ' ' VAL . 8.8 mt-30 -53.6 -43.4 68.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.4 29.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 m -62.38 -52.76 62.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.152 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.43 ' HE2' HD22 ' A' ' 57' ' ' LEU . 26.1 m-85 -66.29 -38.49 87.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 69' ' ' VAL . 66.5 mtt180 -49.81 -36.63 27.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.75 -12.76 44.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.505 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 69.0 mt -91.14 -28.04 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.505 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.7 mmp_? -123.64 -22.12 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.054 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 123.67 130.04 3.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 1.4 pptp? -47.89 -18.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.73 0.3 . . . . 0.0 110.88 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 1.4 6.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.054 HG13 ' O ' ' A' ' 66' ' ' GLY . 34.9 m -59.29 179.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.104 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -120.07 166.96 12.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.577 ' CD1' ' HG2' ' A' ' 58' ' ' GLN . 55.6 m-85 -158.31 134.77 6.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.597 0.713 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.71 163.06 39.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.272 . . . . 0.0 112.357 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -83.01 -29.16 29.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -145.66 173.5 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.614 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 42.3 m-85 -134.79 98.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.652 0.739 . . . . 0.0 110.901 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.7 Cg_endo -69.76 176.4 6.82 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -143.96 133.54 23.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.57 47.86 19.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 17.1 m -157.81 149.17 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -77.98 115.45 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.957 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' ALA . 69.8 mt -82.12 -72.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.54 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.1 -147.2 4.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.481 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 10.5 p -152.84 153.33 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 21.1 m -139.28 143.19 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.13 112.85 20.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.6 tt -76.98 100.16 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.528 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -69.72 -46.83 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -165.44 167.54 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.45 99.25 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 94' ' ' GLN . 99.1 mt -95.07 165.73 12.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 93' ' ' LYS . 17.7 t -103.92 169.03 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 109' ' ' PRO . 4.1 mm-40 -41.12 -24.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' SER . 32.2 ttpt -87.32 -70.15 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.76 ' HB3' HD22 ' A' ' 90' ' ' LEU . 21.6 mm100 -57.12 -47.04 82.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.625 ' CD2' HG21 ' A' ' 111' ' ' VAL . 19.4 t80 -43.64 -57.21 3.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.47 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -69.36 -44.87 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.47 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.0 mt-10 -47.08 -59.56 3.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.869 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.674 HE21 ' NE2' ' A' ' 94' ' ' GLN . 6.3 mt-30 -79.1 -48.23 14.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.3 m-85 -110.06 67.64 0.47 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.642 0.735 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.71 -12.34 32.78 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.752 2.301 . . . . 0.0 112.313 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.24 -21.16 54.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.788 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.6 pt -125.43 23.95 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 44.4 p -65.35 -24.49 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.566 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -95.33 -25.59 16.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.788 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.1 mt-10 -48.17 -36.89 14.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -129.99 134.81 47.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -108.28 27.16 9.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 88.7 p -96.06 155.59 38.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.705 0.764 . . . . 0.0 110.841 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.454 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.76 -24.36 29.74 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.413 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 17.1 m-85 -134.63 90.21 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.625 HG21 ' CD2' ' A' ' 95' ' ' PHE . 40.8 t -79.38 136.82 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.123 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 3.7 m-30 -103.98 104.13 14.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.88 122.72 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.129 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 13.7 m -126.89 155.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -143.34 176.25 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.456 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.17 53.93 6.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.859 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.76 115.16 3.96 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.632 2.221 . . . . 0.0 112.357 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.54 134.64 49.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 150' ' ' GLN . 14.5 tm-20 -100.61 120.82 40.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.547 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 13.6 mtp -62.5 152.92 33.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 149' ' ' LYS . 72.0 t -78.67 -27.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -123.5 149.44 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 7.7 mmtm -114.21 144.77 42.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.638 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -114.84 140.79 25.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.888 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.51 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.359 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.619 HD13 ' HH2' ' A' ' 133' ' ' TRP . 2.8 pp -124.37 168.58 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.596 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 47.5 mmtm -111.99 141.99 44.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -100.67 175.44 26.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.432 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -155.54 162.01 28.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.671 0.748 . . . . 0.0 110.875 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 1.78 4.11 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.648 2.232 . . . . 0.0 112.367 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.572 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.9 mmmm -137.17 -175.01 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.528 HG22 ' CE3' ' A' ' 8' ' ' TRP . 79.4 mt -85.88 133.52 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.619 ' HH2' HD13 ' A' ' 126' ' ' ILE . 7.6 p-90 -137.13 127.31 26.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.428 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 11.0 ttmt -55.72 133.69 50.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.17 174.17 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.49 158.71 23.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.85 -48.65 78.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -70.5 -37.16 74.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.638 HG23 ' CD2' ' A' ' 124' ' ' PHE . 44.9 mm -68.84 -41.29 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -45.58 -62.86 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 142' ' ' GLY . 46.4 mt-30 -53.59 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.57 -51.32 0.76 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.517 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.862 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.07 -47.6 68.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.5 mtpp -60.75 -24.24 65.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -50.81 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -46.87 -19.83 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.423 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.474 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 48.5 mt -82.74 37.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 10.4 ptp -100.59 -39.94 7.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 121' ' ' VAL . 26.0 tttp -134.91 67.39 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 2.7 mm-40 -53.99 -75.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.527 ' OD1' HG12 ' A' ' 154' ' ' VAL . 3.1 p30 -162.96 156.13 19.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.94 -39.17 2.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -47.54 -56.77 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.064 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.527 HG12 ' OD1' ' A' ' 151' ' ' ASN . 14.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.139 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.0 p -94.0 174.95 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p -54.92 132.05 45.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.1 158.43 30.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.9 p -105.99 79.11 1.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.853 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 m -137.99 146.0 42.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.861 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.58 89.05 0.93 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.532 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.707 ' CE3' HG22 ' A' ' 132' ' ' ILE . 88.6 m95 -76.3 168.13 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.699 0.285 . . . . 0.0 110.903 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' CB ' ' HG ' ' A' ' 135' ' ' LEU . 11.8 t -141.69 145.0 34.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.4 tp -134.47 112.03 10.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.403 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 13.1 p -67.99 137.77 55.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 45' ' ' THR . 25.3 t -121.73 157.52 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.493 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.3 m-70 -89.29 116.22 27.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.698 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 52.5 mt-30 -62.79 161.86 25.7 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 110.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.83 -28.98 5.98 Favored 'Cis proline' 0 C--N 1.341 0.15 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.328 0.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.671 ' O ' HD12 ' A' ' 20' ' ' LEU . 12.5 m-90 -29.02 -53.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.698 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.38 -64.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -63.0 -45.04 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 16' ' ' TRP . 70.5 mt -46.36 -35.54 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -62.25 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.486 HG11 ' N ' ' A' ' 82' ' ' GLY . 5.3 m -65.93 -12.18 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.103 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.5 mmt180 -84.14 -39.6 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.53 20.38 3.92 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.474 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.435 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.1 mp -108.38 -36.16 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.0 tptt -107.65 99.15 8.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.481 ' HE ' HD13 ' A' ' 102' ' ' ILE . 22.4 ptt180 -96.53 29.1 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 102' ' ' ILE . 34.2 m -156.55 145.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -121.31 118.98 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.456 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -84.99 123.19 6.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 14.7 mmt180 -142.72 152.3 42.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 110.859 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.482 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 17.8 p -86.93 18.18 3.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.559 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.0 p-90 -142.62 163.95 31.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -105.58 138.79 41.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 34' ' ' THR . 6.7 t -132.26 100.56 15.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.611 0.72 . . . . 0.0 111.099 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.495 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.1 Cg_endo -69.78 7.31 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.671 2.247 . . . . 0.0 112.35 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.407 ' O ' HD22 ' A' ' 86' ' ' LEU . 28.7 t60 -63.83 107.76 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.497 ' NH1' HD22 ' A' ' 86' ' ' LEU . 44.2 mmt-85 -105.48 108.17 19.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.14 -145.19 10.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.462 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.405 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 0.2 OUTLIER -86.72 142.73 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.861 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.4 tp -144.13 115.34 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.672 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 90.4 m95 -73.37 137.75 44.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.527 ' O ' HD23 ' A' ' 80' ' ' LEU . 48.0 mm -107.13 132.64 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -130.61 145.54 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -75.95 125.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.7 p -61.13 -178.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.08 7.13 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -99.92 129.94 46.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.06 135.71 28.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.498 0.666 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.76 133.99 26.9 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.8 m -76.46 161.44 74.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.672 0.749 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.18 27.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -43.23 8.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.35 -40.91 90.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.886 HG12 ' NE2' ' A' ' 58' ' ' GLN . 60.8 t -65.05 -56.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -57.4 -42.79 82.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -66.61 -57.73 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.465 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 87.4 mt -54.22 -42.1 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.886 ' NE2' HG12 ' A' ' 54' ' ' VAL . 11.4 mt-30 -55.11 -42.54 73.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.5 -31.6 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.4 m -66.09 -52.02 52.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.84 -36.14 79.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.502 ' HG2' HG22 ' A' ' 69' ' ' VAL . 56.5 mtt180 -50.68 -34.23 25.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.5 mt -90.6 -12.57 36.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.3 mt -91.59 -28.14 17.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.984 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 4.3 mmm180 -121.97 -29.18 4.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.032 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.78 127.43 2.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -46.53 -19.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.47 16.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.032 HG13 ' O ' ' A' ' 66' ' ' GLY . 21.4 m -65.29 179.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' O ' HD11 ' A' ' 24' ' ' ILE . 20.3 mp0 -115.98 160.06 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.588 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 51.2 m-85 -153.16 139.8 12.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.74 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.487 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.8 Cg_endo -69.79 170.61 16.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.6 -22.34 19.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.49 172.08 16.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.9 m-85 -134.97 87.96 28.29 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 0.0 110.933 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.1 Cg_endo -69.71 172.04 13.31 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -137.15 144.18 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.88 44.81 95.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.464 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.28 158.24 41.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.527 HD23 ' O ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -85.04 117.23 23.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 44' ' ' ALA . 16.3 mt -85.87 -69.46 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.486 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -148.51 -142.49 3.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.619 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 35.7 t -154.41 162.33 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.439 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 22.4 m -149.85 140.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' CB ' HD22 ' A' ' 116' ' ' ASN . 1.8 t70 -81.75 114.86 20.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.497 HD22 ' NH1' ' A' ' 37' ' ' ARG . 4.4 tt -78.17 97.78 5.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.569 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.89 -47.79 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 113' ' ' ILE . 5.0 m-20 -164.54 166.35 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -127.43 101.4 6.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.496 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.2 mt -99.48 167.04 10.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 95' ' ' PHE . 33.0 t -106.89 169.04 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.842 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -46.41 -20.48 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 12.6 tttm -85.08 -58.04 2.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.439 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.2 mm100 -77.22 -51.31 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.553 ' CD2' HG21 ' A' ' 111' ' ' VAL . 42.1 t80 -38.89 -50.14 1.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -71.08 -42.76 68.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -55.12 -61.39 2.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.492 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.8 mt-30 -71.38 -50.53 31.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 113' ' ' ILE . 25.0 m-85 -109.42 68.26 0.41 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.657 0.741 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.75 -14.66 36.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.279 . . . . 0.0 112.304 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.12 -23.77 57.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.832 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.2 pt -120.32 19.38 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 p -60.62 -27.32 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.6 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.2 pp0? -93.47 -25.09 17.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.832 ' CD ' HG22 ' A' ' 102' ' ' ILE . 16.8 mt-10 -49.92 -32.28 14.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.6 t -130.95 150.94 51.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.02 -23.89 8.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.796 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.411 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 1.8 m -51.19 160.19 0.94 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.647 0.737 . . . . 0.0 110.836 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.482 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.3 Cg_endo -69.73 -45.64 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.36 100.87 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.553 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.4 t -84.74 142.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.447 ' CZ ' HG22 ' A' ' 34' ' ' THR . 6.5 m-30 -109.13 106.92 17.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -74.56 122.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.5 m -125.43 155.21 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -143.18 176.62 8.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.492 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.58 51.2 6.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 0.0 110.941 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.7 Cg_endo -69.7 121.72 8.42 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.647 2.232 . . . . 0.0 112.367 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -136.4 136.1 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.452 ' OE1' ' C ' ' A' ' 81' ' ' LEU . 4.3 tp10 -98.25 124.57 42.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.454 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.6 mtp -63.12 151.7 39.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 146' ' ' GLY . 95.0 t -70.9 -31.04 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.19 145.01 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -107.18 148.86 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.436 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.2 m-85 -113.18 142.28 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 82.54 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.233 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.633 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.7 pp -118.82 159.74 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.132 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 37.7 mttp -95.16 139.94 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.19 -179.6 46.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.489 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.9 t30 -165.53 145.24 5.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 53.8 Cg_endo -69.75 4.04 2.42 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.689 2.26 . . . . 0.0 112.356 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.559 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 12.1 mmmm -136.36 -174.42 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.707 HG22 ' CE3' ' A' ' 8' ' ' TRP . 73.2 mt -88.53 130.01 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 4.7 p-90 -138.93 125.59 20.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -55.36 125.56 21.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.423 ' HG ' ' CB ' ' A' ' 9' ' ' CYS . 22.7 mt -59.76 169.64 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 139' ' ' ILE . 7.6 t0 -77.46 126.87 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.4 m -35.7 -41.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -72.85 -41.26 64.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.5 mm -64.85 -42.64 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -42.62 -64.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 142' ' ' GLY . 80.1 mt-30 -53.13 -66.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.0 -42.02 0.7 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.672 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -65.18 -46.67 79.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -56.35 -26.37 52.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -80.05 -53.01 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -37.25 -27.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.495 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 145' ' ' LYS . 14.7 mt -84.51 38.55 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.6 ptp -99.5 -37.4 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.834 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -134.61 76.74 1.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.415 ' HB3' HG11 ' A' ' 154' ' ' VAL . 16.5 mm-40 -64.38 168.4 5.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.975 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -52.77 162.57 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -71.91 -40.36 68.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -59.53 -57.78 11.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 150' ' ' GLN . 12.1 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t 60.35 44.09 12.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.388 . . . . 0.0 110.894 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 t 65.27 39.99 5.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.82 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.02 140.8 6.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.4 t -125.7 107.73 10.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.825 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.5 m -142.97 157.17 44.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.861 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.41 88.91 1.51 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.509 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.53 ' CH2' ' HE3' ' A' ' 134' ' ' LYS . 91.8 m95 -78.25 164.02 25.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.92 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 t -138.23 138.64 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.8 tp -125.56 111.94 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 22.2 p -68.3 140.0 55.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 37.7 t -126.3 152.14 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.405 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 40.8 m-70 -85.87 116.3 24.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.659 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 54.7 mt-30 -62.54 162.1 22.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 -28.46 6.24 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.4 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.535 ' O ' HD12 ' A' ' 20' ' ' LEU . 12.9 m-90 -29.11 -51.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.659 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -34.23 -62.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.106 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -65.69 -47.03 76.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 16' ' ' TRP . 83.1 mt -44.04 -28.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.7 mp -70.59 -65.51 0.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.56 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.9 m -61.3 -12.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.6 mmt180 -82.47 -39.8 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.57 -17.2 5.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.697 ' H ' HD12 ' A' ' 24' ' ' ILE . 4.6 mp -68.16 -59.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.108 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.5 tptp -82.71 117.69 22.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.654 ' HD2' HD13 ' A' ' 102' ' ' ILE . 3.6 ptp180 -114.06 12.85 18.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.675 HG11 HD12 ' A' ' 102' ' ' ILE . 25.3 m -147.37 149.88 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.474 ' OE1' HD21 ' A' ' 20' ' ' LEU . 28.2 tp10 -115.78 146.2 42.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -111.26 112.72 3.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 22.8 mmt180 -137.99 148.77 45.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.479 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 61.6 p -84.39 21.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 4.6 p-90 -141.84 161.84 36.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . 9.8 t80 -105.12 141.47 36.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 34' ' ' THR . 6.0 t -135.19 105.01 10.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.609 0.719 . . . . 0.0 111.186 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.2 Cg_endo -69.81 3.21 2.92 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.451 ' O ' HD22 ' A' ' 86' ' ' LEU . 14.7 t60 -64.87 113.55 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -117.7 119.81 36.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.22 -124.93 1.63 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -100.98 140.75 34.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.852 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.5 tp -144.13 111.32 5.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.615 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 93.1 m95 -71.21 126.55 29.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 mm -96.84 125.49 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -121.8 148.87 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.611 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.89 117.46 22.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 p -54.08 -178.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.28 19.15 5.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.46 126.82 46.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -82.61 124.64 77.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.58 0.705 . . . . 0.0 110.871 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 126.61 13.48 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.351 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.0 m -70.04 156.08 92.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.616 0.722 . . . . 0.0 110.881 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -7.13 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.736 2.291 . . . . 0.0 112.341 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -35.18 12.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.96 -40.55 60.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.502 HG12 ' NE2' ' A' ' 58' ' ' GLN . 46.8 t -66.96 -47.22 82.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.7 t -65.47 -44.71 86.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.52 -52.57 30.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.5 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 77.1 mt -55.37 -40.2 71.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 12.5 mt-30 -54.95 -49.27 71.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.64 -33.07 62.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -64.28 -48.01 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.412 ' HE2' HD22 ' A' ' 57' ' ' LEU . 30.3 m-85 -72.76 -30.03 63.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.545 ' HG2' HG22 ' A' ' 69' ' ' VAL . 42.0 mtt180 -56.48 -36.26 68.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.0 mt -89.59 -13.25 37.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.4 mt -90.36 -29.78 17.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.442 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 5.5 mmm180 -120.78 -29.44 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.045 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.46 125.1 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -42.83 -23.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.873 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -76.82 13.94 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.045 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.7 m -62.89 -179.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 31.7 mt-10 -117.99 165.12 14.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 54.1 m-85 -160.16 135.73 5.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.81 164.1 35.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.699 2.266 . . . . 0.0 112.286 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -80.18 -30.73 38.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -146.76 175.43 10.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 60.9 m-85 -133.87 94.06 19.41 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.69 0.757 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.506 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.9 Cg_endo -69.76 175.82 7.59 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.681 2.254 . . . . 0.0 112.36 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.1 p -142.1 139.19 32.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.27 49.58 44.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 66.0 m -158.22 148.2 19.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.873 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -77.32 114.24 15.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' ' 44' ' ' ALA . 81.3 mt -82.0 -74.98 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.56 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -142.62 -147.95 4.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.0 p -151.56 153.7 35.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.909 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.6 m -139.96 141.07 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.411 ' CB ' HD22 ' A' ' 116' ' ' ASN . 1.7 t70 -83.34 114.18 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.8 tt -78.48 96.96 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.58 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -66.56 -48.95 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.168 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 87' ' ' ILE . 0.7 OUTLIER -162.5 167.84 22.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.1 t -127.49 99.63 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 94' ' ' GLN . 91.5 mt -93.95 171.09 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 93' ' ' LYS . 38.2 t -109.81 169.22 8.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 108' ' ' SER . 18.8 mm-40 -44.54 -21.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.42 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.2 tttt -89.12 -63.1 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.589 ' HB3' HD22 ' A' ' 90' ' ' LEU . 11.0 mt-30 -65.58 -49.55 68.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.574 ' CD2' HG21 ' A' ' 111' ' ' VAL . 37.3 t80 -42.16 -56.12 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 8.7 ptmt -68.46 -42.9 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.421 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 6.6 mt-10 -51.7 -60.36 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.2 mt-30 -75.86 -49.74 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 34.7 m-85 -110.42 66.87 0.48 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.619 0.723 . . . . 0.0 110.844 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.78 -14.18 35.65 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 0.0 112.359 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.79 -22.39 58.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.675 HD12 HG11 ' A' ' 27' ' ' VAL . 1.9 pt -121.83 15.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.7 p -55.68 -21.82 20.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -95.05 -30.47 14.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 12.1 mt-10 -47.58 -26.41 1.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -136.26 141.92 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 5.4 t70 -106.96 -37.17 6.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.48 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.8 m -40.89 161.33 0.12 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 0.0 110.874 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.479 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.81 -43.59 2.53 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.297 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 33' ' ' TYR . 16.9 m-85 -110.06 101.95 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 95' ' ' PHE . 25.7 t -87.07 134.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.8 m-30 -101.34 109.97 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.94 120.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.455 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.1 m -123.59 152.49 41.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -141.25 176.38 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.475 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER 57.47 52.82 5.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.75 112.39 3.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.316 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -126.61 132.19 51.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -98.0 120.35 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.513 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.6 mtp -62.52 154.36 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 148' ' ' MET . 70.7 t -81.55 -25.72 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.07 148.56 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 10.9 mmtm -115.86 142.3 46.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.543 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.8 OUTLIER -114.12 141.65 26.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.661 0.743 . . . . 0.0 110.867 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 90.54 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.56 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.7 pp -125.53 167.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.573 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 43.5 mtpt -110.13 142.61 41.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.99 174.98 24.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -155.87 162.27 27.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.718 . . . . 0.0 110.921 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 2.3 3.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.272 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.403 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 6.8 mmmm -139.94 -175.01 4.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 81.9 mt -83.15 141.92 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 14.5 p-90 -147.18 129.44 15.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.53 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 17.0 ttmt -58.71 128.83 39.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.3 mt -63.22 -177.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 139' ' ' ILE . 2.7 t70 -90.56 128.2 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.3 m -36.23 -41.16 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -72.97 -40.62 65.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.543 HG23 ' CD2' ' A' ' 124' ' ' PHE . 14.4 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -39.78 -62.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' LYS . 16.1 mm100 -55.02 -69.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.56 -42.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.615 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -60.74 -46.18 91.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.5 mtpp -61.97 -24.05 66.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -86.56 -42.84 13.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -51.1 -15.18 1.44 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.512 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.45 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 79.4 mt -82.24 34.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.565 ' O ' HG21 ' A' ' 121' ' ' VAL . 4.5 ptp -117.07 143.24 45.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt 55.33 42.77 29.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 31.2 mm-40 -50.37 175.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -40.4 134.72 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -50.28 -29.44 9.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.13 -67.34 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.5 p -98.36 169.28 9.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.874 0.369 . . . . 0.0 110.888 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -133.36 159.04 41.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.831 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.28 153.54 25.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.528 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.6 m -136.96 122.82 20.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 0.0 110.84 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 m -114.61 148.9 37.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.23 94.39 0.63 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.594 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.3 m95 -83.32 162.37 21.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' HB2' ' CG ' ' A' ' 135' ' ' LEU . 7.2 t -135.16 129.81 34.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.598 HD23 ' CD ' ' A' ' 28' ' ' GLU . 57.5 tp -116.5 113.81 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.426 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 24.0 p -68.15 153.08 44.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.632 HG12 ' N ' ' A' ' 13' ' ' HIS . 90.3 t -136.44 164.6 30.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.632 ' N ' HG12 ' A' ' 12' ' ' VAL . 64.4 m-70 -102.1 110.2 22.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.526 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.9 mm-40 -56.37 157.89 8.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 16' ' ' TRP . 54.2 Cg_endo -69.69 -32.94 3.6 Favored 'Cis proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.382 -0.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.544 ' C ' ' O ' ' A' ' 15' ' ' PRO . 8.3 m-90 -25.16 -58.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -32.08 -53.7 0.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.094 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.0 m -69.71 -55.06 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.9 mt -40.17 -31.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.488 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.6 mp -64.26 -68.04 0.38 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.476 HG11 ' N ' ' A' ' 82' ' ' GLY . 16.5 m -61.6 -10.45 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.453 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.9 mmt180 -84.3 -40.12 18.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.26 -5.2 8.23 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.88 -43.28 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HG2' HD11 ' A' ' 20' ' ' LEU . 8.4 tptp -100.24 105.54 17.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.573 HH21 ' NE ' ' A' ' 65' ' ' ARG . 6.3 ptp180 -102.48 23.63 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 34.1 m -152.51 146.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.598 ' CD ' HD23 ' A' ' 10' ' ' LEU . 3.1 tt0 -117.57 122.1 42.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.03 124.69 7.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -146.45 150.19 35.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.412 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.7 p -86.98 21.26 2.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.562 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.4 p-90 -143.78 160.91 39.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.48 137.78 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 34' ' ' THR . 11.9 t -134.41 98.38 13.88 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.542 0.687 . . . . 0.0 111.16 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.438 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.0 Cg_endo -69.72 9.5 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.427 ' O ' HD22 ' A' ' 86' ' ' LEU . 14.4 t60 -67.93 110.15 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 72.2 mmt-85 -106.94 113.13 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.11 -151.9 22.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -78.58 142.67 37.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.8 tp -143.74 112.45 6.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.584 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 95.0 m95 -72.04 123.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.449 ' O ' HD23 ' A' ' 80' ' ' LEU . 51.8 mm -94.77 130.07 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -128.97 154.72 46.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.64 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -88.07 132.22 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 12' ' ' VAL . 20.1 p -72.73 171.95 11.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.02 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' NZ ' ' O ' ' A' ' 14' ' ' GLN . 5.3 ttpt -64.3 130.16 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -91.36 129.27 43.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.557 0.694 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.91 18.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.669 2.246 . . . . 0.0 112.39 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -75.37 155.41 85.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.695 0.76 . . . . 0.0 110.84 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -3.91 12.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.693 2.262 . . . . 0.0 112.356 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -94.63 -44.37 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.508 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 14.2 mp0 -65.79 -41.86 91.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG12 ' NE2' ' A' ' 58' ' ' GLN . 43.6 t -63.76 -50.14 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.147 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -63.47 -45.36 91.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.22 -54.59 31.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.467 HD22 ' HE2' ' A' ' 61' ' ' TYR . 79.8 mt -54.32 -58.36 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.4 mt-30 -34.85 -48.48 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.5 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -54.62 -52.68 61.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.467 ' HE2' HD22 ' A' ' 57' ' ' LEU . 24.0 m-85 -67.69 -35.86 79.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.456 ' HG2' HG22 ' A' ' 69' ' ' VAL . 31.1 mtt-85 -51.4 -33.84 32.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.6 mt -89.88 -14.28 34.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.434 HD13 ' NE2' ' A' ' 104' ' ' GLN . 60.4 mt -88.61 -31.02 18.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.573 ' NE ' HH21 ' A' ' 26' ' ' ARG . 4.6 mmm180 -119.39 -29.3 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.064 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.63 125.29 2.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.503 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -44.52 -20.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' GLY . 9.1 m-20 -82.67 21.49 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.064 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.4 m -70.69 -178.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.8 pt-20 -116.56 168.65 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 63.8 m-85 -159.93 141.38 9.35 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.67 0.748 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.75 168.04 22.69 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -92.89 -23.71 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -146.64 167.47 23.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 72' ' ' PRO . 83.3 m-85 -133.09 88.34 36.75 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.655 0.741 . . . . 0.0 110.907 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.46 ' HG2' HD21 ' A' ' 81' ' ' LEU . 54.2 Cg_endo -69.72 169.18 19.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.0 p -136.92 136.65 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.29 46.22 50.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.6 m -155.28 152.3 29.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.493 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -77.56 116.08 17.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 44' ' ' ALA . 25.1 mt -83.74 -70.11 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.476 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.04 -141.82 3.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.57 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 6.5 t -153.47 161.37 42.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.0 m -151.56 145.25 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.405 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.9 t70 -90.27 112.91 24.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.7 tt -75.12 98.12 3.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.22 -47.45 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.6 m-20 -163.64 168.16 20.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.37 103.23 7.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 94.9 mt -100.49 165.74 11.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.954 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 93' ' ' LYS . 33.3 t -106.12 169.05 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 108' ' ' SER . 20.3 mm-40 -45.24 -20.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' N ' ' C ' ' A' ' 91' ' ' SER . 26.3 ttmt -87.94 -63.74 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -66.66 -49.19 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 111' ' ' VAL . 32.2 t80 -42.76 -55.26 3.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 97' ' ' GLU . 7.5 ptmt -68.25 -40.34 81.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 6.8 mt-10 -54.8 -59.66 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.6 mt-30 -75.97 -48.55 20.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -110.88 66.74 0.53 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 0.0 110.88 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.71 -12.24 32.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.363 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.71 -22.99 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.615 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.4 pt -122.1 22.26 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 p -62.48 -22.24 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.602 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -94.37 -31.04 14.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.615 ' CD ' HG22 ' A' ' 102' ' ' ILE . 22.3 mt-10 -45.59 -37.06 5.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -128.52 134.32 48.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 10.4 t0 -97.91 -36.29 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.878 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.497 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -39.87 159.94 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 0.0 110.836 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.8 Cg_endo -69.76 -47.34 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -107.37 101.85 11.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.576 HG21 ' CD2' ' A' ' 95' ' ' PHE . 33.2 t -86.52 140.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.46 ' CE1' HG22 ' A' ' 34' ' ' THR . 8.7 m-30 -107.41 109.5 21.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -78.0 120.83 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.0 m -124.27 155.02 39.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -141.17 177.36 8.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 55.91 52.35 7.22 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.74 116.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.317 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -130.88 133.62 46.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -97.77 122.22 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.52 ' HE1' ' CE2' ' A' ' 124' ' ' PHE . 16.5 mtp -62.87 154.21 30.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.928 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -75.24 -30.03 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.172 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.56 142.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -107.55 140.02 41.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.52 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.7 OUTLIER -105.06 142.89 25.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.618 0.723 . . . . 0.0 110.876 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 83.07 0.72 Allowed 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.406 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.7 pp -121.41 155.8 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.585 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 8.2 ptpt -97.08 141.53 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -104.45 162.4 15.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.459 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -137.86 160.66 63.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.62 0.724 . . . . 0.0 110.909 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 2.53 3.45 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.8 mmmm -136.88 -175.15 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.594 HG22 ' CE3' ' A' ' 8' ' ' TRP . 83.6 mt -85.24 133.58 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.585 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.0 p-90 -140.46 128.3 21.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -56.43 126.03 24.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' CG ' ' HB2' ' A' ' 9' ' ' CYS . 25.4 mt -59.98 173.25 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.7 t70 -82.46 127.46 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.54 -39.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -74.42 -41.69 60.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' ASP . 29.1 mm -64.46 -42.56 95.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -40.47 -63.22 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLY . 45.1 mt-30 -53.45 -69.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.75 -51.66 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.584 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.09 -46.82 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -62.45 -23.36 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 147' ' ' LEU . 11.5 mmmm -80.38 -53.1 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -39.26 -24.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 145' ' ' LYS . 28.3 mt -82.66 36.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.323 . . . . 0.0 110.877 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.2 ptp -97.66 -37.02 10.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -134.68 73.38 1.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -68.22 173.67 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -45.73 169.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -57.67 -43.86 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -55.51 -52.25 64.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.059 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.0 m -75.39 119.43 19.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.2 m -86.26 89.04 7.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.48 -178.61 53.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.513 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.8 p -102.49 156.82 17.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.93 0.395 . . . . 0.0 110.845 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 m -158.77 139.16 12.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.16 98.13 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.547 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.688 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.9 m95 -81.4 164.22 22.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.307 . . . . 0.0 110.925 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -138.69 133.34 32.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.597 ' HB2' HD21 ' A' ' 40' ' ' LEU . 31.1 tp -121.17 109.43 14.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.6 m -67.94 134.17 50.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.822 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.775 HG22 HH22 ' A' ' 30' ' ' ARG . 34.0 t -115.24 157.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.479 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 33.6 m-70 -90.54 113.71 25.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.519 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 71.3 mt-30 -59.06 160.51 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.561 0.696 . . . . 0.0 110.958 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.555 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -30.1 5.32 Favored 'Cis proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.36 -0.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.691 ' O ' HD12 ' A' ' 20' ' ' LEU . 9.7 m-90 -26.98 -54.5 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.29 -65.64 0.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 3.4 m -59.67 -43.49 93.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 16' ' ' TRP . 59.3 mt -50.78 -39.19 51.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.8 mp -58.53 -69.58 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.582 HG11 ' N ' ' A' ' 82' ' ' GLY . 26.6 m -57.46 -23.55 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.47 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.8 mmt180 -71.02 -39.14 72.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.67 24.59 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.466 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.39 -37.91 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.543 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -105.17 103.48 13.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.428 ' CD ' HH12 ' A' ' 65' ' ' ARG . 18.7 ptt180 -102.06 28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.494 HG11 HD12 ' A' ' 102' ' ' ILE . 34.0 m -156.51 142.59 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' CD ' ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -115.16 137.92 51.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -102.98 115.03 5.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.775 HH22 HG22 ' A' ' 12' ' ' VAL . 75.0 mmt-85 -138.52 154.11 48.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.477 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 95.7 p -88.99 20.67 3.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 1.8 p-90 -141.74 165.57 27.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -106.54 139.08 41.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 34' ' ' THR . 9.8 t -133.89 99.16 14.01 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.116 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 54.3 Cg_endo -69.73 7.98 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.428 ' O ' HD22 ' A' ' 86' ' ' LEU . 23.7 t60 -64.46 107.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.479 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.4 mmt-85 -103.85 108.8 20.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.42 -148.79 16.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -85.55 144.54 27.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 10' ' ' LEU . 22.0 tp -143.46 114.56 7.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 87.9 m95 -71.27 127.86 33.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -97.77 126.0 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.13 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.32 142.03 49.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.852 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -77.05 118.09 19.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.074 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.3 p -57.59 178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.5 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -98.76 128.61 45.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.909 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -87.61 122.41 70.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.565 0.698 . . . . 0.0 110.869 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 133.0 24.48 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.668 2.246 . . . . 0.0 112.346 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.9 m -78.19 161.29 71.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.684 0.754 . . . . 0.0 110.821 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -10.79 29.41 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.646 2.231 . . . . 0.0 112.352 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -87.33 -49.11 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -41.16 99.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.69 HG12 ' NE2' ' A' ' 58' ' ' GLN . 42.5 t -65.72 -51.14 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 t -63.64 -43.52 96.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -66.7 -52.73 41.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.489 HD22 ' HE2' ' A' ' 61' ' ' TYR . 83.7 mt -58.47 -42.44 87.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.69 ' NE2' HG12 ' A' ' 54' ' ' VAL . 11.8 mt-30 -52.82 -45.29 67.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.43 -36.25 39.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 m -60.43 -52.21 66.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.489 ' HE2' HD22 ' A' ' 57' ' ' LEU . 31.8 m-85 -68.43 -38.55 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.539 ' HG2' HG22 ' A' ' 69' ' ' VAL . 64.8 mtt180 -49.1 -34.25 13.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.92 -13.93 35.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.1 -27.86 19.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.428 HH12 ' CD ' ' A' ' 26' ' ' ARG . 3.9 mmm180 -122.66 -28.74 4.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.023 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.22 127.96 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.81 -19.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.55 14.71 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.023 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.8 m -64.45 -179.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -114.41 160.38 19.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 48.5 m-85 -155.44 134.87 7.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.664 0.745 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.477 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.84 165.08 32.28 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.637 2.224 . . . . 0.0 112.331 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -85.34 -29.08 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -148.01 174.95 11.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.555 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 43.1 m-85 -134.78 100.65 12.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.68 0.752 . . . . 0.0 110.959 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.6 Cg_endo -69.76 179.68 3.53 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.701 2.267 . . . . 0.0 112.345 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.8 p -142.05 141.32 32.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.828 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.85 58.01 16.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 10.2 m -162.15 150.61 14.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.598 HD22 ' SD ' ' A' ' 120' ' ' MET . 0.5 OUTLIER -77.25 118.77 20.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 44' ' ' ALA . 23.2 mt -88.52 -69.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.582 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.93 -143.52 3.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.5 p -157.5 148.63 21.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 110.883 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 18.9 m -135.96 136.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.12 111.58 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 112' ' ' PHE . 4.8 tt -72.97 104.28 4.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -73.15 -47.13 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -164.32 168.16 18.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 t -127.15 103.21 7.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 94' ' ' GLN . 93.6 mt -100.17 165.92 11.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 93' ' ' LYS . 47.9 t -102.91 169.61 8.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.486 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 12.2 mm-40 -45.13 -20.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 25.9 ttpt -91.0 -67.94 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.93 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.536 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.3 mt-30 -58.45 -46.19 87.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.8 t80 -44.09 -57.86 3.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.9 ptpt -68.66 -43.05 77.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.7 mt-10 -49.14 -59.26 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.6 mt-30 -78.74 -46.62 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 33.2 m-85 -111.24 68.56 0.67 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.685 0.755 . . . . 0.0 110.86 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.8 Cg_endo -69.8 -12.5 32.94 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.644 2.229 . . . . 0.0 112.368 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.34 -22.22 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.739 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.9 pt -124.78 23.2 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.506 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 37.0 p -64.21 -28.27 69.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.597 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -90.07 -30.25 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.739 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.5 mt-10 -43.63 -36.09 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.2 t -125.09 151.24 45.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.14 -29.26 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.482 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.4 m -49.3 162.18 0.43 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.678 0.751 . . . . 0.0 110.887 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.486 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.3 Cg_endo -69.74 -46.13 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.714 2.276 . . . . 0.0 112.337 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -109.98 104.71 13.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 95' ' ' PHE . 19.7 t -91.8 132.29 36.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 2.9 m-30 -100.25 108.82 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.41 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -76.01 124.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.482 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.5 m -125.09 155.65 39.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' CG ' HD12 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -138.94 177.56 7.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.844 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 53.43 52.8 10.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.506 ' O ' HG11 ' A' ' 154' ' ' VAL . 53.4 Cg_endo -69.76 115.14 3.96 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.266 . . . . 0.0 112.314 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.85 142.03 49.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.14 124.81 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.864 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.598 ' SD ' HD22 ' A' ' 80' ' ' LEU . 13.8 mtp -63.69 148.44 49.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.62 -33.64 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.092 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.63 142.35 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -106.46 152.93 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.568 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.1 m-85 -119.12 140.06 28.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 88.22 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.294 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.461 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.8 pp -118.18 158.91 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.595 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 30.3 mtpt -89.86 114.94 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.67 158.66 53.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.526 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -145.67 158.75 49.35 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -47.79 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.365 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 4.4 mmmm -91.73 -173.83 3.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.688 HG22 ' CE3' ' A' ' 8' ' ' TRP . 62.7 mt -82.89 137.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 2.1 p-90 -143.59 128.03 17.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -55.21 130.04 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.8 mt -63.6 178.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.0 167.45 15.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 p -72.2 -43.09 65.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -78.51 -18.86 54.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.568 HG23 ' CD2' ' A' ' 124' ' ' PHE . 15.7 mm -89.78 -36.23 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -51.29 -59.98 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 144' ' ' LYS . 82.2 mt-30 -56.7 -66.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.51 -42.18 0.91 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.458 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -61.86 -42.18 98.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.105 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.0 mtpp -65.82 -24.99 67.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 147' ' ' LEU . 23.7 mmmt -80.87 -52.13 7.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 150' ' ' GLN . . . -41.9 -23.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.504 HD11 ' SG ' ' A' ' 83' ' ' CYS . 34.2 mt -82.6 42.16 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 9.5 ptp -107.78 -39.07 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -134.9 53.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.527 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 1.5 mm-40 -41.88 -75.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -168.33 165.46 12.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -42.17 -37.53 1.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.7 119.59 0.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.104 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 117' ' ' PRO . 93.8 t . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.113 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t -94.97 -59.53 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.911 0.386 . . . . 0.0 110.88 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.0 p -83.93 104.4 13.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.97 -123.91 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.1 p -75.81 119.55 19.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -112.5 17.98 18.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.15 58.98 4.1 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.512 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.654 ' CE3' HG22 ' A' ' 132' ' ' ILE . 92.0 m95 -72.65 165.04 25.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.726 0.298 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.477 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 14.1 p -137.76 137.69 38.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 40' ' ' LEU . 10.7 tp -120.34 107.45 12.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 t -67.98 142.0 56.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 8.8 t -126.58 159.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.533 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.2 m-70 -90.52 112.89 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.554 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 57.9 mt-30 -58.57 160.91 9.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.577 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.72 -28.69 6.1 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.369 -0.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.506 ' C ' ' O ' ' A' ' 15' ' ' PRO . 9.5 m-90 -28.72 -57.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.26 -61.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 22' ' ' ARG . 2.2 m -63.1 -46.51 87.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.415 HD23 HD13 ' A' ' 24' ' ' ILE . 53.1 mt -45.74 -31.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 8.8 mp -67.21 -68.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.581 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.1 m -60.67 -10.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.7 mmt180 -84.34 -39.18 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 117' ' ' PRO . . . 123.16 0.14 9.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.483 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.431 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.2 mp -85.1 -49.63 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -88.91 118.54 28.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 10.1 ttt180 -103.8 -0.07 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 28.4 m -143.45 155.62 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 4.9 tm-20 -122.07 152.86 39.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.544 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -111.31 129.36 9.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 13.7 mmt180 -148.82 145.04 27.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.866 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.402 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 61.5 p -83.02 18.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.582 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 2.1 p-90 -143.98 165.82 26.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -105.5 140.67 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 34' ' ' THR . 6.3 t -135.03 104.82 10.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.709 . . . . 0.0 111.114 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.6 Cg_endo -69.8 2.63 3.38 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.641 2.227 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.439 ' O ' HD22 ' A' ' 86' ' ' LEU . 16.4 t60 -62.17 111.77 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 5.8 mmt85 -114.24 122.09 45.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.52 -125.92 2.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -99.47 142.8 30.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 10' ' ' LEU . 15.0 tp -144.03 111.82 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.557 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 94.5 m95 -72.44 121.73 20.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.62 130.14 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -127.67 142.08 51.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.749 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -76.17 122.31 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.9 p -58.96 175.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.35 -15.98 61.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 6.4 ttpt -73.41 144.39 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.52 137.37 19.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.614 0.721 . . . . 0.0 110.889 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.73 128.97 16.83 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.69 2.26 . . . . 0.0 112.324 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 m -73.06 156.2 89.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.665 0.745 . . . . 0.0 110.862 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -36.92 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.24 -42.36 68.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.797 HG12 ' NE2' ' A' ' 58' ' ' GLN . 47.8 t -64.31 -51.23 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t -61.69 -44.58 96.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.29 -56.63 10.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 58' ' ' GLN . 94.1 mt -54.73 -55.91 24.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.797 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.6 mt-30 -37.45 -48.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.48 -44.64 34.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 m -51.97 -53.36 42.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -66.79 -38.67 86.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.4 mtt180 -48.77 -37.63 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -86.47 -15.99 38.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.498 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 59.5 mt -85.78 -28.84 24.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.498 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.9 mmp_? -122.67 -27.44 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.059 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 128.64 129.08 3.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.448 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -45.06 -20.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.5 p30 -70.95 3.18 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.059 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.2 m -60.63 178.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 8.8 mp0 -122.94 172.3 8.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 76.7 m-85 -161.11 141.47 8.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.557 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.77 165.87 29.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 0.0 112.362 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.02 -27.03 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -144.87 166.1 26.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.577 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 76.0 m-85 -130.64 88.47 46.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.645 0.736 . . . . 0.0 110.884 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' N ' HE22 ' A' ' 14' ' ' GLN . 54.3 Cg_endo -69.75 168.43 21.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.67 2.246 . . . . 0.0 112.368 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.3 p -133.36 150.25 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.845 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.06 40.42 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.463 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 28.2 m -147.27 151.72 37.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.665 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -78.85 113.12 16.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 44' ' ' ALA . 26.3 mt -81.18 -70.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.581 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -149.09 -142.95 3.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.541 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -153.79 153.68 32.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 m -140.99 139.86 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.403 ' O ' HD13 ' A' ' 87' ' ' ILE . 2.6 t70 -81.88 112.72 19.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.439 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.5 tt -77.45 100.38 5.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.532 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -70.98 -45.62 71.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 3.5 m-20 -165.46 165.9 18.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.421 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.3 t -127.77 97.09 4.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.519 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 95.4 mt -94.67 168.13 11.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 93' ' ' LYS . 46.3 t -104.84 169.41 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.824 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 108' ' ' SER . 11.6 mm-40 -45.04 -20.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.1 ttmt -91.65 -69.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -57.98 -45.74 86.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.605 ' CD2' HG21 ' A' ' 111' ' ' VAL . 16.5 t80 -44.43 -58.66 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 10.4 ptpt -66.91 -40.01 87.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 10.2 mt-10 -49.99 -56.01 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.498 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.7 mt-30 -81.87 -49.18 10.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.498 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 19.8 m-85 -109.77 69.13 0.48 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.664 0.745 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.2 Cg_endo -69.78 -11.79 31.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.665 2.244 . . . . 0.0 112.354 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.42 -22.14 51.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.717 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.0 OUTLIER -122.44 22.75 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.6 p -64.07 -20.76 66.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.54 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.5 pp0? -96.54 -27.82 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.717 ' CD ' HG22 ' A' ' 102' ' ' ILE . 24.1 mt-10 -47.03 -40.06 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 t -120.09 150.64 40.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -116.2 -27.19 6.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.44 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -52.11 162.34 0.85 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.83 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 54.3 Cg_endo -69.72 -37.27 9.49 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.12 101.18 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.605 HG21 ' CD2' ' A' ' 95' ' ' PHE . 50.7 t -84.39 136.43 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 7.5 m-30 -104.59 102.39 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -70.62 119.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 2.7 m -124.26 154.02 40.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -142.09 176.71 8.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 54.79 52.24 8.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.82 119.94 6.8 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.657 2.238 . . . . 0.0 112.331 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -132.47 138.48 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -102.75 122.26 44.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.665 ' HE1' HD13 ' A' ' 80' ' ' LEU . 16.9 mtp -62.92 153.26 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 149' ' ' LYS . 90.4 t -72.8 -37.29 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.16 138.07 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -102.49 149.58 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -113.11 142.34 27.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 86.66 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.535 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.8 pp -121.06 160.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 15.0 ptmt -99.61 134.6 42.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.79 -178.01 39.45 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -161.12 159.22 24.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.633 0.73 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 0.3 5.87 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.629 2.219 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.582 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 9.1 mmmm -136.94 -175.0 3.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.654 HG22 ' CE3' ' A' ' 8' ' ' TRP . 71.9 mt -84.88 140.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.12 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.503 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 9.4 p-90 -146.51 128.96 15.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.557 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 15.2 ttmt -56.5 130.3 44.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 139' ' ' ILE . 17.8 mt -65.71 168.85 7.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.3 t70 -77.4 127.19 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.7 m -35.13 -40.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.61 -42.54 58.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 24.9 mm -64.04 -38.72 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -46.54 -65.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.7 mm-40 -49.75 -68.49 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -37.05 -54.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.433 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.557 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -53.24 -40.91 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 111.097 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -67.83 -17.03 64.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.6 mmmm -89.84 -50.09 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -40.04 -23.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.539 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 145' ' ' LYS . 22.6 mt -81.67 38.86 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.472 ' C ' ' HE3' ' A' ' 149' ' ' LYS . 6.9 ptp -105.02 -37.0 7.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.649 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -124.32 78.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.893 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 26.3 mm-40 -76.32 167.42 21.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -45.52 171.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.1 -40.01 62.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.74 -58.32 8.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.151 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -72.3 159.3 34.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -121.86 130.49 53.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.893 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.75 111.42 0.36 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.48 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.2 p -78.24 140.24 38.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.901 0.382 . . . . 0.0 110.803 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -98.68 18.86 15.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.9 66.47 1.92 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.486 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.481 ' CE3' HG22 ' A' ' 132' ' ' ILE . 94.0 m95 -83.05 164.17 20.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 41' ' ' TRP . 12.9 p -145.6 142.45 29.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.436 ' CD2' ' HG2' ' A' ' 28' ' ' GLU . 8.9 tp -130.95 114.16 14.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 18.7 m -69.59 147.45 50.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 19.7 t -129.76 154.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.437 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 37.3 m-70 -86.66 120.14 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.631 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 57.6 mt-30 -64.14 161.61 38.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 16' ' ' TRP . 53.5 Cg_endo -69.8 -30.53 5.1 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.325 -0.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.606 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.3 m-90 -26.89 -54.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.631 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -33.26 -64.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 m -63.04 -45.76 90.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.859 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 16' ' ' TRP . 57.4 mt -45.23 -30.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.678 HD21 ' OE1' ' A' ' 28' ' ' GLU . 6.6 mp -68.81 -69.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG21 ' OE1' ' A' ' 119' ' ' GLU . 5.0 m -57.26 -15.48 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.461 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.1 mmt180 -79.38 -39.57 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.63 7.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.3 mp -76.38 -57.01 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 111.152 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.0 tptt -84.03 112.25 20.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HG3' HG13 ' A' ' 27' ' ' VAL . 8.1 ptm180 -109.99 20.24 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.479 HG11 ' CE1' ' A' ' 95' ' ' PHE . 23.6 m -149.94 145.91 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.678 ' OE1' HD21 ' A' ' 20' ' ' LEU . 2.4 tp10 -109.15 146.53 33.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.56 119.86 5.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 24.7 mmt180 -148.89 145.44 27.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -83.31 17.71 2.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 131' ' ' LYS . 4.9 p-90 -139.85 163.49 32.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.6 t80 -105.0 145.33 30.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.494 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.6 t -138.75 106.99 7.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.714 . . . . 0.0 111.128 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 54.1 Cg_endo -69.72 3.86 2.51 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.677 2.251 . . . . 0.0 112.371 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.571 ' O ' HD22 ' A' ' 86' ' ' LEU . 24.1 t60 -65.3 114.27 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -120.18 117.65 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.03 -121.32 1.05 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.464 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -106.35 140.08 39.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 15.6 tp -144.27 113.9 7.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.608 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.1 m95 -72.02 128.88 37.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.0 133.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.24 166.88 17.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -98.87 119.33 37.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.5 p -55.22 -179.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.12 -5.45 57.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HD3' ' ND1' ' A' ' 13' ' ' HIS . 4.2 tttt -86.81 124.71 33.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -85.53 139.28 35.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.531 0.681 . . . . 0.0 110.939 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 54.2 Cg_endo -69.76 132.25 22.95 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 54' ' ' VAL . 15.4 m -76.02 157.52 83.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.697 0.761 . . . . 0.0 110.845 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -5.84 17.19 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.671 2.247 . . . . 0.0 112.342 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.03 -44.39 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.584 HG12 ' NE2' ' A' ' 58' ' ' GLN . 59.7 t -65.34 -49.42 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -65.27 -44.01 89.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.19 -53.77 27.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.953 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.458 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 75.6 mt -56.49 -40.16 74.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.584 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.4 mt-30 -55.03 -42.7 72.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.61 -32.99 28.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -64.67 -52.86 55.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -64.34 -38.22 90.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.534 ' HG2' HG22 ' A' ' 69' ' ' VAL . 54.2 mtt180 -49.79 -34.25 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.0 mt -90.56 -12.19 37.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.89 -28.9 17.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -122.53 -29.25 4.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.039 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.24 126.11 2.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.435 ' HD3' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -44.44 -21.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -79.23 15.29 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 66' ' ' GLY . 19.5 m -64.02 -177.06 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 24' ' ' ILE . 13.0 mt-10 -115.91 165.97 12.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 55.4 m-85 -161.12 132.38 3.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.526 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.71 169.12 19.59 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.68 2.253 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -144.28 170.81 15.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' CZ ' ' HG2' ' A' ' 72' ' ' PRO . 58.1 m-85 -134.21 93.36 19.66 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.628 0.728 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.52 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.8 Cg_endo -69.77 169.79 18.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.2 m -136.37 139.44 42.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.851 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.58 49.41 60.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.1 m -157.08 147.62 21.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.878 0.37 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.656 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.27 120.81 21.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 44' ' ' ALA . 78.6 mt -88.8 -73.75 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.86 -144.63 4.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.572 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 14.2 t -151.14 157.84 43.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 m -143.09 142.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.422 ' CB ' HD22 ' A' ' 116' ' ' ASN . 1.5 t70 -86.49 111.45 20.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.571 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.9 tt -75.24 98.39 3.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.552 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.25 -47.66 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.7 m-20 -164.92 168.2 17.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -127.9 100.42 5.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 94' ' ' GLN . 94.0 mt -94.01 170.06 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.967 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' LYS . 65.0 m -109.41 169.61 8.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 109' ' ' PRO . 3.7 mm-40 -43.0 -22.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' SER . 29.0 ttmt -89.79 -66.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.623 ' HB3' HD22 ' A' ' 90' ' ' LEU . 10.3 mt-30 -60.35 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.526 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 28.6 t80 -46.02 -55.56 6.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 1.9 ptmt -69.69 -39.51 76.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.26 -59.41 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.481 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 9.6 mt-30 -77.51 -49.5 14.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 25.1 m-85 -109.95 67.62 0.46 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.633 0.73 . . . . 0.0 110.84 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.5 Cg_endo -69.77 -12.19 32.37 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 -22.17 51.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.513 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.1 pt -121.35 15.99 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.3 p -58.4 -22.56 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.573 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -94.49 -30.69 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 8.7 mt-10 -47.04 -26.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 t -136.86 138.67 41.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.74 26.61 9.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 16.4 p -100.17 157.69 33.37 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.652 0.739 . . . . 0.0 110.86 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.73 -23.2 31.19 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 0.0 112.348 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -134.97 95.0 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 95' ' ' PHE . 43.4 t -85.63 137.55 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -104.44 108.01 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER -75.13 122.92 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.4 m -125.67 155.97 40.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -144.02 176.49 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.49 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.83 51.73 4.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.634 0.73 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.4 Cg_endo -69.74 114.19 3.62 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.404 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.24 134.7 48.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.541 ' OE1' HG21 ' A' ' 21' ' ' VAL . 3.9 tp10 -97.6 123.53 41.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.656 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.6 mtp -63.76 157.77 23.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 149' ' ' LYS . 91.6 t -81.08 -32.5 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.4 144.42 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -111.05 148.22 33.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.467 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.0 OUTLIER -117.54 142.53 30.61 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.71 0.767 . . . . 0.0 110.822 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 86.83 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.63 2.22 . . . . 0.0 112.391 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.468 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.8 pp -125.01 162.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.5 mmtp -108.15 149.03 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -100.03 178.22 29.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.519 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -154.53 161.06 30.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.66 0.743 . . . . 0.0 110.876 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -1.61 8.79 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 10.2 mmmm -137.27 -174.99 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.481 HG22 ' CE3' ' A' ' 8' ' ' TRP . 74.1 mt -83.11 139.79 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 7.2 p-90 -145.11 127.94 16.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.453 ' NZ ' ' CZ2' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -64.21 125.23 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 139' ' ' ILE . 30.2 mt -52.76 -176.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 139' ' ' ILE . 6.8 t0 -91.7 131.72 36.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -36.65 -36.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -40.33 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.623 HG21 HD22 ' A' ' 135' ' ' LEU . 32.2 mm -67.36 -45.77 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.8 t-160 -36.5 -63.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 41.4 mm-40 -52.48 -69.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.53 -48.23 0.65 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.608 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -58.45 -43.25 88.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.819 0.342 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 15.9 mtpp -64.46 -26.45 68.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.455 ' HE2' ' N ' ' A' ' 145' ' ' LYS . 8.5 mmpt? -80.37 -46.34 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -45.68 -22.38 0.71 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 34.3 mt -86.71 36.83 0.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.4 ptp -89.61 -36.89 15.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.499 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 1.4 mmmm -148.02 108.3 4.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -86.62 174.07 9.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.436 ' OD1' HG12 ' A' ' 154' ' ' VAL . 6.9 p30 -44.84 157.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -101.43 37.79 1.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -117.29 -54.85 2.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.436 HG12 ' OD1' ' A' ' 151' ' ' ASN . 11.0 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.8 m 57.89 41.29 24.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.6 m -125.16 39.77 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.854 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 158.65 31.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.494 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.2 m -112.64 105.84 14.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.833 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -86.47 29.76 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.56 63.29 5.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.505 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.453 ' CE3' HG22 ' A' ' 132' ' ' ILE . 87.3 m95 -72.35 169.79 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HB2' HD11 ' A' ' 135' ' ' LEU . 43.0 t -140.33 139.15 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -130.05 115.57 17.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 m -67.77 156.38 37.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.657 HG22 ' OE2' ' A' ' 28' ' ' GLU . 53.7 t -139.03 157.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.482 ' N ' HG12 ' A' ' 12' ' ' VAL . 43.1 m-70 -90.41 109.43 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.578 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 64.3 mt-30 -58.33 161.14 8.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.7 -30.57 5.05 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.73 -1.779 . . . . 0.0 112.325 -0.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 9.6 m-90 -26.66 -49.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.578 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -35.28 -60.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -67.03 -51.09 59.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 16' ' ' TRP . 91.3 mt -40.51 -30.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 16' ' ' TRP . 5.8 mp -68.32 -65.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 ' N ' ' A' ' 82' ' ' GLY . 10.6 m -62.58 -18.38 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.47 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 14.4 mmt180 -74.81 -39.93 61.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.4 -2.18 7.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.778 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.1 mp -83.07 -55.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.391 . . . . 0.0 111.139 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.506 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.5 tptp -86.59 120.26 27.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.618 ' HD2' HD13 ' A' ' 102' ' ' ILE . 4.3 ptp180 -114.37 15.92 17.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.518 HG11 HD12 ' A' ' 102' ' ' ILE . 33.9 m -147.56 142.92 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.657 ' OE2' HG22 ' A' ' 12' ' ' VAL . 6.9 tp10 -107.97 147.01 31.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -113.18 119.54 4.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.0 mmt180 -146.22 151.96 38.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 0.0 110.887 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.476 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 84.2 p -87.42 22.31 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.458 ' CZ2' ' HG3' ' A' ' 30' ' ' ARG . 3.4 p-90 -142.24 161.12 38.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 12.0 t80 -103.65 139.23 39.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 34' ' ' THR . 7.6 t -134.41 101.66 12.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.566 0.698 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.5 Cg_endo -69.8 8.33 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.646 2.231 . . . . 0.0 112.36 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.599 ' O ' HD22 ' A' ' 86' ' ' LEU . 20.4 t60 -68.67 109.73 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mmt-85 -109.62 107.25 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.98 -153.37 23.89 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -73.02 140.57 47.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 21.2 tp -143.95 113.88 7.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.562 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 95.4 m95 -73.54 120.95 19.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.62 128.94 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.48 153.27 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -88.75 122.55 32.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.8 p -62.45 173.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.27 -9.74 58.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 7.7 ttpt -70.47 127.27 32.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -85.46 125.68 68.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.567 0.698 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 130.82 20.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.247 . . . . 0.0 112.354 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.6 m -76.89 158.97 79.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.666 0.746 . . . . 0.0 110.79 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 -16.98 38.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 0.0 112.372 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -84.44 -39.06 19.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -41.42 76.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.85 HG12 ' NE2' ' A' ' 58' ' ' GLN . 52.5 t -67.94 -48.87 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.162 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -63.62 -45.14 91.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.87 -52.44 43.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.651 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 83.9 mt -59.31 -44.76 92.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.85 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.0 mt-30 -50.18 -46.12 54.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.89 -36.95 41.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.3 m -59.24 -51.18 71.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.403 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 26.5 m-85 -69.06 -37.26 78.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.5 mtt-85 -49.88 -33.99 18.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.78 -15.94 31.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.8 mt -88.06 -28.66 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.448 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.6 mmm180 -121.47 -28.87 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.034 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 132.45 126.98 2.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.476 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.57 -20.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.1 m-20 -80.72 18.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.034 HG13 ' O ' ' A' ' 66' ' ' GLY . 23.2 m -68.02 179.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.117 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.778 ' O ' HD11 ' A' ' 24' ' ' ILE . 11.9 mt-10 -112.25 157.2 21.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -154.51 132.06 6.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.657 0.742 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.7 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.694 2.262 . . . . 0.0 112.322 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -81.4 -32.05 32.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -145.31 174.23 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 55.0 m-85 -133.45 95.47 18.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.665 0.745 . . . . 0.0 110.936 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.507 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.4 Cg_endo -69.75 171.59 14.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.332 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -141.33 133.25 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 46.13 9.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.5 m -159.27 149.39 19.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.409 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -74.23 113.43 11.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.743 HD11 ' HB2' ' A' ' 44' ' ' ALA . 77.8 mt -79.3 -74.4 0.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.501 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -143.9 -145.07 4.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.562 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 5.5 t -149.54 162.49 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.9 m -151.71 140.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.41 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.4 t70 -85.63 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.599 HD22 ' O ' ' A' ' 36' ' ' HIS . 5.6 tt -73.48 99.82 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.526 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.89 -48.29 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.43 167.4 23.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -127.53 101.25 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.517 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.2 mt -96.37 168.38 10.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 15.0 p -106.29 169.19 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.495 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 19.6 mm-40 -46.65 -19.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 91' ' ' SER . 21.9 ttmt -90.88 -59.0 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.504 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.5 mt-30 -68.52 -50.21 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.517 ' N ' ' HB3' ' A' ' 90' ' ' LEU . 31.3 t80 -41.91 -55.9 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -67.25 -41.32 85.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.49 -58.83 5.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.3 mt-30 -76.13 -50.11 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 35.4 m-85 -109.88 67.91 0.46 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.1 Cg_endo -69.74 -13.57 34.92 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.71 2.273 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.68 -23.44 56.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.659 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.6 pt -121.91 23.45 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.2 p -65.0 -26.3 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.598 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.2 pp0? -91.53 -27.98 17.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.659 ' CD ' HG22 ' A' ' 102' ' ' ILE . 18.3 mt-10 -49.3 -38.39 27.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.515 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.3 p -124.08 144.42 49.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 27.2 t70 -107.94 -36.36 6.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.48 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 4.3 m -39.6 157.99 0.13 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.636 0.731 . . . . 0.0 110.856 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.7 Cg_endo -69.79 -49.23 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.661 2.241 . . . . 0.0 112.319 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' A' ' 33' ' ' TYR . 26.2 m-85 -106.32 98.69 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.516 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 22.1 t -83.91 139.62 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.113 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 30' ' ' ARG . 2.6 m-30 -107.29 107.09 17.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.24 122.83 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.1 m -126.8 155.41 42.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.08 176.25 9.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 56.59 51.97 6.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.73 115.52 4.13 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -127.92 134.79 49.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.4 ' O ' ' CD ' ' A' ' 150' ' ' GLN . 11.3 tm-20 -96.88 121.99 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.459 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 13.1 mtp -62.59 151.88 36.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 146' ' ' GLY . 59.3 t -72.74 -37.52 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 1.8 p -118.22 158.51 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.486 ' N ' ' CG2' ' A' ' 122' ' ' VAL . 12.5 mmtm -120.65 140.29 51.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.9 OUTLIER -107.64 136.86 19.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.628 0.728 . . . . 0.0 110.897 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 86.03 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.438 ' C ' HD12 ' A' ' 126' ' ' ILE . 2.9 pp -121.89 163.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.611 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 70.9 mttt -97.95 132.04 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.03 170.9 40.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -153.42 153.07 28.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 1.42 4.46 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.691 2.261 . . . . 0.0 112.301 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.435 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 8.7 mmmm -134.07 -175.39 3.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.453 HG22 ' CE3' ' A' ' 8' ' ' TRP . 72.7 mt -89.03 137.89 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.6 p-90 -146.05 131.48 18.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -59.62 124.59 20.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.476 HD22 HG21 ' A' ' 139' ' ' ILE . 27.1 mt -60.02 170.77 1.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.7 t70 -79.27 129.71 34.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.1 m -37.03 -37.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -76.05 -41.24 51.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 124' ' ' PHE . 37.5 mm -65.56 -39.65 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -45.92 -65.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.817 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 144' ' ' LYS . 28.1 mt-30 -47.89 -69.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.95 -52.85 1.54 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.445 ' HB2' ' HE2' ' A' ' 124' ' ' PHE . . . -52.52 -39.44 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 141' ' ' GLN . 10.7 mtpt -70.47 -14.73 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -86.08 -48.47 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -46.62 -19.15 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.497 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 47.1 mt -82.33 37.51 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.9 ptp -103.83 -40.69 6.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -134.99 59.97 1.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 146' ' ' GLY . 2.3 mm-40 -45.95 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.424 ' OD1' HG12 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -161.76 140.75 9.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -65.95 -25.79 67.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -50.46 -50.8 51.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.424 HG12 ' OD1' ' A' ' 151' ' ' ASN . 14.1 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -101.09 163.91 12.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.881 0.372 . . . . 0.0 110.866 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 m -62.25 121.15 12.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.75 -84.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.47 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m 58.65 43.56 18.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.862 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -76.36 165.11 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.83 102.26 2.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.574 ' CE3' HG22 ' A' ' 132' ' ' ILE . 94.7 m95 -94.96 161.97 13.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.9 t -137.24 140.25 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 28' ' ' GLU . 26.7 tp -124.13 108.88 12.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 3.9 p -67.57 137.17 55.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.718 HG22 ' OE2' ' A' ' 28' ' ' GLU . 33.9 t -121.13 161.44 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.543 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.5 m-70 -95.99 111.76 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.524 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 10.8 mm-40 -56.34 157.83 8.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.3 Cg_endo -69.78 -33.03 3.57 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.361 -0.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 10.7 m-90 -24.97 -54.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.516 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -36.69 -54.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.5 m -70.04 -47.81 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.5 mt -45.39 -28.31 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.6 mp -68.07 -65.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.651 HG11 ' N ' ' A' ' 82' ' ' GLY . 14.6 m -64.77 -14.2 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.3 mmt180 -78.64 -39.13 37.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.61 12.22 6.2 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.5 -47.63 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -88.79 116.66 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.49 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 11.4 ttt180 -101.94 -1.14 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.59 HG11 ' CE1' ' A' ' 95' ' ' PHE . 32.7 m -141.55 152.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.144 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.718 ' OE2' HG22 ' A' ' 12' ' ' VAL . 2.2 tp10 -115.96 143.11 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.55 129.47 9.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.416 ' HD2' ' NE1' ' A' ' 32' ' ' TRP . 20.2 mmt180 -152.96 140.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.1 p -82.81 16.58 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.535 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.2 p-90 -139.29 166.44 24.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 34' ' ' THR . 8.8 t80 -106.45 148.39 28.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.618 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 5.8 t -143.95 107.09 4.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.709 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 54.2 Cg_endo -69.69 2.83 3.14 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.37 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.5 ' O ' HD22 ' A' ' 86' ' ' LEU . 13.3 t60 -65.42 117.91 8.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -123.53 120.43 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 85' ' ' ASP . . . 153.57 -121.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -99.55 140.77 33.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' C ' ' SG ' ' A' ' 83' ' ' CYS . 17.4 tp -144.73 108.99 4.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.61 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 94.8 m95 -71.65 126.15 28.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 mm -96.39 129.3 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -126.63 150.56 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -85.37 126.26 33.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.071 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 12' ' ' VAL . 23.8 p -64.69 173.01 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.42 -21.15 62.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 9.0 ttpt -63.91 149.39 47.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.471 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -108.59 133.98 20.44 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.533 0.682 . . . . 0.0 110.921 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.4 Cg_endo -69.77 128.32 15.86 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.708 2.272 . . . . 0.0 112.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 54' ' ' VAL . 1.9 m -75.21 159.12 83.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 110.869 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -7.35 20.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.72 -41.78 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.63 -40.85 80.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 50' ' ' SER . 33.8 t -67.83 -49.6 67.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.4 t -64.2 -42.06 96.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -70.2 -55.15 10.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HE2' ' A' ' 61' ' ' TYR . 86.5 mt -55.88 -44.03 77.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 8.5 mt-30 -51.05 -47.06 61.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.67 -36.71 51.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -60.17 -51.25 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.676 ' HE2' HD22 ' A' ' 57' ' ' LEU . 46.0 m-85 -69.92 -38.59 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 69' ' ' VAL . 44.8 mtt180 -47.98 -36.34 12.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.5 mt -87.23 -18.14 30.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.0 mt -83.41 -32.28 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -118.4 -27.38 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.056 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 129.4 124.9 2.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.428 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -70.15 4.77 1.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.056 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.3 m -61.5 176.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -116.71 167.82 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 49.5 m-85 -157.67 139.06 9.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.9 Cg_endo -69.71 159.4 53.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.745 2.297 . . . . 0.0 112.334 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.88 -24.09 33.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -150.73 172.22 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.598 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 56.2 m-85 -134.41 98.59 13.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.66 0.743 . . . . 0.0 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 75' ' ' TYR . 53.5 Cg_endo -69.76 -176.33 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.319 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.7 p -150.79 129.83 12.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.38 45.28 24.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.1 m -153.33 149.43 27.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.598 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -75.95 118.34 18.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 44' ' ' ALA . 43.8 mt -85.68 -71.57 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.651 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.26 -143.11 3.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.467 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.598 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.2 t -152.46 158.18 42.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.845 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.8 m -145.71 134.54 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.49 ' HB3' ' ND2' ' A' ' 116' ' ' ASN . 1.4 t70 -79.35 112.8 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 36' ' ' HIS . 3.2 tt -76.41 102.67 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.53 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -72.04 -47.07 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . 7.0 m-20 -166.17 170.02 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.475 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -128.11 99.42 5.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.534 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 96.9 mt -93.04 171.24 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 93' ' ' LYS . 4.7 p -109.79 169.16 8.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' O ' ' CE ' ' A' ' 96' ' ' LYS . 3.1 mm-40 -43.11 -23.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 18.4 ttmt -89.76 -65.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.501 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.1 mt-30 -59.38 -48.63 80.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.604 ' CE2' ' O ' ' A' ' 102' ' ' ILE . 20.1 t80 -43.79 -56.9 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 11.7 ptpt -69.0 -41.96 77.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 7.7 mt-10 -50.06 -59.13 4.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.496 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.4 mt-30 -78.05 -45.07 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 26.0 m-85 -113.66 69.98 1.6 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.666 0.746 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -14.54 36.1 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 0.0 112.349 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -19.67 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.654 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.5 pt -125.73 21.74 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.469 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 58.8 p -64.51 -27.63 69.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.581 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.6 pp0? -89.39 -29.52 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.654 ' CD ' HG22 ' A' ' 102' ' ' ILE . 22.9 mt-10 -45.31 -40.03 7.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.8 t -120.39 140.76 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.18 25.43 10.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.459 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.7 p -101.16 160.34 26.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.869 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 92' ' ' GLN . 53.3 Cg_endo -69.79 -25.16 28.73 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 32' ' ' TRP . 20.2 m-85 -134.82 95.55 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.498 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.7 t -84.51 135.73 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.618 ' CZ ' HG22 ' A' ' 34' ' ' THR . 9.2 m-30 -101.9 103.54 14.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -71.12 122.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.9 m -125.56 156.08 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.433 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 1.9 mmmp? -143.53 176.36 9.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 85' ' ' ASP . 0.3 OUTLIER 58.15 51.95 4.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.894 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.5 Cg_endo -69.79 113.65 3.45 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.266 . . . . 0.0 112.303 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -127.35 141.7 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -103.67 120.96 41.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.598 ' HE1' HD13 ' A' ' 80' ' ' LEU . 17.3 mtp -64.05 143.01 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.94 HG21 ' HB2' ' A' ' 149' ' ' LYS . 29.4 t -69.96 -25.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.146 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.83 141.91 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -110.99 145.09 39.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.445 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.0 OUTLIER -113.41 143.29 29.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 91.49 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.718 2.279 . . . . 0.0 112.316 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.45 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.8 pp -130.63 158.17 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.11 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.591 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 26.0 mttm -103.5 137.23 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -96.24 166.87 24.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.468 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -140.53 161.7 53.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.714 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 0.56 5.45 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.535 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.5 mmmm -138.26 -174.99 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.574 HG22 ' CE3' ' A' ' 8' ' ' TRP . 82.7 mt -83.09 138.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.591 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 6.7 p-90 -146.63 124.2 11.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.47 127.07 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.17 -178.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -88.13 127.47 35.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.8 m -36.39 -40.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -73.44 -41.25 63.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 136' ' ' ASP . 23.5 mm -64.99 -44.99 95.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -38.55 -65.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 142' ' ' GLY . 14.4 mm100 -52.59 -68.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.21 -48.71 1.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.466 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.61 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.79 -45.79 81.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 111.089 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -63.57 -22.48 66.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -84.14 -46.63 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -45.44 -20.45 0.34 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.9 mt -83.33 32.84 0.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 7.2 ptp -94.74 -33.21 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.94 ' HB2' HG21 ' A' ' 121' ' ' VAL . 20.5 mtpt -120.95 50.71 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 149' ' ' LYS . 6.2 mm-40 -33.83 149.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 154' ' ' VAL . 0.9 OUTLIER -90.25 98.42 11.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -71.81 -34.97 69.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 154' ' ' VAL . . . -127.19 -61.01 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.486 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 97.2 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.105 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -137.96 143.78 40.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.6 p -93.1 151.38 19.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.879 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.23 119.41 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.3 m -111.49 172.6 6.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.872 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 57.8 m -141.24 138.3 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.82 102.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.456 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.72 ' CE3' HG22 ' A' ' 132' ' ' ILE . 93.3 m95 -90.23 156.98 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.762 0.315 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.587 ' HB2' HD11 ' A' ' 135' ' ' LEU . 52.7 t -134.5 121.7 21.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.463 HD13 ' HH2' ' A' ' 32' ' ' TRP . 65.6 tp -107.44 109.19 20.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -68.09 154.53 41.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 20' ' ' LEU . 24.5 t -133.65 159.0 42.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.094 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.511 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 57.4 m-70 -90.13 113.72 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.557 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 78.7 mt-30 -59.7 159.75 17.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.573 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.75 -31.52 4.5 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 -1.797 . . . . 0.0 112.355 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.529 ' C ' ' O ' ' A' ' 15' ' ' PRO . 10.0 m-90 -26.81 -48.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.557 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -39.33 -63.44 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -64.03 -40.15 95.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.1 mt -52.62 -28.52 21.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 12' ' ' VAL . 7.1 mp -69.75 -60.46 2.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 82' ' ' GLY . 18.6 m -67.65 -20.5 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.3 mmt180 -73.12 -39.17 65.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.39 14.66 5.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.21 -45.14 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 111.154 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CD ' ' OH ' ' A' ' 61' ' ' TYR . 4.2 tptp -93.81 118.85 32.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -101.05 -4.39 27.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 8.0 m -141.33 152.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -120.35 130.51 54.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.453 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -86.57 132.06 10.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' N ' ' CB ' ' A' ' 108' ' ' SER . 18.9 mmt180 -152.63 144.64 23.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.522 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 9.8 t -85.63 24.26 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.596 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 4.0 p-90 -146.38 160.91 41.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 34' ' ' THR . 7.3 t80 -104.08 145.29 30.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 5.6 t -139.31 105.91 7.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.162 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.1 Cg_endo -69.78 4.0 2.46 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.697 2.265 . . . . 0.0 112.308 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.404 ' O ' HD22 ' A' ' 86' ' ' LEU . 15.5 t60 -65.86 114.68 5.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -119.69 122.92 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.41 -119.15 1.04 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -104.88 138.3 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.405 HD21 ' CB ' ' A' ' 10' ' ' LEU . 26.7 tp -143.57 112.69 6.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.36 132.56 45.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.5 mm -103.34 125.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.113 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -120.97 154.3 36.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.092 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -87.73 116.46 25.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -53.06 -177.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.13 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.65 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 13' ' ' HIS . 6.2 ttpt -78.25 131.13 36.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -92.98 137.06 23.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.557 0.694 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' A' ' 15' ' ' PRO . 53.4 Cg_endo -69.72 130.36 19.24 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.4 m -78.29 158.13 77.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 110.837 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -4.15 13.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.682 2.254 . . . . 0.0 112.317 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.497 ' NE2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -94.84 -38.67 10.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.933 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.17 -39.84 53.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.757 HG12 ' NE2' ' A' ' 58' ' ' GLN . 61.6 t -64.15 -52.73 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -58.12 -46.54 85.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.497 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 11.9 mt-10 -66.41 -57.54 7.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.489 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 76.7 mt -52.92 -41.21 64.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.757 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.8 mt-30 -52.47 -47.9 66.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.33 -37.52 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.072 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -58.3 -50.59 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.438 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 24.8 m-85 -71.03 -31.88 68.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HG2' HG22 ' A' ' 69' ' ' VAL . 32.2 mtt180 -56.05 -39.65 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 mt -86.33 -14.53 43.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.469 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 71.6 mt -89.02 -28.89 19.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.469 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 5.5 mmp_? -121.16 -28.74 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.065 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 131.27 128.21 2.94 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.19 -19.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 66' ' ' GLY . 6.7 m-20 -78.4 13.4 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.065 HG13 ' O ' ' A' ' 66' ' ' GLY . 28.6 m -66.33 -177.84 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 16.3 mm-40 -119.54 167.98 11.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 62.3 m-85 -161.86 135.06 4.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.625 0.726 . . . . 0.0 110.861 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.2 Cg_endo -69.77 159.96 51.47 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 0.0 112.322 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -81.11 -27.76 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -146.15 173.41 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.1 m-85 -134.85 94.61 16.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.683 0.754 . . . . 0.0 110.916 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.4 Cg_endo -69.76 174.36 9.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.5 p -141.26 139.81 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.86 45.36 84.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.7 m -153.45 145.18 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 110.884 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.677 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.1 OUTLIER -74.93 117.85 17.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' ALA . 50.1 mt -85.79 -71.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.49 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.61 -146.4 4.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.587 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 6.3 p -151.28 157.41 42.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 19.8 m -144.67 140.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.1 113.08 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 36' ' ' HIS . 4.2 tt -77.42 93.41 4.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.622 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -60.73 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.184 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.407 ' O ' HG13 ' A' ' 113' ' ' ILE . 1.5 m-20 -163.01 168.46 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.9 t -127.73 101.74 6.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.525 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 88.8 mt -99.32 169.89 9.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' LYS . 34.7 t -105.12 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.487 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 10.1 mm-40 -42.07 -23.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' SER . 15.2 ttmm -91.34 -70.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -53.56 -47.37 70.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.572 ' CD2' HG21 ' A' ' 111' ' ' VAL . 16.9 t80 -43.3 -57.46 3.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.506 ' HG2' ' N ' ' A' ' 97' ' ' GLU . 1.6 pttt -68.36 -38.79 81.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.506 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 12.1 mt-10 -49.56 -52.39 30.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.7 mt-30 -86.68 -45.97 10.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.7 m-85 -110.42 67.69 0.51 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 0.0 110.865 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 54.0 Cg_endo -69.77 -10.35 28.33 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.695 2.264 . . . . 0.0 112.366 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -77.82 -19.16 55.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.449 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 pt -126.17 21.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 59.6 p -60.05 -20.78 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -97.94 -30.71 12.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 5.2 mt-10 -51.23 -28.36 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.5 p -114.24 156.84 23.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -130.15 -32.58 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.518 ' CB ' ' N ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -58.87 164.83 3.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 0.0 110.834 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.522 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.3 Cg_endo -69.78 -43.79 2.44 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.66 2.24 . . . . 0.0 112.322 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -110.34 97.51 6.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 95' ' ' PHE . 12.9 t -79.3 139.21 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CZ ' HG22 ' A' ' 34' ' ' THR . 11.5 m-30 -106.58 105.84 16.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -74.41 117.57 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.093 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.461 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 6.9 m -125.07 151.55 45.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.874 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.403 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 11.3 mmmt -140.5 175.27 9.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 59.22 53.18 4.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 0.0 110.891 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.2 Cg_endo -69.78 112.58 3.12 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.402 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 4.2 pt20 -127.33 141.07 51.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.19 122.24 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.677 ' HE1' HD13 ' A' ' 80' ' ' LEU . 16.6 mtp -63.39 155.33 29.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.693 HG21 ' HB2' ' A' ' 149' ' ' LYS . 32.2 t -81.92 -27.69 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -127.27 135.22 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 14.0 mmtm -103.03 150.44 23.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.577 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.3 m-85 -118.17 143.55 33.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.596 0.713 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 92.05 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.32 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.509 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.9 pp -123.21 167.07 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -110.28 107.16 16.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.27 169.56 23.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.538 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 133' ' ' TRP . 46.9 m-80 -155.29 157.9 31.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.928 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 0.86 5.03 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.711 2.274 . . . . 0.0 112.392 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.596 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.4 mmmp? -136.84 -175.08 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.72 HG22 ' CE3' ' A' ' 8' ' ' TRP . 68.3 mt -86.89 131.99 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.154 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 129' ' ' ASN . 7.5 p-90 -133.8 136.24 44.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.549 ' HE3' ' CH2' ' A' ' 8' ' ' TRP . 8.8 ttmt -56.8 134.87 55.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 9' ' ' CYS . 17.9 mt -76.96 133.29 39.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.521 ' HB2' ' CG1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -45.84 123.23 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 136' ' ' ASP . 4.4 m -34.02 -48.44 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.86 -43.62 87.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.577 HG23 ' CD2' ' A' ' 124' ' ' PHE . 38.7 mm -61.65 -46.09 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.139 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -38.56 -64.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 142' ' ' GLY . 79.9 mt-30 -51.68 -68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.7 -49.09 0.72 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.506 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.72 -46.06 77.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.2 mtpp -64.82 -24.12 67.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -82.8 -42.84 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -51.48 -16.51 2.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.46 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 40.3 mt -85.72 31.91 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.891 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 ptp -92.39 -36.37 13.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.693 ' HB2' HG21 ' A' ' 121' ' ' VAL . 32.5 mttt -120.71 54.04 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 5.4 mm-40 -34.23 142.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 152' ' ' LYS . 0.8 OUTLIER -79.51 122.25 26.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 153' ' ' ALA . 6.0 mtmp? -48.25 177.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 152' ' ' LYS . . . -32.96 -61.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 153' ' ' ALA . 9.8 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.8 p -70.31 166.28 20.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.5 p -104.15 -47.71 4.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.851 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.96 106.73 0.21 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -100.39 77.0 1.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.407 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 57.7 m -149.29 144.68 26.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.82 105.24 1.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.675 ' CE3' HG22 ' A' ' 132' ' ' ILE . 95.0 m95 -92.91 160.79 14.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB2' HD11 ' A' ' 135' ' ' LEU . 39.0 t -133.16 130.95 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.555 HD11 ' HE ' ' A' ' 30' ' ' ARG . 21.9 tp -111.6 110.7 21.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.435 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 2.9 m -69.92 131.09 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 13' ' ' HIS . 69.6 t -116.19 163.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.6 ' N ' HG12 ' A' ' 12' ' ' VAL . 59.0 m-70 -100.65 114.21 27.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 15' ' ' PRO . 15.0 mm-40 -58.36 157.8 16.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.587 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.76 -33.74 3.31 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.721 -1.783 . . . . 0.0 112.338 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.548 ' C ' ' O ' ' A' ' 15' ' ' PRO . 11.5 m-90 -25.07 -59.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . . . -33.39 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.091 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 15' ' ' PRO . 2.4 m -69.6 -53.91 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 mt -40.97 -29.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.7 mp -66.56 -68.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 82' ' ' GLY . 17.4 m -61.21 -11.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.453 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 12.2 mmt180 -82.98 -39.64 21.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.86 0.87 9.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.545 HD11 ' O ' ' A' ' 70' ' ' GLU . 4.6 mp -85.6 -50.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 111.12 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 4.1 tptp -88.53 121.87 31.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -103.89 -4.06 23.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.615 HG11 ' CE1' ' A' ' 95' ' ' PHE . 15.6 m -140.34 162.34 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE1' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -129.03 130.88 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' OE1' ' A' ' 28' ' ' GLU . . . -86.43 128.24 8.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.52 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HE ' HD11 ' A' ' 10' ' ' LEU . 13.0 mmt180 -146.11 143.97 29.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.823 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 77.9 p -83.66 19.47 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.578 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.5 p-90 -144.53 167.62 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.462 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 6.0 t80 -108.8 136.81 47.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.566 HG22 ' CZ ' ' A' ' 112' ' ' PHE . 6.1 t -130.15 104.04 16.7 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.703 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.421 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.8 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.408 ' O ' HD22 ' A' ' 86' ' ' LEU . 15.6 t60 -65.77 117.15 7.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.421 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 8.4 mmt85 -120.97 121.48 38.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.91 -116.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -104.2 138.95 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 10' ' ' LEU . 19.3 tp -143.76 109.38 5.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.597 ' CE3' ' HB2' ' A' ' 83' ' ' CYS . 90.7 m95 -73.4 124.49 25.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 mm -94.84 127.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -127.18 141.18 51.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.102 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.654 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -75.58 121.29 22.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 p -59.94 -177.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.26 21.34 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.073 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' HB3' ' A' ' 13' ' ' HIS . 8.9 ttpt -100.77 132.94 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -87.67 126.7 60.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.555 0.693 . . . . 0.0 110.928 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 134.92 29.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.1 m -79.05 153.29 77.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.669 0.747 . . . . 0.0 110.841 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -6.55 18.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.297 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 -38.47 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.85 -43.52 71.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.542 HG12 ' NE2' ' A' ' 58' ' ' GLN . 42.6 t -63.88 -51.11 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -61.1 -47.44 86.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.17 -55.34 22.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.417 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 84.8 mt -54.46 -54.29 42.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 11.5 mt-30 -38.44 -49.06 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.14 -43.09 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -52.85 -51.3 61.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.458 ' OH ' ' CD ' ' A' ' 25' ' ' LYS . 36.0 m-85 -69.08 -37.96 78.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.507 ' HG2' HG22 ' A' ' 69' ' ' VAL . 58.6 mtt180 -48.44 -33.11 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.1 mt -91.4 -15.69 28.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.558 ' CD1' ' NE2' ' A' ' 104' ' ' GLN . 79.6 mt -86.76 -31.51 20.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -119.36 -28.66 5.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.04 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.46 124.68 2.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.46 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -44.55 -18.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.913 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 66' ' ' GLY . 2.9 m-20 -77.66 13.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.04 HG13 ' O ' ' A' ' 66' ' ' GLY . 33.9 m -69.23 174.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.545 ' O ' HD11 ' A' ' 24' ' ' ILE . 2.6 pm0 -119.66 173.5 6.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 83.1 m-85 -158.93 144.37 11.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.849 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 Cg_endo -69.79 152.82 69.26 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.242 . . . . 0.0 112.321 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -73.23 -28.17 62.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -144.6 174.15 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.587 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 68.5 m-85 -134.97 89.64 23.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 75' ' ' TYR . 53.0 Cg_endo -69.83 172.1 13.34 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.5 p -143.55 142.27 31.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.09 37.27 60.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 86.9 m -149.83 147.62 28.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.618 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -75.03 114.48 13.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' A' ' 44' ' ' ALA . 48.2 mt -81.69 -72.37 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.16 -143.66 3.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.597 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 11.0 t -150.95 159.03 44.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 m -147.66 133.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.439 ' HB3' ' ND2' ' A' ' 116' ' ' ASN . 1.9 t70 -77.79 112.62 14.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.415 HD12 HD22 ' A' ' 40' ' ' LEU . 3.3 tt -77.01 100.4 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.549 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.39 -49.23 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -161.34 168.28 24.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.466 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -127.56 96.59 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.518 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 92.4 mt -93.48 166.35 12.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' LYS . 44.4 t -104.2 169.88 8.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.489 ' CG ' ' HA ' ' A' ' 109' ' ' PRO . 9.4 mm-40 -43.84 -21.92 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.1 ttmt -90.96 -69.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.448 ' HB3' HD22 ' A' ' 90' ' ' LEU . 9.9 mt-30 -56.49 -45.95 80.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.886 ' CD2' HG21 ' A' ' 111' ' ' VAL . 19.5 t80 -44.55 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.496 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 11.5 ptpt -68.73 -42.15 78.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 8.5 mt-10 -48.4 -58.23 4.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 8.6 mt-30 -80.11 -48.25 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 16.7 m-85 -109.78 68.65 0.47 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.1 Cg_endo -69.84 -11.1 30.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.672 2.248 . . . . 0.0 112.316 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -78.37 -21.82 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.817 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.578 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.9 pt -124.99 22.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 49.9 p -64.26 -19.94 65.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.581 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -97.17 -27.93 14.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.581 ' N ' ' NE2' ' A' ' 104' ' ' GLN . 15.5 mt-10 -41.01 -42.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.2 t -123.14 159.37 28.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -119.01 -21.14 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.467 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.5 m -53.81 162.31 1.42 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.9 Cg_endo -69.79 -43.21 2.77 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.378 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 15.7 m-85 -112.34 101.42 9.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.886 HG21 ' CD2' ' A' ' 95' ' ' PHE . 25.6 t -80.91 136.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CZ ' HG22 ' A' ' 34' ' ' THR . 9.8 m-30 -104.44 104.34 14.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.83 120.69 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.2 m -125.43 154.18 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.95 176.16 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 56.77 53.26 6.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.838 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.2 Cg_endo -69.76 116.41 4.55 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.724 2.283 . . . . 0.0 112.371 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.36 133.89 46.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.26 124.77 44.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.618 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.1 mtp -66.91 147.02 53.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.4 t -68.91 -31.77 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.09 153.0 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.05 146.22 45.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.538 ' HE2' ' HB2' ' A' ' 143' ' ' ALA . 0.8 OUTLIER -112.72 141.96 26.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 0.0 110.879 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 87.21 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.344 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.46 HD11 ' HB1' ' A' ' 43' ' ' ALA . 2.9 pp -121.91 163.35 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.602 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 76.1 mttt -102.18 136.36 42.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.99 161.81 27.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.459 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -142.65 156.71 62.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.644 0.735 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -3.08 11.33 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.578 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 1.6 mmmp? -134.2 -173.75 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.675 HG22 ' CE3' ' A' ' 8' ' ' TRP . 95.6 mt -85.91 142.07 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 3.3 p-90 -149.37 127.24 11.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -55.77 127.78 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 9' ' ' CYS . 60.4 mt -65.35 167.94 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 139' ' ' ILE . 3.6 t70 -73.81 126.46 30.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 136' ' ' ASP . 2.0 m -34.94 -42.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -71.68 -44.96 63.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.1 mm -61.47 -41.13 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.106 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -44.27 -65.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 144' ' ' LYS . 26.5 mt-30 -50.07 -68.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -35.5 -54.69 1.02 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.521 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.565 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -56.18 -37.29 69.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 141' ' ' GLN . 17.2 mtpt -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -92.86 -47.11 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -41.56 -23.43 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 145' ' ' LYS . 11.8 mt -82.94 39.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 110.914 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.8 ptp -103.2 -33.65 9.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -131.98 74.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -73.7 177.12 5.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -61.85 159.72 13.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -34.85 79.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.26 -57.17 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -132.25 41.62 3.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.865 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 4' ' ' GLY . 60.0 p -97.34 123.41 41.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.838 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 3' ' ' SER . . . -35.02 132.45 0.55 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.515 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -95.69 37.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.831 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.8 m -108.65 160.77 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.44 84.17 1.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.615 ' CE3' HG22 ' A' ' 132' ' ' ILE . 91.6 m95 -77.8 159.85 28.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.781 0.324 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB2' HD11 ' A' ' 135' ' ' LEU . 40.9 t -137.4 125.46 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' HB2' HD21 ' A' ' 40' ' ' LEU . 66.6 tp -112.27 116.84 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.416 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 14.6 m -68.74 153.85 43.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 13' ' ' HIS . 72.5 t -135.47 158.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.52 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.8 m-70 -94.54 113.75 25.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.52 ' HG2' ' HB3' ' A' ' 17' ' ' ALA . 79.0 mt-30 -60.53 159.28 25.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.624 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 -32.74 3.73 Favored 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.698 -1.792 . . . . 0.0 112.33 -0.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.628 ' O ' HD12 ' A' ' 20' ' ' LEU . 13.4 m-90 -25.36 -52.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -35.4 -63.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 m -62.01 -46.15 90.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.3 mt -45.63 -39.32 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.3 mp -57.93 -66.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 82' ' ' GLY . 18.2 m -61.29 -20.94 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 11.3 mmt180 -73.87 -39.67 63.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.41 20.07 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.532 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.69 -38.4 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HG2' HD11 ' A' ' 20' ' ' LEU . 13.8 tptt -102.72 102.33 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -95.97 13.39 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 21.2 m -144.85 146.53 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.455 ' OE2' HG22 ' A' ' 12' ' ' VAL . 6.7 tt0 -117.53 134.27 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.24 126.65 8.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 32.0 mmt180 -152.5 150.23 29.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.475 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 24.5 p -88.03 21.81 2.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.439 ' HH2' HD13 ' A' ' 10' ' ' LEU . 4.2 p-90 -142.73 166.46 24.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.5 t80 -110.23 144.47 38.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 34' ' ' THR . 5.1 t -136.99 105.51 8.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 0.0 111.186 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.5 Cg_endo -69.78 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -64.11 111.89 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -115.52 120.11 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.01 -121.36 1.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.446 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -106.28 139.21 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 10' ' ' LEU . 38.4 tp -143.95 116.0 8.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.942 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.4 m95 -72.05 132.43 44.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -102.14 130.41 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.77 154.73 42.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.664 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -89.08 118.64 28.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 12' ' ' VAL . 39.8 p -56.12 179.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.36 4.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 14.6 ttpt -91.86 148.81 21.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 16.6 mtmt -105.55 121.54 45.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.608 0.718 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 127.91 15.25 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 54' ' ' VAL . 4.5 m -73.63 158.24 86.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.619 0.723 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -6.15 17.87 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.722 2.281 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.49 -41.68 9.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -41.8 78.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.58 HG12 ' NE2' ' A' ' 58' ' ' GLN . 38.7 t -67.03 -50.52 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 t -62.52 -44.64 95.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -67.33 -54.35 21.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.628 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 82.6 mt -56.61 -39.13 73.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.0 mt-30 -54.52 -47.17 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.05 -35.73 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -60.86 -49.68 76.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -69.83 -39.49 76.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' A' ' 69' ' ' VAL . 45.2 mtt180 -48.01 -36.2 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.24 -16.75 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.05 -27.09 23.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 3.8 mmm180 -123.7 -28.92 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.051 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 131.2 127.83 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.92 -19.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 9.8 t70 -76.16 8.79 2.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.051 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.2 m -63.02 -179.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 3.4 mm-40 -118.2 171.87 7.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 53.5 m-85 -162.25 137.28 5.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.1 Cg_endo -69.73 152.71 69.54 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.722 2.281 . . . . 0.0 112.324 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -72.49 -28.93 63.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.0 176.1 10.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.624 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 61.7 m-85 -134.42 93.94 18.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.955 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.475 ' HG2' HD21 ' A' ' 81' ' ' LEU . 54.0 Cg_endo -69.77 175.07 8.6 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.703 2.268 . . . . 0.0 112.384 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.7 m -144.47 134.66 24.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.824 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.39 47.59 12.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.462 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.6 m -160.14 148.57 16.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.512 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -75.11 118.59 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.664 HD11 ' HB2' ' A' ' 44' ' ' ALA . 80.7 mt -85.11 -74.06 0.41 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.467 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.94 -145.07 4.19 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.9 p -152.75 161.28 42.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.37 . . . . 0.0 110.841 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 114' ' ' CYS . 13.5 m -146.79 146.45 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.456 ' O ' HD13 ' A' ' 87' ' ' ILE . 1.8 t70 -87.01 107.0 18.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.68 97.9 1.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.552 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -67.88 -47.46 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 3.1 m-20 -165.25 166.67 18.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 t -127.35 99.7 5.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 97.0 mt -94.25 169.19 10.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 p -106.91 169.25 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' A' ' 108' ' ' SER . 19.8 mm-40 -47.99 -18.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -90.69 -58.13 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -71.28 -50.68 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.563 ' CD2' HG21 ' A' ' 111' ' ' VAL . 35.2 t80 -40.22 -55.99 2.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 4.2 ptmt -66.45 -42.41 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 9.1 mt-10 -53.23 -59.2 4.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.458 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -74.76 -50.27 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.8 m-85 -111.21 67.62 0.62 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.59 0.709 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.9 Cg_endo -69.75 -13.89 35.35 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.686 2.257 . . . . 0.0 112.363 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -74.33 -23.07 59.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.699 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.8 pt -122.14 20.84 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.9 p -63.22 -23.6 67.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.634 HE21 ' N ' ' A' ' 105' ' ' GLU . 1.8 pp0? -93.13 -25.69 17.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.699 ' CD ' HG22 ' A' ' 102' ' ' ILE . 36.1 mt-10 -53.14 -33.36 52.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.436 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 2.2 p -127.47 146.51 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 1.6 t70 -111.75 -33.77 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.461 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.8 m -43.6 161.39 0.2 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.686 0.755 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.475 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.6 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.93 102.79 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 95' ' ' PHE . 39.7 t -85.91 136.93 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 5.0 m-30 -105.07 107.05 17.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -74.52 118.44 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -119.39 151.3 38.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -143.03 174.07 11.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.434 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 53.95 54.74 11.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.652 0.739 . . . . 0.0 110.869 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.8 Cg_endo -69.8 121.81 8.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 0.0 112.292 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -132.0 131.69 42.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -97.67 123.55 41.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.512 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.4 mtp -64.34 149.92 47.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.736 HG21 ' HB2' ' A' ' 149' ' ' LYS . 98.9 t -78.08 -21.42 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.85 135.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -102.15 154.71 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CE2' ' HE1' ' A' ' 120' ' ' MET . 0.5 OUTLIER -122.19 142.72 37.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.732 . . . . 0.0 110.919 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.666 2.244 . . . . 0.0 112.32 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.06 158.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.14 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.603 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 28.8 mtmt -92.04 134.77 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.72 167.72 46.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.483 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 1.5 t-20 -156.74 144.34 13.96 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.638 0.733 . . . . 0.0 110.884 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.1 Cg_endo -69.75 3.12 2.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.679 2.253 . . . . 0.0 112.339 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 6.9 mmmm -135.34 -173.89 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.615 HG22 ' CE3' ' A' ' 8' ' ' TRP . 71.7 mt -91.57 134.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.603 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 1.3 p-90 -143.21 130.0 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.471 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 11.2 ttmt -53.67 129.81 34.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.589 HD22 HG21 ' A' ' 139' ' ' ILE . 22.9 mt -65.8 162.77 18.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.3 t0 -73.67 129.77 38.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.92 -50.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -65.09 -39.68 93.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.589 HG21 HD22 ' A' ' 135' ' ' LEU . 19.9 mm -64.66 -47.78 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.136 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ILE . 18.0 t-160 -37.09 -65.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' LYS . 91.6 mt-30 -51.66 -69.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.42 -49.14 0.67 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.503 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.31 -43.55 74.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 141' ' ' GLN . 18.1 mtpp -67.72 -23.24 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 147' ' ' LEU . 17.7 mmtp -77.89 -53.1 7.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.17 -27.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 145' ' ' LYS . 17.6 mt -81.5 39.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.843 0.354 . . . . 0.0 110.919 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 5.5 ptp -108.27 -26.0 10.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.736 ' HB2' HG21 ' A' ' 121' ' ' VAL . 20.8 mtpt -125.91 43.8 2.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 149' ' ' LYS . 9.8 mm-40 -34.52 150.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -38.71 155.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -45.69 -50.06 13.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -45.29 -57.45 3.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 p -118.99 -48.1 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 110.897 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.0 p -132.93 150.17 52.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.55 99.36 0.84 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.434 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.3 p -120.67 149.99 41.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 0.0 110.842 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 m -125.72 20.82 7.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.835 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.32 61.57 4.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.7 ' CE3' HG22 ' A' ' 132' ' ' ILE . 90.4 m95 -74.26 162.56 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.774 0.321 . . . . 0.0 110.895 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.2 t -138.83 138.8 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.449 HD13 ' HH2' ' A' ' 32' ' ' TRP . 25.4 tp -123.1 111.85 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.409 ' CB ' ' HA3' ' A' ' 128' ' ' GLY . 60.3 p -70.54 125.83 27.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.54 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 17.7 t -107.98 160.67 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.54 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 56.1 m-70 -91.14 111.14 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.503 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 70.0 mt-30 -58.85 159.93 12.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.664 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.75 -31.36 4.6 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.375 -0.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.541 ' C ' ' O ' ' A' ' 15' ' ' PRO . 9.1 m-90 -25.98 -54.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' HB3' ' CG ' ' A' ' 14' ' ' GLN . . . -36.52 -58.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 66.4 m -66.08 -40.74 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.87 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 16' ' ' TRP . 63.0 mt -51.94 -26.34 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 9.2 mp -71.24 -69.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.885 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.4 m -58.84 -15.0 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 8.9 mmt180 -79.98 -39.49 29.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.44 6.21 8.94 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.458 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.81 -47.59 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HE2' ' CD1' ' A' ' 16' ' ' TRP . 3.4 tptp -90.35 117.7 29.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 13.2 ttt180 -102.62 0.09 32.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.484 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 17.6 m -147.01 154.96 11.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 29' ' ' GLY . 8.2 tm-20 -122.54 153.3 39.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 28' ' ' GLU . . . -112.7 130.55 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.528 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HG3' ' CZ2' ' A' ' 32' ' ' TRP . 9.2 mmt180 -149.05 149.7 31.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.444 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 57.7 p -85.27 20.36 2.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.539 ' CE2' ' HD2' ' A' ' 131' ' ' LYS . 1.9 p-90 -145.09 167.68 22.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 34' ' ' THR . 5.0 t80 -108.82 141.35 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 34' ' ' THR . 6.9 t -134.93 103.56 10.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.571 0.7 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.9 Cg_endo -69.71 2.39 3.55 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.273 . . . . 0.0 112.336 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -60.89 108.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 88' ' ' ASP . 6.3 mmt85 -111.65 122.92 49.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.15 -123.2 1.65 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.1 ttm105 -104.98 140.97 37.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.0 tp -143.98 114.41 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 91.1 m95 -71.27 131.93 44.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.96 127.49 56.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.99 49.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -83.23 119.36 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.5 p -54.24 -174.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.78 -10.47 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 4.9 ttpt -73.6 148.7 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 1.2 pmtp? -108.53 132.56 21.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 0.0 110.872 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 54' ' ' VAL . 3.3 m -73.97 159.81 83.24 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -8.3 23.26 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.739 2.293 . . . . 0.0 112.345 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -42.43 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -40.94 84.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 50' ' ' SER . 62.1 t -65.07 -51.15 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -64.07 -45.82 87.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.25 -53.27 46.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.51 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 79.2 mt -56.03 -43.33 77.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 10.2 mt-30 -51.73 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.71 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 m -61.49 -48.76 79.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -70.89 -33.52 70.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HG2' HG22 ' A' ' 69' ' ' VAL . 43.6 mtt180 -53.5 -36.07 61.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.4 -12.8 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.429 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 71.4 mt -90.65 -29.04 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.965 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' NE ' ' O ' ' A' ' 64' ' ' LEU . 3.8 mmp_? -122.92 -29.06 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.067 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 134.12 129.01 2.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.9 -18.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.319 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.7 t70 -82.43 20.4 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.067 HG13 ' O ' ' A' ' 66' ' ' GLY . 29.3 m -70.91 179.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 13.2 mt-10 -116.61 166.9 11.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 52.7 m-85 -159.87 138.56 7.78 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 0.0 110.842 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 54.3 Cg_endo -69.77 163.86 36.71 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.08 -22.91 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -150.61 166.69 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 78.1 m-85 -130.44 87.93 48.86 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.903 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.54 ' HG2' HD21 ' A' ' 81' ' ' LEU . 53.2 Cg_endo -69.77 171.62 14.14 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.642 2.228 . . . . 0.0 112.325 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.6 p -138.91 144.38 39.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.6 89.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 124' ' ' PHE . 67.0 m -149.79 146.74 27.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -76.26 118.66 19.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 44' ' ' ALA . 56.1 mt -87.69 -71.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.572 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -146.33 -150.44 5.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.501 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 2.1 p -149.59 153.69 37.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.89 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 22.3 m -140.2 142.23 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.29 114.45 21.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tt -77.1 95.67 4.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.597 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -64.61 -46.05 93.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.478 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 1.6 m-20 -166.7 165.9 16.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.44 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.2 t -127.37 99.04 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 83.0 mt -97.02 170.91 8.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.406 ' C ' ' N ' ' A' ' 93' ' ' LYS . 30.4 t -110.04 169.11 8.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -46.62 -20.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 24.7 ttmt -89.64 -60.62 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -70.53 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.615 ' CD2' HG21 ' A' ' 111' ' ' VAL . 21.1 t80 -39.24 -54.95 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.9 ptmm? -68.45 -47.52 66.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 6.7 mt-10 -46.01 -54.37 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 6.5 mt-30 -81.18 -51.81 8.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 18.6 m-85 -107.11 70.92 0.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.627 0.727 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.3 Cg_endo -69.77 -17.48 37.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.385 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.3 -26.7 60.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.594 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.1 pt -120.23 24.35 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.481 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 22.1 p -68.25 -21.16 64.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.538 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.3 pp0? -96.42 -23.52 16.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.565 ' OE2' HG22 ' A' ' 102' ' ' ILE . 11.3 mt-10 -48.04 -41.24 25.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 111' ' ' VAL . 1.5 t -124.1 143.02 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -104.3 -28.63 11.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -45.85 161.49 0.26 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.652 0.739 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.444 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.2 Cg_endo -69.78 -43.66 2.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -112.92 102.49 10.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.615 HG21 ' CD2' ' A' ' 95' ' ' PHE . 59.3 t -85.18 136.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.44 ' HE1' ' HG ' ' A' ' 89' ' ' CYS . 7.3 m-30 -105.0 104.22 13.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.818 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -74.17 121.84 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.106 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.447 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.7 m -122.78 154.09 38.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' CG ' HD12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -139.45 177.03 8.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.46 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 52.6 53.54 12.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.902 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 54.0 Cg_endo -69.66 117.46 5.09 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.714 2.276 . . . . 0.0 112.372 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -131.33 143.59 50.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -107.95 120.6 42.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.584 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.2 mtp -62.67 153.47 32.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.62 -32.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.76 132.57 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.127 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.446 ' NZ ' ' O ' ' A' ' 120' ' ' MET . 16.8 mmtm -102.18 154.28 19.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 79' ' ' CYS . 1.1 m-85 -120.48 142.35 33.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 88.23 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.92 165.24 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.6 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 50.0 mtpt -107.23 135.6 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.409 ' HA3' ' CB ' ' A' ' 11' ' ' SER . . . -90.17 171.89 37.58 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.477 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -150.29 156.43 37.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.316 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.7 mmmm -139.37 -175.33 4.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.7 HG22 ' CE3' ' A' ' 8' ' ' TRP . 62.0 mt -84.8 132.18 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.6 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 4.4 p-90 -138.71 131.74 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.567 ' HE3' ' CZ2' ' A' ' 8' ' ' TRP . 12.3 ttmt -58.25 128.78 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.4 mt -64.68 170.61 3.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 139' ' ' ILE . 5.1 t0 -78.63 127.01 31.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -34.41 -50.3 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -65.46 -40.29 93.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.9 mm -64.12 -45.93 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -40.45 -65.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 142' ' ' GLY . 44.9 mt-30 -52.44 -70.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.67 -43.49 0.8 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.469 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.434 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -61.55 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -61.06 -20.89 63.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' LEU . 18.3 mmmt -90.33 -48.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -40.94 -21.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 145' ' ' LYS . 42.0 mt -79.37 37.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 148' ' ' MET . 2.6 ptp -122.5 133.94 54.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt 60.28 54.96 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.485 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -101.64 176.89 5.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 150' ' ' GLN . 3.6 p30 -35.33 131.29 0.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -89.81 40.06 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.941 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.67 -49.02 1.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.18 179.931 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -64.81 126.54 28.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 110.822 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t -88.07 130.41 35.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.91 130.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.5 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 t -125.58 94.08 4.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.852 0.358 . . . . 0.0 110.852 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.73 115.6 30.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.42 109.16 2.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.475 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.607 ' CZ2' ' HD3' ' A' ' 134' ' ' LYS . 92.7 m95 -93.5 167.92 11.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.3 t -141.28 159.28 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.702 HD23 ' CD ' ' A' ' 28' ' ' GLU . 31.7 tp -145.42 116.65 7.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 129' ' ' ASN . 2.7 t -67.99 146.34 53.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.51 ' CG2' ' OE2' ' A' ' 28' ' ' GLU . 74.3 t -134.26 153.97 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.415 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.2 m-70 -88.68 113.68 24.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.77 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 46.3 mt-30 -59.94 161.88 11.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.621 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.8 Cg_endo -69.72 -28.43 6.25 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.338 -0.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.563 ' O ' HD12 ' A' ' 20' ' ' LEU . 10.5 m-90 -28.7 -53.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.77 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.57 -64.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.42 -43.22 99.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.6 mt -48.97 -36.61 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.8 mp -59.75 -64.83 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG11 ' N ' ' A' ' 82' ' ' GLY . 14.2 m -63.33 -17.92 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.469 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.0 mmt180 -76.49 -39.98 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.54 18.84 3.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 70' ' ' GLU . 5.3 mp -105.61 -37.54 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 111.162 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HG2' HD11 ' A' ' 20' ' ' LEU . 4.9 tptp -102.91 95.54 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.607 ' NE ' HD13 ' A' ' 102' ' ' ILE . 22.4 ptt180 -92.24 14.53 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.623 ' CG1' HD12 ' A' ' 102' ' ' ILE . 30.6 m -146.76 143.94 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.702 ' CD ' HD23 ' A' ' 10' ' ' LEU . 2.5 tt0 -115.97 141.79 47.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.62 122.83 7.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -146.29 149.1 33.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 41.2 p -86.41 23.15 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.49 ' CH2' HG13 ' A' ' 132' ' ' ILE . 3.7 p-90 -146.01 160.16 42.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -100.78 138.95 37.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 34' ' ' THR . 10.6 t -133.16 100.03 14.44 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.565 0.698 . . . . 0.0 111.109 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.76 8.9 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.354 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -67.27 108.18 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.471 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 63.3 mmt-85 -106.86 115.83 30.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.45 -138.72 6.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -94.92 142.61 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -143.97 115.98 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 92.0 m95 -71.07 138.35 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.952 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -109.04 127.3 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.59 152.18 39.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.832 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -85.63 119.03 25.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 12' ' ' VAL . 41.1 p -54.4 -179.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.142 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.83 22.41 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -110.59 132.06 54.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -91.75 130.62 38.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.547 0.689 . . . . 0.0 110.937 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.6 Cg_endo -69.73 134.24 27.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.0 m -75.51 159.21 82.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.697 0.761 . . . . 0.0 110.857 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.689 2.259 . . . . 0.0 112.343 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -94.34 -42.34 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -40.28 86.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.672 HG12 ' NE2' ' A' ' 58' ' ' GLN . 43.5 t -65.62 -50.73 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.03 -42.3 99.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -67.92 -53.74 24.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.405 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 93.9 mt -59.14 -38.74 80.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.672 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.5 mt-30 -55.26 -46.15 76.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.85 -35.35 38.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.2 m -61.42 -51.63 67.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -67.48 -41.29 84.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.935 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 69' ' ' VAL . 52.3 mtt180 -48.16 -36.07 12.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.907 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -86.74 -16.19 37.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.8 mt -88.17 -27.25 21.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -123.38 -26.93 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.066 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 127.74 129.03 3.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.455 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.29 -19.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -72.59 3.85 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.066 HG13 ' O ' ' A' ' 66' ' ' GLY . 35.2 m -61.65 178.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.528 ' O ' HD11 ' A' ' 24' ' ' ILE . 10.7 mp0 -119.73 167.85 11.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.587 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 67.8 m-85 -155.47 141.14 12.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.834 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 53.9 Cg_endo -69.77 165.87 29.51 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.66 2.24 . . . . 0.0 112.323 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -88.88 -20.75 24.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.48 174.38 14.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.621 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 87.7 m-85 -134.99 89.73 23.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.66 0.743 . . . . 0.0 110.947 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.468 ' N ' HE22 ' A' ' 14' ' ' GLN . 53.7 Cg_endo -69.75 168.9 20.21 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.719 2.279 . . . . 0.0 112.354 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 72.0 m -134.91 139.58 45.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.92 92.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.44 ' C ' HD11 ' A' ' 126' ' ' ILE . 81.5 m -152.76 157.33 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.866 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.77 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.4 OUTLIER -80.69 117.83 21.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.832 HD11 ' HB2' ' A' ' 44' ' ' ALA . 17.1 mt -85.87 -71.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.637 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -149.4 -140.35 3.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.484 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 3.2 p -156.33 166.36 33.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 16.4 m -154.16 138.71 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.417 ' CB ' HD22 ' A' ' 116' ' ' ASN . 1.5 t70 -81.6 113.91 19.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.66 94.38 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.607 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -62.67 -46.85 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 113' ' ' ILE . 5.5 m-20 -165.53 170.19 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.17 102.08 6.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 94' ' ' GLN . 97.7 mt -95.87 171.18 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.947 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 93' ' ' LYS . 5.3 p -106.92 169.2 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 108' ' ' SER . 10.0 mm-40 -43.87 -22.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 31.7 ttpt -92.65 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.632 ' HB3' HD22 ' A' ' 90' ' ' LEU . 7.9 mm100 -56.3 -46.42 79.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.59 ' CE1' HG11 ' A' ' 27' ' ' VAL . 17.6 t80 -41.95 -58.95 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.8 OUTLIER -68.86 -44.91 72.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 8.0 mt-10 -43.06 -55.72 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.462 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 5.9 mt-30 -83.62 -43.4 15.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 36.0 m-85 -115.81 68.41 3.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.681 0.753 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 96' ' ' LYS . 53.9 Cg_endo -69.76 -12.86 33.77 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 0.0 112.365 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.29 -16.45 60.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.723 HG22 ' CD ' ' A' ' 105' ' ' GLU . 1.0 OUTLIER -128.77 21.15 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 21.9 p -60.25 -25.87 66.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.576 ' NE2' ' N ' ' A' ' 105' ' ' GLU . 2.4 pp0? -94.28 -28.8 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.723 ' CD ' HG22 ' A' ' 102' ' ' ILE . 20.8 mt-10 -47.44 -36.95 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 t -120.04 157.57 28.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.401 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 3.5 t0 -125.17 -29.27 3.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.505 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -50.19 161.54 0.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.893 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 92' ' ' GLN . 53.6 Cg_endo -69.78 -41.53 4.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.673 2.248 . . . . 0.0 112.311 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -115.65 101.69 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.558 HG21 ' CD2' ' A' ' 95' ' ' PHE . 21.4 t -84.97 139.85 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CZ ' HG22 ' A' ' 34' ' ' THR . 7.3 m-30 -105.9 105.59 15.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -73.95 119.91 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.134 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.8 m -122.51 154.18 38.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -141.36 177.07 8.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.481 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 53.51 51.6 8.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.6 Cg_endo -69.74 120.6 7.37 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.372 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.99 138.94 47.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -101.73 123.13 45.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.77 ' HE1' HD13 ' A' ' 80' ' ' LEU . 15.5 mtp -65.43 136.58 56.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 148' ' ' MET . 51.2 t -62.07 -27.72 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 143.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mttp -114.23 142.73 45.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.495 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.8 OUTLIER -108.03 146.37 33.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.91 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 89.92 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.4 pp -126.28 157.82 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.624 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 10.5 pttm -92.33 157.17 16.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.41 -177.59 28.68 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.507 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.502 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 3.5 t30 -169.74 146.83 2.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.617 0.722 . . . . 0.0 110.885 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HD2' ' CG ' ' A' ' 129' ' ' ASN . 54.0 Cg_endo -69.79 0.32 5.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.353 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 32' ' ' TRP . 7.5 mmmm -133.93 -172.78 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.517 HG22 ' CE3' ' A' ' 8' ' ' TRP . 34.6 mt -82.93 130.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.624 ' CH2' ' O ' ' A' ' 127' ' ' LYS . 6.1 p-90 -136.23 110.04 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.607 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 1.2 ttpp -54.76 127.09 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.9 mt -57.4 169.36 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -73.58 163.1 28.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -42.25 99.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -77.08 -34.67 56.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 124' ' ' PHE . 48.7 mm -72.22 -37.1 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.426 ' NE2' ' HD2' ' A' ' 144' ' ' LYS . 22.4 t-160 -48.89 -63.85 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 142' ' ' GLY . 34.4 mt-30 -50.67 -67.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -33.87 -54.33 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.482 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -52.61 -43.53 65.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 141' ' ' GLN . 11.3 mtpt -66.17 -15.45 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -99.4 -34.09 10.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.02 9.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.464 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 72.5 mt -83.94 23.16 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.406 ' O ' HG21 ' A' ' 121' ' ' VAL . 4.3 ptp -99.53 136.85 38.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? 48.02 42.44 16.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 3.1 mm-40 -37.83 -73.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.477 ' O ' HG12 ' A' ' 154' ' ' VAL . 62.9 m-20 -136.93 167.27 21.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -77.76 -40.13 41.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.84 -59.84 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 151' ' ' ASN . 12.6 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -65.32 165.42 11.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.88 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 t -115.05 -44.32 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 5' ' ' SER . . . -149.59 46.52 0.65 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 4' ' ' GLY . 42.4 p -37.38 -47.78 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.834 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 23.8 m -50.46 135.59 22.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.85 92.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.578 ' CE3' HG22 ' A' ' 132' ' ' ILE . 90.6 m95 -73.81 160.89 30.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.728 0.299 . . . . 0.0 110.904 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' HD11 ' A' ' 135' ' ' LEU . 9.7 t -135.54 123.02 22.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD13 ' HH2' ' A' ' 32' ' ' TRP . 61.9 tp -112.11 118.31 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' CA ' ' A' ' 128' ' ' GLY . 3.2 m -71.83 155.13 40.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 13' ' ' HIS . 53.4 t -138.44 162.3 30.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.573 ' N ' HG12 ' A' ' 12' ' ' VAL . 67.2 m-70 -97.36 114.89 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.518 ' HA ' ' C ' ' A' ' 15' ' ' PRO . 11.6 mm-40 -59.8 158.55 23.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 110.861 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.77 -33.28 3.47 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 -1.807 . . . . 0.0 112.358 -0.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.61 ' CZ2' HD11 ' A' ' 57' ' ' LEU . 16.7 m-90 -25.01 -56.88 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . . . -33.81 -53.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.7 m -72.9 -50.99 20.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD23 HD13 ' A' ' 24' ' ' ILE . 51.7 mt -40.55 -32.43 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.484 HD11 ' HG2' ' A' ' 25' ' ' LYS . 6.8 mp -64.75 -68.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.7 m -60.78 -16.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 10.5 mmt180 -77.19 -39.31 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.21 12.17 5.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.43 HD13 HD23 ' A' ' 19' ' ' LEU . 5.3 mp -98.29 -48.62 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.3 tptt -89.15 117.08 27.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.451 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.9 ttm180 -101.07 -6.85 23.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.521 HG11 ' CE1' ' A' ' 95' ' ' PHE . 21.5 m -133.33 158.34 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.52 124.97 41.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.18 128.45 8.85 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -147.51 147.74 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 91.1 p -85.15 17.52 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.479 ' HH2' HD13 ' A' ' 10' ' ' LEU . 2.5 p-90 -142.51 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.414 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . 4.1 t80 -106.36 139.3 41.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 34' ' ' THR . 8.1 t -134.32 101.71 12.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.613 0.72 . . . . 0.0 111.163 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HA ' ' NH2' ' A' ' 37' ' ' ARG . 53.9 Cg_endo -69.8 6.79 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.357 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -64.54 108.82 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' NH2' ' HA ' ' A' ' 35' ' ' PRO . 55.8 mmt-85 -105.23 112.67 25.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.31 -152.43 23.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -79.28 143.57 35.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.829 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.415 HD21 ' HB2' ' A' ' 10' ' ' LEU . 25.2 tp -143.87 115.08 7.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.572 ' CE3' ' HB3' ' A' ' 83' ' ' CYS . 95.5 m95 -71.12 124.8 25.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.72 122.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.131 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.92 149.84 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.646 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.21 123.63 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.094 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 12' ' ' VAL . 28.5 p -59.43 -174.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.27 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -81.41 135.0 35.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.25 41.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.618 0.723 . . . . 0.0 110.867 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 129.54 17.76 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -76.35 159.27 80.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.68 0.752 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -3.62 12.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.96 -41.41 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.88 -43.31 72.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.712 HG12 ' NE2' ' A' ' 58' ' ' GLN . 33.3 t -65.78 -52.54 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -59.75 -45.7 91.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.34 -56.67 8.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.61 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 92.1 mt -55.9 -38.51 70.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.712 ' NE2' HG12 ' A' ' 54' ' ' VAL . 9.7 mt-30 -57.46 -43.53 84.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.43 -32.61 32.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -66.24 -52.29 49.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.536 ' HE2' HD22 ' A' ' 57' ' ' LEU . 31.9 m-85 -66.32 -38.26 87.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.573 ' HG2' HG22 ' A' ' 69' ' ' VAL . 65.0 mtt180 -47.71 -34.2 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.62 -16.01 31.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 61' ' ' TYR . 48.6 mt -87.28 -29.96 21.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -120.27 -29.13 4.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.056 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.95 124.87 2.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 62' ' ' ARG . 0.4 OUTLIER -43.99 -21.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.776 0.322 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 66' ' ' GLY . 6.5 t0 -79.85 18.88 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.056 HG13 ' O ' ' A' ' 66' ' ' GLY . 24.9 m -69.07 -178.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' O ' ' CD1' ' A' ' 71' ' ' PHE . 5.4 pt-20 -117.51 166.3 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 58' ' ' GLN . 42.6 m-85 -158.92 135.53 6.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.692 0.758 . . . . 0.0 110.87 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 53.7 Cg_endo -69.74 145.76 58.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.364 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.19 -27.08 66.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.426 ' C ' ' CD1' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -149.4 -178.11 6.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.571 ' CE2' ' HB3' ' A' ' 15' ' ' PRO . 13.9 m-85 -141.19 105.0 6.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.697 0.761 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.613 ' HG2' HD21 ' A' ' 81' ' ' LEU . 54.1 Cg_endo -69.75 178.35 4.65 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.652 2.235 . . . . 0.0 112.371 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.1 p -142.66 130.49 21.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.12 48.75 66.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 59.3 m -150.62 148.42 28.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -77.33 115.29 16.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 44' ' ' ALA . 32.3 mt -83.25 -71.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -147.15 -139.68 3.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.572 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 7.1 p -155.81 157.68 36.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 m -144.63 136.7 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.74 110.94 14.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.6 96.16 4.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.58 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -64.29 -50.37 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.405 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -161.23 167.88 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.479 ' HG ' ' HE1' ' A' ' 112' ' ' PHE . 1.3 t -128.2 101.3 6.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 80.8 mt -98.61 170.88 8.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 93' ' ' LYS . 29.3 t -109.44 169.18 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.455 ' NE2' ' O ' ' A' ' 108' ' ' SER . 20.4 mm-40 -46.29 -20.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 91' ' ' SER . 19.5 tttt -89.56 -60.61 1.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -70.02 -50.4 41.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.557 ' CD2' HG21 ' A' ' 111' ' ' VAL . 28.7 t80 -39.72 -55.32 1.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 5.8 ptmm? -67.96 -47.49 68.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.519 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 5.8 mt-10 -45.88 -55.93 6.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 7.0 mt-30 -78.67 -52.73 8.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 23.9 m-85 -108.15 70.1 0.34 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.7 Cg_endo -69.77 -15.46 37.07 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.647 2.231 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -73.36 -26.3 60.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.479 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 1.4 pt -118.96 21.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 96' ' ' LYS . 17.6 p -64.49 -22.14 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.624 HE21 ' N ' ' A' ' 105' ' ' GLU . 1.7 pp0? -96.04 -21.4 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.624 ' N ' HE21 ' A' ' 104' ' ' GLN . 7.5 mt-10 -56.23 -36.25 68.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.49 ' OG ' ' CE2' ' A' ' 95' ' ' PHE . 4.5 p -125.85 138.35 53.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.854 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.45 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 15.4 t70 -104.57 -30.57 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.455 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 1.6 m -44.28 161.04 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.673 0.749 . . . . 0.0 110.866 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.414 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 54.1 Cg_endo -69.75 -47.8 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 33' ' ' TYR . 22.1 m-85 -110.0 99.52 8.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 95' ' ' PHE . 46.5 t -80.86 144.61 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CZ ' HG22 ' A' ' 34' ' ' THR . 12.6 m-30 -110.99 106.18 15.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER -75.07 120.0 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.8 m -126.03 153.64 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' C ' ' ND2' ' A' ' 116' ' ' ASN . 16.6 mmmt -143.09 174.07 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.3 OUTLIER 57.62 52.97 5.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.3 Cg_endo -69.71 119.47 6.42 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.337 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -132.05 134.26 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -99.79 126.01 45.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.51 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.9 mtp -65.69 152.82 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 149' ' ' LYS . 99.3 t -70.23 -36.58 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.5 p -127.07 142.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.152 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -104.74 152.4 22.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.02 139.53 24.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 88.01 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.302 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.66 160.35 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.599 ' O ' ' CZ2' ' A' ' 133' ' ' TRP . 5.7 mtmp? -92.12 128.29 37.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' CA ' ' OG ' ' A' ' 11' ' ' SER . . . -89.37 151.6 22.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.499 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -132.33 154.0 81.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 2.28 3.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.455 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 7.1 mmmm -135.83 -174.12 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.578 HG22 ' CE3' ' A' ' 8' ' ' TRP . 58.1 mt -89.05 132.57 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.599 ' CZ2' ' O ' ' A' ' 127' ' ' LYS . 2.3 p-90 -140.69 129.83 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.05 127.35 28.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 9' ' ' CYS . 31.2 mt -62.45 166.86 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 139' ' ' ILE . 4.4 t0 -76.38 129.04 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.7 m -35.55 -38.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -75.47 -42.62 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 mm -64.16 -40.16 88.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -44.22 -65.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 142' ' ' GLY . 28.3 mt-30 -51.86 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -36.05 -49.01 1.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.494 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.444 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -55.66 -51.02 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.104 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HB2' ' HZ2' ' A' ' 144' ' ' LYS . 2.0 mtpm? -57.84 -32.45 67.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 147' ' ' LEU . 21.3 mmmt -71.59 -50.8 27.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -38.74 -25.51 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 145' ' ' LYS . 23.6 mt -85.18 42.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 ptp -104.59 -36.81 7.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.437 ' O ' HG22 ' A' ' 121' ' ' VAL . 15.9 tptp -131.85 70.75 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 4.0 mm-40 -56.73 163.54 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.886 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -52.36 143.49 14.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 153' ' ' ALA . 41.2 mtpt -87.57 -43.96 11.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 152' ' ' LYS . . . -34.24 -61.49 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.087 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 179.948 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.3 p -42.17 117.83 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 110.823 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -147.45 122.04 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.882 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.03 54.9 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.491 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.0 t -104.2 45.7 0.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.845 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 m -85.75 29.06 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.07 63.79 4.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -72.39 167.51 20.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -135.85 140.54 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.1 tp -131.12 106.66 8.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -67.65 147.32 52.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 13' ' ' HIS . 29.4 t -132.35 157.88 43.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.486 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 40.8 m-70 -88.03 115.26 25.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.78 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 45.1 mt-30 -61.22 162.21 14.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' CB ' ' CE2' ' A' ' 75' ' ' TYR . 53.6 Cg_endo -69.78 -27.46 6.82 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.318 0.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.514 ' O ' HD12 ' A' ' 20' ' ' LEU . 11.5 m-90 -30.33 -52.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.78 ' HB3' ' HG3' ' A' ' 14' ' ' GLN . . . -35.88 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' LEU . 1.7 m -61.33 -52.75 63.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.529 HD23 HD13 ' A' ' 24' ' ' ILE . 57.1 mt -38.37 -41.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 16' ' ' TRP . 6.9 mp -55.99 -68.37 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 ' N ' ' A' ' 82' ' ' GLY . 33.0 m -59.84 -12.94 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' NE ' ' HB3' ' A' ' 72' ' ' PRO . 9.7 mmt180 -83.13 -39.57 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.97 -6.5 8.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.529 HD13 HD23 ' A' ' 19' ' ' LEU . 5.4 mp -78.8 -46.96 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HG2' HD11 ' A' ' 20' ' ' LEU . 12.3 tptt -94.64 111.94 23.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.415 ' HG3' HG13 ' A' ' 27' ' ' VAL . 15.5 ptm180 -108.41 16.67 22.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.568 HG11 ' CE1' ' A' ' 95' ' ' PHE . 27.2 m -149.6 143.95 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' OE1' HD21 ' A' ' 20' ' ' LEU . 6.6 tp10 -111.69 150.14 30.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' HB2' ' A' ' 108' ' ' SER . . . -115.37 123.95 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 85.2 mmt-85 -149.8 151.71 34.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.5 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . 12.2 t -87.93 24.0 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.518 ' CZ2' ' HD2' ' A' ' 30' ' ' ARG . 3.3 p-90 -144.6 157.78 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -99.26 137.77 37.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 34' ' ' THR . 9.3 t -133.59 100.94 13.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.577 0.704 . . . . 0.0 111.169 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 34' ' ' THR . 53.4 Cg_endo -69.77 6.22 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.712 2.275 . . . . 0.0 112.365 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.43 ' O ' HD22 ' A' ' 86' ' ' LEU . 17.8 t60 -64.63 111.37 2.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' A' ' 34' ' ' THR . 15.8 mmt180 -112.67 110.54 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.14 -142.37 8.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.445 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.1 ttp-105 -82.11 142.31 32.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.854 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 tp -143.69 106.83 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.622 ' CZ3' ' HB1' ' A' ' 143' ' ' ALA . 91.4 m95 -71.8 118.83 15.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 43.6 mm -91.59 129.85 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 126' ' ' ILE . . . -122.75 148.57 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.819 ' HB2' HD11 ' A' ' 81' ' ' LEU . . . -82.42 112.42 19.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 12' ' ' VAL . 40.3 p -48.5 175.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.57 -12.46 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -74.35 142.22 45.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -103.22 131.59 21.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.547 0.689 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HG3' ' CB ' ' A' ' 75' ' ' TYR . 54.0 Cg_endo -69.74 133.42 25.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.638 2.225 . . . . 0.0 112.392 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 54' ' ' VAL . 2.8 m -82.16 159.17 65.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.683 0.754 . . . . 0.0 110.815 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -2.81 10.79 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.513 ' NE2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -94.31 -46.53 7.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -69.28 -41.19 77.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.711 HG12 ' NE2' ' A' ' 58' ' ' GLN . 56.9 t -63.15 -51.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -60.51 -44.22 96.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 18.6 mt-10 -66.69 -57.24 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.407 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 90.0 mt -54.03 -40.25 66.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.711 ' NE2' HG12 ' A' ' 54' ' ' VAL . 10.7 mt-30 -55.0 -45.57 75.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.29 -34.98 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.086 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 m -61.99 -50.76 70.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.413 ' HA ' HD12 ' A' ' 64' ' ' LEU . 30.9 m-85 -68.7 -39.18 80.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HG2' HG22 ' A' ' 69' ' ' VAL . 59.7 mtt180 -47.67 -34.03 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 25.7 mt -90.57 -15.53 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 61' ' ' TYR . 59.1 mt -88.0 -29.42 20.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -121.21 -28.96 4.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.032 ' O ' HG13 ' A' ' 69' ' ' VAL . . . 133.37 125.35 2.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.482 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.57 -19.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' GLY . 11.6 t70 -80.69 16.52 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.032 HG13 ' O ' ' A' ' 66' ' ' GLY . 27.6 m -66.75 -177.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.502 ' O ' ' CG ' ' A' ' 71' ' ' PHE . 5.4 pt-20 -116.09 170.07 8.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.597 ' CE1' ' HG2' ' A' ' 58' ' ' GLN . 52.1 m-85 -163.27 136.56 4.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.677 0.751 . . . . 0.0 110.855 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HB3' ' NE ' ' A' ' 22' ' ' ARG . 54.4 Cg_endo -69.75 158.9 55.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.66 2.24 . . . . 0.0 112.385 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -76.92 -30.28 56.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -148.73 177.9 9.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.594 ' CE2' ' CB ' ' A' ' 15' ' ' PRO . 57.4 m-85 -134.87 95.84 15.13 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.65 0.738 . . . . 0.0 110.884 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 14' ' ' GLN . 53.5 Cg_endo -69.8 -179.92 3.27 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.375 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -145.62 143.94 30.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.5 47.23 92.16 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 87.3 m -156.27 146.95 21.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.368 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' HE1' ' A' ' 120' ' ' MET . 0.3 OUTLIER -74.53 121.51 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 44' ' ' ALA . 16.9 mt -88.9 -71.2 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.948 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.639 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -145.95 -147.47 4.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.455 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.585 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . 5.1 p -153.57 154.68 34.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 114' ' ' CYS . 24.3 m -140.7 141.4 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.401 ' CB ' HD22 ' A' ' 116' ' ' ASN . 2.9 t70 -83.25 111.34 18.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 112' ' ' PHE . 2.8 tt -75.85 99.06 4.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.554 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -68.34 -48.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.181 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -162.27 168.57 22.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.87 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.43 103.11 7.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HB3' ' N ' ' A' ' 95' ' ' PHE . 87.0 mt -98.76 166.87 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 93' ' ' LYS . 48.5 t -104.72 168.5 9.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -45.81 -20.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' N ' ' C ' ' A' ' 91' ' ' SER . 23.6 ttpt -91.3 -63.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.59 -49.48 75.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 27' ' ' VAL . 61.3 t80 -43.2 -56.2 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HB2' ' CB ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -66.38 -38.36 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.878 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.406 ' N ' ' HG2' ' A' ' 96' ' ' LYS . 7.0 mt-10 -56.16 -55.21 35.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 10.8 mt-30 -78.48 -52.09 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 98' ' ' GLN . 28.4 m-85 -109.85 68.22 0.46 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.665 0.745 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 98' ' ' GLN . 53.8 Cg_endo -69.81 -14.23 35.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -73.12 -22.31 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 27' ' ' VAL . 2.4 pt -121.34 8.22 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.509 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 89.5 p -49.06 -25.27 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.568 ' CD ' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -90.7 -28.69 18.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.881 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 104' ' ' GLN . 4.1 mt-10 -56.36 -22.57 31.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.498 ' OG ' HG21 ' A' ' 111' ' ' VAL . 1.9 p -113.98 160.3 18.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -134.88 -33.15 0.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.486 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -62.34 165.51 8.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.719 0.771 . . . . 0.0 110.826 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.5 ' CG ' ' HA ' ' A' ' 31' ' ' SER . 53.0 Cg_endo -69.84 -45.11 1.66 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -110.55 98.0 7.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.498 HG21 ' OG ' ' A' ' 106' ' ' SER . 13.5 t -83.37 140.26 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.488 ' HB3' HD11 ' A' ' 86' ' ' LEU . 3.0 m-30 -107.57 110.48 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.15 122.13 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 3.7 m -124.95 154.86 40.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -142.04 176.29 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.4 OUTLIER 57.5 52.67 5.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 116' ' ' ASN . 53.9 Cg_endo -69.76 117.38 5.05 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.671 2.248 . . . . 0.0 112.354 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -133.08 139.08 46.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -101.47 125.55 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.599 ' HE1' HD13 ' A' ' 80' ' ' LEU . 14.2 mtp -67.01 150.91 48.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 149' ' ' LYS . 95.2 t -75.18 -31.01 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.4 146.35 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 20.1 mmtm -112.74 149.48 32.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.555 ' CD2' HG23 ' A' ' 139' ' ' ILE . 1.2 m-85 -115.18 141.07 26.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.864 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 84.58 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.341 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.593 HD13 ' HH2' ' A' ' 133' ' ' TRP . 2.7 pp -115.2 158.81 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' O ' ' CH2' ' A' ' 133' ' ' TRP . 39.5 mmtt -91.45 121.84 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.66 155.79 53.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -148.85 156.0 40.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -51.12 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.667 2.245 . . . . 0.0 112.32 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.466 ' HD2' ' CE2' ' A' ' 32' ' ' TRP . 8.0 mmmm -86.54 -174.53 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.426 HG13 ' CH2' ' A' ' 32' ' ' TRP . 66.3 mt -83.03 141.63 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.593 ' HH2' HD13 ' A' ' 126' ' ' ILE . 1.6 p-90 -146.88 123.98 11.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -56.1 128.31 34.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 mt -63.06 169.97 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 139' ' ' ILE . 1.1 t70 -75.15 127.67 33.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' ASP . 1.9 m -36.47 -40.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -40.99 63.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.555 HG23 ' CD2' ' A' ' 124' ' ' PHE . 22.2 mm -65.0 -44.37 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 139' ' ' ILE . 16.9 t-160 -37.84 -62.51 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' GLY . 23.8 mt-30 -52.96 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' GLN . . . -34.93 -46.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.622 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -57.95 -49.18 77.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.124 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -58.71 -27.82 65.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 147' ' ' LEU . 7.4 mmpt? -76.37 -49.41 16.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.42 -22.72 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.449 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.456 ' HA ' ' NE2' ' A' ' 150' ' ' GLN . 25.1 mt -85.75 35.42 0.62 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 7.5 ptp -97.1 -36.9 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.489 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 35.3 ttmt -134.31 77.67 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.456 ' NE2' ' HA ' ' A' ' 147' ' ' LEU . 23.8 mm-40 -71.19 172.82 8.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -70.4 161.56 30.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 153' ' ' ALA . 0.4 OUTLIER -43.86 -61.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 152' ' ' LYS . . . -34.08 -48.95 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.151 179.961 . . . . . . . . 0 0 . 1 stop_ save_